PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mandl, KD				Mandl, Kenneth D.			Ebola in the United States EHRs as a Public Health Tool at the Point of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mandl, Kenneth D.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	kenneth_mandl@harvard.edu			NATIONAL LIBRARY OF MEDICINE [G08LM009778, R01LM007677] Funding Source: NIH RePORTER; NLM NIH HHS [G08 LM009778, R01 LM007677, 1G08LM009778] Funding Source: Medline; PHITPO CDC HHS [P01HK000088] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PHITPO CDC HHS		Bever L., 2014, WASHINGTON POST; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Kreda D, 2014, OPEN PLATFORM ARCHIT; Mandl KD, 2012, J AM MED INFORM ASSN, V19, P597, DOI 10.1136/amiajnl-2011-000622; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411; Middleton B, 2013, J AM MED INFORM ASSN, V20, pE2, DOI 10.1136/amiajnl-2012-001458; Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P901; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	8	7	7	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2499	2500		10.1001/jama.2014.15064	http://dx.doi.org/10.1001/jama.2014.15064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25329170	Bronze			2022-12-28	WOS:000346346900009
J	Lee, H; Deignan, JL; Dorrani, N; Strom, SP; Kantarci, S; Quintero-Rivera, F; Das, K; Toy, T; Harry, B; Yourshaw, M; Fox, M; Fogel, BL; Martinez-Agosto, JA; Wong, DA; Chang, VY; Shieh, PB; Palmer, CGS; Dipple, KM; Grody, WW; Vilain, E; Nelson, SF				Lee, Hane; Deignan, Joshua L.; Dorrani, Naghmeh; Strom, Samuel P.; Kantarci, Sibel; Quintero-Rivera, Fabiola; Das, Kingshuk; Toy, Traci; Harry, Bret; Yourshaw, Michael; Fox, Michelle; Fogel, Brent L.; Martinez-Agosto, Julian A.; Wong, Derek A.; Chang, Vivian Y.; Shieh, Perry B.; Palmer, Christina G. S.; Dipple, Katrina M.; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.			Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DE-NOVO MUTATIONS; ACMG RECOMMENDATIONS; INCIDENTAL FINDINGS; VARIANTS; GUIDELINES; STANDARDS; EPILEPSY; RETURN	IMPORTANCE Clinical exome sequencing (CES) is rapidly becoming a common molecular diagnostic test for individuals with rare genetic disorders. OBJECTIVE To report on initial clinical indications for CES referrals and molecular diagnostic rates for different indications and for different test types. DESIGN, SETTING, AND PARTICIPANTS Clinical exome sequencing was performed on 814 consecutive patients with undiagnosed, suspected genetic conditions at the University of California, Los Angeles, Clinical Genomics Center between January 2012 and August 2014. Clinical exome sequencing was conducted as trio-CES (both parents and their affected child sequenced simultaneously) to effectively detect de novo and compound heterozygous variants or as proband-CES (only the affected individual sequenced) when parental samples were not available. MAIN OUTCOMES AND MEASURES Clinical indications for CES requests, molecular diagnostic rates of CES overall and for phenotypic subgroups, and differences in molecular diagnostic rates between trio-CES and proband-CES. RESULTS Of the 814 cases, the overall molecular diagnosis rate was 26%(213 of 814; 95% CI, 23%-29%). The molecular diagnosis rate for trio-CES was 31% (127 of 410 cases; 95% CI, 27%-36%) and 22%(74 of 338 cases; 95% CI, 18%-27%) for proband-CES. In cases of developmental delay in children (< 5 years, n = 138), the molecular diagnosis rate was 41% (45 of 109; 95% CI, 32%-51%) for trio-CES cases and 9% (2 of 23, 95% CI, 1%-28%) for proband-CES cases. The significantly higher diagnostic yield (P value =.002; odds ratio, 7.4 [95% CI, 1.6-33.1]) of trio-CES was due to the identification of de novo and compound heterozygous variants. CONCLUSIONS AND RELEVANCE In this sample of patients with undiagnosed, suspected genetic conditions, trio-CES was associated with higher molecular diagnostic yield than proband-CES or traditional molecular diagnostic methods. Additional studies designed to validate these findings and to explore the effect of this approach on clinical and economic outcomes are warranted.	[Lee, Hane; Deignan, Joshua L.; Strom, Samuel P.; Kantarci, Sibel; Quintero-Rivera, Fabiola; Das, Kingshuk; Toy, Traci; Grody, Wayne W.; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lee, Hane; Deignan, Joshua L.; Dorrani, Naghmeh; Strom, Samuel P.; Kantarci, Sibel; Quintero-Rivera, Fabiola; Das, Kingshuk; Toy, Traci; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Clin Genom Ctr, Los Angeles, CA 90095 USA; [Dorrani, Naghmeh; Yourshaw, Michael; Fox, Michelle; Martinez-Agosto, Julian A.; Wong, Derek A.; Chang, Vivian Y.; Dipple, Katrina M.; Grody, Wayne W.; Vilain, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Harry, Bret] Univ Calif Los Angeles, Inst Digital Res & Educ, Los Angeles, CA 90095 USA; [Fogel, Brent L.; Shieh, Perry B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.; Palmer, Christina G. S.; Dipple, Katrina M.; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Palmer, Christina G. S.; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nelson, SF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Clin Genom Ctr, 695 Charles E Young Dr S,GONDA 5506A, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Nelson, Stanley F/D-4771-2009; Martinez-Agosto, Julian A/I-9435-2019; Yourshaw, Michael/F-9807-2015	Nelson, Stanley F/0000-0002-2082-3114; Martinez-Agosto, Julian A/0000-0001-6776-6949; Yourshaw, Michael/0000-0001-7612-0437; Wong, Derek/0000-0002-7762-2276	National Institutes of Health's National Center for Advancing Translational Science [UCLA CTSI UL1TR000124]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIH-P30-5P30AR057230]; California Institute of Regenerative Medicine [RT2-01985]; K12 Child Health Research Career Development Award [2K12HD034610-16]; Hyundai Hope on Wheels Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD034610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082094] Funding Source: NIH RePORTER	National Institutes of Health's National Center for Advancing Translational Science; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); K12 Child Health Research Career Development Award; Hyundai Hope on Wheels Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Part of the study was supported by the National Institutes of Health's National Center for Advancing Translational Science (UCLA CTSI UL1TR000124) and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-P30-5P30AR057230), the California Institute of Regenerative Medicine (RT2-01985), the K12 Child Health Research Career Development Award (2K12HD034610-16), and the Hyundai Hope on Wheels Scholar Award.	Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; American College of Medical Genetics and Genomics, ACMG UPD REC OPT OUT; Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; GraphPad Software, QUICKCALCS; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Griffin HR, J GENET, DOI [10.1038/gim.2014.66, DOI 10.1038/GIM.2014.66]; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Hutchon D. J. R., CALCULATOR CONFIDENC; Jacob HJ, 2013, NEW ENGL J MED, V369, P1557, DOI 10.1056/NEJMe1310846; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Papenhausen P, 2011, AM J MED GENET A, V155A, P757, DOI 10.1002/ajmg.a.33939; Rehder CW, 2013, GENET MED, V15, P150, DOI 10.1038/gim.2012.169; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Strom SP, 2014, GENET MED, V16, P510, DOI 10.1038/gim.2013.183; Strom SP, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-49; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yourshaw M, BRIEF BIOINFORM, DOI [10.1093/bib/bbu008, DOI 10.1093/BIB/BBU008]; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004	24	627	647	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1880	1887		10.1001/jama.2014.14604	http://dx.doi.org/10.1001/jama.2014.14604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25326637	Bronze, Green Accepted			2022-12-28	WOS:000344532600017
J	Marcus, G; Marblestone, A; Dean, T				Marcus, Gary; Marblestone, Adam; Dean, Thomas			The atoms of neural computation	SCIENCE			English	Editorial Material							PREFRONTAL CORTEX; BRAIN; SYNAPSES; MODEL		[Marcus, Gary] NYU, Dept Psychol, New York, NY 10003 USA; [Marcus, Gary] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Marblestone, Adam] MIT, Media Lab, Cambridge, MA 02139 USA; [Dean, Thomas] Google, Mountain View, CA 94043 USA	New York University; New York University; Massachusetts Institute of Technology (MIT); Google Incorporated	Marcus, G (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	gary.marcus@nyu.edu						Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Gallistel C., 2009, MEMORY COMPUTATIONAL, DOI 10.1002/9781444310498; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hayworth KJ, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00073; Kriete T, 2013, P NATL ACAD SCI USA, V110, P16390, DOI 10.1073/pnas.1303547110; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Marcus G., 2001, ALGEBRAIC MIND INTEG; O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X	15	36	37	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		551	552		10.1126/science.1261661	http://dx.doi.org/10.1126/science.1261661			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359953	Green Submitted			2022-12-28	WOS:000343799700024
J	Ioannidis, JPA; Boyack, KW; Small, H; Sorensen, AA; Klavans, R				Ioannidis, John P. A.; Boyack, Kevin W.; Small, Henry; Sorensen, Aaron A.; Klavans, Richard			Bibliometrics: Is your most cited work your best?	NATURE			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Boyack, Kevin W.] SciTech Strategies, Albuquerque, NM USA; [Small, Henry] SciTech Strategies, Bala Cynwyd, PA USA; [Sorensen, Aaron A.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Klavans, Richard] SciTech Strategies, Berwyn, PA USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ioannidis, JPA (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.		Sorensen, Aaron/AAB-2703-2019; Ioannidis, John P. A./G-9836-2011	Sorensen, Aaron/0000-0001-9147-4380; Boyack, Kevin/0000-0001-7814-8951				ASTIN HS, 1991, OUTER CIRCLE WOMEN S, P57; Boyack KW, 2013, EUR J CLIN INVEST, V43, P1339, DOI 10.1111/eci.12171; COZZENS SE, 1988, KNOWLEDGE, V9, P511, DOI 10.1177/0164025988009004004; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V312, P483, DOI 10.1001/jama.2014.6932; Small H, 2004, SCIENTOMETRICS, V60, P305, DOI 10.1023/B:SCIE.0000034376.55800.18; SMALL HG, 1978, SOC STUD SCI, V8, P327, DOI 10.1177/030631277800800305; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; VIRGO JA, 1977, LIBR QUART, V47, P415	8	70	76	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					561	562		10.1038/514561a	http://dx.doi.org/10.1038/514561a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25355346	Bronze			2022-12-28	WOS:000343801500024
J	Muller, J; Muller, CW				Mueller, Juerg; Mueller, Christoph W.			STRUCTURAL BIOLOGY Enzyme-chromatin complex visualized	NATURE			English	Editorial Material							UBIQUITIN LIGASE COMPLEX; POLYCOMB; NUCLEOSOME; PROTEINS		[Mueller, Juerg] Max Planck Inst Biochem, Lab Chromatin Biol, D-82152 Martinsried, Germany; [Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Muller, J (corresponding author), Max Planck Inst Biochem, Lab Chromatin Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	muellerj@biochem.mpg.de; cmueller@embl.de	Müller, Jürg/ABB-3007-2020; Müller, Christoph W/I-7420-2012	Müller, Jürg/0000-0003-2391-4641; Müller, Christoph W/0000-0003-2176-8337				Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	11	2	2	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					572	573		10.1038/514572a	http://dx.doi.org/10.1038/514572a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355356				2022-12-28	WOS:000343801500034
J	Cohen, PA; Maller, G; DeSouza, R; Neal-Kababick, J				Cohen, Pieter A.; Maller, Gregory; DeSouza, Renan; Neal-Kababick, James			Presence of Banned Drugs in Dietary Supplements Following FDA Recalls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Cohen, Pieter A.] Harvard Univ, Sch Med, Boston, MA USA; [Maller, Gregory; DeSouza, Renan] Cornell Univ, Ithaca, NY USA; [Neal-Kababick, James] Flora Res Labs, Grants Pass, OR USA	Harvard University; Harvard Medical School; Cornell University	Cohen, PA (corresponding author), 236 Highland Ave, Somerville, MA 02143 USA.	pcohen@challiance.org						[Anonymous], TAINT SUPPL CDER; Cohen PA, 2012, J GEN INTERN MED, V27, P51, DOI 10.1007/s11606-011-1828-0; Harel Z, 2013, JAMA INTERN MED, V173, P926, DOI 10.1001/jamainternmed.2013.379; Mans DJ, 2013, J PHARMACEUT BIOMED, V83, P122, DOI 10.1016/j.jpba.2013.02.031; US Food and Drug Administration, REC HLTH FRAUD; US Food and Drug Administration, SAF REC MARK WITHDR	6	66	66	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1691	1693		10.1001/jama.2014.10308	http://dx.doi.org/10.1001/jama.2014.10308			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335153	Green Published			2022-12-28	WOS:000343301400028
J	Kalokairinou, L; Howard, HC; Borry, P				Kalokairinou, Louiza; Howard, Heidi Carmen; Borry, Pascal			Changes on the horizon for consumer genomics in the EU	SCIENCE			English	Editorial Material									[Kalokairinou, Louiza; Borry, Pascal] Univ Leuven, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium; [Howard, Heidi Carmen] Uppsala Univ, Ctr Res Eth & Bioeth, SE-75122 Uppsala, Sweden	KU Leuven; Uppsala University	Kalokairinou, L (corresponding author), Univ Leuven, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium.	pascal.borry@med.kuleuven.be	; Borry, Pascal/B-5836-2012	Kalokairinou, Louiza/0000-0002-5787-6535; Borry, Pascal/0000-0002-4931-9560				Brice P., 2013, EU LEGAL AMENDMENTS; Council of Europe, 2008, ADD PROT CONV HUM RI; Global Harmonization Task Force, 2008, PRINC IN VITR DIAGN; Howard HC, 2012, J COMMUN GENET, V3, P105, DOI 10.1007/s12687-011-0062-0; Locke S., 2014, FDA WONT LET 23 ME T	5	8	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					296	298		10.1126/science.1256396	http://dx.doi.org/10.1126/science.1256396			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ7ZY	25324369				2022-12-28	WOS:000343041100015
J	Lewis, B				Lewis, Barbara			ESSAY Joan's family bill of rights: an essay by Barbara Lewis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Joans Family Bill Rights, Los Angeles, CA 90077 USA		Lewis, B (corresponding author), Joans Family Bill Rights, 2934 Beverly Glen Circle,Suite 240, Los Angeles, CA 90077 USA.	BarbaraLewis@JoansFamilyBillOfRights.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6022	10.1136/bmj.g6022	http://dx.doi.org/10.1136/bmj.g6022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25353644				2022-12-28	WOS:000343767700002
J	Heymann, DL				Heymann, David L.			Ebola: learn from the past	NATURE			English	Editorial Material							HEMORRHAGIC-FEVER		[Heymann, David L.] London Sch Hyg & Trop Med, London, England; [Heymann, David L.] Chatham House, Ctr Global Hlth Secur, London, England	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), London Sch Hyg & Trop Med, London, England.	david.heymann@lshtm.ac.uk						Breman J. G., 1977, EBOLA VIRUS HAEMORRH, P86; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298	5	17	17	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					299	300		10.1038/514299a	http://dx.doi.org/10.1038/514299a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318509	Bronze			2022-12-28	WOS:000342988600028
J	Neuman, MD; Wirtalla, C; Werner, RM				Neuman, Mark D.; Wirtalla, Christopher; Werner, Rachel M.			Association Between Skilled Nursing Facility Quality Indicators and Hospital Readmissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POST-ACUTE CARE; OF-CARE; RACIAL DISPARITIES; MEDICAID PAYMENT; HOME QUALITY; FOR-PROFIT; REHOSPITALIZATION; RESIDENTS; COST	IMPORTANCE Hospital readmissions are common, costly, and potentially preventable. Little is known about the association between available skilled nursing facility (SNF) performance measures and the risk of hospital readmission. OBJECTIVE To measure the association between SNF performance measures and hospital readmissions among Medicare beneficiaries receiving postacute care at SNFs in the United States. DESIGN AND PARTICIPANTS Using national Medicare data on fee-for-service Medicare beneficiaries discharged to a SNF after an acute care hospitalization between September 1, 2009, and August 31, 2010, we examined the association between SNF performance on publicly available metrics (SNF staffing intensity, health deficiencies identified through site inspections, and the percentages of SNF patients with delirium, moderate to severe pain, and new or worsening pressure ulcers) and the risk of readmission or death 30 days after discharge to a SNF. Adjusted analyses controlled for patient case mix, SNF facility factors, and the discharging hospital. MAIN OUTCOMES AND MEASURES Readmission to an acute care hospital or death within 30 days of the index hospital discharge. RESULTS Of 1 530 824 patients discharged, 357 752 (23.3%; 99% CI, 23.3%-23.5%) were readmitted or died within 30 days; 72 472 died within 30 days (4.7%; 99% CI, 4.7%-4.8%), and 321 709 were readmitted (21.0%; 99% CI, 20.9%-21.1%). The unadjusted risk of readmission or death was lower at SNFs with better staffing ratings and better facility inspection ratings. [GRAPHICS] Adjustment for patient factors, SNF facility factors, and the discharging hospital attenuated these associations; we observed small differences in the adjusted risk of readmission or death according to SNF facility inspection ratings. Other measures did not predict clinically meaningful differences in the adjusted risk of readmission or death. CONCLUSIONS AND RELEVANCE Among fee-for-service Medicare beneficiaries discharged to a SNF after an acute care hospitalization, available performance measures were not consistently associated with differences in the adjusted risk of readmission or death. Copyright 2014 American Medical Association. All rights reserved.	[Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Werner, Rachel M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Wirtalla, Christopher; Werner, Rachel M.] Univ Penn, Div Gen Internal Med, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Neuman, MD (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, 423 Guardian Dr,1119A Blockley Hall, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221	National Institute on Aging [K08AG043548, R01 AG034182]; NATIONAL INSTITUTE ON AGING [K08AG043548, R01AG034182] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging (grant K08AG043548 to Dr Neuman; grant R01 AG034182 to Dr Werner).	Ackerly DC, 2014, NEW ENGL J MED, V370, P689, DOI 10.1056/NEJMp1315350; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Bostick JE, 2006, J AM MED DIR ASSOC, V7, P366, DOI 10.1016/j.jamda.2006.01.024; Centers for Medicare and Medicaid Services, 2012, DES NURS HOM COMP 5; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Diehr P, 2005, J CLIN EPIDEMIOL, V58, P1115, DOI 10.1016/j.jclinepi.2005.05.002; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Grabowski DC, 2004, HEALTH SERV RES, V39, P793, DOI 10.1111/j.1475-6773.2004.00258.x; Grabowski DC, 2004, HEALTH AFFAIR, V23, P243, DOI 10.1377/hlthaff.23.5.243; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2004, J HEALTH POLIT POLIC, V29, P43, DOI 10.1215/03616878-29-1-43; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Harrington C, 2012, HEALTH SERV RES, V47, P106, DOI 10.1111/j.1475-6773.2011.01311.x; Hillmer MP, 2005, MED CARE RES REV, V62, P139, DOI 10.1177/1077558704273769; Horwitz LI, 2013, MEASURE UPDATES SPEC; Hughes CM, 2000, MED CARE, V38, P1164, DOI 10.1097/00005650-200012000-00003; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kim H, 2009, GERONTOLOGIST, V49, P81, DOI 10.1093/geront/gnp014; Kim H, 2009, J GERONTOL B-PSYCHOL, V64, P269, DOI 10.1093/geronb/gbn019; Li Y, 2011, AM J PUBLIC HEALTH, V101, P875, DOI 10.2105/AJPH.2010.300055; Mechanic R, 2014, NEW ENGL J MED, V370, P692, DOI 10.1056/NEJMp1315607; Mechanic RE, 2011, NEW ENGL J MED, V365, P777, DOI 10.1056/NEJMp1105963; Mor V, 2004, MILBANK Q, V82, P227, DOI 10.1111/j.0887-378X.2004.00309.x; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Morris JN., 2003, VALIDATION LONG TERM; Ouslander JG, 2011, NEW ENGL J MED, V365, P1165, DOI 10.1056/NEJMp1105449; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Rantz MJ, 2004, GERONTOLOGIST, V44, P24, DOI 10.1093/geront/44.1.24; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Saliba D, 2005, DESIGN VALIDATION PO; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Unroe KT, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.04.020; US Department of Health and Human Services; Office of the Inspector General, 2013, MED NURS HOM RES HOS	36	99	99	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1542	1551		10.1001/jama.2014.13513	http://dx.doi.org/10.1001/jama.2014.13513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7HL	25321909	Green Accepted			2022-12-28	WOS:000342983200018
J	Tseng, CY; Su, SC; Chiu, NC; Lin, CY				Tseng, Cheng-Yin; Su, Shey-Chiang; Chiu, Nan-Chang; Lin, Chien-Yu			Disseminated papular lesions in an HIV infected patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PENICILLIUM-MARNEFFEI INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; THAILAND		[Tseng, Cheng-Yin; Su, Shey-Chiang; Lin, Chien-Yu] Hsinchu Mackay Mem Hosp, Dept Infect Dis, Hsinchu 30071, Taiwan; [Chiu, Nan-Chang] Mackay Mem Hosp, Dept Infect Dis, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital	Lin, CY (corresponding author), Hsinchu Mackay Mem Hosp, Dept Pediat & Infect Dis, Hsinchu 30071, Taiwan.	mmhped.lin@gmail.com						Al-Abdely HM, 2004, CURR OPIN INFECT DIS, V17, P527, DOI 10.1097/00001432-200412000-00004; Beiser C, 1997, BRIT MED J, V314, P579, DOI 10.1136/bmj.314.7080.579; Chariyalertsak S, 2001, CLIN INFECT DIS, V32, P955, DOI 10.1086/319348; Hsueh PR, 2000, J INFECT DIS, V181, P1706, DOI 10.1086/315432; Hu YX, 2013, MYCOPATHOLOGIA, V175, P57, DOI 10.1007/s11046-012-9577-0; IMWIDTHAYA P, 1994, MYCOPATHOLOGIA, V127, P135, DOI 10.1007/BF01102912; Kaplan JE, 2009, MMWR RECOMM REP, V58, pCE1; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kawila R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-464; Lee Nelson, 2008, Hong Kong Med J, V14, P88; Lee PPW, 2012, CLIN INFECT DIS, V54, pe8, DOI 10.1093/cid/cir754; Liu DH, 2013, J INFECT CHEMOTHER, V19, P776, DOI 10.1007/s10156-012-0511-7; SEGRETAIN G, 1959, Mycopathol Mycol Appl, V11, P327, DOI 10.1007/BF02089507; Sirisanthana T, 1998, CLIN INFECT DIS, V26, P1107, DOI 10.1086/520280; Sun HY, 2006, CLIN MICROBIOL INFEC, V12, P381, DOI 10.1111/j.1469-0691.2006.01367.x; Thuy L, 2011, CLIN INFECT DIS, V52, P945, DOI 10.1093/cid/cir028; Tsunemi Y, 2003, J AM ACAD DERMATOL, V49, P344, DOI 10.1067/S0190-9622(03)00486-9; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Wheat LJ, 2006, TRANSPL INFECT DIS, V8, P128, DOI 10.1111/j.1399-3062.2006.00165.x; Wong SL, 2011, PUBLIC MANAG REV, V13, P595, DOI 10.4061/2011/764293	20	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2014	349								g6110	10.1136/bmj.g6110	http://dx.doi.org/10.1136/bmj.g6110			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NR	25313166				2022-12-28	WOS:000343767100003
J	Ijspeert, AJ				Ijspeert, Auke J.			Biorobotics: Using robots to emulate and investigate agile locomotion	SCIENCE			English	Review							LEGGED LOCOMOTION; GENERATING ELECTRICITY; DYNAMIC WALKING; FISH; MODELS; HYDRODYNAMICS; PERFORMANCE; DESIGN; FLIGHT; MOBILE	The graceful and agile movements of animals are difficult to analyze and emulate because locomotion is the result of a complex interplay of many components: the central and peripheral nervous systems, the musculoskeletal system, and the environment. The goals of biorobotics are to take inspiration from biological principles to design robots that match the agility of animals, and to use robots as scientific tools to investigate animal adaptive behavior. Used as physical models, biorobots contribute to hypothesis testing in fields such as hydrodynamics, biomechanics, neuroscience, and prosthetics. Their use may contribute to the design of prosthetic devices that more closely take human locomotion principles into account.	Ecole Polytech Fed Lausanne, Biorobot Lab, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Ijspeert, AJ (corresponding author), Ecole Polytech Fed Lausanne, Biorobot Lab, CH-1015 Lausanne, Switzerland.	auke.ijspeert@epfl.ch		Ijspeert, Auke/0000-0003-1417-9980	Swiss National Center of Competence in Research in Robotics; Swiss National Science Foundation; Swiss NanoTera program; EU [FP7-ICT 611832, FP7-ICT 661626]	Swiss National Center of Competence in Research in Robotics(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss NanoTera program; EU(European Commission)	I thank M. Ajallooeian, J. Buchli, P. Eckert, N. van der Noot, and D. Renjewski for useful comments on the manuscript. Supported by the Swiss National Center of Competence in Research in Robotics, the Swiss National Science Foundation, the Swiss NanoTera program, the EU-funded WalkMan project (FP7-ICT 611832), and the EU-funded Symbitron project (FP7-ICT 661626).	Akhtar I, 2007, THEOR COMP FLUID DYN, V21, P155, DOI 10.1007/s00162-007-0045-2; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Ananthanarayanan A, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046005; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Anderson JM, 2002, INTEGR COMP BIOL, V42, P118, DOI 10.1093/icb/42.1.118; [Anonymous], 2007, BODY SHAPES WAY WE T; Autumn K, 2006, J EXP BIOL, V209, P260, DOI 10.1242/jeb.01980; Beal DN, 2006, J FLUID MECH, V549, P385, DOI 10.1017/S0022112005007925; Bhounsule PA, 2014, INT J ROBOT RES, V33, P1305, DOI 10.1177/0278364914527485; BLICKHAN R, 1993, J COMP PHYSIOL A, V173, P509; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Carlo M., 2006, J BIONIC ENGIN, V3, P115, DOI DOI 10.1016/S1672-6529(06)60015-2; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Collins SH, 2001, INT J ROBOT RES, V20, P607, DOI 10.1177/02783640122067561; Crespi A, 2013, IEEE T ROBOT, V29, P308, DOI 10.1109/TRO.2012.2234311; CRUSE H, 1990, TRENDS NEUROSCI, V13, P15, DOI 10.1016/0166-2236(90)90057-H; Delaurier, 1999, CANADIAN AERONAUTICS, V45, P72; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Elzinga MJ, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025001; Faraji S., 2014, P ROB SCI SYST; Feron E., 2008, AERIAL ROBOTICS, P1009; Ferris DP, 2007, INT J HUM ROBOT, V4, P507, DOI 10.1142/S0219843607001138; Fish FE, 2006, BIOINSPIR BIOMIM, V1, pR17, DOI 10.1088/1748-3182/1/2/R01; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Full RJ, 1999, J EXP BIOL, V202, P3325; Gancet J., 2012, 4 IEEE RAS EMBS INT, P1794; Georgiades C., 2004, INT ROB SYST 2004 IR, V4, P3525; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Hines L, 2014, IEEE T ROBOT, V30, P220, DOI 10.1109/TRO.2013.2280057; Hirzinger G, 2001, IEEE INT CONF ROBOT, P3356, DOI 10.1109/ROBOT.2001.933136; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Hutter M., 2012, 15 INT C CLIM WALK R; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Kajita S., 2008, HDB ROBOTICS, P361; Kato N, 2000, IEEE J OCEANIC ENG, V25, P121, DOI 10.1109/48.820744; Kawamoto H, 2003, IEEE SYS MAN CYBERN, P1648; Kim S, 2008, IEEE T ROBOT, V24, P65, DOI 10.1109/TRO.2007.909786; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; Kimura H, 2007, INT J ROBOT RES, V26, P475, DOI 10.1177/0278364907078089; Klaassen B, 2002, ROBOT AUTON SYST, V41, P69, DOI 10.1016/S0921-8890(02)00258-0; Kubow TM, 1999, PHILOS T ROY SOC B, V354, P849, DOI 10.1098/rstb.1999.0437; Kulfan B. M., 2011, BIOMIMETICS NATURE B, P525; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Lauder GV, 2007, J EXP BIOL, V210, P2767, DOI 10.1242/jeb.000265; Leftwich MC, 2012, J EXP BIOL, V215, P416, DOI 10.1242/jeb.061440; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2012, J EXP BIOL, V215, P3293, DOI 10.1242/jeb.061937; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Liu JD, 2010, J BIONIC ENG, V7, P35, DOI 10.1016/S1672-6529(09)60184-0; Lock RJ, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/1/011001; Long JH, 2007, P I MECH ENG C-J MEC, V221, P1193, DOI 10.1243/09544062JMES511; Lynch GA, 2012, INT J ROBOT RES, V31, P974, DOI 10.1177/0278364912442096; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Maladen RD, 2011, J R SOC INTERFACE, V8, P1332, DOI 10.1098/rsif.2010.0678; Maladen RD, 2009, SCIENCE, V325, P314, DOI 10.1126/science.1172490; Manoonpong P, 2007, PLOS COMPUT BIOL, V3, P1305, DOI 10.1371/journal.pcbi.0030134; Markowitz J, 2011, PHILOS T R SOC B, V366, P1621, DOI 10.1098/rstb.2010.0347; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Mittal R, 2006, BIOINSPIR BIOMIM, V1, pS35, DOI 10.1088/1748-3182/1/4/S05; Owaki D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0669; Owen T., 1993, BIOL INSPIRED ROBOTS, V12, P282, DOI 10.1017/S0263574700017264; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Porez M, 2014, INT J ROBOT RES, V33, P1322, DOI 10.1177/0278364914525811; Pratt JE, 2004, IEEE INT CONF ROBOT, P2430, DOI 10.1109/ROBOT.2004.1307425; Renjewski D, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036005; Righetti L, 2011, IEEE INT CONF ROBOT, P1085, DOI 10.1109/ICRA.2011.5980156; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Rudman KE, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-12; Saranli U, 2001, INT J ROBOT RES, V20, P616, DOI 10.1177/02783640122067570; Schroer RT, 2004, IEEE INT CONF ROBOT, P3288, DOI 10.1109/ROBOT.2004.1308761; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Semini C, 2011, P I MECH ENG I-J SYS, V225, P831, DOI 10.1177/0959651811402275; Semini C., 2013, INT S ROB RES ISRR; Sentis L., 2005, INT J HUM ROBOT, V2, P505, DOI [DOI 10.1142/S0219843605000594, 10.1142/S0219843605000594]; Seok S, 2013, IEEE INT CONF ROBOT, P3307, DOI 10.1109/ICRA.2013.6631038; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Sitti M, 2013, IEEE-ASME T MECH, V18, P409, DOI 10.1109/TMECH.2012.2233492; Spenko MJ, 2008, J FIELD ROBOT, V25, P223, DOI 10.1002/rob.20238; Sprowitz A, 2013, INT J ROBOT RES, V32, P932, DOI 10.1177/0278364913489205; Stefanini C, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025001; Tesch M, 2009, ADV ROBOTICS, V23, P1131, DOI 10.1163/156855309X452566; Tolley MT, 2014, SOFT ROBOT, V1, P213, DOI 10.1089/soro.2014.0008; TRIANTAFYLLOU MS, 1995, SCI AM, V272, P64, DOI 10.1038/scientificamerican0395-64; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Tsagarakis NG, 2013, IEEE INT CONF ROBOT, P673, DOI 10.1109/ICRA.2013.6630645; Unver O, 2006, IEEE INT CONF ROBOT, P2329, DOI 10.1109/ROBOT.2006.1642050; van den Bogert AJ, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-17; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; Vanderborght B, 2013, ROBOT AUTON SYST, V61, P1601, DOI 10.1016/j.robot.2013.06.009; Verrelst B, 2005, AUTON ROBOT, V18, P201, DOI 10.1007/s10514-005-0726-x; Walsh CJ, 2007, INT J HUM ROBOT, V4, P487, DOI 10.1142/S0219843607001126; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; Wood RJ, 2008, IEEE T ROBOT, V24, P341, DOI 10.1109/TRO.2008.916997; Zhou XD, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/041001; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	105	253	257	42	465	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					196	203		10.1126/science.1254486	http://dx.doi.org/10.1126/science.1254486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301621	Green Submitted			2022-12-28	WOS:000342721500040
J	Marvi, H; Gong, CH; Gravish, N; Astley, H; Travers, M; Hatton, RL; Mendelson, JR; Choset, H; Hu, DL; Goldman, DI				Marvi, Hamidreza; Gong, Chaohui; Gravish, Nick; Astley, Henry; Travers, Matthew; Hatton, Ross L.; Mendelson, Joseph R., III; Choset, Howie; Hu, David L.; Goldman, Daniel I.			Sidewinding with minimal slip: Snake and robot ascent of sandy slopes	SCIENCE			English	Article							LEGGED LOCOMOTION; FLIGHT; MECHANICS; MODELS	Limbless organisms such as snakes can navigate nearly all terrain. In particular, desert-dwelling sidewinder rattlesnakes (Crotalus cerastes) operate effectively on inclined granular media (such as sand dunes) that induce failure in field-tested limbless robots through slipping and pitching. Our laboratory experiments reveal that as granular incline angle increases, sidewinder rattlesnakes increase the length of their body in contact with the sand. Implementing this strategy in a physical robot model of the snake enables the device to ascend sandy slopes close to the angle of maximum slope stability. Plate drag experiments demonstrate that granular yield stresses decrease with increasing incline angle. Together, these three approaches demonstrate how sidewinding with contact-length control mitigates failure on granular media.	[Marvi, Hamidreza; Hu, David L.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA; [Marvi, Hamidreza; Gravish, Nick; Astley, Henry; Hu, David L.; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Gong, Chaohui; Travers, Matthew; Choset, Howie] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Hatton, Ross L.] Oregon State Univ, Sch Mech Ind & Mfg Engn, Corvallis, OR 97331 USA; [Mendelson, Joseph R., III; Hu, David L.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Mendelson, Joseph R., III] Zoo Atlanta, Dept Herpetol, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Carnegie Mellon University; Oregon State University; University System of Georgia; Georgia Institute of Technology	Goldman, DI (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu		Gravish, Nicholas/0000-0002-9391-2476	National Science Foundation (NSF) [CMMI-1000389, PHY-0848894, PHY-1205878, PHY-1150760]; Army Research Office [W911NF-11-1-0514, W911NF1310092]; Army Research Lab Micro Autonomous Systems and Technology Collaborative Technology Alliance [W911NF-08-2-0004]; Elizabeth Smithgall Watts endowment; Division Of Physics [1205878] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1426443] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Army Research Office; Army Research Lab Micro Autonomous Systems and Technology Collaborative Technology Alliance; Elizabeth Smithgall Watts endowment; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank M. Tesch, E. Cappo, J. Rembisz, and L. Li from Robotics Institute at Carnegie Mellon University for helping with the robot experiments; J. Brock, D. Brothers, R. Hill, L. Wyrwich, and B. Lock from Zoo Atlanta for helping with snake experiments; A. Young and K. Young for assistance with collecting snakes; D. Dimenichi, R. Chrystal, and J. Shieh from Georgia Institute of Technology for helping with construction and video analysis; T. Nowak and C. Hobbs for photography; V. Linevich for CAD drawings; P. Umbanhowar and A. Zangwill for helpful discussion; the National Science Foundation (NSF) (CMMI-1000389, PHY-0848894, PHY-1205878, and PHY-1150760); Army Research Office under grants W911NF-11-1-0514 and W911NF1310092; the Army Research Lab Micro Autonomous Systems and Technology Collaborative Technology Alliance under grant W911NF-08-2-0004; and the Elizabeth Smithgall Watts endowment, for financial support. D. I. G., H. C., and D. H. also acknowledge the Army Research Office and NSF Physics of Living Systems for supporting the Locomotion Systems Science Workshop in Arlington, Virginia, May 2012. The data collected for this study will be made available through the SMARTech data repository at Georgia Institute of Technology.	Albert R, 1999, PHYS REV LETT, V82, P205, DOI 10.1103/PhysRevLett.82.205; Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011; BURDICK JW, 1995, ADV ROBOTICS, V9, P195, DOI 10.1163/156855395X00166; Byrnes G, 2010, J EXP BIOL, V213, P4249, DOI 10.1242/jeb.047225; Clark JE, 2001, IEEE INT CONF ROBOT, P3643, DOI 10.1109/ROBOT.2001.933183; Costantino DJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011305; Costello M, 2008, P I MECH ENG G-J AER, V222, P1067, DOI 10.1243/09544100JAERO304; GRAY J, 1946, J EXP BIOL, V23, P101; Hatton RL, 2010, IEEE INT CONF ROBOT, P691, DOI 10.1109/ROBOT.2010.5509875; Henann DL, 2013, P NATL ACAD SCI USA, V110, P6730, DOI 10.1073/pnas.1219153110; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Hu DL, 2009, P NATL ACAD SCI USA, V106, P10081, DOI 10.1073/pnas.0812533106; JAYNE BC, 1985, COPEIA, P195, DOI 10.2307/1444809; JAYNE BC, 1988, J EXP BIOL, V140, P1; JAYNE BC, 1986, COPEIA, P915, DOI 10.2307/1445288; Katsuragi H, 2007, NAT PHYS, V3, P420, DOI 10.1038/nphys583; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Maladen RD, 2009, SCIENCE, V325, P314, DOI 10.1126/science.1172490; Marvi H, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0188; Marvi H, 2012, J R SOC INTERFACE, V9, P3067, DOI 10.1098/rsif.2012.0132; Mazouchova N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026007; Mazouchova N, 2010, BIOL LETTERS, V6, P398, DOI 10.1098/rsbl.2009.1041; Mosauer W, 1930, AM NAT, V64, P179, DOI 10.1086/280308; NORRIS KS, 1966, COPEIA, P650; Playter R., 2006, P SOC PHOTO-OPT INS, V6230; SECOR SM, 1992, J EXP BIOL, V163, P1; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Socha JJ, 2002, NATURE, V418, P603, DOI 10.1038/418603a; Tesch M, 2009, ADV ROBOTICS, V23, P1131, DOI 10.1163/156855309X452566; Winter AG, 2012, J EXP BIOL, V215, P2072, DOI 10.1242/jeb.058172	32	148	152	13	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					224	229		10.1126/science.1255718	http://dx.doi.org/10.1126/science.1255718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301625	Green Submitted			2022-12-28	WOS:000342721500045
J	Socha, JJ				Socha, John J.			Of snakes and robots	SCIENCE			English	Editorial Material							LOCOMOTION		Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Socha, JJ (corresponding author), Virginia Tech, Biomed Engn & Mech, 495 Old Turner St, Blacksburg, VA 24061 USA.	jjsocha@vt.edu						Enner F., ROB AUT ICRA 2013 IE, P5168; Full RJ, 1999, J EXP BIOL, V202, P3325; Gans C., 1972, TOXINS ANIMAL PLANT, V1, P17; GRAY J, 1946, J EXP BIOL, V23, P101; Greene H. W., 1997, SNAKES EVOLUTION MYS; Hatton R. L., ROB AUT ICRA 2010 IE, P691; JAYNE BC, 1986, COPEIA, P915, DOI 10.2307/1445288; Lillywhite H.B., 2014, SNAKES WORK STRUCTUR; Marvi H, 2014, SCIENCE, V346, P224, DOI 10.1126/science.1255718; Mosauer W, 1930, AM NAT, V64, P179, DOI 10.1086/280308; Nedderman RM, 2005, STATICS KINEMATICS G; Rivera ARV, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0471; SECOR SM, 1992, J EXP BIOL, V163, P1; Winter GAG, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036009	14	2	2	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					160	161		10.1126/science.1259970	http://dx.doi.org/10.1126/science.1259970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301600				2022-12-28	WOS:000342721500017
J	Odorizzi, G				Odorizzi, Greg			ESCRTs Take on a Job in Surveillance	CELL			English	Editorial Material							MACHINERY	Nuclear pore assembly can go awry, but how the cell handles defective intermediates has been an ongoing question. In this issue, Lusk and colleagues describe a surveillance pathway during nuclear pore assembly and, in doing so, identify a new role for proteins that function at the endosome and plasma membrane.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Odorizzi, G (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	odorizzi@colorado.edu		Odorizzi, Greg/0000-0002-1143-1098				Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fernandez-Martinez J, 2009, CURR OPIN CELL BIOL, V21, P603, DOI 10.1016/j.ceb.2009.05.001; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Webster BM, 2014, CELL, V159, P388, DOI 10.1016/j.cell.2014.09.012	8	0	1	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					240	241		10.1016/j.cell.2014.09.046	http://dx.doi.org/10.1016/j.cell.2014.09.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303522	Bronze			2022-12-28	WOS:000343095600007
J	Rasmussen, SA; Jamieson, DJ				Rasmussen, Sonja A.; Jamieson, Denise J.			2009 H1N1 Influenza and Pregnancy-5 Years Later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rasmussen, Sonja A.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Rasmussen, Sonja/0000-0002-0574-4928; Jamieson, Denise/0000-0003-2597-1201				Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Rasmussen SA, 2012, CLIN OBSTET GYNECOL, V55, P487, DOI 10.1097/GRF.0b013e31824df23e; Uyeki TM, 2014, NEW ENGL J MED, V370, P789, DOI 10.1056/NEJMp1400034; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wollenhaupt M, 2014, PHARMACOEPIDEMIOL DR	5	20	20	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1373	1375		10.1056/NEJMp1403496	http://dx.doi.org/10.1056/NEJMp1403496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295498				2022-12-28	WOS:000342674800004
J	Malani, PN; Prager, RL				Malani, Preeti N.; Prager, Richard L.			Journey in Thick Wood: Childhood Henry Norman Bethune	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Malani, Preeti N.] Univ Michigan Hlth Syst, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Prager, Richard L.] Univ Michigan Hlth Syst, Dept Cardiac Surg, Frankel Cardiovasc Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Malani, PN (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA.	pmalani@umich.edu						Bethune N., 1932, FLUOROSCOPE, V1; GIBSON WC, 1979, JAMA-J AM MED ASSOC, V242, P2091, DOI 10.1001/jama.242.19.2091; JUDGE JK, 1987, J LAB CLIN MED, V110, P125; Link EP., 1991, TBS PROGR NORMAN BET	4	1	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1380	1382		10.1001/jama.2014.13198	http://dx.doi.org/10.1001/jama.2014.13198			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291562				2022-12-28	WOS:000342630200001
J	Sedgwick, P				Sedgwick, Philip			Understanding confidence intervals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Deneux-Tharaux C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1541; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8010	3	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2014	349								g6051	10.1136/bmj.g6051	http://dx.doi.org/10.1136/bmj.g6051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LN	25293946				2022-12-28	WOS:000342998700003
J	Carel, H; Gyorffy, G				Carel, Havi; Gyoerffy, Gita			The art of medicine Seen but not heard: children and epistemic injustice	LANCET			English	Editorial Material									[Carel, Havi] Univ Bristol, Dept Philosophy, Bristol, Avon, England; [Gyoerffy, Gita] Taunton NHS Fdn Trust, Musgrove Pk Hosp, Taunton, Somerset, England	University of Bristol; Musgrove Park Hospital	Carel, H (corresponding author), Univ Bristol, Dept Philosophy, Bristol, Avon, England.	havi.carel@bristol.ac.uk		Carel, Havi/0000-0002-1260-2362					0	38	37	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1256	1257		10.1016/S0140-6736(14)61759-1	http://dx.doi.org/10.1016/S0140-6736(14)61759-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AQ7NB	25289422				2022-12-28	WOS:000343003400017
J	Gao, GF; Feng, Y				Gao, George F.; Feng, Yong			On the ground in Sierra Leone	SCIENCE			English	Editorial Material									[Gao, George F.] Chinese Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Feng, Yong] Chinas Natl Hlth & Family Planning Commiss, Int Cooperat Dept, Div African Affairs, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent, Shanghai, Peoples R China.		Gao, George Fu/ABD-5229-2021						0	18	23	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		666	666		10.1126/science.346.6209.666	http://dx.doi.org/10.1126/science.346.6209.666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359978				2022-12-28	WOS:000343799700055
J	Gneezy, U; Keenan, EA; Gneezy, A				Gneezy, Uri; Keenan, Elizabeth A.; Gneezy, Ayelet			Avoiding overhead aversion in charity	SCIENCE			English	Article							FIELD EXPERIMENT; WARM-GLOW; INCENTIVES; DONATIONS; BEHAVIOR; PHILANTHROPY; SUBSIDIES; IDENTITY; IMPACT; MATTER	Donors tend to avoid charities that dedicate a high percentage of expenses to administrative and fundraising costs, limiting the ability of nonprofits to be effective. We propose a solution to this problem: Use donations from major philanthropists to cover overhead expenses and offer potential donors an overhead-free donation opportunity. A laboratory experiment testing this solution confirms that donations decrease when overhead increases, but only when donors pay for overhead themselves. In a field experiment with 40,000 potential donors, we compared the overhead-free solution with other common uses of initial donations. Consistent with prior research, informing donors that seed money has already been raised increases donations, as does a $ 1:$ 1 matching campaign. Our main result, however, clearly shows that informing potential donors that overhead costs are covered by an initial donation significantly increases the donation rate by 80% (or 94%) and total donations by 75% (or 89%) compared with the seed (or matching) approach.	[Gneezy, Uri; Keenan, Elizabeth A.; Gneezy, Ayelet] Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA; [Gneezy, Uri] Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making CREED, NL-1018 WB Amsterdam, Netherlands	University of California System; University of California San Diego; University of Amsterdam	Gneezy, U (corresponding author), Univ Calif San Diego, Rady Sch Management, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ugneezy@ucsd.edu		Keenan, Elizabeth/0000-0003-2111-3656	John Templeton Foundation through the Science of Philanthropy Initiative	John Templeton Foundation through the Science of Philanthropy Initiative	Funding was provided by the John Templeton Foundation through the Science of Philanthropy Initiative. The data reported in this paper are archived in the Harvard Dataverse Network at http://dx.doi.org/10.7910/DVN/27366. We thank the reviewers for valuable comments that helped to improve the manuscript.	Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Andreoni J, 1998, J POLIT ECON, V106, P1186, DOI 10.1086/250044; Ariely D, 2009, AM ECON REV, V99, P544, DOI 10.1257/aer.99.1.544; Baron J., 2011, SCI GIVING EXPT APPR; Barrett W, 2011, FORBES; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bowman W, 2006, NONPROF VOLUNT SEC Q, V35, P288, DOI 10.1177/0899764006287219; Caviola L, 2014, JUDGM DECIS MAK, V9, P303; Croson R, 2008, EXP ECON, V11, P221, DOI 10.1007/s10683-007-9191-z; Cryder CE, 2013, J EXP SOC PSYCHOL, V49, P1078, DOI 10.1016/j.jesp.2013.07.003; Duncan B, 2004, J PUBLIC ECON, V88, P2159, DOI 10.1016/S0047-2727(03)00037-9; Eckel CC, 2005, J PUBLIC ECON, V89, P1543, DOI 10.1016/j.jpubeco.2004.05.012; Eckel CC, 2004, NONPROF VOLUNT SEC Q, V33, P271, DOI 10.1177/0899764004263423; Eckel CC, 2003, J PUBLIC ECON, V87, P681, DOI 10.1016/S0047-2727(01)00094-9; Frey BS, 2004, AM ECON REV, V94, P1717, DOI 10.1257/0002828043052187; Gneezy A, 2012, P NATL ACAD SCI USA, V109, P7236, DOI 10.1073/pnas.1120893109; Gregory A. G., 2009, INNOVATION REV, P49; Imas A, 2014, J PUBLIC ECON, V114, P14, DOI 10.1016/j.jpubeco.2013.11.006; Karlan D, 2007, AM ECON REV, V97, P1774, DOI 10.1257/aer.97.5.1774; Lecy JD, 2015, NONPROF VOLUNT SEC Q, V44, P539, DOI 10.1177/0899764014527175; List JA, 2002, J POLIT ECON, V110, P215, DOI 10.1086/324392; Meier S, 2007, J EUR ECON ASSOC, V5, P1203, DOI 10.1162/JEEA.2007.5.6.1203; Pallotta, 2008, UNCHARITABLE RESTRAI; Potters J, 2007, ECON THEOR, V33, P169, DOI 10.1007/s00199-006-0186-3; Rondeau D, 2008, EXP ECON, V11, P253, DOI 10.1007/s10683-007-9190-0; Steinberg R., 1986, EC NONPROFIT I, P347; Taylor A., 2013, OVERHEAD MYTH LETT D; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tinkelman D, 2007, NONPROF VOLUNT SEC Q, V36, P41, DOI 10.1177/0899764006293176; Vesterlund L, 2003, J PUBLIC ECON, V87, P627, DOI 10.1016/S0047-2727(01)00187-6; Vesterlund L., 2006, NONPROFIT SECTOR RES, V2nd ed.	33	148	148	11	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		632	635		10.1126/science.1253932	http://dx.doi.org/10.1126/science.1253932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359974				2022-12-28	WOS:000343799700049
J	Bell, SP				Bell, Stephen P.			Terminating the replisome	SCIENCE			English	Editorial Material							DNA-REPLICATION; CHROMATIN; COMPLEX		MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barthelme D, 2014, P NATL ACAD SCI USA, V111, pE1687, DOI 10.1073/pnas.1404823111; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Cuvier O, 2008, GENE DEV, V22, P860, DOI 10.1101/gad.445108; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Long DT, 2012, MOL CELL, V46, P111, DOI 10.1016/j.molcel.2012.04.010; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738	16	8	8	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					418	419		10.1126/science.1261245	http://dx.doi.org/10.1126/science.1261245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342784				2022-12-28	WOS:000343822900018
J	Ayanian, JZ; Clark, SJ; Tipirneni, R				Ayanian, John Z.; Clark, Sarah J.; Tipirneni, Renuka			Launching the Healthy Michigan Plan - The First 100 Days	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPANSION		[Ayanian, John Z.; Clark, Sarah J.; Tipirneni, Renuka] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Clark, Sarah J.] Univ Michigan, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Tipirneni, Renuka] Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Ayanian, John Z.; Tipirneni, Renuka] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI USA; [Clark, Sarah J.] Univ Michigan, Sch Med, Div Gen Pediat, Ann Arbor, MI USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ayanian, JZ (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.							Artiga S., 2014, WHAT WORKED WHATS NE; Ayanian JZ, 2013, NEW ENGL J MED, V369, P1773, DOI 10.1056/NEJMp1310910; Jones DK, 2014, JAMA-J AM MED ASSOC, V311, P1965, DOI 10.1001/jama.2014.3700; Michigan. gov, 2014, HLTH MICH PLAN TOOLK; Michigan. gov. Gov, 2014, RICK SNYD SAYS HLTH	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1573	1575		10.1056/NEJMp1409600	http://dx.doi.org/10.1056/NEJMp1409600			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR5UF	25337747				2022-12-28	WOS:000343648500005
J	Wang, GJ; Zhou, MF; Goettel, JT; Schrobilgen, GJ; Su, J; Li, J; Schloder, T; Riedel, S				Wang, Guanjun; Zhou, Mingfei; Goettel, James T.; Schrobilgen, Gary J.; Su, Jing; Li, Jun; Schloeder, Tobias; Riedel, Sebastian			Identification of an iridium-containing compound with a formal oxidation state of IX	NATURE			English	Article							BASIS-SETS; INFRARED-SPECTRA; SPECTROSCOPY; ION; ENERGY; CHEMISTRY; MOLECULE	One of the most important classifications in chemistry and within the periodic table is the concept of formal oxidation states(1-4). The preparation and characterization of compounds containing elements with unusual oxidation states is of great interest to chemists(5). The highest experimentally known formal oxidation state of any chemical element is at present VIII2-4, although higher oxidation states have been postulated(6,7). Compounds with oxidation state VIII include several xenon compounds(8) (for example XeO4 and XeO3F2) and the well-characterized species RuO4 and OsO4 (refs 2-4). Iridium, which has nine valence electrons, is predicted to have the greatest chance of being oxidized beyond the VIII oxidation state(1). In recent matrix-isolation experiments, the IrO4 molecule was characterized as an isolated molecule in rare-gas matrices(9). The valence electron configuration of iridium in IrO4 is 5d(1), with a formal oxidation state of VIII. Removal of the remaining d electron from IrO4 would lead to the iridium tetroxide cation ([IrO4](+)), which was recently predicted to be stable(10) and in which iridium is in a formal oxidation state of IX. There has been some speculation about the formation of [IrO4](+) species(11,12), but these experimental observations have not been structurally confirmed. Here we report the formation of [IrO4](+) and its identification by infrared photodissociation spectroscopy. Quantum-chemical calculations were carried out at the highest level of theory that is available today, and predict that the iridium tetroxide cation, with a T-d-symmetrical structure and a d(0) electron configuration, is the most stable of all possible [IrO4](+) isomers.	[Wang, Guanjun; Zhou, Mingfei] Fudan Univ, Collaborat Innovat Ctr Chem Energy Mat, Shanghai Key Lab Mol Catalysts & Innovat Mat, Dept Chem, Shanghai 200433, Peoples R China; [Goettel, James T.; Schrobilgen, Gary J.] McMaster Univ, Dept Chem, Hamilton, ON L8S 4M1, Canada; [Su, Jing; Li, Jun] Tsinghua Univ, Dept Chem, Minist Educ, Beijing 100084, Peoples R China; [Su, Jing; Li, Jun] Tsinghua Univ, Key Lab Organ Optoelect & Mol Engn, Minist Educ, Beijing 100084, Peoples R China; [Schloeder, Tobias; Riedel, Sebastian] Univ Freiburg, Inst Anorgan & Analyt Chem, D-79104 Freiburg, Germany; [Riedel, Sebastian] Free Univ Berlin, Inst Chem & Biochem Anorgan Chem, D-14195 Berlin, Germany	Fudan University; McMaster University; Tsinghua University; Tsinghua University; University of Freiburg; Free University of Berlin	Zhou, MF (corresponding author), Fudan Univ, Collaborat Innovat Ctr Chem Energy Mat, Shanghai Key Lab Mol Catalysts & Innovat Mat, Dept Chem, Shanghai 200433, Peoples R China.	mfzhou@fudan.edu.cn; schrobil@mcmaster.ca; sriedel@psichem.de	China, iChEM/F-2855-2015; Li, Jun/E-5334-2011	Li, Jun/0000-0002-8456-3980; Goettel, James/0000-0001-8120-3771; Schloder, Tobias/0000-0002-3822-630X	Ministry of Science and Technology of China [2013CB834603, 2012YQ220113-3]; National Natural Science Foundation of China [21173053, 21433005, 91026003]; Committee of Science and Technology of Shanghai [13XD1400800]; Fonds der Chemischen Industrie; GRK [1582]; Natural Sciences and Engineering Research Council of Canada	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology of Shanghai(Shanghai Science & Technology Committee); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); GRK(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Ministry of Science and Technology of China (2013CB834603 and 2012YQ220113-3), the National Natural Science Foundation of China (grant nos 21173053, 21433005 and 91026003), the Committee of Science and Technology of Shanghai (13XD1400800), the Fonds der Chemischen Industrie and the GRK 1582 'Fluorine as a key element'. We also acknowledge the Natural Sciences and Engineering Research Council of Canada for a Discovery Grant (G.J.S.) and for a postgraduate scholarship (J.T.G.). We are grateful to I. Krossing and H. Hillebrecht for their support.	[Anonymous], 2013, V201301 ADF; [Anonymous], 2011, TURB VERS 6 2; Armentrout PB, 2013, J PHYS CHEM A, V117, P7754, DOI 10.1021/jp4063143; Aullon G, 2009, THEOR CHEM ACC, V123, P67, DOI 10.1007/s00214-009-0537-9; Bach RD, 1996, J AM CHEM SOC, V118, P12758, DOI 10.1021/ja961838i; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bieske EJ, 2000, CHEM REV, V100, P3963, DOI 10.1021/cr990064w; CHRISTE KO, 1976, J FLUORINE CHEM, V7, P543, DOI 10.1016/S0022-1139(00)82572-5; Duncan MA, 2003, INT REV PHYS CHEM, V22, P407, DOI 10.1080/0144235031000095201; Figgen D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3119665; Gerken M, 2002, INORG CHEM, V41, P198, DOI 10.1021/ic010627y; Gong Y, 2009, CHEM REV, V109, P6765, DOI 10.1021/cr900185x; Gong Y, 2009, ANGEW CHEM INT EDIT, V48, P7879, DOI 10.1002/anie.200902733; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Guerra CF, 1998, THEOR CHEM ACC, V99, P391, DOI 10.1007/s002140050021; Himmel D, 2010, CHEMPHYSCHEM, V11, P865, DOI 10.1002/cphc.200900910; Jorgensen C. K, 1969, OXIDATION NUMBERS OX; JORGENSEN CK, 1976, NATURWISSENSCHAFTEN, V63, P292, DOI 10.1007/BF00624017; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Koyanagi GK, 2002, J PHYS CHEM A, V106, P4581, DOI 10.1021/jp014145j; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Mennucci B., 2009, GAUSSIAN 09 VERSION, V09; OKUMURA M, 1990, J PHYS CHEM-US, V94, P3416, DOI 10.1021/j100372a014; Peterson KA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2647019; Pyykko P, 2000, CHEM PHYS LETT, V328, P415, DOI 10.1016/S0009-2614(00)00958-1; Riedel S, 2004, PHYS CHEM CHEM PHYS, V6, P1122, DOI 10.1039/b315019d; Riedel S., 2013, COMPREHENSIVE INORGA, P187; Riedel S, 2009, COORDIN CHEM REV, V253, P606, DOI 10.1016/j.ccr.2008.07.014; Robertson WH, 2003, ANNU REV PHYS CHEM, V54, P173, DOI 10.1146/annurev.physchem.54.011002.103801; ROTHER P, 1969, RADIOCHIM ACTA, V11, P203; Schloder T., 2013, COMPREHENSIVE INORGA, V9, P227; Stanton J. F., 2010, CFOUR 1 2; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; Van Lenthe E, 2003, J COMPUT CHEM, V24, P1142, DOI 10.1002/jcc.10255; VANLENTHE E, 1993, J CHEM PHYS, V99, P4597, DOI 10.1063/1.466059; Wang GJ, 2012, J PHYS CHEM A, V116, P2484, DOI 10.1021/jp211936b; Werner HJ, 2008, MOLPRO VERSION 2008; WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303; Xiao H, 2010, J PHYS CHEM A, V114, P8837, DOI 10.1021/jp102107n; Zhou MF, 2000, J PHYS CHEM A, V104, P3457, DOI 10.1021/jp993026p	41	134	135	12	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					475	+		10.1038/nature13795	http://dx.doi.org/10.1038/nature13795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341786				2022-12-28	WOS:000343775900036
J	Jimenez, D; Kopecna, D; Tapson, V				Jimenez, D.; Kopecna, D.; Tapson, V			A 4-marker model predicted a complicated course in normotensive patients with acute symptomatic PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jimenez, D.] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal	Jimenez, D (corresponding author), Hosp Ramon & Cajal, E-28034 Madrid, Spain.	djc_69_98@yahoo.com							0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC13	10.7326/0003-4819-161-8-201410210-02013	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329218				2022-12-28	WOS:000343906800012
J	Ito, Y; Hashimoto, M; Hirota, K; Ohkura, N; Morikawa, H; Nishikawa, H; Tanaka, A; Furu, M; Ito, H; Fujii, T; Nomura, T; Yamazaki, S; Morita, A; Vignali, DAA; Kappler, JW; Matsuda, S; Mimori, T; Sakaguchi, N; Sakaguchi, S				Ito, Yoshinaga; Hashimoto, Motomu; Hirota, Keiji; Ohkura, Naganari; Morikawa, Hiromasa; Nishikawa, Hiroyoshi; Tanaka, Atsushi; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Nomura, Takashi; Yamazaki, Sayuri; Morita, Akimichi; Vignali, Dario A. A.; Kappler, John W.; Matsuda, Shuichi; Mimori, Tsuneyo; Sakaguchi, Noriko; Sakaguchi, Shimon			Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease	SCIENCE			English	Article							RECEPTOR-RETROGENIC MICE; RHEUMATOID-ARTHRITIS; GENE; MECHANISMS; GENERATION; TOLERANCE; SELECTION; MUTATION; ZAP-70	Tcells that mediate autoimmune diseases such as rheumatoid arthritis (RA) are difficult to characterize because they are likely to be deleted or inactivated in the thymus if the self antigens they recognize are ubiquitously expressed. One way to obtain and analyze these autoimmune T cells is to alter T cell receptor (TCR) signaling in developing T cells to change their sensitivity to thymic negative selection, thereby allowing their thymic production. From mice thus engineered to generate Tcells mediating autoimmune arthritis, we isolated arthritogenic TCRs and characterized the self antigens they recognized. One of them was the ubiquitously expressed 60S ribosomal protein L23a (RPL23A), with which T cells and autoantibodies from RA patients reacted. This strategy may improve our understanding of the underlying drivers of autoimmunity.	[Ito, Yoshinaga; Hashimoto, Motomu; Nomura, Takashi; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; [Hashimoto, Motomu; Hirota, Keiji; Ohkura, Naganari; Morikawa, Hiromasa; Nishikawa, Hiroyoshi; Tanaka, Atsushi; Sakaguchi, Noriko; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto 6068507, Japan; [Hashimoto, Motomu; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Ohkura, Naganari; Tanaka, Atsushi] Osaka Univ, Ctr Med Innovat & Translat Res, Dept Frontier Res Tumor Immunol, Osaka 5650871, Japan; [Furu, Moritoshi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Yamazaki, Sayuri; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan; [Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Kappler, John W.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA; [Sakaguchi, Shimon] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Kyoto University; Osaka University; Kyoto University; Kyoto University; Osaka University; Kyoto University; Nagoya City University; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Jewish Health; Howard Hughes Medical Institute; National Jewish Health; Japan Science & Technology Agency (JST)	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@ifrec.osaka-u.ac.jp	Nishikawa, Hiroyoshi/AAI-7044-2020; Tanaka, Atsushi/U-6761-2019; Sakaguchi, Shimon/C-9535-2009; Morikawa, Hiromasa/AAU-9261-2020; Morikawa, Hiromasa/H-5958-2013	Tanaka, Atsushi/0000-0003-1660-9892; Morikawa, Hiromasa/0000-0002-6793-5885; Morikawa, Hiromasa/0000-0002-6793-5885; Hirota, Keiji/0000-0002-4737-0661; Matsuda, Shuichi/0000-0003-0802-1255; Ito, Yoshinaga/0000-0002-5567-7014	Japan Society for the Promotion of Science [20002007, 24790996]; Japan Science and Technology Agency; NIH [R01 DK089125]; American Lebanese Syrian Associated Charities; Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co. Ltd.; AbbVie GK.; Eisai Co. Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089125] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co. Ltd.; AbbVie GK.; Eisai Co. Ltd.(Eisai Co Ltd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. O. Adeegbe, Y. Kitagawa, and K. Chen for critical reacting of the manuscript; E. Yamamoto, M. Matsuura., R. Ishii, Y. Tada, Y. Funabiki, the technical support team (Graduate School of Medicine, Kyoto University), and K. Saito of DNA-chip Development Center for Infectious Diseases (RIMD, Osaka University) for technical assistance; I. Matsushita for histology; T. Kitamura for gifts of the packaging cell line Plat-E; the members of the Department of Rheumatology and Clinical Immunology, Kyoto University, for providing us with patients' sera; and the members of our laboratories for comments. The data presented in this paper are tabulated in the main paper and in the supplementary materials. eFOX mice and plasmids for making retrogenic mice are subject to a material transfer agreement. A patent application related to the work in this paper has been filed (PCT/JP2014/0693063: A way to diagnose autoimmune arthritis; Y.I. and S.S. as inventors). Supported by Grants-in-Aid for Specially Promoted Research 20002007 (S.S. and Y.I.),;for Young Scientists (B) 24790996 (Y.I.) from the Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (S.S.); NIH grant R01 DK089125 (D.A.A.V.); and American Lebanese Syrian Associated Charities (D.A.A.V.). M.H., T.F., M.F., H.I., and T.M. are affiliated with a department that is supported financially by five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Bristol-Myers K.K., Chugai Pharmaceutical Co. Ltd., AbbVie GK., and Eisai Co. Ltd.). The sponsors were not involved in the study design; in the collection, analysis, or interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication.	Bettini ML, 2013, NAT PROTOC, V8, P1837, DOI 10.1038/nprot.2013.111; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Fan WF, 1997, GENOMICS, V46, P234, DOI 10.1006/geno.1997.5038; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; SUZUKI K, 1993, J BIOL CHEM, V268, P2755; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76	22	61	63	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					363	368		10.1126/science.1259077	http://dx.doi.org/10.1126/science.1259077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324392	Green Accepted			2022-12-28	WOS:000343041100048
J	Duxin, JP; Dewar, JM; Yardimci, H; Walter, JC				Duxin, Julien P.; Dewar, James M.; Yardimci, Hasan; Walter, Johannes C.			Repair of a DNA-Protein Crosslink by Replication-Coupled Proteolysis	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; XENOPUS EGG EXTRACTS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; ABASIC SITES; FORMALDEHYDE; MECHANISM; HELICASE; PATHWAY	DNA-protein crosslinks (DPCs) are caused by environmental, endogenous, and chemotherapeutic agents and pose a severe threat to genome stability. We use Xenopus egg extracts to recapitulate DPC repair in vitro and show that this process is coupled to DNA replication. A DPC on the leading strand template arrests the replisome by stalling the CMG helicase. The DPC is then degraded on DNA, yielding a peptide-DNA adduct that is bypassed by CMG. The leading strand subsequently resumes synthesis, stalls again at the adduct, and then progresses past the adduct using DNA polymerase zeta. A DPC on the lagging strand template only transiently stalls the replisome, but it too is degraded, allowing Okazaki fragment bypass. Our experiments describe a versatile, proteolysis-based mechanism of S phase DPC repair that avoids replication fork collapse.	[Duxin, Julien P.; Dewar, James M.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yardimci, Hasan] Imperial Canc Res Fund, Clare Hall Labs, London Res Inst, Canc Res UK, S Mimms EN6 3LD, Herts, England; [Walter, Johannes C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Cancer Research UK; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Walter, Johannes/0000-0002-4186-7570; Yardimci, Hasan/0000-0001-5009-1391; Dewar, James/0000-0003-4153-3818	Department of Defense Bone Marrow Research Program Postdoctoral Traineeship Award [W81XWH-13-1-0049]; NIH [GM62267]; Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267] Funding Source: NIH RePORTER; Cancer Research UK [17575] Funding Source: researchfish	Department of Defense Bone Marrow Research Program Postdoctoral Traineeship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	We thank O.D. Scharer, P.M. Burgers, R. Scully, N. Rhind, N. Tretyakova, and the members of the Walter laboratory for feedback on the manuscript. We thank K.J Marians, T. Bernhardt, B. Kay, and New England Biolabs for plasmids, Thomas Graham for Ulp1 protease and help with the purification of LacI, and Jieqiong Zhang for generation of the FANCI antibody. J.P.D was supported by the Department of Defense Bone Marrow Research Program Postdoctoral Traineeship Award W81XWH-13-1-0049. J.C.W was supported by NIH grant GM62267 and a grant from the Fanconi Anemia Research Fund. J.C.W. is an investigator of the Howard Hughes Medical Institute.	Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HUANG H, 1993, J AM CHEM SOC, V115, P9402, DOI 10.1021/ja00074a005; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Orta ML, 2013, NUCLEIC ACIDS RES, V41, P5827, DOI 10.1093/nar/gkt270; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sabouri N, 2009, J BIOL CHEM, V284, P31555, DOI 10.1074/jbc.M109.043927; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yardimci H, 2012, NATURE, V492, P205, DOI 10.1038/nature11730; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Zecevic A, 2010, MUTAGENESIS, V25, P381, DOI 10.1093/mutage/geq017; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018	45	143	143	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					346	357		10.1016/j.cell.2014.09.024	http://dx.doi.org/10.1016/j.cell.2014.09.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303529	Green Accepted, Bronze			2022-12-28	WOS:000343095600016
J	Li, XC; Roberti, R; Blobel, G				Li, Xiaochun; Roberti, Rita; Blobel, Guenter			Structure of an integral membrane sterol reductase from Methylomicrobium alcaliphilum	NATURE			English	Article							LAMIN-B-RECEPTOR; 3-BETA-HYDROXYSTEROL DELTA(14)-REDUCTASE; CRYSTAL-STRUCTURE; MUTATIONS; PROTEIN; STEROIDOGENESIS; EXPRESSION; DISORDERS; DYSPLASIA; TOPOLOGY	Sterols are essential biological molecules in the majority of life forms. Sterol reductases(1) including Delta(14)-sterol reductase (C14SR, also known as TM7SF2), 7-dehydrocholesterol reductase (DHCR7) and 24-dehydrocholesterol reductase (DHCR24) reduce specific carbon-carbon double bonds of the sterol moiety using a reducing cofactor during sterol biosynthesis. Lamin B receptor(2) (LBR), an integral inner nuclear membrane protein, also contains a functional C14SR domain. Here we report the crystal structure of a Delta(14)-sterol reductase (MaSR1) from the methanotrophic bacterium Methylomicro-bium alcaliphilum 20Z (a homologue of human C14SR, LBR and DHCR7) with the cofactor NADPH. The enzyme contains ten transmembrane segments (TM1-10). Its catalytic domain comprises the carboxy-terminal half (containing TM6-10) and envelops two interconnected pockets, one of which faces the cytoplasm and houses NADPH, while the other one is accessible from the lipid bilayer. Comparison with a soluble steroid 5 beta-reductase structure(3) suggests that the reducing end of NADPH meets the sterol substrate at the juncture of the two pockets. A sterol reductase activity assay proves that MaSR1 can reduce the double bond of a cholesterol biosynthetic intermediate, demonstrating functional conservation to human C14SR. Therefore, our structure as a prototype of integral membrane sterol reductases provides molecular insight into mutations in DHCR7 and LBR for inborn human diseases.	[Li, Xiaochun; Blobel, Guenter] Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY 10065 USA; [Roberti, Rita] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy	Howard Hughes Medical Institute; Rockefeller University; University of Perugia	Li, XC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY 10065 USA.	xli05@rockefeller.edu; blobel@rockefeller.edu		ROBERTI, Rita/0000-0003-4131-5933; Li, Xiaochun/0000-0002-0177-0803	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [P41 GM111244] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Bennati AM, 2006, BBA-MOL CELL BIOL L, V1761, P677, DOI 10.1016/j.bbalip.2006.05.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clayton P, 2010, NUCLEUS-PHILA, V1, P354, DOI 10.4161/nucl.1.4.12435; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HENNEKES H, 1994, J CELL SCI, V107, P1019; Herman GE, 2012, AM J MED GENET C, V160C, P301, DOI 10.1002/ajmg.c.31340; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAIK YK, 1984, J BIOL CHEM, V259, P3413; Porter FD, 2008, EUR J HUM GENET, V16, P535, DOI 10.1038/ejhg.2008.10; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Roberti R, 2002, EUR J BIOCHEM, V269, P283, DOI 10.1046/j.0014-2956.2001.02646.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shchukin VN, 2011, MICROBIOLOGY+, V80, P608, DOI 10.1134/S0026261711050122; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Zwart P.H., 2005, CCP4 NEWSLETTER PROT, V43, P27	36	36	39	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					104	U280		10.1038/nature13797	http://dx.doi.org/10.1038/nature13797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25307054	Green Accepted			2022-12-28	WOS:000347178400044
J	Gnad, T; Scheibler, S; von Kugelgen, I; Scheele, C; Kilic, A; Glode, A; Hoffmann, LS; Reverte-Salisa, L; Horn, P; Mutlu, S; El-Tayeb, A; Kranz, M; Deuther-Conrad, W; Brust, P; Lidell, ME; Betz, MJ; Enerback, S; Schrader, J; Yegutkin, GG; Muller, CE; Pfeifer, A				Gnad, Thorsten; Scheibler, Saskia; von Kuegelgen, Ivar; Scheele, Camilla; Kilic, Ana; Gloede, Anja; Hoffmann, Linda S.; Reverte-Salisa, Laia; Horn, Philipp; Mutlu, Samet; El-Tayeb, Ali; Kranz, Mathias; Deuther-Conrad, Winnie; Brust, Peter; Lidell, Martin E.; Betz, Matthias J.; Enerbaeck, Sven; Schrader, Juergen; Yegutkin, Gennady G.; Mueller, Christa E.; Pfeifer, Alexander			Adenosine activates brown adipose tissue and recruits beige adipocytes via A(2A) receptors	NATURE			English	Article							FAT; RESPIRATION; LIPOLYSIS; MOUSE; CELLS; ATP	Brown adipose tissue (BAT) is specialized in energy expenditure, making it a potential target for anti-obesity therapies(1-5). Following exposure to cold, BAT is activated by the sympathetic nervous system with concomitant release of catecholamines and activation of beta-adrenergic receptors(1-5). Because BAT therapies based on cold exposureor beta-adrenergic agonists are clinically not feasible, alternative strategies must be explored. Purinergic co-transmission might be involved in sympathetic control of BAT and previous studies reported inhibitory effects of the purinergic transmitter adenosine in BAT from hamster or rat(6-8). However, the role of adenosine in human BAT is unknown. Here we show that adenosine activates human and murine brown adipocytes at low nanomolar concentrations. Adenosine is released in BAT during stimulation of sympathetic nerves as well as from brown adipocytes. The adenosine A(2A) receptor is the most abundant adenosine receptor in human and murine BAT. Pharmacological blockade or genetic loss of A(2A) receptors in mice causes adecrease in BAT-dependent thermogenesis, whereas treatment with A(2A) agonists significantly increases energy expenditure. Moreover, pharmacological stimulation of A(2A) receptors or injection of lentiviral vectors expressing the A(2A) receptor into white fat induces brown-like cells-so-called beige adipocytes. Importantly, mice fed a high-fat diet and treated with an A(2A) agonist are leaner with improved glucose tolerance. Taken together, our results demonstrate that adenosine-A(2A) signalling plays an unexpected physiological role in sympathetic BAT activation and protects mice from diet-induced obesity. Those findings reveal new possibilities for developing novel obesity therapies.	[Gnad, Thorsten; Scheibler, Saskia; von Kuegelgen, Ivar; Kilic, Ana; Gloede, Anja; Hoffmann, Linda S.; Reverte-Salisa, Laia; Horn, Philipp; Mutlu, Samet; Pfeifer, Alexander] Univ Bonn, Univ Hosp, Inst Pharmacol & Toxicol, D-53127 Bonn, Germany; [Scheibler, Saskia; Reverte-Salisa, Laia] Univ Bonn, Res Training Grp 1873, D-53127 Bonn, Germany; [Scheele, Camilla] Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Scheele, Camilla] Rigshosp, Ctr Phys Activ Res, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [El-Tayeb, Ali; Mueller, Christa E.] Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany; [Kranz, Mathias; Deuther-Conrad, Winnie; Brust, Peter] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, D-04318 Leipzig, Germany; [Lidell, Martin E.; Betz, Matthias J.; Enerbaeck, Sven] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med & Clin Genet, S-41390 Gothenburg, Sweden; [Schrader, Juergen] Univ Dusseldorf, Dept Mol Cardiol, D-40225 Dusseldorf, Germany; [Yegutkin, Gennady G.] Univ Turku, Med Res Lab, FIN-20520 Turku, Finland; [Mueller, Christa E.; Pfeifer, Alexander] Univ Bonn, Pharma Ctr, D-53127 Bonn, Germany	University of Bonn; University of Bonn; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Bonn; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Gothenburg; Heinrich Heine University Dusseldorf; University of Turku; University of Bonn	Pfeifer, A (corresponding author), Univ Bonn, Univ Hosp, Inst Pharmacol & Toxicol, D-53127 Bonn, Germany.	alexander.pfeifer@uni-bonn.de	Scheele, Camilla/S-6401-2017; von Kügelgen, Ivar/D-2989-2019; Müller, Christa Elisabeth/C-7748-2014; Yegutkin, Gennady G./K-3815-2014; Scheele, Camilla/AAA-3599-2020; Deuther-Conrad, Winnie/B-7558-2015	Scheele, Camilla/0000-0002-6055-9709; von Kügelgen, Ivar/0000-0002-2021-4028; Müller, Christa Elisabeth/0000-0002-0013-6624; Yegutkin, Gennady G./0000-0001-6684-7982; Scheele, Camilla/0000-0002-6055-9709; , Peter/0000-0001-5555-7058; Deuther-Conrad, Winnie/0000-0003-3168-3062; Reverte-Salisa, Laia/0000-0002-9216-682X; Kranz, Mathias/0000-0002-5641-7396; Betz, Matthias Johannes/0000-0002-6946-1871	Deutsche Forschungsgemeinschaft (DFG); Lundbeck Foundation; Novo Nordisk A/S; Danish National Research Foundation [DNRF55]; Trygfonden; BONFOR; Bonn International Graduate School DrugS; Swedish Research Council [2013-4466, 2010-3281, 2012-1652]; Knut and Alice Wallenberg Foundation; Sahlgrenska's University Hospital (LUA-ALF); European Union [HEALTH-F2-2011-278373]; Inga Britt and Arne Lundgren Foundation; Soderberg Foundation; King Gustaf V and Queen Victoria Freemason Foundation; Federal Ministry of Education and research	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk A/S(Novo Nordisk); Danish National Research Foundation(Danmarks Grundforskningsfond); Trygfonden; BONFOR; Bonn International Graduate School DrugS; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska's University Hospital (LUA-ALF); European Union(European Commission); Inga Britt and Arne Lundgren Foundation; Soderberg Foundation; King Gustaf V and Queen Victoria Freemason Foundation; Federal Ministry of Education and research(Federal Ministry of Education & Research (BMBF))	We thank D. Hass, S. Kipschull, N. Galicki James, B. Steckel, J. Mulich, M. Schneider and G. Petersson for technical assistance. We thank M. Idzko for A2A<SUP>-/-</SUP> mice. A.P. was supported by the Deutsche Forschungsgemeinschaft (DFG); S. S. and L.R.-S. were supported by the DFG-funded Research Training Group 1873 "Pharmacology of 7TM-receptors and downstream signalling pathways''; C. S. was supported by the Lundbeck Foundation and Novo Nordisk A/S. CIM is supported by the Danish National Research Foundation (DNRF55) and CFAS is supported by Trygfonden. A.K. and L.S.H. were supported by BONFOR. A. G. was supported by the Bonn International Graduate School DrugS and the Federal Ministry of Education and research. M.E.L. was supported by the Swedish Research Council (2013-4466). S.E. was supported by the Swedish Research Council (2010-3281, 2012-1652), The Knut and Alice Wallenberg Foundation, Sahlgrenska's University Hospital (LUA-ALF), European Union grants (HEALTH-F2-2011-278373; DIABAT), the Inga Britt and Arne Lundgren Foundation, the Soderberg Foundation, and the King Gustaf V and Queen Victoria Freemason Foundation.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Betz MJ, 2013, J CLIN ENDOCR METAB, V98, P4097, DOI 10.1210/jc.2012-3535; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gourine AV, 2009, TRENDS NEUROSCI, V32, P241, DOI 10.1016/j.tins.2009.03.002; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Helenius M, 2012, BBA-MOL CELL RES, V1823, P1967, DOI 10.1016/j.bbamcr.2012.08.001; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; JohanssonA SM, 2008, EUR J PHARMACOL, V597, P92, DOI 10.1016/j.ejphar.2008.08.022; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; MCMAHON KK, 1982, LIFE SCI, V30, P1185, DOI 10.1016/0024-3205(82)90661-0; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; SCHIMMEL RJ, 1984, AM J PHYSIOL, V246, pC301, DOI 10.1152/ajpcell.1984.246.3.C301; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; SZILLAT D, 1983, AM J PHYSIOL, V245, pE555, DOI 10.1152/ajpendo.1983.245.6.E555; UNELIUS L, 1990, AM J PHYSIOL, V258, pC818, DOI 10.1152/ajpcell.1990.258.5.C818; VONKUGELGEN I, 1994, NEUROSCIENCE, V61, P199, DOI 10.1016/0306-4522(94)90223-2; WOODWARD JA, 1986, BIOCHEM J, V238, P395, DOI 10.1042/bj2380395; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	27	238	243	5	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					395	+		10.1038/nature13816	http://dx.doi.org/10.1038/nature13816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25317558				2022-12-28	WOS:000346484800047
J	Sun, W; Boulais, E; Hakobyan, Y; Wang, WL; Guan, A; Bathe, M; Yin, P				Sun, Wei; Boulais, Etienne; Hakobyan, Yera; Wang, Wei Li; Guan, Amy; Bathe, Mark; Yin, Peng			Casting inorganic structures with DNA molds	SCIENCE			English	Article							ENERGY-LOSS SPECTROSCOPY; SINGLE-STRANDED-DNA; NANOSCALE SHAPES; PLASMONIC NANOSTRUCTURES; NUCLEIC-ACID; FOLDING DNA; NANOPARTICLES; GOLD; ORIGAMI; GROWTH	We report a general strategy for designing and synthesizing inorganic nanostructures with arbitrarily prescribed three-dimensional shapes. Computationally designed DNA strands self-assemble into a stiff "nanomold" that contains a user-specified three-dimensional cavity and encloses a nucleating gold "seed." Under mild conditions, this seed grows into a larger cast structure that fills and thus replicates the cavity. We synthesized a variety of nanoparticles with 3-nanometer resolution: three distinct silver cuboids with three independently tunable dimensions, silver and gold nanoparticles with diverse cross sections, and composite structures with homo- and heterogeneous components. The designer equilateral silver triangular and spherical nanoparticles exhibited plasmonic properties consistent with electromagnetism-based simulations. Our framework is generalizable to more complex geometries and diverse inorganic materials, offering a range of applications in biosensing, photonics, and nanoelectronics.	[Sun, Wei; Wang, Wei Li; Guan, Amy; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Sun, Wei; Wang, Wei Li; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Boulais, Etienne; Hakobyan, Yera; Bathe, Mark] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	mark.bathe@mit.edu; py@hms.harvard.edu	Sun, Wei/I-4376-2014; Wang, Wei L/B-8061-2009	Wang, Wei L/0000-0002-5064-8097	Defense Advanced Research Projects Agency Young Faculty Award [N66001111413]; Office of Naval Research (ONR) Young Investigator Program Award [N000141110914]; ONR [N000141010827, N000141310593, N000141410610, DURIP N000141310664, N000141210621]; Army Research Office [W911NF1210238]; NIH Director's New Innovator Award [1DP2OD007292]; NSF Faculty Early Career Development Award [CCF1054898]; NSF Expedition in Computing Award [CCF1317291]; NSF [CCF1162459, CMMI1333215, CMMI1334109, CMMI1344915, ECS-0335765]; Wyss Institute; NSF-DMREF [CMMI1334109]; Natural Sciences and Engineering Research Council of Canada; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC0205CH11231]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1344915] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency Young Faculty Award; Office of Naval Research (ONR) Young Investigator Program Award(Office of Naval Research); ONR(Office of Naval Research); Army Research Office; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Faculty Early Career Development Award(National Science Foundation (NSF)); NSF Expedition in Computing Award; NSF(National Science Foundation (NSF)); Wyss Institute; NSF-DMREF(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Y. Ke, J. Shen, and B. Wei for discussion, and E. Haney, D. Pastuszak and E. Chen for assistance in draft preparation. Supported by Defense Advanced Research Projects Agency Young Faculty Award N66001111413, Office of Naval Research (ONR) Young Investigator Program Award N000141110914, ONR grants N000141010827, N000141310593, and N000141410610, Army Research Office grant W911NF1210238, NIH Director's New Innovator Award 1DP2OD007292, NSF Faculty Early Career Development Award CCF1054898, NSF Expedition in Computing Award CCF1317291, NSF grants CCF1162459, CMMI1333215, CMMI1334109, and CMMI1344915 and Wyss Institute funds (P. Y.); ONR grants DURIP N000141310664 and N000141210621 and NSF-DMREF grant CMMI1334109 (M. B., E. B., and Y. H.); and the Natural Sciences and Engineering Research Council of Canada (E. B.). This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765. CNS is part of Harvard University. The EELS of the Ag NPs was measured at National Center for Electron Microscopy, which is supported by the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy under contract DE-AC0205CH11231. Contributions: W. S. designed the system, conducted the experiments, and analyzed the data; E. B. designed and performed optical and EELS simulations, and analyzed the data; Y. H. designed and performed mechanical simulation, and analyzed the data; W. L. W. performed EELS experiments and analyzed the data; A. G. performed experiments and analyzed the data; M. B. designed and supervised the simulation study and interpreted the data; P. Y. conceived, designed, and supervised the study and interpreted the data; and all authors wrote the manuscript. All data described in this article are presented in the supplementary materials.	Bathe M, 2008, PROTEINS, V70, P1595, DOI 10.1002/prot.21708; Bealing CR, 2012, ACS NANO, V6, P2118, DOI 10.1021/nn3000466; Berti L, 2008, NAT NANOTECHNOL, V3, P81, DOI 10.1038/nnano.2007.460; Boulais E, 2013, J PHYS CHEM C, V117, P9386, DOI 10.1021/jp312475h; Boulais E, 2012, NANO LETT, V12, P4763, DOI 10.1021/nl302200w; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; BROOKS BR, 1995, J COMPUT CHEM, V16, P1522, DOI 10.1002/jcc.540161209; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chaudhuri RG, 2012, CHEM REV, V112, P2373, DOI 10.1021/cr100449n; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Fan FR, 2008, J AM CHEM SOC, V130, P6949, DOI 10.1021/ja801566d; Fischler M, 2007, SMALL, V3, P1049, DOI 10.1002/smll.200600534; Gao CB, 2011, J AM CHEM SOC, V133, P19706, DOI 10.1021/ja209647d; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hohenester U, 2014, COMPUT PHYS COMMUN, V185, P1177, DOI 10.1016/j.cpc.2013.12.010; Hohenester U, 2012, COMPUT PHYS COMMUN, V183, P370, DOI 10.1016/j.cpc.2011.09.009; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Jin Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2690; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Koh AL, 2011, NANO LETT, V11, P1323, DOI 10.1021/nl104410t; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Liu JF, 2011, ACS NANO, V5, P2240, DOI 10.1021/nn1035075; Lohse SE, 2012, J AM CHEM SOC, V134, P15607, DOI 10.1021/ja307589n; Ma N, 2009, NAT NANOTECHNOL, V4, P121, DOI [10.1038/NNANO.2008.373, 10.1038/nnano.2008.373]; Maurin-Pasturel G, 2014, ANGEW CHEM INT EDIT, V53, P3872, DOI 10.1002/anie.201310443; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Ming T, 2009, J AM CHEM SOC, V131, P16350, DOI 10.1021/ja907549n; Myroshnychenko V, 2012, NANO LETT, V12, P4172, DOI 10.1021/nl301742h; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Pilo-Pais M, 2011, NANO LETT, V11, P3489, DOI 10.1021/nl202066c; Pompa PP, 2006, NAT NANOTECHNOL, V1, P126, DOI 10.1038/nnano.2006.93; Puzder A, 2004, NANO LETT, V4, P2361, DOI 10.1021/nl0485861; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Ruan LY, 2013, NANO LETT, V13, P840, DOI 10.1021/nl400022g; Samano EC, 2011, SOFT MATTER, V7, P3240, DOI 10.1039/c0sm01318h; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Scholl JA, 2012, NATURE, V483, P421, DOI 10.1038/nature10904; Schreiber R, 2011, SMALL, V7, P1795, DOI 10.1002/smll.201100465; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Surwade SP, 2013, J AM CHEM SOC, V135, P6778, DOI 10.1021/ja401785h; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Wang F, 2013, J AM CHEM SOC, V135, P5588, DOI 10.1021/ja310501y; Wang F, 2011, J AM CHEM SOC, V133, P1106, DOI 10.1021/ja1095733; Wang ZD, 2012, ANGEW CHEM INT EDIT, V51, P9078, DOI 10.1002/anie.201203716; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yu J, 2010, SMALL, V6, P2242, DOI 10.1002/smll.201000889; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e; Zhang HL, 2012, CHEM COMMUN, V48, P6405, DOI 10.1039/c2cc32204h; Zhao Z, 2011, ANGEW CHEM INT EDIT, V50, P2041, DOI 10.1002/anie.201006818	67	221	225	8	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					717	+	1258361	10.1126/science.1258361	http://dx.doi.org/10.1126/science.1258361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25301973	Green Submitted, Green Accepted			2022-12-28	WOS:000344690100031
J	Bonapace, L; Coissieux, MM; Wyckoff, J; Mertz, KD; Varga, Z; Junt, T; Bentires-Alj, M				Bonapace, Laura; Coissieux, Marie-May; Wyckoff, Jeffrey; Mertz, Kirsten D.; Varga, Zsuzsanna; Junt, Tobias; Bentires-Alj, Mohamed			Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis	NATURE			English	Article							CHEMOATTRACTANT PROTEIN-1; CARCINOMA CELLS; EXPRESSION; INTERLEUKIN-6; MONOCYTES; GROWTH	Secretion of C-C chemokine ligand 2 (CCL2) by mammary tumours recruits CCR2-expressing inflammatory monocytes to primary tumours and metastatic sites, and CCL2 neutralization in mice inhibits metastasis-1 by retaining monocytes in the bone marrow. Here we report a paradoxical effect of CCL2 in four syngeneic mouse models of metastatic breast cancer. Surprisingly, interruption of CCL2 inhibition leads to an overshoot of metastases and accelerates death. This is the result of monocyte release from the bone marrow and enhancement of cancer cell mobilization from the primary tumour, as well as blood vessel formation and increased proliferation of metastatic cells in the lungs in an interleukin (IL)-6- and vascular endothelial growth factor (VEGF)-A-dependent manner. Notably, inhibition of CCL2 and IL-6 markedly reduced metastases and increased survival of the animals. CCL2 has been implicated in various neoplasias and adopted as a therapeutic target(1-3). However, our results call for caution when considering anti-CCL2 agents as monotherapy in metastatic disease and highlight the tumour microenvironment as a critical determinant of successful anti-metastatic therapy.	[Bonapace, Laura; Coissieux, Marie-May; Wyckoff, Jeffrey; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland; [Bonapace, Laura; Junt, Tobias] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Mertz, Kirsten D.; Varga, Zsuzsanna] Univ Zurich Hosp, Dept Pathol, CH-8006 Zurich, Switzerland; [Mertz, Kirsten D.] Cantonal Hosp Baselland, Inst Pathol Liestal, CH-4410 Liestal, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Zurich; University Zurich Hospital; Kantonsspital Baselland	Bonapace, L (corresponding author), Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland.	bentires@fmi.ch	Junt, Tobias/AAE-4389-2021; Mohamed, Bentires-Alj/F-4484-2015; Mertz, Kirsten/AAY-1660-2020	Mohamed, Bentires-Alj/0000-0001-6344-1127; Mertz, Kirsten/0000-0002-3074-6925; Coissieux, Marie-May/0000-0001-5017-5253	Novartis Research Foundation; European Research Council [243211-PTPsBDC]; Swiss Cancer League; Swiss National Foundation; Krebsliga Beider Basel; FP7 Marie Curie Fellowship	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss Cancer League; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Krebsliga Beider Basel; FP7 Marie Curie Fellowship	We thank R. L. Anderson, N. Hynes, and R. Cardiff for cell lines, R. Thierry and M. Kirschmann for scripts for immunohistochemistry and two-photon imaging analysis, M. Stadler and H.-R. Hotz for bioinformatics, H. Kohler for FACS and S. Bichet for technical support, H. Brinkhaus and P. Loetscher for helpful discussions, D. Dylan for the CSFR1 inhibitor, J. van Rheenen, J. Stein, J. Rietdorf, T. Oertner and S. Bundschuh for helping us set up the multiphoton intravital microscope, and the Bentires-Alj group for feedback. Research in the laboratory of M. B.-A. is supported by the Novartis Research Foundation, the European Research Council (243211-PTPsBDC), the Swiss Cancer League, the Swiss National Foundation, and the Krebsliga Beider Basel. M.-M.C. is supported by the FP7 Marie Curie Fellowship.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bonapace L, 2012, J MAMMARY GLAND BIOL, V17, P125, DOI 10.1007/s10911-012-9250-8; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Karnoub A. E., 2007, BREAST DIS, V26, P75, DOI DOI 10.3233/BD-2007-26107; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; PALANGIE T, 1994, EUR J CANCER, V30A, P921, DOI 10.1016/0959-8049(94)90115-5; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5; Wani AA, 2011, ONCOGENE, V30, P2778, DOI 10.1038/onc.2010.644; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1167, DOI 10.1101/pdb.top065904; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	30	432	452	8	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525								10.1038/nature13862	http://dx.doi.org/10.1038/nature13862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RG	25337873				2022-12-28	WOS:000349545400001
J	McCalley, CK; Woodcroft, BJ; Hodgkins, SB; Wehr, RA; Kim, EH; Mondav, R; Crill, PM; Chanton, JP; Rich, VI; Tyson, GW; Saleska, SR				McCalley, Carmody K.; Woodcroft, Ben J.; Hodgkins, Suzanne B.; Wehr, Richard A.; Kim, Eun-Hae; Mondav, Rhiannon; Crill, Patrick M.; Chanton, Jeffrey P.; Rich, Virginia I.; Tyson, Gene W.; Saleska, Scott R.			Methane dynamics regulated by microbial community response to permafrost thaw	NATURE			English	Article							GLOBAL WETLAND EXTENT; STABLE CARBON; PRESENT STATE; PEATLAND; CLIMATE; PATHWAYS; FLUXES; ENVIRONMENTS; OXIDATION	Permafrost contains about 50% of the global soil carbon(1). It is thought that the thawing of permafrost can lead to a loss of soil carbon in the form of methane and carbon dioxide emissions(2,3). The magnitude of the resulting positive climate feedback of such greenhouse gas emissions is still unknown(3) and may to a large extent depend on the poorly understood role of microbial community composition in regulating the metabolic processes that drive such ecosystem-scale greenhouse gas fluxes. Here we show that changes in vegetation and increasing methane emissions with permafrost thaw are associated with a switch from hydrogenotrophic to partly acetoclastic methanogenesis, resulting in a large shift in the delta C-13 signature (1015 parts per thousand) of emitted methane. We used a natural landscape gradient of permafrost thaw in northern Sweden(4,5) as a model to investigate the role of microbial communities in regulating methane cycling, and to test whether a knowledge of community dynamics could improve predictions of carbon emissions under loss of permafrost. Abundance of the methanogen Candidatus Methanoflorens stordalenmirensis(6) is a key predictor of the shifts in methane isotopes, which in turn predicts the proportions of carbon emitted as methane and as carbon dioxide, an important factor for simulating the climate feedback associated with permafrost thaw in global models(3,7). By showing that the abundance of key microbial lineages can be used to predict atmospherically relevant patterns in methane isotopes and the proportion of carbon metabolized to methane during permafrost thaw, we establish a basis for scaling changing microbial communities to ecosystem isotope dynamics. Our findings indicate that microbial ecology may be important in ecosystem-scale responses to global change.	[McCalley, Carmody K.; Wehr, Richard A.; Saleska, Scott R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Woodcroft, Ben J.; Mondav, Rhiannon; Tyson, Gene W.] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hodgkins, Suzanne B.; Chanton, Jeffrey P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Kim, Eun-Hae; Rich, Virginia I.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Crill, Patrick M.] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden	University of Arizona; University of Queensland; State University System of Florida; Florida State University; University of Arizona; Stockholm University	McCalley, CK (corresponding author), Univ New Hampshire, Earth Syst Res Ctr, Durham, NH 03824 USA.	carmody.mccalley@unh.edu; saleska@email.arizona.edu	Hodgkins, Suzanne/AAC-8580-2020; Saleska, Scott R/K-1733-2016; Mondav, Rhiannon/M-1219-2017; Tyson, Gene W/C-6558-2013; Crill, Patrick/ABC-1357-2021	Hodgkins, Suzanne/0000-0002-0489-9207; Saleska, Scott R/0000-0002-4974-3628; Mondav, Rhiannon/0000-0002-5574-5531; Tyson, Gene W/0000-0001-8559-9427; Crill, Patrick/0000-0003-1110-3059; Woodcroft, Ben/0000-0003-0670-7480; Wehr, Richard/0000-0002-0806-9390	US Department of Energy Office of Biological and Environmental Research [DE-SC0004632]; University of Arizona Technology and Research Initiative Fund, through the Water, Environmental and Energy Solutions Initiative; Australian Postgraduate Award Scholarship	US Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); University of Arizona Technology and Research Initiative Fund, through the Water, Environmental and Energy Solutions Initiative; Australian Postgraduate Award Scholarship	We thank the Abisko Scientific Research Station for infrastructure and logistical support; T. Logan and N. Rakos for their assistance in the field; and S. Wofsy and S. Frolking for feedback on a draft of this paper. This work was supported by the US Department of Energy Office of Biological and Environmental Research (award DE-SC0004632), and by the University of Arizona Technology and Research Initiative Fund, through the Water, Environmental and Energy Solutions Initiative. R.M. was supported by an Australian Postgraduate Award Scholarship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backstrand K, 2010, BIOGEOSCIENCES, V7, P95; Backstrand K, 2008, TELLUS B, V60, P226, DOI 10.1111/j.1600-0889.2007.00331.x; Backstrand K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000703; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Bubier J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001946; Camill P, 1998, AM NAT, V151, P207, DOI 10.1086/286112; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan JKC, 2005, WHO CLASSIFICATION T, P85, DOI DOI 10.1016/J.ORGGEOCHEM.2004.10.007; Chanton JP, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000134; Christensen TR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018680; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Corbett JE, 2013, BIOGEOCHEMISTRY, V114, P327, DOI 10.1007/s10533-012-9813-1; Dyke LD, 2010, ARCTIC, V63, P429; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; Hines ME, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002903; Hodgkins SB, 2014, P NATL ACAD SCI USA, V111, P5819, DOI 10.1073/pnas.1314641111; Hornibrook ERC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031231; Hornibrook ERC, 1997, GEOCHIM COSMOCHIM AC, V61, P745, DOI 10.1016/S0016-7037(96)00368-7; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Johansson T, 2006, GLOBAL CHANGE BIOL, V12, P2352, DOI 10.1111/j.1365-2486.2006.01267.x; Jorgenson MT, 2001, CLIMATIC CHANGE, V48, P551, DOI 10.1023/A:1005667424292; Kai FM, 2011, NATURE, V476, P194, DOI 10.1038/nature10259; KEELING CD, 1961, GEOCHIM COSMOCHIM AC, V24, P277, DOI 10.1016/0016-7037(61)90023-0; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Lee H, 2012, GLOBAL CHANGE BIOL, V18, P515, DOI 10.1111/j.1365-2486.2011.02519.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Mondav R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4212; O'Donnell JA, 2012, ECOSYSTEMS, V15, P213, DOI 10.1007/s10021-011-9504-0; Olefeldt D, 2013, GLOBAL CHANGE BIOL, V19, P589, DOI 10.1111/gcb.12071; Pataki DE, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001850; Payette S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020358; Popp TJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P1063, DOI 10.1029/1999GB900060; Quinton WL, 2011, HYDROL PROCESS, V25, P152, DOI 10.1002/hyp.7894; R Development Core Team, 2012, LANG ENV STAT COMP; Riley WJ, 2011, BIOGEOSCIENCES, V8, P1925, DOI 10.5194/bg-8-1925-2011; Santoni GW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016960; Schuur EAG, 2013, CLIMATIC CHANGE, V119, P359, DOI 10.1007/s10584-013-0730-7; Tans PP, 1997, GLOBAL BIOGEOCHEM CY, V11, P77, DOI 10.1029/96GB03940; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Turetsky MR, 2002, SOIL BIOL BIOCHEM, V34, P907, DOI 10.1016/S0038-0717(02)00022-6; Vitt DH, 2000, CAN J FOREST RES, V30, P283, DOI 10.1139/x99-214; Wania R, 2013, GEOSCI MODEL DEV, V6, P617, DOI 10.5194/gmd-6-617-2013; WERLE P, 1993, APPL PHYS B-PHOTO, V57, P131, DOI 10.1007/BF00425997; WHITICAR MJ, 1986, ORG GEOCHEM, V10, P759, DOI 10.1016/S0146-6380(86)80013-4; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; ZOLTAI SC, 1993, ARCTIC ALPINE RES, V25, P240, DOI 10.2307/1551820	57	245	255	43	553	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					478	+		10.1038/nature13798	http://dx.doi.org/10.1038/nature13798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341787	Green Submitted			2022-12-28	WOS:000343775900037
J	Riggs, KR; DeCamp, M				Riggs, Kevin R.; DeCamp, Matthew			Providing Price Displays for Physicians Which Price Is Right?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; ATTITUDES; KNOWLEDGE; IMPACT		[Riggs, Kevin R.; DeCamp, Matthew] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21287 USA; [Riggs, Kevin R.; DeCamp, Matthew] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Riggs, KR (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 E Monument St,Room 2-612B, Baltimore, MD 21287 USA.	kriggs3@jhmi.edu	DeCamp, Matthew/N-6028-2014	Riggs, Kevin/0000-0002-0015-5809; DeCamp, Matthew/0000-0002-9371-8729	NHLBI NIH HHS [T32 HL007180, T32HL007180-38] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Feldman LS, 2013, JAMA INTERN MED, V173, P903, DOI 10.1001/jamainternmed.2013.232; Horn DM, 2014, J GEN INTERN MED, V29, P708, DOI 10.1007/s11606-013-2672-1; Lee JS, 2003, HLTH AFF MILLWOOD S; Post J, 2013, AM J MED, V126, P838, DOI 10.1016/j.amjmed.2013.05.015; Reichert S, 2000, ARCH INTERN MED, V160, P2799, DOI 10.1001/archinte.160.18.2799; Reinhardt UE, 2013, JAMA-J AM MED ASSOC, V310, P1927, DOI 10.1001/jama.2013.281854; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001	7	10	10	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1631	1632		10.1001/jama.2014.7105	http://dx.doi.org/10.1001/jama.2014.7105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335141	Green Accepted			2022-12-28	WOS:000343301400015
J	Lake, F				Lake, Fiona			Pirfenidone reduced disease progression in idiopathic pulmonary fibrosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lake, Fiona] Univ Western Australia, Perth, WA 6009, Australia; [Lake, Fiona] Sir Charles Gairdner Hosp, Perth, WA, Australia	University of Western Australia; University of Western Australia	Lake, F (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.							Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Wells AU, 2014, CURR OPIN PULM MED, V20, P442, DOI 10.1097/MCP.0000000000000085	4	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC4	10.7326/0003-4819-161-8-201410210-02004	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329221				2022-12-28	WOS:000343906800003
J	Wilkie, V				Wilkie, Veronica			British general practice: another Collings moment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Worcester, Inst Hlth & Soc, Worcester, England	University of Worcester	Wilkie, V (corresponding author), Univ Worcester, Inst Hlth & Soc, Worcester, England.	veronicawilkie456@btinternet.com						[Anonymous], 2014, BMA NEWS        1003; BMA, 2013, YOUR GP CAR; Centre for Workforce Intelligence, 2014, IN DEPTH REV GEN PRA; COLLINGS JS, 1950, LANCET, V258, P555; Commonwealth Fund, 2014, MIRR MIRR WALL 2014; Hadfield S., 1953, BMJ-BRIT MED J, V2, P717; Limb M., 2014, BMJ CAREERS; Limb M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4799; NHS GP Taskforce, 2014, SEC FUT GP WORKF DEL; Royal College of General Practitioners, 2014, PUT PAT 1	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2014	349								g6274	10.1136/bmj.g6274	http://dx.doi.org/10.1136/bmj.g6274			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OD	25335969				2022-12-28	WOS:000343768200007
J	Bachetti, M; Harrison, FA; Walton, DJ; Grefenstette, BW; Chakrabarty, D; Furst, F; Barret, D; Beloborodov, A; Boggs, SE; Christensen, FE; Craig, WW; Fabian, AC; Hailey, CJ; Hornschemeier, A; Kaspi, V; Kulkarni, SR; Maccarone, T; Miller, JM; Rana, V; Stern, D; Tendulkar, SP; Tomsick, J; Webb, NA; Zhang, WW				Bachetti, M.; Harrison, F. A.; Walton, D. J.; Grefenstette, B. W.; Chakrabarty, D.; Fuerst, F.; Barret, D.; Beloborodov, A.; Boggs, S. E.; Christensen, F. E.; Craig, W. W.; Fabian, A. C.; Hailey, C. J.; Hornschemeier, A.; Kaspi, V.; Kulkarni, S. R.; Maccarone, T.; Miller, J. M.; Rana, V.; Stern, D.; Tendulkar, S. P.; Tomsick, J.; Webb, N. A.; Zhang, W. W.			An ultraluminous X-ray source powered by an accreting neutron star	NATURE			English	Article							STRONG MAGNETIC-FIELD; XMM-NEWTON; GALAXY M82; DISCOVERY; PULSARS; CHANDRA; PULSATIONS; RADIATION; MODELS; SYSTEM	The majority of ultraluminous X-ray sources are point sources that are spatially offset from the nuclei of nearby galaxies and whose X-ray luminosities exceed the theoretical maximum for spherical infall (the Eddington limit) onto stellar-mass black holes(1,2). Their X-ray luminosities in the 0.5-10 kiloelectronvolt energy band range from 10(39) to 10(41) ergs per second(3). Because higher masses imply less extreme ratios of the luminosity to the isotropic Eddington limit, theoretical models have focused on black hole rather than neutron star systems(1,2). The most challenging sources to explain are those at the luminous end of the range (more than 10(40) ergs per second), which require black hole masses of 50-100 times the solar value or significant departures from the standard thin disk accretion that powers bright Galactic X-ray binaries, or both. Here we report broadband X-ray observations of the nuclear region of the galaxy M82 that reveal pulsations with an average period of 1.37 seconds and a 2.5-day sinusoidal modulation. The pulsations result from the rotation of a magnetized neutron star, and the modulation arises from its binary orbit. The pulsed flux alone corresponds to an X-ray luminosity in the 3-30 kiloelectronvolt range of 4.9 x 10(39) ergs per second. The pulsating source is spatially coincident with a variable source(4) that can reach an X-ray luminosity in the 0.3-10 kiloelectronvolt range of 1.8 x 10(40) ergs per second(1). This association implies a luminosity of about 100 times the Eddington limit for a 1.4-solar-mass object, or more than ten times brighter than any known accreting pulsar. This implies that neutron stars may not be rare in the ultraluminous X-ray population, and it challenges physical models for the accretion of matter onto magnetized compact objects.	[Bachetti, M.; Barret, D.; Webb, N. A.] Univ Toulouse, UPS OMP, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France; [Bachetti, M.; Barret, D.; Webb, N. A.] CNRS, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France; [Harrison, F. A.; Walton, D. J.; Grefenstette, B. W.; Fuerst, F.; Kulkarni, S. R.; Rana, V.; Tendulkar, S. P.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Chakrabarty, D.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Beloborodov, A.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Boggs, S. E.; Tomsick, J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Christensen, F. E.] Tech Univ Denmark, Natl Space Inst, DTU Space, DK-2800 Lyngby, Denmark; [Craig, W. W.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Fabian, A. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Hailey, C. J.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Hornschemeier, A.; Zhang, W. W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Kaspi, V.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Maccarone, T.] Texas Tech Univ, Dept Phys, Lubbock, TX 79409 USA; [Miller, J. M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Stern, D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); California Institute of Technology; Massachusetts Institute of Technology (MIT); Columbia University; University of California System; University of California Berkeley; Technical University of Denmark; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Cambridge; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; McGill University; Texas Tech University System; Texas Tech University; University of Michigan System; University of Michigan; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Bachetti, M (corresponding author), Univ Toulouse, UPS OMP, Inst Rech Astrophys & Planetol, 9 Ave Colonel Roche,BP 44346, F-31028 Toulouse 4, France.	mbachett@oa-cagliari.inaf.it; fiona@srl.caltech.edu	Boggs, Steven E/E-4170-2015; Barret, Didier/AAV-2771-2020; christensen, finn/AAB-8622-2020; Rana, Vikram/R-9180-2018; Bachetti, Matteo/AAC-6882-2022	Boggs, Steven E/0000-0001-9567-4224; Bachetti, Matteo/0000-0002-4576-9337; Miller, Jon/0000-0003-2869-7682; barret, didier/0000-0002-0393-9190; Stern, Daniel/0000-0003-2686-9241	NASA [NNG08FD60C]; NASA; Centre National d'Etudes Spatiales (CNES); Centre National de la Recherche Scientifique (CNRS); UK Space Agency [ST/L005611/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1009987] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); UK Space Agency; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by NASA (grant no. NNG08FD60C), and made use of data from the Nuclear Spectroscopic Telescope Array (NuSTAR) mission, a project led by Caltech, managed by the Jet Propulsion Laboratory and funded by NASA. We thank the NuSTAR operations, software and calibration teams for support with execution and analysis of these observations. This work made use of data supplied by the UK Swift Science Data Centre at the University of Leicester. M.B. thanks the Centre National d'Etudes Spatiales (CNES) and the Centre National de la Recherche Scientifique (CNRS) for support. Line plots were done using Veusz software by J. Sanders.	Arnaud KA, 1996, ASTR SOC P, V101, P17; BASKO MM, 1976, MON NOT R ASTRON SOC, V175, P395, DOI 10.1093/mnras/175.2.395; BASKO MM, 1975, ASTRON ASTROPHYS, V42, P311; BLANDFORD R, 1976, ASTROPHYS J, V205, P580, DOI 10.1086/154315; CANUTO V, 1971, PHYS REV D, V3, P2303, DOI 10.1103/PhysRevD.3.2303; CASH W, 1979, ASTROPHYS J, V228, P939, DOI 10.1086/156922; Davis JE, 2001, ASTROPHYS J, V562, P575, DOI 10.1086/323488; Edwards RT, 2006, MON NOT R ASTRON SOC, V372, P1549, DOI 10.1111/j.1365-2966.2006.10870.x; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Feng H, 2011, NEW ASTRON REV, V55, P166, DOI 10.1016/j.newar.2011.08.002; Feng H, 2010, ASTROPHYS J LETT, V710, pL137, DOI 10.1088/2041-8205/710/2/L137; GHOSH P, 1979, ASTROPHYS J, V234, P296, DOI 10.1086/157498; GNEDIN YN, 1973, ASTRON ASTROPHYS, V25, P233; Goobar A, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L12; Houck JC, 2000, ASTR SOC P, V216, P591; Kaaret P, 2001, MON NOT R ASTRON SOC, V321, pL29, DOI 10.1046/j.1365-8711.2001.04064.x; Kaaret P, 2006, ASTROPHYS J, V646, P174, DOI 10.1086/504830; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Kong AKH, 2007, ASTROPHYS J, V671, P349, DOI 10.1086/522291; Kouveliotou C, 1996, NATURE, V379, P799, DOI 10.1038/379799a0; Liu JF, 2013, NATURE, V503, P500, DOI 10.1038/nature12762; LUCKE R, 1976, ASTROPHYS J, V206, pL25, DOI 10.1086/182125; Mewe R., 1985, Astronomy & Astrophysics Supplement Series, V62, P197; MITSUDA K, 1984, PUBL ASTRON SOC JPN, V36, P741; PRINGLE JE, 1972, ASTRON ASTROPHYS, V21, P1; Ranalli P, 2008, MON NOT R ASTRON SOC, V386, P1464, DOI 10.1111/j.1365-2966.2008.13128.x; Ransom S.M., 2001, THESIS HARVARD U; Roberts TP, 2007, ASTROPHYS SPACE SCI, V311, P203, DOI 10.1007/s10509-007-9547-z; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SKINNER GK, 1982, NATURE, V297, P568, DOI 10.1038/297568a0; TITARCHUK L, 1994, ASTROPHYS J, V434, P570, DOI 10.1086/174760; Weisskopf MC, 2002, PUBL ASTRON SOC PAC, V114, P1, DOI 10.1086/338108	34	474	476	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					202	+		10.1038/nature13791	http://dx.doi.org/10.1038/nature13791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297433	Green Submitted, Green Accepted			2022-12-28	WOS:000342663100036
J	Magill, SS; Edwards, JR; Beldavs, ZG; Dumyati, G; Janelle, SJ; Kainer, MA; Lynfield, R; Nadle, J; Neuhauser, MM; Ray, SM; Richards, K; Rodriguez, R; Thompson, DL; Fridkin, SK				Magill, Shelley S.; Edwards, Jonathan R.; Beldavs, Zintars G.; Dumyati, Ghinwa; Janelle, Sarah J.; Kainer, Marion A.; Lynfield, Ruth; Nadle, Joelle; Neuhauser, Melinda M.; Ray, Susan M.; Richards, Katherine; Rodriguez, Richard; Thompson, Deborah L.; Fridkin, Scott K.		Emerging Infect Program Healthcare; Associated Infect Antimicrobial Us	Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMMUNITY-ACQUIRED PNEUMONIA; ANTIBIOTIC USE; UNITED-STATES; GENERAL HOSPITALS; TRACT-INFECTIONS; RISK-FACTORS; THERAPY; ENTEROBACTERIACEAE; STEWARDSHIP	IMPORTANCE Inappropriate antimicrobial drug use is associated with adverse events in hospitalized patients and contributes to the emergence and spread of resistant pathogens. Targeting effective interventions to improve antimicrobial use in the acute care setting requires understanding hospital prescribing practices. OBJECTIVE To determine the prevalence of and describe the rationale for antimicrobial use in participating hospitals. DESIGN, SETTING, AND PARTICIPANTS One-day prevalence surveys were conducted in acute care hospitals in 10 states between May and September 2011. Patients were randomly selected from each hospital's morning census on the survey date. Data collectors reviewed medical records retrospectively to gather data on antimicrobial drugs administered to patients on the survey date and the day prior to the survey date, including reasons for administration, infection sites treated, and whether treated infections began in community or health care settings. MAIN OUTCOMES AND MEASURES Antimicrobial use prevalence, defined as the number of patients receiving antimicrobial drugs at the time of the survey divided by the total number of surveyed patients. RESULTS Of 11 282 patients in 183 hospitals, 5635 (49.9%; 95% CI, 49.0%-50.9%) were administered at least 1 antimicrobial drug; 77.5%(95% CI, 76.6%-78.3%) of antimicrobial drugs were used to treat infections, most commonly involving the lower respiratory tract, urinary tract, or skin and soft tissues, whereas 12.2%(95% CI, 11.5%-12.8%) were given for surgical and 5.9% (95% CI, 5.5%-6.4%) for medical prophylaxis. Of 7641 drugs to treat infections, the most common were parenteral vancomycin (1103, 14.4%; 95% CI, 13.7%-15.2%), ceftriaxone (825, 10.8%; 95% CI, 10.1%-11.5%), piperacillin-tazobactam (788, 10.3%; 95% CI, 9.6%-11.0%), and levofloxacin (694, 9.1%; 95% CI, 8.5%-9.7%). Most drugs administered to treat infections were given for community-onset infections (69.0%; 95% CI, 68.0%-70.1%) and to patients outside critical care units (81.6%; 95% CI, 80.4%-82.7%). The 4 most common treatment antimicrobial drugs overall were also the most common drugs used for both community-onset and health care facility-onset infections and for infections in patients in critical care and noncritical care locations. CONCLUSIONS AND RELEVANCE In this cross-sectional evaluation of antimicrobial use in US hospitals, use of broad-spectrum antimicrobial drugs such as piperacillin-tazobactam and drugs such as vancomycin for resistant pathogens was common, including for treatment of community-onset infections and among patients outside critical care units. Further work is needed to understand the settings and indications for which reducing antimicrobial use can be most effectively and safely accomplished.	[Magill, Shelley S.; Edwards, Jonathan R.; Neuhauser, Melinda M.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Beldavs, Zintars G.] Oregon Hlth Author, Oregon Publ Hlth Div, Portland, Dorset, England; [Dumyati, Ghinwa] New York Rochester Emerging Infect Program, Rochester, NY USA; [Dumyati, Ghinwa] Univ Rochester, Med Ctr, Rochester, NY 14627 USA; [Janelle, Sarah J.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Kainer, Marion A.] Tennessee Dept Hlth, Nashville, TN USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Nadle, Joelle] Calif Emerging Infect Program, Oakland, CA USA; [Neuhauser, Melinda M.] Pharm Benefits Management Serv, Dept Vet Affairs, Hines, IL USA; [Ray, Susan M.] Atlanta Vet Affairs Med Ctr, Georgia Emerging Infect Program, Decatur, GA USA; [Ray, Susan M.] Emory Univ, Sch Med, Georgia Emerging Infect Program, Atlanta, GA USA; [Richards, Katherine] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Rodriguez, Richard] Connecticut Dept Publ Hlth, Hartford, CT USA; [Thompson, Deborah L.] New Mexico Dept Hlth, Santa Fe, NM USA	Centers for Disease Control & Prevention - USA; University of Rochester; Colorado Department of Public Health & Environment; Tennessee Department Health; Minnesota Department of Health (MHD); California Emerging Infections Program; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Maryland Department of Health & Mental Hygiene; New Mexico Department of Health	Magill, SS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-24, Atlanta, GA 30333 USA.	smagill@cdc.gov		Ray, Susan/0000-0002-6327-088X; Kainer, Marion/0000-0001-7678-8744	Emerging Infections Program; CDC's Division of Healthcare Quality Promotion, Division of Preparedness and Emerging Infections; CDC's Office of Antimicrobial Resistance	Emerging Infections Program; CDC's Division of Healthcare Quality Promotion, Division of Preparedness and Emerging Infections; CDC's Office of Antimicrobial Resistance	The survey was supported through a cooperative agreement with the Emerging Infections Program. Funds to conduct the survey came from the CDC's Division of Healthcare Quality Promotion, Division of Preparedness and Emerging Infections, and Office of Antimicrobial Resistance.	[Anonymous], NAT STAT HEALTHC ASS; [Anonymous], AN THER CLASS STRUCT; Avdic E, 2012, CLIN INFECT DIS, V54, P1581, DOI 10.1093/cid/cis242; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berrios-Torres SI, 2014, INFECT CONT HOSP EP, V35, P231, DOI 10.1086/675289; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; CASTLE M, 1977, JAMA-J AM MED ASSOC, V237, P2819, DOI 10.1001/jama.237.26.2819; CDC, 2013, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention, COR EL HOSP ANT STEW; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Centers for Disease Control and Prevention (CDC), 2010, PREV PER GROUP B STR; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Dean AG, OPENEPI OPEN SOURVE; Fauci AS, 2014, JAMA-J AM MED ASSOC, V311, P1853, DOI 10.1001/jama.2014.2465; Fridkin S, 2014, MMWR-MORBID MORTAL W, V63, P194; Fridkin SK, 2014, CLIN INFECT DIS, V58, P401, DOI 10.1093/cid/cit710; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hawkins RB, 2013, AM J SURG, V206, P451, DOI 10.1016/j.amjsurg.2013.02.009; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Huttner B, 2013, J ANTIMICROB CHEMOTH, V68, P2393, DOI 10.1093/jac/dkt171; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Jinno S, 2012, AM J INFECT CONTROL, V40, P782, DOI 10.1016/j.ajic.2011.10.010; KASS EH, 1978, ANN INTERN MED, V89, P800, DOI 10.7326/0003-4819-89-5-800; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marchaim D, 2012, INFECT CONT HOSP EP, V33, P817, DOI 10.1086/666642; Pakyz AL, 2008, ARCH INTERN MED, V168, P2254, DOI 10.1001/archinte.168.20.2254; Polgreen PM, 2007, INFECT CONT HOSP EP, V28, P212, DOI 10.1086/512174; Schouten JA, 2007, CLIN INFECT DIS, V44, P931, DOI 10.1086/512193; SHAPIRO M, 1979, J INFECT DIS, V139, P698, DOI 10.1093/infdis/139.6.698; Shorr AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-268; Srigley JA, 2013, AM J INFECT CONTROL, V41, P1116, DOI 10.1016/j.ajic.2013.04.017; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; The Joint Commission, IMPR AM HOSP JOINT C; Zilberberg MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-154	38	230	236	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1438	1446		10.1001/jama.2014.12923	http://dx.doi.org/10.1001/jama.2014.12923			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291579	Bronze			2022-12-28	WOS:000342630200020
J	Roderick, P; Pollock, AM				Roderick, Peter; Pollock, Allyson M.			A wolf in sheep's clothing: how Monitor is using licensing powers to reduce hospital and community services in England under the guise of continuity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Roderick, Peter; Pollock, Allyson M.] Queen Mary Univ London, Global Hlth Policy & Innovat Unit, Ctr Primary Care & Publ Hlth, London E1 2AB, England	University of London; Queen Mary University London	Pollock, AM (corresponding author), Queen Mary Univ London, Global Hlth Policy & Innovat Unit, Ctr Primary Care & Publ Hlth, London E1 2AB, England.	a.pollock@qmul.ac.uk		pollock, allyson/0000-0002-7388-3110				[Anonymous], 2013, GUIDANCE FOR COMMISS; [Anonymous], 2013, CONTRACT AWARD NOTIC; [Anonymous], 2012, FINAL REPORT; Comptroller and Auditor General, 2013, MANAGING THE TRANSIT, V537; Ellwood S, 2012, PUBLIC MONEY MANAGE, V32, P335, DOI 10.1080/09540962.2012.703411	5	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2014	349								g5603	10.1136/bmj.g5603	http://dx.doi.org/10.1136/bmj.g5603			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LN	25293979				2022-12-28	WOS:000342998700001
J	Opava, CH; Bjork, M				Opava, Christina H.; Bjork, Mathilda			Towards evidence-based hand exercises in rheumatoid arthritis	LANCET			English	Editorial Material							PHYSICAL-ACTIVITY; DISABILITY; DIAGNOSIS; PEOPLE		[Opava, Christina H.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, SE-14183 Huddinge, Sweden; [Opava, Christina H.] Karolinska Univ Hosp, Dept Rheumatol, Stockholm, Sweden; [Bjork, Mathilda] Linkoping Univ, Rehabil Ctr, Linkoping, Sweden; [Bjork, Mathilda] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Bjork, Mathilda] Jonkoping Univ, Sch Hlth Sci, Dept Rehabil, Jonkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Linkoping University; Jonkoping University	Opava, CH (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, SE-14183 Huddinge, Sweden.	christina.opava@ki.se						Bergstra SA, 2014, CLIN RHEUMATOL, V33, P1539, DOI 10.1007/s10067-014-2691-2; Bjork M, 2009, J RHEUMATOL, V36, P1170, DOI 10.3899/jrheum.080523; BLAKE DR, 1989, LANCET, V1, P289, DOI 10.1016/S0140-6736(89)91305-6; Bodur H, 2006, RHEUMATOL INT, V26, P541, DOI 10.1007/s00296-005-0023-1; Filaire E, 2012, JOINT BONE SPINE, V79, P341, DOI 10.1016/j.jbspin.2012.03.007; Krishnan E, 2012, ANN RHEUM DIS, V71, P213, DOI 10.1136/annrheumdis-2011-200354; Lamb SE, 2014, LANCET; Nessen T, 2014, PHYS THER, V94, P644, DOI 10.2522/ptj.20130393; Nordgren B, 2014, ARTHRIT CARE RES, V66, P662, DOI 10.1002/acr.22189; Taylor P, 2010, J INT MED RES, V38, P1213, DOI 10.1177/147323001003800402; Thyberg I, 2012, CLIN RHEUMATOL, V31, P775, DOI 10.1007/s10067-012-1937-0	11	3	5	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					396	398		10.1016/S0140-6736(14)61285-X	http://dx.doi.org/10.1016/S0140-6736(14)61285-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25308291				2022-12-28	WOS:000348509900005
J	Yamin, D; Gertler, S; Ndeffo-Mbah, ML; Skrip, LA; Fallah, M; Nyenswah, TG; Altice, FL; Galvani, AP				Yamin, Dan; Gertler, Shai; Ndeffo-Mbah, Martial L.; Skrip, Laura A.; Fallah, Mosoka; Nyenswah, Tolbert G.; Altice, Frederick L.; Galvani, Alison P.			Effect of Ebola Progression on Transmission and Control in Liberia	ANNALS OF INTERNAL MEDICINE			English	Article							HEMORRHAGIC-FEVER; WEST-AFRICA; VIRAL LOAD; RESPONSES; DYNAMICS; OUTBREAK; CONGO; RISK	Background: The Ebola outbreak that is sweeping across West Africa is the largest, most volatile, and deadliest Ebola epidemic ever recorded. Liberia is the most profoundly affected country, with more than 3500 infections and 2000 deaths recorded in the past 3 months. Objective: To evaluate the contribution of disease progression and case fatality on transmission and to examine the potential for targeted interventions to eliminate the disease. Design: Stochastic transmission model that integrates epidemiologic and clinical data on incidence and case fatality, daily viral load among survivors and nonsurvivors evaluated on the basis of the 2000-2001 outbreak in Uganda, and primary data on contacts of patients with Ebola in Liberia. Setting: Montserrado County, Liberia, July to September 2014. Measurements: Ebola incidence and case-fatality records from 2014 Liberian Ministry of Health and Social Welfare. Results: The average number of secondary infections generated throughout the entire infectious period of a single infected case, R, was estimated as 1.73 (95% CI, 1.66 to 1.83). There was substantial stratification between survivors (R-Survivors), for whom the estimate was 0.66 (CI, 0.10 to 1.69), and nonsurvivors (R-Nonsurvivors), for whom the estimate was 2.36 (CI, 1.72 to 2.80). The nonsurvivors had the highest risk for transmitting the virus later in the course of disease progression. Consequently, the isolation of 75% of infected individuals in critical condition within 4 days from symptom onset has a high chance of eliminating the disease. Limitation: Projections are based on the initial dynamics of the epidemic, which may change as the outbreak and interventions evolve. Conclusion: These results underscore the importance of isolating the most severely ill patients with Ebola within the first few days of their symptomatic phase.	[Yamin, Dan; Gertler, Shai; Ndeffo-Mbah, Martial L.; Skrip, Laura A.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, New Haven, CT 06510 USA; [Fallah, Mosoka; Nyenswah, Tolbert G.] Minist Hlth & Social Welf, Monrovia 1000 10, Liberia; [Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06510 USA	Yale University; Yale University	Yamin, D (corresponding author), Yale Univ, Sch Publ Hlth, 135 Coll St,Suite 200, New Haven, CT 06510 USA.	dan.yamin@gmail.com	Gertler, Shai/AAD-2052-2019	Ndeffo Mbah, Martial/0000-0003-4158-7613; Altice, Frederick/0000-0002-7860-693X	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health.	Althaus C, 2014, PLOS CURR OUTBREAKS; ANDERSON R M, 1991; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Brauer F., 2005, ELECTRON J DIFFER EQ, V2005, P29; Centers for Disease Control and Prevention, 2014, EBOLA OUTBREAK IN WE; Cooper Helene, 2014, NEW YORK TIMES; Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Eichner Martin, 2011, Osong Public Health Res Perspect, V2, P3, DOI 10.1016/j.phrp.2011.04.001; Formenty P, 2008, CONTROL OF COMMUNICA; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Galvani AP, 2014, ANN INTERN MED, V161, P749, DOI 10.7326/M14-1904; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Liberia Institute of Statistics and Geo-Information Services, 2008, 2008 NATIONAL POPULA; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; Ministry of Health and Social Welfare Republic of Liberia., 2014, LIBERIA EBOLA SITREP; Ministry of Healthand Social Welfare Republic of Liberia, 2014, SITUATION REPORT ON; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Owers S, 2014, PLOS CURR OUTBREAKS; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; World Health Organization, 2014, WHY THE EBOLA OUTBRE; World Health Organization (WHO), 2014, EBOLA RESPONSE ROADM	32	60	61	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					11	U140		10.7326/M14-2255	http://dx.doi.org/10.7326/M14-2255			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25347321	Green Accepted			2022-12-28	WOS:000350103000002
J	Buckley, CD; Tan, JY; Anderson, KL; Hanein, D; Volkmann, N; Weis, WI; Nelson, WJ; Dunn, AR				Buckley, Craig D.; Tan, Jiongyi; Anderson, Karen L.; Hanein, Dorit; Volkmann, Niels; Weis, William I.; Nelson, W. James; Dunn, Alexander R.			The minimal cadherin-catenin complex binds to actin filaments under force	SCIENCE			English	Article							CELL-ADHESION MOLECULES; ALPHA-E-CATENIN; BETA-CATENIN; CATCH BONDS; ADHERENS JUNCTIONS; F-ACTIN; SLIP BONDS; VINCULIN; PROTEIN; DISSOCIATION	Linkage between the adherens junction (AJ) and the actin cytoskeleton is required for tissue development and homeostasis. In vivo findings indicated that the AJ proteins E-cadherin, beta-catenin, and the filamentous (F)-actin binding protein alpha E-catenin form a minimal cadherin-catenin complex that binds directly to F-actin. Biochemical studies challenged this model because the purified cadherin-catenin complex does not bind F-actin in solution. Here, we reconciled this difference. Using an optical trap-based assay, we showed that the minimal cadherin-catenin complex formed stable bonds with an actin filament under force. Bond dissociation kinetics can be explained by a catch-bond model in which force shifts the bond from a weakly to a strongly bound state. These results may explain how the cadherin-catenin complex transduces mechanical forces at cell-cell junctions.	[Buckley, Craig D.; Dunn, Alexander R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Tan, Jiongyi; Weis, William I.; Dunn, Alexander R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Anderson, Karen L.; Hanein, Dorit; Volkmann, Niels] Sanford Burnham Med Res Inst, Bioinformat & Struct Syst Biol Program, La Jolla, CA 92037 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Weis, William I.; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Dunn, Alexander R.] Stanford Univ, Stanford Cardiovascular Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Stanford University; Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	bill.weis@stanford.edu; wjnelson@stanford.edu; alex.dunn@stanford.edu	Weis, William/G-1437-2011	Weis, William/0000-0002-5583-6150	NSF; Stanford Bio-X predoctoral fellowships; Burroughs Wellcome Career Award at the Scientific Interface; NSF [EFRI 1136790]; NIH [1DP2OD007078, GM35527, GM56169, P01GM098412, UO1GM094663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R37GM035527, R01GM056169, P01GM098412, U01GM094663, T32GM008294] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007078] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Stanford Bio-X predoctoral fellowships; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank S. Pokutta, J. Bianchini, and P. Miller for help with protein purification and biochemistry. C. D. B. thanks J. Sung and S. Nag for assistance with optical trapping instrumentation. D. H. and N.V. thank W. Ochoa, M. Rodriguez Lee, and C. Page for their contribution to the study, and H. Freeze and F. Levine for advice and discussion. The data reported in this paper are further detailed in the supplementary materials. This work was supported by NSF predoctoral fellowships (C. D. B. and J. T.), Stanford Bio-X predoctoral fellowships (C. D. B. and J. T.), a Burroughs Wellcome Career Award at the Scientific Interface (A. R. D.), the NSF (EFRI 1136790 to W. I. W., W.J.N., and A. R. D.), and the NIH (New Innovator Award 1DP2OD007078 to A. R. D., GM35527 to W.J.N., GM56169 to W. I. W., P01GM098412 to D. H. and N.V., and UO1GM094663 to W.J.N., W. I. W., D. H., and N.V.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; Bartolo D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051910; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Chakrabarti S, 2014, P NATL ACAD SCI USA, V111, P9048, DOI 10.1073/pnas.1405384111; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Clobes AM, 2014, J MUSCLE RES CELL M, V35, P143, DOI 10.1007/s10974-014-9375-z; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Janssens B, 2001, J CELL SCI, V114, P3177; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Manibog K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4941; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	52	357	359	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		600	+	1254211	10.1126/science.1254211	http://dx.doi.org/10.1126/science.1254211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359979	Green Accepted			2022-12-28	WOS:000343799700039
J	Maruthappu, M; Sood, HS; Keogh, B				Maruthappu, Mahiben; Sood, Harpreet S.; Keogh, Bruce			The NHS Five Year Forward View: implications for clinicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The Five Year Forward View is a look at what the NHS could achieve, given the range of resources that may be available. It sets out how the health service needs to change, arguing for a more engaged relationship with patients, carers, and citizens to promote wellbeing and prevent ill health. Here, we outline how the Forward View supports clinicians to provide better, higher quality and more integrated care. New models of care are presented, including multispecialty providers, primary and acute care systems, urgent and emergency care networks, viable smaller hospitals, specialised services, modern maternity services, and enhanced care homes. The commitments to support clinicians are discussed, including specific proposals for primary care, initiatives to improve the health of NHS staff, dealing with gaps in the NHS workforce, and the use of technology and innovation to further enable clinicians.	[Maruthappu, Mahiben; Sood, Harpreet S.; Keogh, Bruce] NHS England, Redditch, England		Maruthappu, M (corresponding author), NHS England, Redditch, England.							NHS England, 2014, 5 YEAR FORW VIEW	1	14	14	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2014	349								g6518	10.1136/bmj.g6518	http://dx.doi.org/10.1136/bmj.g6518			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DM	25361843				2022-12-28	WOS:000344156600003
J	Amari, T; Canou, A; Aly, JJ				Amari, Tahar; Canou, Aurelien; Aly, Jean-Jacques			Characterizing and predicting the magnetic environment leading to solar eruptions	NATURE			English	Article							2006 DECEMBER 13; CORONAL MASS EJECTIONS; TWISTED FLUX TUBE; ACTIVE-REGION; VECTOR MAGNETOGRAMS; FIELD; FLARE; MODEL; EVOLUTION; ROPE	The physical mechanism responsible for coronal mass ejections has been uncertain for many years, in large part because of the difficulty of knowing the three-dimensional magnetic field in the low corona(1). Two possible models have emerged. In the first, a twisted flux rope moves out of equilibrium or becomes unstable, and the subsequent reconnection then powers the ejection(2-5). In the second, a new flux rope forms as a result of the reconnection of the magnetic lines of an arcade (a group of arches of field lines) during the eruption itself(6). Observational support for both mechanisms has been claimed(7-9). Here we report modelling which demonstrates that twisted flux ropes lead to the ejection, in support of the first model. After seeing a coronal mass ejection, we use the observed photospheric magnetic field in that region from four days earlier as a boundary condition to determine the magnetic field configuration. The field evolves slowly before the eruption, such that it can be treated effectively as a static solution. We find that on the fourth day a flux rope forms and grows (increasing its free energy). This solution then becomes the initial condition as we let the model evolve dynamically under conditions driven by photospheric changes (such as flux cancellation). When the magnetic energy stored in the configuration is too high, no equilibrium is possible and the flux rope is squeezed upwards. The subsequent reconnection drives a mass ejection.	[Amari, Tahar; Canou, Aurelien] Ecole Polytech, Ctr Phys Theor, CNRS, F-91128 Palaiseau, France; [Aly, Jean-Jacques] Univ Paris 07, AIM, CNRS, Ctr Etud Saclay,UMR CEA,UMR 7158, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA; Universite Paris Saclay	Amari, T (corresponding author), Ecole Polytech, Ctr Phys Theor, CNRS, F-91128 Palaiseau, France.	amari@cpht.polytechnique.fr			Centre National d'Etudes Spatiales (CNES)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	The numerical simulations described in this paper were performed on the IBM x3750 of the IDRIS institute of the Centre National de la Recherche Scientifique (CNRS). We thank the Centre National d'Etudes Spatiales (CNES) for its financial support. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in co-operation with ESA and NSC (Norway). Ha data used in this study were provided by Paris-Meudon Observatory, X-ray data came from Hinode/XRT and extreme-ultraviolet data came from SOHO/EIT.	Aly JJ, 2007, GEOPHYS ASTRO FLUID, V101, P249, DOI 10.1080/03091920701495320; Amari T, 2003, ASTROPHYS J, V595, P1231, DOI 10.1086/377444; Amari T, 2000, ASTROPHYS J, V529, pL49, DOI 10.1086/312444; Amari T, 2006, ASTRON ASTROPHYS, V446, P691, DOI 10.1051/0004-6361:20054076; Amari T, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L27; Amari T, 2010, ASTROPHYS J LETT, V717, pL26, DOI 10.1088/2041-8205/717/1/L26; Amari T, 1999, SIAM J SCI COMPUT, V21, P970, DOI 10.1137/S1064827596304824; Amari T., 2012, P ASP C SER, V459, P189; Antiochos SK, 1999, ASTROPHYS J, V510, P485, DOI 10.1086/306563; Aulanier G, 2010, ASTROPHYS J, V708, P314, DOI 10.1088/0004-637X/708/1/314; Boulmezaoud TZ, 2000, Z ANGEW MATH PHYS, V51, P942, DOI 10.1007/PL00001531; Cargill PJ, 2009, SPACE SCI REV, V144, P413, DOI 10.1007/s11214-008-9446-9; Chae J, 2001, ASTROPHYS J, V560, P476, DOI 10.1086/322491; Cheng X, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/28; Crouch AD, 2009, SOL PHYS, V260, P271, DOI 10.1007/s11207-009-9454-2; Fan Y, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/68; Fan Y, 2009, ASTROPHYS J, V697, P1529, DOI 10.1088/0004-637X/697/2/1529; Fan YL, 2012, RES ASTRON ASTROPHYS, V12, P563, DOI 10.1088/1674-4527/12/5/008; Forbes TG, 2006, SPACE SCI REV, V123, P251, DOI 10.1007/s11214-006-9019-8; GARY GA, 1990, SOL PHYS, V126, P21, DOI 10.1007/BF00158295; Guo Y, 2008, ASTROPHYS J, V679, P1629, DOI 10.1086/587684; Hapgood M, 2012, NATURE, V484, P311, DOI 10.1038/484311a; Howard TA, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/64; Inoue S, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/17; Inoue S, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/161; Jing J, 2008, ASTROPHYS J LETT, V676, pL81, DOI 10.1086/587058; Kliem B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255002; Kliem B, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/129; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kumar P, 2013, SOL PHYS, V288, P255, DOI 10.1007/s11207-013-0303-y; Kusano K, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/31; Leka KD, 2009, SOL PHYS, V260, P83, DOI 10.1007/s11207-009-9440-8; Lites BW, 2002, ASTROPHYS J, V575, P1131, DOI 10.1086/341471; Luoni ML, 2011, SOL PHYS, V270, P45, DOI 10.1007/s11207-011-9731-8; METCALF TR, 1994, SOL PHYS, V155, P235, DOI 10.1007/BF00680593; Min S, 2009, SOL PHYS, V258, P203, DOI 10.1007/s11207-009-9425-7; Ravindra B, 2010, B ASTRON SOC INDIA, V38, P147; Regnier S, 2002, ASTRON ASTROPHYS, V392, P1119, DOI 10.1051/0004-6361:20020993; Roussev II, 2012, NAT PHYS, V8, P845, DOI [10.1038/NPHYS2427, 10.1038/nphys2427]; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Schrijver CJ, 2008, ASTROPHYS J, V675, P1637, DOI 10.1086/527413; Shibata K, 2011, LIVING REV SOL PHYS, V8, DOI 10.12942/lrsp-2011-6; SKUMANICH A, 1987, ASTROPHYS J, V322, P473, DOI 10.1086/165743; Titov VS, 2002, ADV SPACE RES-SERIES, V29, P1087, DOI 10.1016/S0273-1177(02)00021-2; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Valori G, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220982; WANG YM, 1991, ASTROPHYS J, V383, P431, DOI 10.1086/170800; Wiegelmann T, 2006, SOL PHYS, V233, P215, DOI 10.1007/s11207-006-2092-z; Yan YH, 2001, ASTROPHYS J, V551, pL115, DOI 10.1086/319829	49	97	98	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					465	+		10.1038/nature13815	http://dx.doi.org/10.1038/nature13815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341785				2022-12-28	WOS:000343775900034
J	Kraemer, KL				Kraemer, Kevin L.			Review: In alcohol use disorders, oral naltrexone, 50 mg/d, or acamprosate reduces return to drinking	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kraemer, KL (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.							Bradley KA, 2014, JAMA-J AM MED ASSOC, V311, P1861, DOI 10.1001/jama.2014.3629; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004332.pub2	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC7	10.7326/0003-4819-161-8-201410210-02007	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329224				2022-12-28	WOS:000343906800006
J	Weinberg, DS; Myers, RE; Keenan, E; Ruth, K; Sifri, R; Ziring, B; Ross, E; Manne, SL				Weinberg, David S.; Myers, Ronald E.; Keenan, Eileen; Ruth, Karen; Sifri, Randa; Ziring, Barry; Ross, Eric; Manne, Sharon L.			Genetic and Environmental Risk Assessment and Colorectal Cancer Screening in an Average-Risk Population A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							GENOMIC MEDICINE; AMERICAN-COLLEGE; COLON-CANCER; FOLATE; HEALTH; IMPACT; INFORMATION; POLYMORPHISMS; POLYPS	Background: New methods are needed to improve health behaviors, such as adherence to colorectal cancer (CRC) screening. Personalized genetic information to guide medical decisions is increasingly available. Whether such information motivates behavioral change is unknown. Objective: To determine whether individualized genetic and environmental risk assessment (GERA) of CRC susceptibility improves adherence to screening in average-risk persons. Design: 2-group, randomized, controlled trial. (ClinicalTrials.gov: NCT0087360) Setting: 4 medical school-affiliated primary care practices. Participants: 783 participants at average risk for CRC who were not adherent to screening at study entry. Intervention: Participants were randomly assigned to usual care or GERA, which evaluated methylenetetrahydrofolate reductase polymorphisms and serum folate levels. On the basis of prespecified combinations of polymorphisms and serum folate levels, GERA recipients were told that they were at elevated or average risk for CRC. Measurements: The primary outcome was CRC screening within 6 months of study entry. Results: Overall screening rates for CRC did not statistically significantly differ between the usual care (35.7%) and GERA (33.1%) groups. After adjustment for baseline participant factors, the odds ratio for screening completion for GERA versus usual care was 0.88 (95% CI, 0.64 to 1.22). Within the GERA group, screening rates did not significantly differ between average-risk (38.1%) and elevated-risk (26.9%) participants. Odds ratios for elevated-versus average-risk participants remained nonsignificant after adjustment for covariates (odds ratio, 0.75 [CI, 0.39 to 1.42]). Limitation: Only 1 personalized genetic and environmental interaction and 1 health behavior (CRC screening) were assessed. Conclusion: In average-risk persons, CRC screening uptake was not positively associated with feedback from a single personalized GERA. Additional studies will be required to evaluate whether other approaches to providing GERA affect screening utilization differently. These findings raise concern about the effectiveness of moderately predictive assessment of genetic risk to promote favorable health care behavior.	[Weinberg, David S.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Canc Inst New Jersey, New Brunswick, NJ USA	Fox Chase Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Weinberg, DS (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	d_weinberg@fccc.edu	Ross, Eric A./S-8478-2019	Myers, Ronald E./0000-0002-8059-7390	National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA112230, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health.	Bloss CS, 2013, J MED GENET, V50, P393, DOI 10.1136/jmedgenet-2012-101207; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Cella D, 2002, HEALTH PSYCHOL, V21, P564, DOI 10.1037//0278-6133.21.6.564; Evans JP, 2011, SCIENCE, V331, P861, DOI 10.1126/science.1198039; Ghazarian AA, 2013, CANCER EPIDEM BIOMAR, V22, P501, DOI 10.1158/1055-9965.EPI-13-0156; Giles J, 2011, NATURE, V470, P18, DOI 10.1038/470018a; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Houlston RS, 2001, GASTROENTEROLOGY, V121, P282, DOI 10.1053/gast.2001.26265; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Keku T, 2002, CANCER EPIDEM BIOMAR, V11, P1611; Kim Y, 1999, NUTR REV, V57, P314; Konings EJM, 2002, CANCER-AM CANCER SOC, V95, P1421, DOI 10.1002/cncr.10866; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Ma J, 1997, CANCER RES, V57, P1098; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; McBride CM, 2012, AM J PUBLIC HEALTH, V102, P401, DOI 10.2105/AJPH.2011.300513; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; McDowell Margaret A, 2008, NCHS Data Brief, P1; Myers RE, 2011, CONTEMP CLIN TRIALS, V32, P25, DOI 10.1016/j.cct.2010.08.013; O'Neill SC, 2010, ANN BEHAV MED, V40, P127, DOI 10.1007/s12160-010-9197-1; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Ransohoff DF, 2010, EUR J CLIN INVEST, V40, P64, DOI 10.1111/j.1365-2362.2009.02232.x; Reid RJ, 2012, GENET MED, V14, P852, DOI 10.1038/gim.2012.52; Ryan BM, 2001, J LAB CLIN MED, V138, P164, DOI 10.1067/mlc.2001.117161; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Smith RA, 2012, ONCOLOGY-NY, V26, P471; Ulvik A, 2001, AM J MED GENET, V101, P246, DOI 10.1002/ajmg.1370; Wilfond BS, 1990, JAMA-J AM MED ASSOC, V263, P2777	33	29	29	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					537	U34		10.7326/M14-0765	http://dx.doi.org/10.7326/M14-0765			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9PL	25329201	Green Accepted			2022-12-28	WOS:000343906800013
J	Adrian, C				Adrian, Chris			Ash Wednesday	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Adrian, C (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	ca2597@cumc.columbia.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1515	1516		10.1001/jama.2014.9261	http://dx.doi.org/10.1001/jama.2014.9261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321906				2022-12-28	WOS:000342983200013
J	Howell, EA; Zeitlin, J; Hebert, PL; Balbierz, A; Egorova, N				Howell, Elizabeth A.; Zeitlin, Jennifer; Hebert, Paul L.; Balbierz, Amy; Egorova, Natalia			Association Between Hospital-Level Obstetric Quality Indicators and Maternal and Neonatal Morbidity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; MORTALITY-RATES; DISCHARGE DATA; RISK-FACTORS; CARE; DELIVERY; DEATHS; INFANTS; VOLUME; AUDIT	IMPORTANCE In an effort to improve the quality of care, several obstetric-specific quality measures are now monitored and publicly reported. The extent to which these measures are associated with maternal and neonatal morbidity is not known. OBJECTIVE To examine whether 2 Joint Commission obstetric quality indicators are associated with maternal and neonatal morbidity. DESIGN, SETTING, AND PARTICIPANTS Population-based observational study using linked New York City discharge and birth certificate data sets from 2010. All delivery hospitalizations were identified and 2 perinatal quality measures were calculated (elective, nonmedically indicated deliveries at 37 or more weeks of gestation and before 39 weeks of gestation; cesarean delivery performed in low-risk mothers). Published algorithms were used to identify severe maternal morbidity (delivery associated with a life-threatening complication or performance of a lifesaving procedure) and morbidity in term newborns without anomalies (births associated with complications such as birth trauma, hypoxia, and prolonged length of stay). Mixed-effects logistic regression models were used to examine the association between maternal morbidity, neonatal morbidity, and hospital-level quality measures while risk-adjusting for patient sociodemographic and clinical characteristics. MAIN OUTCOMES AND MEASURES Individual-and hospital-level maternal and neonatal morbidity. RESULTS Severe maternal morbidity occurred among 2372 of 115 742 deliveries (2.4%), and neonatal morbidity occurred among 8057 of 103 416 term newborns without anomalies (7.8%). Rates for elective deliveries performed before 39 weeks of gestation ranged from 15.5 to 41.9 per 100 deliveries among 41 hospitals. There were 11.7 to 39.3 cesarean deliveries per 100 deliveries performed in low-risk mothers. Maternal morbidity ranged from 0.9 to 5.7 mothers with complications per 100 deliveries and neonatal morbidity from 3.1 to 21.3 neonates with complications per 100 births. The maternal quality indicators elective delivery before 39 weeks of gestation and cesarean delivery performed in low-risk mothers were not associated with severe maternal complications (risk ratio [RR], 1.00 [95% CI, 0.98-1.02] and RR, 0.99 [95% CI, 0.96-1.01], respectively) or neonatal morbidity (RR, 0.99 [95% CI, 0.97-1.01] and RR, 1.01 [95% CI, 0.99-1.03], respectively). CONCLUSIONS AND RELEVANCE Rates for the quality indicators elective delivery before 39 weeks of gestation and cesarean delivery performed in low-risk mothers varied widely in New York City hospitals, as did rates of maternal and neonatal complications. However, there were no correlations between the quality indicator rates and maternal and neonatal morbidity. Current quality indicators may not be sufficiently comprehensive for guiding quality improvement in obstetric care. Copyright 2014 American Medical Association. All rights reserved.	[Howell, Elizabeth A.; Zeitlin, Jennifer; Balbierz, Amy; Egorova, Natalia] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Howell, Elizabeth A.] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Zeitlin, Jennifer] Paris Descartes Univ, INSERM,DHU Risks Pregnancy, UMR 1153,Ctr Epidemiol & Biostat,Sorbonne Paris C, Obstet Perinatal & Pediat Epidemiol Res Team Epop, Paris, France; [Hebert, Paul L.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle	Howell, EA (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, POB 1077,One Gustave L Levy Pl, New York, NY 10029 USA.	elizabeth.howell@mountsinai.org	Zeitlin, Jennifer/G-4973-2017	Zeitlin, Jennifer/0000-0002-9568-2969	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R21HD068765]; European Commission, Research Directorate, Marie Curie, IOF Fellowship grant [254171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068765] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007651] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); European Commission, Research Directorate, Marie Curie, IOF Fellowship grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by grant R21HD068765 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr Zeitlin received funding from the European Commission, Research Directorate, Marie Curie, IOF Fellowship grant 254171.	ACOG Task Force of Hypertension in Pregnancy, 2013, HYPERTENSION PREGNAN; Ash AS, 2012, STAT ISSUES ASSESSIN; Bailit JL, 2006, AM J OBSTET GYNECOL, V194, P402, DOI 10.1016/j.ajog.2005.07.045; Bailit JL, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2013.07.019, DOI 10.1016/J.AJ0G.2013.07.019]; Bailit JL, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2014.03.017, DOI 10.1016/J.AJ0G.2014.03.017]; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; California Maternal Quality Care Collaborative (CMQCC), 2010, OB HEM TOOLK; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Callaghan WM, 2008, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2007.12.020, DOI 10.1016/J.AJ0G.2007.12.020]; Centers for Medicare and Medicaid Services (CMS), HOSP COMP; Conway PH, 2013, JAMA-J AM MED ASSOC, V309, P2215, DOI 10.1001/jama.2013.4929; Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617; De Lange TE, 2008, AUST NZ J OBSTET GYN, V48, P50, DOI 10.1111/j.1479-828X.2007.00801.x; DiGiuseppe David L, 2002, Matern Child Health J, V6, P169, DOI 10.1023/A:1019726112597; Glantz JC, 2005, J REPROD MED, V50, P235; Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011; Green WH, 2000, ECONOMETRIC ANAL; Gregory KD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.033; Grobman WA, 2006, AM J OBSTET GYNECOL, V195, P868, DOI 10.1016/j.ajog.2006.06.020; Holt J, 2002, ACTA OBSTET GYN SCAN, V81, P899, DOI 10.1034/j.1600-0412.2002.811001.x; Howell EA, 2008, PEDIATRICS, V121, pE407, DOI 10.1542/peds.2007-0910; Howell EA, 2013, OBSTET GYNECOL, V121, P1201, DOI 10.1097/AOG.0b013e3182932238; Klein MC, 2002, CAN MED ASSOC J, V166, P1257; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Korst LM, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2014.03.011, DOI 10.1016/J.AJ0G.2014.03.011]; Kuklina EV, 2008, MATERN CHILD HLTH J, V12, P469, DOI 10.1007/s10995-007-0256-6; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Nannini Angela, 2002, J Am Med Womens Assoc (1972), V57, P140; National Quality Forum, HLTH TERM NEWB MEAS; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Panting-Kemp A, 2000, AM J OBSTET GYNECOL, V183, P1207, DOI 10.1067/mob.2000.108846; Panzer RJ, 2013, JAMA-J AM MED ASSOC, V310, P1971, DOI 10.1001/jama.2013.282047; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; PIPER JM, 1993, AM J EPIDEMIOL, V137, P758, DOI 10.1093/oxfordjournals.aje.a116736; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Snowden JM, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2012.09.029, DOI 10.1016/J.AJ0G.2012.09.029]; Srinivas SK, 2010, OBSTET GYNECOL, V115, P1007, DOI 10.1097/AOG.0b013e3181d9f4b6; The joint Commission, 2010, SENT EV AL PREV MAT; The Joint Commission, 2004, SENT EV AL PREV INF; The Joint Commission, 2012, BENCHM HLTH CAR; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	42	69	70	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1531	1541		10.1001/jama.2014.13381	http://dx.doi.org/10.1001/jama.2014.13381			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321908	Bronze, Green Accepted			2022-12-28	WOS:000342983200017
J	Borthakur, S; Heckman, TM; Leitherer, C; Overzier, RA				Borthakur, Sanchayeeta; Heckman, Timothy M.; Leitherer, Claus; Overzier, Roderik A.			A local clue to the reionization of the universe	SCIENCE			English	Article							LYMAN-BREAK GALAXIES; ESCAPE FRACTION; TO 3; CONTINUUM; CONSTRAINTS; FEEDBACK; ANALOGS; IMAGES; DUST	Identifying the population of galaxies that was responsible for the reionization of the universe is a long-standing quest in astronomy. We present a possible local analog that has an escape fraction of ionizing flux of 21%. Our detection confirms the existence of gaps in the neutral gas enveloping the starburst region. The candidate contains a massive yet highly compact star-forming region. The gaps are most likely created by the unusually strong winds and intense ionizing radiation produced by this extreme object. Our study also validates the indirect technique of using the residual flux in saturated low-ionization interstellar absorption lines for identifying such leaky galaxies. Because direct detection of ionizing flux is impossible at the epoch of reionization, this represents a highly valuable technique for future studies.	[Borthakur, Sanchayeeta; Heckman, Timothy M.] Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA; [Leitherer, Claus] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Overzier, Roderik A.] Minist Sci Technol & Innovat, Observ Nacl, Rio De Janeiro, Brazil	Johns Hopkins University; Space Telescope Science Institute	Borthakur, S (corresponding author), Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA.	sanch@pha.jhu.edu	Overzier, Roderik/U-1473-2019	Overzier, Roderik/0000-0002-8214-7617; Borthakur, Sanchayeeta/0000-0002-2724-8298	NASA through Space Telescope Science Institute [12886]; NASA [NAS5-26555]	NASA through Space Telescope Science Institute(Space Telescope Science Institute); NASA(National Aeronautics & Space Administration (NASA))	We thank A. Aloisi for assistance during the observations of this project, and the reviewers for their comments. S. B. is supported by a grant under program 12886 provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy Inc. under NASA contract NAS5-26555. Data used for this paper are publicly available in the Mikulski Archive for Space Telescopes (MAST) under programs 12886 and 11727.	Basu-Zych AR, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/152; Coe D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/32; Goncalves TS, 2010, ASTROPHYS J, V724, P1373, DOI 10.1088/0004-637X/724/2/1373; Grimes JP, 2009, ASTROPHYS J SUPPL S, V181, P272, DOI 10.1088/0067-0049/181/1/272; Heckman TM, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/5; Heckman TM, 2001, ASTROPHYS J, V558, P56, DOI 10.1086/322475; Hoopes CG, 2007, ASTROPHYS J SUPPL S, V173, P441, DOI 10.1086/516644; Huang KH, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/68; Iwata I, 2009, ASTROPHYS J, V692, P1287, DOI 10.1088/0004-637X/692/2/1287; Jones TA, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/52; Leitherer C, 2002, ASTROPHYS J SUPPL S, V140, P303, DOI 10.1086/342486; Leitherer C, 2010, ASTROPHYS J SUPPL S, V189, P309, DOI 10.1088/0067-0049/189/2/309; Massa D., 2013, COS DATA HDB VERSION; Mostardi RE, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/65; Nestor DB, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/47; Ouchi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/102; Overzier RA, 2010, ASTROPHYS J, V710, P979, DOI 10.1088/0004-637X/710/2/979; Overzier RA, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/1/L7; Overzier RA, 2009, ASTROPHYS J, V706, P203, DOI 10.1088/0004-637X/706/1/203; Vanzella E, 2010, ASTROPHYS J, V725, P1011, DOI 10.1088/0004-637X/725/1/1011	20	139	139	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					216	219		10.1126/science.1254214	http://dx.doi.org/10.1126/science.1254214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301623	Green Submitted			2022-12-28	WOS:000342721500043
J	Berend, K; de Vries, APJ; Gans, ROB				Berend, Kenrick; de Vries, Aiko P. J.; Gans, Rijk O. B.			Physiological Approach to Assessment of Acid-Base Disturbances	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RENAL TUBULAR-ACIDOSIS; INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; SERUM ANION GAP; METABOLIC-ACIDOSIS; DISORDERS; DIAGNOSIS; STEWART; ALKALOSIS; LACTATE		[Berend, Kenrick] St Elizabeth Hosp, Dept Internal Med, Breedestr 193, Willemstad, Curacao, Netherlands; [de Vries, Aiko P. J.] Leiden Univ, Med Ctr, Dept Med, Div Nephrol, Leiden, Netherlands; [de Vries, Aiko P. J.] Leiden Univ, Leiden, Netherlands; [Gans, Rijk O. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Groningen	Berend, K (corresponding author), St Elizabeth Hosp, Dept Internal Med, Breedestr 193, Willemstad, Curacao, Netherlands.	kenber2@me.com	de Vries, Aiko P.J./J-5397-2015	de Vries, Aiko P.J./0000-0002-9284-3595; berend, kenrick/0000-0003-0996-8539				Adrogue HJ, 2006, J NEPHROL, V19, pS97; Adrogue HJ, 2009, KIDNEY INT, V76, P1239, DOI 10.1038/ki.2009.359; Ahya SN, 2006, SEMIN NEPHROL, V26, P466, DOI 10.1016/j.semnephrol.2006.11.001; Ayers P, 2008, NUTR CLIN PRACT, V23, P122, DOI 10.1177/0884533608314534; Berend K, 2013, J CRIT CARE, V28, P1103, DOI 10.1016/j.jcrc.2013.04.014; Berend K, 2013, J NEPHROL, V26, P254, DOI 10.5301/jn.5000191; Berend K, 2012, EUR J INTERN MED, V23, P203, DOI 10.1016/j.ejim.2011.11.013; Berkman M, 2009, J EMERG MED, V36, P391, DOI 10.1016/j.jemermed.2007.12.020; Bull SV, 2007, CRIT CARE MED, V35, P41, DOI 10.1097/01.CCM.0000249825.18677.D2; Chang YM, 2010, KIDNEY INT, V77, P261, DOI 10.1038/ki.2009.437; Chawla LS, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-18; Corey HE, 2006, J LAB CLIN MED, V147, P121, DOI 10.1016/j.lab.2005.10.004; Corey HE, 2006, PEDIATR NEPHROL, V21, P206, DOI 10.1007/s00467-005-2081-8; Crapo RO, 1999, AM J RESP CRIT CARE, V160, P1525, DOI 10.1164/ajrccm.160.5.9806006; Dubin A, 2007, CRIT CARE MED, V35, P1264, DOI 10.1097/01.CCM.0000259536.11943.90; Duewall Jennifer L, 2010, Proc (Bayl Univ Med Cent), V23, P19; Durward A, 2001, INTENS CARE MED, V27, P828, DOI 10.1007/s001340100915; Emmett M, 2002, ACID BASE ELECTROLYT, P41; Farwell Wildon R, 2010, CMAJ, V182, P137, DOI 10.1503/cmaj.090329; Feldman M, 2005, J LAB CLIN MED, V146, P317, DOI 10.1016/j.lab.2005.07.008; Fidkowski C, 2009, CAN J ANAESTH, V56, P247, DOI 10.1007/s12630-008-9037-y; Finkel KW, 2002, ACID BASE ELECTROLYT, P55; Funk GC, 2005, LIVER INT, V25, P505, DOI 10.1111/j.1478-3231.2005.01013.x; Funk GC, 2007, LIVER INT, V27, P901, DOI 10.1111/j.1478-3231.2007.01510.x; Gennari FJ, 2008, CLIN J AM SOC NEPHRO, V3, P1861, DOI 10.2215/CJN.02450508; Ghosh A K, 2006, J Assoc Physicians India, V54, P720; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; Guyton A.C., 2006, TXB MED PHYSL; Handy J., 2006, CURR ANAESTH CRIT CA, V17, P71; Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148; Hassan H, 2004, MT SINAI J MED, V71, P281; Hasselbalch K. A., 1917, BIOCHEM Z, V78, P112; Hatherill M, 2002, ARCH DIS CHILD, V87, P526, DOI 10.1136/adc.87.6.526; Heffner AC, 2009, CRITICAL CARE NEPHRO, P621; Henderson LJ, 1908, AM J PHYSIOL, V21, P427, DOI 10.1152/ajplegacy.1908.21.4.427; Horinek EL, 2009, ANN PHARMACOTHER, V43, P1964, DOI 10.1345/aph.1M313; Jammalamadaka D, 2010, AM J MED SCI, V339, P276, DOI 10.1097/MAJ.0b013e3181c94601; Jones BJ, 2009, INT J CLIN PRACT, V63, P1409, DOI 10.1111/j.1742-1241.2009.02074.x; JONES JS, 1993, ANN EMERG MED, V22, P1177, DOI 10.1016/S0196-0644(05)80985-0; Jones Norman L, 2003, Can Respir J, V10, P301; Katzir Z, 2008, NEPHROL DIAL TRANSPL, V23, P1211, DOI 10.1093/ndt/gfm583; Kellum JA, 2005, INTENSIVE CARE MEDICINE: ANNUAL UPDATE 2005, P675; Kellum JA, 2005, CRIT CARE CLIN, V21, P329, DOI 10.1016/j.ccc.2005.01.010; Kellum JA, 2009, CRITICAL CARE NEPHRO, P611; KRAPF R, 1991, NEW ENGL J MED, V324, P1394, DOI 10.1056/NEJM199105163242003; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807; Kurtz I, 2008, AM J PHYSIOL-RENAL, V294, pF1009, DOI 10.1152/ajprenal.00475.2007; Laski ME, 2006, SEMIN NEPHROL, V26, P404, DOI 10.1016/j.semnephrol.2006.09.001; Leverve XM, 2005, CRIT CARE, V9, P622, DOI 10.1186/cc3935; Lolekha PH, 2001, CLIN CHIM ACTA, V307, P87, DOI 10.1016/S0009-8981(01)00437-5; Lolekha PH, 2001, CLIN CHIM ACTA, V307, P33, DOI 10.1016/S0009-8981(01)00459-4; Lynd LD, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-5; Maciel AT, 2009, J CRIT CARE, V24, P477, DOI 10.1016/j.jcrc.2009.01.005; Mansoor S, 2007, CLIN BIOCHEM, V40, P226, DOI 10.1016/j.clinbiochem.2006.10.011; Martinu Tereza, 2003, Can Respir J, V10, P311; Mehta AN, 2008, LANCET, V372, P892, DOI 10.1016/S0140-6736(08)61398-7; Meng QH, 2010, CLIN CHIM ACTA, V411, P601, DOI 10.1016/j.cca.2010.01.003; Mirza N, 2009, BRIT J CLIN PHARMACO, V68, P655, DOI 10.1111/j.1365-2125.2009.03521.x; Moammar MQ, 2008, CLIN EXP PHARMACOL P, V35, P1032, DOI 10.1111/j.1440-1681.2008.04971.x; Moe OW, 2003, BEST PRACT RES CL EN, V17, P559, DOI 10.1016/S1521-690X(03)00054-X; Mokhlesi B, 2003, CHEST, V123, P577, DOI 10.1378/chest.123.2.577; Morris CG, 2008, ANAESTHESIA, V63, P294, DOI 10.1111/j.1365-2044.2007.05370.x; Mrozik LT, 2009, AUST CRIT CARE, V22, P172, DOI 10.1016/j.aucc.2009.05.001; NARINS RG, 1980, MEDICINE, V59, P161, DOI 10.1097/00005792-198005000-00001; Nguyen BV, 2009, ANESTH ANALG, V109, P1517, DOI 10.1213/ANE.0b013e3181b62664; Noritomi DT, 2009, CRIT CARE MED, V37, P2733, DOI 10.1097/CCM.0b013e3181a59165; Otani N, 2010, AM J EMERG MED, V28, P577, DOI 10.1016/j.ajem.2009.02.011; Palmer BF, 2008, PRIMARY CARE, V35, P195, DOI 10.1016/j.pop.2008.01.004; Rastegar A, 2007, J AM SOC NEPHROL, V18, P2429, DOI 10.1681/ASN.2006121408; Reddy P, 2009, INT J CLIN PRACT, V63, P1516, DOI 10.1111/j.1742-1241.2009.02000.x; Rennke HG, 2010, RENAL PATHOPHYSIOLOG; Rowe JK, 2007, SURGERY, V25, P375; Sarrazin Frederic, 2007, J Clin Monit Comput, V21, P253, DOI 10.1007/s10877-007-9082-z; Soriano JR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023430.92674.E5; Story DA, 2006, ANESTH ANALG, V103, P144, DOI 10.1213/01.ane.0000221449.67354.52; Taylor D, 2006, INTENS CARE MED, V32, P295, DOI 10.1007/s00134-005-0009-1; Tuhay G, 2008, CRIT CARE, V12, DOI 10.1186/cc6896; Ucgun I, 2008, RESPIRATION, V76, P270, DOI 10.1159/000131707; Whittington JE, 2010, CLIN CHEM, V56, P1353, DOI 10.1373/clinchem.2010.147199; Zavorsky GS, 2005, CLIN J SPORT MED, V15, P261	82	120	129	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1434	1445		10.1056/NEJMra1003327	http://dx.doi.org/10.1056/NEJMra1003327			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295502				2022-12-28	WOS:000342674800012
J	Xiong, FZ; Ma, WZ; Hiscock, TW; Mosaliganti, KR; Tentner, AR; Brakke, KA; Rannou, N; Gelas, A; Souhait, L; Swinburne, IA; Obholzer, ND; Megason, SG				Xiong, Fengzhu; Ma, Wenzhe; Hiscock, Tom W.; Mosaliganti, Kishore R.; Tentner, Andrea R.; Brakke, Kenneth A.; Rannou, Nicolas; Gelas, Arnaud; Souhait, Lydie; Swinburne, Ian A.; Obholzer, Nikolaus D.; Megason, Sean G.			Interplay of Cell Shape and Division Orientation Promotes Robust Morphogenesis of Developing Epithelia	CELL			English	Article							TISSUE MORPHOGENESIS; CLEAVAGE PLANE; EMBRYONIC-DEVELOPMENT; ENVELOPING LAYER; ZEBRAFISH; MICROSCOPY; DROSOPHILA; POLARITY; ADHESION; DOMAINS	Epithelial cells acquire functionally important shapes (e.g., squamous, cuboidal, columnar) during development. Here, we combine theory, quantitative imaging, and perturbations to analyze how tissue geometry, cell divisions, and mechanics interact to shape the presumptive enveloping layer (pre-EVL) on the zebrafish embryonic surface. We find that, under geometrical constraints, pre-EVL flattening is regulated by surface cell number changes following differentially oriented cell divisions. The division pattern is, in turn, determined by the cell shape distribution, which forms under geometrical constraints by cell-cell mechanical coupling. An integrated mathematical model of this shape-division feedback loop recapitulates empirical observations. Surprisingly, the model predicts that cell shape is robust to changes of tissue surface area, cell volume, and cell number, which we confirm in vivo. Further simulations and perturbations suggest the parameter linking cell shape and division orientation contributes to epithelial diversity. Together, our work identifies an evolvable design logic that enables robust cell-level regulation of tissue-level development.	[Xiong, Fengzhu; Ma, Wenzhe; Hiscock, Tom W.; Mosaliganti, Kishore R.; Tentner, Andrea R.; Rannou, Nicolas; Gelas, Arnaud; Souhait, Lydie; Swinburne, Ian A.; Obholzer, Nikolaus D.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Brakke, Kenneth A.] Susquehanna Univ, Dept Math, Selinsgrove, PA 17870 USA	Harvard University; Harvard Medical School; Susquehanna University	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	megason@hms.harvard.edu	Ma, Wenzhe/N-3320-2017; XIONG, FENGZHU/A-9590-2015	XIONG, FENGZHU/0000-0002-6153-0254; Hiscock, Tom/0000-0002-0319-8679	NIH [HG004071, DC010791, GM026875, 5F32HL097599]; Hearing Health Foundation Emerging Research Grant; Novartis Fellowship in Systems Biology; Biological Sciences in Dental Medicine at Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097599] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875, R37GM026875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation Emerging Research Grant; Novartis Fellowship in Systems Biology; Biological Sciences in Dental Medicine at Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. D'India for fish care. H. Otsuna, M. Wuhr, J. Zhang, K. Ishihara, M. Yajima, C. Heisenberg, P. Keller, N. Papalopulu, T. Mitchison, M. Kirschner, R. Ward, and the S. G. M. laboratory members for reagents, communications, and comments. This work is supported by NIH grants HG004071, DC010791, and GM026875. I. A. S. acknowledges NIH fellowship 5F32HL097599, a Hearing Health Foundation Emerging Research Grant, and a Novartis Fellowship in Systems Biology. F. X. is also supported by the graduate program of Biological Sciences in Dental Medicine at Harvard University.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brakke K.A., 1992, EXP MATH, V1, P141, DOI [DOI 10.1080/10586458.1992.10504253, 10.1080/10586458.1992.10504253]; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Deramaudt T, 2005, BBA-REV CANCER, V1756, P97, DOI 10.1016/j.bbcan.2005.08.003; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; FANKHAUSER G, 1945, J EXP ZOOL, V100, P445, DOI 10.1002/jez.1401000310; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Herbst E.C., 2002, THESIS U N CAROLINA; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; HO RK, 1992, DEVELOPMENT, P65; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KIMMEL CB, 1985, DEV BIOL, V108, P78, DOI 10.1016/0012-1606(85)90010-7; Kolega J., 1986, P103; Krens SFG, 2011, P NATL ACAD SCI USA, V108, pE9, DOI 10.1073/pnas.1010767108; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Megason SG, 2011, CURR OPIN GENET DEV, V21, P519, DOI 10.1016/j.gde.2011.09.012; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; Rebollo E, 2009, DEVELOPMENT, V136, P3393, DOI 10.1242/dev.041822; Sagerstrom CG, 2005, DEV DYNAM, V232, P85, DOI 10.1002/dvdy.20198; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOLPERT L, 1961, EXP CELL RES, V25, P374, DOI 10.1016/0014-4827(61)90287-7; Wray Gregory A., 1997, P309; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Zhang J, 2011, DEV GROWTH DIFFER, V53, P679, DOI 10.1111/j.1440-169X.2011.01275.x	64	73	73	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					415	427		10.1016/j.cell.2014.09.007	http://dx.doi.org/10.1016/j.cell.2014.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303534	Bronze, Green Accepted			2022-12-28	WOS:000343095600021
J	Malani, PN				Malani, Preeti N.			Contemporary Challenges to Human Health Infectious Disease Theme Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan Hlth Syst, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Malani, PN (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Infect Dis, 3119 Taubman Ctr, Ann Arbor, MI 48109 USA.	pmalani@umich.edu						Belshe RB, 2014, JAMA-J AM MED ASSOC, V312, P1420, DOI 10.1001/jama.2014.12609; Cooke CR, 2014, JAMA-J AM MED ASSOC, V312, P1397, DOI 10.1001/jama.2014.11350; Epstein L, 2014, JAMA-J AM MED ASSOC, V312, P1447, DOI 10.1001/jama.2014.12720; Frieden TR, 2014, JAMA-J AM MED ASSOC, V312, P1393, DOI 10.1001/jama.2014.11450; Kollef MH, 2014, JAMA-J AM MED ASSOC, V312, P1403, DOI 10.1001/jama.2014.8427; Magill SS, 2011, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.12923, DOI 10.1001/JAMA.2014]; Malani PN, 2014, JAMA-J AM MED ASSOC, V312, P1380, DOI 10.1001/jama.2014.13198; Morgan DJ, 2014, JAMA-J AM MED ASSOC, V312, P1395, DOI 10.1001/jama.2014.10142; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; Rutala WA, 2014, JAMA-J AM MED ASSOC, V312, P1405, DOI 10.1001/jama.2014.12559; Treanor JJ, 2014, JAMA-J AM MED ASSOC, V312, P1401, DOI 10.1001/jama.2014.12558	12	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1407	1408		10.1001/jama.2014.12673	http://dx.doi.org/10.1001/jama.2014.12673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291576				2022-12-28	WOS:000342630200016
J	Tasioulas, J; Vayena, E				Tasioulas, John; Vayena, Effy			Getting human rights right in global health policy	LANCET			English	Editorial Material									[Tasioulas, John] Kings Coll London, Dickson Poon Sch Law, Yeoh Tiong Lay Ctr Polit Philosophy & Law, London WC2R 2LS, England; [Tasioulas, John] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA; [Vayena, Effy] Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland	University of London; King's College London; Harvard University; University of Zurich	Tasioulas, J (corresponding author), Kings Coll London, Dickson Poon Sch Law, Somerset House, London WC2R 2LS, England.	john.tasioulas@kcl.ac.uk	Vayena, Effy/ABD-8272-2021	Vayena, Effy/0000-0003-1303-5467				Amnesty International, 2013, HUM RIGHTS POST 2015; Daniels N, 2008, JUST HLTH M HLTH NEE, P37; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Ferraz Octavio Luiz Motta, 2009, Health Hum Rights, V11, P33; Gostin L, 2014, GLOB HLTH LAW, P257; Gostin LO, 2013, B WORLD HEALTH ORGAN, V91, P790, DOI 10.2471/BLT.12.114447; Gostin Lawrence O, 2013, Yale J Health Policy Law Ethics, V13, P1; Raz J, 1997, RATIO JURIS, V5, P127; Sen A, 2008, LANCET, V372, P2010; Sen Amartya, 2006, CARDOZO LAW REV, V27, P2913; Tasioulas J., 2012, PHILOS HUMAN RIGHTS, P17; Tasioulas J, 2010, ETHICS, V120, P647, DOI 10.1086/653432; UN, 2013, REP HIGH LEV PAN EM; United Nations, OUTC DOC OP WORK GRO; United Nations Human Rights, 2013, SOC CULT RIGHTS GEN	15	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					E42	E44		10.1016/S0140-6736(14)61418-5	http://dx.doi.org/10.1016/S0140-6736(14)61418-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25308288				2022-12-28	WOS:000353418000003
J	Amrolia, PJ; Pule, M				Amrolia, Persis J.; Pule, Martin			Chimeric antigen receptor T cells for ALL	LANCET			English	Editorial Material							LYMPHOMA		[Amrolia, Persis J.] UCL, Inst Child Hlth, London WC1N 1EH, England; UCL, Inst Canc, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Amrolia, PJ (corresponding author), UCL, Inst Child Hlth, London WC1N 1EH, England.	persis.amrolia@gosh.nhs.uk		Pule, Martin/0000-0002-8347-9867				Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Lee DW, 2014, LANCET; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110	11	14	16	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					488	490		10.1016/S0140-6736(14)61729-3	http://dx.doi.org/10.1016/S0140-6736(14)61729-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25319502				2022-12-28	WOS:000349213600008
J	Maganga, GD; Kapetshi, J; Berthet, N; Ilunga, BK; Kabange, F; Kingebeni, PM; Mondonge, V; Muyembe, JJT; Bertherat, E; Briand, S; Cabore, J; Epelboin, A; Formenty, P; Kobinger, G; Gonzalez-Angulo, L; Labouba, I; Manuguerra, JC; Okwo-Bele, JM; Dye, C; Leroy, EM				Maganga, Gael D.; Kapetshi, Jimmy; Berthet, Nicolas; Ilunga, Benoit Kebela; Kabange, Felix; Kingebeni, Placide Mbala; Mondonge, Vital; Muyembe, Jean-Jacques T.; Bertherat, Eric; Briand, Sylvie; Cabore, Joseph; Epelboin, Alain; Formenty, Pierre; Kobinger, Gary; Gonzalez-Angulo, Lice; Labouba, Ingrid; Manuguerra, Jean-Claude; Okwo-Bele, Jean-Marie; Dye, Christopher; Leroy, Eric M.			Ebola Virus Disease in the Democratic Republic of Congo	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND The seventh reported outbreak of Ebola virus disease (EVD) in the equatorial African country of the Democratic Republic of Congo (DRC) began on July 26, 2014, as another large EVD epidemic continued to spread in West Africa. Simultaneous reports of EVD in equatorial and West Africa raised the question of whether the two outbreaks were linked. METHODS We obtained data from patients in the DRC, using the standard World Health Organization clinical-investigation form for viral hemorrhagic fevers. Patients were classified as having suspected, probable, or confirmed EVD or a non-EVD illness. Blood samples were obtained for polymerase-chain-reaction-based diagnosis, viral isolation, sequencing, and phylogenetic analysis. RESULTS The outbreak began in Inkanamongo village in the vicinity of Boende town in Equateur province and has been confined to that province. A total of 69 suspected, probable, or confirmed cases were reported between July 26 and October 7, 2014, including 8 cases among health care workers, with 49 deaths. As of October 7, there have been approximately six generations of cases of EVD since the outbreak began. The reported weekly case incidence peaked in the weeks of August 17 and 24 and has since fallen sharply. Genome sequencing revealed Ebola virus (EBOV, Zaire species) as the cause of this outbreak. A coding-complete genome sequence of EBOV that was isolated during this outbreak showed 99.2% identity with the most closely related variant from the 1995 outbreak in Kikwit in the DRC and 96.8% identity to EBOV variants that are currently circulating in West Africa. CONCLUSIONS The current EVD outbreak in the DRC has clinical and epidemiologic characteristics that are similar to those of previous EVD outbreaks in equatorial Africa. The causal agent is a local EBOV variant, and this outbreak has a zoonotic origin different from that in the 2014 epidemic in West Africa.	[Maganga, Gael D.; Berthet, Nicolas; Labouba, Ingrid; Leroy, Eric M.] World Hlth Org WHO Collaborating Ctr, Ctr Int Rech Med Franceville, Franceville, Gabon; [Ilunga, Benoit Kebela; Kabange, Felix] Minist Hlth, Kinshasa, DEM REP CONGO; [Kapetshi, Jimmy; Kingebeni, Placide Mbala; Muyembe, Jean-Jacques T.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mondonge, Vital; Cabore, Joseph] WHO, Kinshasa, DEM REP CONGO; [Berthet, Nicolas] CNRS, Unite Epidemiol & Physiopathol Virus Oncogenes, UMR3569, Paris, France; [Epelboin, Alain] CNRS, MNHN, UMR 7206, Paris, France; [Manuguerra, Jean-Claude] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infect, Paris, France; [Leroy, Eric M.] CNRS 5290, Inst Rech Dev, Unite Malad Infect & Vectuers Ecol Genet Evolut &, IRD 224,UM1,UM2, Montpellier, France; [Kobinger, Gary] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Bertherat, Eric; Briand, Sylvie; Formenty, Pierre; Gonzalez-Angulo, Lice; Okwo-Bele, Jean-Marie; Dye, Christopher] WHO, CH-1211 Geneva, Switzerland	World Health Organization; Institute Nacional de Recherche Biomedical; World Health Organization; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Public Health Agency of Canada; World Health Organization	Dye, C (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	dyec@who.int	LEROY, Eric M/I-4347-2016; CABORE, Joseph Waogodo/AAV-5998-2021; Berthet, Nicolas/J-9373-2012; GONZÁLEZ-ANGULO, Lice/HDO-5359-2022; Dye, Christopher/AIC-4659-2022	LEROY, Eric M/0000-0003-0022-0890; GONZÁLEZ-ANGULO, Lice/0000-0002-6934-0586; Dye, Christopher/0000-0002-2957-1793; CABORE, Joseph Waogodo/0000-0003-4602-6110	Centre International de Recherches Medicales de Franceville	Centre International de Recherches Medicales de Franceville	Funded by the Centre International de Recherches Medicales de Franceville and others.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Epelboin A., 2008, HUMANITARIAN STAKES, V1, P25; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212	10	155	162	0	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2083	2091		10.1056/NEJMoa1411099	http://dx.doi.org/10.1056/NEJMoa1411099			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25317743	Green Published, Bronze			2022-12-28	WOS:000345580000007
J	Woodard, SC; Rosenthal, Y; Miller, KG; Wright, JD; Chiu, BK; Lawrence, KT				Woodard, Stella C.; Rosenthal, Yair; Miller, Kenneth G.; Wright, James D.; Chiu, Beverly K.; Lawrence, Kira T.			Antarctic role in Northern Hemisphere glaciation	SCIENCE			English	Article							SOUTHERN-OCEAN; MID-PLIOCENE; BOTTOM-WATER; DEEP-WATER; CLIMATE TRANSITIONS; ISOTOPE RECORD; ICE-SHEET; ATLANTIC; TEMPERATURE; CIRCULATION	Earth's climate underwent a major transition from the warmth of the late Pliocene, when global surface temperatures were similar to 2 degrees to 3 degrees C higher than today, to extensive Northern Hemisphere glaciation (NHG) similar to 2.73 million years ago (Ma). We show that North Pacific deep waters were substantially colder (4 degrees C) and probably fresher than the North Atlantic Deep Water before the intensification of NHG. At similar to 2.73 Ma, the Atlantic-Pacific temperature gradient was reduced to < 1 degrees C, suggesting the initiation of stronger heat transfer from the North Atlantic to the deep Pacific. We posit that increased glaciation of Antarctica, deduced from the 21 +/- 10-meter sea-level fall from 3.15 to 2.75 Ma, and the development of a strong polar halocline fundamentally altered deep ocean circulation, which enhanced interhemispheric heat and salt transport, thereby contributing to NHG.	[Woodard, Stella C.; Rosenthal, Yair] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Yair; Miller, Kenneth G.; Wright, James D.; Chiu, Beverly K.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08845 USA; [Lawrence, Kira T.] Lafayette Coll, Dept Geol & Environm Geosci, Easton, PA 18042 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Lafayette College	Woodard, SC (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	woodard@marine.rutgers.edu	Wright, James/AAF-7180-2019	Wright, James/0000-0001-5212-9146	NSF [EAR-1052257, OCE-1334691]; Rutgers Aresty Undergraduate Research Fellowship	NSF(National Science Foundation (NSF)); Rutgers Aresty Undergraduate Research Fellowship	We thank N. Venti and K. Billups for providing samples and J. Crisicone, N. Abdul, and R. Mortlock for lab assistance. Funding was provided by NSF grants EAR-1052257 and OCE-1334691. B.K.C. thanks Rutgers Aresty Undergraduate Research Fellowship for its support.	Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Cronin TM, 2005, MAR MICROPALEONTOL, V54, P249, DOI 10.1016/j.marmicro.2004.12.003; Dowsett HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02013; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; Elderfield H, 2010, QUATERNARY SCI REV, V29, P160, DOI 10.1016/j.quascirev.2009.07.013; FAIRBANKS RG, 1978, QUATERNARY RES, V10, P181, DOI 10.1016/0033-5894(78)90100-X; Fantle MS, 2006, GEOCHIM COSMOCHIM AC, V70, P3883, DOI 10.1016/j.gca.2006.06.009; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; HILLENBRAND CD, 2001, P OCEAN DRILLING PRO, V0178; Hodell DA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001211; Jansen E, 2000, PALEOCEANOGRAPHY, V15, P709, DOI 10.1029/1999PA000435; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Knies J, 2014, EARTH PLANET SC LETT, V387, P132, DOI 10.1016/j.epsl.2013.11.007; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Maslin MA, 1996, GEOL RUNDSCH, V85, P452, DOI 10.1007/BF02369002; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Menviel L, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001892; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Passchier S, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002061; Ravelo AC, 2000, GEOPHYS RES LETT, V27, P1001, DOI 10.1029/1999GL007000; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; SHACKLETON NJ, 1983, EARTH PLANET SC LETT, V65, P233, DOI 10.1016/0012-821X(83)90162-0; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Steph S, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001092; Wright JD, 1996, PALEOCEANOGRAPHY, V11, P157, DOI 10.1029/95PA03696; Zhang ZS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2521	37	37	41	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					847	851		10.1126/science.1255586	http://dx.doi.org/10.1126/science.1255586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25342658				2022-12-28	WOS:000344659900044
J	Youngster, I; Russell, GH; Pindar, C; Ziv-Baran, T; Sauk, J; Hohmann, EL				Youngster, Ilan; Russell, George H.; Pindar, Christina; Ziv-Baran, Tomer; Sauk, Jenny; Hohmann, Elizabeth L.			Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VANCOMYCIN; EPIDEMIOLOGY; FIDAXOMICIN; METRONIDAZOLE; METAANALYSIS; RECURRENCE; GUIDELINES; CHILDREN; DISEASE; COST	IMPORTANCE Fecal microbiota transplantation (FMT) has been shown to be effective in treating relapsing or refractory Clostridium difficile infection, but practical barriers and safety concerns have prevented its widespread use. OBJECTIVE To evaluate the safety and rate of resolution of diarrhea following administration of frozen FMT capsules from prescreened unrelated donors to patients with recurrent C difficile infection. DESIGN, SETTING, AND PARTICIPANTS Open-label, single-group, preliminary feasibility study conducted from August 2013 through June 2014 at Massachusetts General Hospital, Boston. Twenty patients (median age, 64.5 years; range, 11-89 years) with at least 3 episodes of mild to moderate C difficile infection and failure of a 6- to 8-week taper with vancomycin or at least 2 episodes of severe C difficile infection requiring hospitalization were enrolled. INTERVENTIONS Healthy volunteers were screened as potential donors and FMT capsules were generated and stored at -80 degrees C (-112 degrees F). Patients received 15 capsules on 2 consecutive days and were followed up for symptom resolution and adverse events for up to 6 months. MAIN OUTCOMES AND MEASURES The primary end points were safety, assessed by adverse events of grade 2 or above, and clinical resolution of diarrhea with no relapse at 8 weeks. Secondary end points included improvement in subjective well-being per standardized questionnaires and daily number of bowel movements. RESULTS No serious adverse events attributed to FMT were observed. Resolution of diarrhea was achieved in 14 patients (70%; 95% CI, 47%-85%) after a single capsule-based FMT. All 6 nonresponders were re-treated; 4 had resolution of diarrhea, resulting in an overall 90% (95% CI, 68%-98%) rate of clinical resolution of diarrhea (18/20). Daily number of bowel movements decreased from a median of 5 (interquartile range [IQR], 3-6) the day prior to administration to 2 (IQR, 1-3) at day 3 (P = .001) and 1 (IQR, 1-2) at 8 weeks (P < .001). Self-ranked health scores improved significantly on a scale of 1 to 10 from a median of 5 (IQR, 5-7) for overall health and 4.5 (IQR, 3-7) for gastrointestinal-specific health on the day prior to FMT to 8 (IQR, 7-9) after FMT administration for both overall and gastrointestinal health (P = .001). Patients needing a second treatment to obtain resolution of diarrhea had lower pretreatment health scores (median, 6.5 [IQR, 5-7.3] vs 5 [IQR, 2.8-5]; P = .02). CONCLUSIONS AND RELEVANCE This preliminary study among patients with relapsing C difficile infection provides data on adverse events and rates of resolution of diarrhea following administration of FMT using frozen encapsulated inoculum from unrelated donors. Larger studies are needed to confirm these results and to evaluate long-term safety and effectiveness. Copyright 2014 American Medical Association. All rights reserved.	[Youngster, Ilan; Pindar, Christina; Hohmann, Elizabeth L.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Youngster, Ilan; Russell, George H.; Sauk, Jenny; Hohmann, Elizabeth L.] Harvard Univ, Sch Med, Boston, MA USA; [Youngster, Ilan] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02445 USA; [Russell, George H.] Boston Childrens Hosp, Dept Gastroenterol & Nutr, Boston, MA 02445 USA; [Ziv-Baran, Tomer] Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel; [Sauk, Jenny] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Massachusetts General Hospital	Youngster, I (corresponding author), Boston Childrens Hosp, Div Infect Dis, 300 Longwood Ave, Boston, MA 02445 USA.	ilan.youngster@childrens.harvard.edu	Ziv-Baran, Tomer/AAA-8408-2022; Youngster, Ilan/J-5047-2014; Youngster, Ilan/AAZ-1225-2020	Youngster, Ilan/0000-0001-5233-1213; Youngster, Ilan/0000-0001-5233-1213	National Center for Research Resources, National Institutes of Health [8UL1TR000170-05]; National Center for Advancing Translational Sciences, National Institutes of Health [8UL1TR000170-05]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by internal hospital division funds. Dr Youngster received career support from Harvard Catalyst, the Harvard Clinical and Translational Science Center, funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health award 8UL1TR000170-05, and financial contributions from Harvard University and its affiliated academic health care centers.	Austin M, 2014, AM J MED, V127, P479, DOI 10.1016/j.amjmed.2014.02.017; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Burke KE, 2014, GUT LIVER, V8, P1, DOI [10.5009/gn1.2014.8.1.1, 10.5009/gnl.2014.8.1.1]; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Dutta SK, 2014, CLIN GASTROENTEROL H, V12, P1572, DOI 10.1016/j.cgh.2013.12.032; Food and Drug Administration USA, 2013, ENF POL REG INV NEW; Fridey JL, 2007, TRANSFUS MED REV, V21, P181, DOI 10.1016/j.tmrv.2007.03.001; Garbacz G, 2014, EUR J PHARM SCI, V57, P264, DOI 10.1016/j.ejps.2013.08.039; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khanna S, 2013, CLIN INFECT DIS, V56, P1401, DOI 10.1093/cid/cit075; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Petrella LA, 2012, CLIN INFECT DIS, V55, P351, DOI 10.1093/cid/cis430; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; US Food and Drug Administration, 2014, ENF POL REG INV NEW; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004; Wendt JM, 2014, PEDIATRICS, V133, P651, DOI 10.1542/peds.2013-3049; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135	25	429	476	0	102	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1772	1778		10.1001/jama.2014.13875	http://dx.doi.org/10.1001/jama.2014.13875			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25322359	Green Published, Bronze			2022-12-28	WOS:000344194500015
J	Patel, DJ				Patel, Dinshaw J.			Complete pairing not needed	SCIENCE			English	Editorial Material							ARGONAUTE PROTEINS; CRYSTAL-STRUCTURE; BIOGENESIS; RNA; DNA								NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434	15	1	1	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		542	543		10.1126/science.1262123	http://dx.doi.org/10.1126/science.1262123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359948	Green Accepted			2022-12-28	WOS:000343799700019
J	Ruths, J; Ruths, D				Ruths, Justin; Ruths, Derek			Response to Comment on "Control profiles of complex networks"	SCIENCE			English	Editorial Material								Campbell, Shea, and Albert propose an adaptation of the Barabasi-Albert model of network formation that permits a level of tuning of the control profiles of these networks. We point out some limitations and generalizations of this method as well as highlight opportunities for future work to refine formation mechanisms to provide control profile tuning in synthetic networks.	[Ruths, Justin] Singapore Univ Technol & Design, Singapore, Singapore; [Ruths, Derek] McGill Univ, Dept Comp Sci, Montreal, PQ, Canada	Singapore University of Technology & Design; McGill University	Ruths, J (corresponding author), Singapore Univ Technol & Design, Singapore, Singapore.	justinruths@sutd.edu.sg						Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Campbell C, 2014, SCIENCE, V346, DOI 10.1126/science.1256492; Jackson MO, 2007, AM ECON REV, V97, P890, DOI 10.1257/aer.97.3.890; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063	4	6	6	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI					10.1126/science.1256714	http://dx.doi.org/10.1126/science.1256714			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359961				2022-12-28	WOS:000343799700032
J	Song, ZR; Rose, S; Safran, DG; Landon, BE; Day, MP; Chernew, ME				Song, Zirui; Rose, Sherri; Safran, Dana G.; Landon, Bruce E.; Day, Matthew P.; Chernew, Michael E.			Changes in Health Care Spending and Quality 4 Years into Global Payment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELIVERY-SYSTEM REFORM; ALTERNATIVE QUALITY; ACCOUNTABLE CARE; RISK ADJUSTMENT; MEDICAL HOME; CONTRACT; ORGANIZATIONS; PAYER; MASSACHUSETTS; PATIENT	BACKGROUND Spending and quality under global budgets remain unknown beyond 2 years. We evaluated spending and quality measures during the first 4 years of the Blue Cross Blue Shield of Massachusetts Alternative Quality Contract (AQC). METHODS We compared spending and quality among enrollees whose physician organizations entered the AQC from 2009 through 2012 with those among persons in control states. We studied spending changes according to year, category of service, site of care, experience managing risk contracts, and price versus utilization. We evaluated process and outcome quality. RESULTS In the 2009 AQC cohort, medical spending on claims grew an average of $62.21 per enrollee per quarter less than it did in the control cohort over the 4-year period (P<0.001). This amount is equivalent to a 6.8% savings when calculated as a proportion of the average post-AQC spending level in the 2009 AQC cohort. Analogously, the 2010, 2011, and 2012 cohorts had average savings of 8.8% (P<0.001), 9.1% (P<0.001), and 5.8% (P = 0.04), respectively, by the end of 2012. Claims savings were concentrated in the outpatient-facility setting and in procedures, imaging, and tests, explained by both reduced prices and reduced utilization. Claims savings were exceeded by incentive payments to providers during the period from 2009 through 2011 but exceeded incentive payments in 2012, generating net savings. Improvements in quality among AQC cohorts generally exceeded those seen elsewhere in New England and nationally. CONCLUSIONS As compared with similar populations in other states, Massachusetts AQC enrollees had lower spending growth and generally greater quality improvements after 4 years. Although other factors in Massachusetts may have contributed, particularly in the later part of the study period, global budget contracts with quality incentives may encourage changes in practice patterns that help reduce spending and improve quality.	[Song, Zirui] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Song, Zirui; Rose, Sherri; Landon, Bruce E.; Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Safran, Dana G.; Day, Matthew P.] Tufts Univ, Sch Med, Blue Cross Blue Shield Massachusetts, Boston, MA 02111 USA; [Safran, Dana G.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Song, Zirui; Chernew, Michael E.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tufts University; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; National Bureau of Economic Research	Song, ZR (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	zirui_song@post.harvard.edu			Commonwealth Fund; National Institute on Aging [F30-AG039175]; National Bureau of Economic Research Fellowship in Aging and Health Economics [T32-AG000186]; Charles H. Hood Foundation; NATIONAL INSTITUTE ON AGING [T32AG000186, F30AG039175] Funding Source: NIH RePORTER	Commonwealth Fund; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Bureau of Economic Research Fellowship in Aging and Health Economics; Charles H. Hood Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant from the Commonwealth Fund (to Dr. Chernew), a predoctoral M.D./Ph.D. National Research Service Award from the National Institute on Aging (F30-AG039175, to Dr. Song), a grant from the National Bureau of Economic Research Fellowship in Aging and Health Economics (T32-AG000186, to Dr. Song), and a grant from the Charles H. Hood Foundation (to Dr. Chernew).	Adamson D M, 2010, HLTH RES DATA REAL W; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; [Anonymous], 2012, DXCG RISK SOL DXCG S; [Anonymous], 2001, ECONOMETRIC ANAL CRO; [Anonymous], 2011, 2011 LEAD CHANG GUID; Ayanian JZ, 2013, NEW ENGL J MED, V369, P1773, DOI 10.1056/NEJMp1310910; Blue Cross Blue Shield of Massachusetts, 2012, MASS PAYM REF MOD RE; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; Ellis RP, 2007, J HEALTH ECON, V26, P25, DOI 10.1016/j.jhealeco.2006.06.004; Epstein AM, 2014, HEALTH AFFAIR, V33, P95, DOI 10.1377/hlthaff.2013.1063; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Greenberg JO, 2014, JAMA INTERN MED, V174, P454, DOI 10.1001/jamainternmed.2013.14093; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Lewis VA, 2013, HEALTH SERV RES, V48, P1840, DOI 10.1111/1475-6773.12102; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; McWilliams JM, 2013, JAMA-J AM MED ASSOC, V310, P829, DOI 10.1001/jama.2013.276302; Mechanic RE, 2011, HEALTH AFFAIR, V30, P1734, DOI 10.1377/hlthaff.2011.0264; Merrell K, 2010, HEALTH AFFAIR, V29, P852, DOI 10.1377/hlthaff.2009.0995; Muhlestein D., 2014, ACCOUNTABLE CARE GRO; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Rajkumar R, 2014, NEW ENGL J MED, V370, P493, DOI 10.1056/NEJMp1314868; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; Shortell SM, 2014, HLTH SERV RES; Silow-Carroll Sharon, 2013, Issue Brief (Commonw Fund), V10, P1; Song ZR, 2013, HEALTHCARE-J DEL SCI, V1, P15, DOI 10.1016/j.hjdsi.2013.04.003; Song ZR, 2013, JAMA-J AM MED ASSOC, V309, P35, DOI 10.1001/jama.2012.96870; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; Song ZR, 2012, NEW ENGL J MED, V366, P1560, DOI 10.1056/NEJMp1201261; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Stecker EC, 2013, NEW ENGL J MED, V368, P982, DOI 10.1056/NEJMp1214141; Wallack AR, 2011, NEW ENGL J MED, V365, P584, DOI 10.1056/NEJMp1104562; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wroten David, 2012, J Ark Med Soc, V109, P28	36	150	151	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1704	1714		10.1056/NEJMsa1404026	http://dx.doi.org/10.1056/NEJMsa1404026			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354104	Bronze, Green Accepted			2022-12-28	WOS:000343768500008
J	Maric, M; Maculins, T; De Piccoli, G; Labib, K				Maric, Marija; Maculins, Timurs; De Piccoli, Giacomo; Labib, Karim			Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replication	SCIENCE			English	Article							EUKARYOTIC DNA; SACCHAROMYCES-CEREVISIAE; POLYMERASE ALPHA; DVC1 C1ORF124; YEAST GENES; AAA-ATPASE; COMPLEX; MCM2-7; GINS; SUMO	Chromosome replication is initiated by a universal mechanism in eukaryotic cells, involving the assembly and activation at replication origins of the CMG (Cdc45-MCM-GINS) DNA helicase, which is essential for the progression of replication forks. Disassembly of CMG is likely to be a key regulated step at the end of chromosome replication, but the mechanism was unknown until now. Here we show that the ubiquitin ligase known as SCFDia2 promotes ubiquitylation of CMG during the final stages of chromosome replication in Saccharomyces cerevisiae. The Cdc48/p97 segregase then associates with ubiquitylated CMG, leading rapidly to helicase disassembly. These findings indicate that the end of chromosome replication in eukaryotes is controlled in a similarly complex fashion to the much-better-characterized initiation step.	[Maric, Marija; Labib, Karim] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Coll Life Sci, Dundee DD1 5EH, Scotland; [Maric, Marija; Maculins, Timurs; De Piccoli, Giacomo] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	University of Dundee; Cancer Research UK; University of Manchester	Labib, K (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	kpmlabib@dundee.ac.uk		Maculins, Timurs/0000-0002-9333-301X	Cancer Research UK; Medical Research Council; Wellcome Trust [097945/B/11/Z, 102943/Z/13/Z]; MRC [MC_UU_12016/13] Funding Source: UKRI; Cancer Research UK [16326] Funding Source: researchfish; Medical Research Council [MC_UU_12016/13] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Cancer Research UK, the Medical Research Council, and the Wellcome Trust (references 097945/B/11/Z for flow cytometry and 102943/Z/13/Z for an award to K.L.) for funding our work. We are grateful to M. Foltman for assistance in the early stages of the project; H. Ulrich, M. Foltman, and S. Sengupta for plasmids; R. Deshaies, M. Kanemaki, H. Morohashi, K. Nasmyth, K. Nishimura, P. Zegerman, and S. Sengupta for providing strains; A. Gambus for helpful discussions; I. Hagan and C. Wilkinson for their support during the latter stages of this work; and all members of our group for helpful discussions.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Li Y, 2013, GENES CELLS, V18, P266, DOI 10.1111/gtc.12040; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samson RY, 2013, MOL CELL, V50, P457, DOI 10.1016/j.molcel.2013.05.008; Sanchez-Diaz A., 2004, SCI STKE; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; SIKORSKI RS, 1989, GENETICS, V122, P19; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Takara TJ, 2009, CELL, V139, P652, DOI 10.1016/j.cell.2009.10.037; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	55	142	142	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					440	+	1253596	10.1126/science.1253596	http://dx.doi.org/10.1126/science.1253596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YT	25342810	Green Accepted			2022-12-28	WOS:000349773700003
J	Millard, PS				Millard, Peter S.			Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Krumholz HM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2548; Loder E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2630	2	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC2	10.7326/0003-4819-161-8-201410210-02002	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329219				2022-12-28	WOS:000343906800001
J	Zervou, FN; Zacharioudakis, IM; Mylonakis, E				Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios			Weekly dalbavancin was noninferior to daily vancomycin for acute bacterial skin infection in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Zervou, FN (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.							Jauregui LE, 2005, CLIN INFECT DIS, V41, P1407, DOI 10.1086/497271	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC9	10.7326/0003-4819-161-8-201410210-02009	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329226				2022-12-28	WOS:000343906800008
J	Dhillon, RS; Srikrishna, D; Sachs, J				Dhillon, Ranu S.; Srikrishna, Devabhaktuni; Sachs, Jeffrey			Controlling Ebola: next steps	LANCET			English	Editorial Material									[Dhillon, Ranu S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Srikrishna, Devabhaktuni] Patient Knowhow, San Mateo, CA USA; [Dhillon, Ranu S.; Sachs, Jeffrey] Columbia Univ, Earth Inst, New York, NY 10027 USA	Harvard University; Brigham & Women's Hospital; Columbia University	Sachs, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	sachs@ei.columbia.edu						Babcock C, 2012, ACAD MED, V87, P1609, DOI 10.1097/ACM.0b013e31826db6a2; Bulger C, 2014, VITAL LINK HLTH SERV; Clark P, 2014, WASHINGTON POST; Elsharkawi H., 2010, HUMANITARIAN EXCHANG, P46; European Mobile Laboratory Project, 2014, 3 UN EUR MOB LAB PRO; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Humanitarian Response, 2014, FACTS LAT S; Iyengar R, 2016, INFORM TECHNOL DEV, V22, P525, DOI 10.1080/02681102.2014.940267; Khan AS, 1999, J INFECT DIS; McKay B, 2014, WALL STREET J; Medecins Sans Frontieres, 2014, LIB MASS DISTR FAM P; Medecins Sans Frontieres, 2014, EB TREATM CTR INT EX; Mitman G, 2014, NEW ENGL J MED, V371, P1763, DOI 10.1056/NEJMp1411244; MULRINE ANNA, 2014, CHRISTIAN SCI MONITO; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; UK Government, 2014, BRIT SUPPL ARR FREET; US Agency for International Development Centers for Disease Control and Prevention, 2014, USG RESP EB OUTBR W; US Agency for International Development Maternal and Child Health Integrated Program, 2013, DEV STRENGTH COMM HL; Vogel G, 2014, SCIENCE, V345, P1549, DOI 10.1126/science.345.6204.1549; World Health Organization, 2014, EB RESP ROADM SIT RE; World Health Organization, 2013, ASS COMM HLTH WORK I	23	25	27	2	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1409	1411		10.1016/S0140-6736(14)61696-2	http://dx.doi.org/10.1016/S0140-6736(14)61696-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25308287				2022-12-28	WOS:000343107000007
J	Maude, SL; Frey, N; Shaw, PA; Aplenc, R; Barrett, DM; Bunin, NJ; Chew, A; Gonzalez, VE; Zheng, ZH; Lacey, SF; Mahnke, YD; Melenhorst, JJ; Rheingold, SR; Shen, A; Teachey, DT; Levine, BL; June, CH; Porter, DL; Grupp, SA				Maude, Shannon L.; Frey, Noelle; Shaw, Pamela A.; Aplenc, Richard; Barrett, David M.; Bunin, Nancy J.; Chew, Anne; Gonzalez, Vanessa E.; Zheng, Zhaohui; Lacey, Simon F.; Mahnke, Yolanda D.; Melenhorst, Jan J.; Rheingold, Susan R.; Shen, Angela; Teachey, David T.; Levine, Bruce L.; June, Carl H.; Porter, David L.; Grupp, Stephan A.			Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CYTOKINE RELEASE SYNDROME; ADOPTIVE IMMUNOTHERAPY; BLINATUMOMAB; SURVIVAL; PERSISTENCE; ACTIVATION; LYMPHOMA; THERAPY; DOMAINS	BACKGROUND Relapsed acute lymphoblastic leukemia (ALL) is difficult to treat despite the availability of aggressive therapies. Chimeric antigen receptor-modified T cells targeting CD19 may overcome many limitations of conventional therapies and induce remission in patients with refractory disease. METHODS We infused autologous T cells transduced with a CD19-directed chimeric antigen receptor (CTL019) lentiviral vector in patients with relapsed or refractory ALL at doses of 0.76x10(6) to 20.6x10(6) CTL019 cells per kilogram of body weight. Patients were monitored for a response, toxic effects, and the expansion and persistence of circulating CTL019 T cells. RESULTS A total of 30 children and adults received CTL019. Complete remission was achieved in 27 patients (90%), including 2 patients with blinatumomab-refractory disease and 15 who had undergone stem-cell transplantation. CTL019 cells proliferated in vivo and were detectable in the blood, bone marrow, and cerebrospinal fluid of patients who had a response. Sustained remission was achieved with a 6-month event-free survival rate of 67% (95% confidence interval [CI], 51 to 88) and an overall survival rate of 78% (95% CI, 65 to 95). At 6 months, the probability that a patient would have persistence of CTL019 was 68% (95% CI, 50 to 92) and the probability that a patient would have relapse-free B-cell aplasia was 73% (95% CI, 57 to 94). All the patients had the cytokine-release syndrome. Severe cytokine-release syndrome, which developed in 27% of the patients, was associated with a higher disease burden before infusion and was effectively treated with the anti-interleukin-6 receptor antibody tocilizumab. CONCLUSIONS Chimeric antigen receptor-modified T-cell therapy against CD19 was effective in treating relapsed and refractory ALL. CTL019 was associated with a high remission rate, even among patients for whom stem-cell transplantation had failed, and durable remissions up to 24 months were observed. (Funded by Novartis and others; CART19 ClinicalTrials.gov numbers, NCT01626495 and NCT01029366.)	[Maude, Shannon L.; Aplenc, Richard; Barrett, David M.; Bunin, Nancy J.; Rheingold, Susan R.; Teachey, David T.; Grupp, Stephan A.] Univ Penn, Childrens Hosp Philadelphia, Div Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Maude, Shannon L.; Aplenc, Richard; Barrett, David M.; Bunin, Nancy J.; Rheingold, Susan R.; Teachey, David T.; Grupp, Stephan A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shaw, Pamela A.; Aplenc, Richard] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Melenhorst, Jan J.; Levine, Bruce L.; June, Carl H.; Grupp, Stephan A.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Frey, Noelle; Porter, David L.] Univ Penn, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Frey, Noelle; Chew, Anne; Gonzalez, Vanessa E.; Zheng, Zhaohui; Lacey, Simon F.; Mahnke, Yolanda D.; Melenhorst, Jan J.; Levine, Bruce L.; June, Carl H.; Porter, David L.; Grupp, Stephan A.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shen, Angela] Novartis Pharmaceut, E Hanover, NJ USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Novartis	Grupp, SA (corresponding author), Childrens Hosp Philadelphia, Div Oncol, 3006 Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	grupp@email.chop.edu	Melenhorst, Jan/AAW-2546-2020	Melenhorst, Jan/0000-0001-7677-537X; Mahnke, Yolanda/0000-0002-2727-9887; Teachey, David/0000-0001-7373-8987	Novartis; NATIONAL CANCER INSTITUTE [P30CA147859, R01CA102646, P30CA016520, R01CA165206, R01CA116660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Novartis and others; CART19 ClinicalTrials.gov numbers, NCT01626495 and NCT01029366.	Berg SL, 2005, J CLIN ONCOL, V23, P3376, DOI 10.1200/JCO.2005.03.426; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Forman SJ, 2013, BLOOD, V121, P1077, DOI 10.1182/blood-2012-08-234492; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Jeha S, 2004, BLOOD, V103, P784, DOI 10.1182/blood-2003-06-2122; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; O'Brien S, 2013, J CLIN ONCOL, V31, P676, DOI 10.1200/JCO.2012.46.2309; Poon LM, 2013, BIOL BLOOD MARROW TR, V19, P1059, DOI 10.1016/j.bbmt.2013.04.014; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; Risma K, 2012, CURR OPIN PEDIATR, V24, P9, DOI 10.1097/MOP.0b013e32834ec9c1; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Schlegel P, 2014, HAEMATOLOGICA, V99, P1212, DOI 10.3324/haematol.2013.100073; Teachey DT, 2013, BLOOD, V121, P5154, DOI 10.1182/blood-2013-02-485623; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Topp MS, 2012, BLOOD, V120, P5185, DOI 10.1182/blood-2012-07-441030; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270	30	3282	3542	107	853	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1507	1517		10.1056/NEJMoa1407222	http://dx.doi.org/10.1056/NEJMoa1407222			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317870	Green Accepted			2022-12-28	WOS:000342994700007
J	Stepanek, O; Prabhakar, AS; Osswald, C; King, CG; Bulek, A; Naeher, D; Beaufils-Hugot, M; Abanto, ML; Galati, V; Hausmann, B; Lang, R; Cole, DK; Huseby, ES; Sewell, AK; Chakraborty, AK; Palmer, E				Stepanek, Ondrej; Prabhakar, Arvind S.; Osswald, Celine; King, Carolyn G.; Bulek, Anna; Naeher, Dieter; Beaufils-Hugot, Marina; Abanto, Michael L.; Galati, Virginie; Hausmann, Barbara; Lang, Rosemarie; Cole, David K.; Huseby, Eric S.; Sewell, Andrew K.; Chakraborty, Arup K.; Palmer, Ed			Coreceptor Scanning by the T Cell Receptor Provides a Mechanism for T Cell Tolerance	CELL			English	Article							POSITIVE SELECTION; SIGNAL-TRANSDUCTION; NEGATIVE SELECTION; THYMIC SELECTION; TYROSINE KINASE; AFFINITY THRESHOLD; ANTIGEN RECEPTOR; IN-SITU; TCR; PEPTIDE	In the thymus, high-affinity, self-reactive thymocytes are eliminated from the pool of developing T cells, generating central tolerance. Here, we investigate how developing T cells measure self-antigen affinity. We show that very few CD4 or CD8 coreceptor molecules are coupled with the signal-initiating kinase, Lck. To initiate signaling, an antigen-engaged T cell receptor (TCR) scans multiple coreceptor molecules to find one that is coupled to Lck; this is the first and rate-limiting step in a kinetic proofreading chain of events that eventually leads to TCR triggering and negative selection. MHCII-restricted TCRs require a shorter antigen dwell time (0.2 s) to initiate negative selection compared to MHCI-restricted TCRs (0.9 s) because more CD4 coreceptors are Lck-loaded compared to CD8. We generated a model (Lck come&stay/signal duration) that accurately predicts the observed differences in antigen dwell-time thresholds used by MHCI- and MHCII-restricted thymocytes to initiate negative selection and generate self-tolerance.	[Stepanek, Ondrej; Osswald, Celine; King, Carolyn G.; Naeher, Dieter; Beaufils-Hugot, Marina; Abanto, Michael L.; Galati, Virginie; Hausmann, Barbara; Lang, Rosemarie; Palmer, Ed] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Stepanek, Ondrej; Osswald, Celine; King, Carolyn G.; Naeher, Dieter; Beaufils-Hugot, Marina; Abanto, Michael L.; Galati, Virginie; Hausmann, Barbara; Lang, Rosemarie; Palmer, Ed] Univ Basel Hosp, Dept Nephrol, CH-4031 Basel, Switzerland; [Stepanek, Ondrej; Osswald, Celine; King, Carolyn G.; Naeher, Dieter; Beaufils-Hugot, Marina; Abanto, Michael L.; Galati, Virginie; Hausmann, Barbara; Lang, Rosemarie; Palmer, Ed] Univ Basel, CH-4031 Basel, Switzerland; [Prabhakar, Arvind S.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Bulek, Anna; Cole, David K.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, MGH, Ragon Inst, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Harvard Univ, Cambridge, MA 02139 USA	University of Basel; University of Basel; University of Basel; Massachusetts Institute of Technology (MIT); Cardiff University; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Stepanek, O (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	ondrej.stepanek@unibas.ch; ed.palmer@unibas.ch	Stepanek, Ondrej/AAG-3180-2020; Stepanek, Ondrej/F-8882-2013; Sewell, Andrew/GPT-4220-2022	Stepanek, Ondrej/0000-0002-2735-3311; Stepanek, Ondrej/0000-0002-2735-3311; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; King, Carolyn G./0000-0001-6059-323X	Synergia [SNF]; Sybilla [EU FP7]; TerraIncognita [ERC]; NIH [1-P01-AI071195, R01-DK095077]; BBSRC [BB/H001085/1];  [310030-149972/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109858, P01AI091580, P01AI071195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095077] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish	Synergia [SNF]; Sybilla [EU FP7]; TerraIncognita [ERC]; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank U. Schneider for animal husbandry and E. Traunecker and T. Krebs for cell sorting. This study was funded by grants to E.P. (310030-149972/1 and Synergia [SNF], Sybilla [EU FP7], and TerraIncognita [ERC]), A.K.C. (1-P01-AI071195 [NIH]), E.S.H. (R01-DK095077 [NIH]), and A.K.S. (BB/H001085/1 [BBSRC]). D.K.C. is a Wellcome Trust Career Development Fellow. A.K.S. is a Wellcome Trust Senior Investigator.	Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dushek O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001430; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kerry SE, 2003, J IMMUNOL, V171, P4493, DOI 10.4049/jimmunol.171.9.4493; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Melichar HJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004400; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; Peterson DA, 1999, J IMMUNOL, V162, P3117; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; Robert P, 2012, BIOPHYS J, V102, P248, DOI 10.1016/j.bpj.2011.11.4018; Schrum A.G., 2007, SCI STKE, V2007, ppl2; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stepanek O, 2011, J BIOL CHEM, V286, P22101, DOI 10.1074/jbc.M110.196733; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Valitutti S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00272; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Vidal K, 1999, J IMMUNOL, V163, P4811; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yin L, 2013, PROTEIN CELL, V4, P8, DOI 10.1007/s13238-012-2077-7	45	116	117	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					333	345		10.1016/j.cell.2014.08.042	http://dx.doi.org/10.1016/j.cell.2014.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25284152	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000343095600015
J	Payne, KAP; Quezada, CP; Fisher, K; Dunstan, MS; Collins, FA; Sjuts, H; Levy, C; Hay, S; Rigby, SEJ; Leys, D				Payne, Karl A. P.; Quezada, Carolina P.; Fisher, Karl; Dunstan, Mark S.; Collins, Fraser A.; Sjuts, Hanno; Levy, Colin; Hay, Sam; Rigby, Stephen E. J.; Leys, David			Reductive dehalogenase structure suggests a mechanism for B12-dependent dehalogenation	NATURE			English	Article							MOLECULAR CHARACTERIZATION; HALORESPIRATION; COB(II)ALAMIN; ENZYME	Organohalide chemistry underpins many industrial and agricultural processes, and a large proportion of environmental pollutants are organohalides(1). Nevertheless, organohalide chemistry is not exclusively of anthropogenic origin, with natural abiotic and biological processes contributing to the global halide cycle(2,3). Reductive dehalogenases are responsible for biological dehalogenation in organohalide respiring bacteria(4,5), with substrates including polychlorinated biphenyls or dioxins(6,7). Reductive dehalogenases form a distinct subfamily of cobalamin (B12)-dependent enzymes that are usuallymembrane associated and oxygen sensitive, hindering detailed studies(8-12). Here we report the characterization of a soluble, oxygen-tolerant reductive dehalogenase and, by combining structure determination with EPR (electron paramagnetic resonance) spectroscopy and simulation, show that a direct interaction between the cobalamin cobalt and the substrate halogen underpins catalysis. In contrast to the carbon-cobalt bond chemistry catalysed by the other cobalamin-dependent subfamilies(13), we propose that reductive dehalogenases achieve reduction of the organohalide substrate via halogen-cobalt bond formation. This presents a new model in both organohalide and cobalamin (bio) chemistry that will guide future exploitation of these enzymes in bioremediation or biocatalysis.	[Payne, Karl A. P.; Quezada, Carolina P.; Fisher, Karl; Dunstan, Mark S.; Collins, Fraser A.; Sjuts, Hanno; Levy, Colin; Hay, Sam; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Quezada, Carolina Paz/AAG-1981-2019; Hay, Sam/D-5974-2012; Fisher, Karl/A-5956-2013	Quezada, Carolina Paz/0000-0002-0260-5754; Hay, Sam/0000-0003-3274-0938; Fisher, Karl/0000-0003-3539-8939; Dunstan, Mark/0000-0002-9416-5505; payne, karl/0000-0002-6331-6374	ERC grant [DEHALORES206080]; CONICYT Chile; BBSRC [BB/E013007/1, BB/H021523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, 1626769, 1338042, BB/C00521X/1, BB/H021523/1] Funding Source: researchfish	ERC grant; CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an ERC grant (DEHALORES206080) to D.L. S.H. is a BBSRC David Phillips research fellow. C.P.Q. is supported by CONICYT Chile. We thank Diamond Light Source for access to beamline IO4 (proposal number MX8997) that contributed to the results presented here; R. Biedendieck (Technische Universitat Braunschweig, Germany), S. Moore and M. Warren (University of Kent, UK) for providing plasmids and assistance with B. megaterium molecular biology; the assistance given by IT Services and the use of the Computational Shared Facility at The University of Manchester; and A. Munro (University of Manchester) for critical comments and discussion.	Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BAYSTON JH, 1970, BIOCHEMISTRY-US, V9, P2164, DOI 10.1021/bi00812a020; Bommer M., 2014, SCIENCE; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Chen K, 2013, MOL MICROBIOL, V89, P1121, DOI 10.1111/mmi.12332; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Frisch M. J., 2010, GAUSSIAN 09; Gamer M, 2009, APPL MICROBIOL BIOT, V82, P1195, DOI 10.1007/s00253-009-1952-5; Gribble GW, 2012, ALKALOIDS-CHEM BIOL, V71, P1, DOI 10.1016/B978-0-12-398282-7.00001-1; Grostern A, 2009, APPL ENVIRON MICROB, V75, P2684, DOI 10.1128/AEM.02037-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Krasotkina J, 2001, J BIOL CHEM, V276, P40991, DOI 10.1074/jbc.M106217200; Lai QL, 2012, J BACTERIOL, V194, P6958, DOI 10.1128/JB.01905-12; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leys D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0316; Maillard J, 2003, APPL ENVIRON MICROB, V69, P4628, DOI 10.1128/AEM.69.8.4628-4638.2003; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14906, DOI 10.1073/pnas.1308098110; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neumann A, 2002, ARCH MICROBIOL, V177, P420, DOI 10.1007/s00203-002-0409-3; Oberg G, 2002, APPL MICROBIOL BIOT, V58, P565, DOI 10.1007/s00253-001-0895-2; Ren Z, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00018; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Stringer R, 2001, CHLORINE ENV OVERVIE; Stroupe M. E., 2005, TETRAPYRROLES THEIR, P373; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van de Pas BA, 1999, J BIOL CHEM, V274, P20287, DOI 10.1074/jbc.274.29.20287; Van Doorslaer S, 2003, J AM CHEM SOC, V125, P5915, DOI 10.1021/ja021218j; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlfarth G, 1997, CURR OPIN BIOTECH, V8, P290, DOI 10.1016/S0958-1669(97)80006-7	34	174	175	19	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					513	+		10.1038/nature13901	http://dx.doi.org/10.1038/nature13901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25327251	Green Accepted			2022-12-28	WOS:000348196500041
J	Wu, HM; Fairley, JK; Steinberg, J; Kozarsky, P				Wu, Henry M.; Fairley, Jessica K.; Steinberg, James; Kozarsky, Phyllis			The Potential Ebola-Infected Patient in the Ambulatory Care Setting: Preparing for the Worst Without Compromising Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Wu, HM (corresponding author), 550 Peachtree St NE,Med Off Tower 7, Atlanta, GA 30308 USA.	hmwu@emory.edu	Fairley, Jessica K/W-2777-2019					[Anonymous], 2014, CAS DEF EB VIR DIS E; Center for Disease Control, 2014, 2014 EB OUTBR W AFR; Centers for Disease Control and Prevention, 2014, CAS EB DIAGN US; Centers for Disease Control and Prevention, 2014, INT GUID ENV INF CON; Centers for Disease Control and Prevention, 2014, GUID PERS PROT EQ BE; Centers for Disease Control and Prevention, 2014, INT GUID SPEC COLL T; Isakov A, 2014, ANN INTERN MED, V161, P829, DOI 10.7326/M14-2084; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007	9	10	10	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					66	U109		10.7326/M14-2312	http://dx.doi.org/10.7326/M14-2312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25329137				2022-12-28	WOS:000350103000009
J	Dickson, VK; Pedi, L; Long, SB				Dickson, Veronica Kane; Pedi, Leanne; Long, Stephen B.			Structure and insights into the function of a Ca2+-activated Cl- channel	NATURE			English	Article							VITELLIFORM MACULAR DYSTROPHY; CHLORIDE CHANNEL; CRYSTAL-STRUCTURE; MOUSE BESTROPHIN-2; AROMATIC RINGS; FAMILY; PROTEIN; GENE; MUTATIONS; RELEASE	Bestrophin calcium-activated chloride channels (CaCCs) regulate the flow of chloride and other monovalent anions across cellular membranes in response to intracellular calcium (Ca2+) levels. Mutations in bestrophin 1 (BEST1) cause certain eye diseases. Here we present X-ray structures of chicken BEST1-Fab complexes, at 2.85 angstrom resolution, with permeant anions and Ca2+. Representing, to our knowledge, the first structure of a CaCC, the eukaryotic BEST1 channel, which recapitulates CaCC function in liposomes, is formed from a pentameric assembly of subunits. Ca2+ binds to the channel's large cytosolic region. A single ion pore, approximately 95 angstrom in length, is located along the central axis and contains at least 15 binding sites for anions. A hydrophobic neck within the pore probably forms the gate. Phenylalanine residues within it may coordinate permeating anions via anion-pi interactions. Conformational changes observed near the 'Ca2+ clasp' hint at the mechanism of Ca2+-dependent gating. Disease-causing mutations are prevalent within the gating apparatus.	[Dickson, Veronica Kane; Pedi, Leanne; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	Longs@mskcc.org		Kane Dickson, Veronica/0000-0002-8649-8094; Long, Stephen/0000-0002-8144-1398	Burroughs Wellcome Career Award in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM110396] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the staff at beamlines X25 and X29 of the National Synchrotron Light Source, beamline 24-ID-C of the Advanced Photon Source, and F. Weis-Garcia and the Monoclonal Antibody Facility at MSKCC. We thank C. Lima, M. Long, N. Pavletich, V. Ruta and members of the laboratory for discussions. S.B.L. is a recipient of a Burroughs Wellcome Career Award in the Biomedical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bharill S, 2014, P NATL ACAD SCI USA, V111, P6491, DOI 10.1073/pnas.1400248111; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gomez NM, 2013, PFLUG ARCH EUR J PHY, V465, P481, DOI 10.1007/s00424-012-1181-0; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hille B., 1992, IONIC CHANNELS EXCIT; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Jackson MR, 2007, J PHYS CHEM B, V111, P8242, DOI 10.1021/jp0661995; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kinnick TR, 2011, RETINA-J RET VIT DIS, V31, P581, DOI 10.1097/IAE.0b013e318203ee60; Konecny Robert, 2012, Computational Science and Discovery, V5, DOI 10.1088/1749-4699/5/1/015005; Kranjc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004672; Kunzelmann K, 2011, BIOL CHEM, V392, P125, DOI 10.1515/BC.2011.010; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marchant D, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044511; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; THOMAS KA, 1982, P NATL ACAD SCI-BIOL, V79, P4843, DOI 10.1073/pnas.79.16.4843; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wittstrom E, 2011, OPHTHALMIC GENET, V32, P217, DOI 10.3109/13816810.2011.567884; Woo DH, 2012, CELL, V151, P25, DOI 10.1016/j.cell.2012.09.005; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Yu K, 2006, INVEST OPHTH VIS SCI, V47, P4956, DOI 10.1167/iovs.06-0524; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670	62	144	146	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					213	+		10.1038/nature13913	http://dx.doi.org/10.1038/nature13913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25337878	Green Accepted			2022-12-28	WOS:000346383500037
J	Zuppinger-Dingley, D; Schmid, B; Petermann, JS; Yadav, V; De Deyn, GB; Flynn, DFB				Zuppinger-Dingley, Debra; Schmid, Bernhard; Petermann, Jana S.; Yadav, Varuna; De Deyn, Gerlinde B.; Flynn, Dan F. B.			Selection for niche differentiation in plant communities increases biodiversity effects	NATURE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIPS; GRASSLAND EXPERIMENT; SPECIES-DIVERSITY; EVOLUTION; GENOTYPES; RICHNESS	In experimental plant communities, relationships between biodiversity and ecosystem functioning have been found to strengthen over time(1,2), a fact often attributed to increased resource complementarity between species in mixtures(3) and negative plant-soil feedbacks in monocultures(4). Here we show that selection for niche differentiation between species can drive this increasing biodiversity effect. Growing 12 grassland species in test monocultures and mixtures, we found character displacement between species and increased biodiversity effects when plants had been selected over 8 years in species mixtures rather than in monocultures. When grown in mixtures, relative differences in height and specific leaf area between plant species selected in mixtures (mixture types) were greater than between species selected inmonocultures (monoculture types). Furthermore, net biodiversity and complementarity effects(1,2) were greater in mixtures of mixture types than inmixtures of monoculture types. Our study demonstrates a novel mechanism for the increase in biodiversity effects: selection for increased niche differentiation through character displacement. Selection in diverse mixtures may therefore increase species coexistence and ecosystem functioning in natural communities and may also allow increased mixture yields in agriculture or forestry. However, loss of biodiversity and prolonged selection of crops in monoculture may compromise this potential for selection in the longer term.	[Zuppinger-Dingley, Debra; Schmid, Bernhard; Yadav, Varuna; Flynn, Dan F. B.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Zuppinger-Dingley, Debra; Schmid, Bernhard; Yadav, Varuna; Flynn, Dan F. B.] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland; [Petermann, Jana S.] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Petermann, Jana S.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [De Deyn, Gerlinde B.] Wageningen Univ, NL-6708 PB Wageningen, Netherlands; [Flynn, Dan F. B.] Harvard Univ, Arnold Arboretum, Boston, MA 02131 USA	University of Zurich; University of Zurich; Free University of Berlin; Wageningen University & Research; Harvard University	Schmid, B (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernhard.schmid@ieu.uzh.ch; dan.flynn@ieu.uzh.ch	Schmid, Bernhard/C-8625-2009; Petermann, Jana/E-2130-2013; De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/F-7080-2017; De Deyn, Gerlinde/AFI-8702-2022; Flynn, Dan/A-4200-2008; Flynn, Dan/AAT-7028-2020; Zuppinger-Dingley, Debra/N-7022-2013; Petermann, Jana/AAK-9787-2020	Schmid, Bernhard/0000-0002-8430-3214; Petermann, Jana/0000-0002-3898-5656; De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; Flynn, Dan/0000-0002-2978-5257; Flynn, Dan/0000-0002-2978-5257; Petermann, Jana/0000-0002-3898-5656; Zuppinger-Dingley, Debra/0000-0002-4573-0563	Swiss National Science Foundation [130720]; University Research Priority Program Global Change and Biodiversity of the University of Zurich; NWO-ALW VIDI grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University Research Priority Program Global Change and Biodiversity of the University of Zurich; NWO-ALW VIDI grant	This study was supported by the Swiss National Science Foundation (grant number 130720 to B. S.) and the University Research Priority Program Global Change and Biodiversity of the University of Zurich. Thanks to D. Trujillo Villegas, L. Oesch, T. Zwimpfer, M. Furler, R. Husi, the gardeners of the Jena Experiment and student helpers for technical assistance. G. B. D. D. acknowledges the NWO-ALW VIDI grant scheme for financial support.	Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CONNELL J H, 1971, P298; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kulmatiski A, 2012, P ROY SOC B-BIOL SCI, V279, P3020, DOI 10.1098/rspb.2012.0285; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Roscher C, 2013, PERSPECT PLANT ECOL, V15, P139, DOI 10.1016/j.ppees.2013.02.004; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Strauss SY, 2008, ECOL LETT, V11, P199, DOI 10.1111/j.1461-0248.2007.01128.x; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TURKINGTON R, 1979, J ECOL, V67, P219, DOI 10.2307/2259346; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wacker L, 2009, J PLANT ECOL-UK, V2, P95, DOI 10.1093/jpe/rtp010; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Zeller SL, 2012, ECOL APPL, V22, P1817, DOI 10.1890/11-0876.1	30	209	215	18	430	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					108	+		10.1038/nature13869	http://dx.doi.org/10.1038/nature13869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25317555				2022-12-28	WOS:000344187500039
J	Schirle, NT; Sheu-Gruttadauria, J; MacRae, IJ				Schirle, Nicole T.; Sheu-Gruttadauria, Jessica; MacRae, Ian J.			Structural basis for microRNA targeting	SCIENCE			English	Article							POSTTRANSCRIPTIONAL REGULATION; PASSENGER-STRAND; GUIDE STRAND; C-ELEGANS; ARGONAUTE; RNA; SIRNA; CLEAVAGE; RISC; COMPLEXES	MicroRNAs (miRNAs) control expression of thousands of genes in plants and animals. miRNAs function by guiding Argonaute proteins to complementary sites in messenger RNAs (mRNAs) targeted for repression. We determined crystal structures of human Argonaute-2 (Ago2) bound to a defined guide RNA with and without target RNAs representing miRNA recognition sites. These structures suggest a stepwise mechanism, in which Ago2 primarily exposes guide nucleotides (nt) 2 to 5 for initial target pairing. Pairing to nt 2 to 5 promotes conformational changes that expose nt 2 to 8 and 13 to 16 for further target recognition. Interactions with the guide-target minor groove allow Ago2 to interrogate target RNAs in a sequence-independent manner, whereas an adenosine binding-pocket opposite guide nt 1 further facilitates target recognition. Spurious slicing of miRNA targets is avoided through an inhibitory coordination of one catalytic magnesium ion. These results explain the conserved nucleotide-pairing patterns in animal miRNA target sites first observed over two decades ago.	[Schirle, Nicole T.; Sheu-Gruttadauria, Jessica; MacRae, Ian J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022		National Institute of General Medical Sciences [P41 GM103403]; U.S. Department of Energy [DE-AC02-06CH11357]; NIH [R01 GM104475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104475, P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to P. D. Zamore and J. R. Williamson for generous advice and scientific insights. Diffraction data were collected at beam lines 11-1 and 12-2 at the Stanford Synchrotron Radiation Lightsource and 24-ID-E at the Advanced Photon Source, supported by National Institute of General Medical Sciences grant P41 GM103403 and U.S. Department of Energy contract DE-AC02-06CH11357. N.T.S. is a predoctoral fellow of the American Heart Association and an Achievement Rewards for College Scientists (ARCS) scholar. The work was supported by NIH grant R01 GM104475 to I. J. M. Coordinates of the Ago2-guide and guide-target complexes have been deposited in the Protein Data Bank (PDB) (4W5N, 4W5O, 4W5Q, 4W5R, and 4W5T).	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hauptmann J, 2013, NAT STRUCT MOL BIOL, V20, P814, DOI 10.1038/nsmb.2577; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Nakanishi K, 2013, CELL REP, V3, P1893, DOI 10.1016/j.celrep.2013.06.010; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Poulsen C, 2013, PLANT CELL, V25, P22, DOI 10.1105/tpc.112.105643; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; ROSS PD, 1960, P NATL ACAD SCI USA, V46, P1360, DOI 10.1073/pnas.46.10.1360; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	45	341	364	3	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		608	613		10.1126/science.1258040	http://dx.doi.org/10.1126/science.1258040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359968	Green Submitted, Green Accepted			2022-12-28	WOS:000343799700042
J	McLornan, DP; List, A; Mufti, GJ				McLornan, Donal P.; List, Alan; Mufti, Ghulam J.			Applying Synthetic Lethality for the Selective Targeting of Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; BREAST-CANCER; IN-VIVO; HOMOLOGOUS RECOMBINATION; REPAIR; P53; BRCA1; CELLS; PARP		[McLornan, Donal P.; Mufti, Ghulam J.] Kings Coll Hosp NHS Fdn Trust, London SE5 9RS, England; [List, Alan] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	King's College Hospital NHS Foundation Trust; H Lee Moffitt Cancer Center & Research Institute	Mufti, GJ (corresponding author), Kings Coll Hosp NHS Fdn Trust, Denmark Hill Campus, London SE5 9RS, England.	alan.list@moffitt.org; ghulammufti@kcl.ac.uk		LIST, ALAN/0000-0002-1647-2972				Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Baldwin A, 2010, P NATL ACAD SCI USA, V107, P12463, DOI 10.1073/pnas.1007462107; Bang YJ, 2013, J CLIN ONCOL, V31; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Bell-McGuinn KM, 2013, J CLIN ONCOL, V31; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Bryant HE, 2007, NATURE, V447, P346, DOI 10.1038/nature05789; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Chiarugi A, 2012, TRENDS PHARMACOL SCI, V33, P42, DOI 10.1016/j.tips.2011.10.001; DeBono J., 2013, J CLIN ONCOL S, P2580; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Erler JT, 2012, CELL, V149, P731, DOI 10.1016/j.cell.2012.04.014; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gowen LC, 2003, SCIENCE, V300, P1657; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Konstantinopoulos, 2010, J CLIN ONCOL, V28, P4868, DOI 10.1200/JCO.2010.33.2205; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Kristeleit RS, 2013, J CLIN ONCOL S, P2585; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Lin YF, 2014, NUCLEIC ACIDS RES, V42, P4463, DOI 10.1093/nar/gku116; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo TP, 2012, P NATL ACAD SCI USA, V109, P2860, DOI 10.1073/pnas.1120589109; Mahadevan D, 2012, CLIN CANCER RES, V18, P2210, DOI 10.1158/1078-0432.CCR-11-2413; Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Michie CO, 2013, J CLIN ONCOL, V31; Molife LR, 2013, J CLIN ONCOL, V31; Morandell S, 2013, CELL REP, V5, P868, DOI 10.1016/j.celrep.2013.10.025; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Murai J, 2014, MOL CANCER THER, V13, P433, DOI 10.1158/1535-7163.MCT-13-0803; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neri P, 2011, BLOOD, V118, P6368, DOI 10.1182/blood-2011-06-363911; Nosho K, 2006, EUR J CANCER, V42, P2374, DOI 10.1016/j.ejca.2006.01.061; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pourdehnad M, 2013, P NATL ACAD SCI USA, V110, P1760; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Schoffski P, 2012, EUR J CANCER, V48, P179, DOI 10.1016/j.ejca.2011.11.001; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shibata A, 2005, ONCOGENE, V24, P1328, DOI 10.1038/sj.onc.1208289; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang XS, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-30; Weaver AN, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00290; Wei S, 2013, P NATL ACAD SCI USA, V110, P14504, DOI 10.1073/pnas.1314144110; WRIGHT S, 1946, GENETICS, V31, P125; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471	76	169	180	2	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1725	1735		10.1056/NEJMra1407390	http://dx.doi.org/10.1056/NEJMra1407390			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354106				2022-12-28	WOS:000343768500010
J	Mohamed, M; Tan, J				Mohamed, Muhajir; Tan, Jocelyn			PICTURE QUIZ A man with transient ischaemic attack and thrombocytopenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FACTOR-CLEAVING PROTEASE; PURPURA; IDENTIFICATION		[Mohamed, Muhajir] Launceston Gen Hosp, Launceston, Tas 7250, Australia; [Mohamed, Muhajir] Univ Tasmania, Launceston Clin Sch, Hobart, Tas 7001, Australia; [Tan, Jocelyn] Launceston Gen Hosp, Dept Med, Launceston, Tas, Australia	University of Tasmania	Mohamed, M (corresponding author), Launceston Gen Hosp, Launceston, Tas 7250, Australia.	muhajirbm@yahoo.com						Cataland SR, 2011, AM J HEMATOL, V86, P87, DOI 10.1002/ajh.21881; Fuchs TA, 2010, BLOOD, V116, P617; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; George JN, 2012, AM J HEMATOL, V87, pS88, DOI 10.1002/ajh.23126; George JN, 2010, BLOOD, V116, P4060, DOI 10.1182/blood-2010-07-271445; Hovinga JAK, 2004, HAEMATOLOGICA, V89, P320; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Kavanagh D, 2011, HEMATOL-AM SOC HEMAT, P15, DOI 10.1182/asheducation-2011.1.15; Kwaan HC, 2001, ACTA HAEMATOL-BASEL, V106, P52, DOI 10.1159/000046589; Peyvandi F, 2004, BRIT J HAEMATOL, V127, P433, DOI 10.1111/j.1365-2141.2004.05217.x; Peyvandi F, 2008, HAEMATOLOGICA, V93, P232, DOI 10.3324/haematol.11739; Scully M, 2014, BRIT J HAEMATOL, V164, P759, DOI 10.1111/bjh.12718; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Vesely SK, 2004, TRANSFUSION, V44, P1149, DOI 10.1111/j.1537-2995.2004.03422.x; Zini G, 2012, INT J LAB HEMATOL, V34, P107, DOI 10.1111/j.1751-553X.2011.01380.x	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2014	349								g6472	10.1136/bmj.g6472	http://dx.doi.org/10.1136/bmj.g6472			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DI	25358329				2022-12-28	WOS:000344156100006
J	Stringer, C				Stringer, Chris			Small remains still pose big problems	NATURE			English	Editorial Material							HOMO-FLORESIENSIS; INDONESIA; HOMININ		Nat Hist Museum, London SW7 5BD, England	Natural History Museum London	Stringer, C (corresponding author), Nat Hist Museum, Cromwell Rd, London SW7 5BD, England.	c.stringer@nhm.ac.uk						Baab KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069119; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brown P, 2012, J HUM EVOL, V62, P201, DOI 10.1016/j.jhevol.2011.10.011; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; Morwood M., 2000, NEW HUMAN STARTLING; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Orr CM, 2013, J HUM EVOL, V64, P109, DOI 10.1016/j.jhevol.2012.10.003; Stringer C., 2012, ORIGIN OUR SPECIES; Vannucci RC, 2013, ANAT REC, V296, P630, DOI 10.1002/ar.22663	13	5	5	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					427	429		10.1038/514427a	http://dx.doi.org/10.1038/514427a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7RC	25341772	Bronze			2022-12-28	WOS:000343775900016
J	Bisseling, T; Scheres, B				Bisseling, Ton; Scheres, Ben			Nutrient computation for root architecture	SCIENCE			English	Editorial Material							NODULATION; PEPTIDE		[Bisseling, Ton] Wageningen Univ, Mol Biol Lab, Dept Plant Sci, NL-6708 PB Wageningen, Netherlands; [Bisseling, Ton] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia; [Scheres, Ben] Wageningen Univ, NL-6708 PB Wageningen, Netherlands	Wageningen University & Research; King Saud University; Wageningen University & Research	Bisseling, T (corresponding author), Wageningen Univ, Mol Biol Lab, Dept Plant Sci, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	ton.bisseling@wur.nl	Bisseling, Ton/A-2421-2013	Scheres, Ben/0000-0001-5400-9578				Araya T, 2014, P NATL ACAD SCI USA, V111, P2029, DOI 10.1073/pnas.1319953111; Beeckman T, 2010, DEV CELL, V18, P877, DOI 10.1016/j.devcel.2010.05.020; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; Reid DE, 2011, ANN BOT-LONDON, V108, P789, DOI 10.1093/aob/mcr205; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Tabata R, 2014, SCIENCE, V346, P343, DOI 10.1126/science.1257800	9	24	24	9	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					300	301		10.1126/science.1260942	http://dx.doi.org/10.1126/science.1260942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324371				2022-12-28	WOS:000343041100017
J	Moynihan, R				Moynihan, Ray			TOO MUCH MEDICINE Evening the score on sex drugs: feminist movement or marketing masquerade?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Robina, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Robina, Australia.		Moynihan, Ray/ABC-3010-2020					American Psychiatric Association, 2013, HIGHL CHANG DSM4TR D; American Sexual Health Association, FOR 990 RET ORG EX I; Clayton Anita H, 2014, BMC Res Notes, V7, P459, DOI 10.1186/1756-0500-7-459; DeBruyn J., 2014, TRIANGLE BUSINESS J; FDA, WARN LETT SLAT PHARM; Katz M, 2013, J SEX MED, V10, P1807, DOI 10.1111/jsm.12189; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moynihan R, 2005, BRIT MED J, V330, P192, DOI 10.1136/bmj.330.7484.192; Moynihan R., 2010, SEX LIES PHARM; Moynihan R, 2010, BMJ-BRIT MED J, V30, P341; Moynihan R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3339	11	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6246	10.1136/bmj.g6246	http://dx.doi.org/10.1136/bmj.g6246			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25354348				2022-12-28	WOS:000343767700004
J	Chomiuk, L; Linford, JD; Yang, J; O'Brien, TJ; Paragi, Z; Mioduszewski, AJ; Beswick, RJ; Cheung, CC; Mukai, K; Nelson, T; Ribeiro, VARM; Rupen, MP; Sokoloski, JL; Weston, J; Zheng, Y; Bode, MF; Eyres, S; Roy, N; Taylor, GB				Chomiuk, Laura; Linford, Justin D.; Yang, Jun; O'Brien, T. J.; Paragi, Zsolt; Mioduszewski, Amy J.; Beswick, R. J.; Cheung, C. C.; Mukai, Koji; Nelson, Thomas; Ribeiro, Valerio A. R. M.; Rupen, Michael P.; Sokoloski, J. L.; Weston, Jennifer; Zheng, Yong; Bode, Michael F.; Eyres, Stewart; Roy, Nirupam; Taylor, Gregory B.			Binary orbits as the driver of gamma-ray emission and mass ejection in classical novae	NATURE			English	Article							COMMON ENVELOPE PHASE; MERLIN OBSERVATIONS; EVOLUTION; RADIO; REMNANTS; WINDS	Classical novae are the most common astrophysical thermonuclear explosions, occurring on the surfaces of white dwarf stars accreting gas from companions in binary star systems(1). Novae typically expel about 10(-4) solar masses of material at velocities exceeding 1,000 kilometres per second. However, the mechanism of mass ejection in novae is poorly understood, and could be dominated by the impulsive flash of thermonuclear energy(2), prolonged optically thick winds(3) or binary interaction with the nova envelope(4). Classical novae are now routinely detected at gigaelectronvolt gamma-ray wavelengths(5), suggesting that relativistic particles are accelerated by strong shocks in the ejecta. Here we report high-resolution radio imaging of the gamma-ray-emitting nova V959 Mon. We find that its ejecta were shaped by the motion of the binary system: some gas was expelled rapidly along the poles as a wind from the white dwarf, while denser material drifted out along the equatorial plane, propelled by orbital motion(6,7). At the interface between the equatorial and polar regions, we observe synchrotron emission indicative of shocks and relativistic particle acceleration, thereby pinpointing the location of gamma-ray production. Binary shaping of the nova ejecta and associated internal shocks are expected to be widespread among novae(8), explaining why many novae are gamma-ray emitters(5).	[Chomiuk, Laura; Linford, Justin D.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Yang, Jun] Chalmers Univ Technol, Onsala Space Observ, Dept Earth & Space Sci, SE-43992 Onsala, Sweden; [Yang, Jun; Paragi, Zsolt] Joint Inst VLBI Europe, NL-7990 AA Dwingeloo, Netherlands; [Yang, Jun] Chinese Acad Sci, Shanghai Astron Observ, Shanghai 200030, Peoples R China; [O'Brien, T. J.; Beswick, R. J.] Univ Manchester, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Mioduszewski, Amy J.; Rupen, Michael P.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Cheung, C. C.] Naval Res Lab, Space Sci Div, Washington, DC 20375 USA; [Mukai, Koji] Univ Maryland Baltimore Cty, Sch Phys & Astron, Baltimore, MD 21250 USA; [Mukai, Koji] NASA, Goddard Space Flight Ctr, CRESST, Greenbelt, MD 20771 USA; [Mukai, Koji] NASA, Goddard Space Flight Ctr, Xray Astrophys Lab, Greenbelt, MD 20771 USA; [Nelson, Thomas] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Ribeiro, Valerio A. R. M.] Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Rondebosch, South Africa; [Rupen, Michael P.] Natl Res Council Canada, Herzberg Astron & Astrophys, Penticton, BC V2A 6J9, Canada; [Sokoloski, J. L.; Weston, Jennifer; Zheng, Yong] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Bode, Michael F.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Eyres, Stewart] Univ Cent Lancashire, Jeremiah Horrocks Inst Math Phys & Astron, Preston PR1 2HE, Lancs, England; [Roy, Nirupam] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Taylor, Gregory B.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	Michigan State University; Chalmers University of Technology; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; University of Manchester; Jodrell Bank Centre for Astrophysics; National Radio Astronomy Observatory (NRAO); United States Department of Defense; United States Navy; Naval Research Laboratory; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Minnesota System; University of Minnesota Twin Cities; University of Cape Town; National Research Council Canada; Columbia University; Liverpool John Moores University; University of Central Lancashire; Max Planck Society; University of New Mexico	Chomiuk, L (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	chomiuk@pa.msu.edu	Roy, Nirupam/Y-5408-2019; Eyres, Stewart/AAF-6931-2020; Eyres, Stewart/AAF-1660-2020; Ribeiro, Valério A. R. M./N-2028-2019; Beswick, Robert/AAA-2050-2022	Eyres, Stewart/0000-0002-6663-7675; Ribeiro, Valério A. R. M./0000-0003-3617-4400; O'Brien, Tim/0000-0001-7687-3543; Taylor, Greg/0000-0001-6495-7731; Paragi, Zsolt/0000-0002-5195-335X	European Commission [283393, RI-261525]; Moore Foundation; Norris Foundation; McDonnell Foundation; Associates of the California Institute of Technology; University of Chicago; state of California; state of Illinois; state of Maryland; NSF; NASA [DPR S-15633-Y, 10-FERMI10-C4-0060, NNX13AO91G]; NSF [AST-1211778]; South African SKA Project; Alexander von Humboldt Foundation; Direct For Mathematical & Physical Scien [1139950, 1139998, 1140063] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1140019, 1140031] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/J001465/1, ST/L000768/1] Funding Source: researchfish; STFC [ST/J001465/1, ST/L000768/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Moore Foundation(Gordon and Betty Moore Foundation); Norris Foundation; McDonnell Foundation; Associates of the California Institute of Technology; University of Chicago(University of Chicago); state of California; state of Illinois; state of Maryland; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); South African SKA Project(SKA South Africa); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The National Radio Astronomy Observatory (NRAO) is a facility of the US National Science Foundation (NSF) operated under cooperative agreement by Associated Universities, Inc. The EVN is a joint facility of European, Chinese, South African and other radio astronomy institutes funded by their respective national research councils. The EVN and e-VLBI research infrastructures were supported by the European Commission Seventh Framework Programme (FP/2007-2013) under grant agreements nos 283393 (RadioNet3) and RI-261525 (NEXPReS). e-MERLIN is operated by The University of Manchester at Jodrell Bank Observatory on behalf of the Science and Technology Facilities Council. The SMA is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics. Support for CARMA construction came from the Moore Foundation, the Norris Foundation, the McDonnell Foundation, the Associates of the California Institute of Technology, the University of Chicago, the states of California, Illinois and Maryland, and the NSF. Ongoing CARMA development and operations are supported by the NSF and by the CARMA partner universities. L.C. is a Jansky Fellow of the NRAO. This research received funding from NASA programmes DPR S-15633-Y and 10-FERMI10-C4-0060 (C.C.C.), NASA award NNX13AO91G (T.N.), NSF award AST-1211778 (J.L.S. and J.W.), the South African SKA Project (V.A.R.M.R.) and the Alexander von Humboldt Foundation (N.R.).	Abdo AA, 2010, SCIENCE, V329, P817, DOI 10.1126/science.1192537; Briggs D. S., 1995, BAAS, V27, P1444; Cheung C. C., 2013, ASTRON TELEGRAM, V5649; Chomiuk L., 2012, ASTRON TELEGRAM, V4352; Dubus G, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0064-5; Eyres SPS, 1996, MON NOT R ASTRON SOC, V279, P249, DOI 10.1093/mnras/279.1.249; Fuhrmann L., 2012, ASTRON TELEGRAM, V4376; Gehrz RD, 1998, PUBL ASTRON SOC PAC, V110, P3, DOI 10.1086/316107; Greisen EW, 2003, ASTROPHYS SPACE SC L, V285, P109; Heywood I, 2005, MON NOT R ASTRON SOC, V362, P469, DOI 10.1111/j.1365-2966.2005.09328.x; Hoard DW, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/68; Ivanova N, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0059-2; Kantharia N. G., 2014, ASTRON TELEGRAM, V5962; KATO M, 1994, ASTROPHYS J, V437, P802, DOI 10.1086/175041; LIVIO M, 1990, ASTROPHYS J, V356, P250, DOI 10.1086/168836; Lloyd HM, 1997, MON NOT R ASTRON SOC, V284, P137, DOI 10.1093/mnras/284.1.137; MACDONALD J, 1980, MON NOT R ASTRON SOC, V191, P933, DOI 10.1093/mnras/191.4.933; McMullin JP, 2007, ASTR SOC P, V376, P127; Munari U, 2013, MON NOT R ASTRON SOC, V435, P771, DOI 10.1093/mnras/stt1340; NAPIER PJ, 1983, P IEEE, V71, P1295, DOI 10.1109/PROC.1983.12765; Nelson T., 2012, ASTRON TELEGRAM, V4321; O'Brien TJ, 2006, NATURE, V442, P279, DOI 10.1038/nature04949; O'Brien T. J., 2012, ASTRON TELEGRAM, V4408; Page KL, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/2/L26; Passy JC, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/52; Porter JM, 1998, MON NOT R ASTRON SOC, V296, P943, DOI 10.1046/j.1365-8711.1998.01470.x; Ribeiro VARM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/49; Roy N, 2012, B ASTRON SOC INDIA, V40, P293; Sault RJ, 1995, ASTR SOC P, V77, P433; Seaquist ER, 2008, CAM ASTROPH, P141; SEAQUIST ER, 1989, ASTROPHYS J, V344, P805, DOI 10.1086/167846; SHANKAR A, 1991, ASTROPHYS J, V374, P623, DOI 10.1086/170148; Shore SN, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201321095; SOKER N, 1989, ASTROPHYS J, V339, P268, DOI 10.1086/167294; STARRFIELD S, 1972, ASTROPHYS J, V176, P169, DOI 10.1086/151619; TAYLOR AR, 1988, NATURE, V335, P235, DOI 10.1038/335235a0; Taylor GB., 1994, B AM ASTRON SOC, V26, P987; The Fermi-LAT collaboration, 2014, SCIENCE, V345, P554	38	75	75	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					339	+		10.1038/nature13773	http://dx.doi.org/10.1038/nature13773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25296250	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000342988600045
J	Modlin, J; Wenger, J				Modlin, John; Wenger, Jay			Achieving and Maintaining Polio Eradication - New Strategies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE; INDIA		[Modlin, John; Wenger, Jay] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Modlin, J (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.							Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; John J, 2014, LANCET; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x	5	9	9	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1476	1479		10.1056/NEJMp1407783	http://dx.doi.org/10.1056/NEJMp1407783			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7KV	25317869				2022-12-28	WOS:000342994700004
J	Lee, R; Mason, A				Lee, Ronald; Mason, Andrew		NTA Network	Is low fertility really a problem? Population aging, dependency, and consumption	SCIENCE			English	Article								Longer lives and fertility far below the replacement level of 2.1 births per woman are leading to rapid population aging in many countries. Many observers are concerned that aging will adversely affect public finances and standards of living. Analysis of newly available National Transfer Accounts data for 40 countries shows that fertility well above replacement would typically be most beneficial for government budgets. However, fertility near replacement would be most beneficial for standards of living when the analysis includes the effects of age structure on families as well as governments. And fertility below replacement would maximize per capita consumption when the cost of providing capital for a growing labor force is taken into account. Although low fertility will indeed challenge government programs and very low fertility undermines living standards, we find that moderately low fertility and population decline favor the broader material standard of living.	[Lee, Ronald] Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA; [Lee, Ronald] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [Mason, Andrew] Univ Hawaii Manoa, Dept Econ, Honolulu, HI 96821 USA; [Mason, Andrew] East West Ctr, Honolulu, HI 96848 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Hawaii System; University of Hawaii Manoa; East West Center	Lee, R (corresponding author), Univ Calif Berkeley, Dept Demog, 2232 Piedmont Ave, Berkeley, CA 94720 USA.	rlee@demog.berkeley.edu; amason@hawaii.edu	Queiroz, Bernardo L/U-7783-2017; Zannella, Marina/AAJ-2329-2020; Gal, Robert/AAD-8449-2022; Rice, James Mahmud/C-3581-2008; Rentería, Elisenda/I-2567-2015; Bucheli, Marisa/I-5639-2019	Queiroz, Bernardo L/0000-0002-2890-1025; Zannella, Marina/0000-0003-2412-0819; Gal, Robert/0000-0002-2326-8558; Rice, James Mahmud/0000-0001-5986-9139; Rentería, Elisenda/0000-0002-7072-8465; Bucheli, Marisa/0000-0003-0159-4712; Turra, Cassio/0000-0003-4051-3567; Olaniyan, Olanrewaju/0000-0002-7115-7983; Dramani, Latif/0000-0001-6178-875X; d'Albis, Hippolyte/0000-0002-6409-4320; Olivera, Javier/0000-0002-8769-7845; SECKIN, ZENNUBE AYLIN/0000-0003-4139-2728; Tovar, Jorge/0000-0001-5525-6829	NIH, National Institute on Aging [R37 AG025247]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE ON AGING [R37AG025247] Funding Source: NIH RePORTER; ESRC [ES/L500343/1] Funding Source: UKRI; Economic and Social Research Council [ES/L500343/1] Funding Source: researchfish	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	R.L.'s research for this paper was funded by the NIH, National Institute on Aging grant R37 AG025247, and R. L. and A.M.'s research was funded by the Bill and Melinda Gates Foundation through a grant provided to Johns Hopkins Bloomberg School of Public Health. Construction of NTA for many developing countries was possible due to the support of the International Development Research Centre (Canada). The content is solely the responsibility of the authors. The views expressed in this paper are those of J.B. and do not necessarily reflect those of the United Nations. We are grateful to D. Stojanovic for able research assistance. The data are available at http://ntaccounts.org/web/nta/show/Science.	[Anonymous], 1975, INT EC REV, DOI DOI 10.2307/2525993; ARTHUR WB, 1978, INT ECON REV, V19, P241, DOI 10.2307/2526407; Backus D, 2008, J MONETARY ECON, V55, P48, DOI 10.1016/j.jmoneco.2007.11.008; Bloom D., 2002, DEMOGRAPHIC DIVIDEND; CALVO GA, 1988, ECONOMETRICA, V56, P411, DOI 10.2307/1911079; CUTLER DM, 1990, BROOKINGS PAPERS EC, V1990; Deardorff A. V., 1976, INT ECON REV, V17, P510; ESPENSHADE TJ, 1982, DEMOGRAPHY, V19, P125, DOI 10.2307/2061132; Feenstra RC, NEXT GENERATION PENN; Goldstein J. R., 2009, INT HDB POPULATION A, P7; Lee R, 2011, POPULATION AGING AND THE GENERATIONAL ECONOMY: A GLOBAL PERSPECTIVE, P1; Lee R, 1994, DEMOGRAPHY AGING, P8; LEE RD, 1994, J HUM RESOUR, V29, P1027, DOI 10.2307/146133; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Mason A., 2009, BUREAU EC RES SERIES, P89; Piketty T., 2014, CAPITAL SIGLO 21; Samuelson P.A., 1976, INT ECON REV, V17, P516; SCHMERTMANN CP, 1992, DEMOGRAPHY, V29, P595, DOI 10.2307/2061854; United Nations Department of Economic and Social Affairs, 2013, NAT TRANSF ACC MAN M; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP POL DAT; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; Willis R. J., 1988, EC CHANGING AGE DIST, P106	22	80	81	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					229	234		10.1126/science.1250542	http://dx.doi.org/10.1126/science.1250542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301626	Green Accepted			2022-12-28	WOS:000342721500046
J	DeLong, EF				DeLong, Edward F.			Alien Invasions and Gut "Island Biogeography"	CELL			English	Editorial Material							ECOLOGY; LIFE	Animals harbor gut microbiota characteristic of the host and diet of origin. Whether bacteria from diverse nonindigenous origins successfully invade foreign gut habitats is not well known. Now, Seedorf et al. show that microbiota from a variety of disparate habitats can successfully colonize and compete in the mammalian gut environment.	[DeLong, Edward F.] Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA; [DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Hawaii System; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA.	delong@mit.edu						Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Ettinger G, 2013, BIOESSAYS, V35, P508, DOI 10.1002/bies.201300015; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; MAC ARTHUR ROBERT H., 1967; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373	9	12	13	3	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					233	235		10.1016/j.cell.2014.09.043	http://dx.doi.org/10.1016/j.cell.2014.09.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303519	Bronze			2022-12-28	WOS:000343095600004
J	Huttenhower, C; Knight, R; Brown, CT; Caporaso, JG; Clemente, JC; Gevers, D; Franzosa, EA; Kelley, ST; Knights, D; Ley, RE; Mahurkar, A; Ravel, J; White, O				Huttenhower, Curtis; Knight, Rob; Brown, C. Titus; Caporaso, J. Gregory; Clemente, Jose C.; Gevers, Dirk; Franzosa, Eric A.; Kelley, Scott T.; Knights, Dan; Ley, Ruth E.; Mahurkar, Anup; Ravel, Jacques; White, Owen		Scientists Advancement Microbiome	Advancing the Microbiome Research Community	CELL			English	Editorial Material							METADATA	The human microbiome has become a recognized factor in promoting and maintaining health. We outline opportunities in interdisciplinary research, analytical rigor, standardization, and policy development for this relatively new and rapidly developing field. Advances in these aspects of the research community may in turn advance our understanding of human microbiome biology.	[Huttenhower, Curtis; Franzosa, Eric A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob; Gevers, Dirk] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, HHMI, Boulder, CO 80309 USA; [Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86001 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Knights, Dan] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Mahurkar, Anup; Ravel, Jacques; White, Owen] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [White, Owen] Univ Maryland, Sch Med, Ctr Hlth Related Informat & Bioimaging, Baltimore, MD 21201 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Michigan State University; Michigan State University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; California State University System; San Diego State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	White, O (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	owhite@som.umaryland.edu	Ravel, Jacques/D-2530-2009; Knight, Rob/D-1299-2010; raes, jeroen/D-7835-2018; Ley, Ruth E/M-8542-2014; Gevers, Dirk/C-1451-2009	raes, jeroen/0000-0002-1337-041X; Ley, Ruth E/0000-0002-9087-1672; Knight, Rob/0000-0002-0975-9019; Caporaso, Greg/0000-0002-8865-1670; Brown, C. Titus/0000-0001-6001-2677; Ravel, Jacques/0000-0002-0851-2233	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005969, U01HG004866, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008404, R01AI089878, UH2AI083264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, U54DK102557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014826] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [U54 HG003067, U54HG003067, R01 HG005969, R01HG005969, U01 HG004866] Funding Source: Medline; NIAID NIH HHS [R01 AI089878, R01AI089878, UH2AI083264, UH2 AI083264, U19AI08404] Funding Source: Medline; NIDCR NIH HHS [U54 DE023798, U54DE023798] Funding Source: Medline; NIDDK NIH HHS [P30 DK043351, U54 DK102557] Funding Source: Medline; NIGMS NIH HHS [R01 GM103604, R01GM103604] Funding Source: Medline; NINR NIH HHS [R01 NR014826, R01NR014826] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Beauharnais CC, 2012, CLIN TRIALS, V9, P198, DOI 10.1177/1740774511434844; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Hirschman L, 2008, OMICS, V12, P129, DOI 10.1089/omi.2008.0016; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Pan HQ, 2012, HUM MUTAT, V33, P849, DOI 10.1002/humu.22074; Rhodes R, 2011, AM J BIOETHICS, V11, P1, DOI 10.1080/15265161.2011.615588; Richesson R, 2010, ADV EXP MED BIOL, V686, P87, DOI 10.1007/978-90-481-9485-8_6; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	14	48	49	1	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					227	230		10.1016/j.cell.2014.09.022	http://dx.doi.org/10.1016/j.cell.2014.09.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303518	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000343095600002
J	Perry, M; Swain, S; Kemmis-Betty, S; Cooper, P				Perry, Mark; Swain, Sharon; Kemmis-Betty, Sophia; Cooper, Paul		Guideline Dev Grp	GUIDELINES Multiple sclerosis: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Perry, Mark; Swain, Sharon; Kemmis-Betty, Sophia] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Cooper, Paul] Salford Royal Fdn Trust, Neurol Dept, Salford, Lancs, England; [Cooper, Paul] Univ Manchester, Dept Med, Manchester M13 9PL, Lancs, England	Royal College of Physicians; Salford Royal NHS Foundation Trust; University of Manchester	Perry, M (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	mark.perry@rcplondon.ac.uk	Cooper, Paul N/L-9819-2013	Cooper, Paul N/0000-0002-7232-3365; Chinthapalli, Krishna/0000-0003-4136-4882					0	16	16	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2014	349								g5701	10.1136/bmj.g5701	http://dx.doi.org/10.1136/bmj.g5701			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LP	25298369				2022-12-28	WOS:000342998900003
J	Hoon, AH; Stashinko, EE				Hoon, Alexander H., Jr.; Stashinko, Elaine E.			Quality of life in adolescents with cerebral palsy	LANCET			English	Editorial Material									[Hoon, Alexander H., Jr.; Stashinko, Elaine E.] Kennedy Krieger Inst, Baltimore, MD 21205 USA	Kennedy Krieger Institute	Hoon, AH (corresponding author), Kennedy Krieger Inst, Baltimore, MD 21205 USA.	hoon@kennedykrieger.org						Bjornson KF, 2008, ARCH PHYS MED REHAB, V89, P121, DOI 10.1016/j.apmr.2007.09.016; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Colver A, 2014, LANCET; Colver A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-105; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Novak I, 2012, PEDIATRICS, V130, pE1285, DOI 10.1542/peds.2012-0924; Peterson MD, 2013, OBES REV, V14, P171, DOI 10.1111/j.1467-789X.2012.01052.x; Ravens-Sieberer Ulrike, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P353, DOI 10.1586/14737167.5.3.353; Ronen GM, 2011, DEV MED CHILD NEUROL, V53, P305, DOI 10.1111/j.1469-8749.2011.03919.x; Stashinko EE, 2010, AM J MED GENET C, V154C, P197, DOI 10.1002/ajmg.c.30237; University of Toronto Centre for Health Promotion Quality of Life Research Unit, QUAL LIF MOD	13	2	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					670	672		10.1016/S0140-6736(14)61599-3	http://dx.doi.org/10.1016/S0140-6736(14)61599-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7ED	25301504	hybrid			2022-12-28	WOS:000349788300007
J	Wang, XX; Ren, JS; Gao, Q; Hu, ZY; Sun, Y; Li, XM; Rowlands, DJ; Yin, WD; Wang, JZ; Stuart, DI; Rao, ZH; Fry, EE				Wang, Xiangxi; Ren, Jingshan; Gao, Qiang; Hu, Zhongyu; Sun, Yao; Li, Xuemei; Rowlands, David J.; Yin, Weidong; Wang, Junzhi; Stuart, David I.; Rao, Zihe; Fry, Elizabeth E.			Hepatitis A virus and the origins of picornaviruses	NATURE			English	Article							CAPSID PROTEIN; CRYSTAL-STRUCTURE; POLIOVIRUS; RESOLUTION; RECEPTOR; STABILITY; MODEL; SITE	Hepatitis A virus(HAV) remains enigmatic, despite 1.4 million cases worldwide annually(1). It differs radically from other picornaviruses, existing in an enveloped form(2) and being unusually stable, both genetically and physically(3), but has proved difficult to study. Here we report high-resolution X-ray structures for the mature virus and the empty particle. The structures of the two particles are indistinguishable, apart from some disorder on the inside of the empty particle. The full virus contains the small viral protein VP4, whereas the empty particle harbours only the uncleaved precursor, VP0. The smooth particle surface is devoid of depressions that might correspond to receptor-binding sites. Peptide scanning data extend the previously reported VP3 antigenic site4, while structure-based predictions(5) suggest further epitopes. HAV contains no pocket factor and can withstand remarkably high temperature and low pH, and empty particles are even more robust than full particles. The virus probably uncoats via a novel mechanism, being assembled differently to other picornaviruses. It utilizes a VP2 'domain swap' characteristic of insect picorna-like viruses(6,7), and structure-based phylogenetic analysis places HAV between typical picornaviruses and the insect viruses. The enigmatic properties of HAV may reflect its position as a link between 'modern' picornaviruses and the more 'primitive' precursor insect viruses; for instance, HAV retains the ability to move from cell-to-cell by transcytosis(8,9).	[Wang, Xiangxi; Gao, Qiang; Sun, Yao; Li, Xuemei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China; [Ren, Jingshan; Stuart, David I.; Fry, Elizabeth E.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Gao, Qiang; Yin, Weidong] Sinovac Biotech Co Ltd, Beijing 100085, Peoples R China; [Hu, Zhongyu; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Rowlands, David J.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Rowlands, David J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Stuart, David I.] Diamond Light Sources, Didcot OX11 0DE, Oxon, England; [Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Rao, Zihe] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Oxford; National Institute of Food & Drug Control - China; University of Leeds; University of Leeds; Diamond Light Source; Tsinghua University; Nankai University	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genomic Med, Oxford OX3 7BN, England.	wangjz@nicpbp.org.cn; dave@strubi.ox.ac.uk; raozh@xtal.tsinghua.edu.cn	Ren, Jingshan/AAT-7729-2021; Rao, Zihe/HCH-6944-2022	Ren, Jingshan/0000-0003-4015-1404; Stuart, David/0000-0002-3426-4210; Fry, Elizabeth/0000-0001-9754-5303	Chinese Academy of Sciences [XDB08020200]; Ministry of Science and Technology 973 Project [2014CB542800]; National Major Project of Infectious Disease [2012ZX10004701]; National Science Foundation [81330036]; MRC [G19/3, G1000099, MR/N00065X/1] Funding Source: UKRI; STFC [ST/J001465/1] Funding Source: UKRI; Medical Research Council [G19/3, MR/N00065X/1, G1100525, G1000099] Funding Source: researchfish	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology 973 Project(National Basic Research Program of China); National Major Project of Infectious Disease; National Science Foundation(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Strategic Priority Research Program of the Chinese Academyof Sciences, grant no. XDB08020200, the Ministry of Science and Technology 973 Project (grant no. 2014CB542800), the National Major Project of Infectious Disease (2012ZX10004701) and National Science Foundation grant 81330036. D. I. S. and E. E. F. are supported by the UK Medical Research Council (grant G1000099) and J. R. by the Wellcome Trust. This work is a contribution fromthe Instruct Centre, Oxford. Administrative support was provided by the Wellcome Trust (075491/Z/04). We thank J. Johnson and A. Routh for supplying CrPV, and S. Lemon and K. McKnight for discussions.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; [Anonymous], 2002, PYMOL MOL GRAPH SYST; BISHOP NE, 1993, VIROLOGY, V197, P616, DOI 10.1006/viro.1993.1636; Borley DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061122; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butan C, 2014, J VIROL, V88, P1758, DOI 10.1128/JVI.01949-13; CHAPMAN MS, 1993, VIROLOGY, V195, P745, DOI 10.1006/viro.1993.1425; De Colibus LG, 2014, NAT STRUCT MOL BIOL, V21, P282, DOI 10.1038/nsmb.2769; DEINHARDT F, 1992, VACCINE, V10, pS10, DOI 10.1016/0264-410X(92)90532-O; Dotauer A, 2005, J GEN VIROL, V86, P2747, DOI 10.1099/vir.0.81157-0; Dotzauer A, 2000, J VIROL, V74, P10950, DOI 10.1128/JVI.74.23.10950-10957.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; FILMAN DJ, 1989, EMBO J, V8, P1567, DOI 10.1002/j.1460-2075.1989.tb03541.x; Garriga D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002473; Graff J, 1999, J VIROL, V73, P6015, DOI 10.1128/JVI.73.7.6015-6023.1999; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEMON SM, 1983, INFECT IMMUN, V42, P418, DOI 10.1128/IAI.42.1.418-420.1983; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Ren JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2889; Riffel N, 2002, STRUCTURE, V10, P1627, DOI 10.1016/S0969-2126(02)00896-1; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIEGL G, 1984, INTERVIROLOGY, V22, P218, DOI 10.1159/000149554; SIEGL G, 1981, J GEN VIROL, V57, P331, DOI 10.1099/0022-1317-57-2-331; Squires G, 2013, ACTA CRYSTALLOGR D, V69, P1026, DOI 10.1107/S0907444913004617; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; TESAR M, 1993, VIROLOGY, V194, P616, DOI 10.1006/viro.1993.1301; Walter TS, 2012, J VIROL METHODS, V185, P166, DOI 10.1016/j.jviromet.2012.06.014; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; WARWICKER J, 1992, J MOL BIOL, V223, P247, DOI 10.1016/0022-2836(92)90729-4; WHO, 2013, HEP A	39	114	119	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					85	U214		10.1038/nature13806	http://dx.doi.org/10.1038/nature13806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25327248	Green Accepted			2022-12-28	WOS:000347178400040
J	Yang, YP; Muzny, DM; Xia, F; Niu, Z; Person, R; Ding, Y; Ward, P; Braxton, A; Wang, M; Buhay, C; Veeraraghavan, N; Hawes, A; Chiang, T; Leduc, M; Beuten, J; Zhang, J; He, WM; Scull, J; Willis, A; Landsverk, M; Craigen, WJ; Bekheirnia, MR; Stray-Pedersen, A; Liu, PF; Wen, S; Alcaraz, W; Cui, H; Walkiewicz, M; Reid, J; Bainbridge, M; Patel, A; Boerwinkle, E; Beaudet, AL; Lupski, JR; Plon, SE; Gibbs, RA; Eng, CM				Yang, Yaping; Muzny, Donna M.; Xia, Fan; Niu, Zhiyv; Person, Richard; Ding, Yan; Ward, Patricia; Braxton, Alicia; Wang, Min; Buhay, Christian; Veeraraghavan, Narayanan; Hawes, Alicia; Chiang, Theodore; Leduc, Magalie; Beuten, Joke; Zhang, Jing; He, Weimin; Scull, Jennifer; Willis, Alecia; Landsverk, Megan; Craigen, William J.; Bekheirnia, Mir Reza; Stray-Pedersen, Asbjorg; Liu, Pengfei; Wen, Shu; Alcaraz, Wendy; Cui, Hong; Walkiewicz, Magdalena; Reid, Jeffrey; Bainbridge, Matthew; Patel, Ankita; Boerwinkle, Eric; Beaudet, Arthur L.; Lupski, James R.; Plon, Sharon E.; Gibbs, Richard A.; Eng, Christine M.			Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCIDENTAL FINDINGS; ACMG RECOMMENDATIONS; DEVELOPMENTAL DELAY; KABUKI SYNDROME; MUTATIONS; DISORDERS; MOSAICISM; STANDARDS; DIAGNOSIS; AUTONOMY	IMPORTANCE Clinical whole-exome sequencing is increasingly used for diagnostic evaluation of patients with suspected genetic disorders. OBJECTIVE To perform clinical whole-exome sequencing and report (1) the rate of molecular diagnosis among phenotypic groups, (2) the spectrum of genetic alterations contributing to disease, and (3) the prevalence of medically actionable incidental findings such as FBN1 mutations causing Marfan syndrome. DESIGN, SETTING, AND PATIENTS Observational study of 2000 consecutive patients with clinical whole-exome sequencing analyzed between June 2012 and August 2014. Whole-exome sequencing tests were performed at a clinical genetics laboratory in the United States. Results were reported by clinical molecular geneticists certified by the American Board of Medical Genetics and Genomics. Tests were ordered by the patient's physician. The patients were primarily pediatric (1756 [88%]; mean age, 6 years; 888 females [44%], 1101 males [55%], and 11 fetuses [1% gender unknown]), demonstrating diverse clinical manifestations most often including nervous system dysfunction such as developmental delay. MAIN OUTCOMES AND MEASURES Whole-exome sequencing diagnosis rate overall and by phenotypic category, mode of inheritance, spectrum of genetic events, and reporting of incidental findings. RESULTS A molecular diagnosis was reported for 504 patients (25.2%) with 58% of the diagnostic mutations not previously reported. Molecular diagnosis rates for each phenotypic category were 143/526 (27.2%; 95% CI, 23.5%-31.2%) for the neurological group, 282/1147 (24.6%; 95% CI, 22.1%-27.2%) for the neurological plus other organ systems group, 30/83 (36.1%; 95% CI, 26.1%-47.5%) for the specific neurological group, and 49/244 (20.1%; 95% CI, 15.6%-25.8%) for the nonneurological group. The Mendelian disease patterns of the 527 molecular diagnoses included 280 (53.1%) autosomal dominant, 181 (34.3%) autosomal recessive (including 5 with uniparental disomy), 65 (12.3%) X-linked, and 1 (0.2%) mitochondrial. Of 504 patients with a molecular diagnosis, 23 (4.6%) had blended phenotypes resulting from 2 single gene defects. About 30% of the positive cases harbored mutations in disease genes reported since 2011. There were 95 medically actionable incidental findings in genes unrelated to the phenotype but with immediate implications for management in 92 patients (4.6%), including 59 patients (3%) with mutations in genes recommended for reporting by the American College of Medical Genetics and Genomics. CONCLUSIONS AND RELEVANCE Whole-exome sequencing provided a potential molecular diagnosis for 25% of a large cohort of patients referred for evaluation of suspected genetic conditions, including detection of rare genetic events and new mutations contributing to disease. The yield of whole-exome sequencingmay offer advantages over traditional molecular diagnostic approaches in certain patients.	[Yang, Yaping; Xia, Fan; Niu, Zhiyv; Person, Richard; Ward, Patricia; Braxton, Alicia; Leduc, Magalie; Beuten, Joke; Zhang, Jing; He, Weimin; Scull, Jennifer; Willis, Alecia; Landsverk, Megan; Craigen, William J.; Bekheirnia, Mir Reza; Liu, Pengfei; Wen, Shu; Alcaraz, Wendy; Cui, Hong; Walkiewicz, Magdalena; Patel, Ankita; Beaudet, Arthur L.; Lupski, James R.; Plon, Sharon E.; Gibbs, Richard A.; Eng, Christine M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Muzny, Donna M.; Ding, Yan; Wang, Min; Buhay, Christian; Veeraraghavan, Narayanan; Hawes, Alicia; Chiang, Theodore; Reid, Jeffrey; Bainbridge, Matthew; Boerwinkle, Eric; Lupski, James R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Craigen, William J.; Stray-Pedersen, Asbjorg; Lupski, James R.; Plon, Sharon E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Eng, CM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	ceng@bcm.edu	Leduc, Magalie/R-9884-2019; niu, zhiyv/A-6558-2009; Liu, Pengfei/U-9743-2019; chandarana, Jignesh/W-8379-2019	Liu, Pengfei/0000-0002-4177-709X; chandarana, Jignesh/0000-0003-0374-5721; Stray-Pedersen, Asbjorg/0000-0002-9168-0878	National Human Genome Research Institute [U54 HG003273, U01 HG006485, U54 HG006542]; National Institute of Neurological Disorders and Stroke [R01 NS058529]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, U54HG003273, U01HG006485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by grants U54 HG003273 (awarded to Dr Gibbs), U01 HG006485 (Dr Plon), and U54 HG006542 (Dr Lupski) from the National Human Genome Research Institute and grant R01 NS058529 (awarded to Dr Lupski) from the National Institute of Neurological Disorders and Stroke.	Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Bayer DK, 2014, CLIN EXP IMMUNOL, V178, P459, DOI 10.1111/cei.12421; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Eng CM, 2014, NEW ENGL J MED, V370, P1068, DOI 10.1056/NEJMc1315908; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Miyake N, 2013, AM J MED GENET A, V161, P2234, DOI 10.1002/ajmg.a.36072; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Muzny DM, 2013, 63 ANN M AM SOC HUM; Pagon RA, GENEREVIEWS; Pletcher BA, 2008, GENET MED, V10, P33, DOI [10.1097/GIM.0b013e31815f6eac, 10.1097/GIM.0b013e31815f247c]; Pyeritz RE, 2012, GENET MED, V14, P171, DOI [10.1038/gim.2012.74, 10.1038/gim.2011.48]; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards CS, 2014, AM COLL MED GEN GEN; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Shaffer Lisa G., 2001, Genetics in Medicine, V3, P206, DOI 10.1097/00125817-200105000-00011; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Tapper WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086940; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	35	903	927	1	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1870	1879		10.1001/jama.2014.14601	http://dx.doi.org/10.1001/jama.2014.14601			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25326635	Green Accepted			2022-12-28	WOS:000344532600016
J	Freischlag, JA; Kibbe, MR				Freischlag, Julie A.; Kibbe, Melina R.			The Evolution of Surgery The Story of "Two Poems"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-LIFE; EDUCATION; CARE		[Freischlag, Julie A.] Univ Calif Davis, Off Vice Chancellor, Sacramento, CA 95817 USA; [Kibbe, Melina R.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine	Freischlag, JA (corresponding author), Univ Calif Davis, Sch Med, 4610 X St,Ste 3101, Sacramento, CA 95817 USA.	jafreischlag@ucdavis.edu						ACS NSQIP, SURG RISK CALC; Antiel RM, 2013, JAMA SURG, V148, P448, DOI 10.1001/jamasurg.2013.1368; Hicks CW, 2014, JAMA SURG, V149, P863, DOI 10.1001/jamasurg.2014.172; Lindeman BM, 2013, J SURG EDUC, V70, P769, DOI 10.1016/j.jsurg.2013.06.018; Nicholas LH, 2011, JAMA-J AM MED ASSOC, V306, P1447, DOI 10.1001/jama.2011.1410; Simon RW, 2014, ASSOC OPER ROOM NURS, V99, P147, DOI 10.1016/j.aorn.2013.10.008; Tuso Philip, 2013, Perm J, V17, P58, DOI 10.7812/TPP/12-141	7	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1737	1738		10.1001/jama.2014.14448	http://dx.doi.org/10.1001/jama.2014.14448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25343524				2022-12-28	WOS:000344194500008
J	Hen, O; Sargsian, M; Weinstein, LB; Piasetzky, E; Hakobyan, H; Higinbotham, DW; Braverman, M; Brooks, WK; Gilad, S; Adhikari, KP; Arrington, J; Asryan, G; Avakian, H; Ball, J; Baltzell, NA; Battaglieri, M; Beck, A; Beck, SMT; Bedlinskiy, I; Bertozzi, W; Biselli, A; Burkert, VD; Cao, T; Carman, DS; Celentano, A; Chandavar, S; Colaneri, L; Cole, PL; Crede, V; D'Angelo, A; De Vita, R; Deur, A; Djalali, C; Doughty, D; Dugger, M; Dupre, R; Egiyan, H; El Alaoui, A; El Fassi, L; Elouadrhiri, L; Fedotov, G; Fegan, S; Forest, T; Garillon, B; Garcon, M; Gevorgyan, N; Ghandilyan, Y; Gilfoyle, GP; Girod, FX; Goetz, JT; Gothe, RW; Griffioen, KA; Guidal, M; Guo, L; Hafidi, K; Hanretty, C; Hattawy, M; Hicks, K; Holtrop, M; Hyde, CE; Ilieva, Y; Ireland, DG; Ishkanov, BI; Isupov, EL; Jiang, H; Jo, HS; Joo, K; Keller, D; Khandaker, M; Kim, A; Kim, W; Klein, FJ; Koirala, S; Korover, I; Kuhn, SE; Kubarovsky, V; Lenisa, P; Levine, WI; Livingston, K; Lowry, M; Lu, HY; MacGregor, IJD; Markov, N; Mayer, M; McKinnon, B; Mineeva, T; Mokeev, V; Movsisyan, A; Camacho, CM; Mustapha, B; Nadel-Turonski, P; Niccolai, S; Niculescu, G; Niculescu, I; Osipenko, M; Pappalardo, LL; Paremuzyan, R; Park, K; Pasyuk, E; Phelps, W; Pisano, S; Pogorelko, O; Price, JW; Procureur, S; Prok, Y; Protopopescu, D; Puckett, AJR; Rimal, D; Ripani, M; Ritchie, BG; Rizzo, A; Rosner, G; Roy, P; Rossi, P; Sabatie, F; Schott, D; Schumacher, RA; Sharabian, YG; Smith, GD; Shneor, R; Sokhan, D; Stepanyan, SS; Stepanyan, S; Stoler, P; Strauch, S; Sytnik, V; Taiuti, M; Tkachenko, S; Ungaro, M; Vlassov, AV; Voutier, E; Walford, NK; Wei, X; Wood, MH; Wood, SA; Zachariou, N; Zana, L; Zhao, ZW; Zheng, X; Zonta, I				Hen, O.; Sargsian, M.; Weinstein, L. B.; Piasetzky, E.; Hakobyan, H.; Higinbotham, D. W.; Braverman, M.; Brooks, W. K.; Gilad, S.; Adhikari, K. P.; Arrington, J.; Asryan, G.; Avakian, H.; Ball, J.; Baltzell, N. A.; Battaglieri, M.; Beck, A.; Beck, S. May-Tal; Bedlinskiy, I.; Bertozzi, W.; Biselli, A.; Burkert, V. D.; Cao, T.; Carman, D. S.; Celentano, A.; Chandavar, S.; Colaneri, L.; Cole, P. L.; Crede, V.; D'Angelo, A.; De Vita, R.; Deur, A.; Djalali, C.; Doughty, D.; Dugger, M.; Dupre, R.; Egiyan, H.; El Alaoui, A.; El Fassi, L.; Elouadrhiri, L.; Fedotov, G.; Fegan, S.; Forest, T.; Garillon, B.; Garcon, M.; Gevorgyan, N.; Ghandilyan, Y.; Gilfoyle, G. P.; Girod, F. X.; Goetz, J. T.; Gothe, R. W.; Griffioen, K. A.; Guidal, M.; Guo, L.; Hafidi, K.; Hanretty, C.; Hattawy, M.; Hicks, K.; Holtrop, M.; Hyde, C. E.; Ilieva, Y.; Ireland, D. G.; Ishkanov, B. I.; Isupov, E. L.; Jiang, H.; Jo, H. S.; Joo, K.; Keller, D.; Khandaker, M.; Kim, A.; Kim, W.; Klein, F. J.; Koirala, S.; Korover, I.; Kuhn, S. E.; Kubarovsky, V.; Lenisa, P.; Levine, W. I.; Livingston, K.; Lowry, M.; Lu, H. Y.; MacGregor, I. J. D.; Markov, N.; Mayer, M.; McKinnon, B.; Mineeva, T.; Mokeev, V.; Movsisyan, A.; Camacho, C. Munoz; Mustapha, B.; Nadel-Turonski, P.; Niccolai, S.; Niculescu, G.; Niculescu, I.; Osipenko, M.; Pappalardo, L. L.; Paremuzyan, R.; Park, K.; Pasyuk, E.; Phelps, W.; Pisano, S.; Pogorelko, O.; Price, J. W.; Procureur, S.; Prok, Y.; Protopopescu, D.; Puckett, A. J. R.; Rimal, D.; Ripani, M.; Ritchie, B. G.; Rizzo, A.; Rosner, G.; Roy, P.; Rossi, P.; Sabatie, F.; Schott, D.; Schumacher, R. A.; Sharabian, Y. G.; Smith, G. D.; Shneor, R.; Sokhan, D.; Stepanyan, S. S.; Stepanyan, S.; Stoler, P.; Strauch, S.; Sytnik, V.; Taiuti, M.; Tkachenko, S.; Ungaro, M.; Vlassov, A. V.; Voutier, E.; Walford, N. K.; Wei, X.; Wood, M. H.; Wood, S. A.; Zachariou, N.; Zana, L.; Zhao, Z. W.; Zheng, X.; Zonta, I.		Jefferson Lab CLAS Collaboration	Momentum sharing in imbalanced Fermi systems	SCIENCE			English	Article							NUCLEAR; SCATTERING	The atomic nucleus is composed of two different kinds of fermions: protons and neutrons. If the protons and neutrons did not interact, the Pauli exclusion principle would force the majority of fermions (usually neutrons) to have a higher average momentum. Our high-energy electron-scattering measurements using C-12, Al-27, Fe-56, and Pb-208 targets show that even in heavy, neutron-rich nuclei, short-range interactions between the fermions form correlated high-momentum neutron-proton pairs. Thus, in neutron-rich nuclei, protons have a greater probability than neutrons to have momentum greater than the Fermi momentum. This finding has implications ranging from nuclear few-body systems to neutron stars and may also be observable experimentally in two-spin-state, ultracold atomic gas systems.	[Hen, O.; Piasetzky, E.; Braverman, M.; Beck, A.; Beck, S. May-Tal; Korover, I.; Shneor, R.] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Sargsian, M.; Guo, L.; Phelps, W.; Rimal, D.] Florida Int Univ, Miami, FL 33199 USA; [Weinstein, L. B.; Adhikari, K. P.; El Fassi, L.; Hyde, C. E.; Koirala, S.; Kuhn, S. E.; Mayer, M.; Prok, Y.] Old Dominion Univ, Norfolk, VA 23529 USA; [Hakobyan, H.; Brooks, W. K.; Sytnik, V.] Univ Tecn Federico Santa Maria, Valparaiso, Chile; [Hakobyan, H.; Asryan, G.; Gevorgyan, N.; Ghandilyan, Y.; Paremuzyan, R.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Higinbotham, D. W.; Avakian, H.; Burkert, V. D.; Carman, D. S.; Cole, P. L.; Deur, A.; Doughty, D.; Egiyan, H.; Elouadrhiri, L.; Girod, F. X.; Guo, L.; Kubarovsky, V.; Lowry, M.; Mokeev, V.; Nadel-Turonski, P.; Park, K.; Pasyuk, E.; Rossi, P.; Sharabian, Y. G.; Stepanyan, S.; Ungaro, M.; Wei, X.; Wood, S. A.] Thomas Jefferson Natl Accelerator Facil, Newport News, VA 23606 USA; [Gilad, S.; Bertozzi, W.] MIT, Cambridge, MA 02139 USA; [Arrington, J.; Baltzell, N. A.; El Alaoui, A.; Hafidi, K.; Mustapha, B.] Argonne Natl Lab, Argonne, IL 60439 USA; [Ball, J.; Garcon, M.; Procureur, S.; Sabatie, F.] Ctr Saclay, Irfu, Commissariat Energie Atom & Energies Alternat, Serv Phys Nucl, F-91191 Gif Sur Yvette, France; [Battaglieri, M.; Celentano, A.; De Vita, R.; Fegan, S.; Osipenko, M.; Ripani, M.] Ist Nazl Fis Nucl, Sez Genova, I-16146 Genoa, Italy; [Beck, A.; Beck, S. May-Tal] Nucl Res Ctr Negev, IL-84190 Beer Sheva, Israel; [Bedlinskiy, I.; Pogorelko, O.; Vlassov, A. V.] Inst Theoret & Expt Phys, Moscow 117259, Russia; [Biselli, A.] Fairfield Univ, Fairfield, CT 06824 USA; [Cao, T.; Djalali, C.; Fedotov, G.; Gothe, R. W.; Ilieva, Y.; Jiang, H.; Lu, H. Y.; Strauch, S.; Wood, M. H.; Zachariou, N.] Univ S Carolina, Columbia, SC 29208 USA; [Chandavar, S.; Goetz, J. T.; Hicks, K.] Ohio Univ, Athens, OH 45701 USA; [Colaneri, L.; D'Angelo, A.; Rizzo, A.; Zonta, I.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Cole, P. L.; Forest, T.; Khandaker, M.] Idaho State Univ, Pocatello, ID 83209 USA; [Cole, P. L.; Klein, F. J.; Walford, N. K.] Catholic Univ Amer, Washington, DC 20064 USA; [Crede, V.; Roy, P.] Florida State Univ, Tallahassee, FL 32306 USA; [D'Angelo, A.] Univ Roma Tor Vergata, I-00133 Rome, Italy; [Djalali, C.] Univ Iowa, Iowa City, IA 52242 USA; [Doughty, D.] Christopher Newport Univ, Newport News, VA 23606 USA; [Dugger, M.; Ritchie, B. G.] Arizona State Univ, Tempe, AZ 85287 USA; [Dupre, R.; Garillon, B.; Guidal, M.; Hattawy, M.; Jo, H. S.; Mokeev, V.; Camacho, C. Munoz; Niccolai, S.] Inst Phys Nucl ORSAY, Orsay, France; [Fedotov, G.; Ishkanov, B. I.; Isupov, E. L.] Skobeltsyn Inst Nucl Phys, Lomonosov, Russia; [Gilfoyle, G. P.] Univ Richmond, Richmond, VA 23173 USA; [Griffioen, K. A.] Coll William & Mary, Williamsburg, VA 23187 USA; [Hanretty, C.; Keller, D.; Prok, Y.; Tkachenko, S.; Zhao, Z. W.; Zheng, X.] Univ Virginia, Charlottesville, VA 22901 USA; [Holtrop, M.; Paremuzyan, R.; Zana, L.] Univ New Hampshire, Durham, NH 03824 USA; [Ilieva, Y.; Schott, D.; Strauch, S.] George Washington Univ, Washington, DC 20052 USA; [Ireland, D. G.; Livingston, K.; MacGregor, I. J. D.; McKinnon, B.; Protopopescu, D.; Rosner, G.; Sokhan, D.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Joo, K.; Markov, N.; Mineeva, T.; Puckett, A. J. R.] Univ Connecticut, Storrs, CT 06269 USA; [Khandaker, M.] Norfolk State Univ, Norfolk, VA 23504 USA; [Kim, A.; Kim, W.; Park, K.; Stepanyan, S. S.] Kyungpook Natl Univ, Taegu 702701, South Korea; [Lenisa, P.; Movsisyan, A.; Pappalardo, L. L.] Ist Nazl Fis Nucl, Sez Ferrara, I-44100 Ferrara, Italy; [Levine, W. I.; Schumacher, R. A.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Mokeev, V.] Moscow MV Lomonosov State Univ, Moscow 119234, Russia; [Niculescu, G.; Niculescu, I.] James Madison Univ, Harrisonburg, VA 22807 USA; [Pappalardo, L. L.] Univ Ferrara, I-44122 Ferrara, Italy; [Pisano, S.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; [Price, J. W.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA; [Smith, G. D.; Zana, L.] Univ Edinburgh, Edinburgh EH9 3JZ, Midlothian, Scotland; [Stoler, P.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Taiuti, M.] Univ Genoa, I-16146 Genoa, Italy; [Voutier, E.] Univ Grenoble 1, Lab Phys Subatom & Cosmol, CNRS, IN2P3,Inst Natl Polytech, Grenoble, France; [Wood, M. H.] Canisius Coll, Buffalo, NY 14208 USA	Tel Aviv University; State University System of Florida; Florida International University; Old Dominion University; Universidad Tecnica Federico Santa Maria; Yerevan Physics Institute; United States Department of Energy (DOE); Jefferson National Accelerator; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Argonne National Laboratory; CEA; Istituto Nazionale di Fisica Nucleare (INFN); National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Fairfield University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Ohio; Ohio University; Istituto Nazionale di Fisica Nucleare (INFN); Idaho; Idaho State University; Catholic University of America; State University System of Florida; Florida State University; University of Rome Tor Vergata; University of Iowa; Arizona State University; Arizona State University-Tempe; UDICE-French Research Universities; Universite Paris Saclay; University of Richmond; William & Mary; University of Virginia; University System Of New Hampshire; University of New Hampshire; George Washington University; University of Glasgow; University of Connecticut; Norfolk State University; Kyungpook National University; Istituto Nazionale di Fisica Nucleare (INFN); Carnegie Mellon University; Lomonosov Moscow State University; James Madison University; University of Ferrara; Istituto Nazionale di Fisica Nucleare (INFN); California State University System; California State University Dominguez Hills; University of Edinburgh; Rensselaer Polytechnic Institute; University of Genoa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Hen, O (corresponding author), Tel Aviv Univ, IL-69978 Tel Aviv, Israel.	or.chen@mail.huji.ac.il	Ireland, David G/E-8618-2010; Taiuti, Mauro GF/K-5324-2014; Cao, Tongtong/AAS-8774-2021; Deur, Alexandre/H-9778-2019; Sabatie, Franck/K-9066-2015; Ireland, David/N-4957-2019; Rizzo, Alessandro/C-6397-2014; Pappalardo, Luciano/AAB-2380-2021; Rossi, Patrizia/B-5943-2019; MacGregor, Ian J D/D-4072-2011; Hyde, Charles E/W-9190-2018; Schumacher, Reinhard A/K-6455-2013; Rosner, Guenther/ABB-5516-2021; Battaglieri, Marco/I-6262-2018; Jo, Hyon-Suk/HGC-7070-2022; Arrington, John R/D-1116-2012; Celentano, Andrea/J-6190-2012; Osipenko, Mikhail/ABE-6806-2021; D'Angelo, Annalisa/A-2439-2012; Osipenko, Mikhail/N-8292-2015; Brooks, William K/C-8636-2013; Alaoui, Ahmed El/B-4638-2015; Lu, Haiyun/B-4083-2012; Higinbotham, Douglas W./J-9394-2014; Burkert, Volker/AAF-7395-2020; Holtrop, Maurik/A-9017-2010; Zachariou, Nicholas/R-8360-2018; Rizzo, Alessandro/O-6986-2019; Dugger, Michael/AAR-5206-2021; McKinnon, Bryan/J-2928-2018	Ireland, David G/0000-0001-7713-7011; Deur, Alexandre/0000-0002-2203-7723; Sabatie, Franck/0000-0001-7031-3975; Ireland, David/0000-0001-7713-7011; Rizzo, Alessandro/0000-0001-5597-8514; Rossi, Patrizia/0000-0002-2366-1085; MacGregor, Ian J D/0000-0002-8005-9787; Hyde, Charles E/0000-0001-7282-8120; Schumacher, Reinhard A/0000-0002-3860-1827; Arrington, John R/0000-0002-0702-1328; Celentano, Andrea/0000-0002-7104-2983; Osipenko, Mikhail/0000-0001-9618-3013; D'Angelo, Annalisa/0000-0003-3050-4907; Osipenko, Mikhail/0000-0001-9618-3013; Brooks, William K/0000-0001-6161-3570; Higinbotham, Douglas W./0000-0003-2758-6526; Holtrop, Maurik/0000-0002-1110-1152; Zachariou, Nicholas/0000-0001-7621-5612; Dugger, Michael/0000-0001-5927-7045; Markov, Nikolay/0000-0001-8499-3481; Isupov, Evgeny/0000-0001-7524-2408; Cole, Philip/0000-0003-0487-0647; Voutier, Eric/0000-0003-4990-3369; Pasyuk, Eugene/0000-0003-3877-1815; Mayer, Michael/0000-0001-7600-0873; Hen, Or/0000-0002-4890-6544; Zonta, Irene/0000-0003-4952-2160	U.S. Department of Energy (DOE); National Science Foundation; Israel Science Foundation; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; French Centre National de la Recherche Scientifique and Commissariat a l'Energie Atomique; French-American Cultural Exchange; Italian Istituto Nazionale di Fisica Nucleare; National Research Foundation of Korea; UK's Science and Technology Facilities Council; DOE, Office of Science, Office of Nuclear Physics [DE-AC05-06OR23177]; STFC [ST/L005719/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1205782] Funding Source: National Science Foundation; Division Of Physics [1306737] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/L005719/1] Funding Source: researchfish	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Israel Science Foundation(Israel Science Foundation); Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; French Centre National de la Recherche Scientifique and Commissariat a l'Energie Atomique(Centre National de la Recherche Scientifique (CNRS)); French-American Cultural Exchange; Italian Istituto Nazionale di Fisica Nucleare(Istituto Nazionale di Fisica Nucleare (INFN)); National Research Foundation of Korea(National Research Foundation of Korea); UK's Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); DOE, Office of Science, Office of Nuclear Physics(United States Department of Energy (DOE)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the U.S. Department of Energy (DOE) and the National Science Foundation, the Israel Science Foundation, the Chilean Comision Nacional de Investigacion Cientifica y Tecnologica, the French Centre National de la Recherche Scientifique and Commissariat a l'Energie Atomique, the French-American Cultural Exchange, the Italian Istituto Nazionale di Fisica Nucleare, the National Research Foundation of Korea, and the UK's Science and Technology Facilities Council. Jefferson Science Associates operates the Thomas Jefferson National Accelerator Facility for the DOE, Office of Science, Office of Nuclear Physics under contract DE-AC05-06OR23177. The raw data from this experiment are archived in Jefferson Lab's mass storage silo.	[Anonymous], 2013, I NUCL THEOR INT WOR; Arrington J, 2012, PROG PART NUCL PHYS, V67, P898, DOI 10.1016/j.ppnp.2012.04.002; Blomqvist KI, 1998, PHYS LETT B, V421, P71, DOI 10.1016/S0370-2693(98)00024-0; Braaten E, 2012, LECT NOTE PHYS, V836, P193; Carbone A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/22001; Dutta D, 2013, PROG PART NUCL PHYS, V69, P1, DOI 10.1016/j.ppnp.2012.11.001; Egiyan K. Sh., 2006, PHYS REV LETT, V96; Fomin N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.092502; FRANKFURT L, 1988, PHYS REP, V160, P235, DOI 10.1016/0370-1573(88)90179-2; FRIEDES JL, 1965, PHYS REV LETT, V15, P38, DOI 10.1103/PhysRevLett.15.38; Hen O, 2013, PHYS LETT B, V722, P63, DOI 10.1016/j.physletb.2013.04.011; Hen O, 2013, INT J MOD PHYS E, V22, DOI 10.1142/S0218301313300178; Kuhnle ED, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.070402; LAPIKAS L, 1993, NUCL PHYS A, V553, pC297, DOI 10.1016/0375-9474(93)90630-G; Lattimer JM, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/51; Li BA, 2008, PHYS REP, V464, P113, DOI 10.1016/j.physrep.2008.04.005; MARDOR I, 1992, PHYS REV C, V46, P761, DOI 10.1103/PhysRevC.46.761; Mecking BA, 2003, NUCL INSTRUM METH A, V503, P513, DOI 10.1016/S0168-9002(03)01001-5; Pandharipande VR, 1997, REV MOD PHYS, V69, P981, DOI 10.1103/RevModPhys.69.981; Piasetzky E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.162504; Sargsian MM, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034305; Sargsian MM, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.044615; Schiavilla R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.132501; Starink R, 2000, PHYS LETT B, V474, P33, DOI 10.1016/S0370-2693(99)01510-5; Stewart JT, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.235301; Subedi R, 2008, SCIENCE, V320, P1476, DOI 10.1126/science.1156675; Tan S, 2008, ANN PHYS-NEW YORK, V323, P2971, DOI 10.1016/j.aop.2008.03.005; Tan S, 2008, ANN PHYS-NEW YORK, V323, P2952, DOI 10.1016/j.aop.2008.03.004; Tan S, 2008, ANN PHYS-NEW YORK, V323, P2987, DOI 10.1016/j.aop.2008.03.003; Vidana I, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.062801; Weinstein LB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.052301; Wiringa RB, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.024305; Xu C, 2013, J PHYS CONF SER, V420, DOI 10.1088/1742-6596/420/1/012090; Zeller GP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.239902	38	179	185	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		614	617		10.1126/science.1256785	http://dx.doi.org/10.1126/science.1256785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25323697	Green Submitted			2022-12-28	WOS:000343799700043
J	Siddiky, A; Sarwar, K; Ahmad, N; Gilbert, J				Siddiky, Abul; Sarwar, Kashif; Ahmad, Niaz; Gilbert, James			Management of arteriovenous fistulas	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VASCULAR ACCESS; HEMODIALYSIS COHORT; BUTTONHOLE; GRAFTS; CANNULATION; THROMBOSIS; OUTCOMES; FAILURE		[Siddiky, Abul] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England; [Sarwar, Kashif] Leeds City Med Practice, Leeds, W Yorkshire, England; [Ahmad, Niaz] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Gilbert, James] Oxford Univ Hosp NHS Trust, Oxford, England	University of Oxford; University of Leeds; Oxford University Hospitals NHS Foundation Trust	Siddiky, A (corresponding author), Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England.	ahsiddiky@doctors.org.uk	Gilbert, James/AAC-7932-2022	Gilbert, James/0000-0003-3291-2541				[Anonymous], 2002, NEPHROL DIAL TRANSPL, V17, P76; Australia and New Zealand Dialysis and Transplant Registry, 2012, HAEM; BRESCIA MJ, 1966, NEW ENGL J MED, V275, P1089, DOI 10.1056/NEJM196611172752002; CHURCHILL DN, 1992, AM J KIDNEY DIS, V19, P214, DOI 10.1016/S0272-6386(13)80002-9; Da Silva AF, 2003, COCHRANE DB SYST REV, V2; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; Endstage Renal Disease National Coordinating Centre, 2014, FIST 1 CATH LAST FFC; ENGELBERTS I, 1995, AM J NEPHROL, V15, P323, DOI 10.1159/000168857; FAN PY, 1992, J AM SOC NEPHROL, V3, P1; Guy's and St Thomas' NHS Foundation Trust, 2013, CAR YOUR AV FIST; Ifudu O, 1998, NEPHROL DIAL TRANSPL, V13, P2311, DOI 10.1093/ndt/13.9.2311; KESSLER M, 1993, NEPHRON, V64, P95, DOI 10.1159/000187285; Knox RC, 2002, J VASC SURG, V36, P250, DOI 10.1067/mva.2002.125025; Leon C, 2007, CLIN J AM SOC NEPHRO, V2, P175, DOI 10.2215/CJN.02230606; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; Lynch JR, 2011, CURR OPIN NEPHROL HY, V20, P583, DOI 10.1097/MNH.0b013e32834b33c4; MacRae JM, 2012, CLIN J AM SOC NEPHRO, V7, P1632, DOI 10.2215/CJN.02730312; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Maya ID, 2008, AM J KIDNEY DIS, V51, P702, DOI 10.1053/j.ajkd.2007.10.046; Metha S., 1991, VASCULAR ACCESS HEMO, P145; Muir CA, 2014, CLIN J AM SOC NEPHRO, V9, P110, DOI 10.2215/CJN.03930413; National Institute for Health and Care Excellence, 2011, CHRON KID DIS QUAL S; National Kidney and Urologic Diseases Information Clearinghouse, 2012, KID DIS STAT US; NKF-K/DOQI, 2001, AM J KIDNEY DIS S, V37, pS169; NKF-K/DOQI, 2001, AM J KIDNEY DIS S, V37, pS162; NKF-K/DOQI, 2001, AM J KIDNEY DIS S, V37, pS143; Oliver MJ, 2001, KIDNEY INT, V60, P1532, DOI 10.1046/j.1523-1755.2001.00956.x; Oxford University Hospitals NHS Trust, 2013, ACC HAEM 3; Oxford University Hospitals NHS Trust, 2013, ACC HAEM 2; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Rogers NM, 2007, NEPHROL DIAL TRANSPL, V22, P933, DOI 10.1093/ndt/gfl722; ROMERO A, 1986, INT SURG, V71, P122; Saxena AK, 2005, SAUDI J KIDNEY DIS T, V16, P46; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schild AF, 2008, J VASC ACCESS, V9, P231, DOI 10.1177/112972980800900402; Schon D, 2007, CLIN J AM SOC NEPHRO, V2, P268, DOI 10.2215/CJN.01880606; Stolic R, 2013, MED PRIN PRACT, V22, P220, DOI 10.1159/000343669; Thomson P, 2010, NEPHROL DIAL TRANSPL, V25, P1596, DOI 10.1093/ndt/gfp667; Turmel-Rodrigues L, 2000, NEPHROL DIAL TRANSPL, V15, P2029, DOI 10.1093/ndt/15.12.2029; UK Renal Association, 2010, PER DIAL; UK Renal Association, 2011, VASC ACC HAEM; UK Renal Registry, 2013, 16 UK REN REG; van Loon MM, 2010, NEPHROL DIAL TRANSPL, V25, P225, DOI 10.1093/ndt/gfp420	43	8	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2014	349								g6262	10.1136/bmj.g6262	http://dx.doi.org/10.1136/bmj.g6262			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DI	25358517				2022-12-28	WOS:000344156100005
J	Kmietowicz, Z				Kmietowicz, Zosia			BRIEFING E-cigarettes latest: users on the up but rules tighten	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOW; CALLS											Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5501; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5335; Kmietowicz Z, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4103; Kmietowicz Zosia, 2014, BMJ, V348, pg4016, DOI 10.1136/bmj.g4016; Kmietowicz Z, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2987; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7630; McKee M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5780; O'Dowd A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6180; Stafford N, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3859; Travasso C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1669; Vardavas CI, 2015, TOB CONTROL, V24, P442, DOI [10.1136/tobaccocontrol-2013-051394, 10.1136/tobaccocontrol-2012-050857]; Watson R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1895	17	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2014	349								g6444	10.1136/bmj.g6444	http://dx.doi.org/10.1136/bmj.g6444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3CT	25348208				2022-12-28	WOS:000344154600009
J	Huang, PS; Oberdorfer, G; Xu, CF; Pei, XY; Nannenga, BL; Rogers, JM; DiMaio, F; Gonen, T; Luisi, B; Baker, D				Huang, Po-Ssu; Oberdorfer, Gustav; Xu, Chunfu; Pei, Xue Y.; Nannenga, Brent L.; Rogers, Joseph M.; DiMaio, Frank; Gonen, Tamir; Luisi, Ben; Baker, David			High thermodynamic stability of parametrically designed helical bundles	SCIENCE			English	Article							COILED-COIL; PROTEINS	We describe a procedure for designing proteins with backbones produced by varying the parameters in the Crick coiled coil-generating equations. Combinatorial design calculations identify low-energy sequences for alternative helix supercoil arrangements, and the helices in the lowest-energy arrangements are connected by loop building. We design an antiparallel monomeric untwisted three-helix bundle with 80-residue helices, an antiparallel monomeric right-handed four-helix bundle, and a pentameric parallel left-handed five-helix bundle. The designed proteins are extremely stable (extrapolated Delta G(fold) > 60 kilocalories per mole), and their crystal structures are close to those of the design models with nearly identical core packing between the helices. The approach enables the custom design of hyperstable proteins with fine-tuned geometries for a wide range of applications.	[Huang, Po-Ssu; Oberdorfer, Gustav; Xu, Chunfu; DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Oberdorfer, Gustav; Xu, Chunfu; DiMaio, Frank; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Oberdorfer, Gustav] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Pei, Xue Y.; Luisi, Ben] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Nannenga, Brent L.; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Rogers, Joseph M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Graz; University of Cambridge; Howard Hughes Medical Institute; University of Cambridge; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Rogers, Joseph/AGZ-9056-2022; Xu, Chunfu/B-5963-2012	Baker, David/0000-0001-7896-6217; Xu, Chunfu/0000-0002-8668-0566; Nannenga, Brent/0000-0001-6859-3429; Oberdorfer, Gustav/0000-0002-6144-9114; Huang, Possu/0000-0002-7948-2895; Rogers, Joseph/0000-0002-1313-4089	Advanced Light Source (U.S. Department of Energy) [DE-AC02-05CH11231]; Howard Hughes Medical Institute; Defense Threat Reduction Agency; Wellcome Trust; Biotechnology and Biological Sciences Research Council	Advanced Light Source (U.S. Department of Energy)(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are indebted to G. Grigoryan and W. DeGrado for their paper on coiled-coil geometry and to G. Grigoryan for the CCCP Web server that was used in initial exploratory calculations, and for helpful advice. We thank S. Gordon for protein production, Rosetta@Home volunteers for providing the computing throughput to rigorously test designs by ab initio structure prediction, and the staff at Diamond Light source and at the Advanced Light Source (U.S. Department of Energy contract no. DE-AC02-05CH11231) for access and assistance with x-ray data collection. This work was supported by Howard Hughes Medical Institute, Defense Threat Reduction Agency, and the Wellcome Trust. G.O. is a Marie Curie International Outgoing Fellowship fellow (332094 ASR-CompEnzDes FP7-People-2012-IOF). J.M.R. was supported by a studentship from the Biotechnology and Biological Sciences Research Council. Coordinates and structure factors have been deposited in the Protein Data Bank with the accession codes 4TQL (3H5L_2), 4UOS (4H3L_3), and 4UOT (5L2L_2.1). P.S.H., G.O., C.X., and D.B. designed the research. D.B. wrote the parametric backbone generation code; P.S.H. wrote the loop modeling code; and P.S.H., G.O., C.X., and D.B. carried out design calculations and biophysical analyses. J.M.R. characterized 3H5L_2 and 3H5L_2_mini. With help from G.O. and F.D., X.Y.P. and B.L. solved structures of 4H3L_3 and 5H2L_2, and B.L.N. and T.G. solved the 3H5L_2 bundle structure and did electron microscopy analysis.	Boyle AL, 2011, CHEM SOC REV, V40, P4295, DOI 10.1039/c0cs00152j; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; CHOU KC, 1990, J MOL BIOL, V213, P315, DOI 10.1016/S0022-2836(05)80193-7; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Pace C N, 1986, Methods Enzymol, V131, P266; Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]	18	181	188	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					481	485		10.1126/science.1257481	http://dx.doi.org/10.1126/science.1257481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342806	Green Submitted, Green Accepted			2022-12-28	WOS:000343822900046
J	Moreno, SP; Bailey, R; Campion, N; Herron, S; Gambus, A				Moreno, Sara Priego; Bailey, Rachael; Campion, Nicholas; Herron, Suzanne; Gambus, Agnieszka			Polyubiquitylation drives replisome disassembly at the termination of DNA replication	SCIENCE			English	Article							CHROMATIN; PROGRESSION; PROTEINS; XENOPUS; CDT1; ASSOCIATION; DESTRUCTION; PROTEOLYSIS; COMPLEXES; PREVENTS	Resolution of replication forks during termination of DNA replication is essential for accurate duplication of eukaryotic genomes. Here we present evidence consistent with the idea that polyubiquitylation of a replisome component (Mcm7) leads to its disassembly at the converging terminating forks because of the action of the p97/VCP/Cdc48 protein remodeler. Using Xenopus laevis egg extract, we have shown that blocking polyubiquitylation results in the prolonged association of the active helicase with replicating chromatin. The Mcm7 subunit is the only component of the active helicase that we find polyubiquitylated during replication termination. The observed polyubiquitylation is followed by disassembly of the active helicase dependent on p97/VCP/Cdc48. Altogether, our data provide insight into the mechanism of replisome disassembly during eukaryotic DNA replication termination.	[Moreno, Sara Priego; Bailey, Rachael; Campion, Nicholas; Herron, Suzanne; Gambus, Agnieszka] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Gambus, A (corresponding author), Univ Birmingham, Sch Canc Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	a.gambus@bham.ac.uk	Gambus, Aga/AAK-4687-2021	Gambus, Aga/0000-0002-4648-0332; Priego Moreno, Sara/0000-0001-9168-4302	U.K. Medical Research Council Career Development Award [MR/K007106/1]; Cancer Research UK Birmingham Centre award [DF/270312]; ERASMUS scholarship; Wellcome Trust strategic award [ISSFPP47]; Cancer Research UK Birmingham Centre [CAICS/05/12]; MRC [MR/K007106/1] Funding Source: UKRI; Medical Research Council [MR/K007106/1] Funding Source: researchfish	U.K. Medical Research Council Career Development Award; Cancer Research UK Birmingham Centre award; ERASMUS scholarship; Wellcome Trust strategic award(Wellcome Trust); Cancer Research UK Birmingham Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank K. Labib for sharing his data and critical discussions, J. Blow for support and help with egg extract, R. Hay for advice, O. Stemmann for vectors to express p97, and E. Petermann for help with fibers. A.G. would like to thank D. Tennant for support. This work was supported by U.K. Medical Research Council Career Development Award MR/K007106/1 to A.G. and Cancer Research UK Birmingham Centre award DF/270312 to A.G. S.P.M. was funded by ERASMUS scholarship and Wellcome Trust strategic award ISSFPP47; N.C. was funded by Cancer Research UK Birmingham Centre award CAICS/05/12.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Cuvier O, 2008, GENE DEV, V22, P860, DOI 10.1101/gad.445108; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Germe T, 2005, EMBO REP, V6, P729, DOI 10.1038/sj.embor.7400465; Heubes S, 2007, J CELL SCI, V120, P1325, DOI 10.1242/jcs.006924; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kuipers MA, 2011, J CELL BIOL, V192, P29, DOI 10.1083/jcb.201007111; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Mahaffey DT, 2003, EXP CELL RES, V288, P225, DOI 10.1016/S0014-4827(03)00088-0; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	29	123	124	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					477	481		10.1126/science.1253585	http://dx.doi.org/10.1126/science.1253585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342805				2022-12-28	WOS:000343822900045
J	Pancera, M; Zhou, TQ; Druz, A; Georgiev, IS; Soto, C; Gorman, J; Huang, JH; Acharya, P; Chuang, GY; Ofek, G; Stewart-Jones, GBE; Stuckey, J; Bailer, RT; Joyce, MG; Louder, MK; Tumba, N; Yang, YP; Zhang, BS; Cohen, MS; Haynes, BF; Mascola, JR; Morris, L; Munro, JB; Blanchard, SC; Mothes, W; Connors, M; Kwong, PD				Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr; Georgiev, Ivelin S.; Soto, Cinque; Gorman, Jason; Huang, Jinghe; Acharya, Priyamvada; Chuang, Gwo-Yu; Ofek, Gilad; Stewart-Jones, Guillaume B. E.; Stuckey, Jonathan; Bailer, Robert T.; Joyce, M. Gordon; Louder, Mark K.; Tumba, Nancy; Yang, Yongping; Zhang, Baoshan; Cohen, Myron S.; Haynes, Barton F.; Mascola, John R.; Morris, Lynn; Munro, James B.; Blanchard, Scott C.; Mothes, Walther; Connors, Mark; Kwong, Peter D.			Structure and immune recognition of trimeric pre-fusion HIV-1 Env	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN TRIMERS; B-CELL RESPONSES; NEUTRALIZING ANTIBODY; CRYSTAL-STRUCTURE; INFLUENZA-VIRUS; EBOLA-VIRUS; POTENT NEUTRALIZATION; DEPENDENT EPITOPE; CORE STRUCTURE	The human immunodeficiency virus type 1 (HIV-1) envelope (Env) spike, comprising three gp120 and three gp41 subunits, is a conformational machine that facilitates HIV-1 entry by rearranging from a mature unliganded state, through receptor-bound intermediates, to a post-fusion state. As the sole viral antigen on the HIV-1 virion surface, Env is both the target of neutralizing antibodies and a focus of vaccine efforts. Here we report the structure at 3.5 angstrom resolution for an HIV-1 Env trimer captured in a mature closed state by antibodies PGT122 and 35O22. This structure reveals the pre-fusion conformation of gp41, indicates rearrangements needed for fusion activation, and defines parameters of immune evasion and immune recognition. Pre-fusion gp41 encircles amino- and carboxy-terminal strands of gp120 with four helices that form a membrane-proximal collar, fastened by insertion of a fusion peptide-proximal methionine into a gp41-tryptophan clasp. Spike rearrangements required for entry involve opening the clasp and expelling the termini. N-linked glycosylation and sequence-variable regions cover the pre-fusion closed spike; we used chronic cohorts to map the prevalence and location of effective HIV-1-neutralizing responses, which were distinguished by their recognition of N-linked glycan and tolerance for epitope-sequence variation.	[Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr; Georgiev, Ivelin S.; Soto, Cinque; Gorman, Jason; Acharya, Priyamvada; Chuang, Gwo-Yu; Ofek, Gilad; Stewart-Jones, Guillaume B. E.; Stuckey, Jonathan; Bailer, Robert T.; Joyce, M. Gordon; Louder, Mark K.; Yang, Yongping; Zhang, Baoshan; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Huang, Jinghe; Connors, Mark] NIAID, HIV Specif Immun Sect, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA; [Tumba, Nancy; Morris, Lynn] NHLS, Ctr HIV & STIs, Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa; [Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Med, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Surg, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Pediat, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC 27710 USA; [Morris, Lynn] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Morris, Lynn] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, ZA-4041 Durban, South Africa; [Munro, James B.; Mothes, Walther] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University; Duke University; University of Witwatersrand; University of Kwazulu Natal; Yale University; Cornell University	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Mascola, John/AAI-7193-2021; Zhou, Tongqing/A-6880-2010; Huang, Jinghe/O-1986-2015; Huang, Jinghe/P-8068-2019; Blanchard, Scott C./A-5804-2009; Morris, Lynn/V-3941-2018; Gorman, Jason/AGG-9417-2022	Zhou, Tongqing/0000-0002-3935-4637; Blanchard, Scott C./0000-0003-2717-9365; Morris, Lynn/0000-0003-3961-7828; Huang, Jinghe/0000-0002-1968-871X; Acharya, Priyamvada/0000-0002-0089-277X; Gorman, Jason/0000-0002-3775-6560	Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Division of AIDS, NIAID, NIH [R21-AI100696, CHAVI-AI0678501, CHAVI-Immunogen Discovery-AI100645]; National Institutes of General Medical Sciences [P01-GM56550, R01-GM098859]; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); UK Department for International Development (DFID); United States Agency for International Development (USAID); US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005111, ZICAI005114, ZIAAI005023, P30AI050410, ZIAAI005024, UM1AI100645, R21AI100696, ZICAI005112, ZICAI005113, ZIAAI005002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098859, P01GM056550] Funding Source: NIH RePORTER	Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Division of AIDS, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); UK Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Binley for the JR-FL plasmid used in smFRET; D. Burton and W. Koff for PGT122; J. Chrzas and SER-CAT staff for assistance with data collection; B. Graham for discussions on RSV; R. Sanders for furin plasmid; R. Schwartz and the Vaccine Production Program for antibody VRC01; J. Sodroski for information on C34-Ig; I. Wilson for discussions on pre-fusion Env structure; Z. Yang for assistance with cloning; G. Nabel, G. Scott and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript; and the WCMC/AMC/TSRI HIVRAD team for their contributions to the design and validation of near-native mimicry for soluble BG505 SOSIP.664 trimers. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong,J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 envelope plasmids used in our neutralization panel. The authors acknowledge the contributions of the Center for HIV/AIDS Vaccine Discovery (CHAVI) Clinical Core Team for recruiting study participants and carrying out all aspects of the CHAVI001 and CHAVI008 protocols at Chapel Hill, North Carolina (J. Eron); Blantyre, Malawi (J. Kumwenda, T. Taha); Lilongwe, Malawi (I. Hoffman, G. Kaminga); Johannesburg, South Africa (H. Rees); Durban, South Africa (S. Abdool Karim); Moshi, Tanzania (S. Noel, S. Kapiga, J. Crump); and London, UK (S. Fidler). Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); and by grants from the Division of AIDS, NIAID, NIH (R21-AI100696, CHAVI-AI0678501, and CHAVI-Immunogen Discovery-AI100645), from the National Institutes of General Medical Sciences (P01-GM56550 and R01-GM098859), from the Irvington Fellows Program of the Cancer Research Program, and from the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium. IAVI's work is made possible by support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the UK Department for International Development (DFID): and the United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. Use of sector 22 (Southeast Region Collaborative Access Team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI 10.1089/AID.2010.0281; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CHEN CH, 1995, J VIROL, V69, P3771, DOI 10.1128/JVI.69.6.3771-3777.1995; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cimbro R, 2014, P NATL ACAD SCI USA, V111, P3152, DOI 10.1073/pnas.1314718111; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gorny MK, 2000, VIROLOGY, V267, P220, DOI 10.1006/viro.1999.0095; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang J, 2014, NATURE 0903; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kwong PD, 1999, J APPL CRYSTALLOGR, V32, P102, DOI 10.1107/S0021889898009686; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Leavitt M, 2003, J VIROL, V77, P560, DOI 10.1128/JVI.77.1.560-570.2003; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Munro J. B., 2014, SCIENCE; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; NISHIKAWA K, 1972, J PHYS SOC JPN, V32, P1331, DOI 10.1143/JPSJ.32.1331; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; RINI JM, 1993, P NATL ACAD SCI USA, V90, P6325, DOI 10.1073/pnas.90.13.6325; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; Stanfield Robyn L., 2005, Human Antibodies, V14, P73; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; THALI M, 1992, J VIROL, V66, P5516, DOI 10.1128/JVI.66.9.5516-5524.1992; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tugarinov V, 1999, NAT STRUCT BIOL, V6, P331; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WL D, 2002, PYMOL MOL GRAPHICS S; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yuan W, 2004, J VIROL, V78, P5448, DOI 10.1128/JVI.78.10.5448-5457.2004; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	127	543	569	2	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					455	+		10.1038/nature13808	http://dx.doi.org/10.1038/nature13808			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25296255	Green Submitted, Green Accepted			2022-12-28	WOS:000343775900032
J	Sanders, RW; Moore, JP				Sanders, Rogier W.; Moore, John P.			A stamp on the envelope	NATURE			English	Editorial Material							GLYCOPROTEIN COMPLEX; GP120; RECEPTOR; TRIMERS; VACCINE; GP41		[Sanders, Rogier W.; Moore, John P.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Cornell University; University of Amsterdam; Academic Medical Center Amsterdam	Sanders, RW (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA.	r.w.sanders@amc.uva.nl; jpm2003@med.cornell.edu			European Research Council [280829] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Guttman M, 2013, J VIROL, V87, P11462, DOI 10.1128/JVI.01681-13; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Medina-Ramirez M, 2014, EXPERT REV VACCINES, V13, P449, DOI 10.1586/14760584.2014.894469; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schiller J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004254; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111	15	24	26	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					437	438		10.1038/nature13926	http://dx.doi.org/10.1038/nature13926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25296251	Green Accepted, Bronze			2022-12-28	WOS:000343775900025
J	Baird, NA; Douglas, PM; Simic, MS; Grant, AR; Moresco, JJ; Wolff, SC; Yates, JR; Manning, G; Dillin, A				Baird, Nathan A.; Douglas, Peter M.; Simic, Milos S.; Grant, Ana R.; Moresco, James J.; Wolff, Suzanne C.; Yates, John R., III; Manning, Gerard; Dillin, Andrew			HSF-1-mediated cytoskeletal integrity determines thermotolerance and life span	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; CAENORHABDITIS-ELEGANS; C.-ELEGANS; PROTEINS; TROPONIN; HSF1; ORGANIZATION; CONTRACTION; ENDOCYTOSIS; EXPRESSION	The conserved heat shock transcription factor-1 (HSF-1) is essential to cellular stress resistance and life-span determination. The canonical function of HSF-1 is to regulate a network of genes encoding molecular chaperones that protect proteins from damage caused by extrinsic environmental stress or intrinsic age-related deterioration. In Caenorhabditis elegans, we engineered a modified HSF-1 strain that increased stress resistance and longevity without enhanced chaperone induction. This health assurance acted through the regulation of the calcium-binding protein PAT-10. Loss of pat-10 caused a collapse of the actin cytoskeleton, stress resistance, and life span. Furthermore, overexpression of pat-10 increased actin filament stability, thermotolerance, and longevity, indicating that in addition to chaperone regulation, HSF-1 has a prominent role in cytoskeletal integrity, ensuring cellular function during stress and aging.	[Baird, Nathan A.; Douglas, Peter M.; Simic, Milos S.; Wolff, Suzanne C.; Dillin, Andrew] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Grant, Ana R.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA; [Manning, Gerard] Genentech Inc, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Scripps Research Institute; Roche Holding; Genentech	Dillin, A (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	dillin@berkeley.edu	Manning, Gerard/C-8308-2009	Moresco, James/0000-0003-1178-1642; Douglas, Peter/0000-0002-0734-1049; Simic, Milos/0000-0002-1167-0857; Grant, Ana/0000-0002-5439-9331; Manning, Gerard/0000-0002-5087-9151	Howard Hughes Medical Institute, National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; National Institute on Aging [R01AG027463-04]; Leona M. & Harry B. Helmsley Charitable Trust; George E. Hewitt Foundation for Medical Research; National Institute of Aging [1K99AG042495-0141]; NIH-Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463, P01AG031097, R00AG042495, K99AG042495] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Center for Research Resources; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Leona M. & Harry B. Helmsley Charitable Trust; George E. Hewitt Foundation for Medical Research; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Bioinformatic analysis is included in the supplementary materials. The following funding sources supported this research: Howard Hughes Medical Institute, National Center for Research Resources (5P41RR011823-17) National Institute of General Medical Sciences (8 P41 GM103533-17), and National Institute on Aging (R01AG027463-04). N.A.B. was funded by a postdoctoral fellowship to the Salk Center for Nutritional Genomics from the Leona M. & Harry B. Helmsley Charitable Trust; P.M.D. was funded by George E. Hewitt Foundation for Medical Research and National Institute of Aging (1K99AG042495-0141). We thank the laboratory of G. Lithgow for generously sharing the HSP-16 antibody and J. Durieux for helping design figure illustrations. Some of the nematode strains used in this work were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is supported by the NIH-Office of Research Infrastructure Programs (P40 OD010440).	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Greene W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000512; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Nguyen CH, 2013, BIOCHEM J, V452, P321, DOI 10.1042/BJ20130098; Obinata T, 2010, J CELL SCI, V123, P1557, DOI 10.1242/jcs.065060; Ono K, 2004, MOL BIOL CELL, V15, P2782, DOI 10.1091/mbc.E04-03-0179; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Terami H, 1999, J CELL BIOL, V146, P193, DOI 10.1083/jcb.146.1.193; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]	22	106	108	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					360	363		10.1126/science.1253168	http://dx.doi.org/10.1126/science.1253168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324391	Green Accepted			2022-12-28	WOS:000343041100047
J	Sun, JL; Ramos, A; Chapman, B; Johnnidis, JB; Le, L; Ho, YJ; Klein, A; Hofmann, O; Camargo, FD				Sun, Jianlong; Ramos, Azucena; Chapman, Brad; Johnnidis, Jonathan B.; Le, Linda; Ho, Yu-Jui; Klein, Allon; Hofmann, Oliver; Camargo, Fernando D.			Clonal dynamics of native haematopoiesis	NATURE			English	Article							STEM-CELLS; IN-VIVO; LIFELONG HEMATOPOIESIS; SELF-RENEWAL; BONE-MARROW; MICE; INTEGRATION; DIFFERENTIATION; PROGENITORS; HOMEOSTASIS	It is currently thought that life-long blood cell production is driven by the action of a small number of multipotent haematopoietic stem cells. Evidence supporting this view has been largely acquired through the use of functional assays involving transplantation. However, whether these mechanisms also govern native non-transplant haematopoiesis is entirely unclear. Here we have established a novel experimental model in mice where cells can be uniquely and genetically labelled in situ to address this question. Using this approach, we have performed longitudinal analyses of clonal dynamics in adult mice that reveal unprecedented features of native haematopoiesis. In contrast to what occurs following transplantation, steady-state blood production is maintained by the successive recruitment of thousands of clones, each with a minimal contribution to mature progeny. Our results demonstrate that a large number of long-lived progenitors, rather than classically defined haematopoietic stem cells, are the main drivers of steady-state haematopoiesis during most of adulthood. Our results also have implications for understanding the cellular origin of haematopoietic disease.	[Sun, Jianlong; Ramos, Azucena; Le, Linda; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Sun, Jianlong; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Sun, Jianlong; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Chapman, Brad; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Johnnidis, Jonathan B.] Univ Penn, Dept Immunol, Philadelphia, PA 19104 USA; [Ho, Yu-Jui] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Klein, Allon] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Cold Spring Harbor Laboratory; Harvard University; Harvard Medical School	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	Camargo@fas.harvard.edu	; Hofmann, Oliver/F-1800-2013	camargo, fernando/0000-0002-5630-5909; Hofmann, Oliver/0000-0002-7738-1513; Ho, Yu-jui/0000-0002-7540-024X	NIH [P30 DK049216, DP2OD006472]; Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006472] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to members of the Camargo laboratory, L. Zon, S. Orkin, M. Goodell and F. Mercier for comments. We thank R. Mathew for cell sorting and Y. Fujiwara for transgenic injections (supported by NIH P30 DK049216). We thank Z. Izsvak (Max-Delbruck-Center) for HSB expression vector and M. Kay (Stanford University) for transposon plasmid. This work was supported by the NIH Director's New Innovator Award (DP2OD006472) to F.D.C. and funds from the Harvard Stem Cell Institute to B.C. and O.H.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Brugman MH, 2013, HUM GENE THER METHOD, V24, P68, DOI 10.1089/hgtb.2012.175; BUESCHER ES, 1985, J CLIN INVEST, V76, P1581, DOI 10.1172/JCI112140; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Drize NJ, 2001, EXP HEMATOL, V29, P786, DOI 10.1016/S0301-472X(01)00634-8; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Harkey MA, 2007, STEM CELLS DEV, V16, P381, DOI 10.1089/scd.2007.0015; HARRISON DE, 1987, BLOOD, V69, P773; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KAY HEM, 1965, LANCET, V2, P418; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; SHAPOSHNIKOV VL, 1979, B EXP BIOL MED+, V87, P510, DOI 10.1007/BF00806699; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zavidij O, 2012, STEM CELLS, V30, P1961, DOI 10.1002/stem.1151	33	500	509	7	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					322	+		10.1038/nature13824	http://dx.doi.org/10.1038/nature13824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25296256	Green Accepted			2022-12-28	WOS:000342988600042
J	Chinthapalli, K				Chinthapalli, Krishna			HEADS UP We need to wake up to the value of sleep medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE; SCHOOLS					kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Durham University Center for Medical Education, 2012, IMP WORK TIM REG MED; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Montagna P, 2005, SLEEP MED REV, V9, P339, DOI 10.1016/j.smrv.2005.02.001; Neely D, 2008, MED EDUC, V42, P176, DOI 10.1111/j.1365-2923.2007.02980.x; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Urquhart DS, 2012, ARCH DIS CHILD, V97, DOI 10.1136/archdischild-2011-301073; Wagner U, 2006, BIOL PSYCHIAT, V60, P788, DOI 10.1016/j.biopsych.2006.03.061; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	9	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2014	349								g6099	10.1136/bmj.g6099	http://dx.doi.org/10.1136/bmj.g6099			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NU	25319585				2022-12-28	WOS:000343767400003
J	Aubert, M; Brumm, A; Ramli, M; Sutikna, T; Saptomo, EW; Hakim, B; Morwood, MJ; van den Bergh, GD; Kinsley, L; Dosseto, A				Aubert, M.; Brumm, A.; Ramli, M.; Sutikna, T.; Saptomo, E. W.; Hakim, B.; Morwood, M. J.; van den Bergh, G. D.; Kinsley, L.; Dosseto, A.			Pleistocene cave art from Sulawesi, Indonesia	NATURE			English	Article							ROCK ART; HUMAN COLONIZATION; AUSTRALIA; SERIES; CORALS; RECORD	Archaeologists have long been puzzled by the appearance in Europe similar to 40-35 thousand years (kyr) ago of a rich corpus of sophisticated art-works, including parietal art (that is, paintings, drawings and engravings on immobile rock surfaces)(1,2) and portable art (for example, carved figurines)(3,4), and the absence or scarcity of equivalent, well-dated evidence elsewhere, especially along early human migration routes in South Asia and the Far East, including Wallacea and Australia(5-8), where modern humans (Homo sapiens) were established by 50 kyr ago(9,10). Here, using uranium-series dating of coralloid speleothems directly associated with 12 human hand stencils and two figurative animal depictions from seven cave sites in the Maros karsts of Sulawesi, we show that rock art traditions on this Indonesian island are at least compatible in age with the oldest European art(11). The earliest dated image from Maros, with a minimum age of 39.9 kyr, is now the oldest known hand stencil in the world. In addition, a painting of a babirusa ('pig-deer') made at least 35.4 kyr ago is among the earliest dated figurative depictions worldwide, if not the earliest one. Among the implications, it can now be demonstrated that humans were producing rock art by similar to 40 kyr ago at opposite ends of the Pleistocene Eurasian world.	[Aubert, M.; Brumm, A.; Sutikna, T.; van den Bergh, G. D.] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Aubert, M.] Griffith Univ, PERAHU, Gold Coast, Qld 4222, Australia; [Ramli, M.] Balai Pelestarian Peninggalan Purbakala, Makassar 90111, Indonesia; [Sutikna, T.; Saptomo, E. W.] Natl Ctr Archaeol ARKENAS, Jakarta 12001, Indonesia; [Hakim, B.] Balai Arkeol Makassar, Makassar 90242, Indonesia; [Kinsley, L.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Dosseto, A.] Univ Wollongong, Wollongong Isotope Geochronol Lab, Wollongong, NSW 2522, Australia; [Dosseto, A.] Univ Wollongong, GeoQuEST Res Ctr, Wollongong, NSW 2522, Australia	University of Wollongong; Griffith University; Australian National University; University of Wollongong; University of Wollongong	Aubert, M (corresponding author), Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	m.aubert@griffith.edu.au	van den Bergh, Gerrit D/I-7670-2016; Dosseto, Anthony/A-2543-2008; Aubert, Maxime/AAT-6198-2020; Sutikna, Thomas/C-4709-2018	Dosseto, Anthony/0000-0002-3575-0106; Aubert, Maxime/0000-0002-4189-531X; Sutikna, Thomas/0000-0002-9742-4226; van den Bergh, Gerrit Dirk/0000-0003-1507-3336	University of Wollongong; Australian Research Council [DP110102898/DE140100254, DP0879624/DE130101560]; Centre for Archaeological Science (CAS), University of Wollongong	University of Wollongong; Australian Research Council(Australian Research Council); Centre for Archaeological Science (CAS), University of Wollongong	The fieldwork was authorized by the director of the Makassar Heritage Department (BPPP), M. Said, and the director of the National Centre for Archaeology in Jakarta (ARKENAS), B. Sulistyanto. We further acknowledge Balai Arkeologi Makassar, the Indonesian State Ministry of Research and Technology, and the Geological Survey Institute in Bandung, for facilitating the research. We thank the University of Wollongong's Deputy Vice Chancellor (Research), J. Raper, for additional project support. Field assistants included M. Andi Pampang and A. A. Oktaviana. Technical laboratory assistance involved G. Mortimer, H. Price, L. Sweetman and L. Yu., and C. Owers provided map data. We thank P. Tacon and M. W. Moore for critical feedback on the manuscript. This research was supported by grants from the Australian Research Council to M.A. (DP110102898/DE140100254) and A.B. (DP0879624/DE130101560) and the Centre for Archaeological Science (CAS), University of Wollongong.	Aubert M, 2012, J ARCHAEOL SCI, V39, P573, DOI 10.1016/j.jas.2011.11.009; Bourdon B., 2003, URANIUM SERIES GEOCH; Brumm A, 2005, CAMB ARCHAEOL J, V15, P157, DOI 10.1017/S0959774305000089; Bulbeck D., 2004, MOD QUAT RES SE ASIA, P111; Bulbeck D., 2000, ASIAN PERSPECT, P71, DOI [10.1353/asi.2000.0004, DOI 10.1353/ASI.2000.0004]; Chaloupka George, 1993, JOURNEY TIME WORLDS; Chazine Jean-Michel, 2009, BORNEO MEMOIRE GROTT; Cheng H, 2000, GEOCHIM COSMOCHIM AC, V64, P2401, DOI 10.1016/S0016-7037(99)00422-6; Combier J, 2014, ANTHROPOLOGIE, V118, P115, DOI 10.1016/j.anthro.2013.12.001; Conard NJ, 2003, NATURE, V426, P830, DOI 10.1038/nature02186; David B, 2013, J ARCHAEOL SCI, V40, P3, DOI 10.1016/j.jas.2012.08.019; Dowson T. A., 2001, ARCHAEOLOGY SHAMANIS, P165; Eriawati Y., 2003, LUKISAN GUA GUA MARO; Garcia-Diez M, 2013, J ARCHAEOL SCI, V40, P4098, DOI 10.1016/j.jas.2013.05.011; Glover I., 1981, MODERN Q ATERNARY RE, P1; GLOVER IC, 1979, WORLD ARCHAEOL, V10, P302, DOI 10.1080/00438243.1979.9979739; Hill C., 1997, CAVE MINERALS WORLD; Langley MC, 2011, J HUM EVOL, V61, P197, DOI 10.1016/j.jhevol.2011.03.002; Leclerc P, 1987, EXPEDITION THAI MARO, P147; Lewis-Williams D., 2002, ARCHITECTURE P JOHNS; McCulloch MT, 2008, AUST J EARTH SCI, V55, P955, DOI 10.1080/08120090802097435; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; McDonald R.C., 1976, Z GEOMORPHOL S, V26, P79; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Morwood MJ., 2002, VISIONS ARCHAEOLOGY; O'Connor S., 2003, ASIAN PERSPECT, V42, P96, DOI [DOI 10.1353/ASI.2003.0028, 10.1353/asi.2003.0028]; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Plagnes V, 2003, QUATERNARY RES, V60, P172, DOI 10.1016/S0033-5894(03)00064-4; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Simanjuntak T., 2008, AUSTRONESIAN SULAWES; Tacon P., 2012, ROCK ART STUD NEWS, P207; Valladas H, 2005, BULL SOC PREHIST FR, V102, P109, DOI 10.3406/bspf.2005.13342; van Heekeren H. R., 1952, LAPORAN TAHUNAN DINA, V1950, P22; White R, 2012, P NATL ACAD SCI USA, V109, P8450, DOI 10.1073/pnas.1119663109	35	266	270	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					223	+		10.1038/nature13422	http://dx.doi.org/10.1038/nature13422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3BG	25297435				2022-12-28	WOS:000342663100041
J	Finland, M				Finland, Maxwell			Antibiotic-Resistant Micrococcic Infections (Reprinted from JAMA, vol 158, pg 188, 1955)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1954, JAMA-J AM MED ASSOC, V156, P608; FINLAND M, 1955, JAMA-J AM MED ASSOC, V158, P188, DOI 10.1001/jama.1955.02960030038012	2	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1475	1475		10.1001/jama.2013.279776	http://dx.doi.org/10.1001/jama.2013.279776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291597				2022-12-28	WOS:000342630200037
J	McKee, M				McKee, Martin			PUBLIC HEALTH Social media attacks on public health advocates	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X				[Anonymous], 2014, GUARDIAN; Hager N, 2014, DIRTY POLITICS; Nissen W, 2014, NZ HERALD; Slater C, 2014, WHALEOIL BLOG   0227; Slater C, 2014, WHALEOIL BLOG   0114	5	5	5	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2014	349								g6006	10.1136/bmj.g6006	http://dx.doi.org/10.1136/bmj.g6006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LP	25297373	Green Published			2022-12-28	WOS:000342998900004
J	Hershberger, PJ; Bricker, DA				Hershberger, Paul J.; Bricker, Dean A.			Who Determines Physician Effectiveness?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Hershberger, Paul J.] Wright State Univ, Boonshoft Sch Med, Dept Family Med, Dayton, OH 45406 USA; [Bricker, Dean A.] Wright State Univ, Boonshoft Sch Med, Dept Med, Dayton, OH 45406 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Hershberger, PJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Family Med, 2345 Philadelphia Dr, Dayton, OH 45406 USA.	paul.hershberger@wright.edu						Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Greene J, 2013, HEALTH AFFAIR, V32, P1299, DOI 10.1377/hlthaff.2012.1409; Jagosh J, 2011, PATIENT EDUC COUNS, V85, P369, DOI 10.1016/j.pec.2011.01.028; Kaplan RM, 2014, J PREV MED, DOI [10.1016/j.ypmed.2014.04.014, DOI 10.1016/J.YPMED.2014.04.014]; Montez JK, 2014, DEMOGRAPHY, V51, P413, DOI 10.1007/s13524-013-0261-x; Tamblyn R, 2014, ANN INTERN MED, V160, P441, DOI 10.7326/M13-1705; VanBuskirk KA, 2014, J BEHAV MED, V37, P768, DOI 10.1007/s10865-013-9527-4	8	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2613	2614		10.1001/jama.2014.13304	http://dx.doi.org/10.1001/jama.2014.13304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX5KW	25317546				2022-12-28	WOS:000346966100007
J	Lucic, V				Lucic, Vladan			Towards unified vesicle endocytosis	NATURE			English	Editorial Material							TERMINALS; MEMBRANE		Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Lucic, V (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	vladan@biochem.mpg.de	Lucic, Vladan/AAA-8128-2020	Lucic, Vladan/0000-0003-3698-7436				Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Gaffield MA, 2007, J NEUROSCI, V27, P13691, DOI 10.1523/JNEUROSCI.3910-07.2007; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Wu YM, 2014, ELIFE, V3, DOI 10.7554/eLife.01621	11	0	0	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					207	208		10.1038/nature13925	http://dx.doi.org/10.1038/nature13925			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25296252				2022-12-28	WOS:000344631400037
J	Roehrig, C				Roehrig, Charles			National Health Spending in 2014-Acceleration Delayed	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Altarum Inst, Ctr Sustainable Hlth Spending, Ann Arbor, MI 48105 USA		Roehrig, C (corresponding author), Altarum Inst, Ctr Sustainable Hlth Spending, Ann Arbor, MI 48105 USA.							Getzen TE, 2014, ENCY HLTH EC, P165; Roehrig C, 2014, WHY HLTH SPENDING IS; Roehrig C, 2014, UNDERLYING PATH HLTH; Sisko AM, 2014, HLTH AFF MILLWOOD	4	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1767	1769		10.1056/NEJMp1409360	http://dx.doi.org/10.1056/NEJMp1409360			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS3IH	25296381				2022-12-28	WOS:000344170300005
J	Harper, S				Harper, Sarah			Economic and social implications of aging societies	SCIENCE			English	Review							HEALTH-CARE EXPENDITURE; POPULATION; FERTILITY; TRENDS; COMPRESSION; PARENTHOOD; DISABILITY; MORBIDITY; MORTALITY; REASONS	The challenge of global population aging has been brought into sharper focus by the financial crisis of 2008. In particular, growing national debt has drawn government attention to two apparently conflicting priorities: the need to sustain public spending on pensions and health care versus the need to reduce budget deficits. A number of countries are consequently reconsidering their pension and health care provisions, which account for up to 40% of all government spending in advanced economies. Yet population aging is a global phenomenon that will continue to affect all regions of the world. By 2050 there will be the same number of old as young in the world, with 2 billion people aged 60 or over and another 2 billion under age 15, each group accounting for 21% of the world's population.	Univ Oxford, Oxford Inst Populat Ageing, Oxford OX2 6PR, England	University of Oxford	Harper, S (corresponding author), Univ Oxford, Oxford Inst Populat Ageing, Oxford OX2 6PR, England.	sarah.harper@ageing.ox.ac.uk		Harper, Sarah/0000-0001-8248-7016				Basten S, 2013, DEMOGR RES, V28, P1145, DOI 10.4054/DemRes.2013.28.39; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Bloom D. E., 2011, PROGRAM ON THE GLOBA; Bloom DE, 2010, OXFORD REV ECON POL, V26, P583, DOI 10.1093/oxrep/grq038; Blossfeld HP, 2006, ROUTL ADV SOCIOL, P1; Breyer F, 2010, OXFORD REV ECON POL, V26, P674, DOI 10.1093/oxrep/grq032; Brucker H., 2002, CAN INTERNATIONAL MI; CALDWELL JC, 1980, POPUL DEV REV, V6, P225, DOI 10.2307/1972729; Chesnais J. C., 1998, REV POPULATION SOCIA, V7, P83; D'Addio A. C., 2005, TRENDS AND DETERMINA; D'Addio A.C., 2005, POLICIES INSTITUTION; Dustmann C, 2010, FISC STUD, V31, P1, DOI 10.1111/j.1475-5890.2010.00106.x; Eurostat, 2013, PROJECTED OLD AGE DE; Eurostat, 2013, TOTAL FERTILITY RATE; Fehr H., 2004, NBER WORKING PAPER 1; Fina-Sanglas L., 2000, EUROPES POPULATION A, V33, P43; FRIES JF, 1989, MILBANK Q, V67, P208, DOI 10.2307/3350138; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Haberkern K, 2010, AGEING SOC, V30, P299, DOI 10.1017/S0144686X09990316; Harper S., 2014, INTERNATIONAL HANDBO; Harper S., 2006, AGEING SOCIETIES MYT; Harper S., 2012, PEOPLE AND THE PLANE; Harper S., 2004, FAMILIES IN AGEING S; Harper S, 2010, INT SOC SECUR REV, V63, P177, DOI 10.1111/j.1468-246X.2010.01374.x; Howse K., 2011, ENHANCING HUMAN CAPA; Howse K., 2010, IARU WORKING PAPER; Howse K, 2012, PERSPECT PUBLIC HEAL, V132, P171, DOI 10.1177/1757913912444805; Iacovou M, 2011, POPUL DEV REV, V37, P89, DOI 10.1111/j.1728-4457.2011.00391.x; Jagger C, 2009, AGE AGEING, V38, P319, DOI 10.1093/ageing/afp016; Jenkner E., 2010, HEALTH CARE SPENDING; Kreyenfeld M, 2010, EUR SOCIOL REV, V26, P351, DOI 10.1093/esr/jcp026; Lee R, 2011, POPULATION AGING AND THE GENERATIONAL ECONOMY: A GLOBAL PERSPECTIVE, P1; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Leeson G. W., 2004, WORKING PAPER WP204; Lutz Wolfgang, 2006, VIENNA YB POPULATION, V4, P167, DOI DOI 10.1553/POPULATIONYEARBOOK2006S167; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Morgan SP, 2010, POPUL DEV REV, V36, P91, DOI 10.1111/j.1728-4457.2010.00319.x; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; OECD, 2007, BABIES AND BOSSES RE; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; Robine J. M., 2005, AGEING HORIZONS, V3, P14; Robine JM, 2003, EXP GERONTOL, V38, P735, DOI 10.1016/S0531-5565(03)00100-1; Seshamani M, 2004, AGE AGEING, V33, P556, DOI 10.1093/ageing/afh187; Seshamani Meena, 2003, Appl Health Econ Health Policy, V2, P9; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; United Nations, 2013, WORLD POPULATION PRO; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Yong V, 2009, DEMOGR RES, V20, P467, DOI 10.4054/DemRes.2009.20.19; Zweifel P, 2004, GENEVA PAP R I-ISS P, V29, P652, DOI 10.1111/j.1468-0440.2004.00308.x; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	56	278	285	43	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		587	591		10.1126/science.1254405	http://dx.doi.org/10.1126/science.1254405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359967				2022-12-28	WOS:000343799700038
J	Hepburn, L; Prajsnar, TK; Klapholz, C; Moreno, P; Loynes, CA; Ogryzko, NV; Brown, K; Schiebler, M; Hegyi, K; Antrobus, R; Hammond, KL; Connolly, J; Ochoa, B; Bryant, C; Otto, M; Surewaard, B; Seneviratne, SL; Grogono, DM; Cachat, J; Ny, T; Kaser, A; Torok, ME; Peacock, SJ; Holden, M; Blundell, T; Wang, LH; Ligoxygakis, P; Minichiello, L; Woods, CG; Foster, SJ; Renshaw, SA; Floto, RA				Hepburn, Lucy; Prajsnar, Tomasz K.; Klapholz, Catherine; Moreno, Pablo; Loynes, Catherine A.; Ogryzko, Nikolay V.; Brown, Karen; Schiebler, Mark; Hegyi, Krisztina; Antrobus, Robin; Hammond, Katherine L.; Connolly, John; Ochoa, Bernardo; Bryant, Clare; Otto, Michael; Surewaard, Bas; Seneviratne, Suranjith L.; Grogono, Dorothy M.; Cachat, Julien; Ny, Tor; Kaser, Arthur; Toeroek, M. Estee; Peacock, Sharon J.; Holden, Matthew; Blundell, Tom; Wang, Lihui; Ligoxygakis, Petros; Minichiello, Liliana; Woods, C. Geoff; Foster, Simon J.; Renshaw, Stephen A.; Floto, R. Andres			A Spaetzle-like role for nerve growth factor beta in vertebrate immunity to Staphylococcus aureus	SCIENCE			English	Article							HOST-DEFENSE; TOLL; ACTIVATION; MECHANISM; MUTATION; RELEASE; SPATZLE; PAIN	Many key components of innate immunity to infection are shared between Drosophila and humans. However, the fly Toll ligandSpaetzle is not thought to have a vertebrate equivalent. We have found that the structurally related cystine-knot protein, nerve growth factor beta (NGF beta), plays an unexpected Spaetzle-like role in immunity to Staphylococcus aureus infection in chordates. Deleterious mutations of either human NGF beta or its high-affinity receptor tropomyosin-related kinase receptor A (TRKA) were associated with severe S. aureus infections. NGF beta was released by macrophages in response to S. aureus exoproteins through activation of the NOD-like receptors NLRP3 and NLRP4 and enhanced phagocytosis and superoxide-dependent killing, stimulated proinflammatory cytokine production, and promoted calcium-dependent neutrophil recruitment. TrkA knockdown in zebrafish increased susceptibility to S. aureus infection, confirming an evolutionarily conserved role for NGF beta-TRKA signaling in pathogen-specific host immunity.	[Hepburn, Lucy; Klapholz, Catherine; Moreno, Pablo; Brown, Karen; Schiebler, Mark; Hegyi, Krisztina; Antrobus, Robin; Woods, C. Geoff; Floto, R. Andres] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1TN, England; [Hepburn, Lucy; Klapholz, Catherine; Brown, Karen; Schiebler, Mark; Hegyi, Krisztina; Grogono, Dorothy M.; Kaser, Arthur; Toeroek, M. Estee; Peacock, Sharon J.; Floto, R. Andres] Univ Cambridge, Dept Med, Cambridge CB2 1TN, England; [Prajsnar, Tomasz K.; Connolly, John; Foster, Simon J.; Renshaw, Stephen A.] Univ Sheffield, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England; [Prajsnar, Tomasz K.; Connolly, John; Foster, Simon J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Prajsnar, Tomasz K.; Loynes, Catherine A.; Ogryzko, Nikolay V.; Hammond, Katherine L.; Renshaw, Stephen A.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; [Loynes, Catherine A.; Hammond, Katherine L.; Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Sheffield S10 2TN, S Yorkshire, England; [Brown, Karen; Grogono, Dorothy M.; Floto, R. Andres] Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge CB3 8RE, England; [Ochoa, Bernardo; Blundell, Tom] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England; [Bryant, Clare] Univ Cambridge, Dept Vet Med, Cambridge CB2 1TN, England; [Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Surewaard, Bas] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Seneviratne, Suranjith L.] Royal Free Hosp London, Dept Clin Immunol, London, England; [Cachat, Julien] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Ny, Tor] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Peacock, Sharon J.; Holden, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Holden, Matthew] Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland; [Wang, Lihui; Ligoxygakis, Petros] Univ Oxford, Biochem Dept, Oxford OX1 2JD, England; [Minichiello, Liliana] Univ Oxford, Pharmacol Dept, Oxford OX1 2JD, England; [Woods, C. Geoff] Univ Cambridge, Dept Med Genet, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Papworth Hospital; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utrecht University; Utrecht University Medical Center; University of Geneva; Umea University; Wellcome Trust Sanger Institute; University of St Andrews; University of Oxford; University of Oxford; University of Cambridge	Renshaw, SA (corresponding author), Univ Sheffield, Krebs Inst, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	s.a.renshaw@sheffield.ac.uk; arf27@cam.ac.uk	Grogono, Dorothy/Y-3306-2019; Moreno, Pablo/AAC-7057-2020; Peacock, Sharon J/ABE-6331-2020; Ogryzko, Nikolay/K-2478-2019; Renshaw, Steve/E-6192-2010; Minichiello, Liliana/AAA-7190-2022; Schiebler, Mark/V-5201-2019; Holden, Matthew TG/K-6449-2014	Moreno, Pablo/0000-0002-9856-1679; Ogryzko, Nikolay/0000-0003-0199-5567; Renshaw, Steve/0000-0003-1790-1641; Holden, Matthew TG/0000-0002-4958-2166; Peacock, Sharon/0000-0002-1718-2782; Prajsnar, Tomasz/0000-0001-6562-8630; Otto, Michael/0000-0002-2222-4115; Grogono, Dorothy/0000-0002-3423-3158; Torok, Mili Estee/0000-0001-9098-8590; Connolly, John/0000-0002-9232-7929	Wellcome Trust [084953, 089981]; Wellcome Trust [Medical Research Council, UK] [G0700091, G0701932]; Papworth Hospital; National Institute for Health Research Cambridge Biomedical Research Centre; NIAID, NIH; BBSRC [BB/K006436/1] Funding Source: UKRI; MRC [G108/595, G0300170, G0701932, MR/M004864/1, MR/K006312/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF4-Torok] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/K006436/1] Funding Source: researchfish; Medical Research Council [G0700091B, G0701932, G0300170, MR/M004864/1, G108/595, MR/K006312/1] Funding Source: researchfish; National Centre for the Replacement [NC/K500392/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust [Medical Research Council, UK](UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Papworth Hospital; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Clegg and E. Henderson for help with patient samples, R. Mifsud and D. Cusens for initial phylogenetic and functional analysis, A. Segal for provision of Nod2<SUP>-/-</SUP> mouse bone marrow, and the aquarium staff of the Bateson Centre, University of Sheffield for zebrafish husbandry. This work was supported by The Wellcome Trust [Senior Clinical Research Fellowship to R. A. F. (084953), project grant to S.J.F./S.A.R. (089981), The Medical Research Council, UK (Research center grant (G0700091), Senior Clinical Fellowship to S.A.R. (G0701932)], Papworth Hospital and the National Institute for Health Research Cambridge Biomedical Research Centre, and the Intramural Research Program of NIAID, NIH.	ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; BISCHOFF SC, 1992, BLOOD, V79, P2662; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; COHEN S, 1956, P NATL ACAD SCI USA, V42, P571, DOI 10.1073/pnas.42.9.571; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rotthier A, 2012, NAT REV NEUROL, V8, P73, DOI 10.1038/nrneurol.2011.227; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	30	50	51	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		641	646		10.1126/science.1258705	http://dx.doi.org/10.1126/science.1258705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359976	Green Accepted, Green Submitted			2022-12-28	WOS:000343799700052
J	Dunn, A				Dunn, Andrew			In suspected PE with Wells score > 4 or positive D-dimer, multiorgan ultrasonography had 90% sensitivity for PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PULMONARY-EMBOLISM		Mt Sinai Hlth Syst, New York, NY 10019 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Hlth Syst, New York, NY 10019 USA.							Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Chan CM, 2010, J THROMB HAEMOST, V8, P1509, DOI 10.1111/j.1538-7836.2010.03888.x; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172	3	0	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC12	10.7326/0003-4819-161-8-201410210-02012	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329217				2022-12-28	WOS:000343906800011
J	Heintzman, J; Gold, R; Bailey, SR; DeVoe, JE				Heintzman, John; Gold, Rachel; Bailey, Steffani R.; DeVoe, Jennifer E.			The Oregon experiment re-examined: the need to bolster primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-INSURANCE EXPERIMENT; MEDICAID; ACCESS; COVERAGE; FUTURE; ADULTS; RATES		[Heintzman, John; Bailey, Steffani R.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Gold, Rachel] Kaiser Ctr Hlth Res, Portland, OR USA; [DeVoe, Jennifer E.] OCHIN, Portland, OR USA	Oregon Health & Science University; Kaiser Permanente	Heintzman, J (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	heintzma@ohsu.edu	Tracker, OCHIN Publications/GMX-3380-2022; Bailey, Steffani/AAK-8530-2021		AHRQ HHS [K08 HS021522] Funding Source: Medline; NHLBI NIH HHS [R01 HL107647] Funding Source: Medline; AHRQ [5K08HS021522-04] Funding Source: Federal RePORTER; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS021522] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107647] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen H, 2014, HEALTH AFFAIR, V33, P292, DOI 10.1377/hlthaff.2013.1002; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; CCO Oregon, 2013, HLTH SYST TRANSF Q P; Cunningham P, 2004, HEALTH AFFAIR, V23, P234, DOI 10.1377/hlthaff.23.4.234; Decker SL, 2013, HEALTH AFFAIR, V32, P1183, DOI 10.1377/hlthaff.2013.0361; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; DeVoe JE, 2011, J GEN INTERN MED, V26, P1059, DOI 10.1007/s11606-011-1666-0; Devoe JE, 2012, J PEDIATR HEALTH CAR, V26, pE25, DOI 10.1016/j.pedhc.2011.01.003; Devoe JE, 2009, DIABETES CARE, V32, P983, DOI 10.2337/dc09-0025; Doohan NC, 2014, J AM BOARD FAM MED, V27, P142, DOI 10.3122/jabfm.2014.01.130219; Fairbrother G, 2004, J HEALTH CARE POOR U, V15, P30, DOI 10.1353/hpu.2004.0003; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Gold R, 2014, J AMBUL CARE MANAG, V37, P282, DOI 10.1097/JAC.0000000000000023; Henry J Kaiser Family Foundation, 2012, GUID SUPR COURTS AFF; Henry J Kaiser Family Foundation, 2014, MED MOV FORW; Henry J Kaiser Family Foundation, 2014, IS ACA IMP MED ENR; Hostetler C, 2014, ORIGINS OREGON ALTER; Institute for Healthcare Improvement, IHI TRIPL AIM IN; Institute of Medicine of the National Academies, 2014, GRAD MED ED MEETS NA; Medicaid, MED EL; Medicaid, WAIV; Parchman ML, 1999, ARCH FAM MED, V8, P487, DOI 10.1001/archfami.8.6.487; Richman IB, 2007, ACAD EMERG MED, V14, P279, DOI 10.1197/j.aem.2006.10.093; Shi LY, 2007, MED CARE, V45, P206, DOI 10.1097/01.mlr.0000252160.21428.24; Starfield B, 2004, PEDIATRICS, V113, P1493; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steventon A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2641; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; United States Department of Health & Human Services Health Resources and Services Administration, WHAT AR FED QUAL HLT	30	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2014	349								g5976	10.1136/bmj.g5976	http://dx.doi.org/10.1136/bmj.g5976			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OC	25331018	Green Published			2022-12-28	WOS:000343768100002
J	Albertazzi, B; Ciardi, A; Nakatsutsumi, M; Vinci, T; Beard, J; Bonito, R; Billette, J; Borghesi, M; Burkley, Z; Chen, SN; Cowan, TE; Herrmannsdorfer, T; Higginson, DP; Kroll, F; Pikuz, SA; Naughton, K; Romagnani, L; Riconda, C; Revet, G; Riquier, R; Schlenvoigt, HP; Skobelev, IY; Faenov, AY; Soloviev, A; Huarte-Espinosa, M; Frank, A; Portugall, O; Pepin, H; Fuchs, J				Albertazzi, B.; Ciardi, A.; Nakatsutsumi, M.; Vinci, T.; Beard, J.; Bonito, R.; Billette, J.; Borghesi, M.; Burkley, Z.; Chen, S. N.; Cowan, T. E.; Herrmannsdoerfer, T.; Higginson, D. P.; Kroll, F.; Pikuz, S. A.; Naughton, K.; Romagnani, L.; Riconda, C.; Revet, G.; Riquier, R.; Schlenvoigt, H. -P.; Skobelev, I. Yu.; Faenov, A. Ya.; Soloviev, A.; Huarte-Espinosa, M.; Frank, A.; Portugall, O.; Pepin, H.; Fuchs, J.			Laboratory formation of a scaled protostellar jet by coaligned poloidal magnetic field	SCIENCE			English	Article							ACCRETION DISCS; DRIVEN JETS; DG-TAURI; SIMULATIONS; COLLIMATION; DISCOVERY; PLASMAS	Although bipolar jets are seen emerging from a wide variety of astrophysical systems, the issue of their formation and morphology beyond their launching is still under study. Our scaled laboratory experiments, representative of young stellar object outflows, reveal that stable and narrow collimation of the entire flow can result from the presence of a poloidal magnetic field whose strength is consistent with observations. The laboratory plasma becomes focused with an interior cavity. This gives rise to a standing conical shock from which the jet emerges. Following simulations of the process at the full astrophysical scale, we conclude that it can also explain recently discovered x-ray emission features observed in low-density regions at the base of protostellar jets, such as the well-studied jet HH 154.	[Albertazzi, B.; Nakatsutsumi, M.; Vinci, T.; Burkley, Z.; Chen, S. N.; Higginson, D. P.; Romagnani, L.; Revet, G.; Riquier, R.; Fuchs, J.] Univ Paris 06, LULI, Ecole Polytech, CNRS,Commissariat Enervie Atom & Energies Alterna, F-91128 Palaiseau, France; [Albertazzi, B.; Pepin, H.] INRS EMT, Varennes, PQ, Canada; [Ciardi, A.] Univ Paris 06, Sorbonne Univ, UMR 8112, LERMA, F-75005 Paris, France; [Ciardi, A.] Observ Paris, F-75014 Paris, France; [Ciardi, A.] CNRS, UMR 8112, LERMA, Paris, France; [Beard, J.; Billette, J.; Portugall, O.] CNRS Univ Joseph Fourier UJF Univ Paul Sabatier U, UPR 3228, LNCMI, F-31400 Toulouse, France; [Bonito, R.] Univ Palermo, Dipartimento Fis & Chim, I-90134 Palermo, Italy; [Bonito, R.] Osserv Astron Palermo, Natl Inst Astrophys INAF, I-90134 Palermo, Italy; [Borghesi, M.; Naughton, K.] Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; [Borghesi, M.] Acad Sci Czech Republ, Inst Phys, Extreme Light Infrastruct ELI Beamlines Project, Prague 18221, Czech Republic; [Cowan, T. E.; Kroll, F.] Tech Univ Dresden, D-01062 Dresden, Germany; [Cowan, T. E.; Herrmannsdoerfer, T.; Kroll, F.; Schlenvoigt, H. -P.] Helmholtz Zentrum Dresden Rossendorf, D-01328 Dresden, Germany; [Pikuz, S. A.; Skobelev, I. Yu.; Faenov, A. Ya.] Russian Acad Sci, Joint Inst High Temp, Moscow 125412, Russia; [Pikuz, S. A.] Natl Res Nucl Univ MEPhl, Moscow 115409, Russia; [Riconda, C.] Univ Paris 06, UMR 7605, Sorbonne Univ, LULL, F-75005 Paris, France; [Riquier, R.] CEA Bruyeres le Chatel, F-91297 Arpajon, France; [Faenov, A. Ya.] Osaka Univ, Inst Acad Initiat, Suita, Osaka 5650871, Japan; [Soloviev, A.; Fuchs, J.] Inst Appl Phys, Nlizhny Novgorod 603950, Russia; [Huarte-Espinosa, M.; Frank, A.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Huarte-Espinosa, M.] Univ Houston, Ctr Adv Comp & Data Syst, Houston, TX 77204 USA; [Albertazzi, B.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; University of Quebec; Institut national de la recherche scientifique (INRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Palermo; Istituto Nazionale Astrofisica (INAF); Queens University Belfast; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Russian Academy of Sciences; Joint Institute for High Temperatures of the Russian Academy of Sciences; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; CEA; Institut Polytechnique de Paris; CEA; Osaka University; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; University of Rochester; University of Houston System; University of Houston; Osaka University	Fuchs, J (corresponding author), Univ Paris 06, LULI, Ecole Polytech, CNRS,Commissariat Enervie Atom & Energies Alterna, F-91128 Palaiseau, France.	julien.fuchs@polytechnique.fr	Herrmannsdörfer, Thomas O/K-5888-2015; Portugall, Oliver/W-5896-2018; Cowan, Thomas E/A-8713-2011; Soloviev, Alexander A/L-4599-2017; Kroll, Florian/AAB-4186-2019; Higginson, Drew/G-5942-2016; Fuchs, Julien/D-3450-2016; Pikuz, Sergey A/F-7768-2014; Romagnani, Lorenzo/ABE-3974-2020; Béard, Jérôme/ABG-2702-2021; Vinci, Tommaso/AAN-2065-2021	Portugall, Oliver/0000-0002-9294-9082; Cowan, Thomas E/0000-0002-5845-000X; Soloviev, Alexander A/0000-0001-8595-5604; Kroll, Florian/0000-0002-0275-9892; Higginson, Drew/0000-0002-7699-3788; Fuchs, Julien/0000-0001-9765-0787; Pikuz, Sergey A/0000-0003-2529-1142; Béard, Jérôme/0000-0001-9089-6266; Vinci, Tommaso/0000-0002-1595-1752; Ciardi, Andrea/0000-0001-5865-6772; Romagnani, Lorenzo/0000-0002-7053-3967; Frank, Adam/0000-0002-4948-7820; Bonito, Rosaria/0000-0001-9297-7748; Schlenvoigt, Hans-Peter/0000-0003-4400-1315	Region Ile-de-France [E1127]; Agence Nationale de la recherche (ANR) [12-BS09-025-01]; ELAM from Reseau thematique de recherche avance (RTRA)-Saclay; RTRA-Triangle de la Physique; Engineering and Physical Sciences Research Council (ERSRC) [EP/I029206/1, EP/J500094/1]; Natural Sciences and Engineering Research Council of Canada (NSERC) [26558-2007]; Agence Nationale de la Recherche as part of the program "Investissements d'avenir" [ANR-11-IDEX-0004-02]; Ministry of Education and Science of the Russian Federation [14.Z50.31.0007]; NSF [1064468]; Office Of The Director [1064468] Funding Source: National Science Foundation; EPSRC [EP/I029206/1] Funding Source: UKRI	Region Ile-de-France(Region Ile-de-France); Agence Nationale de la recherche (ANR)(French National Research Agency (ANR)); ELAM from Reseau thematique de recherche avance (RTRA)-Saclay; RTRA-Triangle de la Physique; Engineering and Physical Sciences Research Council (ERSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agence Nationale de la Recherche as part of the program "Investissements d'avenir"(French National Research Agency (ANR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NSF(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the support of the LULI teams and of S. Dittrich and S. Nitsche (Helmholtz-Zentrum Dresden-Rossendorf) and discussions with P. Audebert. This work was supported by grant E1127 from Region Ile-de-France, Agence Nationale de la recherche (ANR) white grant 12-BS09-025-01 SILAMPA, grant ELAM from Reseau thematique de recherche avance (RTRA)-Saclay, a grant from RTRA-Triangle de la Physique, grants Engineering and Physical Sciences Research Council (ERSRC) EP/I029206/1 and EP/J500094/1 and the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant 26558-2007 RGPIN. This work was partly done within the LABEX Plas@Par project and received financial state aid managed by the Agence Nationale de la Recherche, as part of the program "Investissements d'avenir" under the reference ANR-11-IDEX-0004-02. This work was supported in part by the Ministry of Education and Science of the Russian Federation under contract no. 14.Z50.31.0007. S.N.C. acknowledges the support received during this work by NSF grant 1064468. Experimental data and simulations are, respectively, archived on servers at LULI and LERMA laboratories and can be consulted upon demand. Part of the experimental system is covered by a patent (1000183285, 2013, Institut National de la Propriete Industrielle-France).	Ainsworth RE, 2013, MON NOT R ASTRON SOC, V436, pL64, DOI 10.1093/mnrasl/slt114; Albertazzi B, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4795551; Atzeni S, 2005, COMPUT PHYS COMMUN, V169, P153, DOI 10.1016/j.cpc.2005.03.036; Balick B, 2002, ANNU REV ASTRON ASTR, V40, P439, DOI 10.1146/annurev.astro.40.060401.093849; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; Bonito R, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/54; Cabrit S., 2007, P IAU S, V243, P203; Chapman NL, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/151; Ciardi A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025002; Faenov A, 1996, PHYS SCRIPTA, V53, P591, DOI 10.1088/0031-8949/53/5/016; Farley DR, 1999, PHYS REV LETT, V83, P1982, DOI 10.1103/PhysRevLett.83.1982; Favata FF, 2006, ASTRON ASTROPHYS, V450, pL17, DOI 10.1051/0004-6361:20065106; Ferreira J, 1997, ASTRON ASTROPHYS, V319, P340; Frank A., 2014, PROTOSTARS PLANETS; Gudel M, 2008, ASTRON ASTROPHYS, V478, P797, DOI 10.1051/0004-6361:20078141; Hartigan P, 2007, ASTROPHYS J, V661, P910, DOI 10.1086/513499; Loupias B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.265001; Matsakos T, 2009, ASTRON ASTROPHYS, V502, P217, DOI 10.1051/0004-6361/200811046; Matt S, 2003, MON NOT R ASTRON SOC, V345, P660, DOI 10.1046/j.1365-8711.2003.06977.x; Maurri L, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201117510; Moll R, 2008, ASTRON ASTROPHYS, V492, P621, DOI 10.1051/0004-6361:200810523; Nicolai P, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2963083; Ryutov DD, 2000, ASTROPHYS J SUPPL S, V127, P465, DOI 10.1086/313320; Schneider PC, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016305; Spruit HC, 1997, MON NOT R ASTRON SOC, V288, P333, DOI 10.1093/mnras/288.2.333; STAMPER JA, 1991, LASER PART BEAMS, V9, P841, DOI 10.1017/S0263034600006595; Stute M, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200811204	27	138	144	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					325	328		10.1126/science.1259694	http://dx.doi.org/10.1126/science.1259694			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324383	Green Accepted			2022-12-28	WOS:000343041100037
J	Arie, S				Arie, Sophie			EBOLA Only the military can get the Ebola epidemic under control: MSF head	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Hussain M., 2014, MSF CALLS MILITARY M; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6094; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5866; *MSF, 2014, UN SPEC BRIEF EB; undp, HUM DEV IND; World Health Organization, 2014, EB RESP ROADM SIT RE	6	3	3	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2014	349								g6151	10.1136/bmj.g6151	http://dx.doi.org/10.1136/bmj.g6151			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LQ	25304485	Bronze, Green Published			2022-12-28	WOS:000342999100004
J	Bambini, V; Nunes, GD; Schneider, T; Gottfried, C				Bambini-Junior, Victorio; Nunes, Gustavo Della Flora; Schneider, Tomasz; Gottfried, Carmem			Comment on "Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring"	SCIENCE			English	Editorial Material							VALPROIC ACID EXPOSURE; FRAGILE-X-SYNDROME; SOCIAL-INTERACTION; PRENATAL EXPOSURE; ANIMAL-MODEL; MICE	Tyzio et al. (Reports, 7 February 2014, p. 675) reported that bumetanide restored the impaired oxytocin-mediated g-aminobutyric acid (GABA) excitatory-inhibitory shift during delivery in animal models of autism, ameliorating some autistic-like characteristics in the offspring. However, standard practices in the study of these models, such as the use of sex-dimorphic or males-only analyses and implementation of tests measuring social behavior, are lacking to definitely associate their findings to autism.	[Bambini-Junior, Victorio; Nunes, Gustavo Della Flora; Gottfried, Carmem] Univ Fed Rio Grande do Sul, Res Grp Neuroglial Plast, Dept Biochem, Inst Hlth Basic Sci, Porto Alegre, RS, Brazil; [Bambini-Junior, Victorio; Nunes, Gustavo Della Flora; Gottfried, Carmem] Univ Fed Rio Grande do Sul, Translat Res Grp Autism Spectrum Disorders GETTEA, Porto Alegre, RS, Brazil; [Schneider, Tomasz] Univ Durham, Sch Med Pharm & Hlth, Durham TS17 6BH, England	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Durham University	Bambini, V (corresponding author), Univ Fed Rio Grande do Sul, Res Grp Neuroglial Plast, Dept Biochem, Inst Hlth Basic Sci, Porto Alegre, RS, Brazil.	victoriobambini@gmail.com	Gottfried, Carmem/AAG-2355-2019; Nunes, Gustavo Della-Flora/AAR-9617-2021; Bambini-Junior, Victorio/O-7563-2014; Bambini-Junior, Victorio/AAO-7056-2021	Gottfried, Carmem/0000-0001-8838-1300; Nunes, Gustavo Della-Flora/0000-0001-9323-3556; Bambini-Junior, Victorio/0000-0002-8590-6770				Bambini V, 2011, BRAIN RES, V1408, P8, DOI 10.1016/j.brainres.2011.06.015; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Hara Y, 2012, J PHARMACOL SCI, V118, P543, DOI 10.1254/jphs.12025SC; Kim KC, 2013, J NEUROCHEM, V124, P832, DOI 10.1111/jnc.12147; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Stanley DA, 2013, NEURON, V80, P816, DOI 10.1016/j.neuron.2013.10.038; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	15	5	6	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206								10.1126/science.1255679	http://dx.doi.org/10.1126/science.1255679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301610				2022-12-28	WOS:000342721500031
J	Gerland, P; Raftery, AE; Sevcikova, H; Li, N; Gu, DA; Spoorenberg, T; Alkema, L; Fosdick, BK; Chunn, J; Lalic, N; Bay, G; Buettner, T; Heilig, GK; Wilmoth, J				Gerland, Patrick; Raftery, Adrian E.; Sevcikova, Hana; Li, Nan; Gu, Danan; Spoorenberg, Thomas; Alkema, Leontine; Fosdick, Bailey K.; Chunn, Jennifer; Lalic, Nevena; Bay, Guiomar; Buettner, Thomas; Heilig, Gerhard K.; Wilmoth, John			World population stabilization unlikely this century	SCIENCE			English	Article							SUB-SAHARAN AFRICA; LIFE EXPECTANCY; PROBABILISTIC PROJECTIONS; FERTILITY; COUNTRIES	The United Nations (UN) recently released population projections based on data until 2012 and a Bayesian probabilistic methodology. Analysis of these data reveals that, contrary to previous literature, the world population is unlikely to stop growing this century. There is an 80% probability that world population, now 7.2 billion people, will increase to between 9.6 billion and 12.3 billion in 2100. This uncertainty is much smaller than the range from the traditional UN high and low variants. Much of the increase is expected to happen in Africa, in part due to higher fertility rates and a recent slowdown in the pace of fertility decline. Also, the ratio of working-age people to older people is likely to decline substantially in all countries, even those that currently have young populations.	[Gerland, Patrick; Li, Nan; Gu, Danan; Spoorenberg, Thomas; Wilmoth, John] UN, Dept Econ & Social Affairs, Populat Div, New York, NY 10017 USA; [Raftery, Adrian E.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Raftery, Adrian E.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Sevcikova, Hana] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA; [Alkema, Leontine] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117546, Singapore; [Alkema, Leontine] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117546, Singapore; [Fosdick, Bailey K.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Chunn, Jennifer] James Cook Univ Singapore, Singapore 574421, Singapore; [Lalic, Nevena] Univ Washington, Inst Res, Seattle, WA 98195 USA; [Bay, Guiomar] United Nations Econ Commiss Latin Amer & Caribbea, Populat Div, Latin Amer & Caribbean Demog Ctr CELADE, Santiago, Chile; [Buettner, Thomas; Heilig, Gerhard K.] UN, Populat Div, New York, NY 10017 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National University of Singapore; National University of Singapore; Colorado State University; University of Washington; University of Washington Seattle	Gerland, P (corresponding author), UN, Dept Econ & Social Affairs, Populat Div, New York, NY 10017 USA.	gerland@un.org; raftery@u.washington.edu	Spoorenberg, Thomas/H-4167-2019; Alkema, Leontine/K-1585-2013; Gerland, Patrick/F-7390-2013	Spoorenberg, Thomas/0000-0001-8608-1398; Alkema, Leontine/0000-0001-8806-5957; Gerland, Patrick/0000-0002-2082-3122; Fosdick, Bailey/0000-0003-3736-2219	NIH [R01 HD054511, R01 HD070936]; Science Foundation Ireland [11/W.1/I2079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070936, R01HD054511] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the entire team involved in the production of the 2012 Revision of the World Population Prospects-in particular, K. Andreev and F. Pelletier. We also thank two anonymous reviewers for helpful comments. This work was supported by NIH grants R01 HD054511 and R01 HD070936. A.E.R.'s research was also supported by a Science Foundation Ireland ETS Walton visitor award, grant reference 11/W.1/I2079. Views expressed in this article are those of the authors and do not necessarily reflect those of NIH or the UN.	Alkema L, 2011, DEMOGRAPHY, V48, P815, DOI 10.1007/s13524-011-0040-5; Andreev K., 2013, 20133 DEP EC SOC AFF; [Anonymous], 2012, LOND SUMM FAM PLANN; Bongaarts J., 2013, INT UN SCI STUD POP; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; CALDWELL JC, 1987, POPUL DEV REV, V13, P409, DOI 10.2307/1973133; CALDWELL JC, 1988, STUD FAMILY PLANN, V19, P19, DOI 10.2307/1966736; Fosdick BK, 2014, DEMOGR RES, V30, P1011, DOI 10.4054/DemRes.2014.30.35; HIRSCHMAN C, 1994, ANNU REV SOCIOL, V20, P203; LEE RD, 1994, J AM STAT ASSOC, V89, P1175, DOI 10.2307/2290980; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 1997, NATURE, V387, P803, DOI 10.1038/42935; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; National Research Council, 2000, 6 BILL FOR WORLDS PO; National Research Council, 2012, AG MACR; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Peterson HB, 2013, LANCET, V381, P1696, DOI 10.1016/S0140-6736(13)60999-X; Raftery AE, 2014, STAT SCI, V29, P58, DOI 10.1214/13-STS419; Raftery AE, 2014, DEMOGR RES, V30, P795, DOI 10.4054/DemRes.2014.30.27; Raftery AE, 2013, DEMOGRAPHY, V50, P777, DOI 10.1007/s13524-012-0193-x; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; Tim?us, 2014, ANN M POP ASS AM BOS; UNAIDS, 2013, GLOBAL REPORT UNAIDS; United Nations, 2013, POP FACTS; United Nations, 2013, WORLD POP AG 2013; United Nations, 2014, MOD BAS EST PROJ FAM; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366	27	735	746	23	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					234	237		10.1126/science.1257469	http://dx.doi.org/10.1126/science.1257469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301627	Green Accepted			2022-12-28	WOS:000342721500047
J	Magnusson, JP; Goritz, C; Tatarishvili, J; Dias, DO; Smith, EMK; Lindvall, O; Kokaia, Z; Frisen, J				Magnusson, Jens P.; Goritz, Christian; Tatarishvili, Jemal; Dias, David O.; Smith, Emma M. K.; Lindvall, Olle; Kokaia, Zaal; Frisen, Jonas			A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse	SCIENCE			English	Article							INJURED BRAIN; SELF-RENEWAL; ADULT BRAIN; IN-VIVO; CELLS; STROKE; DIFFERENTIATION; REPLACEMENT; GENERATION; STRIATUM	Neurogenesis is restricted in the adult mammalian brain; most neurons are neither exchanged during normal life nor replaced in pathological situations. We report that stroke elicits a latent neurogenic program in striatal astrocytes in mice. Notch1 signaling is reduced in astrocytes after stroke, and attenuated Notch1 signaling is necessary for neurogenesis by striatal astrocytes. Blocking Notch signaling triggers astrocytes in the striatum and the medial cortex to enter a neurogenic program, even in the absence of stroke, resulting in 850 +/- 210 (mean +/- SEM) new neurons in a mouse striatum. Thus, under Notch signaling regulation, astrocytes in the adult mouse brain parenchyma carry a latent neurogenic program that may potentially be useful for neuronal replacement strategies.	[Magnusson, Jens P.; Goritz, Christian; Dias, David O.; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Tatarishvili, Jemal; Lindvall, Olle; Kokaia, Zaal] Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden; [Smith, Emma M. K.] Lund Univ, Div Translat Canc Res, SE-22363 Lund, Sweden	Karolinska Institutet; Lund University; Skane University Hospital; Lund University	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021; Kokaia, Zaal/AAL-6009-2020	Göritz, Christian/0000-0003-0799-766X; Kokaia, Zaal/0000-0003-2296-2449; Magnusson, Jens/0000-0002-3928-8959; Smith, Emma/0000-0003-0609-4864; Oliveira Dias, David/0000-0002-2144-6621	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; The Swedish Heart and Lung Foundation; StratRegen; StemTherapy; European Union [279017]; Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse; Portuguese government [SFRH/BD/63164/2009]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; The Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); StratRegen; StemTherapy; European Union(European Commission); Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Portuguese government(Portuguese Foundation for Science and Technology)	We thank E. Andersson, E.-B. Braune, J. Dias, S.-B. Jin, and U. Lendahl for valuable discussions. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, The Swedish Heart and Lung Foundation, StratRegen, StemTherapy, European Union project TargetBraIn (279017), Torsten Soderbergs Stiftelse, and Knut och Alice Wallenbergs Stiftelse. D.O.D. was supported by the Portuguese government (SFRH/BD/63164/2009). C. G. is a Hallsten Academy and Wallenberg Academy fellow. We thank F. W. Pfrieger for providing Cx30 and GLAST transgenic mice through a material transfer agreement with the Institut Genetique Biologie Moleculaire Cellulaire (Strasbourg, France). Requests for mice should be directed to F. W. Pfrieger (CNRS, France). We declare no conflicts of interest. The supplementary materials contain additional data.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Smith E, 2012, GENESIS, V50, P700, DOI 10.1002/dvg.22030; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x	20	272	293	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					237	241		10.1126/science.346.6206.237	http://dx.doi.org/10.1126/science.346.6206.237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301628				2022-12-28	WOS:000342721500048
J	Hacein-Bey-Abina, S; Pai, SY; Gaspar, HB; Armant, M; Berry, CC; Blanche, S; Bleesing, J; Blondeau, J; de Boer, H; Buckland, KF; Caccavelli, L; Cros, G; De Oliveira, S; Fernandez, KS; Guo, D; Harris, CE; Hopkins, G; Lehmann, LE; Lim, A; London, WB; van der Loo, JCM; Malani, N; Male, F; Malik, P; Marinovic, MA; McNicol, AM; Moshous, D; Neven, B; Oleastro, M; Picard, C; Ritz, J; Rivat, C; Schambach, A; Shaw, KL; Sherman, EA; Silberstein, LE; Six, E; Touzot, F; Tsytsykova, A; Xu-Bayford, J; Baum, C; Bushman, FD; Fischer, A; Kohn, DB; Filipovich, AH; Notarangelo, LD; Cavazzana, M; Williams, DA; Thrasher, AJ				Hacein-Bey-Abina, S.; Pai, S. -Y.; Gaspar, H. B.; Armant, M.; Berry, C. C.; Blanche, S.; Bleesing, J.; Blondeau, J.; de Boer, H.; Buckland, K. F.; Caccavelli, L.; Cros, G.; De Oliveira, S.; Fernandez, K. S.; Guo, D.; Harris, C. E.; Hopkins, G.; Lehmann, L. E.; Lim, A.; London, W. B.; van der Loo, J. C. M.; Malani, N.; Male, F.; Malik, P.; Marinovic, M. A.; McNicol, A. -M.; Moshous, D.; Neven, B.; Oleastro, M.; Picard, C.; Ritz, J.; Rivat, C.; Schambach, A.; Shaw, K. L.; Sherman, E. A.; Silberstein, L. E.; Six, E.; Touzot, F.; Tsytsykova, A.; Xu-Bayford, J.; Baum, C.; Bushman, F. D.; Fischer, A.; Kohn, D. B.; Filipovich, A. H.; Notarangelo, L. D.; Cavazzana, M.; Williams, D. A.; Thrasher, A. J.			A Modified gamma-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; SCID-X1 GENE-THERAPY; DNA INTEGRATION; TRANSPLANTATION; DEFICIENCY; RECONSTITUTION; SURVIVAL; MARROW; SITES; FATE	BACKGROUND In previous clinical trials involving children with X-linked severe combined immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based gamma-retrovirus vector expressing interleukin-2 receptor gamma-chain (gamma c) complementary DNA successfully restored immunity in most patients but resulted in vector-induced leukemia through enhancer-mediated mutagenesis in 25% of patients. We assessed the efficacy and safety of a self-inactivating retrovirus for the treatment of SCID-X1. METHODS We enrolled nine boys with SCID-X1 in parallel trials in Europe and the United States to evaluate treatment with a self-inactivating (SIN) gamma-retrovirus vector containing deletions in viral enhancer sequences expressing gamma c (SIN-gamma c). RESULTS All patients received bone marrow-derived CD34+ cells transduced with the SIN-gamma c vector, without preparative conditioning. After 12.1 to 38.7 months of follow-up, eight of the nine children were still alive. One patient died from an overwhelming adenoviral infection before reconstitution with genetically modified T cells. Of the remaining eight patients, seven had recovery of peripheral-blood T cells that were functional and led to resolution of infections. The patients remained healthy thereafter. The kinetics of CD3+ T-cell recovery was not significantly different from that observed in previous trials. Assessment of insertion sites in peripheral blood from patients in the current trial as compared with those in previous trials revealed significantly less clustering of insertion sites within LMO2, MECOM, and other lymphoid proto-oncogenes in our patients. CONCLUSIONS This modified gamma-retrovirus vector was found to retain efficacy in the treatment of SCID-X1. The long-term effect of this therapy on leukemogenesis remains unknown.	[Hacein-Bey-Abina, S.; Blondeau, J.; Caccavelli, L.; Touzot, F.; Cavazzana, M.] Univ Paris 05, Dept Biotherapy, Le Kremlin Bicetre, France; [Blanche, S.; Cros, G.; Moshous, D.; Neven, B.; Picard, C.; Touzot, F.; Fischer, A.] Univ Paris 05, Dept Immunol & Pediat Hematol, Le Kremlin Bicetre, France; [Picard, C.] Univ Paris 05, Ctr Etud Deficits Immunitaires, Le Kremlin Bicetre, France; [Hacein-Bey-Abina, S.; Blondeau, J.; Caccavelli, L.; Touzot, F.; Cavazzana, M.] Univ Paris 05, Hop Necker Enfants Malad, AP HP,INSERM, Biotherapy Clin Invest Ctr,Grp Hosp Univ Ouest, Le Kremlin Bicetre, France; [Hacein-Bey-Abina, S.] Univ Paris 05, Fac Sci Pharmaceut & Biol, Unite Technol Chim & Biol Sante, CNRS,INSERM 8258,U1022, Le Kremlin Bicetre, France; [Hacein-Bey-Abina, S.] Univ Paris 11, Grp Hosp, AP HP, Immunol Lab, Le Kremlin Bicetre, France; [Blanche, S.; Blondeau, J.; Caccavelli, L.; Moshous, D.; Neven, B.; Picard, C.; Six, E.; Fischer, A.; Cavazzana, M.] Imagine Inst, Paris, France; [Blondeau, J.; Caccavelli, L.; Six, E.; Touzot, F.; Fischer, A.; Cavazzana, M.] Lab Human Lymphohematopoiesis, INSERM, Unite Mixtes Rech 1163, Paris, France; [Lim, A.] Inst Pasteur, Dept Immunol, Grp Immunoscope, F-75724 Paris, France; [Fischer, A.] Coll France, F-75231 Paris, France; [Pai, S. -Y.; de Boer, H.; Guo, D.; Harris, C. E.; Hopkins, G.; Lehmann, L. E.; London, W. B.; Williams, D. A.] Harvard Univ, Sch Med, Div Hematol Oncol, Boston, MA USA; [Notarangelo, L. D.] Harvard Univ, Sch Med, Div Immunol, Boston, MA USA; [Pai, S. -Y.; Guo, D.; Lehmann, L. E.; London, W. B.; Williams, D. A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA USA; [Pai, S. -Y.; Armant, M.; Lehmann, L. E.; London, W. B.; Ritz, J.; Silberstein, L. E.; Tsytsykova, A.; Notarangelo, L. D.; Williams, D. A.] Harvard Univ, Sch Med, Boston, MA USA; [Armant, M.; Ritz, J.; Silberstein, L. E.; Tsytsykova, A.] Boston Childrens Hosp, Ctr Human Cell Therapy, Program Cellular & Mol Med, Boston, MA 02115 USA; [Ritz, J.] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Notarangelo, L. D.] Manton Ctr Orphan Dis Res, Boston, MA USA; [Gaspar, H. B.; Buckland, K. F.; McNicol, A. -M.; Rivat, C.; Thrasher, A. J.] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Gaspar, H. B.; Buckland, K. F.; McNicol, A. -M.; Rivat, C.; Thrasher, A. J.] UCL, Inst Child Hlth, Sect Mol & Cellular Immunol, London WC1E 6BT, England; [Berry, C. C.] Univ Calif San Diego, Dept Family & Prevent Med, Div Biostat & BioInformat, La Jolla, CA 92093 USA; [Bleesing, J.; Filipovich, A. H.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [van der Loo, J. C. M.; Malik, P.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [De Oliveira, S.; Kohn, D. B.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Mattel Childrens Hosp, Dept Pediat,Childrens Discovery & Innovat Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Fernandez, K. S.] Univ Illinois, Coll Med, Peoria, IL 61656 USA; [Malani, N.; Male, F.; Sherman, E. A.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Marinovic, M. A.] Clin Santa Maria, Unidad Inmunol & Alergias, Santiago, Chile; [Oleastro, M.] Hosp Nacl Pediat Garrahan, Serv Inmunol Reumatol, Buenos Aires, DF, Argentina; [Schambach, A.; Baum, C.] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Illinois System; University of Illinois Peoria; University of Pennsylvania; Hospital de Pediatria Doctor Juan Garrahan; Hannover Medical School	Williams, DA (corresponding author), Boston Childrens Hosp, Dana Farber Boston Childrens Canc & Blood Disorde, 300 Longwood Ave,Karp 08125-3, Boston, MA 02115 USA.	alain.fischer@nck.aphp.fr; dawilliams@childrens.harvard.edu	De Oliveira, Satiro/D-8860-2014; Picard, Capucine/H-3914-2017; London, Wendy Beth/ABA-8948-2021; Ritz, Jerome/C-7929-2009; Six, Emmanuelle/H-7891-2017; London, Wendy/ABD-4624-2021; Notarangelo, Luigi D/F-9718-2016; Moshous, Despina/B-7507-2017; Pai, Sung-Yun/AAH-7762-2019; Touzot, Fabien/T-7797-2018; Schambach, Axel/C-5491-2011; Caccavelli, Laure/H-8880-2017	De Oliveira, Satiro/0000-0002-8181-7316; Picard, Capucine/0000-0001-8788-5056; London, Wendy Beth/0000-0003-3571-6538; Ritz, Jerome/0000-0001-5526-4669; Six, Emmanuelle/0000-0001-7806-0968; Notarangelo, Luigi D/0000-0002-8335-0262; Moshous, Despina/0000-0001-6719-3693; Pai, Sung-Yun/0000-0002-0158-8147; Touzot, Fabien/0000-0002-0889-4905; Sherman, Erin/0000-0002-1835-8604; Malik, Punam/0000-0002-8942-2108; Cavazzana, Marina/0000-0002-0264-0891; Thrasher, Adrian/0000-0002-6097-6115; Buckland, Karen/0000-0001-6989-2228; Caccavelli, Laure/0000-0001-6324-2304; Shaw, Kit/0000-0002-1293-8050	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, U01AI087628, R01AI082020] Funding Source: NIH RePORTER; Medical Research Council [G0501969] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10001] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1242] Funding Source: researchfish; MRC [G0501969] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the National Institutes of Health and others; ClinicalTrials.gov numbers, NCT01410019, NCT01175239, and NCT01129544.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Berry CC, 2014, BIOINFORMATICS, V30, P1493, DOI 10.1093/bioinformatics/btu035; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Brady T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr140; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Buckley RH, 2011, IMMUNOL RES, V49, P25, DOI 10.1007/s12026-010-8191-9; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Coffin J, 1997, RETROVIRUSES; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002715; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GATTI RA, 1968, LANCET, V2, P1366; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Hardin JW, 2012, GEN ESTIMATING EQUAT; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; OREILLY RJ, 1977, NEW ENGL J MED, V297, P1311, DOI 10.1056/NEJM197712152972403; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; REISNER Y, 1983, BLOOD, V61, P341; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Thornhill SI, 2008, MOL THER, V16, P590, DOI 10.1038/sj.mt.6300393; van der Loo JCM, 2012, GENE THER, V19, P872, DOI 10.1038/gt.2012.37; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	37	254	261	1	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1407	1417		10.1056/NEJMoa1404588	http://dx.doi.org/10.1056/NEJMoa1404588			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295500	Green Accepted, Green Published			2022-12-28	WOS:000342674800009
J	Krivanek, OL; Lovejoy, TC; Dellby, N; Aoki, T; Carpenter, RW; Rez, P; Soignard, E; Zhu, JT; Batson, PE; Lagos, MJ; Egerton, RF; Crozier, PA				Krivanek, Ondrej L.; Lovejoy, Tracy C.; Dellby, Niklas; Aoki, Toshihiro; Carpenter, R. W.; Rez, Peter; Soignard, Emmanuel; Zhu, Jiangtao; Batson, Philip E.; Lagos, Maureen J.; Egerton, Ray F.; Crozier, Peter A.			Vibrational spectroscopy in the electron microscope	NATURE			English	Article							ENERGY-LOSS SPECTROSCOPY; ABERRATION; EXCITATIONS; INTERFACES; FILMS	Vibrational spectroscopies using infrared radiation(1,2), Raman scattering(3), neutrons(4), low-energy electrons(5) and inelastic electron tunnelling(6) are powerful techniques that can analyse bonding arrangements, identify chemical compounds and probe many other important properties of materials. The spatial resolution of these spectroscopies is typically one micrometre or more, although it can reach a few tens of nanometres or even a few a angstroms when enhanced by the presence of a sharp metallic tip(6,7). If vibrational spectroscopy could be combined with the spatial resolution and flexibility of the transmission electron microscope, it would open up the study of vibrational modes in many different types of nanostructures. Unfortunately, the energy resolution of electron energy loss spectroscopy performed in the electron microscope has until now been too poor to allow such a combination. Recent developments that have improved the attainable energy resolution of electron energy loss spectroscopy in a scanning transmission electron microscope to around ten millielectronvolts now allow vibrational spectroscopy to be carried out in the electron microscope. Here we describe the innovations responsible for the progress, and present examples of applications in inorganic and organic materials, including the detection of hydrogen. We also demonstrate that the vibrational signal has both high-and low-spatial-resolution components, that the first component can be used to map vibrational features at nanometre-level resolution, and that the second component can be used for analysis carried out with the beam positioned just outside the sample-that is, for 'aloof' spectroscopy that largely avoids radiation damage.	[Krivanek, Ondrej L.; Lovejoy, Tracy C.; Dellby, Niklas] Nion Co, Kirkland, WA 98033 USA; [Krivanek, Ondrej L.; Rez, Peter] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Aoki, Toshihiro; Soignard, Emmanuel; Zhu, Jiangtao] Arizona State Univ, LeRoy Eyring Ctr Solid State Sci, Tempe, AZ 85287 USA; [Carpenter, R. W.; Soignard, Emmanuel] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Batson, Philip E.; Lagos, Maureen J.] Rutgers State Univ, Inst Adv Mat Devices & Nanotechnol, Piscataway, NJ 08854 USA; [Batson, Philip E.; Lagos, Maureen J.] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Batson, Philip E.; Lagos, Maureen J.] Rutgers State Univ, Dept Mat Sci, Piscataway, NJ 08854 USA; [Egerton, Ray F.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Crozier, Peter A.] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Alberta; Arizona State University; Arizona State University-Tempe	Krivanek, OL (corresponding author), Nion Co, 1102 Eighth St, Kirkland, WA 98033 USA.	krivanek@nion.com; crozier@asu.edu	Aoki, Toshihiro/I-4852-2015	Lagos, Maureen Joel/0000-0002-1452-5196; Crozier, Peter A./0000-0002-1837-2481	National Science Foundation [DMR MRI 0821796, DMR MRI-R2 959905]; Department of Energy [DE-SC0004954, DE-SC0005132, DE-SC0007694]; Natural Sciences and Engineering Council of Canada; UK Engineering and Physical Research Council (capital equipment grant) [EP/J021156/1]; Arizona State University; Rutgers University; Nion Co.	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); UK Engineering and Physical Research Council (capital equipment grant); Arizona State University; Rutgers University; Nion Co.	We thank A. Howie and J.-C. Idrobo for discussions, W. J. Bowman, J. Bruley, J. H. Butler, V. Domnich, R. A. Haber, Y. Ikuhara, M. R. Libera, D. S. Lowry and V. Nicolosi for provision of samples, J. Mardinly for help with running the instruments, our co-workers at Nion, especially N. J. Bacon, G. J. Corbin, P. J. Cramer, Z. Dellby, R. W. Hayner, P. Hrncirik, P. Phoungphidok, M. C. Sarahan, G. S. Skone, Z. Szilagyi and T. Yoo for help with the construction of the hardware, electronics and software for HERMES, and C. Trevor of Gatan Inc. for an instability-analysing script. We also acknowledge the use of facilities within the LeRoy Eyring Center for Solid State Science at Arizona State University. Financial support for the purchase of the microscopes was provided by National Science Foundation grants DMR MRI 0821796 (Arizona State University) and DMR MRI-R2 959905(Rutgers University). Department of Energy grant DE-SC0004954 provided support for P.A.C. and microscopy performed at Arizona State University, and Department of Energy grant DE-SC0005132 provided support for P. E. B., M. J. L. and microscopy performed at Rutgers University. Additional support was provided by the Department of Energy (grant DE-SC0007694), the Natural Sciences and Engineering Council of Canada, the UK Engineering and Physical Research Council (capital equipment grant EP/J021156/1), Arizona State University, Rutgers University and Nion Co.	BASHKIN IO, 1993, Z PHYS CHEM, V179, P335, DOI 10.1524/zpch.1993.179.Part_1_2.335; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Bock J., 1970, Journal of the American Ceramic Society, V53, P69, DOI 10.1111/j.1151-2916.1970.tb12012.x; BOERSCH H, 1966, PHYS REV LETT, V17, P379, DOI 10.1103/PhysRevLett.17.379; Cohen H, 1998, PHYS REV LETT, V80, P782, DOI 10.1103/PhysRevLett.80.782; Cueva P, 2013, MICROSC MICROANAL, V19, P1130; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; de Abajo FJG, 1999, INST PHYS CONF SER, P327; Dwyer C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054103; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; Griffiths O.R., 2007, FOURIER TRANSFORM IN; Gubbens A, 2010, ULTRAMICROSCOPY, V110, P962, DOI 10.1016/j.ultramic.2010.01.009; HAIDER M, 1995, OPTIK, V99, P167; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; HOWIE A, 1985, ULTRAMICROSCOPY, V18, P427, DOI 10.1016/0304-3991(85)90161-5; Ibach H., 1982, ELECT ENERGY LOSS SP; Krivanek OL, 2008, ULTRAMICROSCOPY, V108, P179, DOI 10.1016/j.ultramic.2007.07.010; Krivanek O L, 2011, SCANNING TRANSMISSIO, P613; KRIVANEK OL, 1992, MICROSC MICROANAL M, V3, P187, DOI 10.1051/mmm:0199200302-3018700; Krivanek OL, 1997, INST PHYS CONF SER, P35; Krivanek OL, 2014, J PHYS CONF SER, V522, DOI 10.1088/1742-6596/522/1/012023; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; LI JP, 1993, APPL PHYS LETT, V62, P3135, DOI 10.1063/1.109106; Lovejoy T. C., 2014, MICROSC MICROANAL S3, V20, P558; McCreery R.L., 2005, RAMAN SPECTROSCOPY C, VVolume 225; Mitchell PCH, 2005, VIBRATIONAL SPECTROS; Oshima C, 1997, J PHYS-CONDENS MAT, V9, P1, DOI 10.1088/0953-8984/9/1/004; Pennycook S. J., 2011, SCANNING TRANSMISSIO; Ramasse QM, 2013, NANO LETT, V13, P4989, DOI 10.1021/nl304187e; Rez P, 2014, MICROSC MICROANAL, V20, P671, DOI 10.1017/S1431927614000129; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Suenaga K, 2010, NATURE, V468, P1088, DOI 10.1038/nature09664; Terauchi M, 1999, J MICROSC-OXFORD, V194, P203, DOI 10.1046/j.1365-2818.1999.00450.x; Tiemeijer P. C., 2012, MICROSC MICROANAL S2, V8, P70; WALLS MG, 1989, ULTRAMICROSCOPY, V28, P40, DOI 10.1016/0304-3991(89)90266-0; Wang ZL, 1996, MICRON, V27, P265, DOI 10.1016/0968-4328(96)00011-X; Zhou W, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.206803	42	353	359	21	469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					209	+		10.1038/nature13870	http://dx.doi.org/10.1038/nature13870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297434				2022-12-28	WOS:000342663100038
J	Wood, JM; Athanasiadis, T; Allen, J				Wood, John M.; Athanasiadis, Theodore; Allen, Jacqui			Laryngitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GASTROESOPHAGEAL-REFLUX DISEASE; VOICE DISORDERS; VOCAL HYGIENE; LARYNGOPHARYNGEAL; SARCOIDOSIS; DIAGNOSIS; LARYNX		[Wood, John M.] Princess Margaret Hosp, Subiaco, WA, Australia; [Athanasiadis, Theodore] Adelaide Voice Specialists, Adelaide, SA 5000, Australia; [Allen, Jacqui] North Shore Hosp, Auckland, New Zealand		Athanasiadis, T (corresponding author), Adelaide Voice Specialists, Adelaide, SA 5000, Australia.	theoathans@gmail.com						Athanasiadis T, 2013, CURR OPIN OTOLARYNGO, V21, P517, DOI 10.1097/MOO.0b013e3283658eca; Barker E, 2006, CLIN EXP IMMUNOL, V143, P6, DOI 10.1111/j.1365-2249.2005.02950.x; Behlau M, 2009, CURR OPIN OTOLARYNGO, V17, P149, DOI 10.1097/MOO.0b013e32832af105; Bhat VK, 2009, AM J OTOLARYNG, V30, P327, DOI 10.1016/j.amjoto.2008.07.005; Birchall MA, 2008, ANN OTO RHINOL LARYN, V117, P891, DOI 10.1177/000348940811701205; Chandran SK, 2009, ENT-EAR NOSE THROAT, V88, P1026, DOI 10.1177/014556130908800803; Chen HK, 2012, AUSTRALAS MED J, V5, P175, DOI 10.4066/AMJ.2012.1101; Cheung TK, 2009, DIGESTION, V79, P52, DOI 10.1159/000205267; Cohen SM, 2014, OTOLARYNG HEAD NECK, V150, P95, DOI 10.1177/0194599813512982; Dworkin JP, 2008, OTOLARYNG CLIN N AM, V41, P419, DOI 10.1016/j.otc.2007.11.011; Gupta SK, 2006, HEAD NECK SURG OTOLA; Hamdan AL, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/103081; Higgins TS, 2010, LARYNGOSCOPE, V120, P529, DOI 10.1002/lary.20763; Hom C, 2013, DRUGS, V73, P1281, DOI 10.1007/s40265-013-0101-8; Ingle JW, 2014, LARYNGOSCOPE, V124, P921, DOI 10.1002/lary.23691; Johnston N, 2010, ANN OTO RHINOL LARYN, V119, P547, DOI 10.1177/000348941011900808; Kadakia S., 2013, J SING, V69, P571; McGlashan JA, 2014, LARYNGOLOGY OTORHINO; Merati AL, 2010, CUMMINGS OTOLARYNGOL; Mrowka-Kata K, 2010, EUR ARCH OTO-RHINO-L, V267, P1507, DOI 10.1007/s00405-010-1331-y; Myerson DN, 2013, ENT-EAR NOSE THROAT, V92, P60, DOI 10.1177/014556131309200206; Omori K., 2011, JPN MED ASS J, V54, P248; Pasa G, 2007, LOGOP PHONIATR VOCO, V32, P128, DOI 10.1080/14015430701207774; Powell J, 2013, LARYNGOSCOPE, V123, P985, DOI 10.1002/lary.23693; Ratnasingam D, 2011, WORLD J SURG, V35, P342, DOI 10.1007/s00268-010-0838-0; Reveiz L, 2013, COCHRANE DB SYST REV, V3; Roth D, 2010, CURR OPIN OTOLARYNGO, V18, P176, DOI 10.1097/MOO.0b013e32833952af; Royal College of General Practitioners, 2001, COMM RESP DIS REP EN; Salminen P, 2010, DIGEST SURG, V27, P509, DOI 10.1159/000321883; Schwartz SR, 2009, OTOLARYNG HEAD NECK, V141, pS1, DOI 10.1016/j.otohns.2009.06.744; Sims JR, 2013, AM J OTOLARYNG, V34, P236, DOI 10.1016/j.amjoto.2012.11.006; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; van den Broek EMJM, 2013, J VOICE, V27, P647, DOI 10.1016/j.jvoice.2013.03.010; Watson MG, 2011, ALIMENT PHARM THER, V33, P53; Williams NR, 2003, OCCUP MED-OXFORD, V53, P456, DOI 10.1093/occmed/kqg113; Wood JM, 2011, J LARYNGOL OTOL, V125, P1218, DOI 10.1017/S0022215111002234; Wood N, 2005, INTERN MED J, V35, P530, DOI 10.1111/j.1445-5994.2005.00909.x; Xu KT, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-7	38	10	11	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2014	349								g5827	10.1136/bmj.g5827	http://dx.doi.org/10.1136/bmj.g5827			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LK	25300640				2022-12-28	WOS:000342998200011
J	Morgan, DJ; Kaye, KS; Diekema, DJ				Morgan, Daniel J.; Kaye, Keith S.; Diekema, Daniel J.			Reconsidering Isolation Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTACT PRECAUTIONS; INTENSIVE-CARE; TRANSMISSION; ACQUISITION; BACTERIA		[Morgan, Daniel J.] Univ Maryland, Sch Med, VA Maryland Healthcare Syst, Baltimore, MD 21201 USA; [Kaye, Keith S.] Detroit Med Ctr, Detroit, MI USA; [Kaye, Keith S.] Wayne State Univ, Detroit, MI USA; [Kaye, Keith S.] Univ Hlth Ctr, Detroit, MI USA; [Diekema, Daniel J.] Univ Iowa, Dept Internal Med, Div Infect Dis, Coll Med, Iowa City, IA 52242 USA	University System of Maryland; University of Maryland Baltimore; Detroit Medical Center; Wayne State University; University of Iowa	Morgan, DJ (corresponding author), Univ Maryland, Sch Med, VA Maryland Healthcare Syst, 10 S Pine St,MSTF 334, Baltimore, MD 21201 USA.	dmorgan@epi.umaryland.edu	Kaye, Keith/AAF-1048-2019	Diekema, Daniel/0000-0003-1273-0724				Dhar S, 2014, INFECT CONT HOSP EP, V35, P213, DOI 10.1086/675294; Haessler S, 2014, SUCCESS STORIES MRSA; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Siegel JD, 2006, MANAGEMENT MULTIDRUG	8	25	26	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1395	1396		10.1001/jama.2014.10142	http://dx.doi.org/10.1001/jama.2014.10142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291571				2022-12-28	WOS:000342630200010
J	Brannstrom, M; Johannesson, L; Bokstrom, H; Kvarnstrom, N; Molne, J; Dahm-Kahler, P; Enskog, A; Milenkovic, M; Ekberg, J; Diaz-Garcia, C; Gabel, M; Hanafy, A; Hagberg, H; Olausson, M; Nilsson, L				Brannstrom, Mats; Johannesson, Liza; Bokstrom, Hans; Kvarnstrom, Niclas; Molne, Johan; Dahm-Kahler, Pernilla; Enskog, Anders; Milenkovic, Milan; Ekberg, Jana; Diaz-Garcia, Cesar; Gabel, Markus; Hanafy, Ash; Hagberg, Henrik; Olausson, Michael; Nilsson, Lars			Livebirth after uterus transplantation	LANCET			English	Article							IN-VITRO FERTILIZATION; KUSTER-HAUSER SYNDROME; PREGNANCY; WOMEN; EMBRYO; BIRTH; FORMS; AGE	Background Uterus transplantation is the first available treatment for absolute uterine infertility, which is caused by absence of the uterus or the presence of a non-functional uterus. Eleven human uterus transplantation attempts have been done worldwide but no livebirth has yet been reported. Methods In 2013, a 35-year-old woman with congenital absence of the uterus (Rokitansky syndrome) underwent transplantation of the uterus in Sahlgrenska University Hospital, Gothenburg, Sweden. The uterus was donated from a living, 61-year-old, two-parous woman. In-vitro fertilisation treatment of the recipient and her partner had been done before transplantation, from which 11 embryos were cryopreserved. Findings The recipient and the donor had essentially uneventful postoperative recoveries. The recipient's first menstruation occurred 43 days after transplantation and she continued to menstruate at regular intervals of between 26 and 36 days (median 32 days). 1 year after transplantation, the recipient underwent her first single embryo transfer, which resulted in pregnancy. She was then given triple immunosuppression (tacrolimus, azathioprine, and corticosteroids), which was continued throughout pregnancy. She had three episodes of mild rejection, one of which occurred during pregnancy. These episodes were all reversed by corticosteroid treatment. Fetal growth parameters and blood flows of the uterine arteries and umbilical cord were normal throughout pregnancy. The patient was admitted with pre-eclampsia at 31 full weeks and 5 days, and 16 h later a caesarean section was done because of abnormal cardiotocography. A male baby with a normal birthweight for gestational age (1775 g) and with APGAR scores 9, 9, 10 was born. Interpretation We describe the first livebirth after uterus transplantation. This report is a proof-of-concept for uterus transplantation as a treatment for uterine factor infertility. Furthermore, the results show the feasibility of live uterus donation, even from a postmenopausal donor.	[Johannesson, Liza; Bokstrom, Hans; Dahm-Kahler, Pernilla; Milenkovic, Milan; Hagberg, Henrik; Nilsson, Lars] Univ Gothenburg, Dept Obstet & Gynecol, Sahlgrenska Acad, SE-41345 Gothenburg, Sweden; [Kvarnstrom, Niclas; Ekberg, Jana; Gabel, Markus; Olausson, Michael] Univ Gothenburg, Sahlgrenska Acad, Dept Transplantat, SE-41345 Gothenburg, Sweden; [Molne, Johan] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Pathol & Genet, SE-41345 Gothenburg, Sweden; [Enskog, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Anesthesiol & Intens Care, SE-41345 Gothenburg, Sweden; [Brannstrom, Mats; Johannesson, Liza; Dahm-Kahler, Pernilla; Milenkovic, Milan; Nilsson, Lars] Stockholm IVF, Stockholm, Sweden; [Diaz-Garcia, Cesar] Univ Valencia, La Fe Univ Hosp, Dept Obstet & Gynecol, Valencia, Spain; [Hanafy, Ash] Griffith Univ, Dept Obstet & Gynecol, Gold Coast, Qld, Australia; [Hagberg, Henrik] Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, Ctr Developing Brain, London WC2R 2LS, England	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Valencia; Griffith University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Brannstrom, M (corresponding author), Univ Gothenburg, Dept Obstet & Gynecol, Sahlgrenska Acad, SE-41345 Gothenburg, Sweden.	mats.brannstrom@obgyn.gu.se	Olausson, Michael/E-5822-2012; Milenković, Milan/AAN-6425-2021	Olausson, Michael/0000-0002-3949-9430; Diaz-Garcia, Cesar/0000-0002-2773-1343; Hagberg, Henrik/0000-0003-3962-1448; Johannesson, Liza/0000-0001-8572-3811; Molne, Johan/0000-0001-6241-7117	Jane and Dan Olsson Foundation for Science	Jane and Dan Olsson Foundation for Science	Funding Jane and Dan Olsson Foundation for Science.	Akar ME, 2013, FERTIL STERIL, V100, P1358, DOI 10.1016/j.fertnstert.2013.06.027; Al-Inany H, 2001, ACTA OBSTET GYN SCAN, V80, P986, DOI 10.1034/j.1600-0412.2001.801103.x; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Brannstrom M, 2010, HUM REPROD UPDATE, V16, P329, DOI 10.1093/humupd/dmp049; Dahm-Kahler P, 2008, J OBSTET GYNAECOL RE, V34, P784, DOI 10.1111/j.1447-0756.2008.00854.x; Diaz-Garcia C, 2012, MOL HUM REPROD, V18, P68, DOI 10.1093/molehr/gar055; Dubernard JM, 2000, TRANSPL INT; Fageeh W, 2002, INT J GYNECOL OBSTET, V76, P245, DOI 10.1016/S0020-7292(01)00597-5; Grimbizis GF, 2001, HUM REPROD UPDATE, V7, P161, DOI 10.1093/humupd/7.2.161; Johannesson L, 2013, HUM REPROD, V28, P189, DOI 10.1093/humrep/des381; Kallen B, 2005, BJOG-INT J OBSTET GY, V112, P904, DOI 10.1111/j.1471-0528.2005.00607.x; Levron Y, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.044; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Nicolaides K., 2002, DOPPLER OBSTET; Olausson M, 2014, FERTIL STERIL, V102, P40, DOI 10.1016/j.fertnstert.2014.03.048; Ozkan O, 2013, FERTIL STERIL, V99, P470, DOI 10.1016/j.fertnstert.2012.09.035; Paulson RJ, 2002, JAMA-J AM MED ASSOC, V288, P2320, DOI 10.1001/jama.288.18.2320; Raziel A, 2012, HUM REPROD, V27, P126, DOI 10.1093/humrep/der356; Reisaeter AV, 2009, AM J TRANSPLANT, V9, P820, DOI 10.1111/j.1600-6143.2008.02427.x; Saravelos SH, 2008, HUM REPROD UPDATE, V14, P415, DOI 10.1093/humupd/dmn018; Sazonova A, 2012, HUM REPROD, V27, P1343, DOI 10.1093/humrep/des036; Sieunarine K, 2005, INT SURG, V90, P249; STEPTOE PC, 1978, LANCET, V2, P366; STRUBBE EH, 1993, AM J ROENTGENOL, V160, P331, DOI 10.2214/ajr.160.2.8424345; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032	26	459	476	5	64	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					607	616		10.1016/S0140-6736(14)61728-1	http://dx.doi.org/10.1016/S0140-6736(14)61728-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25301505	Green Published			2022-12-28	WOS:000349214000029
J	Lee, DW; Kochenderfer, JN; Stetler-Stevenson, M; Cui, YZK; Delbrook, C; Feldman, SA; Fry, TJ; Orentas, R; Sabatino, M; Shah, NN; Steinberg, SM; Stroncek, D; Tschemia, N; Yuan, C; Zhang, H; Zhang, L; Rosenberg, SA; Wayne, AS; Mackall, CL				Lee, Daniel W.; Kochenderfer, James N.; Stetler-Stevenson, Maryalice; Cui, Yongzhi K.; Delbrook, Cindy; Feldman, Steven A.; Fry, Terry J.; Orentas, Rimas; Sabatino, Marianna; Shah, Nirali N.; Steinberg, Seth M.; Stroncek, Dave; Tschemia, Nick; Yuan, Constance; Zhang, Hua; Zhang, Ling; Rosenberg, Steven A.; Wayne, Alan S.; Mackall, Crystal L.			T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial	LANCET			English	Article							C-REACTIVE PROTEIN; PEDIATRIC-PATIENTS; SURVIVAL; TRANSPLANTATION; CLOFARABINE; MANAGEMENT; CANCER	Background Chimeric antigen receptor (CAR) modified T cells targeting CD19 have shown activity in case series of patients with acute and chronic lymphocytic leukaemia and B-cell lymphomas, but feasibility, toxicity, and response rates of consecutively enrolled patients treated with a consistent regimen and assessed on an intention-to-treat basis have not been reported. We aimed to define feasibility, toxicity, maximum tolerated dose, response rate, and biological correlates of response in children and young adults with refractory B-cell malignancies treated with CD19-CAR T cells. Methods This phase 1, dose-escalation trial consecutively enrolled children and young adults (aged 1-30 years) with relapsed or refractory acute lymphoblastic leukaemia or non-Hodgkin lymphoma. Autologous T cells were engineered via an 11-day manufacturing process to express a CD19-CAR incorporating an anti-CD19 single-chain variable fragment plus TCR zeta and CD28 signalling domains. All patients received fludarabine and cyclophosphamide before a single infusion of CD19-CAR T cells. Using a standard 3 + 3 design to establish the maximum tolerated dose, patients received either 1 x 106 CAR-transduced T cells per kg (dose 1), 3 x 106 CAR-transduced T cells per kg (dose 2), or the entire CAR T-cell product if sufficient numbers of cells to meet the assigned dose were not generated. After the dose-escalation phase, an expansion cohort was treated at the maximum tolerated dose. The trial is registered with ClinicalTrials.gov, number NCT01593696. Findings Between July 2, 2012, and June 20, 2014, 21 patients (including eight who had previously undergone allogeneic haematopoietic stem-cell transplantation) were enrolled and infused with CD19-CAR T cells. 19 received the prescribed dose of CD19-CAR T cells, whereas the assigned dose concentration could not be generated for two patients (90% feasible). All patients enrolled were assessed for response. The maximum tolerated dose was defi ned as 1 x 106 CD19-CAR T cells per kg. All toxicities were fully reversible, with the most severe being grade 4 cytokine release syndrome that occurred in three (14%) of 21 patients (95% CI 3.0-36.3). The most common non-haematological grade 3 adverse events were fever (nine [43%] of 21 patients), hypokalaemia (nine [43%] of 21 patients), fever and neutropenia (eight [38%] of 21 patients), and cytokine release syndrome (three [14%) of 21 patients). Interpretation CD19-CAR T cell therapy is feasible, safe, and mediates potent anti-leukaemic activity in children and young adults with chemotherapy-resistant B-precursor acute lymphoblastic leukaemia. All toxicities were reversible and prolonged B-cell aplasia did not occur.	[Lee, Daniel W.; Cui, Yongzhi K.; Delbrook, Cindy; Fry, Terry J.; Orentas, Rimas; Shah, Nirali N.; Zhang, Hua; Zhang, Ling; Mackall, Crystal L.] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Kochenderfer, James N.] NCI, Transplantat & Immunol Branch, Bethesda, MD 20892 USA; [Stetler-Stevenson, Maryalice; Yuan, Constance] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Feldman, Steven A.; Rosenberg, Steven A.] NCI, Surg Branch, Bethesda, MD 20892 USA; [Steinberg, Seth M.] NCI, Off Clin Director, Biostat & Data Management Sect, Bethesda, MD 20892 USA; [Sabatino, Marianna; Stroncek, Dave] NIH, Dept Transfus Med, Cell Proc Sect, Bethesda, MD 20892 USA; [Tschemia, Nick] Univ Nevada, Sch Med, Med Student Training Program, NIH, Reno, NV 89557 USA; [Wayne, Alan S.] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Childrens Ctr Canc & Blood Dis,Div Hematol Oncol, Los Angeles, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Nevada System of Higher Education (NSHE); University of Nevada Reno; Children's Hospital Los Angeles; University of Southern California	Mackall, CL (corresponding author), NCI, Pediat Oncol Branch, Bldg 10,Rm 1W-3750,10 Ctr Dr MSC 1104, Bethesda, MD 20892 USA.	mackallc@mail.nih.gov	Kochenderfer, James/X-5231-2019; Stetler-Stevenson, Maryalice/AAV-7393-2020	Tschernia, Nicholas/0000-0002-2389-9974; Kochenderfer, James/0000-0002-4362-9875	Intramural Research Program of the National Cancer Institute; St Baldrick's Foundation Scholar Award; Stand Up To Cancer-St Baldrick's-National Cancer Institute Pediatric Dream Team Translational Cancer Research Gran; NATIONAL CANCER INSTITUTE [ZICBC011104, ZIABC011565, ZICBC011093, ZICSC009372] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002120] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St Baldrick's Foundation Scholar Award; Stand Up To Cancer-St Baldrick's-National Cancer Institute Pediatric Dream Team Translational Cancer Research Gran; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported, in part, by the Intramural Research Program of the National Cancer Institute. DWL's work is also supported by a St Baldrick's Foundation Scholar Award. Research was also supported by a Stand Up To Cancer-St Baldrick's-National Cancer Institute Pediatric Dream Team Translational Cancer Research Grant. Stand Up To Cancer is a programme of the Entertainment Industry Foundation administered by the American Association for Cancer Research. We would like to thank Laurence Cooper for supplying the CD19-CAR anti-idiotype antibody, Mario Roederer, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, for assistance in design of T-cell subset panels and analysis, and Linda Weaver who worked on standardisation of methodology.	Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Burke MJ, 2013, BIOL BLOOD MARROW TR, V19, P138, DOI 10.1016/j.bbmt.2012.08.020; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Forman SJ, 2013, BLOOD, V121, P1077, DOI 10.1182/blood-2012-08-234492; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Hegde M, 2013, MOL THER, V21, P2087, DOI 10.1038/mt.2013.185; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Jeha S, 2006, J CLIN ONCOL, V24, P1917, DOI 10.1200/JCO.2005.03.8554; Jeha S, 2004, BLOOD, V103, P784, DOI 10.1182/blood-2003-06-2122; Jena B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057838; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lee DW, 2012, CLIN CANCER RES, V18, P2780, DOI 10.1158/1078-0432.CCR-11-1920; Leung W, 2011, BLOOD, V118, P223, DOI 10.1182/blood-2011-01-333070; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Pulte D, 2009, BLOOD, V113, P1408, DOI 10.1182/blood-2008-06-164863; Pulte D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085554; Robison LL, 2011, HEMATOL-AM SOC HEMAT, P238, DOI 10.1182/asheducation-2011.1.238; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Topp MS, 2012, BLOOD, V120, P5185, DOI 10.1182/blood-2012-07-441030; Tumaini B, 2013, CYTOTHERAPY, V15, P1406, DOI 10.1016/j.jcyt.2013.06.003; US Food and Drug Administration Guidance for industry: gene therapy clinical trialsobserving subjects for delayed adverse events, GUID IND GEN THER CL; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B	34	1895	2048	68	622	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					517	528		10.1016/S0140-6736(14)61403-3	http://dx.doi.org/10.1016/S0140-6736(14)61403-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25319501	Green Accepted			2022-12-28	WOS:000349213600030
J	Gostin, LO; Hodge, JG; Burris, S				Gostin, Lawrence O.; Hodge, James G., Jr.; Burris, Scott			Is the United States Prepared for Ebola?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Tempe, AZ USA; [Burris, Scott] Temple Univ, Publ Hlth Law Res Program, Beasley Sch Law, Philadelphia, PA 19122 USA	Georgetown University; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Altimari Daniela, 2014, HARTFORD COURANT; Association of State and Territorial Health Officials, UDGET CUTS CONTINUE; CDC/DHS, 2014, ENHANCED EBOLA SCREE; Gostin LO, LANCET; Institute of Medicine, 2009, CRISIS STANDARDS OF	5	28	29	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2497	2498		10.1001/jama.2014.15041	http://dx.doi.org/10.1001/jama.2014.15041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25325877	Green Published, Bronze			2022-12-28	WOS:000346346900008
J	Bucher, G; Sander, W				Bucher, Goetz; Sander, Wolfram			Clarifying the structure of carbonic acid	SCIENCE			English	Editorial Material							FTIR SPECTROSCOPIC CHARACTERIZATION; GAS-PHASE		[Bucher, Goetz] Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Sander, Wolfram] Ruhr Univ Bochum, Lehrstuhl Organ Chem 2, D-44780 Bochum, Germany	University of Glasgow; Ruhr University Bochum	Bucher, G (corresponding author), Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland.	wolfram.sander@rub.de	/A-1378-2010	/0000-0002-5478-8265; Sander, Wolfram/0000-0002-1640-7505				Adamczyk K, 2009, SCIENCE, V326, P1690, DOI 10.1126/science.1180060; Bernard J, 2013, J AM CHEM SOC, V135, P7732, DOI 10.1021/ja4020925; Bucher G, 2010, EUR J ORG CHEM, V2010, P1070, DOI 10.1002/ejoc.200901212; HAGE W, 1993, J AM CHEM SOC, V115, P8427, DOI 10.1021/ja00071a061; Hage W, 1998, SCIENCE, V279, P1332, DOI 10.1126/science.279.5355.1332; Hage W, 1997, J MOL STRUCT, V408, P527, DOI 10.1016/S0022-2860(96)09701-3; JONSSON B, 1977, J AM CHEM SOC, V99, P4628, DOI 10.1021/ja00456a018; Loerting T, 2000, ANGEW CHEM INT EDIT, V39, P892; MOORE MH, 1991, SPECTROCHIM ACTA A, V47, P255, DOI 10.1016/0584-8539(91)80097-3; Reisenauer HP, 2014, ANGEW CHEM INT EDIT, V53, P11766, DOI 10.1002/anie.201406969; TERLOUW JK, 1987, ANGEW CHEM INT EDIT, V26, P354, DOI 10.1002/anie.198703541	11	14	14	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		544	545		10.1126/science.1260117	http://dx.doi.org/10.1126/science.1260117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359949				2022-12-28	WOS:000343799700020
J	Dutrey, A; Di Folco, E; Guilloteau, S; Boehler, Y; Bary, J; Beck, T; Beust, H; Chapillon, E; Gueth, F; Hure, JM; Pierens, A; Pietu, V; Simon, M; Tang, YW				Dutrey, Anne; Di Folco, Emmanuel; Guilloteau, Stephane; Boehler, Yann; Bary, Jeff; Beck, Tracy; Beust, Herve; Chapillon, Edwige; Gueth, Frederic; Hure, Jean-Marc; Pierens, Arnaud; Pietu, Vincent; Simon, Michal; Tang, Ya-Wen			Possible planet formation in the young, low-mass, multiple stellar system GG Tau A	NATURE			English	Article							GAS ACCRETION; PROTOPLANETARY DISCS; SPECTROSCOPIC SURVEY; BINARY-SYSTEMS; LINE EMISSION; DISKS; DYNAMICS; EVOLUTION; MIGRATION; SPECTRA	The formation of planets around binary stars may be more difficult than around single stars(1-3). In a close binary star (with a separation of less than a hundred astronomical units), theory predicts the presence of circumstellar disks around each star, and an outer circum-binary disk surrounding a gravitationally cleared inner cavity around the stars(4,5). Given that the inner disks are depleted by accretion onto the stars on timescales of a few thousand years, any replenishing material must be transferred from the outer reservoir to fuel planet formation (which occurs on timescales of about one million years). Gas flowing through disk cavities has been detected in single star systems(6). A circumbinary disk was discovered around the young low-mass binary system GG Tau A(ref. 7), which has recently been shown to be a hierarchical triple system(8). It has one large inner disk(9) around the single star, GG Tau Aa, and shows small amounts of shocked hydrogen gas residing within the central cavity(10), but other than a single weak detection(11), the distribution of cold gas in this cavity or in any other binary or multiple star system has not hitherto been determined. Here we report imaging of gas fragments emitting radiation characteristic of carbon monoxide within the GG Tau A cavity. From the kinematics we conclude that the flow appears capable of sustaining the inner disk (around GG Tau Aa) beyond the accretion lifetime, leaving time for planet formation to occur there. These results show the complexity of planet formation around multiple stars and confirm the general picture predicted by numerical simulations.	[Dutrey, Anne; Di Folco, Emmanuel; Guilloteau, Stephane; Chapillon, Edwige; Hure, Jean-Marc; Pierens, Arnaud] Univ Bordeaux, LAB, UMR 5804, F-33270 Floirac, France; [Dutrey, Anne; Di Folco, Emmanuel; Guilloteau, Stephane; Hure, Jean-Marc; Pierens, Arnaud] CNRS, UMR 5804, LAB, F-33270 Floirac, France; [Boehler, Yann] Univ Mexico, CRyA, Morelia 58089, Michoacan, Mexico; [Bary, Jeff] Colgate Univ, Dept Phys & Astron, Hamilton, NY 13346 USA; [Beck, Tracy] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Beust, Herve] IPAG, UMR 5274, F-38041 Grenoble 9, France; [Chapillon, Edwige; Gueth, Frederic; Pietu, Vincent] IRAM, F-38046 St Martin Dheres, France; [Simon, Michal] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Tang, Ya-Wen] Acad Sinica, Inst Astron & Astrophys, Taipei 106, Taiwan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Colgate University; Space Telescope Science Institute; Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Academia Sinica - Taiwan	Dutrey, A (corresponding author), Univ Bordeaux, LAB, UMR 5804, F-33270 Floirac, France.	Anne.Dutrey@obs.u-bordeaux1.fr	Tang湯雅雯, Ya-Wen/AAZ-7382-2020	Tang湯雅雯, Ya-Wen/0000-0002-0675-276X; Guilloteau, Stephane/0000-0003-3773-1870	INSU/CNRS (France); MPG (Germany); IGN (Spain); French programme PNP; French programme PCMI; French programme PNPS; French programme ASA	INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); MPG (Germany)(Max Planck Society); IGN (Spain); French programme PNP; French programme PCMI; French programme PNPS; French programme ASA	ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. IRAM is supported by INSU/CNRS (France), MPG (Germany) and IGN (Spain). A. D. thanks the French programmes PNP, PCMI, PNPS and ASA for providing funding for this study.	Andrews SM, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/148; ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; Bate MR, 1997, MON NOT R ASTRON SOC, V285, P33, DOI 10.1093/mnras/285.1.33; Beck TL, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/72; BECKWITH SVW, 1993, ASTROPHYS J, V402, P280, DOI 10.1086/172131; Beust H, 2006, ASTRON ASTROPHYS, V446, P137, DOI 10.1051/0004-6361:20053163; Beust H, 2005, ASTRON ASTROPHYS, V439, P585, DOI 10.1051/0004-6361:20042441; Boehler Y, 2013, MON NOT R ASTRON SOC, V431, P1573, DOI 10.1093/mnras/stt278; Boley AC, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L21; Casassus S, 2013, NATURE, V493, P191, DOI 10.1038/nature11769; de Gregorio-Monsalvo I, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321603; Delorme P, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201321169; Di Folco E, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423675; Duchene G, 2013, ANNU REV ASTRON ASTR, V51, P269, DOI 10.1146/annurev-astro-081710-102602; Ducourant C, 2005, ASTRON ASTROPHYS, V438, P769, DOI 10.1051/0004-6361:20052788; Dutrey A, 2008, ASTRON ASTROPHYS, V490, pL15, DOI 10.1051/0004-6361:200810732; DUTREY A, 1994, ASTRON ASTROPHYS, V286, P149; Dutrey A., 2014, PREPRINT; Nguyen DC, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/119; Guilloteau S, 1999, ASTRON ASTROPHYS, V348, P570; Guilloteau S, 1998, ASTRON ASTROPHYS, V339, P467; Guilloteau S, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220331; Guilloteau S, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015209; Guilloteau S., 2001, IAU S, V200, P229; Madlener D, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201117615; Mayer L, 2005, MON NOT R ASTRON SOC, V363, P641, DOI 10.1111/j.1365-2966.2005.09468.x; MoriartySchieven GH, 1997, ASTROPHYS J, V474, P768, DOI 10.1086/303474; Nelson AF, 2000, ASTROPHYS J, V537, pL65, DOI 10.1086/312752; Pety J., 2002, ALMA MEMO, V386, P1; Pierens A, 2007, ASTRON ASTROPHYS, V472, P993, DOI 10.1051/0004-6361:20077659; Pierens A, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321777; Pietu V, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322388; Pietu V, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015682; Rosenfeld KA, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/62; Skemer AJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/43; SKRUTSKIE MF, 1993, ASTROPHYS J, V409, P422, DOI 10.1086/172675; Takeuchi T, 1996, ASTROPHYS J, V460, P832, DOI 10.1086/177013; Thebault P, 2006, ICARUS, V183, P193, DOI 10.1016/j.icarus.2006.01.022; Thi WF, 1999, ASTROPHYS J, V521, pL63, DOI 10.1086/312171; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; White RJ, 1999, ASTROPHYS J, V520, P811, DOI 10.1086/307494; Wolf S, 2005, ASTROPHYS J, V619, P1114, DOI 10.1086/426662; Wolf S, 2002, ASTROPHYS J, V566, pL97, DOI 10.1086/339544	49	48	48	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					600	+		10.1038/nature13822	http://dx.doi.org/10.1038/nature13822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355359	Green Submitted			2022-12-28	WOS:000343801500042
J	Morrison, VR; Chatelain, RP; Tiwari, KL; Hendaoui, A; Bruhacs, A; Chaker, M; Siwick, BJ				Morrison, Vance R.; Chatelain, Robert. P.; Tiwari, Kunal L.; Hendaoui, Ali; Bruhacs, Andrew; Chaker, Mohamed; Siwick, Bradley J.			A photoinduced metal-like phase of monoclinic VO2 revealed by ultrafast electron diffraction	SCIENCE			English	Article							INSULATOR; TRANSITION; VIEW	The complex interplay among several active degrees of freedom (charge, lattice, orbital, and spin) is thought to determine the electronic properties of many oxides. We report on combined ultrafast electron diffraction and infrared transmissivity experiments in which we directly monitored and separated the lattice and charge density reorganizations that are associated with the optically induced semiconductor-metal transition in vanadium dioxide (VO2). By photoexciting the monoclinic semiconducting phase, we were able to induce a transition to a metastable state that retained the periodic lattice distortion characteristic of the semiconductor but also acquired metal-like mid-infrared optical properties. Our results demonstrate that ultrafast electron diffraction is capable of following details of both lattice and electronic structural dynamics on the ultrafast time scale.	[Morrison, Vance R.; Chatelain, Robert. P.; Tiwari, Kunal L.; Siwick, Bradley J.] McGill Univ, Dept Phys, Ctr Phys Mat, Montreal, PQ H3A 2T8, Canada; [Bruhacs, Andrew; Siwick, Bradley J.] McGill Univ, Dept Chem, Montreal, PQ H3A 0B8, Canada; [Hendaoui, Ali; Chaker, Mohamed] Univ Quebec, Ctr Energie Mat & Telecommun, Inst Natl Rech Sci, Varennes, PQ J3X 1S2, Canada	McGill University; McGill University; University of Quebec; Institut national de la recherche scientifique (INRS)	Siwick, BJ (corresponding author), McGill Univ, Dept Phys, Ctr Phys Mat, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	bradley.siwick@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation; Canada Research Chairs program; NSERC PGS-D fellowship; NSERC CGS-D fellowship; Fonds de Recherche du Quebec-Nature et Technologies	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs program(Canada Research Chairs); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec-Nature et Technologies	Supported by Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation, the Canada Research Chairs program, NSERC PGS-D and CGS-D fellowships (R.P.C. and V.M.), and Fonds de Recherche du Quebec-Nature et Technologies. We thank C. Weber for insightful discussion regarding the contemporary theoretical treatment of the electronic structure of VO<INF>2</INF>.	Abeykoon M, 2012, Z KRIST-CRYST MATER, V227, P248, DOI 10.1524/zkri.2012.1510; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Belozerov AS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045109; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; Biermann S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026404; Cavalleri A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161102; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Chatelain RP, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747155; Cocker TL, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155120; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Eyert V, 2002, ANN PHYS-BERLIN, V11, P650, DOI 10.1002/1521-3889(200210)11:9<650::AID-ANDP650>3.0.CO;2-K; Gao M, 2013, NATURE, V496, P343, DOI 10.1038/nature12044; Gao M, 2012, OPT EXPRESS, V20, P12048, DOI 10.1364/OE.20.012048; GOODENOUGH JB, 1971, J SOLID STATE CHEM, V3, P490, DOI 10.1016/0022-4596(71)90091-0; Haverkort MW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196404; Hendaoui A, 2013, CURR APPL PHYS, V13, P875, DOI 10.1016/j.cap.2012.12.028; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Koethe TC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116402; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Nag J, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764040; Pashkin A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195120; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; Qazilbash MM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165108; Ruan CY, 2007, NANO LETT, V7, P1290, DOI 10.1021/nl070269h; Sakuma R, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/6/064226; Sciaini G, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/9/096101; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; van Oudheusden T, 2007, J APPL PHYS, V102, DOI 10.1063/1.2801027; Wall S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115126; Weber C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256402; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; Whittaker L, 2011, J PHYS CHEM LETT, V2, P745, DOI 10.1021/jz101640n; Yao Y, 2013, MOD PHYS LETT B, V27, DOI 10.1142/S0217984913300159; Zheng JC, 2005, J APPL CRYSTALLOGR, V38, P648, DOI 10.1107/S0021889805016109; Zuo JM, 2004, REP PROG PHYS, V67, P2053, DOI 10.1088/0034-4885/67/11/R03; ZYLBERSZTEJN A, 1975, PHYS REV B, V11, P4383, DOI 10.1103/PhysRevB.11.4383	36	358	363	22	426	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					445	448		10.1126/science.1253779	http://dx.doi.org/10.1126/science.1253779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342797				2022-12-28	WOS:000343822900036
J	Stuart, YE; Campbell, TS; Hohenlohe, PA; Reynolds, RG; Revell, LJ; Losos, JB				Stuart, Y. E.; Campbell, T. S.; Hohenlohe, P. A.; Reynolds, R. G.; Revell, L. J.; Losos, J. B.			Rapid evolution of a native species following invasion by a congener	SCIENCE			English	Article							CHARACTER DISPLACEMENT; ANOLIS-CAROLINENSIS; HABITAT USE; POPULATIONS; COMPETITORS; PREDATION; BEHAVIOR; SAGREI	In recent years, biologists have increasingly recognized that evolutionary change can occur rapidly when natural selection is strong; thus, real-time studies of evolution can be used to test classic evolutionary hypotheses directly. One such hypothesis is that negative interactions between closely related species can drive phenotypic divergence. Such divergence is thought to be ubiquitous, though well-documented cases are surprisingly rare. On small islands in Florida, we found that the lizard Anolis carolinensis moved to higher perches following invasion by Anolis sagrei and, in response, adaptively evolved larger toepads after only 20 generations. These results illustrate that interspecific interactions between closely related species can drive evolutionary change on observable time scales.	[Stuart, Y. E.; Reynolds, R. G.; Losos, J. B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Stuart, Y. E.; Reynolds, R. G.; Losos, J. B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Campbell, T. S.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Hohenlohe, P. A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Hohenlohe, P. A.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Reynolds, R. G.; Revell, L. J.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	Harvard University; Harvard University; University of Tampa; Idaho; University of Idaho; Idaho; University of Idaho; University of Massachusetts System; University of Massachusetts Boston	Stuart, YE (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	yestuart@utexas.edu	Revell, Liam J/AAF-1151-2019; Hohenlohe, Paul/AAE-7744-2019	Revell, Liam J/0000-0003-0767-4713; Hohenlohe, Paul/0000-0002-7616-0161; Reynolds, Robert Graham/0000-0002-0056-8304	Harvard University; Museum of Comparative Zoology; University of Massachusetts Boston; University of Tennessee Knoxville; University of Tampa; NSF [DEB-1110521]; NIH [P30GM103324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103324] Funding Source: NIH RePORTER	Harvard University; Museum of Comparative Zoology; University of Massachusetts Boston; University of Tennessee Knoxville; University of Tampa; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Kamath, C. Gilman, A. Algar, J. Allen, E. Boates, A. Echternacht, A. Harrison, H. Lyons-Galante, T. Max, J. McCrae, J. Newman, J. Rifkin, M. Stimola, P. VanMiddlesworth, K. Winchell, C. Wiench, K. Wollenberg, and three reviewers; M. Legare and J. Lyon (Merritt Island National Wildlife Refuge), J. Stiner and C. Carter (Canaveral National Seashore); and Harvard University, Museum of Comparative Zoology, University of Massachusetts Boston, University of Tennessee Knoxville, University of Tampa, NSF (DEB-1110521), and NIH (P30GM103324) for funding. Y.E.S., T.S.C., and J.B.L. designed the study; Y.E.S., T.S.C., P.A.H., L.J.R, and R.G.R. collected the data; Y.E.S., T.S.C., and P.A.H. analyzed the data; all authors contributed to the manuscript. Data are accessioned on datadryad.org: doi:10.5061/dryad.96g44.	Bono LM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0616; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Campbell T.S., 2000, THESIS U TENNESSEE K; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; Collette B. B., 1961, Bulletin of the Museum of Comparative Zoology, V125, P137; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Edwards JR, 2013, BIOL J LINN SOC, V110, P843, DOI 10.1111/bij.12180; Edwards JR, 2012, ETHOLOGY, V118, P494, DOI 10.1111/j.1439-0310.2012.02037.x; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Glossip D, 1997, HERPETOLOGICA, V53, P192; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Macrini TE, 2003, J HERPETOL, V37, P52, DOI 10.1670/0022-1511(2003)037[0052:EDITCB]2.0.CO;2; Meiri S, 2011, J ANIM ECOL, V80, P824, DOI 10.1111/j.1365-2656.2011.01827.x; Pfennig D. W., 2012, EVOLUTIONS WEDGE; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Rodriguez Schettino Lourdes, 2010, Breviora, P1; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; Shine R, 2012, EVOL APPL, V5, P107, DOI 10.1111/j.1752-4571.2011.00201.x; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; TAPER ML, 1990, SERIES ENTOM, V46, P289; TOKARZ RR, 1987, ANIM BEHAV, V35, P722, DOI 10.1016/S0003-3472(87)80108-2; Tyerman JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-34	27	188	195	10	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					463	466		10.1126/science.1257008	http://dx.doi.org/10.1126/science.1257008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342801	Green Submitted			2022-12-28	WOS:000343822900041
J	Jindani, A; Harrison, TS; Nunn, AJ; Phillips, PPJ; Churchyard, GJ; Charalambous, S; Hatherill, M; Geldenhuys, H; McIlleron, HM; Zvada, SP; Mungofa, S; Shah, NA; Zizhou, S; Magweta, L; Shepherd, J; Nyirenda, S; van Dijk, JH; Clouting, HE; Coleman, D; Bateson, ALE; McHugh, TD; Butcher, PD; Mitchison, DA				Jindani, Amina; Harrison, Thomas S.; Nunn, Andrew J.; Phillips, Patrick P. J.; Churchyard, Gavin J.; Charalambous, Salome; Hatherill, Mark; Geldenhuys, Hennie; McIlleron, Helen M.; Zvada, Simbarashe P.; Mungofa, Stanley; Shah, Nasir A.; Zizhou, Simukai; Magweta, Lloyd; Shepherd, James; Nyirenda, Sambayawo; van Dijk, Janneke H.; Clouting, Heather E.; Coleman, David; Bateson, Anna L. E.; McHugh, Timothy D.; Butcher, Philip D.; Mitchison, Denny A.		RIFAQUIN Trial Team	High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ONCE-WEEKLY RIFAPENTINE; POPULATION PHARMACOKINETICS; RECORDING-SYSTEM; REGIMENS; PHASE; CHEMOTHERAPY; MULTIPLICITY; MULTICENTER; TRIALS; TWICE	BACKGROUND Tuberculosis regimens that are shorter and simpler than the current 6-month daily regimen are needed. METHODS We randomly assigned patients with newly diagnosed, smear-positive, drug-sensitive tuberculosis to one of three regimens: a control regimen that included 2 months of ethambutol, isoniazid, rifampicin, and pyrazinamide administered daily followed by 4 months of daily isoniazid and rifampicin; a 4-month regimen in which the isoniazid in the control regimen was replaced by moxifloxacin administered daily for 2 months followed by moxifloxacin and 900 mg of rifapentine administered twice weekly for 2 months; or a 6-month regimen in which isoniazid was replaced by daily moxifloxacin for 2 months followed by one weekly dose of both moxifloxacin and 1200 mg of rifapentine for 4 months. Sputum specimens were examined on microscopy and after culture at regular intervals. The primary end point was a composite treatment failure and relapse, with noninferiority based on a margin of 6 percentage points and 90% confidence intervals. RESULTS We enrolled a total of 827 patients from South Africa, Zimbabwe, Botswana, and Zambia; 28% of patients were coinfected with the human immunodefiency virus. In the per-protocol analysis, the proportion of patients with an unfavorable response was 4.9% in the control group, 3.2% in the 6-month group (adjusted difference from control, -1.8 percentage points; 90% confidence interval [CI], -6.1 to 2.4), and 18.2% in the 4-month group (adjusted difference from control, 13.6 percentage points; 90% CI, 8.1 to 19.1). In the modified intention-to-treat analysis these proportions were 14.4% in the control group, 13.7% in the 6-month group (adjusted difference from control, 0.4 percentage points; 90% CI, -4.7 to 5.6), and 26.9% in the 4-month group (adjusted difference from control, 13.1 percentage points; 90% CI, 6.8 to 19.4). CONCLUSIONS The 6-month regimen that included weekly administration of high-dose rifapentine and moxifloxacin was as effective as the control regimen. The 4-month regimen was not noninferior to the control regimen. (Funded by the European and Developing Countries Clinical Trials Partnership and the Wellcome Trust; RIFAQUIN Current Controlled Trials number, ISRCTN44153044.)	[Jindani, Amina; Harrison, Thomas S.; Coleman, David; Butcher, Philip D.; Mitchison, Denny A.] St Georges Univ London, London SW17 0RE, England; [Nunn, Andrew J.; Phillips, Patrick P. J.; Clouting, Heather E.] UCL, Med Res Council Clin Trials Unit, London WC1E 6BT, England; [Bateson, Anna L. E.; McHugh, Timothy D.] UCL, Ctr Clin Biol, London WC1E 6BT, England; [Churchyard, Gavin J.; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Hatherill, Mark; Geldenhuys, Hennie] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Hatherill, Mark; Geldenhuys, Hennie] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [McIlleron, Helen M.; Zvada, Simbarashe P.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Mungofa, Stanley; Shah, Nasir A.] Harare City Hlth Dept, Harare, Zimbabwe; [Zizhou, Simukai; Magweta, Lloyd] Med Directorate Mashonaland East, Marondera, Zimbabwe; [Shepherd, James; Nyirenda, Sambayawo] CDC, Gaborone, Botswana; [van Dijk, Janneke H.] Macha Res Trust, Macha, Zambia	St Georges University London; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London; University of Witwatersrand; University of Cape Town; University of Cape Town; University of Cape Town	Jindani, A (corresponding author), St Georges Univ London, Inst Infect & Immun, Cranmer Terrace, London SW17 0RE, England.	ajindani@sgul.ac.uk	McHugh, Timothy/O-3683-2019; Trajman, Anete/C-7679-2016; Yorke-Edwards, Victoria/AAA-2942-2019; McHugh, Timothy D/AAF-7231-2020; Phillips, Patrick/B-6347-2008	Trajman, Anete/0000-0002-4000-4984; Yorke-Edwards, Victoria/0000-0002-6465-7330; McHugh, Timothy D/0000-0003-4658-8594; Hanekom, Willem/0000-0003-3070-6154; Thomason, Margaret/0000-0003-3590-0140; Churchyard, Gavin/0000-0002-4269-3699; Phillips, Patrick/0000-0002-6336-7024; Nunn, Andrew/0000-0002-9158-4595; Butcher, Philip/0000-0003-1223-9097; McIlleron, Helen/0000-0002-0982-6226; Charalambous, Salome/0000-0001-7143-1009; Harrison, Thomas/0000-0003-3619-4348; Jindani, Amina/0000-0002-7110-5286	European and Developing Countries Clinical Trials Partnership; Wellcome Trust; Medical Research Council [MC_U122888469] Funding Source: researchfish; MRC [MC_U122888469] Funding Source: UKRI	European and Developing Countries Clinical Trials Partnership; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the European and Developing Countries Clinical Trials Partnership, which provided funding for the trial, and the Wellcome Trust, which provided funding for the pharmacokinetic study.	[Anonymous], 2011, REMOXTB LAB MANUAL; [Anonymous], 2013, TUB DRUG MAK SAN DRO; [Anonymous], 1998, STAT PRINC CLIN TRIA; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Division of AIDS, 1992, DIV AIDS GRAD SEV AD; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Food and Drug Administration, 2000, PRIFT RIF DRUG APPR; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436; Lounis N, 2001, ANTIMICROB AGENTS CH, V45, P3482, DOI 10.1128/AAC.45.12.3482-3486.2001; Machin DC, 2009, SAMPLE SIZE TABLES C; Merle CSC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-61; Mitchison DA, 2012, INT J TUBERC LUNG D, V16, P1186, DOI 10.5588/ijtld.11.0818; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Rosenthal IM, 2007, PLOS MED, V4, P1931, DOI 10.1371/journal.pmed.0040344; Rosenthal IM, 2006, AM J RESP CRIT CARE, V174, P94, DOI 10.1164/rccm.200602-280OC; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Tam CM, 1998, AM J RESP CRIT CARE, V157, P1726, DOI 10.1164/ajrccm.157.6.9707037; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Zvada SP, 2012, ANTIMICROB AGENTS CH, V56, P4471, DOI 10.1128/AAC.00404-12; Zvada SP, 2010, ANTIMICROB AGENTS CH, V54, P3390, DOI 10.1128/AAC.00345-10	29	296	303	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1599	1608		10.1056/NEJMoa1314210	http://dx.doi.org/10.1056/NEJMoa1314210			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337749	Green Published, Green Accepted			2022-12-28	WOS:000343648500008
J	Walshe, K				Walshe, Kieran			Counting the cost of England's NHS reorganisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England	University of Manchester	Walshe, K (corresponding author), Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England.	kieran.walshe@mbs.ac.uk		Walshe, Kieran/0000-0002-0696-480X				Chorley Matt., 2014, DAILY MAIL; Department of Health and Social Care, 2022, GOV DEL RESTR MULT D; Health and Social Care Information Centre, NHS WORKF STAT JUN 2; National Audit Office, 2013, DEP HLTH MAN TRANS R; West D, 2014, HLTH SERV J	5	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2014	349								g6340	10.1136/bmj.g6340	http://dx.doi.org/10.1136/bmj.g6340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OE	25338811				2022-12-28	WOS:000343768300004
J	Whaley, C; Chafen, JS; Pinkard, S; Kellerman, G; Bravata, D; Kocher, R; Sood, N				Whaley, Christopher; Chafen, Jennifer Schneider; Pinkard, Sophie; Kellerman, Gabriella; Bravata, Dena; Kocher, Robert; Sood, Neeraj			Association Between Availability of Health Service Prices and Payments for These Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLANS; CARE	IMPORTANCE Recent governmental and private initiatives have sought to reduce health care costs by making health care prices more transparent. OBJECTIVE To determine whether the use of an employer-sponsored private price transparency platform was associated with lower claims payments for 3 common medical services. DESIGN Payments for clinical services provided were compared between patients who searched a pricing website before using the service with patients who had not researched prior to receiving this service. Multivariable generalized linear model regressions with propensity score adjustment controlled for demographic, geographic, and procedure differences. To test for selection bias, payments for individuals who used the platform to search for services (searchers) were compared with those who did not use the platform to search for services (nonsearchers) in the period before the platform was available. The exposure was the use of the price transparency platform to search for laboratory tests, advanced imaging services, or clinician office visits before receiving care for that service. SETTING AND PARTICIPANTS Medical claims from 2010-2013 of 502 949 patients who were insured in the United States by 18 employers who provided a price transparency platform to their employees. MAIN OUTCOMES AND MEASURES The primary outcome was total claims payments (the sum of employer and employee spending for each claim) for laboratory tests, advanced imaging services, and clinician office visits. RESULTS Following access to the platform, 5.9% of 2 988 663 laboratory test claims, 6.9% of 76 768 advanced imaging claims, and 26.8% of 2 653 227 clinician office visit claims were associated with a prior search on the price transparency platform. Before having access to the price transparency platform, searchers had higher claims payments than nonsearchers for laboratory tests (4.11%; 95% CI, 1.87%-6.41%), higher payments for advanced imaging services (5.57%; 95% CI, 1.83%-9.44%), and no difference in payments for clinician office visits (0.26%; 95% CI; 0.53%-0.005%). Following access to the price transparency platform, relative claim payments for searchers were lower for searchers than nonsearchers by 13.93% (95% CI, 10.28%-17.43%) for laboratory tests, 13.15%(95% CI, 9.49%-16.66%) for advanced imaging, and 1.02%(95% CI, 0.57%-1.47%) for clinician office visits. The absolute payment differences were $3.45 (95% CI, $1.78-$5.12) for laboratory tests, $124.74 (95% CI, $83.06-$166.42) for advanced imaging services, and $1.18 (95% CI, $0.66-$1.70) for clinician office visits. CONCLUSIONS AND RELEVANCE Use of price transparency information was associated with lower total claims payments for common medical services. Themagnitude of the difference was largest for advanced imaging services and smallest for clinical office visits. Patient access to pricing information before obtaining clinical services may result in lower overall payments made for clinical care. Copyright 2014 American Medical Association. All rights reserved.	[Whaley, Christopher] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Whaley, Christopher; Chafen, Jennifer Schneider; Pinkard, Sophie; Kellerman, Gabriella; Bravata, Dena] Castlight Hlth, San Francisco, CA USA; [Chafen, Jennifer Schneider; Bravata, Dena; Kocher, Robert] Stanford Univ, Stanford, CA 94305 USA; [Kocher, Robert] Venrock, Palo Alto, CA USA; [Kocher, Robert; Sood, Neeraj] Univ So Calif, Los Angeles, CA USA; [Sood, Neeraj] Natl Bur Econ Res, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Stanford University; University of Southern California; National Bureau of Economic Research	Sood, N (corresponding author), Schaeffer Ctr Hlth Policy & Econ, 3335 S Figueroa St,Unit A, Los Angeles, CA 90089 USA.	nsood@healthpolicy.usc.edu		Sood, Neeraj/0000-0001-9805-213X	National Institutes of Health [1R01AG043850-01]; NATIONAL INSTITUTE ON AGING [R01AG043850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Sood was supported by grant 1R01AG043850-01 from the National Institutes of Health.	Baker L, 2013, HEALTH AFFAIR, V32, P1583, DOI 10.1377/hlthaff.2013.0309; Bloche MG, 2006, NEW ENGL J MED, V355, P1756, DOI 10.1056/NEJMp068127; Claxton G, 2013, HEALTH AFFAIR, V32, P1667, DOI 10.1377/hlthaff.2013.0644; Claxton Gary, 2013, EMPLOYER HLTH BENEFI; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Government Accountability Office, 2011, HLTH CAR PRIC TRANSP; Hostetter M, 2012, HLTH CARE PRICE TRAN; Hsia RY, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004017; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Massachusetts Division of Health Care Finance and Policy, 2011, MASS HLTH CAR COST T; Mehrotra A, 2012, HEALTH AFFAIR, V31, P843, DOI 10.1377/hlthaff.2011.1181; Phillips K, 2014, HLTH AFFAIRS; Reed M, 2009, HEALTH AFFAIR, V28, P1145, DOI 10.1377/hlthaff.28.4.1145; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; Robinson JC, 2011, HEALTH SERV RES, V46, P1928, DOI 10.1111/j.1475-6773.2011.01288.x; Rosenthal JA, 2013, JAMA INTERN MED, V173, P427, DOI 10.1001/jamainternmed.2013.460; Sood Neeraj, 2013, FORUM HLTH EC POLICY, V16	17	73	73	2	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1670	1676		10.1001/jama.2014.13373	http://dx.doi.org/10.1001/jama.2014.13373			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR0YF	25335149	Bronze			2022-12-28	WOS:000343301400024
J	Bottos, A; Hynes, NE				Bottos, Alessia; Hynes, Nancy E.			CANCER Staying together on the road to metastasis	NATURE			English	Editorial Material							CIRCULATING TUMOR-CELLS		[Bottos, Alessia; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Bottos, A (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	alessia.bottos@fmi.ch; nancy.hynes@fmi.ch						Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aktary Zackie, 2012, Int J Cell Biol, V2012, P189521, DOI 10.1155/2012/189521; Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Hakimelahi S, 2000, J BIOL CHEM, V275, P10905, DOI 10.1074/jbc.275.15.10905; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	11	25	28	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					309	310		10.1038/514309a	http://dx.doi.org/10.1038/514309a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318518				2022-12-28	WOS:000342988600036
J	Kalil, AC; Van Schooneveld, TC; Fey, PD; Rupp, ME				Kalil, Andre C.; Van Schooneveld, Trevor C.; Fey, Paul D.; Rupp, Mark E.			Association Between Vancomycin Minimum Inhibitory Concentration and Mortality Among Patients With Staphylococcus aureus Bloodstream Infections A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MIC CREEP; CLINICAL-FEATURES; SUSCEPTIBILITY TRENDS; TREATMENT OUTCOMES; TREATMENT FAILURE; BACTEREMIA; PREVALENCE; IMPACT; HETERORESISTANCE; ENDOCARDITIS	IMPORTANCE Staphylococcus aureus bacteremia (SAB) is a worldwide problem. It is unclear whether higher-vancomycin minimum inhibitory concentration (MIC) is associated with mortality. This potential association has direct consequences for patients and public health. DATA SOURCES PubMed, Embase, the Cochrane Library, Evidence-based Medicine BMJ, and the American College of Physicians Journal Club were searched from inception through April 2014. STUDY SELECTION Studies reporting mortality and vancomycin MIC in patients with SAB were included. DATA EXTRACTION AND SYNTHESIS Two authors performed the literature search and the study selection separately. Random-effects modeling was used for all analyses. MAIN OUTCOMES AND MEASURES All-cause mortality. FINDINGS Among 38 included studies that involved 8291 episodes of SAB, overall mortality was 26.1%. The estimated mortality was 26.8% among SAB episodes (n = 2740) in patients with high-vancomycin MIC (>= 1.5mg/L) compared with 25.8% mortality among SAB episodes (n = 5551) in patients with low-vancomycin MIC (<1.5mg/L) (adjusted risk difference [RD], 1.6%[95% CI, -2.3% to 5.6%]; P = .43). For the highest-quality studies, the estimated mortality was 26.2% among SAB episodes (n = 2318) in patients with high-vancomycin MIC compared with 27.8% mortality among SAB episodes (n = 4168) in patients with low-vancomycin MIC (RD, 0.9%[95% CI, -2.9% to 4.6%]; P = .65). In studies that included only methicillin-resistant S aureus infections (n = 7232), the mortality among SAB episodes (n = 2384) in patients with high-vancomycin MIC was 27.6% compared with mortality of 27.4% among SAB episodes (n = 4848) in patients with low-vancomycin MIC (adjusted RD, 1.6%[95% CI, -2.3% to 5.5%]; P = .41). No significant differences in risk of death were observed in subgroups with high-vancomycin MIC vs low-vancomycin MIC values across different study designs, microbiological susceptibility assays, MIC cutoffs, clinical outcomes, duration of bacteremia, previous vancomycin exposure, and treatment with vancomycin. CONCLUSIONS AND RELEVANCE In this meta-analysis of SAB episodes, there were no statistically significant differences in the risk of death when comparing patients with S aureus exhibiting high-vancomycin MIC (>= 1.5mg/L) to those with low-vancomycin MIC (<1.5mg/L), although the findings cannot definitely exclude an increased mortality risk. These findings should be considered when interpreting vancomycin susceptibility and in determining whether alternative antistaphylococcal agents are necessary for patients with SAB with elevated but susceptible vancomycin MIC values. Copyright 2014 American Medical Association. All rights reserved.	[Kalil, Andre C.; Van Schooneveld, Trevor C.; Rupp, Mark E.] Univ Nebraska Med Ctr, Dept Internal Med, Div Infect Dis, Omaha, NE 68198 USA; [Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Infect Dis, 985400 Nebraska Med Ctr, Omaha, NE 68198 USA.	akalil@unmc.edu		Van Schooneveld, Trevor/0000-0002-9928-4546	Cubist; ViroPharma; Actelion; Biofire; 3M; Magnolia; Molnlycke	Cubist; ViroPharma; Actelion; Biofire; 3M(3M); Magnolia; Molnlycke	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Van Schooneveld reports receipt of research grants from Cubist, ViroPharma, and Actelion in the form of contracts to the University of Nebraska Medical Center. Dr Fey reports receipt of research grants from Biofire in the form of contracts to the University of Nebraska Medical Center. Dr Rupp reports receipt of research grants from 3M, Magnolia, and Molnlycke in the form of contracts to the University of Nebraska Medical Center, and advisory board and consultant honoraria from 3M, Bard, Molnlycke, Artise, Trius. No other disclosures were reported.	Aguado Jose Maria, 2011, Emerg Infect Dis, V17, P1099, DOI 10.3201/eid/1706.101037; [Anonymous], 2009, PRISMA STATEMENT PLO, DOI [DOI 10.1136/BMJ.B2535, 10.1136/bmj.b2535]; Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; Barnett AG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003587; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borenstein M., 2009, INTRO METAANALYSIS; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Cameron DR, 2012, J INFECT DIS, V205, P1677, DOI 10.1093/infdis/jis252; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Chen SY, 2012, CLIN INFECT DIS, V55, P1329, DOI 10.1093/cid/cis717; Clemens EC, 2011, DIAGN MICR INFEC DIS, V71, P408, DOI 10.1016/j.diagmicrobio.2011.08.002; Clinical and Laboratory Standards Institute, M100S23 CLIN LAB STA; de Sanctis JT, 2011, DIAGN MOL PATHOL, V20, P184, DOI 10.1097/PDM.0b013e318208fc47; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards B, 2012, J CLIN MICROBIOL, V50, P318, DOI 10.1128/JCM.05520-11; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in europe, 2012, ANN REP EUR ANT RES; Fong RKC, 2009, EUR J CLIN MICROBIOL, V28, P983, DOI 10.1007/s10096-009-0741-5; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Gasch O, 2013, CLIN MICROBIOL INFEC, V19, P1049, DOI 10.1111/1469-0691.12108; Han JH, 2012, ANTIMICROB AGENTS CH, V56, P5164, DOI 10.1128/AAC.00757-12; Holmes NE, 2011, J INFECT DIS, V204, P340, DOI 10.1093/infdis/jir270; Honda H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-335; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; Jacob JT, 2013, INT J INFECT DIS, V17, pE93, DOI 10.1016/j.ijid.2012.08.005; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Kan LP, 2014, J MICROBIOL IMMUNOL, V47, P15, DOI 10.1016/j.jmii.2012.08.015; Khatib R, 2011, J ANTIMICROB CHEMOTH, V66, P1594, DOI 10.1093/jac/dkr169; Lalueza A, 2010, J INFECT DIS, V201, P311, DOI 10.1086/649572; Lewis T, 2011, INT J INFECT DIS, V15, pE131, DOI 10.1016/j.ijid.2010.09.013; Liao CH, 2008, INT J ANTIMICROB AG, V32, P326, DOI 10.1016/j.ijantimicag.2008.04.011; Lin SH, 2010, J ANTIMICROB CHEMOTH, V65, P1792, DOI 10.1093/jac/dkq188; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Ludwig F, 2012, J CLIN MICROBIOL, V50, P3383, DOI 10.1128/JCM.01158-12; Maor Y, 2007, J CLIN MICROBIOL, V45, P1511, DOI 10.1128/JCM.01262-06; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; Mavros MN, 2012, INT J ANTIMICROB AG, V40, P496, DOI 10.1016/j.ijantimicag.2012.07.023; Miller CE, 2012, CLIN INFECT DIS, V54, P591, DOI 10.1093/cid/cir858; Moore CL, 2010, J CLIN MICROBIOL, V48, P2307, DOI 10.1128/JCM.00409-10; Mulrow CD, 1998, SYSTEMATIC REV SYNTH; Musta AC, 2009, J CLIN MICROBIOL, V47, P1640, DOI 10.1128/JCM.02135-08; Neoh Hui-min, 2007, Ann Clin Microbiol Antimicrob, V6, P13, DOI 10.1186/1476-0711-6-13; Neuner EA, 2010, DIAGN MICR INFEC DIS, V67, P228, DOI 10.1016/j.diagmicrobio.2010.02.026; Patel N, 2011, CLIN INFECT DIS, V52, P969, DOI 10.1093/cid/cir078; Pitz AM, 2011, J CLIN MICROBIOL, V49, P269, DOI 10.1128/JCM.00914-10; Price J, 2009, CLIN INFECT DIS, V48, P997, DOI 10.1086/597359; Roberts JA, 2011, ANTIMICROB AGENTS CH, V55, P2704, DOI 10.1128/AAC.01708-10; Rojas L, 2012, J ANTIMICROB CHEMOTH, V67, P1760, DOI 10.1093/jac/dks128; Schwaber MJ, 2003, EMERG INFECT DIS, V9, P657; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093/jac/dkm258; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takesue Y, 2011, J INFECT CHEMOTHER, V17, P52, DOI 10.1007/s10156-010-0086-0; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021217; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Walraven CJ, 2011, J ANTIMICROB CHEMOTH, V66, P2386, DOI 10.1093/jac/dkr301; Wang JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-159; Wells G., NEWCASTLE OTTAWA SCA; Yeh YC, 2012, J MICROBIOL IMMUNOL, V45, P214, DOI 10.1016/j.jmii.2011.11.006; Yoon YK, 2014, ANTIMICROB AGENTS CH, V58, P317, DOI 10.1128/AAC.00520-13; Ziakas PD, 2014, CRIT CARE MED, V42, P433, DOI 10.1097/CCM.0b013e3182a66bb8	65	127	129	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1552	1564		10.1001/jama.2014.6364	http://dx.doi.org/10.1001/jama.2014.6364			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321910				2022-12-28	WOS:000342983200020
J	Ruskov, R; Tahan, C				Ruskov, Rusko; Tahan, Charles			Catching the quantum sound wave	SCIENCE			English	Editorial Material							RESONANCE FLUORESCENCE		[Ruskov, Rusko; Tahan, Charles] Lab Phys Sci, College Pk, MD 20740 USA		Ruskov, R (corresponding author), Lab Phys Sci, College Pk, MD 20740 USA.	charlie@tahan.com	Ruskov, Rusko/AAB-9063-2022					Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Eichenfield M, 2009, NATURE, V462, P78, DOI 10.1038/nature08524; Gustafsson MV, 2014, SCIENCE, V346, P207, DOI 10.1126/science.1257219; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; LaHaye MD, 2009, NATURE, V459, P960, DOI 10.1038/nature08093; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Rabl P, 2010, NAT PHYS, V6, P602, DOI 10.1038/NPHYS1679; Ruskov R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064308; Soykal OO, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.235502	11	2	2	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					165	166		10.1126/science.1260180	http://dx.doi.org/10.1126/science.1260180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301603				2022-12-28	WOS:000342721500020
J	Pagliuca, FW; Millman, JR; Gurtler, M; Segel, M; Van Dervort, A; Ryu, JH; Peterson, QP; Greiner, D; Melton, DA				Pagliuca, Felicia W.; Millman, Jeffrey R.; Guertler, Mads; Segel, Michael; Van Dervort, Alana; Ryu, Jennifer Hyoje; Peterson, Quinn P.; Greiner, Dale; Melton, Douglas A.			Generation of Functional Human Pancreatic beta Cells In Vitro	CELL			English	Article							EMBRYONIC STEM-CELLS; INSULIN-SECRETION; DIFFERENTIATION; ISLETS; ENDODERM; MATURATION; MODELS; MICE; PROGENITORS; EXPRESSION	The generation of insulin-producing pancreatic beta cells from stem cells in vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes. However, insulin-producing cells previously generated from human pluripotent stem cells (hPSC) lack many functional characteristics of bona fide beta cells. Here, we report a scalable differentiation protocol that can generate hundreds of millions of glucose-responsive beta cells from hPSC in vitro. These stem-cell-derived beta cells (SC-beta) express markers found in mature beta cells, flux Ca2+ in response to glucose, package insulin into secretory granules, and secrete quantities of insulin comparable to adult beta cells in response to multiple sequential glucose challenges in vitro. Furthermore, these cells secrete human insulin into the serum of mice shortly after transplantation in a glucose-regulated manner, and transplantation of these cells ameliorates hyperglycemia in diabetic mice.	[Pagliuca, Felicia W.; Millman, Jeffrey R.; Guertler, Mads; Segel, Michael; Van Dervort, Alana; Ryu, Jennifer Hyoje; Peterson, Quinn P.; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Greiner, Dale] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA	Harvard University; University of Massachusetts System; University of Massachusetts Worcester	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Segel, Michael/0000-0001-8986-7417; Peterson, Quinn/0000-0001-8701-0575; Alter, Isaac/0000-0002-0253-2161; Millman, Jeffrey/0000-0003-0426-3492	Harvard Stem Cell Institute; Juvenile Diabetes Research Foundation; NIH; Helmsley Charitable Trust; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089572, UC4DK104218] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Chunhui Xie, Eliza Scadden, and Isaac Alter for excellent technical assistance; Maria Ericsson, Elizabeth Benecchi, and Louise Trakimas from the HMS Conventional Electron Microscopy Facility for assistance with electron microscopy; and Dena Cohen, Jeffrey Davis, Adam Roose, Barak Blum, and the Greiner and BetaLogics laboratories for helpful discussions. We also thank the members of the Harvard Stem Cell Institute Histology Core and Flow Cytometry Core facilities for invaluable assistance. The NRG-Akita mice were generously provided by Dr. Leonard Shultz. J.R.M. was supported by a fellowship from the Harvard Stem Cell Institute. Q.P.P. was supported by a fellowship from the Juvenile Diabetes Research Foundation. D.A.M. is an Investigator of the Howard Hughes Medical Institute. This work was supported by grants from the Harvard Stem Cell Institute, NIH, Helmsley Charitable Trust, the JPB Foundation and the generosity of M. and A. Barry. D.G. is a consultant for The Jackson Laboratory.	Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DECONINCK JF, 1971, DIABETOLOGIA, V7, P266, DOI 10.1007/BF01211879; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Fujita Y, 2011, ISLETS, V3, P1, DOI 10.4161/isl.3.1.14131; GAMER LW, 1995, DEV BIOL, V171, P240, DOI 10.1006/dbio.1995.1275; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Henry GL, 1998, SCIENCE, V281, P91, DOI 10.1126/science.281.5373.91; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim SK, 2000, GENE DEV, V14, P1866; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LIKE AA, 1972, DIABETES, V21, P511, DOI 10.2337/diab.21.2.S511; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Mohammed JS, 2009, LAB CHIP, V9, P97, DOI 10.1039/b809590f; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Narayanan K, 2014, TISSUE ENG PT A, V20, P424, DOI [10.1089/ten.tea.2013.0257, 10.1089/ten.TEA.2013.0257]; Ninomiya H, 1999, DEV GROWTH DIFFER, V41, P391; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rutter GA, 2013, MOL ENDOCRINOL, V27, P1984, DOI 10.1210/me.2013-1278; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Thowfeequ S, 2007, DIABETOLOGIA, V50, P1688, DOI 10.1007/s00125-007-0724-y; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	44	1220	1314	7	380	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					428	439		10.1016/j.cell.2014.09.040	http://dx.doi.org/10.1016/j.cell.2014.09.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303535	Green Accepted, Bronze			2022-12-28	WOS:000343095600022
J	Belshe, RB; Frey, SE; Graham, IL; Anderson, EL; Jackson, LA; Spearman, P; Edupuganti, S; Mulligan, MJ; Rouphael, N; Winokur, P; Dolor, RJ; Woods, CW; Walter, EB; Chen, WH; Turley, C; Edwards, KM; Creech, CB; Hill, H; Bellamy, AR				Belshe, Robert B.; Frey, Sharon E.; Graham, Irene L.; Anderson, Edwin L.; Jackson, Lisa A.; Spearman, Paul; Edupuganti, Srilatha; Mulligan, Mark J.; Rouphael, Nadine; Winokur, Patricia; Dolor, Rowena J.; Woods, Christopher W.; Walter, Emmanuel B.; Chen, Wilbur H.; Turley, Christine; Edwards, Kathryn M.; Creech, C. Buddy; Hill, Heather; Bellamy, Abbie R.		Natl Inst Allergy Infect Dis; Funded Vaccine and Treatment Evalu	Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SAFETY	IMPORTANCE The need to respond quickly to potential influenza pandemics is important. Immunologic priming (initial presentation of an antigen to allow antibody responses on revaccination) with vaccine directed toward an older avian influenza H5 strain might lead to secondary antibody responses to a single dose of more current H5 avian influenza vaccine. OBJECTIVES To assess priming with the older avian influenza A/Vietnam/1203/2004(H5N1) (Vietnam) vaccine and to conduct dose-response studies with vaccine directed against the more contemporary H5N1 avian influenza virus, influenza A/Anhui/01/2005 (Anhui). DESIGN, SETTING, AND PARTICIPANTS Multicenter US randomized clinical trial beginning in June 2010 with follow-up continuing through October 2011 enrolling 72 healthy adults who were vaccinated 1 year previously with the Vietnam vaccine and 565 vaccine-naive adults. INTERVENTIONS Participants who were previously vaccinated with 90 mu g of unadjuvanted Vietnam vaccine were randomly assigned to receive 3.75 mu g of avian influenza Anhui vaccine with or without MF59 adjuvant, stratified by 1 vs 2 previous doses (1 dose: n = 18 with MF59 and n = 17 without; 2 doses: n = 19 with MF59 and n = 18 without). Vaccine-naive individuals were randomly assigned to receive Ahnui vaccine with or without MF59 adjuvant in 1 of 5 doses (3.75 mu g [n = 55 with MF59 and n = 59 without], 7.5 mu g [n = 51 with MF59 and n = 57 without], 15 mu g [n = 48 with MF59 and n = 44 without], 45 mu g [n = 47 with MF59 and n = 47 without], or 90 mu g [n = 57 without adjuvant]) or placebo (n = 100) given at days 0 and 28. MAIN OUTCOMES AND MEASURES The primary immunogenicity outcome was hemagglutination inhibition assay (HAI) titer against each vaccine antigen 1 month (day 28) and 6 months (day 180) after last vaccination. The primary safety outcomes were local and systemic adverse events on days 0 to 7 after each vaccination and serious adverse events. RESULTS Previously vaccinated participants manifested secondary antibody responses after receipt of low-dose Anhui vaccine ("boosting"); by day 28, 21% to 50% developed HAI responses of 1: 40 or greater. Use of adjuvant was not associated with increased HAI responses. Among vaccine-naive participants (n = 565), the optimum dose was 7.5 mu g of antigen with adjuvant (geometric mean titer [GMT], 63.3; 95% CI, 43.0-93.1). The greatest response to unadjuvanted antigen was seen at the highest dose, 90 mu g (GMT, 28.5; 95% CI, 19.7-41.2). Local or systemic reactions occurred, respectively, in 40 (78%) and 25 (49%) of 51 participants who received 7.5 mu g plus adjuvant vs 50 (88%) and 29 (51%) of 57 who received 90 mu g of unadjuvanted vaccine. In general, antibodies were short-lived, and by day 180, HAI titers had decreased to less than 1: 20 in all treatment groups. CONCLUSIONS AND RELEVANCE Previous receipt of a single dose of influenza A(H5N1) Vietnam vaccine was associated with sufficient immunologic priming to facilitate antibody response to a different H5N1 antigen using low-dose Anhui (booster) vaccine. In participants who had not previously received H5 vaccine, low-dose Anhui vaccine plus adjuvant was more immunogenic compared with higher doses of unadjuvanted vaccine.	[Belshe, Robert B.; Frey, Sharon E.; Graham, Irene L.; Anderson, Edwin L.] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63104 USA; [Jackson, Lisa A.] Grp Hlth Res Inst, Seattle, WA USA; [Spearman, Paul] Emory Childrens Ctr, Atlanta, GA USA; [Edupuganti, Srilatha; Mulligan, Mark J.; Rouphael, Nadine] Emory Univ, Hope Clin, Atlanta, GA 30322 USA; [Winokur, Patricia] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Dolor, Rowena J.; Woods, Christopher W.; Walter, Emmanuel B.] Duke Univ, Sch Med, Duke Clin Vaccine Unit, Durham, NC USA; [Chen, Wilbur H.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Turley, Christine] Univ Texas Med Branch, Galveston, TX 77555 USA; [Edwards, Kathryn M.; Creech, C. Buddy] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Res Program, Nashville, TN USA; [Hill, Heather; Bellamy, Abbie R.] EMMES Corp, Rockville, MD USA	Saint Louis University; Emory University; University of Iowa; Duke University; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Medical Branch Galveston; Vanderbilt University; Emmes Corporation	Belshe, RB (corresponding author), St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, 1100 S Grand Blvd,DRC 8, St Louis, MO 63104 USA.	belsherb@slu.edu	Mulligan, Mark/V-9275-2019	Winokur, Patricia/0000-0002-4826-1790; Dolor, Rowena/0000-0001-7317-9468; Rouphael, Nadine/0000-0002-2512-7919	National Institutes of Health under NIAID [HHSN272200800003C, HHSN2722008800004C, HHSN272200800005C, HHSN272200800008C, HHSN272200800001C, N01AI800002, HHSN272200800007C, HHSN272200800013C]	National Institutes of Health under NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institutes of Health under NIAID-Funded Vaccine and Treatment Evaluation Unit contracts HHSN272200800003C (Saint Louis University), HHSN2722008800004C (Group Health Research Institute), HHSN272200800005C (Emory University), HHSN272200800008C (University of Iowa), HHSN272200800001C (University of Maryland), N01AI800002 (Baylor University), HHSN272200800007C (Vanderbilt University), and HHSN272200800013C (EMMES Corporation).	Belshe RB, 2011, J INFECT DIS, V203, P666, DOI 10.1093/infdis/jiq093; Department of Health and Human Services, INFL VACC ADJ STOCKP; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Tsai TF, 2013, INFECT CHEMOTHER, V45, P159, DOI 10.3947/ic.2013.45.2.159; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; US Food and Drug Administration, SAN PAST INFL VIR VA; Zangwill KM, 2008, J INFECT DIS, V197, P580, DOI 10.1086/526537	14	42	42	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1420	1428		10.1001/jama.2014.12609	http://dx.doi.org/10.1001/jama.2014.12609			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291578				2022-12-28	WOS:000342630200018
J	Ladapo, JA; Blecker, S; Douglas, PS				Ladapo, Joseph A.; Blecker, Saul; Douglas, Pamela S.			Physician Decision Making and Trends in the Use of Cardiac Stress Testing in the United States An Analysis of Repeated Cross-sectional Data	ANNALS OF INTERNAL MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; GENDER-DIFFERENCES; TEMPORAL TRENDS; HEART-DISEASE; APPROPRIATENESS CRITERIA; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; AMERICAN SOCIETY; CORONARY; ANGIOGRAPHY	Background: Cardiac stress testing, particularly with imaging, has been the focus of debates about rising health care costs, inappropriate use, and patient safety in the context of radiation exposure. Objective: To determine whether U. S. trends in cardiac stress test use may be attributable to population shifts in demographics, risk factors, and provider characteristics and evaluate whether racial/ethnic disparities exist in physician decision making. Design: Analyses of repeated cross-sectional data. Setting: National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey (1993 to 2010). Patients: Adults without coronary heart disease. Measurements: Cardiac stress test referrals and inappropriate use. Results: Between 1993 to 1995 and 2008 to 2010, the annual number of U. S. ambulatory visits in which a cardiac stress test was ordered or performed increased from 28 per 10 000 visits to 45 per 10 000 visits. No trend was found toward more frequent testing after adjustment for patient characteristics, risk factors, and provider characteristics (P = 0.134). Cardiac stress tests with imaging comprised a growing portion of all tests, increasing from 59% in 1993 to 1995 to 87% in 2008 to 2010. At least 34.6% were probably inappropriate, with associated annual costs and harms of $501 million and 491 future cases of cancer. Authors found no evidence of a lower likelihood of black patients receiving a cardiac stress test (odds ratio, 0.91 [95% CI, 0.69 to 1.21]) than white patients, although some evidence of disparity in Hispanic patients was found (odds ratio, 0.75 [CI, 0.55 to 1.02]). Limitation: Cross-sectional design with limited clinical data. Conclusion: National growth in cardiac stress test use can largely be explained by population and provider characteristics, but use of imaging cannot. Physician decision making about cardiac stress test use does not seem to contribute to racial/ethnic disparities in cardiovascular disease.	NYU, Sch Med, New York, NY 10016 USA; Duke Univ, Sch Med, Durham, NC 27715 USA	New York University; Duke University	Ladapo, JA (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,VZ30 6th Floor,Room 614, New York, NY 10016 USA.	joseph.ladapo@nyumc.org		Ladapo, Joseph/0000-0002-8518-4800; Douglas, Pamela/0000-0001-9876-4049	National Heart, Lung, and Blood Institute; National Center for Advancing Translational Sciences; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000053] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116787] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Heart, Lung, and Blood Institute and the National Center for Advancing Translational Sciences.	American Academy of Family Physicians ABIM Foundation, 2012, CHOOS WIS EKGS EX ST; American College of Cardiology ABIM Foundation, 2013, CHOOS WIS IM TESTS H; American College of Physicians ABIM Foundation, 2012, CHOOS WIS STRESS TES; American Society of Nuclear Cardiology ABIM Foundation, 2012, CHOOS WIS STRESS TES; Andrus BW, 2012, CIRC-CARDIOVASC QUAL, V5, P31, DOI 10.1161/CIRCOUTCOMES.111.961813; [Anonymous], 2014, ACR APPR CRIT; [Anonymous], 2009, ECHOC MARK GUID US S; [Anonymous], 2007, MYOC PERF IM MARK S; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Brenner DJ, 2010, NEW ENGL J MED, V362, P943, DOI 10.1056/NEJMe1000802; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Centers for Disease Control and Prevention, 2014, HLTH PEOPL HLTH PEOP; Chang AM, 2007, ACAD EMERG MED, V14, P599, DOI 10.1197/j.aem.2007.03.1355; Cohen MC, 1999, AM HEART J, V138, P1019, DOI 10.1016/S0002-8703(99)70065-7; de Gonzalez AB, 2010, CIRCULATION, V122, P2403, DOI 10.1161/CIRCULATIONAHA.110.941625; Einstein AJ, 2010, JAMA-J AM MED ASSOC, V304, P2137, DOI 10.1001/jama.2010.1664; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Gibbons RJ, 2008, J AM COLL CARDIOL, V51, P1283, DOI 10.1016/j.jacc.2007.10.064; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; HSIAO WC, 1988, JAMA-J AM MED ASSOC, V260, P2347, DOI 10.1001/jama.260.16.2347; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Ladapo JA, 2008, AM J ROENTGENOL, V191, P455, DOI 10.2214/AJR.07.3611; Ladapo JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000505; Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012; Lauer MS, 1996, AM J CARDIOL, V78, P278, DOI 10.1016/S0002-9149(96)00277-9; Levin DC, 2011, AM J ROENTGENOL, V196, pW25, DOI 10.2214/AJR.10.4835; Lillie-Blanton M, 2004, J AM COLL CARDIOL, V44, P503, DOI 10.1016/j.jacc.2004.04.043; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Miller TD, 2001, J AM COLL CARDIOL, V38, P690, DOI 10.1016/S0735-1097(01)01413-9; National Center for Health Statistics, 2013, AMB HLTH CAR DAT REL; National Center for Health Statistics, 2009, 2009 NAMCS PUBL US D; National Center for Health Statistics, 2013, AMB HLTH CAR DAT QUE; Nelson K, 2002, ARCH INTERN MED, V162, P929, DOI 10.1001/archinte.162.8.929; Rao VM, 2012, ANN INTERN MED, V157, P574, DOI 10.7326/0003-4819-157-8-201210160-00535; Roger VL, 1998, J AM COLL CARDIOL, V32, P345, DOI 10.1016/S0735-1097(98)00229-0; Rozanski A, 2013, J AM COLL CARDIOL, V61, P1054, DOI 10.1016/j.jacc.2012.11.056; Shaw LJ, 2010, JACC-CARDIOVASC IMAG, V3, P789, DOI 10.1016/j.jcmg.2010.05.004; Shaw LJ, 2005, EUR HEART J, V26, P447, DOI 10.1093/eurheartj/ehi102; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Will JC, 2014, CIRC-CARDIOVASC QUAL, V7, P110, DOI 10.1161/CIRCOUTCOMES.113.000450; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009	45	113	114	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					482	+		10.7326/M14-0296	http://dx.doi.org/10.7326/M14-0296			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25285541	Green Accepted			2022-12-28	WOS:000343896700007
J	Edmond, MB; Diekema, DJ; Perencevich, EN				Edmond, Michael B.; Diekema, Daniel J.; Perencevich, Eli N.			Ebola Virus Disease and the Need for New Personal Protective Equipment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Edmond, Michael B.; Diekema, Daniel J.; Perencevich, Eli N.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Perencevich, Eli N.] Iowa City VA Hlth Syst, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Edmond, MB (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, C512 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	michael-edmond@uiowa.edu		Edmond, Michael/0000-0002-4144-8974; Diekema, Daniel/0000-0003-1273-0724; Perencevich, Eli/0000-0002-3721-3355				[Anonymous], FIGHT EB GRAND CHALL; [Anonymous], VOM LARR VIS CONT; Centers for Disease Control and Prevention, REV HUM TO HUM TRANS; Centers for Disease Control and Prevention, GUID PERS PROT EQ US; del Rio C, 2014, ANN INTERN MED, V161, P746, DOI 10.7326/M14-1880; Kwon S, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-5; Morgan DJ, 2012, CRIT CARE MED, V40, P1045, DOI 10.1097/CCM.0b013e31823bc7c8; Morgan DJ, 2010, INFECT CONT HOSP EP, V31, P716, DOI 10.1086/653201; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004	9	25	27	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2495	2496		10.1001/jama.2014.15497	http://dx.doi.org/10.1001/jama.2014.15497			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25350321				2022-12-28	WOS:000346346900007
J	Gerber, JS; Prasad, PA; Fiks, AG; Localio, AR; Bell, L; Keren, R; Zaoutis, TE				Gerber, Jeffrey S.; Prasad, Priya A.; Fiks, Alexander G.; Localio, A. Russell; Bell, LouisM.; Keren, Ron; Zaoutis, Theoklis E.			Durability of Benefits of an Outpatient Antimicrobial Stewardship Intervention After Discontinuation of Audit and Feedback	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Gerber, Jeffrey S.; Prasad, Priya A.; Zaoutis, Theoklis E.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Fiks, Alexander G.; Bell, LouisM.; Keren, Ron] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Localio, A. Russell] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Gerber, JS (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 3535 Market St,Ste 1518, Philadelphia, PA 19104 USA.	gerberj@email.chop.edu	Gerber, Jeffrey/GYD-3567-2022	Gerber, Jeffrey/0000-0002-3076-3186	PHS HHS [HHSA2900200710013] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337	6	94	95	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2569	2570		10.1001/jama.2014.14042	http://dx.doi.org/10.1001/jama.2014.14042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25317759	Bronze			2022-12-28	WOS:000346346900022
J	Martel, A; Blooi, M; Adriaensen, C; Van Rooij, P; Beukema, W; Fisher, MC; Farrer, RA; Schmidt, BR; Tobler, U; Goka, K; Lips, KR; Muletz, C; Zamudio, KR; Bosch, J; Lotters, S; Wombwell, E; Garner, TWJ; Cunningham, AA; Spitzen-van der Sluijs, A; Salvidio, S; Ducatelle, R; Nishikawa, K; Nguyen, TT; Kolby, JE; Van Bocxlaer, I; Bossuyt, F; Pasmans, F				Martel, A.; Blooi, M.; Adriaensen, C.; Van Rooij, P.; Beukema, W.; Fisher, M. C.; Farrer, R. A.; Schmidt, B. R.; Tobler, U.; Goka, K.; Lips, K. R.; Muletz, C.; Zamudio, K. R.; Bosch, J.; Loetters, S.; Wombwell, E.; Garner, T. W. J.; Cunningham, A. A.; Spitzen-van der Sluijs, A.; Salvidio, S.; Ducatelle, R.; Nishikawa, K.; Nguyen, T. T.; Kolby, J. E.; Van Bocxlaer, I.; Bossuyt, F.; Pasmans, F.			Recent introduction of a chytrid fungus endangers Western Palearctic salamanders	SCIENCE			English	Article							BATRACHOCHYTRIUM-SALAMANDRIVORANS; DENDROBATIDIS; AMPHIBIANS; EXTINCTION	Emerging infectious diseases are reducing biodiversity on a global scale. Recently, the emergence of the chytrid fungus Batrachochytrium salamandrivorans resulted in rapid declines in populations of European fire salamanders. Here, we screened more than 5000 amphibians from across four continents and combined experimental assessment of pathogenicity with phylogenetic methods to estimate the threat that this infection poses to amphibian diversity. Results show that B. salamandrivorans is restricted to, but highly pathogenic for, salamanders and newts (Urodela). The pathogen likely originated and remained in coexistence with a clade of salamander hosts for millions of years in Asia. As a result of globalization and lack of biosecurity, it has recently been introduced into naive European amphibian populations, where it is currently causing biodiversity loss.	[Martel, A.; Blooi, M.; Adriaensen, C.; Van Rooij, P.; Ducatelle, R.; Pasmans, F.] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, B-9820 Merelbeke, Belgium; [Blooi, M.] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Beukema, W.] Univ Porto, Inst Ciencias Agr Vairao, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Fisher, M. C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Farrer, R. A.] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA 02142 USA; [Schmidt, B. R.; Tobler, U.] KARCH, CH-2000 Neuchatel, Switzerland; [Schmidt, B. R.; Tobler, U.] Univ Zurich, Inst Evolut Biol & Umweltwissensch, CH-8057 Zurich, Switzerland; [Goka, K.] Natl Inst Environm Studies, Invas Alien Species Res Team, Tsukuba, Ibaraki 3058506, Japan; [Lips, K. R.; Muletz, C.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Zamudio, K. R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Bosch, J.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Loetters, S.] Univ Trier, Biogeog Dept, D-54286 Trier, Germany; [Wombwell, E.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Wombwell, E.; Garner, T. W. J.; Cunningham, A. A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Spitzen-van der Sluijs, A.] Reptile Amphibian & Fish Conservat Netherlands RA, NL-6501 BK Nijmegen, Netherlands; [Salvidio, S.] Univ Genoa, Dept Earth Sci Environm & Life Di STAV, I-16132 Genoa, Italy; [Nishikawa, K.] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Nguyen, T. T.] Vietnam Acad Sci & Technol, Vietnam Natl Museum Nat, Hanoi, Vietnam; [Kolby, J. E.] James Cook Univ, Hlth Res Grp 1, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Van Bocxlaer, I.; Bossuyt, F.] Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, B-1050 Brussels, Belgium	Ghent University; Universidade do Porto; Imperial College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Zurich; National Institute for Environmental Studies - Japan; University System of Maryland; University of Maryland College Park; Cornell University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universitat Trier; University of Kent; Zoological Society of London; University of Genoa; Kyoto University; Vietnam Academy of Science & Technology (VAST); James Cook University; Vrije Universiteit Brussel	Martel, A (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	an.martel@ugent.be	Kolby, Jonathan/GWV-5557-2022; Kolby, Jonathan/GWZ-3092-2022; Schmidt, Benedikt R./B-8491-2008; Garner, Trenton WJ/D-6873-2011; Bosch, Jaime/H-3042-2011; Spitzen, Annemarieke/AAV-3970-2021; Beukema, Wouter/D-6365-2014; Cunningham, Andrew A/E-7536-2010; Zamudio, Kelly/R-3533-2016; Van Bocxlaer, Ines/L-4852-2015; Pasmans, Frank/D-3667-2014; Fisher, Matthew/B-9094-2011; Spitzen, Annemarieke/B-3453-2012; Muletz-Wolz, Carly/N-3816-2013	Schmidt, Benedikt R./0000-0002-4023-1001; Garner, Trenton WJ/0000-0002-0336-9706; Bosch, Jaime/0000-0002-0099-7934; Beukema, Wouter/0000-0002-5839-7683; Zamudio, Kelly/0000-0001-5107-6206; Fisher, Matthew/0000-0002-1862-6402; Farrer, Rhys/0000-0001-8456-7458; Adriaensen, Connie/0000-0002-1481-1635; Lips, Karen/0000-0002-2719-1551; Spitzen, Annemarieke/0000-0003-2008-9375; Bossuyt, Franky/0000-0001-6804-9271; Muletz-Wolz, Carly/0000-0001-5047-9601	Dutch Ministry of Economic Affairs; UK Department for Environment, Food and Rural Affairs [FC1195]; Royal Zoological Society of Antwerp; Ghent University Special Research Fund [BOF13/PDO/130]; Morris Animal Foundation [D12z0-002]; UK Natural Environment Research Council (NERC); Wellcome Trust; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich European Union of Aquarium Curators; Zurcher Tierschutz; Fundacion General CSIC; Banco Santander; Economic and Social Research Council (ESRC)-NERC Interdisciplinary Ph. D. studentship; Royal Society Wolfson research merit award; Ministry of Education, Science and Culture, Japan [20770066, 23770084]; Japan Society for the Promotion of Science (JSPS); JSPS RONPAKU program; European Research Council [204509]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Division Of Environmental Biology [1120161, 1120249] Funding Source: National Science Foundation; NERC [NE/K014455/1, NE/K012509/1] Funding Source: UKRI; Natural Environment Research Council [NE/K014455/1, NE/K012509/1] Funding Source: researchfish	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Royal Zoological Society of Antwerp; Ghent University Special Research Fund(Ghent University); Morris Animal Foundation; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich European Union of Aquarium Curators; Zurcher Tierschutz; Fundacion General CSIC; Banco Santander; Economic and Social Research Council (ESRC)-NERC Interdisciplinary Ph. D. studentship; Royal Society Wolfson research merit award(Royal Society of London); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS RONPAKU program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Schenkel and J. Beukema for providing samples and the National Museum of Natural History-Naturalis, Leiden, Netherlands, for providing museum specimens. We thank the many amphibian breeders (including S. Bogaerts, M. Sparreboom, H. Janssen, F. Maillet, A. Jamin, and S. Voitel) who provided offspring to conduct the infection experiments. Financial support was partly provided by the Dutch Ministry of Economic Affairs and by the UK Department for Environment, Food and Rural Affairs, project grant FC1195. M. B. is funded by a Dehousse grant from the Royal Zoological Society of Antwerp. P. V. R. is funded by Ghent University Special Research Fund (BOF13/PDO/130). F. P. and T. W. J. G. are funded by the Morris Animal Foundation (D12z0-002). M. C. F. and T. W. J. G. are funded by the UK Natural Environment Research Council (NERC). R. A. F. is supported by the Wellcome Trust. U. T. and B. R. S. are funded by the Vontobel Stiftung, Janggen-Pohn Stiftung, Basler Stiftung fur biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zurich, Grun Stadt Zurich European Union of Aquarium Curators, and Zurcher Tierschutz. J. B. is funded by Fundacion General CSIC and Banco Santander. E. W. is funded by Economic and Social Research Council (ESRC)-NERC Interdisciplinary Ph. D. studentship. A. A. C. is supported by a Royal Society Wolfson research merit award. K. N. is funded by grants from the Ministry of Education, Science and Culture, Japan (nos. 20770066 and 23770084) and Japan Society for the Promotion of Science (JSPS) AA Core-to-Core program Type B. Asia-Africa Science Platforms. T. T. N. is funded by the JSPS RONPAKU program. F. B. is supported by European Research Council Starting Grant 204509 [project Tracing Antimicrobial Peptides and Pheromones in the Amphibian Skin (TAPAS)]. I. V. B is supported by a postdoctoral Fellowship from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO). All data described in the paper are presented in the supplementary materials.	Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Herrel A, 2014, HERPETOL J, V24, P103; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Spitzen-Van der Sluijs A, 2014, CONSERV BIOL, V28, P1302, DOI 10.1111/cobi.12281; Spitzen-van der Sluijs A, 2013, AMPHIBIA-REPTILIA, V34, P233, DOI 10.1163/15685381-00002891; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	8	323	345	6	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		630	631		10.1126/science.1258268	http://dx.doi.org/10.1126/science.1258268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359973	Green Accepted, Green Published			2022-12-28	WOS:000343799700048
J	McInerney, NM; O'Shaughnessy, M; Clover, J				McInerney, Niall M.; O'Shaughnessy, Michael; Clover, James			PICTURE QUIZ A hand flexion contracture with progression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COLLAGENASE CLOSTRIDIUM-HISTOLYTICUM; PERCUTANEOUS NEEDLE FASCIOTOMY; DUPUYTRENS-DISEASE; SEGMENTAL APONEURECTOMY; LIMITED FASCIECTOMY; PREVALENCE; ALCOHOL; WORK		[McInerney, Niall M.; O'Shaughnessy, Michael; Clover, James] Cork Univ Hosp, Dept Plast & Reconstruct Surg, Cork, Ireland	University College Cork	McInerney, NM (corresponding author), Cork Univ Hosp, Dept Plast & Reconstruct Surg, Cork, Ireland.	nmac@ymail.com						ANDREW JG, 1991, J HAND SURG-BRIT EUR, V16B, P255, DOI 10.1016/0266-7681(91)90048-S; Atroshi I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004166; ATTALI P, 1987, ARCH INTERN MED, V147, P1065, DOI 10.1001/archinte.147.6.1065; Badalamente MA, 1996, J HAND SURG-AM, V21A, P210, DOI 10.1016/S0363-5023(96)80102-X; Betz N, 2010, STRAHLENTHER ONKOL, V186, P82, DOI 10.1007/s00066-010-2063-z; Burge P, 1997, J BONE JOINT SURG BR, V79B, P206, DOI 10.1302/0301-620X.79B2.6990; Coleman S, 2014, J HAND SURG-AM, V39, P57, DOI 10.1016/j.jhsa.2013.10.002; CRITCHLEY EMR, 1976, J NEUROL NEUROSUR PS, V39, P498, DOI 10.1136/jnnp.39.5.498; Descatha A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-96; ELLIOT D, 1988, J HAND SURG-BRIT EUR, V13B, P246, DOI 10.1016/0266-7681(88)90078-2; Gilpin D, 2010, J HAND SURG-AM, V35A, P2027, DOI 10.1016/j.jhsa.2010.08.007; Hovius SER, 2011, PLAST RECONSTR SURG, V128, P221, DOI 10.1097/PRS.0b013e31821741ba; Hueston JT., 1963, DUPUYTRENS CONTRACTU; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; Lanting R, 2014, PLAST RECONSTR SURG, V133, P593, DOI 10.1097/01.prs.0000438455.37604.0f; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; MCCASH C R, 1964, Br J Plast Surg, V17, P271, DOI 10.1016/S0007-1226(64)80043-6; MCFARLANE RM, 1991, J HAND SURG-AM, V16A, P775, DOI 10.1016/S0363-5023(10)80134-0; McFarlane RM, 1990, HAND UPPER LIMB SERI, V5, P360; Mehta S, 2014, J PLAST RECONSTR AES, V67, P368, DOI 10.1016/j.bjps.2013.12.030; MOERMANS JP, 1991, J HAND SURG-BRIT EUR, V16B, P243, DOI 10.1016/0266-7681(91)90047-R; Moermans JP, 1996, J HAND SURG-BRIT EUR, V21B, P797, DOI 10.1016/S0266-7681(96)80195-1; MURRELL GAC, 1991, J HAND SURG-BRIT EUR, V16B, P263, DOI 10.1016/0266-7681(91)90050-X; Ojwang JO, 2010, J HAND SURG-AM, V35A, P2039, DOI 10.1016/j.jhsa.2010.08.008; Peimer CA, 2013, J HAND SURG-AM, V38A, P12, DOI 10.1016/j.jhsa.2012.09.028; Rayan GM, 1999, HAND CLIN, V15, P87; RENARD E, 1994, DIABETES METAB, V20, P513; SMITH AC, 1991, HAND CLIN, V7, P635; Spillane AJ, 2000, ANN SURG ONCOL, V7, P218, DOI 10.1007/BF02523657; Turker T, 2013, J HAND SURG-AM, V38A, P2365, DOI 10.1016/j.jhsa.2013.08.122; van Rijssen AL, 2006, J HAND SURG-AM, V31A, P717, DOI 10.1016/j.jhsa.2006.02.021; van Rijssen AL, 2012, PLAST RECONSTR SURG, V129, P469, DOI 10.1097/PRS.0b013e31823aea95; VARIAN J P W, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P376, DOI 10.1016/S0753-9053(05)80513-7; Verhoekx JSN, 2013, PLAST RECONSTR SURG, V132, P1139, DOI 10.1097/PRS.0b013e3182a3bf2b; Werker PMN, 2012, J HAND SURG-AM, V37A, P2095, DOI 10.1016/j.jhsa.2012.06.032	36	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2014	349								g6137	10.1136/bmj.g6137	http://dx.doi.org/10.1136/bmj.g6137			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DI	25358591				2022-12-28	WOS:000344156100001
J	Stone, MB				Stone, Marc B.			The FDA Warning on Antidepressants and Suicidality - Why the Controversy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEPRESSION		US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Stone, MB (corresponding author), US FDA, Silver Spring, MD 20993 USA.		Stone, Marc/H-3223-2019					Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Schumock GT, 2011, DRUG HEALTHC PATIENT, V3, P47, DOI 10.2147/DHPS.S23665; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007	5	26	28	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1668	1671		10.1056/NEJMp1411138	http://dx.doi.org/10.1056/NEJMp1411138			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354102				2022-12-28	WOS:000343768500004
J	Ubil, E; Duan, J; Pillai, ICL; Rosa-Garrido, M; Wu, Y; Bargiacchi, F; Lu, Y; Stanbouly, S; Huang, J; Rojas, M; Vondriska, TM; Stefani, E; Deb, A				Ubil, Eric; Duan, Jinzhu; Pillai, Indulekha C. L.; Rosa-Garrido, Manuel; Wu, Yong; Bargiacchi, Francesca; Lu, Yan; Stanbouly, Seta; Huang, Jie; Rojas, Mauricio; Vondriska, Thomas M.; Stefani, Enrico; Deb, Arjun			Mesenchymal-endothelial transition contributes to cardiac neovascularization	NATURE			English	Article							ISCHEMIC-MYOCARDIUM; BONE-MARROW; CELLS; FIBROBLASTS; P53; REPAIR; MICROSCOPY; FIBROSIS; HYPOXIA; TISSUE	Endothelial cells contribute to a subset of cardiac fibroblasts by undergoing endothelial-to-mesenchymal transition, but whether cardiac fibroblasts can adopt an endothelial cell fate and directly contribute to neovascularization after cardiac injury is not known. Here, using genetic fate map techniques, we demonstrate that cardiac fibroblasts rapidly adopt an endothelial-cell-like phenotype after acute ischaemic cardiac injury. Fibroblast-derived endothelial cells exhibit anatomical and functional characteristics of native endothelial cells. We show that the transcription factor p53 regulates such a switch in cardiac fibroblast fate. Loss of p53 in cardiac fibroblasts severely decreases the formation of fibroblast-derived endothelial cells, reduces post-infarct vascular density and worsens cardiac function. Conversely, stimulation of the p53 pathway in cardiac fibroblasts augments mesenchymal-to-endothelial transition, enhances vascularity and improves cardiac function. These observations demonstrate that mesenchymal-to-endothelial transition contributes to neovascularization of the injured heart and represents a potential therapeutic target for enhancing cardiac repair.	[Ubil, Eric] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Rosa-Garrido, Manuel; Lu, Yan; Stanbouly, Seta; Huang, Jie; Vondriska, Thomas M.; Deb, Arjun] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Rosa-Garrido, Manuel; Lu, Yan; Stanbouly, Seta; Huang, Jie; Vondriska, Thomas M.; Stefani, Enrico; Deb, Arjun] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Deb, Arjun] Univ Calif Los Angeles, Eli & Edythe Broad Inst Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Deb, Arjun] Univ Calif Los Angeles, Coll Letters & Sci, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Deb, Arjun] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Vondriska, Thomas M.; Deb, Arjun] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Rosa-Garrido, Manuel; Wu, Yong; Vondriska, Thomas M.; Stefani, Enrico] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Rosa-Garrido, Manuel; Vondriska, Thomas M.; Stefani, Enrico] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Bargiacchi, Francesca] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rojas, Mauricio] Univ N Carolina, McAllister Heart Inst, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Deb, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA.	adeb@mednet.ucla.edu	Wu, Yong/E-9761-2014; Rosa-Garrido, Manuel/AAE-4188-2019; Pillai, Indulekha/P-8398-2014	Rosa-Garrido, Manuel/0000-0002-2169-3972; Pillai, Indulekha/0000-0002-5038-6031; Ubil, Eric/0000-0002-5112-464X	National Institutes of Health [NIH R01HL102190]; NIH [HL088640, HL105699]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102190, R01HL088640, R01HL105699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Michael Hooker Confocal Microscopy and the Histology Research Core facilities at UNC, Chapel Hill. We thank the confocal and advanced light microscopy facilities in the Division of Molecular Medicine and California Nanosystems Institute at UCLA, Histology facilities at Brain Research Institute & Pathology and Laboratory Medicine, UCLA, Broad Stem Cell Research Center UCLA flow cytometry laboratories and the Vector core facility at UCLA for technical assistance. We thank K. Caron, V. Bauch, J. Taylor, C. Otey at UNC, Chapel Hill and J. Lusis at UCLA for scientific suggestions and discussion. This work was supported by grants from the National Institutes of Health (NIH R01HL102190) to A. Deb. Super-resolution studies and ChIP studies were supported by NIH grant HL088640 to E. S. and NIH grant HL105699 to T. V. E. Ubil was supported in part by a pre-doctoral grant from the American Heart Association. This work was initiated when A. D. was at the University of North Carolina, Chapel Hill and completed at the University of California, Los Angeles.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Agocha AE, 1997, MOL CELL BIOCHEM, V172, P195, DOI 10.1023/A:1006848512174; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boudreau N, 1997, J CELL BIOL, V139, P257, DOI 10.1083/jcb.139.1.257; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Hasan NM, 1999, INT J CANCER, V80, P400, DOI 10.1002/(SICI)1097-0215(19990129)80:3<400::AID-IJC11>3.0.CO;2-U; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu SX, 2014, WOUND REPAIR REGEN, V22, P119, DOI 10.1111/wrr.12131; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marino S, 2000, GENE DEV, V14, P994; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Melo LG, 2004, CIRCULATION, V109, P2386, DOI 10.1161/01.CIR.0000128597.37025.00; NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shi YD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-571; Singh H, 2012, MITOCHONDRION, V12, P230, DOI 10.1016/j.mito.2011.09.004; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Webster KA, 1999, J CLIN INVEST, V104, P239; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao L, 2001, BBA-MOL CELL RES, V1538, P273, DOI 10.1016/S0167-4889(01)00078-7; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	40	230	239	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					585	+		10.1038/nature13839	http://dx.doi.org/10.1038/nature13839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25317562	Green Accepted, Green Submitted			2022-12-28	WOS:000343801500039
J	Gorbachev, RV; Song, JCW; Yu, GL; Kretinin, AV; Withers, F; Cao, Y; Mishchenko, A; Grigorieva, IV; Novoselov, KS; Levitov, LS; Geim, AK				Gorbachev, R. V.; Song, J. C. W.; Yu, G. L.; Kretinin, A. V.; Withers, F.; Cao, Y.; Mishchenko, A.; Grigorieva, I. V.; Novoselov, K. S.; Levitov, L. S.; Geim, A. K.			Detecting topological currents in graphene superlattices	SCIENCE			English	Article							DIRAC FERMIONS; BERRYS PHASE; QUANTUM; TRANSITION	Topological materials may exhibit Hall-like currents flowing transversely to the applied electric field even in the absence of a magnetic field. In graphene superlattices, which have broken inversion symmetry, topological currents originating from graphene's two valleys are predicted to flow in opposite directions and combine to produce long-range charge neutral flow. We observed this effect as a nonlocal voltage at zero magnetic field in a narrow energy range near Dirac points at distances as large as several micrometers away from the nominal current path. Locally, topological currents are comparable in strength with the applied current, indicating large valley-Hall angles. The long-range character of topological currents and their transistor-like control by means of gate voltage can be exploited for information processing based on valley degrees of freedom.	[Gorbachev, R. V.; Yu, G. L.; Cao, Y.; Mishchenko, A.; Geim, A. K.] Univ Manchester, Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Gorbachev, R. V.; Kretinin, A. V.; Withers, F.; Grigorieva, I. V.; Novoselov, K. S.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Oxford M13 9PL, England; [Song, J. C. W.; Levitov, L. S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Song, J. C. W.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	University of Manchester; University of Manchester; Massachusetts Institute of Technology (MIT); Harvard University	Levitov, LS (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	levitov@mit.edu; geim@manchester.ac.uk	Novoselov, Kostya S/G-9581-2014; Song, Justin CW/M-1353-2017; Kretinin, Andrey V/L-5122-2013; Gorbachev, Roman/I-2512-2013; Mishchenko, Artem/C-7561-2011; Geim, Andre K/J-7888-2012; Kretinin, Andrey/L-1105-2019	Novoselov, Kostya S/0000-0003-4972-5371; Song, Justin CW/0000-0002-5175-6970; Kretinin, Andrey V/0000-0003-4110-4837; Gorbachev, Roman/0000-0003-3604-5617; Mishchenko, Artem/0000-0002-0427-5664; Geim, Andre K/0000-0003-2861-8331; Kretinin, Andrey/0000-0003-4110-4837; hai yan, he/0000-0003-0366-6185; Withers, Freddie/0000-0001-5039-8297; Levitov, Leonid/0000-0002-4268-731X	European Research Council; Royal Society; Office of Naval Research; Air Force Office of Scientific Research; Engineering and Physical Sciences Research Council (UK); National Science Foundation; EPSRC [EP/K005014/1, EP/G02491X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G02491X/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Research Council, the Royal Society, the Office of Naval Research, the Air Force Office of Scientific Research, the Engineering and Physical Sciences Research Council (UK), and the National Science Foundation.	Abanin DA, 2011, SCIENCE, V332, P328, DOI 10.1126/science.1199595; Abanin DA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035304; Ando T, 1998, J PHYS SOC JPN, V67, P2857, DOI 10.1143/JPSJ.67.2857; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Chen ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5461; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Haldane FDM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.206602; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; KOHN W, 1957, PHYS REV, V108, P590, DOI 10.1103/PhysRev.108.590; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Renard J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.116601; Rycerz A, 2007, NAT PHYS, V3, P172, DOI 10.1038/nphys547; Song J. C. W., 2014, TOPOLOGICAL BANDS G; Sundaram G, 1999, PHYS REV B, V59, P14915, DOI 10.1103/PhysRevB.59.14915; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Titov M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.166601; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747; Zhou BB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026205	29	481	488	9	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					448	451		10.1126/science.1254966	http://dx.doi.org/10.1126/science.1254966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342798	Green Accepted, Green Submitted			2022-12-28	WOS:000343822900037
J	Blendon, RJ; Benson, JM; Hero, JO				Blendon, Robert J.; Benson, John M.; Hero, Joachim O.			Public Trust in Physicians - US Medicine in International Perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Hero, Joachim O.] Harvard Univ, Program Hlth Policy, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Buhr Tami, 2011, AM PUBLIC OPINION HL, P15; GLASER WA, 1994, J HEALTH POLIT POLIC, V19, P705; Hetherington M. J., 2005, WHY TRUST MATTERS DE; Melhado EM, 2006, MILBANK Q, V84, P359, DOI 10.1111/j.1468-0009.2006.00451.x; Schlesinger M, 2002, MILBANK Q, V80, P185, DOI 10.1111/1468-0009.t01-1-00010	5	177	178	7	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1570	1572		10.1056/NEJMp1407373	http://dx.doi.org/10.1056/NEJMp1407373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR5UF	25337746				2022-12-28	WOS:000343648500004
J	Choy, E; Attar, EC; Oh, KS; Huang, AJ; Kerr, DA				Choy, Edwin; Attar, Eyal C.; Oh, Kevin S.; Huang, Ambrose J.; Kerr, Darcy A.			Case 33-2014: A 60-Year-Old Man with Bone Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA; RANDOMIZED-TRIAL; LIPOSOMAL DOXORUBICIN; FRACTION RADIOTHERAPY; INTERFERON-ALPHA; FOLLOW-UP; 8 GY; BEVACIZUMAB; METASTASES; MASTOCYTOSIS		[Choy, Edwin; Attar, Eyal C.] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Oh, Kevin S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Huang, Ambrose J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kerr, Darcy A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Choy, Edwin; Attar, Eyal C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Oh, Kevin S.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Huang, Ambrose J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kerr, Darcy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Choy, E (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA.				Amgen; Pfizer; Bayer; NPS Pharmaceuticals; Celgene; Janssen Pharmaceuticals	Amgen(Amgen); Pfizer(Pfizer); Bayer(Bayer AG); NPS Pharmaceuticals; Celgene(Bristol-Myers SquibbCelgene Corporation); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Choy reports receiving consulting fees from Amgen, Pfizer, Bayer, and NPS Pharmaceuticals; and Dr. Attar, receiving consulting fees from Celgene and Janssen Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Agulnik M, 2013, ANN ONCOL, V24, P257, DOI 10.1093/annonc/mds237; [Anonymous], 2013, WHO CLASSIFICATION T; Ashton A, 1999, RADIOTHER ONCOL, V52, P111; Belmont L, 2008, J THORAC ONCOL, V3, P557, DOI 10.1097/JTO.0b013e31816e2400; Blease, 2004, DIAGNOSTIC IMAGING O; Brant WE., 2012, FUNDAMENTALS DIAGNOS; Calabro L, 2007, J EXP CLIN CANC RES, V26, P145; Chow E, 2007, J CLIN ONCOL, V25, P1423, DOI 10.1200/JCO.2006.09.5281; Currie JW, 2011, CURR PROBL DIAGN RAD, V40, P45, DOI 10.1067/j.cpradiol.2009.11.002; Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; Galvao FHF, 2005, TRANSPL P, V37, P4354, DOI 10.1016/j.transproceed.2005.11.022; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Grenader T, 2011, J CLIN ONCOL, V29, pE722, DOI 10.1200/JCO.2011.35.5891; Ho LM, 1996, AM J ROENTGENOL, V167, P716, DOI 10.2214/ajr.167.3.8751688; Kallmes DF, 2012, NEW ENGL J MED, V366, P970; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kamat AM, 2004, J UROLOGY, V171, P1886, DOI 10.1097/01.ju.0000119821.10704.6a; Kelly H, 2005, LANCET ONCOL, V6, P813, DOI 10.1016/S1470-2045(05)70392-2; Kim YH, 2010, J THORAC ONCOL, V5, P1107, DOI 10.1097/JTO.0b013e3181e2bc5d; Kobayashi T, 2009, ANN ONCOL, V20, P1943, DOI 10.1093/annonc/mdp242; Manaster BJ, 2007, MUSCULOSKELETAL IMAG; Mascarenhas RCV, 2004, ONCOLOGY-BASEL, V67, P471, DOI 10.1159/000082932; Mendlick MR, 2001, AM J SURG PATHOL, V25, P684, DOI 10.1097/00000478-200105000-00019; Mizota A, 2011, J THORAC ONCOL, V6, P651, DOI 10.1097/JTO.0b013e31820b9e23; Pflugmacher R, 2008, EUR SPINE J, V17, P1042, DOI 10.1007/s00586-008-0701-2; Pinet C, 1999, EUR RESPIR J, V14, P237, DOI 10.1034/j.1399-3003.1999.14a40.x; Pintoffl J, 2009, ANTI-CANCER DRUG, V20, P73, DOI 10.1097/CAD.0b013e32831b9b0b; Raphael Claire, 2010, J Med Case Rep, V4, P413, DOI 10.1186/1752-1947-4-413; Roos DE, 2005, RADIOTHER ONCOL, V75, P54, DOI 10.1016/j.radonc.2004.09.017; Salech F, 2011, ANN HEPATOL, V10, P99; Sandler A, 2007, NEW ENGL J MED, V356, P318; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Stacher E, 2009, LUNG CANCER, V65, P49, DOI 10.1016/j.lungcan.2008.10.031; Steenland E, 1999, RADIOTHER ONCOL, V52, P101, DOI 10.1016/S0167-8140(99)00110-3; Sumrall A, 2010, J NEURO-ONCOL, V97, P275, DOI 10.1007/s11060-009-0017-z; Tanas MR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002409; Tolkach Y, 2012, ONKOLOGIE, V35, P376, DOI 10.1159/000338944; Trautmann K, 2011, ACTA ONCOL, V50, P153, DOI 10.3109/0284186X.2010.498829; van den Hout WB, 2003, JNCI-J NATL CANCER I, V95, P222, DOI 10.1093/jnci/95.3.222; Weiss SW, 2008, ENZINGER WEISSS SOFT, P681; Woelfel C, 2011, CANCER GENET-NY, V204, P671, DOI 10.1016/j.cancergen.2011.11.007	42	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1630	1640		10.1056/NEJMcpc1310000	http://dx.doi.org/10.1056/NEJMcpc1310000			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337753				2022-12-28	WOS:000343648500012
J	Musher, DM; Thorner, AR				Musher, Daniel M.; Thorner, Anna R.			Community-Acquired Pneumonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INFECTIOUS-DISEASES-SOCIETY; ACUTE MYOCARDIAL-INFARCTION; STREPTOCOCCUS-PNEUMONIAE; URINARY ANTIGEN; PNEUMOCOCCAL PNEUMONIA; ANTIMICROBIAL RESISTANCE; LEGIONELLA-PNEUMONIA; ANTIBIOTIC-THERAPY; RISK-FACTORS; ADULTS		[Musher, Daniel M.] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX 77030 USA; [Musher, Daniel M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Musher, Daniel M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Thorner, Anna R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Thorner, Anna R.] Harvard Univ, Sch Med, Boston, MA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Musher, DM (corresponding author), Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX 77030 USA.	dmusher@bcm.edu						Abers MS, 2014, QJM-INT J MED, V107, P595, DOI 10.1093/qjmed/hcu096; Afzal Z, 2013, AM J THER; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Bazaz R, 2013, J INFECTION, V66, P1, DOI 10.1016/j.jinf.2012.09.009; Beovic B, 2003, EUR J CLIN MICROBIOL, V22, P584, DOI 10.1007/s10096-003-0997-0; Blazquez RM, 2005, EUR J CLIN MICROBIOL, V24, P488, DOI 10.1007/s10096-005-1361-3; Boulware DR, 2007, J INFECTION, V55, P300, DOI 10.1016/j.jinf.2007.06.014; Brass EP, 2013, NEW ENGL J MED, V369, P580, DOI 10.1056/NEJMc1306999; Bruns AHW, 2011, CLIN MICROBIOL INFEC, V17, P763, DOI 10.1111/j.1469-0691.2010.03296.x; Bruns AHW, 2010, J GEN INTERN MED, V25, P203, DOI 10.1007/s11606-009-1182-7; Chalmers JD, 2011, CLIN INFECT DIS, V53, P503, DOI 10.1093/cid/cir463; Chalmers JD, 2011, INTENS CARE MED, V37, P1409, DOI 10.1007/s00134-011-2261-x; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, J INFECTION, V63, P187, DOI 10.1016/j.jinf.2011.06.009; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Desaki M, 2000, BIOCHEM BIOPH RES CO, V267, P124, DOI 10.1006/bbrc.1999.1917; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Doern GV, 2005, CLIN INFECT DIS, V41, P139, DOI 10.1086/430906; Dunbar LM, 2004, CURR MED RES OPIN, V20, P555, DOI 10.1185/030079904125003304; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; ESPOSITO AL, 1984, ARCH INTERN MED, V144, P945, DOI 10.1001/archinte.144.5.945; Falguera M, 2009, RESPIROLOGY, V14, P105, DOI 10.1111/j.1440-1843.2008.01371.x; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; Fernandez-Sabe N, 2003, CLIN INFECT DIS, V37, P483, DOI 10.1086/376627; File TM, 2011, CLIN INFECT DIS, V52, P967, DOI 10.1093/cid/cir061; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fiumefreddo Rico, 2009, BMC Pulm Med, V9, P4, DOI 10.1186/1471-2466-9-4; FOY HM, 1966, J AMER MED ASSOC, V197, P859, DOI 10.1001/jama.197.11.859; Frei CR, 2010, CLIN THER, V32, P293, DOI 10.1016/j.clinthera.2010.02.006; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gray Barry M., 2008, P3; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Heffron R, 1939, PNEUMONIA SPECIAL RE; HELMS CM, 1979, ANN INTERN MED, V90, P543, DOI 10.7326/0003-4819-90-4-543; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; JENKINSON SG, 1979, JAMA-J AM MED ASSOC, V241, P2815; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Johnstone J, 2008, MEDICINE, V87, P329, DOI 10.1097/MD.0b013e318190f444; Johnstone J, 2013, INFECT DIS CLIN N AM, V27, P71, DOI 10.1016/j.idc.2012.11.001; Johnstone J, 2008, CHEST, V134, P1141, DOI 10.1378/chest.08-0888; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Li JZ, 2007, AM J MED, V120, P783, DOI 10.1016/j.amjmed.2007.04.023; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Louie J., 2009, Morbidity and Mortality Weekly Report, V58, P1071; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035; Mandell LA, 2003, CLIN INFECT DIS, V37, P761, DOI 10.1086/377567; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marrie TJ, 2005, RESP MED, V99, P60, DOI 10.1016/j.rmed.2004.05.010; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Metersky ML, 2012, CHEST, V142, P476, DOI 10.1378/chest.11-2393; Metlay JP, 1997, ARCH INTERN MED, V157, P1453, DOI 10.1001/archinte.157.13.1453; Metlay JP, 1997, J GEN INTERN MED, V12, P423, DOI 10.1046/j.1525-1497.1997.00074.x; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Mortensen EM, 2014, JAMA-J AM MED ASSOC, V311, P2199, DOI 10.1001/jama.2014.4304; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; MUSHER DM, 1977, MEDICINE, V56, P383, DOI 10.1097/00005792-197709000-00002; Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Oosterheert JJ, 2005, CLIN INFECT DIS, V41, P1438, DOI 10.1086/497134; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Pavia AT, 2013, INFECT DIS CLIN N AM, V27, P157, DOI 10.1016/j.idc.2012.11.007; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Polverino E, 2013, THORAX, V68, P1007, DOI 10.1136/thoraxjnl-2013-203828; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Restrepo MI, 2008, CHEST, V133, P610, DOI 10.1378/chest.07-1456; Rozenbaum MH, 2013, EUR J CLIN MICROBIOL, V32, P305, DOI 10.1007/s10096-012-1778-4; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Sandvall B, 2013, CLIN INFECT DIS, V56, P1145, DOI 10.1093/cid/cis1207; Sangil A, 2012, EUR J CLIN MICROBIOL, V31, P2765, DOI 10.1007/s10096-012-1626-6; Scalera NM, 2013, CURR INFECT DIS REP, V15, P191, DOI 10.1007/s11908-013-0327-3; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Sheng ZM, 2011, P NATL ACAD SCI USA, V108, P16416, DOI 10.1073/pnas.1111179108; Sherwin RL, 2013, J INFECT DIS, V208, P1813, DOI 10.1093/infdis/jit506; Shimada T, 2009, CHEST, V136, P1576, DOI 10.1378/chest.08-2602; Shorr AF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002898; Smith MD, 2009, J CLIN MICROBIOL, V47, P1046, DOI 10.1128/JCM.01480-08; Sopena N, 2004, SCAND J INFECT DIS, V36, P330, DOI 10.1080/00365540410020091; Spindler C, 2012, SCAND J INFECT DIS, V44, P885, DOI 10.3109/00365548.2012.700120; Stralin K, 2008, INT J ANTIMICROB AG, V31, P3, DOI 10.1016/j.ijantimicag.2007.06.037; SUTTON DR, 1970, THORAX, V25, P241, DOI 10.1136/thx.25.2.241; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; TOWNSEND EH, 1965, CLIN PEDIATR, V4, P117, DOI 10.1177/000992286500400211; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84; Wiemken T, 2013, INFECT DIS CLIN N AM, V27, P33, DOI 10.1016/j.idc.2012.11.015; Wood Jr WB, 1959, TEXTBOOK MEDICINE, P113; WOODHEAD MA, 1987, BRIT J DIS CHEST, V81, P133, DOI 10.1016/0007-0971(87)90130-6	104	351	385	6	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1619	1628		10.1056/NEJMra1312885	http://dx.doi.org/10.1056/NEJMra1312885			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337751				2022-12-28	WOS:000343648500010
J	Tanenbaum, ME; Gilbert, LA; Qi, LS; Weissman, JS; Vale, RD				Tanenbaum, Marvin E.; Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.; Vale, Ronald D.			A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging	CELL			English	Article							TRANSCRIPTION FACTOR SP1; SYNERGISTIC ACTIVATION; STEM-CELLS; IN-VIVO; RNA; BINDING; LOCALIZATION; INTRABODIES; HUNTINGTIN; CRISPR/CAS	Signals in many biological processes can be amplified by recruiting multiple copies of regulatory proteins to a site of action. Harnessing this principle, we have developed a protein scaffold, a repeating peptide array termed SunTag, which can recruit multiple copies of an antibody-fusion protein. We show that the SunTag can recruit up to 24 copies of GFP, thereby enabling long-term imaging of single protein molecules in living cells. We also use the SunTag to create a potent synthetic transcription factor by recruiting multiple copies of a transcriptional activation domain to a nuclease-deficient CRISPR/Cas9 protein and demonstrate strong activation of endogenous gene expression and re-engineered cell behavior with this system. Thus, the SunTag provides a versatile platform for multimerizing proteins on a target protein scaffold and is likely to have many applications in imaging and controlling biological outputs.	[Tanenbaum, Marvin E.; Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Tanenbaum, Marvin E.; Gilbert, Luke A.; Weissman, Jonathan S.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@ucsf.edu	Gilbert, Luke/AAC-5300-2019; Qi, Lei S/AAC-5088-2019	Weissman, Jonathan/0000-0003-2445-670X; Gilbert, Luke/0000-0001-5854-0825; Qi, Lei S/0000-0002-3965-3223	Dutch Cancer Society (KWF); UCSF Center for Systems and Synthetic Biology; NIH Office of The Director (OD); National Institute of Dental & Craniofacial Research (NIDCR); NIH P50 [GM081879, GM102706]; NIH Director's Early Independence Award [GM081879]; NIH R01 [DA036858]; NIH U01 [CA168370]; Leukemia and Lymphoma Society; Howard Hughes Medical Institute;  [GM38499]; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499, P50GM081879, R01GM038499, P50GM102706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); UCSF Center for Systems and Synthetic Biology; NIH Office of The Director (OD); National Institute of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH P50; NIH Director's Early Independence Award; NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U01; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Evan Whitehead for making the dCas9-2xNLS-10xGCN4 and scFv-GCN4- sfGFP-2xNLS-VP64 plasmids, Viki Allan for the EB3-tdTomato plasmid, Xiaokun Shu for the IFP2.0 protein, and Max Horlbeck for designing the CDKN1B sgRNAs. We also thank Nico Stuurman for help with microscopy, Kate Carbone for help with single-particle tracking, Andreas Pluckthun for helpful discussions, and the Vale lab members for helpful comments. M.E.T. was financially supported by a fellowship from the Dutch Cancer Society (KWF). L.S.Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology, NIH Office of The Director (OD), and National Institute of Dental & Craniofacial Research (NIDCR). This work was in part supported by NIH P50 (grant GM081879 to L.S.Q.), NIH Director's Early Independence Award (grant OD017887 to L.S.Q.), NIH R01 (grant DA036858 to L.S.Q. and J.S.W.), NIH P50 (grant GM102706 to J.S.W.), NIH U01 (grant CA168370 to J.S.W.), grant GM38499 to R.D.V., the Leukemia and Lymphoma Society (L.A.G.), and the Howard Hughes Medical Institute (R.D.V. and J.S.W.). A patent has been filed for the SunTag technology.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Brenner S, 2004, STEM CELLS, V22, P1128, DOI 10.1634/stemcells.2003-0196; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; CHEN XR, 1992, ONCOGENE, V7, P1805; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Coller J, 2007, METHOD ENZYMOL, V429, P299, DOI 10.1016/S0076-6879(07)29014-7; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Huang CJ, 1999, MOL MED, V5, P129, DOI 10.1007/BF03402147; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; PETTERSSON M, 1990, J MOL BIOL, V214, P373, DOI 10.1016/0022-2836(90)90187-Q; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795	38	834	884	19	298	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					635	646		10.1016/j.cell.2014.09.039	http://dx.doi.org/10.1016/j.cell.2014.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25307933	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000344521700018
J	Baker, LC; Bundorf, MK; Royalty, AB; Levin, Z				Baker, Laurence C.; Bundorf, M. Kate; Royalty, Anne B.; Levin, Zachary			Physician Practice Competition and Prices Paid by Private Insurers for Office Visits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; MEDICARE; SIZE	IMPORTANCE Physician practice consolidation could promote higher-quality care but may also create greater economic market power that could lead to higher prices for physician services. OBJECTIVE To assess the relationship between physician competition and prices paid by private preferred provider organizations (PPOs) for 10 types of office visits in 10 prominent specialties. DESIGN AND SETTING Retrospective study in 1058 US counties in urbanized areas, representing all 50 states, examining the relationship between measured physician competition and prices paid for office visits in 2010 and the relationship between changes in competition and prices between 2003 and 2010, using regression analysis to control for possible confounding factors. EXPOSURES Variation in the mean Hirschman-Herfindahl Index (HHI) of physician practices within a county by specialty (HHIs range from 0, representing maximally competitive markets, to 10 000 in markets served by a single [monopoly] practice). MAIN OUTCOMES AND MEASURES Mean price paid by county to physicians in each specialty by private PPOs for intermediate office visits with established patients (Current Procedural Terminology [CPT] code 99213) and a price index measuring the county-weighted mean price for 10 types of office visits with new and established patients (CPT codes 99201-99205, 99211-99215) relative to national mean prices. RESULTS In 2010, across all specialties studied, HHIs were 3 to 4 times higher in the 90th-percentile county than the 10th-percentile county (eg, for family practice: 10th percentile HHI = 1023 and 90th percentile HHI = 3629). Depending on specialty, mean price for a CPT code 99213 visit was between $70 and $75. After adjustment for potential confounders, depending on specialty, prices at the 90th-percentile HHI were between $5.85 (orthopedics; 95% CI, $3.46-$8.24) and $11.67 (internal medicine; 95% CI, $9.13-$14.21) higher than at the 10th percentile. Including all types of office visits, price indexes at the 90th-percentile HHI were 8.3%(orthopedics; 95% CI, 5.0%-11.6%) to 16.1%(internal medicine; 95% CI, 12.8%-19.5%) higher. Between 2003 and 2010, there were larger price increases in areas that were less competitive in 2002 than in initially more competitive areas. CONCLUSIONS AND RELEVANCE More competition among physicians is related to lower prices paid by private PPOs for office visits. These results may inform work on policies that influence practice competition. Copyright 2014 American Medical Association. All rights reserved.	[Baker, Laurence C.; Bundorf, M. Kate; Levin, Zachary] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Baker, Laurence C.; Bundorf, M. Kate] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Royalty, Anne B.] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA	Stanford University; National Bureau of Economic Research; Indiana University System; Indiana University-Purdue University Indianapolis	Baker, LC (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA.	lcbaker@stanford.edu		Bundorf, M. Kate/0000-0002-9824-4868; Baker, Laurence/0000-0001-5032-794X	National Institute for Health Care Management	National Institute for Health Care Management	The National Institute for Health Care Management provided funding to support this work.	Adamson D., 2006, HLTH RES DATA REAL W; Baicker K, 2013, NEW ENGL J MED, V369, P789, DOI 10.1056/NEJMp1306268; Baker L, 2013, HEALTH AFFAIR, V32, P1583, DOI 10.1377/hlthaff.2013.0309; Berenson RA, 2010, HEALTH AFFAIR, V29, P699, DOI 10.1377/hlthaff.2009.0715; Casalino LP, 2006, J HEALTH POLIT POLIC, V31, P569, DOI 10.1215/03616878-2005-007; Centers for Medicare & Medicaid Services, 2013, NAT HLTH EXP TYP SER; Centers for Medicare & Medicaid Services, 2011, PHYS GROUP PRACT TRA; Chernew ME, 2010, AM J MANAG CARE, V16, P131; Crosson FJ, 2009, NEW ENGL J MED, V361, P1324, DOI 10.1056/NEJMp0906917; Dafny L, 2011, BE J ECON ANAL POLI, V11; Dor A, 2012, CANCER-AM CANCER SOC, V118, P5741, DOI 10.1002/cncr.27573; Dunn A, 2014, J LAW ECON, V57, P159, DOI 10.1086/674407; Dunn A, 2013, HEALTH SERV RES, V48, P1173, DOI 10.1111/1475-6773.12008; Ellis P, 2012, HEALTH AFFAIR, V31, P2084, DOI 10.1377/hlthaff.2012.0361; Emmons DW, 2012, COMPETITION HLTH CAR; Federal Trade Commission, 1996, STAT ANT ENF POL HLT; Federal Trade Commission; Department of Justice, 2011, FED REGISTER, V76, P67026; Federal Trade Commission (FTC)-U. S. Department of Justice (DOJ), 2010, HOR MERG GUID; Gaynor M, 2012, HBK ECON; Ginsburg PB., 2010, WIDE VARIATION HOSP; Institute of Medicine, 2013, VAR HLTH CAR SPEND T; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Ketcham JD, 2007, HEALTH AFFAIR, V26, P195, DOI 10.1377/hlthaff.26.1.195; Kleiner S., 2012, HLTH MANAGEMENT POLI, V1, P3; Liehaber A, 2007, PHYS MOVING MIDSIZED; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pope GC, 2002, PHYS GROUP PRACTICE; Rittenhouse DR, 2011, HEALTH AFFAIR, V30, P1575, DOI 10.1377/hlthaff.2010.1210; Schneider JE, 2008, INT J HEALTH CARE FI, V8, P13, DOI 10.1007/s10754-007-9029-4; Viscusi WK, 2005, EC REGULATION ANTITR; Weeks WB, 2010, HEALTH AFFAIR, V29, P991, DOI 10.1377/hlthaff.2009.0388; Welch WP, 2013, HEALTH AFFAIR, V32, P1659, DOI 10.1377/hlthaff.2012.1256	33	81	81	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1653	1662		10.1001/jama.2014.10921	http://dx.doi.org/10.1001/jama.2014.10921			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR0YF	25335147	Bronze			2022-12-28	WOS:000343301400022
J	Marcantonio, ER; Ngo, LH; O'Connor, M; Jones, RN; Crane, PK; Metzger, ED; Inouye, SK				Marcantonio, Edward R.; Ngo, Long H.; O'Connor, Margaret; Jones, Richard N.; Crane, Paul K.; Metzger, Eran D.; Inouye, Sharon K.			3D-CAM: Derivation and Validation of a 3-Minute Diagnostic Interview for CAM-Defined Delirium A Cross-sectional Diagnostic Test Study	ANNALS OF INTERNAL MEDICINE			English	Article							CONFUSION ASSESSMENT METHOD; INTENSIVE-CARE-UNIT; ALZHEIMERS ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; RELIABILITY; EMERGENCY; VALIDITY; RECOMMENDATIONS; DOCUMENTATION; PREVALENCE	Background: Delirium is common, leads to other adverse outcomes, and is costly. However, it often remains unrecognized in most clinical settings. The Confusion Assessment Method (CAM) is the most widely used diagnostic algorithm, and operationalizing its features would be a substantial advance for clinical care. Objective: To derive the 3D-CAM, a new 3-minute diagnostic assessment for CAM-defined delirium, and validate it against a clinical reference standard. Design: Derivation and validation study. Setting: 4 general medicine units in an academic medical center. Participants: 201 inpatients aged 75 years or older. Measurements: 20 items that best operationalized the 4 CAM diagnostic features were identified to create the 3D-CAM. For prospective validation, 3D-CAM assessments were administered by trained research assistants. Clinicians independently did an extensive assessment, including patient and family interviews and medical record reviews. These data were considered by an expert panel to determine the presence or absence of delirium and dementia (reference standard). The 3D-CAM delirium diagnosis was compared with the reference standard in all patients and subgroups with and without dementia. Results: The 201 participants in the prospective validation study had a mean age of 84 years, and 28% had dementia. The expert panel identified 21% with delirium, 88% of whom had hypoactive or normal psychomotor features. Median administration time for the 3D-CAM was 3 minutes (interquartile range, 2 to 5 minutes), sensitivity was 95% (95% CI, 84% to 99%), and specificity was 94% (CI, 90% to 97%). The 3D-CAM did well in patients with dementia (sensitivity, 96% [CI, 82% to 100%]; specificity, 86% [CI, 67% to 96%]) and without dementia (sensitivity, 93% [CI, 66% to 100%]; specificity, 96% [CI, 91% to 99%]). Limitation: Limited to single-center, cross-sectional, and medical patients only. Conclusion: The 3D-CAM operationalizes the CAM algorithm using a 3-minute structured assessment with high sensitivity and specificity relative to a reference standard and could be an important tool for improving recognition of delirium.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Hebrew SeniorLife, Boston, MA 02131 USA; Brown Univ, Warren Alpert Sch Med, Providence, RI 02903 USA; Univ Washington, Sch Med, Seattle, WA 98104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Hebrew SeniorLife; Brown University; University of Washington; University of Washington Seattle	Marcantonio, ER (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gen Med & Primary Care, 330 Brookline Ave,CO-216, Boston, MA 02215 USA.	emarcant@bidmc.harvard.edu	Inouye, Sharon/R-7216-2019; Marcantonio, Edward R/U-3929-2017; Jones, Richard Norman/J-3488-2013	Marcantonio, Edward R/0000-0002-2911-4250; Jones, Richard Norman/0000-0002-1049-218X	National Institute on Aging; NATIONAL INSTITUTE ON AGING [K24AG035075, K07AG041835, R01AG030618, P01AG031720] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 1994, DIAGN STAT MAN PSYCH; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Brummel NE, 2013, CRIT CARE MED, V41, P2196, DOI 10.1097/CCM.0b013e31829a6f1e; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fick DM, 2002, J AM GERIATR SOC, V50, P1723, DOI 10.1046/j.1532-5415.2002.50468.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; GUSTAFSON Y, 1991, J AM GERIATR SOC, V39, P760, DOI 10.1111/j.1532-5415.1991.tb02697.x; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; Han JH, 2014, ACAD EMERG MED, V21, P180, DOI 10.1111/acem.12309; Han JH, 2013, ANN EMERG MED, V62, P457, DOI 10.1016/j.annemergmed.2013.05.003; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Huang LW, 2012, J AM GERIATR SOC, V60, P1044, DOI 10.1111/j.1532-5415.2012.03996.x; Hustey FM, 2002, ANN EMERG MED, V39, P248, DOI 10.1067/mem.2002.122057; Inouye SK, 2014, ANN INTERN MED, V160, P526, DOI 10.7326/M13-1927; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kales HC, 2003, J GERIATR PSYCH NEUR, V16, P32, DOI 10.1177/0891988702250535; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kiely DK, 2007, J GERONTOL A-BIOL, V62, P174, DOI 10.1093/gerona/62.2.174; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lemiengre J, 2006, J AM GERIATR SOC, V54, P685, DOI 10.1111/j.1532-5415.2006.00667.x; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; Marcantonio ER, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-01006; Marcantonio ER, 2010, J AM GERIATR SOC, V58, P1019, DOI 10.1111/j.1532-5415.2010.02871.x; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McNicoll L, 2005, J AM GERIATR SOC, V53, P495, DOI 10.1111/j.1532-5415.2005.53171.x; Meagher D, 2012, BRIT J PSYCHIAT, V200, P37, DOI 10.1192/bjp.bp.111.095273; Milisen Koen, 2002, J Gerontol Nurs, V28, P23; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neufeld KJ, 2011, PSYCHOSOMATICS, V52, P133, DOI 10.1016/j.psym.2010.12.018; Simon SE, 2006, J AM MED DIR ASSOC, V7, P412, DOI 10.1016/j.jamda.2006.02.006; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182; Yang FM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-8; Yang FM, 2009, PSYCHOSOMATICS, V50, P248, DOI 10.1176/appi.psy.50.3.248; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	41	203	217	2	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					554	U53		10.7326/M14-0865	http://dx.doi.org/10.7326/M14-0865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9PL	25329203	Green Accepted			2022-12-28	WOS:000343906800015
J	Peter, H; Tian, H; Curdt, W; Schmit, D; Innes, D; De Pontieu, B; Lemen, J; Title, A; Boerner, P; Hurlburt, N; Tarbell, TD; Wuelser, JP; Martinez-Sykora, J; Kleint, L; Golub, L; McKillop, S; Reeves, KK; Saar, S; Testa, P; Kankelborg, C; Jaeggli, S; Carlsson, M; Hansteen, V				Peter, H.; Tian, H.; Curdt, W.; Schmit, D.; Innes, D.; De Pontieu, B.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Martinez-Sykora, Juan; Kleint, L.; Golub, L.; McKillop, S.; Reeves, K. K.; Saar, S.; Testa, P.; Kankelborg, C.; Jaeggli, S.; Carlsson, M.; Hansteen, V.			Hot explosions in the cool atmosphere of the Sun	SCIENCE			English	Article							ELLERMAN BOMBS; H-ALPHA; SOLAR; FLUX; EMERGENCE; REGION; CHROMOSPHERE; CONVECTION	The solar atmosphere was traditionally represented with a simple one-dimensional model. Over the past few decades, this paradigm shifted for the chromosphere and corona that constitute the outer atmosphere, which is now considered a dynamic structured envelope. Recent observations by the Interface Region Imaging Spectrograph (IRIS) reveal that it is difficult to determine what is up and down, even in the cool 6000-kelvin photosphere just above the solar surface: This region hosts pockets of hot plasma transiently heated to almost 100,000 kelvin. The energy to heat and accelerate the plasma requires a considerable fraction of the energy from flares, the largest solar disruptions. These IRIS observations not only confirm that the photosphere is more complex than conventionally thought, but also provide insight into the energy conversion in the process of magnetic reconnection.	[Peter, H.; Curdt, W.; Schmit, D.; Innes, D.] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany; [Tian, H.; Golub, L.; McKillop, S.; Reeves, K. K.; Saar, S.; Testa, P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [De Pontieu, B.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Martinez-Sykora, Juan; Kleint, L.] LMSAL, Palo Alto, CA 94304 USA; [Martinez-Sykora, Juan; Kleint, L.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Kleint, L.] NASA, Ames Res Ctr, Moffett Field, CA 94305 USA; [Kankelborg, C.; Jaeggli, S.] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA; [De Pontieu, B.; Carlsson, M.; Hansteen, V.] Univ Oslo, Inst Theoret Astrophys, NO-0315 Oslo, Norway	Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Montana State University System; Montana State University Bozeman; University of Oslo	Peter, H (corresponding author), Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany.	peter@mps.mpg.de	Reeves, Katharine/P-9163-2014	Tian, Hui/0000-0002-1369-1758; Golub, Leon/0000-0001-9638-3082; Reeves, Katharine/0000-0002-6903-6832	Norwegian Space Centre through European Space Agency PRODEX; NASA [NNG09FA40C, NNX11AO98G]; Lockheed Martin Independent Research Program; European Research Council [291058]	Norwegian Space Centre through European Space Agency PRODEX; NASA(National Aeronautics & Space Administration (NASA)); Lockheed Martin Independent Research Program; European Research Council(European Research Council (ERC)European Commission)	H.P. thanks LMSAL for hospitality during his visit. We thank R. Rutten for countless comments and good discussions and two anonymous referees for valuable comments. IRIS is a NASA Small Explorer mission developed and operated by LMSAL, with mission, operations executed at NASA Ames Research Center and major contributions to downlink communications funded by the Norwegian Space Centre through a European Space Agency PRODEX contract. This work is supported by NASA contract NNG09FA40C (IRIS), the Lockheed Martin Independent Research Program, European Research Council grant agreement 291058, and NASA grant NNX11AO98G. The Solar Dynamics Observatory (SDO) data that we used are provided courtesy of NASA/SDO and the Atmospheric Imaging Assembly and Helioseismic and Magnetic Imager science teams. All data used in this study are publicly available through the Virtual Solar Observatory (http://sdac.virtualsolar.org). The IRIS data are archived at http://iris.lmsal.com/data.html, where manuals for data reduction are also available.	Archontis V, 2009, ASTRON ASTROPHYS, V508, P1469, DOI 10.1051/0004-6361/200912455; Asplund M, 2004, ASTRON ASTROPHYS, V417, P751, DOI 10.1051/0004-6361:20034328; Aulanier G, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220406; Aulanier G, 1998, ASTRON ASTROPHYS, V329, P1125; Carlsson M, 1997, ASTROPHYS J, V481, P500, DOI 10.1086/304043; Chen F, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322859; Cheung MCM, 2010, ASTROPHYS J, V720, P233, DOI 10.1088/0004-637X/720/1/233; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; Ellerman F, 1917, ASTROPHYS J, V46, P298, DOI 10.1086/142366; Georgoulis MK, 2002, ASTROPHYS J, V575, P506, DOI 10.1086/341195; Gonzalez NB, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321632; Ariste AL, 2006, ASTRON ASTROPHYS, V456, P725, DOI 10.1051/0004-6361:20064923; Magara T, 2006, ASTROPHYS J, V653, P1499, DOI 10.1086/508926; Martinez-Sykora J, 2009, ASTROPHYS J, V702, P129, DOI 10.1088/0004-637X/702/1/129; Nordlund A, 2009, LIVING REV SOL PHYS, V6, DOI 10.12942/lrsp-2009-2; Pariat E, 2007, ASTRON ASTROPHYS, V473, P279, DOI 10.1051/0004-6361:20067011; Pariat E, 2004, ASTROPHYS J, V614, P1099, DOI 10.1086/423891; Rempel M, 2009, SCIENCE, V325, P171, DOI 10.1126/science.1173798; Rutten RJ, 2013, J PHYS CONF SER, V440, DOI 10.1088/1742-6596/440/1/012007; Schmieder B, 2004, ASTROPHYS J, V601, P530, DOI 10.1086/380199; Schrijver CJ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017706; Schrijver CJ, 2001, ASTR SOC P, V223, P131; Solanki SK, 2003, NATURE, V425, P692, DOI 10.1038/nature02035; VERNAZZA JE, 1981, ASTROPHYS J SUPPL S, V45, P635, DOI 10.1086/190731; Watanabe H, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/71; Wedemeyer-Bohm S, 2009, SPACE SCI REV, V144, P317, DOI 10.1007/s11214-008-9447-8	27	206	211	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207							1255726	10.1126/science.1255726	http://dx.doi.org/10.1126/science.1255726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324397	Green Submitted			2022-12-28	WOS:000343041100033
J	Munang, ML; O'Shea, MK; Dedicoat, M				Munang, Melinda L.; O'Shea, Matthew K.; Dedicoat, Martin			THERAPEUTICS Novel drugs and drug combinations for treating tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; 12-DOSE REGIMEN; INFECTION; MOXIFLOXACIN; METAANALYSIS; RIFAPENTINE; THERAPY; ETHAMBUTOL		[Munang, Melinda L.; O'Shea, Matthew K.; Dedicoat, Martin] Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5SS, W Midlands, England; [Munang, Melinda L.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [O'Shea, Matthew K.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford OX3 7DQ, England	Heart of England NHS Foundation Trust; University of Birmingham; University of Warwick; University of Oxford; Jenner Institute	Dedicoat, M (corresponding author), Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5SS, W Midlands, England.	martin.dedicoat@heartofengland.nhs.uk	Dedicoat, Martin/AFC-7815-2022	Dedicoat, Martin/0000-0001-9833-4882; O'Shea, Matthew/0000-0001-6414-8088				Albanna AS, 2013, EUR RESPIR J, V42, P721, DOI 10.1183/09031936.00180612; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Ena J, 2005, CLIN INFECT DIS, V40, P670, DOI 10.1086/427802; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Gao XF, 2009, INT J TUBERC LUNG D, V13, P810; Gillespie SH, 2014, N ENGL J MED; Girling D. J., 1991, American Review of Respiratory Disease, V143, P700; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; *HONG KONG CHEST S, 1987, AM REV RESPIR DIS, V136, P1339; Jindani A, 2013, 20 C RETR OPP INF AT; Laserson KF, 2001, INT J TUBERC LUNG D, V5, P448; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Shepardson D, 2013, INT J TUBERC LUNG D, V17, P1531, DOI 10.5588/ijtld.13.0423; Shepardson D, 2014, INT J TUBERC LUNG D, V18, P751, DOI 10.5588/ijtld.14.0052; Skripconoka V, 2013, EUR RESPIR J, V41, P1393, DOI 10.1183/09031936.00125812; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Takiff H, 2011, ANTIMICROB AGENTS CH, V55, P5421, DOI 10.1128/AAC.00695-11; Tulkens PM, 2012, DRUGS R&D, V12, P71, DOI 10.2165/11634300-000000000-00000; US National Institutes of Health, SAF EFF TRIAL DEL 6; Wang PY, 2012, INT J TUBERC LUNG D, V16, P589, DOI 10.5588/ijtld.11.0377; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, FIX DOS COMB HIV AID; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2013, USE BEDAQUILINE TREA	30	4	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2014	349								g5948	10.1136/bmj.g5948	http://dx.doi.org/10.1136/bmj.g5948			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NW	25324128	Green Published			2022-12-28	WOS:000343767500001
J	Johnston, A; Bailey, M				Johnston, Andy; Bailey, Mark			Operation Gritrock: first UK army medics fly to Sierra Leone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Johnston, Andy] Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham B15 2TH, W Midlands, England; [Bailey, Mark] Heartlands Hosp, Birmingham, W Midlands, England	Royal Centre for Defence Medicine; University of Birmingham; Heart of England NHS Foundation Trust	Johnston, A (corresponding author), Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham B15 2TH, W Midlands, England.	andy.johnston@uhb.nhs.uk	Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589					0	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2014	349								g6237	10.1136/bmj.g6237	http://dx.doi.org/10.1136/bmj.g6237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NT	25315203	Bronze, Green Published			2022-12-28	WOS:000343767300024
J	Bowers, S				Bowers, Simon			Why are we failing young patients with ADHD?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Liverpool CCG, Liverpool, Merseyside, England		Bowers, S (corresponding author), Liverpool CCG, Liverpool, Merseyside, England.	Simon.Bowers@livgp.nhs.uk						National Collaborating Centre for Mental Health (UK), 2018, BR PSYCHOL SOC	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2014	349								g6082	10.1136/bmj.g6082	http://dx.doi.org/10.1136/bmj.g6082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NR	25313163				2022-12-28	WOS:000343767100002
J	Stone, R; Lavine, M				Stone, Richard; Lavine, Marc			the social life of Robots	SCIENCE			English	Editorial Material																			0	12	12	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					178	179		10.1126/science.346.6206.178	http://dx.doi.org/10.1126/science.346.6206.178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301612				2022-12-28	WOS:000342721500033
J	Fakhry, C; Gillison, ML; D'Souza, G				Fakhry, Carole; Gillison, Maura L.; D'Souza, Gypsyamber			Tobacco Use and Oral HPV-16 Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HUMAN-PAPILLOMAVIRUS; UNITED-STATES; CANCER		[Fakhry, Carole] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Gillison, Maura L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	cfakhry@jhmi.edu; gdsouza2@jhu.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021395, P50DE019032, R01DE023175] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01DE023175, R01 DE023175, R01 DE021395, R01DE021395, P50DE019032, P50 DE019032] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Centers for Disease Control and Prevention (U.S.), NAT HLTH NUTR EX SUR; Chaturvedi AK, 2014, J INFECT DIS, V210, P441, DOI 10.1093/infdis/jiu116; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803	6	52	52	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1465	1467		10.1001/jama.2014.13183	http://dx.doi.org/10.1001/jama.2014.13183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291584	Green Accepted			2022-12-28	WOS:000342630200025
J	Pittelkow, CM; Liang, XQ; Linquist, BA; van Groenigen, KJ; Lee, J; Lundy, ME; van Gestel, N; Six, J; Venterea, RT; van Kessel, C				Pittelkow, Cameron M.; Liang, Xinqiang; Linquist, Bruce A.; van Groenigen, Kees Jan; Lee, Juhwan; Lundy, Mark E.; van Gestel, Natasja; Six, Johan; Venterea, Rodney T.; van Kessel, Chris			Productivity limits and potentials of the principles of conservation agriculture	NATURE			English	Article							FOOD SECURITY; METAANALYSIS; AFRICA; IMPACT; MAIZE; YIELD	One of the primary challenges of our time is to feed a growing and more demanding world population with reduced external inputs and minimal environmental impacts, all under more variable and extreme climate conditions in the future(1-4). Conservation agriculture represents a set of three crop management principles that has received strong international support to help address this challenge(5,6), with recent conservation agriculture efforts focusing on smallholder farming systems in sub-Saharan Africa and South Asia(7). However, conservation agriculture is highly debated, with respect to both its effects on crop yields(8-10) and its applicability in different farming contexts(7,11-13). Here we conduct a global meta-analysis using 5,463 paired yield observations from 610 studies to compare no-till, the original and central concept of conservation agriculture, with conventional tillage practices across 48 crops and 63 countries. Overall, our results show that no-till reduces yields, yet this response is variable and under certain conditions no-till can produce equivalent or greater yields than conventional tillage. Importantly, when no-till is combined with the other two conservation agriculture principles of residue retention and crop rotation, its negative impacts are minimized. Moreover, no-till in combination with the other two principles significantly increases rainfed crop productivity in dry climates, suggesting that it may become an important climate-change adaptation strategy for ever-drier regions of the world. However, any expansion of conservation agriculture should be done with caution in these areas, as implementation of the other two principles is often challenging in resource-poor and vulnerable smallholder farming systems, thereby increasing the likelihood of yield losses rather than gains. Although farming systems are multifunctional, and environmental and socio-economic factors need to be considered(14-16), our analysis indicates that the potential contribution of no-till to the sustainable intensification of agriculture is more limited than often assumed.	[Pittelkow, Cameron M.; Linquist, Bruce A.; Lundy, Mark E.; van Kessel, Chris] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Liang, Xinqiang] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China; [van Groenigen, Kees Jan; van Gestel, Natasja] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Lee, Juhwan; Six, Johan] ETH, Dept Environm Syst Sci, Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Venterea, Rodney T.] ARS, USDA, Soil & Water Management Unit, St Paul, MN 55108 USA; [Venterea, Rodney T.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of California System; University of California Davis; Zhejiang University; Northern Arizona University; Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Pittelkow, CM (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	cmpitt@illinois.edu	six, johan/J-5228-2015; Venterea, Rodney T/A-3930-2009; van Groenigen, Kees Jan/Q-7081-2018	six, johan/0000-0001-9336-4185; van Groenigen, Kees Jan/0000-0002-9165-3925; Lundy, Mark/0000-0003-4043-0841; Pittelkow, Cameron/0000-0001-8654-9552; Lee, Juhwan/0000-0002-7967-2955	National Key Science and Technology Project of China [2014ZX07101-012]	National Key Science and Technology Project of China	We are grateful to the National Key Science and Technology Project of China for supporting X.Q.L. with grant number 2014ZX07101-012.	Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; [Anonymous], 2012, CONTESTED AGRONOMY A; Brouder SM, 2014, AGR ECOSYST ENVIRON, V187, P11, DOI 10.1016/j.agee.2013.08.010; Canty A, 2014, BOOT BOOTSTRAP R S P; Cook B. I., CLIM DYN IN PRESS; Corbeels M, 2014, AGR ECOSYST ENVIRON, V187, P155, DOI 10.1016/j.agee.2013.10.011; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Erenstein O, 2002, SOIL TILL RES, V67, P115, DOI 10.1016/S0167-1987(02)00062-4; Erenstein O, 2012, J SUSTAIN AGR, V36, P180, DOI 10.1080/10440046.2011.620230; FAO ITTO., 2011, STAT FOR AM BAS CONG; Farooq M, 2011, SOIL TILL RES, V117, P172, DOI 10.1016/j.still.2011.10.001; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Friedrich T., 2012, FIELD ACTIONS SCI RE, V6, DOI DOI 10.1080/00207233.2018.1494927; Giller KE, 2011, FIELD CROP RES, V124, P468, DOI 10.1016/j.fcr.2011.04.010; Giller KE, 2009, FIELD CROP RES, V114, P23, DOI 10.1016/j.fcr.2009.06.017; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Govaerts B, 2009, CRIT REV PLANT SCI, V28, P97, DOI 10.1080/07352680902776358; Grassini P, 2012, P NATL ACAD SCI USA, V109, P1074, DOI 10.1073/pnas.1116364109; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs PR, 2008, PHILOS T R SOC B, V363, P543, DOI 10.1098/rstb.2007.2169; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Palm C, 2014, AGR ECOSYST ENVIRON, V187, P87, DOI 10.1016/j.agee.2013.10.010; R Development Core Team, 2009, R LANG ENV STAT COMP; Rusinamhodzi L, 2011, AGRON SUSTAIN DEV, V31, P657, DOI 10.1007/s13593-011-0040-2; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; Serraj R, 2012, FIELD CROP RES, V132, P1, DOI 10.1016/j.fcr.2012.03.002; Stevenson JR, 2014, AGR ECOSYST ENVIRON, V187, P1, DOI 10.1016/j.agee.2014.01.018; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; UNEP, 1997, ARNOLD HODDER HEADLI	31	735	766	62	1054	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					365	U482		10.1038/nature13809	http://dx.doi.org/10.1038/nature13809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25337882				2022-12-28	WOS:000347810300045
J	Maddalo, D; Manchado, E; Concepcion, CP; Bonetti, C; Vidigal, JA; Han, YC; Ogrodowski, P; Crippa, A; Rekhtman, N; de Stanchina, E; Lowe, SW; Ventura, A				Maddalo, Danilo; Manchado, Eusebio; Concepcion, Carla P.; Bonetti, Ciro; Vidigal, Joana A.; Han, Yoon-Chi; Ogrodowski, Paul; Crippa, Alessandra; Rekhtman, Natasha; de Stanchina, Elisa; Lowe, Scott W.; Ventura, Andrea			In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; ACUTE-LEUKEMIA; MOUSE MODELS; FUSION GENE; CRE-LOXP; CANCER; TRANSLOCATIONS; ALK; RESISTANCE; NPM	Chromosomal rearrangements have a central role in the pathogenesis of human cancers and often result in the expression of therapeutically actionable gene fusions(1). A recently discovered example is a fusion between the genes echinoderm microtubule-associated protein like 4 (EML4) and anaplastic lymphoma kinase (ALK), generated by an inversion on the short arm of chromosome 2: inv(2) (p21p23). The EML4-ALK oncogene is detected in a subset of human non-small cell lung cancers (NSCLC)(2) and is clinically relevant because it confers sensitivity to ALK inhibitors(3). Despite their importance, modelling such genetic events in mice has proven challenging and requires complex manipulation of the germ line. Here we describe an efficient method to induce specific chromosomal rearrangements in vivo using viral-mediated delivery of the CRISPR/Cas9 system to somatic cells of adult animals. We apply it to generate a mouse model of Eml4-Alk-driven lung cancer. The resulting tumours invariably harbour the Eml4-Alk inversion, express the Eml4-Alk fusion gene, display histopathological and molecular features typical of ALK(+) human NSCLCs, and respond to treatment with ALK inhibitors. The general strategy described here substantially expands our ability to model human cancers in mice and potentially in other organisms.	[Maddalo, Danilo; Manchado, Eusebio; Concepcion, Carla P.; Bonetti, Ciro; Vidigal, Joana A.; Han, Yoon-Chi; Ogrodowski, Paul; Lowe, Scott W.; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Concepcion, Carla P.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Crippa, Alessandra] Milano Bicocca Univ, Dept Med Oncol, San Gerardo Hosp, I-20052 Monza, Italy; [Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; San Gerardo Hospital; University of Milano-Bicocca; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Ventura, A (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10065 USA.	venturaa@mskcc.org		Maddalo, Danilo/0000-0002-3228-1703; A. Vidigal, Joana/0000-0003-2765-6985; Ventura, Andrea/0000-0003-4320-9907	Geoffrey Beene Cancer Research Foundation; NCI (Cancer Center Support Grant) [P30 CA008748]; HHMI; NCI; American Italian Cancer Foundation; Foundation Blanceflor Boncompagni Ludovisi, nee Bildt; Jane Coffin Childs Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA129243, P01CA013106] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Foundation; NCI (Cancer Center Support Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Italian Cancer Foundation; Foundation Blanceflor Boncompagni Ludovisi, nee Bildt; Jane Coffin Childs Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. Fazio, M. Ladanyi, G. Riely, S. Armstrong, and the members of the Ventura, Lowe and Jacks laboratories for discussion and comments. We also thank J. Hollenstein for editing the manuscript, T. Jacks for providing tumour samples from K-Ras<SUP>G12D</SUP> mice, and the Cytogenetic Core Facility of MSKCC for tissue processing and histology. This work was supported by grants from the Geoffrey Beene Cancer Research Foundation (A.V.), NCI (Cancer Center Support Grant P30 CA008748, E.d.S.), HHMI (S.W.L.), NCI Project Grant (S.W.L.); and by fellowships from the American Italian Cancer Foundation (D.M.), the Foundation Blanceflor Boncompagni Ludovisi, nee Bildt (D.M.), and the Jane Coffin Childs Foundation (E.M.). C.P.C. was supported by an NCI training grant.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Collins EC, 2000, EMBO REP, V1, P127, DOI 10.1093/embo-reports/kvd021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Pirazzoli V, 2014, CELL REP, V7, P999, DOI 10.1016/j.celrep.2014.04.014; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Taki T, 2006, CURR OPIN ONCOL, V18, P62, DOI 10.1097/01.cco.0000198972.69541.04; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	30	407	438	5	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					423	+		10.1038/nature13902	http://dx.doi.org/10.1038/nature13902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25337876	Green Accepted			2022-12-28	WOS:000346484800053
J	Sanchez-Rivera, FJ; Papagiannakopoulos, T; Romero, R; Tammela, T; Bauer, MR; Bhutkar, A; Joshi, NS; Subbaraj, L; Bronson, RT; Xue, W; Jacks, T				Sanchez-Rivera, Francisco J.; Papagiannakopoulos, Thales; Romero, Rodrigo; Tammela, Tuomas; Bauer, Matthew R.; Bhutkar, Arjun; Joshi, Nikhil S.; Subbaraj, Lakshmipriya; Bronson, Roderick T.; Xue, Wen; Jacks, Tyler			Rapid modelling of cooperating genetic events in cancer through somatic genome editing	NATURE			English	Article							LUNG ADENOCARCINOMA; SEQUENCING DATA; HUMAN-CELLS; PROGRESSION; CATENIN; REPAIR; CAS9; ENDONUCLEASE; NUCLEASES; HALLMARKS	Cancer is a multistep process that involves mutations and other alterations in oncogenes and tumour suppressor genes(1). Genome sequencing studies have identified a large collection of genetic alterations that occur in human cancers(2-4). However, the determination of which mutations are causally related to tumorigenesis remains a major challenge. Here we describe a novel CRISPR/Cas9-based approach for rapid functional investigation of candidate genes in well-established autochthonous mouse models of cancer. Using a Kras(G12D)-driven lung cancer model(5), we performed functional characterization of a panel of tumour suppressor genes with knownloss-of-function alterations in human lung cancer. Cre-dependent somatic activation of oncogenic Kras(G12D) combined with CRISPR/Cas9-mediated genome editing of tumour suppressor genes resulted in lung adenocarcinomas with distinct histopathological and molecular features. This rapid somatic genome engineering approach enables functional characterization of putative cancer genes in the lung and other tissues using autochthonous mouse models. We anticipate that this approach can be used to systematically dissect the complex catalogue of mutations identified in cancer genome sequencing studies.	[Sanchez-Rivera, Francisco J.; Papagiannakopoulos, Thales; Romero, Rodrigo; Tammela, Tuomas; Bauer, Matthew R.; Bhutkar, Arjun; Joshi, Nikhil S.; Subbaraj, Lakshmipriya; Xue, Wen; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sanchez-Rivera, Francisco J.; Romero, Rodrigo; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Bronson, Roderick T.] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu	Huang, ZhiXin/H-5123-2017; Sánchez-Rivera, Francisco J./AAV-6985-2020	Huang, ZhiXin/0000-0003-0705-1970; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Subbaraj, Lakshmipriya/0000-0001-5777-3547; Romero, Rodrigo/0000-0002-9388-8306; Joshi, Nikhil/0000-0002-7045-7837; Romero, Rodrigo/0000-0003-1689-0784; /0000-0003-3675-6961	Howard Hughes Medical Institute; Ludwig Center for Molecular Oncology at MIT; Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA014051, K99CA169512, R00CA169512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Molecular Oncology at MIT; Cancer Center Support (core) grant from the National Cancer Institute; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. McFadden and Y. Soto-Feliciano for critical reading of the manuscript, H. Yin, S. Levine and T. Mason for MiSeq sequencing support, R. Stott, J. Bartlebaugh and C. Shivalila for technical assistance and K. Cormier and C. Condon from the Hope Babette Tang (1983) Histology Facility for technical support. This work was supported by the Howard Hughes Medical Institute, the Ludwig Center for Molecular Oncology at MIT and in part by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.P. is supported by the Hope Funds for Cancer Research. T. J. is a Howard Hughes Medical Institute Investigator, the David H. Koch Professor of Biology, and a Daniel K. Ludwig Scholar.	Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Farago AF, 2012, CELL, V149, P246, DOI 10.1016/j.cell.2012.03.015; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Psarras S, 2004, J GENE MED, V6, P32, DOI 10.1002/jgm.442; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	39	268	282	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					428	+		10.1038/nature13906	http://dx.doi.org/10.1038/nature13906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25337879	Green Submitted, Green Accepted			2022-12-28	WOS:000346484800054
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			Voters and the Affordable Care Act in the 2014 Election	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.				Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Supported by a grant from the Robert Wood Johnson Foundation.	[Anonymous], 2013, WASHINGTON POST; [Anonymous], 2014, SENTAE RACE RATING; Blendon RJ, 2012, NEW ENGL J MED, V367, P1658, DOI 10.1056/NEJMsr1211472; Kamarck E, 2014, 2014 CONGRESSIONAL P; Real Clear Politics, BATTL SEN; Wesleyan Media Project, 2014, GEN EL ADV OP EV MOR; WILNER ELIZABETH, 2014, AFFORDABLE CARE ACTS	7	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20							e31	10.1056/NEJMsr1412118	http://dx.doi.org/10.1056/NEJMsr1412118			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25353968				2022-12-28	WOS:000344709800016
J	Planavsky, NJ; Reinhard, CT; Wang, XL; Thomson, D; McGoldrick, P; Rainbird, RH; Johnson, T; Fischer, WW; Lyons, TW				Planavsky, Noah J.; Reinhard, Christopher T.; Wang, Xiangli; Thomson, Danielle; McGoldrick, Peter; Rainbird, Robert H.; Johnson, Thomas; Fischer, Woodward W.; Lyons, Timothy W.			Low Mid-Proterozoic atmospheric oxygen levels and the delayed rise of animals	SCIENCE			English	Article							CHROMIUM ISOTOPES; EARLY HISTORY; ENVIRONMENT; DIAGENESIS; PALEOSOLS; REDUCTION; OXIDATION; REDOX; SOILS; OCEAN	The oxygenation of Earth's surface fundamentally altered global biogeochemical cycles and ultimately paved the way for the rise of metazoans at the end of the Proterozoic. However, current estimates for atmospheric oxygen (O-2) levels during the billion years leading up to this time vary widely. On the basis of chromium (Cr) isotope data from a suite of Proterozoic sediments from China, Australia, and North America, interpreted in the context of data from similar depositional environments from Phanerozoic time, we find evidence for inhibited oxidation of Cr at Earth's surface in the mid-Proterozoic (1.8 to 0.8 billion years ago). These data suggest that atmospheric O-2 levels were at most 0.1% of present atmospheric levels. Direct evidence for such low O-2 concentrations in the Proterozoic helps explain the late emergence and diversification of metazoans.	[Planavsky, Noah J.; Wang, Xiangli] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Reinhard, Christopher T.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Wang, Xiangli; Johnson, Thomas] Univ Illinois, Dept Geol, Champaign, IL 61820 USA; [Thomson, Danielle] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [McGoldrick, Peter] Univ Tasmania, Ctr Ore Deposit & Explorat Sci, Hobart, Tas 7001, Australia; [Rainbird, Robert H.] Geol Survey Canada, Ottawa, ON, Canada; [Fischer, Woodward W.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	Yale University; University System of Georgia; Georgia Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Carleton University; University of Tasmania; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; California Institute of Technology; University of California System; University of California Riverside	Planavsky, NJ (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	noah.planavsky@yale.edu; chris.reinhard@eas.gatech.edu	wang, Xiangli/AAT-7987-2020	Rainbird, Robert/0000-0003-4538-4637; Wang, Xiangli/0000-0002-0420-3070	NASA Exobiology Program; NSF-ELT program; California Institute of Technology; National Science and Engineering Research Council of Canada Discovery Grant; Natural Resources Canada's GEM Program; Australian Research Council's Centres of Excellence Program; Division Of Earth Sciences [1338299] Funding Source: National Science Foundation	NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NSF-ELT program; California Institute of Technology; National Science and Engineering Research Council of Canada Discovery Grant; Natural Resources Canada's GEM Program; Australian Research Council's Centres of Excellence Program(Australian Research Council); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	N.J.P., C. T. R., X. W., T.J, and T. W. L. acknowledge funding from NASA Exobiology Program. N.J.P., C. T. R., and T. W. L. acknowledge funding from the NSF-ELT program. C. T. R. acknowledges an O.K. Earl fellowship from the California Institute of Technology. R. H. R. and D. T. acknowledge funding from a National Science and Engineering Research Council of Canada Discovery Grant and by Natural Resources Canada's GEM Program. P. McG. acknowledges funding through the Australian Research Council's Centres of Excellence Program and thanks S. Gilbert for expert help with the LA-ICPMS work. We are indebted to A. Bekker, B. Maynard, A. Hofmann, K. Konhauser, J. Owens, C. Li, and G. Love for discussion and samples. Full data tables are in the supplementary materials.	ALLER RC, 1986, CONT SHELF RES, V6, P263, DOI 10.1016/0278-4343(86)90064-6; BARTLETT R, 1979, J ENVIRON QUAL, V8, P31, DOI 10.2134/jeq1979.00472425000800010008x; Brown AC, 2005, ECON GEOL, V100, P765, DOI 10.2113/100.4.765; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Crowe SA, 2013, NATURE, V501, P535, DOI 10.1038/nature12426; Ellis AS, 2004, ENVIRON SCI TECHNOL, V38, P3604, DOI 10.1021/es0352294; Ellis AS, 2002, SCIENCE, V295, P2060, DOI 10.1126/science.1068368; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Johnson TM, 2004, REV MINERAL GEOCHEM, V55, P289, DOI 10.2138/gsrmg.55.1.289; Knoll AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016121; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Leach D.L., 2005, ONE 100 ANNIVERSARY, V105, P561, DOI [10.5382/AV100.18, DOI 10.5382/AV100.18]; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Mills DB, 2014, P NATL ACAD SCI USA, V111, P4168, DOI 10.1073/pnas.1400547111; Payne JL, 2011, PHOTOSYNTH RES, V107, P37, DOI 10.1007/s11120-010-9593-1; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schauble E, 2004, CHEM GEOL, V205, P99, DOI 10.1016/j.chemgeo.2003.12.015; Schoenberg R, 2008, CHEM GEOL, V249, P294, DOI 10.1016/j.chemgeo.2008.01.009; Sheldon ND, 2006, PRECAMBRIAN RES, V147, P148, DOI 10.1016/j.precamres.2006.02.004; Sperling EA, 2013, EARTH PLANET SC LETT, V371, P143, DOI 10.1016/j.epsl.2013.04.003; van Acken D, 2013, PRECAMBRIAN RES, V236, P124, DOI 10.1016/j.precamres.2013.07.012; ZBINDEN EA, 1988, PRECAMBRIAN RES, V42, P141, DOI 10.1016/0301-9268(88)90014-9; Zink S, 2010, GEOCHIM COSMOCHIM AC, V74, P5729, DOI 10.1016/j.gca.2010.07.015	31	469	507	15	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		635	638		10.1126/science.1258410	http://dx.doi.org/10.1126/science.1258410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359975				2022-12-28	WOS:000343799700050
J	Davis, K; Ballreich, J				Davis, Karen; Ballreich, Jeromie			Equitable Access to Care - How the United States Ranks Internationally	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Davis, Karen; Ballreich, Jeromie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Davis, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.			Ballreich, Jeromie/0000-0003-2564-4577	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000029] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS000029] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Baron RJ, 2014, NEW ENGL J MED, V370, P99, DOI 10.1056/NEJMp1314933; Davis K, 2014, MIRROR MIRROR WALL; Davis K, 2010, STARTING PATH HIGH P; Schoen C, 2013, HEALTH AFFAIR, V32, P2205, DOI 10.1377/hlthaff.2013.0879	4	29	29	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1567	1570		10.1056/NEJMp1406707	http://dx.doi.org/10.1056/NEJMp1406707			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337745				2022-12-28	WOS:000343648500003
J	Herrigel, DJ; Willett, LR				Herrigel, Dana J.; Willett, Laura Rees			Intensive population-level screening and counseling did not reduce ischemic heart disease at 10 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Herrigel, Dana J.; Willett, Laura Rees] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Herrigel, DJ (corresponding author), Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.							Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Hurt RD, 2012, ARCH INTERN MED, V172, P1635, DOI 10.1001/2013.jamainternmed.46; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC3	10.7326/0003-4819-161-8-201410210-02003	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329220				2022-12-28	WOS:000343906800002
J	Schwefel, HGL				Schwefel, Harald G. L.			In optical pumping, less can be more	SCIENCE			English	Editorial Material									[Schwefel, Harald G. L.] Univ Erlangen Nurnberg, Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Schwefel, Harald G. L.] Univ Erlangen Nurnberg, Inst Opt Informat & Photon, D-91058 Erlangen, Germany	Max Planck Society; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schwefel, HGL (corresponding author), Univ Erlangen Nurnberg, Max Planck Inst Sci Light, D-91058 Erlangen, Germany.	harald.schwefel@mpl.mpg.de	Schwefel, Harald G L/D-2710-2009	Schwefel, Harald G L/0000-0002-4304-6469				Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Boriskina SV, 2006, OPT LETT, V31, P338, DOI 10.1364/OL.31.000338; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; Dembowski C, 2001, PHYS REV LETT, V86, P787, DOI 10.1103/PhysRevLett.86.787; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Jing H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053604; Peng B, 2014, SCIENCE, V346, P328, DOI 10.1126/science.1258004; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Preu S, 2008, OPT EXPRESS, V16, P7336, DOI 10.1364/OE.16.007336; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Wenzel H, 1996, IEEE J QUANTUM ELECT, V32, P69, DOI 10.1109/3.481922; Wiersig J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203901; Yang L, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1873043	14	1	1	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					304	305		10.1126/science.1260707	http://dx.doi.org/10.1126/science.1260707			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324374				2022-12-28	WOS:000343041100020
J	Tabata, R; Sumida, K; Yoshii, T; Ohyama, K; Shinohara, H; Matsubayashi, Y				Tabata, Ryo; Sumida, Kumiko; Yoshii, Tomoaki; Ohyama, Kentaro; Shinohara, Hidefumi; Matsubayashi, Yoshikatsu			Perception of root-derived peptides by shoot LRR-RKs mediates systemic N-demand signaling	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; RESPONSES; PLANTS; IDENTIFICATION; NODULATION; NITRATE; KINASE	Nitrogen (N) is a critical nutrient for plants but is often distributed unevenly in the soil. Plants therefore have evolved a systemic mechanism by which N starvation on one side of the root system leads to a compensatory and increased nitrate uptake on the other side. Here, we study the molecular systems that support perception of N and the long-distance signaling needed to alter root development. Rootlets starved of N secrete small peptides that are translocated to the shoot and received by two leucine-rich repeat receptor kinases (LRR-RKs). Arabidopsis plants deficient in this pathway show growth retardation accompanied with N-deficiency symptoms. Thus, signaling from the root to the shoot helps the plant adapt to fluctuations in local N availability.	[Tabata, Ryo; Sumida, Kumiko; Shinohara, Hidefumi; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshii, Tomoaki; Ohyama, Kentaro] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	matsu@bio.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019; Tabata, Ryo/R-5798-2016; Tabata, Ryo/ABI-7295-2020	Tabata, Ryo/0000-0002-9071-9945; Matsubayashi, Yoshikatsu/0000-0002-2669-2119	Ministry of Education, Culture, Sports, Science, and Technology [25221105]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science, and Technology (no. 25221105). The supplementary materials contain additional data.	Bryan AC, 2012, PLANTA, V235, P111, DOI 10.1007/s00425-011-1489-6; De Coninck B, 2013, J EXP BOT, V64, P5297, DOI 10.1093/jxb/ert295; Delay C, 2013, J EXP BOT, V64, P5383, DOI 10.1093/jxb/ert332; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Gansel X, 2001, PLANT J, V26, P143, DOI 10.1046/j.1365-313x.2001.01016.x; Imin N, 2013, J EXP BOT, V64, P5395, DOI 10.1093/jxb/ert369; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; Reid DE, 2011, ANN BOT-LONDON, V108, P789, DOI 10.1093/aob/mcr205; Roberts I, 2013, J EXP BOT, V64, P5371, DOI 10.1093/jxb/ert331; Ruffel S, 2008, PLANT PHYSIOL, V146, P2020, DOI 10.1104/pp.107.115667; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003	14	315	347	10	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					343	346		10.1126/science.1257800	http://dx.doi.org/10.1126/science.1257800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324386				2022-12-28	WOS:000343041100042
J	Iglehart, JK				Iglehart, John K.			Diversity Dynamics - Challenges to a Representative U.S. Medical Workforce	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Association of American Medical Colleges, 2010, DIV PHYS WORKF FACTS DIV PHYS WORKF FACTS; Association of American Medical Colleges, 2012, DIV MED ED FACTS FIG; Department of Health and Human Services, 2009, PIP PROGR IMPR RAC E; Leonhardt D., 2014, NY TIMES, pA3; Nivet MA, 2011, ACAD MED, V86, P1487, DOI 10.1097/ACM.0b013e3182351f79	5	21	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1471	1474		10.1056/NEJMp1408647	http://dx.doi.org/10.1056/NEJMp1408647			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7KV	25317867				2022-12-28	WOS:000342994700002
J	Motch, C; Pakull, MW; Soria, R; Grise, F; Pietrzynski, G				Motch, C.; Pakull, M. W.; Soria, R.; Grise, F.; Pietrzynski, G.			A mass of less than 15 solar masses for the black hole in an ultraluminous X-ray source	NATURE			English	Article							GALAXY NGC 7793; B-SUPERGIANTS; ACCRETION DISC; STELLAR; EMISSION; HERCULES-X-1; PARAMETERS; EVOLUTION; BINARIES; SPECTRA	Most ultraluminous X-ray sources(1) have a typical set of properties not seen in Galactic stellar-mass black holes. They have luminosities of more than 3 x 10(39) ergs per second, unusually soft X-ray components (with a typical temperature of less than about 0.3 kiloelectronvolts) and a characteristic downturn(2,3) in their spectra above about 5 kiloelectronvolts. Such puzzling properties have been interpreted either as evidence of intermediate-mass black holes(4,5) or as emission from stellar-mass black holes accreting above their Eddington limit(6,7), analogous to some Galactic black holes at peak luminosity(8,9). Recently, a very soft X-ray spectrum was observed in a rare and transient stellar-mass black hole(10). Here we report that the X-ray source P13 in the galaxy NGC 7793(11) is in a binary system with a period of about 64 days and exhibits all three canonical properties of ultraluminous sources. By modelling the strong optical and ultraviolet modulations arising from X-ray heating of the B9Ia donor star, we constrain the black hole mass to be less than 15 solar masses. Our results demonstrate that in P13, soft thermal emission and spectral curvature are indeed signatures of supercritical accretion. By analogy, ultraluminous X-ray sources with similar X-ray spectra and luminosities of up to a few times 10(40) ergs per second can be explained by supercritical accretion onto massive stellar-mass black holes.	[Motch, C.; Pakull, M. W.; Grise, F.] Univ Strasbourg, CNRS, Observ Astron Strasbourg, UMR 7550, F-67000 Strasbourg, France; [Soria, R.] Curtin Univ, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Grise, F.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Grise, F.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Grise, F.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Pietrzynski, G.] Univ Concepcion, Dept Astron, Concepcion, Octava Region, Chile; [Pietrzynski, G.] Univ Warsaw Observ, PL-00478 Warsaw, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Curtin University; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Iowa; Universidad de Concepcion; University of Warsaw; Warsaw University Observatory	Motch, C (corresponding author), Univ Strasbourg, CNRS, Observ Astron Strasbourg, UMR 7550, 11 Rue Univ, F-67000 Strasbourg, France.	christian.motch@unistra.fr	Soria, Roberto/AAU-3154-2020	Soria, Roberto/0000-0002-4622-796X; Pietrzynski, Grzegorz/0000-0002-9443-4138; Grise, Fabien/0000-0002-3603-9789	Australian Research Council [DP120102393]; CNES (CNRS/INSU/CNES) [92532]; Spanish Ministry of Science and Innovation (MICINN) [AYA 2010-18080]; Ideas Plus programme of the Polish Ministry of Science; ESO telescopes at the La Silla Paranal Observatory [084.D-0881, 087.D-0602]; ESA member states; NASA	Australian Research Council(Australian Research Council); CNES (CNRS/INSU/CNES); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ideas Plus programme of the Polish Ministry of Science; ESO telescopes at the La Silla Paranal Observatory; ESA member states(European Space Agency); NASA(National Aeronautics & Space Administration (NASA))	R.S. acknowledges an Australian Research Council Discovery Projects funding scheme (project number DP120102393). F.G. acknowledges support from CNES (CNRS/INSU/CNES contract no. 92532) and partly from the Spanish Ministry of Science and Innovation (MICINN) under grant AYA 2010-18080. Support from the Ideas Plus programme of the Polish Ministry of Science is also acknowledged. We thank J. Orosz for providing us with the ELC code. We acknowledge the Swift team for executing our observing programme. This work is based on observations made with ESO telescopes at the La Silla Paranal Observatory under programme IDs 084.D-0881 and 087.D-0602, and uses observations made with the NASA/ESA Hubble Space Telescope (HST) and obtained from the Hubble Legacy Archive, which is a collaboration between the Space Telescope Science Institute (STScI/NASA), the Space Telescope European Coordinating Facility (ST-ECF/ESA) and the Canadian Astronomy Data Centre (CADC/NRC/CSA). The scientific results reported in this article are based in part on observations made by the Chandra X-ray Observatory and in part on observations obtained with XMM-Newton (OBSIDs 0693760101 and 0693760401), an ESA science mission with instruments and contributions directly funded by ESA member states and NASA.	Colbert EJM, 1999, ASTROPHYS J, V519, P89, DOI 10.1086/307356; DEETER J, 1976, ASTROPHYS J, V206, P861, DOI 10.1086/154449; Done C, 2004, MON NOT R ASTRON SOC, V349, P393, DOI 10.1111/j.1365-2966.2004.07545.x; Feng H, 2011, NEW ASTRON REV, V55, P166, DOI 10.1016/j.newar.2011.08.002; GIACCONI R, 1973, ASTROPHYS J, V184, P227, DOI 10.1086/152321; Gierlinski M, 2009, MON NOT R ASTRON SOC, V392, P1106, DOI 10.1111/j.1365-2966.2008.14166.x; Gladstone JC, 2009, MON NOT R ASTRON SOC, V397, P1836, DOI 10.1111/j.1365-2966.2009.15123.x; Kawashima T, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/18; Kudritzki RP, 1999, ASTRON ASTROPHYS, V350, P970; LENNON DJ, 1992, ASTRON ASTROPHYS SUP, V94, P569; Liu JF, 2013, NATURE, V503, P500, DOI 10.1038/nature12762; Markova N, 2008, ASTRON ASTROPHYS, V478, P823, DOI 10.1051/0004-6361:20077919; Meynet G, 2000, ASTRON ASTROPHYS, V361, P101; Middleton MJ, 2013, NATURE, V493, P187, DOI 10.1038/nature11697; Miller JM, 2003, ASTROPHYS J, V585, pL37, DOI 10.1086/368373; Motch C, 2011, ASTRON NACHR, V332, P367, DOI 10.1002/asna.201011501; Orosz JA, 2000, ASTRON ASTROPHYS, V364, P265; Pannuti TG, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/20; Patruno A, 2010, MON NOT R ASTRON SOC, V403, pL69, DOI 10.1111/j.1745-3933.2010.00817.x; Pearson KJ, 2006, ASTROPHYS J, V648, P1169, DOI 10.1086/506191; Pietrzynski G, 2010, ASTRON J, V140, P1475, DOI 10.1088/0004-6256/140/5/1475; Podsiadlowski P, 2003, MON NOT R ASTRON SOC, V341, P385, DOI 10.1046/j.1365-8711.2003.06464.x; Poutanen J, 2007, MON NOT R ASTRON SOC, V377, P1187, DOI 10.1111/j.1365-2966.2007.11668.x; Radburn-Smith DJ, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/2/18; Rappaport SA, 2005, MON NOT R ASTRON SOC, V356, P401, DOI 10.1111/j.1365-2966.2004.08489.x; Read AM, 1999, ASTRON ASTROPHYS, V341, P8; Roberts TP, 2005, MON NOT R ASTRON SOC, V357, P1363, DOI 10.1111/j.1365-2966.2005.08758.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Still MD, 1997, MON NOT R ASTRON SOC, V292, P52, DOI 10.1093/mnras/292.1.52; Zorec J, 2009, ASTRON ASTROPHYS, V501, P297, DOI 10.1051/0004-6361/200811147	30	165	166	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					198	+		10.1038/nature13730	http://dx.doi.org/10.1038/nature13730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297432	Green Submitted			2022-12-28	WOS:000342663100035
J	Webster, BM; Colombi, P; Jager, J; Lusk, P				Webster, Brant M.; Colombi, Paolo; Jaeger, Jens; Lusk, Patrick			Surveillance of Nuclear Pore Complex Assembly by ESCRT-III/Vps4	CELL			English	Article							MEDIATED ABSCISSION CHECKPOINT; ESCRT-III; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; RNA TRANSPORT; PROTEIN; YEAST; ENVELOPE; PATHWAY; DEGRADATION	The maintenance of nuclear compartmentalization by the nuclear envelope and nuclear pore complexes (NPCs) is essential for cell function; loss of compartmentalization is associated with cancers, laminopathies, and aging. We uncovered a pathway that surveils NPC assembly intermediates to promote the formation of functional NPCs. Surveillance is mediated by Heh2, a member of the LEM (Lap2-emerin-MAN1) family of integral inner nuclear membrane proteins, which binds to an early NPC assembly intermediate, but not to mature NPCs. Heh2 recruits the endosomal sorting complex required for transport (ESCRT)-III subunit Snf7 and the AAA-ATPase Vps4 to destabilize and clear defective NPC assembly intermediates. When surveillance or clearance is compromised, malformed NPCs accumulate in a storage of improperly assembled nuclear pore complexes compartment, or SINC. The SINC is retained in old mothers to prevent loss of daughter lifespan, highlighting a continuum of mechanisms to ensure nuclear compartmentalization.	[Webster, Brant M.; Colombi, Paolo; Jaeger, Jens; Lusk, Patrick] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Lusk, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	patrick.lusk@yale.edu		Lusk, C. Patrick/0000-0003-4703-0533	NIH [R01 GM105672, R21HG006742, 5T32GM007223]; Mather's Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105672, T32GM007223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mather's Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the Mather's Foundation for their support and to A. Frost for sharing unpublished data. Thank you to C. Burd and D. Katzmann for advice and reagents, and to M. King, T. Carroll, C. Schlieker, and M. Hochstrasser for comments on the manuscript. We appreciate reagents from E. Hurt, M. Rout, and T. Walther and the EM expertise of M. Graham and X. Liu. We are indebted to R. Christiano, Z. Hakhverdyan, and M. Rout for help during revisions. All authors are supported by NIH R01 GM105672 with additional funds to C.P.L. and P.C. from NIH R21HG006742. B.M.W. was also supported by NIH 5T32GM007223.	Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chadrin A, 2010, J CELL BIOL, V189, P795, DOI 10.1083/jcb.200910043; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Colombi P, 2013, J CELL BIOL, V203, P215, DOI 10.1083/jcb.201305115; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Fernandez-Martinez J, 2009, CURR OPIN CELL BIOL, V21, P603, DOI 10.1016/j.ceb.2009.05.001; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Funakoshi T, 2011, MOL BIOL CELL, V22, P1058, DOI 10.1091/mbc.E10-07-0641; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayakawa A, 2012, J CELL BIOL, V196, P19, DOI 10.1083/jcb.201108124; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Lee CP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002904; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lusk CP, 2014, NUCLEUS-PHILA, V5, P97, DOI 10.4161/nucl.28314; Mackay DR, 2010, J CELL BIOL, V191, P923, DOI 10.1083/jcb.201007124; Makio T, 2013, J CELL BIOL, V203, P187, DOI 10.1083/jcb.201304047; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Stauffer DR, 2001, J CELL SCI, V114, P2383; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Verzijlbergen KF, 2010, P NATL ACAD SCI USA, V107, P64, DOI 10.1073/pnas.0911164107; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Yewdell WT, 2011, MOL BIOL CELL, V22, P1375, DOI 10.1091/mbc.E10-06-0554	70	146	151	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					388	401		10.1016/j.cell.2014.09.012	http://dx.doi.org/10.1016/j.cell.2014.09.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303532	Bronze, Green Accepted			2022-12-28	WOS:000343095600019
J	Chaloupka, FJ; Gruber, J; Warner, KE				Chaloupka, Frank J.; Gruber, Jonathan; Warner, Kenneth E.			Accounting for "Lost Pleasure" in a Cost-Benefit Analysis of Government Regulation: The Case of the Food and Drug Administration's Proposed Cigarette Labeling Regulation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WARNING LABELS		[Chaloupka, Frank J.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60608 USA; [Gruber, Jonathan] MIT, Dept Econ, Cambridge, MA 02139 USA; [Warner, Kenneth E.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Gruber, J (corresponding author), MIT, Dept Econ, 40 Ames St,E17-220, Cambridge, MA 02139 USA.	gruberj@mit.edu		Warner, Kenneth/0000-0002-8214-1776				Azagba S, 2013, NICOTINE TOB RES, V15, P708, DOI 10.1093/ntr/nts194; Fong Geoffrey T, 2004, Nicotine Tob Res, V6 Suppl 3, pS341; Gruber J.H., 2005, BE J ECON ANAL POLI, V5, DOI DOI 10.1515/1538-0637.1412; Huang Jidong, 2014, Tob Control, V23 Suppl 1, pi7, DOI 10.1136/tobaccocontrol-2013-051170; Johnston L. D., 2013, MONITORING FUTURE NA, V2; Kollath-Cattano CL, 2014, AM J PREV MED, V47, P26, DOI 10.1016/j.amepre.2014.02.006; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONS SMOK 50 YE; Warner KE, 2010, NICOTINE TOB RES, V12, P876, DOI 10.1093/ntr/ntq125	9	17	17	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					64	U106		10.7326/M14-1910	http://dx.doi.org/10.7326/M14-1910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25322210				2022-12-28	WOS:000350103000008
J	Fuchs, VR				Fuchs, Victor R.			Critiquing US Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Stanford Inst Econ Policy Res, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford Inst Econ Policy Res, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Fuchs VR, 2013, JAMA-J AM MED ASSOC, V309, P33, DOI 10.1001/jama.2012.125458; National Research Council; Institute of Medicine, 2013, US HLTH INT PERSP SH	2	9	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2095	2096		10.1001/jama.2014.14114	http://dx.doi.org/10.1001/jama.2014.14114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25322201				2022-12-28	WOS:000345626800009
J	Watanabe, S; Trimbuch, T; Camacho-Perez, M; Rost, BR; Brokowski, B; Sohl-Kielczynski, B; Felies, A; Davis, MW; Rosenmund, C; Jorgensen, EM				Watanabe, Shigeki; Trimbuch, Thorsten; Camacho-Perez, Marcial; Rost, Benjamin R.; Brokowski, Bettina; Soehl-Kielczynski, Berit; Felies, Annegret; Davis, M. Wayne; Rosenmund, Christian; Jorgensen, Erik M.			Clathrin regenerates synaptic vesicles from endosomes	NATURE			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; MEDIATED ENDOCYTOSIS; PHYSIOLOGICAL TEMPERATURES; CAENORHABDITIS-ELEGANS; MEMBRANE RETRIEVAL; TERMINALS; RELEASE; DYNAMIN; TRAFFICKING	Ultrafast endocytosis can retrieve a single, large endocytic vesicle as fast as 50-100 ms after synaptic vesicle fusion. However, the fate of the large endocytic vesicles is not known. Here we demonstrate that these vesicles transition to a synaptic endosome about one second after stimulation. The endosome is resolved into coated vesicles after 3 s, which in turn become small-diameter synaptic vesicles 5-6 s after stimulation. We disrupted clathrin function using RNA interference (RNAi) and found that clathrin is not required for ultrafast endocytosis but is required to generate synaptic vesicles from the endosome. Ultrafast endocytosis fails when actin polymerization is disrupted, or when neurons are stimulated at room temperature instead of physiological temperature. In the absence of ultrafast endocytosis, synaptic vesicles are retrieved directly from the plasma membrane by clathrin-mediated endocytosis. These results may explain discrepancies among published experiments concerning the role of clathrin in synaptic vesicle endocytosis.	[Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Trimbuch, Thorsten; Camacho-Perez, Marcial; Rost, Benjamin R.; Brokowski, Bettina; Soehl-Kielczynski, Berit; Felies, Annegret; Rosenmund, Christian] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Brokowski, Bettina] German Ctr Neurodegenerat Dis DZNE, D-10117 Berlin, Germany	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	christian.rosenmund@charite.de; jorgensen@biology.utah.edu	Rosenmund, Christian/AAC-3596-2020; Rost, Benjamin/AHD-2242-2022	Rosenmund, Christian/0000-0002-3905-2444; Rost, Benjamin/0000-0003-1906-0081; Camacho Perez, Marcial/0000-0002-2367-1259; Trimbuch, Thorsten/0000-0001-7512-8955; Watanabe, Shigeki/0000-0001-7580-8141; Davis, Mikel/0000-0003-1867-1593	EMBO; US National Institutes of Health [NS034307]; European Research Council grant [249939 SYNVGLUT]; German Research Council grants [Neurocure EXC 257, SFB 665, SFB 958]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307, R37NS034307] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council grant(European Research Council (ERC)); German Research Council grants; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Lorenz and A. Muenster-Wandowski for providing access to electron microscopy, J. Iwasa for the original model figure, S. Jorgensen for image processing, and C. Garner for discussions. We thank EMBO for providing the travel funds (S.W.). The research was funded by the US National Institutes of Health (NS034307 EMJ), European Research Council grant (249939 SYNVGLUT CR), and German Research Council grants (Neurocure EXC 257 EMJ+CR, SFB 665 + SFB 958 CR). E.M.J. is an Investigator of the Howard Hughes Medical Institute and is an Alexander von Humboldt Scholar.	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gisselsson LL, 2005, J CEREBR BLOOD F MET, V25, P1346, DOI 10.1038/sj.jcbfm.9600131; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gu MY, 2013, ELIFE, V2, DOI 10.7554/eLife.00190; Hartmann-Petersen R, 2000, CYTOMETRY, V40, P260, DOI 10.1002/1097-0320(20000801)40:4<260::AID-CYTO2>3.0.CO;2-J; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Heuser J., 1979, 4 INTENSIVE STUDY PR, P573; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KANE RE, 1976, J CELL BIOL, V71, P704, DOI 10.1083/jcb.71.3.704; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kittelmann M, 2013, P NATL ACAD SCI USA, V110, pE3007, DOI 10.1073/pnas.1305679110; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Schikorski T, 2014, P NATL ACAD SCI USA, V111, P5415, DOI 10.1073/pnas.1321541111; SIK A, 1995, J NEUROSCI, V15, P6651; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Teng HB, 1999, J NEUROSCI, V19, P4855; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	50	178	178	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					228	U168		10.1038/nature13846	http://dx.doi.org/10.1038/nature13846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25296249	Green Accepted			2022-12-28	WOS:000344631400041
J	Stephens, IW; Looney, LW; Kwon, W; Fernandez-Lopez, M; Hughes, AM; Mundy, LG; Crutcher, RM; Li, ZY; Rao, R				Stephens, Ian W.; Looney, Leslie W.; Kwon, Woojin; Fernandez-Lopez, Manuel; Hughes, A. Meredith; Mundy, Lee G.; Crutcher, Richard M.; Li, Zhi-Yun; Rao, Ramprasad			Spatially resolvedmagnetic field structure in the disk of a T Tauri star	NATURE			English	Article							YOUNG STELLAR OBJECTS; MAGNETIC-FIELDS; HL TAURI; ACCRETION DISKS; MILLIMETER; POLARIZATION; PROTOSTAR; EMISSION; OUTFLOWS; REGIONS	Magnetic fields in accretion disks play a dominant part during the star formation process(1,2) but have hitherto beenobservationally poorly constrained. Field strengths have been inferred on T Tauri stars(3) and possibly in the innermost part of their accretion disks(4), but the strength and morphology of the field in the bulk of a disk have not beenobserved. Spatially unresolved measurements of polarized emission (arising from elongated dust grains aligned perpendicularly to the field(5)) imply average fields aligned with the disks(6,7). Theoretically, the fields are expected to be largely toroidal, poloidal or a mixture of the two(1,2,8-10), whichimply different mechanisms for transporting angular momentum in the disks of actively accreting young stars such as HL Tau (ref. 11). Here we report resolved measurements of the polarized 1.25-millimetre continuum emission from the disk of HL Tau. The magnetic field on a scale of 80 astronomical units is coincident with the major axis (about 210 astronomical units long(12)) of the disk. From this we conclude that the magnetic field inside the disk at this scale cannot be dominated by a vertical component, though a purely toroidal field also does not fit the data well. The unexpected morphology suggests that the role of the magnetic field in the accretion of a T Tauri star is more complex than our current theoretical understanding.	[Stephens, Ian W.] Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; [Stephens, Ian W.; Looney, Leslie W.; Fernandez-Lopez, Manuel; Crutcher, Richard M.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Kwon, Woojin] Univ Groningen, SRON Netherlands Inst Space Res, NL-9747 AD Groningen, Netherlands; [Fernandez-Lopez, Manuel] CCT La Plata CONICET, Inst Argentino Radioastron, RA-1894 Villa Elisa, Argentina; [Hughes, A. Meredith] Wesleyan Univ, Dept Astron, Van Vleck Observ, Middletown, CT 06459 USA; [Mundy, Lee G.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Mundy, Lee G.] Univ Maryland, Lab Millimeter Wave Astron, College Pk, MD 20742 USA; [Li, Zhi-Yun] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Rao, Ramprasad] Acad Sinica, Inst Astron & Astrophys, Hilo, HI 96720 USA	Boston University; University of Illinois System; University of Illinois Urbana-Champaign; University of Groningen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Argentino de Radioastronomia; Wesleyan University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Virginia; Academia Sinica - Taiwan	Stephens, IW (corresponding author), Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA.	ianws@bu.edu	Fernandez-Lopez, Manuel/ABH-4739-2020; Rao, Ramprasad/L-2115-2017	Fernandez-Lopez, Manuel/0000-0001-5811-0454; Rao, Ramprasad/0000-0002-1407-7944; Looney, Leslie/0000-0002-4540-6587; Hughes, A. Meredith/0000-0002-4803-6200	NSF [AST-1139950, AST-1139998]; state of California; state of Illinois; state of Maryland; James S. McDonnell Foundation; Gordon and Betty Moore Foundation; Kenneth T. and Eileen L. Norris Foundation; University of Chicago; Associates of the California Institute of Technology; National Science Foundation; CARMA partner universities;  [NSF AST 08-38226]; Direct For Mathematical & Physical Scien [1139950, 1140031] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1007713, 1140019, 1140063, 1139998] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); state of California; state of Illinois; state of Maryland; James S. McDonnell Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Kenneth T. and Eileen L. Norris Foundation; University of Chicago(University of Chicago); Associates of the California Institute of Technology; National Science Foundation(National Science Foundation (NSF)); CARMA partner universities; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank R. L. Plambeck and C. L. H. Hull for consultation during the data reduction process and C. F. Gammie for discussions. This research made use of APLpy, an open-source plotting package for Python hosted at http://aplpy.github.com. Work at the Universities of Illinois and Maryland was supported by NSF AST-1139950 and AST-1139998, respectively. Support for CARMA construction was derived from the states of California, Illinois and Maryland, the James S. McDonnell Foundation, the Gordon and Betty Moore Foundation, the Kenneth T. and Eileen L. Norris Foundation, the University of Chicago, the Associates of the California Institute of Technology, and the National Science Foundation. Ongoing CARMA development and operations are supported under a cooperative agreement (NSF AST 08-38226) and by the CARMA partner universities.	[Anonymous], 1986, MITT ASTRON GES HAMB; Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; Cho J, 2007, ASTROPHYS J, V669, P1085, DOI 10.1086/521805; Donati JF, 2005, NATURE, V438, P466, DOI 10.1038/nature04253; Dullemond CP, 2004, ASTRON ASTROPHYS, V417, P159, DOI 10.1051/0004-6361:20031768; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Girart JM, 2006, SCIENCE, V313, P812, DOI 10.1126/science.1129093; Greaves JS, 2008, MON NOT R ASTRON SOC, V391, pL74, DOI 10.1111/j.1745-3933.2008.00559.x; Hennebelle P, 2009, ASTRON ASTROPHYS, V506, pL29, DOI 10.1051/0004-6361/200913008; Hughes AM, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/4/115; Hughes AM, 2009, ASTROPHYS J, V698, P131, DOI 10.1088/0004-637X/698/1/131; Hull CLH, 2014, ASTROPHYS J SUPPL S, V213, DOI 10.1088/0067-0049/213/1/13; Hull CLH, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/159; Johns-Krull CM, 2007, ASTROPHYS J, V664, P975, DOI 10.1086/519017; Konigl A., 2000, Protostars and planets 4, P759; Kwon W, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/3; Lay OP, 1997, ASTROPHYS J, V489, P917, DOI 10.1086/304815; Lazarian A, 2007, J QUANT SPECTROSC RA, V106, P225, DOI 10.1016/j.jqsrt.2007.01.038; Loinard L, 2013, MON NOT R ASTRON SOC, V430, pL10, DOI 10.1093/mnrasl/sls038; Marrone DP, 2008, P SOC PHOTO-OPT INS, V7020, DOI 10.1117/12.788677; Movsessian TA, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118529; Rao R, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L6; Rebull LM, 2004, ASTRON J, V127, P1029, DOI 10.1086/380931; Robitaille TP, 2007, ASTROPHYS J SUPPL S, V169, P328, DOI 10.1086/512039; Sault RJ, 1995, ASTR SOC P, V77, P433; Stephens IW, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L15; Tafoya D, 2004, ASTROPHYS J, V610, P827, DOI 10.1086/421729; TAMURA M, 1995, ASTROPHYS J, V448, P346, DOI 10.1086/175965; Tamura M, 1999, ASTROPHYS J, V525, P832, DOI 10.1086/307953; WARDLE M, 1993, ASTROPHYS J, V410, P218, DOI 10.1086/172739; Welch WJ, 2000, ASTROPHYS J, V540, P362, DOI 10.1086/309290	32	104	104	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					597	+		10.1038/nature13850	http://dx.doi.org/10.1038/nature13850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25337883	Green Submitted, Green Published			2022-12-28	WOS:000343801500041
J	De Pontieu, B; van der Voort, LR; McIntosh, SW; Pereira, TMD; Carlsson, M; Hansteen, V; Skogsrud, H; Lemen, J; Title, A; Boerner, P; Hurlburt, N; Tarbell, TD; Wuelser, JP; De Luca, EE; Golub, L; McKillop, S; Reeves, K; Saar, S; Testa, P; Tian, H; Kankelborg, C; Jaeggli, S; Kleint, L; Martinez-Sykora, J				De Pontieu, B.; van der Voort, L. Rouppe; McIntosh, S. W.; Pereira, T. M. D.; Carlsson, M.; Hansteen, V.; Skogsrud, H.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; De Luca, E. E.; Golub, L.; McKillop, S.; Reeves, K.; Saar, S.; Testa, P.; Tian, H.; Kankelborg, C.; Jaeggli, S.; Kleint, L.; Martinez-Sykora, J.			On the prevalence of small-scale twist in the solar chromosphere and transition region	SCIENCE			English	Article							ALFVENIC WAVES; CORONA; ENERGY; ATMOSPHERE; DRIVEN; POWER; WIND; IRIS	The solar chromosphere and transition region (TR) form an interface between the Sun's surface and its hot outer atmosphere. There, most of the nonthermal energy that powers the solar atmosphere is transformed into heat, although the detailed mechanism remains elusive. High-resolution (0.33-arc second) observations with NASA's Interface Region Imaging Spectrograph (IRIS) reveal a chromosphere and TR that are replete with twist or torsional motions on sub-arc second scales, occurring in active regions, quiet Sun regions, and coronal holes alike. We coordinated observations with the Swedish 1-meter Solar Telescope (SST) to quantify these twisting motions and their association with rapid heating to at least TR temperatures. This view of the interface region provides insight into what heats the low solar atmosphere.	[De Pontieu, B.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.] LMSAL, 3251 Hanover St,Org A021S,Bldg 252, Palo Alto, CA 94304 USA; [De Pontieu, B.; van der Voort, L. Rouppe; Pereira, T. M. D.; Carlsson, M.; Hansteen, V.; Skogsrud, H.] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; [McIntosh, S. W.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [De Luca, E. E.; Golub, L.; McKillop, S.; Reeves, K.; Saar, S.; Testa, P.; Tian, H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kankelborg, C.; Jaeggli, S.] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA; [Kleint, L.; Martinez-Sykora, J.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA	University of Oslo; National Center Atmospheric Research (NCAR) - USA; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Montana State University System; Montana State University Bozeman	De Pontieu, B (corresponding author), LMSAL, 3251 Hanover St,Org A021S,Bldg 252, Palo Alto, CA 94304 USA.	bdp@lmsal.com	Reeves, Katharine/P-9163-2014; Pereira, Tiago/G-4079-2014	Rouppe van der Voort, Luc/0000-0003-2088-028X; Pereira, Tiago/0000-0003-4747-4329; Tian, Hui/0000-0002-1369-1758; Reeves, Katharine/0000-0002-6903-6832; Golub, Leon/0000-0001-9638-3082	Norwegian Space Center through a European Space Agency PRODEX; NASA [NNG09FA40C]; Lockheed Martin Independent Research Program; European Research Council [291058]	Norwegian Space Center through a European Space Agency PRODEX; NASA(National Aeronautics & Space Administration (NASA)); Lockheed Martin Independent Research Program; European Research Council(European Research Council (ERC)European Commission)	We thank A. Ortiz, E. Scullion, and A. Sainz-Dalda for assistance with SST observations. IRIS is a NASA Small Explorer developed and operated by LMSAL with mission operations executed at NASA Ames research center and major contributions to downlink communications funded by the Norwegian Space Center through a European Space Agency PRODEX contract. IRIS date can be downloaded from iris.lmsal.com. This work is supported by NASA contract NNG09FA40C (IRIS), the Lockheed Martin Independent Research Program, and European Research Council grant no. 291058. The SST is operated on the island of La Palma by the Institute for Solar Physics of Stockholm. University in the Observatorio del Roque de los Muchachos of the Institute de Astrofisica de Canarias.	Asgari-Targhi M, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/81; Bonet JA, 2008, ASTROPHYS J LETT, V687, pL131, DOI 10.1086/593329; Cirtain JW, 2013, NATURE, V493, P501, DOI 10.1038/nature11772; Curdt W, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117116; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; De Pontieu B, 2012, ASTROPHYS J LETT, V752, DOI [10.1088/2041-8205/752/1/L12, 10.1088/2041-8205/752/1/L12L12]; De Pontieu B, 2007, PUBL ASTRON SOC JPN, V59, pS655, DOI 10.1093/pasj/59.sp3.S655; Hansteen V, 2014, SCIENCE, V346, DOI 10.1126/science.1255757; Hansteen VH, 2006, ASTROPHYS J, V647, pL73, DOI 10.1086/507452; HOLLWEG JV, 1981, SOL PHYS, V70, P25, DOI 10.1007/BF00154391; Jess DB, 2009, SCIENCE, V323, P1582, DOI 10.1126/science.1168680; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; Leenaarts J, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/89; Leenaarts J, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/90; Martinez-Sykora J, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/66; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; McLaughlin JA, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015552; Moll R, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117441; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; Pascoe DJ, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/73; Pereira TMD, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/143; Pike CD, 1998, SOL PHYS, V182, P333, DOI 10.1023/A:1005065704108; Rouppe van der Voort L., 2009, ASTROPHYS J, V705, P272, DOI [10.1088/0004-637X/705/1/272, DOI 10.1088/0004-637X/705/1/272]; Scharmer GB, 2008, ASTROPHYS J LETT, V689, pL69, DOI 10.1086/595744; Scharmer GB, 2003, P SOC PHOTO-OPT INS, V4853, P341, DOI 10.1117/12.460377; Sekse DH, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/108; Tian H, 2014, SCIENCE, V346, DOI 10.1126/science.1255711; van Ballegooijen AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/3; Wedemeyer-Bohm S, 2012, NATURE, V486, P505, DOI 10.1038/nature11202	30	105	106	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207							1255732	10.1126/science.1255732	http://dx.doi.org/10.1126/science.1255732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324398	Green Submitted			2022-12-28	WOS:000343041100030
J	Peng, B; Ozdemir, SK; Rotter, S; Yilmaz, H; Liertzer, M; Monifi, F; Bender, CM; Nori, F; Yang, L				Peng, B.; Oezdemir, S. K.; Rotter, S.; Yilmaz, H.; Liertzer, M.; Monifi, F.; Bender, C. M.; Nori, F.; Yang, L.			Loss-induced suppression and revival of lasing	SCIENCE			English	Article							NON-HERMITIAN HAMILTONIANS; EXCEPTIONAL POINTS; MICROCAVITIES; LASERS; SYMMETRY; CAVITY	Controlling and reversing the effects of loss are major challenges in optical systems. For lasers, losses need to be overcome by a sufficient amount of gain to reach the lasing threshold. In this work, we show how to turn losses into gain by steering the parameters of a system to the vicinity of an exceptional point (EP), which occurs when the eigenvalues and the corresponding eigenstates of a system coalesce. In our system of coupled microresonators, EPs are manifested as the loss-induced suppression and revival of lasing. Below a critical value, adding loss annihilates an existing Raman laser. Beyond this critical threshold, lasing recovers despite the increasing loss, in stark contrast to what would be expected from conventional laser theory. Our results exemplify the counterintuitive features of EPs and present an innovative method for reversing the effect of loss.	[Peng, B.; Oezdemir, S. K.; Yilmaz, H.; Monifi, F.; Yang, L.] Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA; [Rotter, S.; Liertzer, M.] Vienna Univ Technol, Inst Theoret Phys, A-1040 Vienna, Austria; [Bender, C. M.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Nori, F.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Nori, F.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Technische Universitat Wien; Washington University (WUSTL); RIKEN; University of Michigan System; University of Michigan	Ozdemir, SK (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA.	ozdemir@ese.wustl.edu; yang@ese.wustl.edu	Nori, Franco/B-1222-2009; Yang, Lan/B-5407-2018; Peng, Bo/J-7026-2015; Rotter, Stefan/E-1997-2011; Yang, Lan/AAC-5397-2019; Yilmaz, Huzeyfe/AAW-3235-2021; Ozdemir, Sahin Kaya/Y-9338-2019; Yang, Lan/AAC-5390-2019; Ozdemir, Sahin K/C-8879-2009	Nori, Franco/0000-0003-3682-7432; Yang, Lan/0000-0002-9052-0450; Rotter, Stefan/0000-0002-4123-1417; Yilmaz, Huzeyfe/0000-0003-1595-7019; Ozdemir, Sahin Kaya/0000-0002-2625-3992; Yang, Lan/0000-0002-9052-0450; Ozdemir, Sahin K/0000-0002-2625-3992	Army Research Office (ARO) [W911NF-12-1-0026]; U.S. Department of Energy [DE-FG02-91ER40628]; RIKEN iTHES Project, Multidisciplinary University Research Initiatives (MURI) Center for Dynamic Magneto-Optics; Vienna Science and Technology Fund (WWTF) [MA09-030]; Austrian Science Fund (FWF) [SFB-IR-ON F25-P14, SFB-NextLite F49-P10]	Army Research Office (ARO); U.S. Department of Energy(United States Department of Energy (DOE)); RIKEN iTHES Project, Multidisciplinary University Research Initiatives (MURI) Center for Dynamic Magneto-Optics; Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	S.K.O. am L.Y. conceived the idea and designed the experiments. B.P. and S.K.O performed the experiments with help from H.Y. and F.M. Theoretical background and simulations were provided by B.P., S.K.O., S.R., M.L., C.M.B., and F.N. All authors discussed the results, and S.K.O. S.R., and L.Y. wrote the manuscript with input from all authors. This work was supported by Army Research Office (ARO) grant no. W911NF-12-1-0026. C.M.B. was supported by U.S. Department of Energy grant no. DE-FG02-91ER40628. F.N. is partially supported by the RIKEN iTHES Project, Multidisciplinary University Research Initiatives (MURI) Center for Dynamic Magneto-Optics, Grant-in-Aid for Scientific Research (S). S.R. and M.L. are supported by the Vienna Science and Technology Fund (WWTF) project no. MA09-030 and by the Austrian Science Fund (FWF) project no SFB-IR-ON F25-P14, SFB-NextLite F49-P10.	Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Berry MV, 2003, J MOD OPTIC, V50, P63, DOI 10.1080/09500340210135402; Brandstetter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5034; Carmon T, 2004, OPT EXPRESS, V12, P4742, DOI 10.1364/OPEX.12.004742; Dembowski C, 2001, PHYS REV LETT, V86, P787, DOI 10.1103/PhysRevLett.86.787; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022; Feng L, 2014, OPT EXPRESS, V22, P1760, DOI 10.1364/OE.22.001760; Feng L, 2013, NAT MATER, V12, P108, DOI [10.1038/NMAT3495, 10.1038/nmat3495]; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; He LN, 2013, LASER PHOTONICS REV, V7, P60, DOI 10.1002/lpor.201100032; Heiss WD, 2004, J PHYS A-MATH GEN, V37, P2455, DOI 10.1088/0305-4470/37/6/034; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Lee SB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.134101; Moiseyev N., 2011, NONHERMITIAN QUANTUM; O'Shea D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193601; Ozdemir SK, 2014, P NATL ACAD SCI USA, V111, pE3836, DOI 10.1073/pnas.1408283111; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Persson E, 2000, PHYS REV LETT, V85, P2478, DOI 10.1103/PhysRevLett.85.2478; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Rotter I, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/15/153001; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Spillane SM, 2002, NATURE, V415, P621, DOI 10.1038/415621a; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; Wenzel H, 1996, IEEE J QUANTUM ELECT, V32, P69, DOI 10.1109/3.481922; Zhu JG, 2010, NAT PHOTONICS, V4, P46, DOI 10.1038/NPHOTON.2009.237	29	609	616	23	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					328	332		10.1126/science.1258004	http://dx.doi.org/10.1126/science.1258004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324384	Green Submitted			2022-12-28	WOS:000343041100038
J	Durand, ML; Lin, DT; Juliano, AF; Sadow, PM				Durand, Marlene L.; Lin, Derrick T.; Juliano, Amy F.; Sadow, Peter M.			Case 32-2014: A 78-Year-Old Woman with Chronic Sore Throat and a Tonsillar Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VARICELLA-ZOSTER-VIRUS; NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; HISTOPLASMOSIS; TUBERCULOSIS; INFECTION; HERPES; HEAD		[Durand, Marlene L.] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA; [Juliano, Amy F.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Durand, Marlene L.] Harvard Univ, Sch Med, Dept Infect Dis, Boston, MA USA; [Lin, Derrick T.] Harvard Univ, Sch Med, Dept Head & Neck Oncol, Boston, MA USA; [Juliano, Amy F.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lin, Derrick T.; Sadow, Peter M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Juliano, Amy F.] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary	Durand, ML (corresponding author), Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA.		Sadow, Peter/E-7691-2015; Sadow, Peter/AAO-9878-2020	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367				Antonello VS, 2011, REV SOC BRAS MED TRO, V44; Arduino PG, 2008, J ORAL PATHOL MED, V37, P107, DOI 10.1111/j.1600-0714.2007.00586.x; Arnold MG, 2004, LARYNGOSCOPE, V114, P747, DOI 10.1097/00005537-200404000-00029; Assi MA, 2007, MEDICINE, V86, P162, DOI 10.1097/md.0b013e3180679130; Baddley JW, 2011, EMERG INFECT DIS, V17, P1664, DOI 10.3201/eid1709.101987; Centers for Disease Control and Prevention, HIST STAT; Chen PS, 2012, ARCH OTOLARYNGOL, V138, P592, DOI 10.1001/archoto.2012.600; Chitose SI, 2008, J LARYNGOL OTOL, V122, P170, DOI 10.1017/S0022215107000898; Choi JH, 2013, AM J OTOLARYNG, V34, P369, DOI 10.1016/j.amjoto.2013.01.008; Efde MN, 2005, NETH J MED, V63, P112; Galgiani JN, 2010, PRINCIPLES PRACTICE, P3333; Goldani LZ, 1997, INFECT DIS ANTIMICRO, P242; GOODWIN RA, 1980, MEDICINE, V59, P1, DOI 10.1097/00005792-198001000-00001; Hage CA, 2010, CLIN INFECT DIS, V50, P85, DOI 10.1086/648724; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kolokotronis A, 2006, J ORAL PATHOL MED, V35, P123, DOI 10.1111/j.1600-0714.2006.00363.x; Lin YY, 2011, LARYNGOSCOPE, V121, P1627, DOI 10.1002/lary.21859; Ling L, 2010, INT J INFECT DIS, V14, pE230, DOI 10.1016/j.ijid.2009.05.002; Nisa L, 2013, J VOICE, V27, P636, DOI 10.1016/j.jvoice.2013.02.011; O'Hara CD, 2004, ARCH PATHOL LAB MED, V128, P574; Pinto JA, 2002, J VOICE, V16, P560, DOI 10.1016/S0892-1997(02)00131-5; Rucci J, 2014, AM J OTOLARYNG, V35, P390, DOI 10.1016/j.amjoto.2013.12.013; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989; Zhang SZ, 2000, ARCH OTOLARYNGOL, V126, P672, DOI 10.1001/archotol.126.5.672	27	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1535	1543		10.1056/NEJMcpc1406191	http://dx.doi.org/10.1056/NEJMcpc1406191			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317874				2022-12-28	WOS:000342994700012
J	Michel-Kerjan, E				Michel-Kerjan, Erwann			How terror-proof is your economy?	NATURE			English	Editorial Material									[Michel-Kerjan, Erwann] Univ Penn, Wharton Risk Management Ctr, Philadelphia, PA 19104 USA; [Michel-Kerjan, Erwann] OECD Board Financial Management Catastrophes, Paris, France	University of Pennsylvania	Michel-Kerjan, E (corresponding author), Univ Penn, Wharton Risk Management Ctr, Philadelphia, PA 19104 USA.	erwannmk@wharton.upenn.edu							0	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					275	275		10.1038/514275a	http://dx.doi.org/10.1038/514275a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ7JH	25318486	Bronze			2022-12-28	WOS:000342988600013
J	Hoffmann, KF; Brindley, PJ; Berriman, M				Hoffmann, Karl F.; Brindley, Paul J.; Berriman, Matthew			Halting harmful helminths	SCIENCE			English	Editorial Material							SCHISTOSOMA-MANSONI; DISEASE; BURDEN; CELLS; LINE		[Hoffmann, Karl F.] Aberystwyth Univ, IBERS, Aberystwyth SY23 3DA, Dyfed, Wales; [Brindley, Paul J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Brindley, Paul J.] George Washington Univ, Res Ctr Neglected Dis Poverty, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Berriman, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); George Washington University; George Washington University; Wellcome Trust Sanger Institute	Hoffmann, KF (corresponding author), Aberystwyth Univ, IBERS, Aberystwyth SY23 3DA, Dyfed, Wales.	krh@aber.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Hoffmann, Karl/0000-0002-3932-5502; Brindley, Paul J./0000-0003-1765-0002				Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Beckmann S, 2007, EXP PARASITOL, V117, P292, DOI 10.1016/j.exppara.2007.04.007; Bhardwaj R, 2011, METHODS MOL BIOL, V764, P223, DOI 10.1007/978-1-61779-188-8_15; Collins JJ, 2013, NATURE, V494, P476, DOI 10.1038/nature11924; Hahnel S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002336; Holtfreter M., 2014, EUROSURVEILLANCE, V19, P153; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Majoros G, 2008, EMERG INFECT DIS, V14, P1812, DOI 10.3201/eid1411.080479; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mann VH, 2014, TRANSGENIC RES, V23, P539, DOI 10.1007/s11248-013-9779-3; Albani CM, 2013, ACTA TROP, V128, P124, DOI 10.1016/j.actatropica.2013.07.001; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Ye Q, 2013, BIOTECHNOL ADV, V31, P1722, DOI 10.1016/j.biotechadv.2013.09.003	15	24	24	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					168	169		10.1126/science.1261139	http://dx.doi.org/10.1126/science.1261139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301604				2022-12-28	WOS:000342721500022
J	Fisher, MC; Stone, JH; Palmer, WE				Fisher, Mark C.; Stone, John H.; Palmer, William E.			Case 31-2014: A 50-Year-Old Man with Back Pain, Fatigue, Weight Loss, and Knee Swelling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-THE-LITERATURE; ANKYLOSING-SPONDYLITIS; CLINICAL-FEATURES; DISEASE; SPONDYLODISCITIS; OSTEOMYELITIS; TUMORS; SPINE		[Fisher, Mark C.; Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Palmer, William E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Fisher, Mark C.; Stone, John H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Palmer, William E.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fisher, MC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Armstrong DJ, 2007, RHEUMATOL INT, V27, P399, DOI 10.1007/s00296-006-0224-2; Arvikar SL, 2011, CURR REV MUSCULOSKE, V4, P123, DOI 10.1007/s12178-011-9085-8; Awada H, 2000, JOINT BONE SPINE, V67, P194; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Callhoff J, 2014, ANN RHEUM DIS; CLIFF JM, 1971, ANN RHEUM DIS, V30, P171, DOI 10.1136/ard.30.2.171; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Cottle L, 2008, J INFECTION, V56, P401, DOI 10.1016/j.jinf.2008.02.005; Dik VK, 2010, SCAND J RHEUMATOL, V39, P38, DOI 10.3109/03009740903096101; Fantoni M, 2012, EUR REV MED PHARMACO, V16, P2; FORNASIER VL, 1975, CANCER, V36, P590, DOI 10.1002/1097-0142(197508)36:2<590::AID-CNCR2820360240>3.0.CO;2-F; Gabe MJ, 2010, CLIN IMAG, V34, P309, DOI 10.1016/j.clinimag.2009.08.028; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Hasni SA, 2010, SPINE, V35, pE904, DOI 10.1097/BRS.0b013e3181dc9a54; Kelley SP, 2007, EUR SPINE J, V16, P405, DOI 10.1007/s00586-006-0188-7; Lubrano E, 2012, CLIN RHEUMATOL, V31, P1027, DOI 10.1007/s10067-012-1990-8; MAU G, 1981, EUR J PEDIATR, V137, P85, DOI 10.1007/BF00441176; Murphey MD, 1996, RADIOGRAPHICS, V16, P1131, DOI 10.1148/radiographics.16.5.8888395; Oztekin O, 2010, RADIOL MED, V115, P794, DOI 10.1007/s11547-010-0530-3; Park YS, 2011, J BONE JOINT SURG BR, V93B, P961, DOI 10.1302/0301-620X.93B7.26337; Pato E, 2000, J RHEUMATOL, V27, P2198; PATZAKIS MJ, 1991, CLIN ORTHOP RELAT R, P178; Sasiadek M, 2011, NEURORADIOLOGY, V53, pS169, DOI 10.1007/s00234-011-0935-2; Schiff D, 1997, NEUROLOGY, V49, P452, DOI 10.1212/WNL.49.2.452; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Sieper J, 2002, ANN RHEUM DIS, V61, P8; Tsuchiya K, 2002, Mod Rheumatol, V12, P113, DOI 10.3109/s101650200020; Uderhardt S, 2010, ANN RHEUM DIS, V69, P592, DOI 10.1136/ard.2008.102046; UNKILAKALLIO L, 1994, PEDIATRICS, V93, P59	29	2	5	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1447	1455		10.1056/NEJMcpc1404517	http://dx.doi.org/10.1056/NEJMcpc1404517			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295504				2022-12-28	WOS:000342674800014
J	Gladstone, JC				Gladstone, Jeanette C.			ULTRALUMINOUS X-RAY SOURCES Small field with a large impact	NATURE			English	Editorial Material							BLACK-HOLE		Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	University of Alberta	Gladstone, JC (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada.	j.c.gladstone@ualberta.ca						Bachetti M, 2014, NATURE, V514, P202, DOI 10.1038/nature13791; Bachetti M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/163; FABBIANO G, 1989, ANNU REV ASTRON ASTR, V27, P87; Gladstone JC, 2009, MON NOT R ASTRON SOC, V397, P1836, DOI 10.1111/j.1365-2966.2009.15123.x; Liu JF, 2013, NATURE, V503, P500, DOI 10.1038/nature12762; McHardy IM, 2006, NATURE, V444, P730, DOI 10.1038/nature05389; Motch C, 2014, NATURE, V514, P198, DOI 10.1038/nature13730; Pasham DR, 2014, NATURE, V513, P74, DOI 10.1038/nature13710	8	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					171	172		10.1038/514171a	http://dx.doi.org/10.1038/514171a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297429				2022-12-28	WOS:000342663100026
J	Rasmussen, AL; Okumura, A; Ferris, MT; Green, R; Feldmann, F; Kelly, SM; Scott, DP; Safronetz, D; Haddock, E; LaCasse, R; Thomas, MJ; Sova, P; Carter, VS; Weiss, JM; Miller, DR; Shaw, GD; Korth, MJ; Heise, MT; Baric, RS; de Villena, FPM; Fedlmann, H; Katze, MG				Rasmussen, Angela L.; Okumura, Atsushi; Ferris, Martin T.; Green, Richard; Feldmann, Friederike; Kelly, Sara M.; Scott, Dana P.; Safronetz, David; Haddock, Elaine; LaCasse, Rachel; Thomas, Matthew J.; Sova, Pavel; Carter, Victoria S.; Weiss, Jeffrey M.; Miller, Darla R.; Shaw, Ginger D.; Korth, Marcus J.; Heise, Mark T.; Baric, Ralph S.; de Villena, Fernando Pardo-Manuel; Fedlmann, Heinz; Katze, Michael G.			Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance	SCIENCE			English	Article							VIRUS INFECTION; GUINEA-PIGS; COAGULATION; OUTBREAK; MAP	Existing mouse models of lethal Ebola virus infection do not reproduce hallmark symptoms of Ebola hemorrhagic fever, neither delayed blood coagulation and disseminated intravascular coagulation nor death fromshock, thus restricting pathogenesis studies to nonhuman primates. Here we show that mice from the Collaborative Cross panel of recombinant inbred mice exhibit distinct disease phenotypes after mouse-adapted Ebola virus infection. Phenotypes range from complete resistance to lethal disease to severe hemorrhagic fever characterized by prolonged coagulation times and 100% mortality. Inflammatory signaling was associated with vascular permeability and endothelial activation, and resistance to lethal infection arose by induction of lymphocyte differentiation and cellular adhesion, probably mediated by the susceptibility allele Tek. These data indicate that genetic background determines susceptibility to Ebola hemorrhagic fever.	[Rasmussen, Angela L.; Okumura, Atsushi; Green, Richard; Kelly, Sara M.; Thomas, Matthew J.; Sova, Pavel; Carter, Victoria S.; Weiss, Jeffrey M.; Korth, Marcus J.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ferris, Martin T.; Miller, Darla R.; Shaw, Ginger D.; Heise, Mark T.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Feldmann, Friederike; Scott, Dana P.; LaCasse, Rachel] NIAID, Rocky Mt Vet Branch, NIH, Rocky Mt Labs, Hamilton, MT USA; [Okumura, Atsushi; Safronetz, David; Haddock, Elaine; Fedlmann, Heinz] NIAID, Virol Lab, NIH, Rocky Mt Labs, Hamilton, MT USA; [Heise, Mark T.; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill	Katze, MG (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	honey@uw.edu	Okumura, Atsushi/E-8012-2015	Okumura, Atsushi/0000-0002-7779-3059; Rasmussen, Angela/0000-0001-9462-3169; Green, Richard/0000-0001-8851-7204	National Institute of Allergy and Infectious Diseases, National Institutes of Health [U54 AI081680, U19 AI109761, U19 AI100625]; Office of the Director, National Institutes of Health [P51 OD010425]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, U19AI109761, U19AI100625, U54AI081680] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by awards U54 AI081680, U19 AI109761, and U19 AI100625 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; P51 OD010425 from the Office of the Director, National Institutes of Health; and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Microarray data have been deposited with the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) (accession number GSE57214), and raw data can be obtained at https://www.ccebola.org/project/Supplemental/begin.view. Mice were developed by the Collaborative Cross Consortium, an international consortium of researchers who designed, planned, and implemented the Collaborative Cross project. Initial animals were provided by the Jackson Laboratory, and CC lines were developed independently at the Oak Ridge National Laboratories in Tennessee, USA; Tel Aviv University, Israel; and Geniad, Ltd., Australia. CC lines are currently produced and distributed at the University of North Carolina, Chapel Hill. A.L.R. designed the study, performed functional analysis of microarray data, and wrote the manuscript; A.O. performed infections, veterinary examinations, and necropsies and assessed phenotype, collected and processed samples, and titrated virus from organs by focus-forming assay; M.T.F., M.T.H., F.P.-M.V., and R.S.B. established systems for designing and breeding CC-RIX mouse populations and utilizing them for virus pathogenesis studies and contributed to strain selection and data analysis; R.G. performed microarray data normalization, batch correction, and differential expression analysis; S.M.K. and J.M.W. performed target preparation and hybridization of microarrays; R.L. coordinated veterinary care for experimental animals; D.P.S. performed histopathological staining and analyzed the histopathology data; F.F., D.S., and E.H. assisted with mouse procedures in high biocontainment; M.J.T. and R.G. performed sequencing and subsequent analysis of viral RNA; A.F. performed functional analysis of microarray data; P.S. quantified viral RNA by quantitative polymerase chain reaction; M.J.K. edited the manuscript; and H.F. and M.G.K. contributed significantly to study design, provided space and infrastructure for the experiments and analysis, assisted in data analysis, and edited the manuscript.	Antoniak S, 2014, J CARDIOVASC TRANSL, V7, P203, DOI 10.1007/s12265-013-9515-7; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Brouillard P, 2000, GENOMICS, V67, P96, DOI 10.1006/geno.2000.6232; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Ebihara H, 2011, J INFECT DIS, V204, pS991, DOI 10.1093/infdis/jir336; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Flanagan JM, 2011, BLOOD, V117, P6681, DOI 10.1182/blood-2011-01-332205; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Johnson JC, 2014, ANTIVIR RES, V107, P102, DOI 10.1016/j.antiviral.2014.04.014; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Ryabchikova E, 1996, ARCH VIROL, V141, P909, DOI 10.1007/BF01718165; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Strong JE, 2008, P NATL ACAD SCI USA, V105, P17982, DOI 10.1073/pnas.0809698105; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yen JY, 2011, J INFECT DIS, V204, pS1043, DOI 10.1093/infdis/jir345; Zheng QP, 2013, GENE, V523, P195, DOI 10.1016/j.gene.2013.02.053	27	175	181	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					987	991		10.1126/science.1259595	http://dx.doi.org/10.1126/science.1259595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25359852	Green Accepted, Green Submitted			2022-12-28	WOS:000345696000042
J	Lee, YN; Barsbold, R; Currie, PJ; Kobayashi, Y; Lee, HJ; Godefroit, P; Escuillie, F; Chinzorig, T				Lee, Yuong-Nam; Barsbold, Rinchen; Currie, Philip J.; Kobayashi, Yoshitsugu; Lee, Hang-Jae; Godefroit, Pascal; Escuillie, Francois; Chinzorig, Tsogtbaatar			Resolving the long-standing enigmas of a giant ornithomimosaur Deinocheirus mirificus	NATURE			English	Article							NORTH-AMERICA; DINOSAURS; THEROPODA; ECOMORPHOLOGY; PYGOSTYLE; DESERT	The holotype of Deinocheirus mirificus was collected by the 1965 Polish-Mongolian Palaeontological Expedition at Altan Uul III in the southern Gobi of Mongolia(1). Because the holotype consists mostly of giant forelimbs (2.4 min length) with scapulocoracoids(2), for almost 50 years Deinocheirus has remained one of the most mysterious dinosaurs. The mosaic of ornithomimosaur and nonornithomimosaur characters in the holotype has made it difficult to resolve the phylogenetic status of Deinocheirus(3,4). Here we describe two new specimens of Deinocheirus that were discovered in the Nemegt Formation of Altan Uul IV in 2006 and Bugiin Tsav in 2009. The Bugiin Tsav specimen (MPC-D100/127) includes a left forelimb clearly identifiable as Deinocheirus and is 6% longer than the holotype. The Altan Uul IV specimen(MPC-D100/128) is approximately 74% the size of MPC-D 100/127. Cladistic analysis indicates that Deinocheirus is the largest member of the Ornithomimosauria; however, it has many unique skeletal features unknown in other ornithomimosaurs, indicating that Deinocheirus was a heavily built, non-cursorial animal with an elongate snout, a deep jaw, tall neural spines, a pygostyle, a U-shaped furcula, an expanded pelvis for strong muscle attachments, a relatively short hind limb and broad-tipped pedal unguals. Ecomorphological features in the skull, more than a thousand gastroliths, and stomach contents (fish remains) suggest that Deinocheirus was a megaomnivore that lived in mesic environments.	[Lee, Yuong-Nam; Lee, Hang-Jae] Korea Inst Geosci & Mineral Resources, Geol Museum, Taejon 305350, South Korea; [Barsbold, Rinchen; Chinzorig, Tsogtbaatar] Mongolian Acad Sci, Paleontol Ctr, Ulaanbaatar 210351, Mongolia; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan; [Godefroit, Pascal] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium; [Escuillie, Francois] Eldonia, F-3800 Gannat, France	Korea Institute of Geoscience & Mineral Resources (KIGAM); Mongolian Academy of Sciences; University of Alberta; Hokkaido University; Royal Belgian Institute of Natural Sciences	Lee, YN (corresponding author), Korea Inst Geosci & Mineral Resources, Geol Museum, Taejon 305350, South Korea.	ylee@kigam.re.kr	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Tsogtbaatar, Chinzorig/0000-0001-5231-0113	Hwaseong City, Gyeonggi Province, South Korea; Korea Institute of Geosciences and Mineral Resources, Korea; Paleontological Center of Mongolian Academy of Sciences, Mongolia	Hwaseong City, Gyeonggi Province, South Korea; Korea Institute of Geosciences and Mineral Resources, Korea; Paleontological Center of Mongolian Academy of Sciences, Mongolia	Information gained from Zofia Kielan-Jaworowska and Wojtec Skarzynski (who respectively found and excavated the holotype) allowed us to refind the original quarry at Altan Uul III. Thanks go to all members of Korea-Mongolia International Dinosaur Expedition (KID) in 2006 and 2009. The KID expedition was supported by a grant to Y.-N.L. from Hwaseong City, Gyeonggi Province, South Korea. Research support was from Korea Institute of Geosciences and Mineral Resources, Korea and Paleontological Center of Mongolian Academy of Sciences, Mongolia.	Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; Barsbold R, 2000, NATURE, V403, P155, DOI 10.1038/35003103; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Choiniere JN, 2012, J AFR EARTH SCI, V71-72, P1, DOI 10.1016/j.jafrearsci.2012.05.005; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; KIELANJA.Z, 1966, B ACAD POL SCI BIOL, V14, P249; Kobayashi Y, 2005, CAN J EARTH SCI, V42, P1501, DOI 10.1139/E05-044; Kobayashi Yoshitsugu, 2006, Journal of the Paleontological Society of Korea, V22, P195; Lautenschlager S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0497; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Mallon JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067182; Norell MA, 2001, NATURE, V412, P873, DOI 10.1038/35091139; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Osmolska H, 1970, PALAEONTOLOGIA POLON, V21, P5; Persons WS, 2014, ACTA PALAEONTOL POL, V59, P553, DOI 10.4202/app.2012.0093; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schwarz-Wings D, 2010, P ROY SOC B-BIOL SCI, V277, P11, DOI 10.1098/rspb.2009.1275; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zelenitsky DK, 2012, SCIENCE, V338, P510, DOI 10.1126/science.1225376	28	69	70	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					257	U231		10.1038/nature13874	http://dx.doi.org/10.1038/nature13874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25337880				2022-12-28	WOS:000344631400048
J	Lee, PA				Lee, Patrick A.			Seeking out Majorana under the microscope	SCIENCE			English	Editorial Material									MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lee, PA (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	palee@mit.edu						Churchill HOH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241401; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Liu J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064509; Liu J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.267002; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Nilsson J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.120403; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380	9	20	20	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		545	546		10.1126/science.1260282	http://dx.doi.org/10.1126/science.1260282			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359950				2022-12-28	WOS:000343799700021
J	Edwards, EA				Edwards, Elizabeth Anne			Breathing the unbreathable	SCIENCE			English	Editorial Material							STRICTLY ANAEROBIC BACTERIUM; GEN-NOV; TETRACHLOROETHENE; DECHLORINATION; RESPIRATION; ETHENE		Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada	University of Toronto	Edwards, EA (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.	elizabeth.edwards@utoronto.ca	Edwards, Elizabeth/GXV-2307-2022	Edwards, Elizabeth/0000-0002-8071-338X				Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; DEWEERD KA, 1990, ARCH MICROBIOL, V154, P23; FREEDMAN DL, 1989, APPL ENVIRON MICROB, V55, P2144, DOI 10.1128/AEM.55.9.2144-2151.1989; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; HILL DW, 1967, J WATER POLLUT CON F, V39, P1259; Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577; Hug LA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0322; Leys D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0316; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; SCHOLZMURAMATSU H, 1995, ARCH MICROBIOL, V163, P48, DOI 10.1007/BF00262203; SHELTON DR, 1984, APPL ENVIRON MICROB, V48, P840, DOI 10.1128/AEM.48.4.840-848.1984; Stroo HF, 2013, SERDP ESTCP REMEDIAT, P117, DOI 10.1007/978-1-4614-4115-1_4	14	2	2	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					424	425		10.1126/science.1261194	http://dx.doi.org/10.1126/science.1261194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342788				2022-12-28	WOS:000343822900022
J	Rajsbaum, R; Garcia-Sastre, A				Rajsbaum, Ricardo; Garcia-Sastre, Adolfo			Unanchored ubiquitin in virus uncoating	SCIENCE			English	Editorial Material							AGGRESOME FORMATION; PROTEIN; AUTOPHAGY; CHAINS		[Rajsbaum, Ricardo] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	University of Texas System; University of Texas Medical Branch Galveston; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rajsbaum, R (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.	rirajsba@utmb.edu; adolfo.garcia-sastre@mssm.edu	Rajsbaum, Ricardo/AAD-4775-2020	Garcia-Sastre, Adolfo/0000-0002-6551-1827				Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; BUKRINSKAYA AG, 1982, J GEN VIROL, V60, P49, DOI 10.1099/0022-1317-60-1-49; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	13	13	13	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					427	428		10.1126/science.1261509	http://dx.doi.org/10.1126/science.1261509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342790				2022-12-28	WOS:000343822900024
J	Merle, CS; Fielding, K; Sow, OB; Gninafon, M; Lo, MB; Mthiyane, T; Odhiambo, J; Amukoye, E; Bah, B; Kassa, F; N'Diaye, A; Rustomjee, R; de Jong, BC; Horton, J; Perronne, C; Sismanidis, C; Lapujade, O; Olliaro, PL; Lienhardt, C				Merle, Corinne S.; Fielding, Katherine; Sow, Omou Bah; Gninafon, Martin; Lo, Mame B.; Mthiyane, Thuli; Odhiambo, Joseph; Amukoye, Evans; Bah, Boubacar; Kassa, Ferdinand; N'Diaye, Alimatou; Rustomjee, Roxana; de Jong, Bouke C.; Horton, John; Perronne, Christian; Sismanidis, Charalambos; Lapujade, Olivier; Olliaro, Piero L.; Lienhardt, Christian		OFLOTUB Gatifloxacin TB Project	A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY TUBERCULOSIS; PHASE-II; MOXIFLOXACIN; ETHAMBUTOL; TRIAL	BACKGROUND Shortening the course of treatment for tuberculosis would be a major improvement for case management and disease control. This phase 3 trial assessed the efficacy and safety of a 4-month gatifloxacin-containing regimen for treating rifampin-sensitive pulmonary tuberculosis. METHODS We conducted a noninferiority, randomized, open-label, controlled trial involving patients 18 to 65 years of age with smear-positive, rifampin-sensitive, newly diagnosed pulmonary tuberculosis in five sub-Saharan African countries. A standard 6-month regimen that included ethambutol during the 2-month intensive phase was compared with a 4-month regimen in which gatifloxacin (400 mg per day) was substituted for ethambutol during the intensive phase and was continued, along with rifampin and isoniazid, during the continuation phase. The primary efficacy end point was an unfavorable outcome (treatment failure, recurrence, or death or study dropout during treatment) measured 24 months after the end of treatment, with a noninferiority margin of 6 percentage points, adjusted for country. RESULTS A total of 1836 patients were assigned to the 4-month regimen (experimental group) or the standard regimen (control group). Baseline characteristics were well balanced between the groups. At 24 months after the end of treatment, the adjusted difference in the risk of an unfavorable outcome (experimental group [21.0%] minus control group [17.2%]) in the modified intention-to-treat population (1356 patients) was 3.5 percentage points (95% confidence interval, -0.7 to 7.7). There was heterogeneity across countries (P = 0.02 for interaction, with differences in the rate of an unfavorable outcome ranging from -5.4 percentage points in Guinea to 12.3 percentage points in Senegal) and in baseline cavitary status (P = 0.04 for interaction) and body-mass index (P = 0.10 for interaction). The standard regimen, as compared with the 4-month regimen, was associated with a higher dropout rate during treatment (5.0% vs. 2.7%) and more treatment failures (2.4% vs. 1.7%) but fewer recurrences (7.1% vs. 14.6%). There was no evidence of increased risks of prolongation of the QT interval or dysglycemia with the 4-month regimen. CONCLUSIONS Noninferiority of the 4-month regimen to the standard regimen with respect to the primary efficacy end point was not shown. (Funded by the Special Program for Research and Training in Tropical Diseases and others; ClinicalTrials.gov number, NCT00216385.)	[Merle, Corinne S.; Fielding, Katherine; Sismanidis, Charalambos] London Sch Hyg & Trop Med, London WC1, England; [Horton, John] Trop Projects, Hitchin, England; [Sow, Omou Bah; Bah, Boubacar] Hop Ignace Deen, Serv Pneumophtisiol, Conakry, Guinea; [Gninafon, Martin; Kassa, Ferdinand] Ctr Natl Hosp Pneumophtisiol, Cotonou, Benin; [Lo, Mame B.; N'Diaye, Alimatou] Programme Natl Lutte TB, Dakar, Senegal; [Mthiyane, Thuli; Rustomjee, Roxana] MRC, Durban, South Africa; [Odhiambo, Joseph; Amukoye, Evans] Kenya Govt Med Res Ctr, Nairobi, Kenya; [de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium; [Perronne, Christian] Hop Univ Paris Ile de France Ouest, Assistance Publ Hop Paris, Paris, France; [Lapujade, Olivier; Lienhardt, Christian] Inst Rech Dev, Marseille, France; [Olliaro, Piero L.] WHO, Special Program Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Institute of Tropical Medicine (ITM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); World Health Organization	Olliaro, PL (corresponding author), WHO, Special Program Res & Training Trop Dis, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	olliarop@who.int	vaillant, michel/H-5635-2019; de Jong, Bouke/A-3636-2013; Lienhardt, Christian/AAU-4969-2021; TISSOT-DUPONT, Hervé/P-5808-2016	vaillant, michel/0000-0003-4714-8128; de Jong, Bouke/0000-0002-1017-4675; Lienhardt, Christian/0000-0003-0233-893X; Merle, Corinne/0000-0003-4229-365X; Webb, Emily/0000-0002-4019-7456; Mthiyane, Thuli/0000-0002-1782-5485; Ndiaye, Jean/0000-0003-0450-5551; amukoye, Evans/0000-0003-0683-0585; Fielding, Katherine/0000-0002-6524-3754	Special Program for Research and Training in Tropical Diseases (TDR); United Nations Children's Fund; United Nations Development Program; World Bank; WHO; European Commission; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Special Program for Research and Training in Tropical Diseases (TDR); United Nations Children's Fund; United Nations Development Program; World Bank(The World Bank India); WHO(World Health Organization); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Special Program for Research and Training in Tropical Diseases (TDR), a cosponsored program of the United Nations Children's Fund, the United Nations Development Program, the World Bank, and the WHO, and in part by the European Commission (International Cooperation with Developing Countries program). TDR funding was provided by governmental and cosponsor core contributions to TDR. Specific support was also provided by the U. S. Agency for International Development, the government of Japan, the Global Alliance for TB Drug Development, and the Li Ka Shing Foundation Global Health Programme at the University of Oxford. Lupin Pharmaceuticals, India, provided study drugs.	[Anonymous], RAND CLIN TRIAL TRIA; [Anonymous], GLOB TUB REP; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Food and Drug Administration, 2013, GUID IND PULM TUB DE; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; Gospodarevskaya E, 2014, INT J TUBERC LUNG D, V18, P810, DOI 10.5588/ijtld.13.0391; Jindani A, 2013, 20 C RETR OPP INF AT; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Merle CSC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-61; Mohr JF, 2005, PHARMACOTHERAPY, V25, P1303, DOI 10.1592/phco.2005.25.10.1303; Onyenwenyi AJ, 2008, PHARM WORLD SCI, V30, P544, DOI 10.1007/s11096-008-9205-8; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Phillips PPJ, 2013, INT J TUBERC LUNG D, V17, P807, DOI 10.5588/ijtld.12.0725; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Smythe W, 2013, ANTIMICROB AGENTS CH, V57, P4164, DOI 10.1128/AAC.00479-13; Sulochana S, 2005, J CHEMOTHERAPY, V17, P169, DOI 10.1179/joc.2005.17.2.169; *WHO, 2004, TREATM TUB GUID NAT; World Health Organization(WHO), BMI CLASS	23	283	289	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1588	1598		10.1056/NEJMoa1315817	http://dx.doi.org/10.1056/NEJMoa1315817			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337748	Green Accepted			2022-12-28	WOS:000343648500007
J	Chopra, V; Govindan, S; Kuhn, L; Ratz, D; Sweis, RF; Melin, N; Thompson, R; Tolan, A; Barron, J; Saint, S				Chopra, Vineet; Govindan, Sushant; Kuhn, Latoya; Ratz, David; Sweis, Randy F.; Melin, Natalie; Thompson, Rachel; Tolan, Aaron; Barron, James; Saint, Sanjay			Do Clinicians Know Which of Their Patients Have Central Venous Catheters? A Multicenter Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							INSERTED CENTRAL CATHETERS; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; HOSPITALIST EXPERIENCES; RISK; COMPLICATIONS; INTERVENTION; METAANALYSIS; KNOWLEDGE; OPINIONS	Background: Complications associated with central venous catheters (CVCs) increase over time. Although early removal of unnecessary CVCs is important to prevent complications, the extent to which clinicians are aware that their patients have a CVC is unknown. Objective: To assess how often clinicians were unaware of the presence of triple-lumen catheters or peripherally inserted central catheters (PICCs) in hospitalized patients. Design: Multicenter, cross-sectional study. Setting: 3 academic medical centers in the United States. Patients: Hospitalized medical patients in intensive care unit (ICU) and non-ICU settings. Measurements: To ascertain awareness of CVCs, whether a PICC or triple-lumen catheter was present was determined; clinicians were then queried about device presence. Differences in device awareness among clinicians were assessed by chi-square tests. Results: 990 patients were evaluated, and 1881 clinician assessments were done. The overall prevalence of CVCs was 21.1% (n = 209), of which 60.3% (126 of 209) were PICCs. A total of 21.2% (90 of 425) of clinicians interviewed were unaware of the presence of a CVC. Unawareness was greatest among patients with PICCs, where 25.1% (60 of 239) of clinicians were unaware of PICC presence. Teaching attendings and hospitalists were more frequently unaware of the presence of CVCs than interns and residents (25.8% and 30.5%, respectively, vs. 16.4%). Critical care physicians were more likely to be aware of CVC presence than general medicine physicians (12.6% vs. 26.2%; P = 0.003). Limitations: Awareness was determined at 1 point in time and was not linked to outcomes. Patient length of stay and indication for CVC were not recorded. Conclusion: Clinicians are frequently unaware of the presence of PICCs and triple-lumen catheters in hospitalized patients. Further study of mechanisms that ensure that clinicians are aware of these devices so that they may assess their necessity seems warranted.	[Chopra, Vineet] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; Spectrum Hlth Syst, Grand Rapids, MI 49503 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Harborview Medical Center; University of Washington; University of Washington Seattle	Chopra, V (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, 2800 Plymouth Rd,Bldg 16,Room 432W, Ann Arbor, MI 48109 USA.	vineetc@umich.edu	Saint, Sanjay/AAF-5126-2019	Sweis, Randy/0000-0002-0497-9637; Chopra, Vineet/0000-0001-8670-9376	Agency for Healthcare Research and Quality [1-K08-HS022835-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS022835] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009566] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Chopra was supported by a career development award (1-K08-HS022835-01) from the Agency for Healthcare Research and Quality.	Chopra V, 2013, J HOSP MED, V8, P635, DOI 10.1002/jhm.2095; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Chopra V, 2013, J HOSP MED, V8, P309, DOI 10.1002/jhm.2031; Ajenjo MC, 2011, INFECT CONT HOSP EP, V32, P125, DOI 10.1086/657942; Evans RS, 2013, CHEST, V143, P627, DOI 10.1378/chest.12-0923; Garcia-Rodriguez JF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-445; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Gibson C, 2013, J VASC INTERV RADIOL, V24, P1323, DOI 10.1016/j.jvir.2013.04.010; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kiyoshi-Teo H, 2013, INFECT CONT HOSP EP, V34, P1099, DOI 10.1086/673147; Leroyer C, 2013, MED MALADIES INFECT, V43, P350, DOI 10.1016/j.medmal.2013.06.013; Mueller JT, 2014, AM J MED QUAL, V29, P191, DOI 10.1177/1062860613494752; O'Brien J, 2013, J AM COLL RADIOL, V10, P864, DOI 10.1016/j.jacr.2013.06.003; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; Saman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061097; Tejedor SC, 2013, INFECT CONT HOSP EP, V34, P900, DOI 10.1086/671736; Tejedor SC, 2012, INFECT CONT HOSP EP, V33, P50, DOI 10.1086/663645; Tiwari MM, 2011, J HOSP INFECT, V78, P128, DOI 10.1016/j.jhin.2011.03.004; Zingg W, 2011, J HOSP INFECT, V77, P304, DOI 10.1016/j.jhin.2010.11.011	23	35	37	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					562	U61		10.7326/M14-0703	http://dx.doi.org/10.7326/M14-0703			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329204	Green Accepted			2022-12-28	WOS:000343906800017
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Multiple hypothesis testing and Bonferroni's correction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PITFALLS		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Sedgwick P, 2013, BMJ-BRIT MED J, V346, pf363; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5310; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130	6	63	64	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2014	349								g6284	10.1136/bmj.g6284	http://dx.doi.org/10.1136/bmj.g6284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OC	25331533				2022-12-28	WOS:000343768100006
J	Ailon, J; Mourad, O; Chien, V; Saun, T; Dev, SP				Ailon, Jonathan; Mourad, Ophyr; Chien, Vince; Saun, Tomas; Dev, Shelly P.			Ultrasound-Guided Insertion of a Radial Arterial Catheter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ailon, Jonathan; Mourad, Ophyr; Chien, Vince; Saun, Tomas; Dev, Shelly P.] Univ Toronto, Toronto, ON, Canada	University of Toronto	Ailon, J (corresponding author), St Michaels Hosp, Dept Gen Internal Med, 30 Bond St,4CC 146, Toronto, ON M5B 1W8, Canada.	ailonj@smh.ca	Saun, Tomas J./ABF-1630-2021	Saun, Tomas J./0000-0002-1053-0895				Feller-Kopman D, 2006, CHEST, V129, P1709, DOI 10.1378/chest.129.6.1709; Hofmann LJ, 2010, J VASC ACCESS, V11, P106, DOI 10.1177/112972981001100204; Kohn KT, 1999, ERR IS HUMAN BUILDIN; Levin PD, 2003, CRIT CARE MED, V31, P481, DOI 10.1097/01.CCM.0000050452.17304.2F; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489; Shiloh AL, 2011, CHEST, V139, P524, DOI 10.1378/chest.10-0919; Shiver S, 2006, ACAD EMERG MED, V13, P1275, DOI 10.1197/j.aem.2006.07.015; Tegtmeyer Ken, 2006, N Engl J Med, V354, pe13, DOI 10.1056/NEJMvcm044149	10	12	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					E21	U8		10.1056/NEJMvcm1213181	http://dx.doi.org/10.1056/NEJMvcm1213181			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295509				2022-12-28	WOS:000342674800001
J	Dworzynski, K; Roberts, E; Ludman, A; Mant, J				Dworzynski, Katharina; Roberts, Emmert; Ludman, Andrew; Mant, Jonathan		Guideline Dev Grp	GUIDELINES Diagnosing and managing acute heart failure in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dworzynski, Katharina] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Roberts, Emmert] South London & Maudsley Mental Hlth Trust, Maudsley Hosp, London, England; [Ludman, Andrew] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Mant, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	Royal College of Physicians; South London & Maudsley NHS Trust; University of Exeter; University of Cambridge	Dworzynski, K (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Katharina.Dworzynski@rcplondon.ac.uk	Ludman, Andrew/ABG-6513-2020	Ludman, Andrew/0000-0001-8000-4295; Roberts, Emmert/0000-0002-4152-5570; Mant, Jonathan/0000-0002-9531-0268; mcmurray, john/0000-0002-6317-3975	National Institute for Health and Care Excellence	National Institute for Health and Care Excellence	Funding: The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Care Excellence to write this summary.	[Anonymous], 2010, CHRON HEART FAIL MAN; Cleland J, 2013, NATL HEART FAILURE A; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Felker GM, 2012, J AM COLL CARDIOL, V59, P2145, DOI 10.1016/j.jacc.2011.10.910; Intensive Care Society, 2009, LEV CRIT CAR AD PAT; National Institute for Health and Care Excellence, 2014, AC HEART FAIL DIAGN; National Institute for Health and Clinical Excellence, 2012, GUID MAN	7	18	20	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2014	349								g5695	10.1136/bmj.g5695	http://dx.doi.org/10.1136/bmj.g5695			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LP	25296764				2022-12-28	WOS:000342998900002
J	Long, JA; Mark-Kurik, E; Johanson, Z; Lee, MSY; Young, GC; Min, Z; Ahlberg, PE; Newman, M; Jones, R; den Blaauwen, J; Choo, B; Trinajstic, K				Long, John A.; Mark-Kurik, Elga; Johanson, Zerina; Lee, Michael S. Y.; Young, Gavin C.; Min, Zhu; Ahlberg, Per E.; Newman, Michael; Jones, Roger; den Blaauwen, Jan; Choo, Brian; Trinajstic, Kate			Copulation in antiarch placoderms and the origin of gnathostome internal fertilization	NATURE			English	Article							JAWED VERTEBRATES; VIVIPARITY; EVOLUTION	Reproduction in jawed vertebrates (gnathostomes) involves either external or internal fertilization(1). It is commonly argued that internal fertilization can evolve from external, but not the reverse. Male copulatory claspers are present in certain placoderms(2-4), fossil jawed vertebrates retrieved as a paraphyletic segment of the gnathostome stem group in recent studies(5-8). This suggests that internal fertilization could be primitive for gnathostomes, but such a conclusion depends on demonstrating that copulation was not just a specialized feature of certain placoderm subgroups. The reproductive biology of antiarchs, consistently identified as the least crownward placoderms(5-8) and thus of great interest in this context, has until now remained unknown. Here we show that certain antiarchs possessed dermal claspers in the males, while females bore paired dermal plates inferred to have facilitated copulation. These structures are not associated with pelvic fins. The clasper morphology resembles that of ptyctodonts, a more crownward placoderm group(7,8), suggesting that all placoderm claspers are homologous and that internal fertilization characterized all placoderms. This implies that external fertilization and spawning, which characterize most extant aquatic gnathostomes, must be derived from internal fertilization, even though this transformation has been thought implausible. Alternatively, the substantial morphological evidence for placoderm paraphyly must be rejected.	[Long, John A.; Choo, Brian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Long, John A.; Choo, Brian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 2100, Australia; [Long, John A.] Nat Hist Museum Los Angeles Cty, Los Angeles, CA USA; [Long, John A.] Museum Victoria, Melbourne, Vic 3001, Australia; [Mark-Kurik, Elga] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia; [Johanson, Zerina] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Lee, Michael S. Y.] S Australian Museum, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Young, Gavin C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Min, Zhu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Ahlberg, Per E.] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, S-75236 Uppsala, Sweden; [Newman, Michael] Vine Lodge, Haverfordwest SA62 3NZ, Pembroke, Wales; [den Blaauwen, Jan] Univ Amsterdam, NL-1098 XH Amsterdam, Netherlands; [Trinajstic, Kate] Curtin Univ, Dept Chem, Western Australian Organ & Isotope Geochem Ctr, Perth, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Earth & Planetary Sci, Perth, WA 6000, Australia	Flinders University South Australia; Flinders University South Australia; Museum Victoria; Tallinn University of Technology; Natural History Museum London; University of Adelaide; Australian National University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Uppsala University; University of Amsterdam; Curtin University; Western Australian Museum	Long, JA (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	john.long@flinders.edu.au	min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012	Zhu, Min/0000-0002-4786-0898; Trinajstic, Kate/0000-0002-6519-6396; Ahlberg, Per/0000-0001-9054-2900; Long, John/0000-0001-8012-0114; Choo, Brian/0000-0002-9983-0762; Johanson, Zerina/0000-0002-8444-6776	Australian Research Council	Australian Research Council(Australian Research Council)	For access to collections we thank E. Bernard, D. Pickering, E. Fitzgerald, L. Grande, W. Simpson and H.-D. Sues. For photography we thank P. Hurst, G. Baranov and D. Hubert. We thank M. Brazeau for reviewing an earlier version of the paper. Travel to Tallinn, London and Washington for J.A.L. to examine specimens was supported by Flinders University. G.C.Y., J.A.L. and K.T. acknowledge support from the Australian Research Council.	Ahlberg P, 2009, NATURE, V460, P888, DOI 10.1038/nature08176; Blackburn D. G., 2014, J MORPHOL; Brazeau MD, 2014, ZOOL J LINN SOC-LOND, V170, P779, DOI 10.1111/zoj.12111; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Downs JP, 2011, P ACAD NAT SCI PHILA, V161, P191, DOI 10.1635/053.161.0111; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Goodrich E.S., 1958, STUDIES STRUCTURE DE, V1, P1; Hemmings S.K., 1978, Palaeontographical Society Monographs (London), V131, P1; Johanson Z, 1997, GEOL MAG, V134, P813, DOI 10.1017/S0016756897007838; Leigh-Sharpe H., 1922, J MORPHOL, V36, P190; LONG JA, 1986, ALCHERINGA, V10, P355, DOI 10.1080/03115518608619146; Lysarkaya L. A., 1981, BALTIC DEVONIAN PLAC, P1; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; Miles R. S., 1967, ZOOLOGICAL J LINNEAN, V47, P99; PAN JA, 1984, VERTEBRAT PALASIATIC, V22, P8; Parenti LR, 2010, J MORPHOL, V271, P1399, DOI 10.1002/jmor.10886; ROUSE G, 1994, ZOOL SCR, V23, P271, DOI 10.1111/j.1463-6409.1994.tb00390.x; STENSI6 ERIK A:SON, 1948, MEDDELELSER OM GRONLAND, V139, P1; Trinajstic K. M., 2014, BIOL REV; Wang Jun-Qing, 1999, Vertebrata Palasiatica, V37, P200; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033	25	78	81	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					196	U171		10.1038/nature13825	http://dx.doi.org/10.1038/nature13825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25327249				2022-12-28	WOS:000347477600035
J	Chaabane, H; Turki, H				Chaabane, Hend; Turki, Hamida			Cutaneous Leishmaniasis with a Paronychia-like Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chaabane, Hend; Turki, Hamida] Hedi Chaker Hosp, Sfax, Tunisia	Universite de Sfax; Hopital Hedi Chaker	Chaabane, H (corresponding author), Hedi Chaker Hosp, Sfax, Tunisia.	chaabane.hend@gmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1736	1736		10.1056/NEJMicm1314869	http://dx.doi.org/10.1056/NEJMicm1314869			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354107				2022-12-28	WOS:000343768500011
J	Rodell, CB; Burdick, JA				Rodell, Christopher B.; Burdick, Jason A.			MATERIALS SCIENCE Radicals promote magnetic gel assembly	NATURE			English	Editorial Material									[Rodell, Christopher B.; Burdick, Jason A.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Rodell, CB (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	burdick2@seas.upenn.edu						DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Gramlich WM, 2013, BIOMATERIALS, V34, P9803, DOI 10.1016/j.biomaterials.2013.08.089; Harada A, 2011, NAT CHEM, V3, P34, DOI [10.1038/nchem.893, 10.1038/NCHEM.893]; Hull CW, 1986, US Patent, Patent No. [4,575,330, 4575330]; Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Tasoglu S, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5702, 10.1038/ncomms4124]; Tasoglu S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4124	9	3	3	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					574	575		10.1038/514574a	http://dx.doi.org/10.1038/514574a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355357				2022-12-28	WOS:000343801500035
J	Warttig, S; Ward, S; Rogers, G				Warttig, Sheryl; Ward, Steven; Rogers, Gabriel		Guideline Dev Grp	GUIDELINE Diagnosis and management of gallstone disease: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Warttig, Sheryl; Ward, Steven; Rogers, Gabriel; Guideline Dev Grp] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England	National Institute for Health & Care Excellence	Warttig, S (corresponding author), Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England.	sheryl.warttig@nice.org.uk		Rogers, Gabriel/0000-0001-9339-7374; Mortimore, Gerri/0000-0001-6890-4346; Toogood, Giles/0000-0003-4535-6249; Madden, Angela/0000-0001-6353-6492				Halldestam I, 2004, BRIT J SURG, V91, P734, DOI 10.1002/bjs.4547; National Institute for Health and Care Excellence, 2014, GALLST DIS DIAGN MAN; National Institute for Health and Care Excellence, 2012, GUID MAN; National Institute for Health and Care Excellence, 2014, GALLST INF PUBL NICE; NHS Choices, 2014, CHOL AC	5	35	42	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2014	349								g6241	10.1136/bmj.g6241	http://dx.doi.org/10.1136/bmj.g6241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DI	25360037				2022-12-28	WOS:000344156100003
J	Roman, S; Kahrilas, PJ				Roman, Sabine; Kahrilas, Peter J.			The diagnosis and management of hiatus hernia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GASTROESOPHAGEAL-REFLUX DISEASE; PARAESOPHAGEAL HERNIA; LAPAROSCOPIC FUNDOPLICATION; ACID POCKET; RISK-FACTOR; OBESITY; GUIDELINES		[Roman, Sabine] Univ Lyon 1, Hosp Civils Lyon, F-69365 Lyon, France; [Roman, Sabine] INSERM 1032, Labtau, Lyon, France; [Kahrilas, Peter J.] Northwestern Univ, Dept Med, Div Gastroenterol, Chicago, IL 60611 USA	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Northwestern University	Kahrilas, PJ (corresponding author), Northwestern Univ, Dept Med, Div Gastroenterol, Chicago, IL 60611 USA.	p-kahrilas@northwestern.edu	Roman, Sabine/AAH-2564-2019	Roman, Sabine/0000-0002-7798-7638				Annibale B, 2001, AM J MED, V111, P439, DOI 10.1016/S0002-9343(01)00883-X; Beaumont H, 2010, GUT, V59, P441, DOI 10.1136/gut.2009.178061; Eren S, 2005, EUR J RADIOL, V54, P448, DOI 10.1016/j.ejrad.2004.09.008; Fuchs KH, 2014, SURG ENDOSC, V28, P1753, DOI 10.1007/s00464-014-3431-z; Hunter JG, 1999, ANN SURG, V230, P595, DOI 10.1097/00000658-199910000-00015; Hunter JG, 1999, ANN SURG, V230, P04; Jones MP, 2001, AM J GASTROENTEROL, V96, P1711, DOI 10.1016/S0002-9270(01)02489-3; Jones MP, 2002, NEUROGASTROENT MOTIL, V14, P625, DOI 10.1046/j.1365-2982.2002.00362.x; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kahrilas PJ, 1999, GUT, V44, P476, DOI 10.1136/gut.44.4.476; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, p91 e1; Karpelowsky JS, 2006, J PEDIATR SURG, V41, P1588, DOI 10.1016/j.jpedsurg.2006.05.020; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Katz PO, 2013, AM J GASTROENTEROL, V108, P29; Kohn GP, 2013, SURG ENDOSC, V27, P4409, DOI 10.1007/s00464-013-3173-3; Lee YY, 2014, GUT, V63, P1053, DOI 10.1136/gutjnl-2013-305803; Maganty K, 2008, DIGESTION, V77, P214, DOI 10.1159/000144281; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P133, DOI 10.1097/MEG.0b013e3283426f57; Morgenthal CB, 2007, SURG ENDOSC, V21, P1978, DOI 10.1007/s00464-007-9490-7; Morrow EH, 2013, SURG LAPARO ENDO PER, V23, P446, DOI 10.1097/SLE.0b013e3182a12739; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Pandolfino JE, 2007, AM J GASTROENTEROL, V102, P1056, DOI 10.1111/j.1572-0241.2007.01138.x; Pandolfino JE, 2010, SURGERY, V147, P57, DOI 10.1016/j.surg.2009.05.011; Peters JH, 1994, MINIMALLY INVASIVE S; Poulose BK, 2008, J GASTROINTEST SURG, V12, P1888, DOI 10.1007/s11605-008-0625-5; Rohof WO, 2013, CLIN GASTROENTEROL H, V11, P1585, DOI 10.1016/j.cgh.2013.04.046; Rydberg L, 1999, BRIT J SURG, V86, P405, DOI 10.1046/j.1365-2168.1999.01025.x; Sakaguchi M, 2008, J GASTROENTEROL, V43, P57, DOI 10.1007/s00535-007-2128-7; Schuchert MJ, 2011, J GASTROINTEST SURG, V15, P23, DOI 10.1007/s11605-010-1307-7; Shaheen NJ, 2012, ANN INTERN MED, V157, P808, DOI 10.7326/0003-4819-157-11-201212040-00008; Skinner DB, 1985, HERNIA; STENELARSEN G, 1988, SCAND J GASTROENTERO, V23, P427, DOI 10.3109/00365528809093890; Thukkani N, 2010, ALIMENT PHARM THER, V31, P852, DOI 10.1111/j.1365-2036.2010.04245.x; Vakil N, 2003, AM J MED, V114, P1, DOI 10.1016/S0002-9343(02)01390-6; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Yang YX, 2010, GASTROENTEROLOGY, V139, P1115, DOI 10.1053/j.gastro.2010.08.023	36	46	49	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2014	349								g6154	10.1136/bmj.g6154	http://dx.doi.org/10.1136/bmj.g6154			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OH	25341679				2022-12-28	WOS:000343768600001
J	Liu, S; Watcha, D; Holodniy, M; Goldhaber-Fiebert, JD				Liu, Shan; Watcha, Daena; Holodniy, Mark; Goldhaber-Fiebert, Jeremy D.			Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in US Incarcerated Populations A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; TREATMENT-NAIVE; PEGYLATED INTERFERON; VIROLOGICAL RESPONSE; PROTEASE INHIBITORS; ANTIVIRAL THERAPY; TRIPLE THERAPY; ALL-CAUSE; RIBAVIRIN; HEALTH	Background: Prevalence of chronic hepatitis C virus (HCV) infection is high among incarcerated persons in the United States. New, short-duration, high-efficacy therapies may expand treatment eligibility in this population. Objective: To assess the cost-effectiveness of sofosbuvir for HCV treatment in incarcerated populations. Design: Markov model. Data Sources: Published literature and expert opinion. Target Population: Treatment-naive men with chronic, genotype 1 HCV monoinfection. Time Horizon: Lifetime. Perspective: Societal. Intervention: No treatment, 2-drug therapy (pegylated interferon and ribavirin), or 3-drug therapy with either boceprevir or sofosbuvir. For inmates with short remaining sentences (<1.5 years), only no treatment or sofosbuvir 3-drug therapy was feasible; for those with long sentences (>= 1.5 years; mean, 10 years), all strategies were considered. After release, eligible persons could receive sofosbuvir 3-drug therapy. Outcome Measures: Discounted costs (in 2013 U. S. dollars), discounted quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The strategies yielded 13.12, 13.57, 14.43, and 15.18 QALYs, respectively, for persons with long sentences. Sofosbuvir produced the largest absolute reductions in decompensated cirrhosis (16%) and hepatocellular carcinoma (9%), resulting in 2.1 additional QALYs at an added cost exceeding $54 000 compared with no treatment. For persons with short sentences, sofosbuvir cost $25 700 per QALY gained compared with no treatment; for those with long sentences, it dominated other treatments, costing $28 800 per QALY gained compared with no treatment. Results of Sensitivity Analysis: High reinfection rates in prison attenuated cost-effectiveness for persons with long sentences. Limitations: Data on sofosbuvir's long-term effectiveness and price are limited. The analysis did not consider women, Hispanic persons, or patients co-infected with HIV or hepatitis B virus. Conclusion: Sofosbuvir-based treatment is cost-effective for incarcerated persons, but affordability is an important consideration.	Univ Washington, Seattle, WA 98195 USA; UCSF Sch Med, San Francisco, CA 94143 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Goldhaber-Fiebert, JD (corresponding author), Stanford Univ, Ctr Hlth Policy, 117 Encina Commons, Stanford, CA 94305 USA.	jeremygf@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Holodniy, Mark/0000-0002-6655-7982	National Institutes of Health; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.	Arias Elizabeth, 2014, NATL VITAL STAT REPO; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Beck AJ, 2004, HEPATITIS TESTING TR; Blazquez-Perez A, 2013, PHARMACOECONOMICS, V31, P919, DOI 10.1007/s40273-013-0080-3; Camma C, 2012, HEPATOLOGY, V56, P850, DOI 10.1002/hep.25734; Carson E.A., 2014, PRISONERS 2011, P1; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Cipriano LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045176; Clarke Jennifer G., 2001, Subst Abus, V22, P209; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Di Martino V, 2011, J VIRAL HEPATITIS, V18, P493, DOI 10.1111/j.1365-2893.2011.01476.x; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Elbasha EH, 2013, APPL HEALTH ECON HEA, V11, P65, DOI 10.1007/s40258-012-0007-8; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Federal Bureau of Prisons, 2014, SENT IMP; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold M, 1996, MED CARE, V34, pDS197; Gold MR, 1996, COST EFFECTIVENESS H; Hartwell D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15170; Holtz-Eakin D, 2005, PRICES BRAND NAME DR; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Narasimhan G, 2006, J VIRAL HEPATITIS, V13, P783, DOI 10.1111/j.1365-2893.2006.00763.x; Noonan M., 2011, PRISON JAIL DEATHS C; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poret AW, 2002, DIS MANAG, V5, P95; Rice JP, 2012, HEPATOLOGY, V56, P1252, DOI 10.1002/hep.25770; Rowell TL, 2012, AM J DRUG ALCOHOL AB, V38, P593, DOI 10.3109/00952990.2012.694536; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Spaulding AC, 2012, JAMA-J AM MED ASSOC, V307, P1259, DOI 10.1001/jama.2012.374; Spaulding Anne S, 2013, Top Antivir Med, V21, P27; Sterling RK, 2005, AM J GASTROENTEROL, V100, P313, DOI 10.1111/j.1572-0241.2005.40116.x; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sutton AJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-170; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; The Pew Charitable Trusts, 2014, MAN PRIS HLTH CAR SP; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; U.S. Department of Justice, 2008, FED BUR PRIS EFF MAN; US Bureau of Labor Statistics, 2014, CONS PRIC IND; Varan A, 2012, 5 AC HLTH POL C CORR; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Weinbaum Cindy, 2003, MMWR Recomm Rep, V52, P1; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Younossi ZM, 2014, J HEPATOL, V60, P741, DOI 10.1016/j.jhep.2013.12.006; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009	65	64	65	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					546	U43		10.7326/M14-0602	http://dx.doi.org/10.7326/M14-0602			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329202	Green Accepted			2022-12-28	WOS:000343906800014
J	Cobb, NK; Abrams, DB				Cobb, Nathan K.; Abrams, David B.			The FDA, E-Cigarettes, and the Demise of Combusted Tobacco	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cobb, Nathan K.] Georgetown Univ, Med Ctr, Dept Med, Div Pulm & Crit Care, Washington, DC 20007 USA; [Abrams, David B.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Abrams, David B.] Georgetown Univ, Med Ctr, Canc Prevent & Control Program, Washington, DC 20007 USA; [Abrams, David B.] Schroeder Inst Tobacco Res & Policy Studies Legac, Washington, DC USA; [Cobb, Nathan K.; Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Cobb, Nathan K.] MeYou Hlth, Boston, MA USA	Georgetown University; Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cobb, NK (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Pulm & Crit Care, Washington, DC 20007 USA.		Abrams, David B/AAY-7699-2020	Abrams, David B/0000-0002-0868-4350; Cobb, Nathan/0000-0003-4210-226X				[Anonymous], 2014, FED REGISTER, V79, P23141; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Chatham-Stephens K, 2014, MMWR-MORBID MORTAL W, V63, P292; Christensen C., 2013, INNOVATORS DILEMMA N; Warner KE, 2013, TOB CONTROL, V22, P3, DOI 10.1136/tobaccocontrol-2013-050989	5	37	38	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1469	1471		10.1056/NEJMp1408448	http://dx.doi.org/10.1056/NEJMp1408448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317866				2022-12-28	WOS:000342994700001
J	Waxman, DA; Greenberg, MD; Ridgely, MS; Kellermann, AL; Heaton, P				Waxman, Daniel A.; Greenberg, Michael D.; Ridgely, M. Susan; Kellermann, Arthur L.; Heaton, Paul			The Effect of Malpractice Reform on Emergency Department Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFENSIVE MEDICINE; PHYSICIANS; COSTS; RISK	BACKGROUND Many believe that fear of malpractice lawsuits drives physicians to order otherwise unnecessary care and that legal reforms could reduce such wasteful spending. Emergency physicians practice in an information-poor, resource-rich environment that may lend itself to costly defensive practice. Three states, Texas (in 2003), Georgia (in 2005), and South Carolina (in 2005), enacted legislation that changed the malpractice standard for emergency care to gross negligence. We investigated whether these substantial reforms changed practice. METHODS Using a 5% random sample of Medicare fee-for-service beneficiaries, we identified all emergency department visits to hospitals in the three reform states and in neighboring (control) states from 1997 through 2011. Using a quasi-experimental design, we compared patient-level outcomes, before and after legislation, in reform states and control states. We controlled for characteristics of the patients, time-invariant hospital characteristics, and temporal trends. Outcomes were policy-attributable changes in the use of computed tomography (CT) or magnetic resonance imaging (MRI), per-visit emergency department charges, and the rate of hospital admissions. RESULTS For eight of the nine state-outcome combinations tested, no policy-attributable reduction in the intensity of care was detected. We found no reduction in the rates of CT or MRI utilization or hospital admission in any of the three reform states and no reduction in charges in Texas or South Carolina. In Georgia, reform was associated with a 3.6% reduction (95% confidence interval, 0.9 to 6.2) in per-visit emergency department charges. CONCLUSIONS Legislation that substantially changed the malpractice standard for emergency physicians in three states had little effect on the intensity of practice, as measured by imaging rates, average charges, or hospital admission rates. (Funded by the Veterans Affairs Office of Academic Affiliations and others.)	[Waxman, Daniel A.; Greenberg, Michael D.; Ridgely, M. Susan] RAND Hlth, Santa Monica, CA 90407 USA; [Heaton, Paul] RAND Inst Civil Justice, Santa Monica, CA USA; [Waxman, Daniel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90095 USA; [Kellermann, Arthur L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Uniformed Services University of the Health Sciences - USA	Waxman, DA (corresponding author), RAND Hlth, 1776 Main St, Santa Monica, CA 90407 USA.	dwaxman@rand.org			Veterans Affairs Office of Academic Affiliations	Veterans Affairs Office of Academic Affiliations	Funded by the Veterans Affairs Office of Academic Affiliations and others.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2009, COMMUNICATION; Avraham Ronen, 2011, DATABASE STATE TORT; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Baugh CW, 2013, NEW ENGL J MED, V369, P302, DOI 10.1056/NEJMp1304493; Bishop TF, 2010, ARCH INTERN MED, V170, P1081, DOI 10.1001/archinternmed.2010.155; Brill Steven, 2013, Time, V181, P16; Bureau of Labor Statistics, 2013, CONS PRIC IND; Department of Health and Human Services National Center for Health Statistics, 2004, HLTH CAR AM TRENDS U; Department of Health and Human Services Office of Inspector General, 2013, OEI021200040 DEP HLT; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Frakes M, 2014, DOES MED MALPRACTICE; Gabayan GZ, 2011, ANN EMERG MED, V58, P551, DOI 10.1016/j.annemergmed.2011.07.001; Gonzalez Morganti K, 2013, EVOLVING ROLE EMERGE; Graves JR, 2010, GEORGIA LAW REV, V45, P275; Hossfeld G., 2011, EMERGENCY MED NEWS; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kachalia A, 2014, HEALTH AFFAIR, V33, P59, DOI 10.1377/hlthaff.2013.0834; KEETON W, 1984, PROSSER KEETON TORTS; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kowey PR, 2011, JAMA-J AM MED ASSOC, V306, P18, DOI 10.1001/jama.2011.904; Massachusetts Medical Society, 2008, INV DEF MED MASS; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Merriman K., 2012, IDENTIFY EMERGENCY R; Orszag PR, 2011, HLTH CARE CAN SAVE S; Paik M, 2012, J EMPIR LEGAL STUD, V9, P173, DOI 10.1111/j.1740-1461.2012.01251.x; Pitts SR, 2012, NEW ENGL J MED, V367, P2465, DOI 10.1056/NEJMp1211315; PriceWaterhouseCoopers, 2010, PRIC EXC ID WAST HEA; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609	29	55	55	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1518	1525		10.1056/NEJMsa1313308	http://dx.doi.org/10.1056/NEJMsa1313308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7KV	25317871	Bronze			2022-12-28	WOS:000342994700008
J	Ussar, S; Tschop, MH				Ussar, Siegfried; Tschoep, Matthias H.			[Br]eaking FAt	CELL			English	Editorial Material							INSULIN-RESISTANCE; ADIPOSE-TISSUE	Fatty acids are an important class of signaling molecules regulating key aspects of whole body metabolism and physiology. In this issue, Yore et al. report a group of branched fatty acid esters of hydroxy fatty acids that regulate insulin secretion and glucose uptake through the activation of GPR120.	[Ussar, Siegfried; Tschoep, Matthias H.] Helmholtz Ctr Munich, Inst Diabet & Obes, Helmholtz Diabet Ctr, D-85748 Munich, Germany; [Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, Dept Med, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Tschop, MH (corresponding author), Helmholtz Ctr Munich, Inst Diabet & Obes, Helmholtz Diabet Ctr, D-85748 Munich, Germany.	siegfried.ussar@helmholtz-muenchen.de; tschoep@helmholtz-muenchen.de	Ussar, Siegfried/AAL-4331-2021	Ussar, Siegfried/0000-0001-7575-0920; Tschoep, Matthias/0000-0002-4744-371X				Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Milligan G., 2014, BR J PHARM; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Stone VM, 2014, DIABETOLOGIA, V57, P1182, DOI 10.1007/s00125-014-3213-0; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	10	8	8	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					238	240		10.1016/j.cell.2014.09.045	http://dx.doi.org/10.1016/j.cell.2014.09.045			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303521	Bronze			2022-12-28	WOS:000343095600006
J	Kreuels, B; Wichmann, D; Emmerich, P; Schmidt-Chanasit, J; de Heer, G; Kluge, S; Sow, A; Renne, T; Gunther, S; Lohse, AW; Addo, MM; Schmiedel, S				Kreuels, Benno; Wichmann, Dominic; Emmerich, Petra; Schmidt-Chanasit, Jonas; de Heer, Geraldine; Kluge, Stefan; Sow, Abdourahmane; Renne, Thomas; Guenther, Stephan; Lohse, Ansgar W.; Addo, Marylyn M.; Schmiedel, Stefan			A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Ebola virus disease (EVD) developed in a patient who contracted the disease in Sierra Leone and was airlifted to an isolation facility in Hamburg, Germany, for treatment. During the course of the illness, he had numerous complications, including septicemia, respiratory failure, and encephalopathy. Intensive supportive treatment consisting of high-volume fluid resuscitation (approximately 10 liters per day in the first 72 hours), broad-spectrum antibiotic therapy, and ventilatory support resulted in full recovery without the use of experimental therapies. Discharge was delayed owing to the detection of viral RNA in urine (day 30) and sweat (at the last assessment on day 40) by means of polymerase-chain-reaction (PCR) assay, but the last positive culture was identified in plasma on day 14 and in urine on day 26. This case shows the challenges in the management of EVD and suggests that even severe EVD can be treated effectively with routine intensive care.	[Kreuels, Benno; Lohse, Ansgar W.; Addo, Marylyn M.; Schmiedel, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Div Trop Med, D-20246 Hamburg, Germany; [Wichmann, Dominic; de Heer, Geraldine; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, D-20246 Hamburg, Germany; [Renne, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, D-20246 Hamburg, Germany; [Schmiedel, Stefan] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit Outpatient Care, D-20246 Hamburg, Germany; [Kreuels, Benno; Schmidt-Chanasit, Jonas; Guenther, Stephan; Lohse, Ansgar W.; Addo, Marylyn M.; Schmiedel, Stefan] German Ctr Infect Res, Hamburg, Germany; [Kreuels, Benno] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, D-20359 Hamburg, Germany; [Emmerich, Petra; Schmidt-Chanasit, Jonas; Guenther, Stephan] Bernhard Nocht Inst Trop Med, World Hlth Org Collaborating Ctr Arbovirus & Hemo, D-20359 Hamburg, Germany; [Sow, Abdourahmane] Inst Pasteur, Arboviruses & Hemorrhag Fever Viruses Unit, Dakar, Senegal; [Sow, Abdourahmane] Cheikh Anta Diop Univ, Publ Hlth & Dev Inst, Dakar, Senegal; [Sow, Abdourahmane] Bordeaux Univ, INSERM, U897, Bordeaux Publ Hlth Inst, Bordeaux, France; [Renne, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Addo, Marylyn M.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Karolinska Institutet; Harvard University; Massachusetts General Hospital	Addo, MM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Martinistr 52, D-20246 Hamburg, Germany.	m.addo@uke.de; s.schmiedel@uke.de	Addo, Marylyn M./GNP-2548-2022	Renne, Thomas/0000-0003-4594-5975; Gunther, Stephan/0000-0002-6562-0230; Addo, Marylyn/0000-0003-2836-9224; SOW, Abdourahmane/0000-0002-0197-5817				Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310; Roddy P, 2011, J INFECT DIS, V204, pS791, DOI 10.1093/infdis/jir297; Wischmeyer PE, 2014, CRIT CARE, V18, DOI 10.1186/cc13836; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519	8	216	231	3	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2394	2401		10.1056/NEJMoa1411677	http://dx.doi.org/10.1056/NEJMoa1411677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25337633				2022-12-28	WOS:000346425800008
J	Skourti-Stathaki, K; Kamieniarz-Gdula, K; Proudfoot, NJ				Skourti-Stathaki, Konstantina; Kamieniarz-Gdula, Kinga; Proudfoot, Nicholas J.			R-loops induce repressive chromatin marks over mammalian gene terminators	NATURE			English	Article							RNA; METHYLATION; HP1-GAMMA; G9A	The formation of R-loops is a natural consequence of the transcription process, caused by invasion of the DNA duplex by nascent transcripts. These structures have been considered rare transcriptional by-products with potentially harmful effects on genome integrity owing to the fragility of the displaced DNA coding strand(1). However, R-loops may also possess beneficial effects, as their widespread formation has been detected over CpG island promoters in human genes(2,3). Furthermore, we have previously shown that R-loops are particularly enriched over G-rich terminator elements. These facilitate RNA polymerase II (Pol II) pausing before efficient termination(4). Here we reveal an unanticipated link between R-loops and RNA-interference-dependent H3K9me2 formation over pause-site termination regions in mammalian protein-coding genes. We show that R-loops induce antisense transcription over these pause elements, which in turn leads to the generation of double-stranded RNA and the recruitment of DICER, AGO1, AGO2 and the G9a histone lysine methyltransferase. Consequently, an H3K9me2 repressive mark is formed and heterochromatin protein 1 gamma (HP1 gamma) is recruited, which reinforces Pol II pausing before efficient transcriptional termination. We predict that R-loops promote a chromatin architecture that defines the termination region for a substantial subset of mammalian genes.	[Skourti-Stathaki, Konstantina; Kamieniarz-Gdula, Kinga; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222; Kamieniarz-Gdula, Kinga/0000-0003-3789-5381	Wellcome Trust [091805/Z/10/Z]; European Research Council [339270-polyloop]; Marie Curie Actions grant from EU FP7 (REA grant) [327985]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Marie Curie Actions grant from EU FP7 (REA grant)	This work was supported by a Wellcome Trust Programme grant (091805/Z/10/Z) and a European Research Council Advanced grant (339270-polyloop) to N.J.P., and a Marie Curie Actions grant from EU FP7 (REA grant agreement, 327985) to K.K.-G. We are grateful to R. Nunes Bastos for valuable help with immunofluorescence/imaging analysis and figure formatting. We also thank Q. Sun for helpful discussions and advice. We thank R. J. Crouch for the gift of the GFP-RNase H1 expression plasmid, G. Hannon for the Ago2-knockout mouse cell line and Y. Shinkai for the G9a/Glp double-knockout mouse embryonic stem cells.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Nakama M, 2012, GENES CELLS, V17, P218, DOI 10.1111/j.1365-2443.2012.01583.x; Nojima T, 2013, CELL REP, V3, P1080, DOI 10.1016/j.celrep.2013.03.012; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	23	225	228	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					436	+		10.1038/nature13787	http://dx.doi.org/10.1038/nature13787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25296254	Green Accepted			2022-12-28	WOS:000346484800056
J	Geng, J; Kim, K; Zhang, JF; Escalada, A; Tunuguntla, R; Comolli, LR; Allen, FI; Shnyrova, AV; Cho, KR; Munoz, D; Wang, YM; Grigoropoulos, CP; Ajo-Franklin, CM; Frolov, VA; Noy, A				Geng, Jia; Kim, Kyunghoon; Zhang, Jianfei; Escalada, Artur; Tunuguntla, Ramya; Comolli, Luis R.; Allen, Frances I.; Shnyrova, Anna V.; Cho, Kang Rae; Munoz, Dayannara; Wang, Y. Morris; Grigoropoulos, Costas P.; Ajo-Franklin, Caroline M.; Frolov, Vadim A.; Noy, Aleksandr			Stochastic transport through carbon nanotubes in lipid bilayers and live cell membranes	NATURE			English	Article							ALPHA-HEMOLYSIN; WATER; CHANNEL; DNA; INSERTION	There is much interest in developing synthetic analogues of biological membrane channels(1) with high efficiency and exquisite selectivity for transporting ions and molecules. Bottom-up(2) and top-down(3) methods can produce nanopores of a size comparable to that of endogenous protein channels, but replicating their affinity and transport properties remains challenging. In principle, carbon nanotubes (CNTs) should be an ideal membrane channel platform: they exhibit excellent transport properties(4-8) and their narrow hydrophobic inner pores mimic structural motifs typical of biological channels(1). Moreover, simulations predict that CNTs with a length comparable to the thickness of a lipid bilayer membrane can self-insert into the membrane(9,10). Functionalized CNTs have indeed been found to penetrate lipid membranes and cell walls(11,12), and short tubes have been forced into membranes to create sensors(13), yet membrane transport applications of short CNTs remain underexplored. Here we show that short CNTs spontaneously insert into lipid bilayers and live cell membranes to form channels that exhibit a unitary conductance of 70-100 picosiemens under physiological conditions. Despite their structural simplicity, these 'CNT porins' transport water, protons, small ions and DNA, stochastically switch between metastable conductance substates, and display characteristic macromolecule-induced ionic current blockades. We also show that local channel and membrane charges can control the conductance and ion selectivity of the CNT porins, thereby establishing these nanopores as a promising biomimetic platform for developing cell interfaces, studying transport in biological channels, and creating stochastic sensors.	[Geng, Jia; Kim, Kyunghoon; Tunuguntla, Ramya; Cho, Kang Rae; Munoz, Dayannara; Noy, Aleksandr] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA; [Geng, Jia; Zhang, Jianfei; Noy, Aleksandr] Univ Calif, Sch Nat Sci, Merced, CA 95340 USA; [Geng, Jia; Kim, Kyunghoon; Tunuguntla, Ramya; Noy, Aleksandr] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Kim, Kyunghoon; Grigoropoulos, Costas P.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Escalada, Artur; Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, CSIC, Biophys Unit, Leioa 48940, Spain; [Escalada, Artur; Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Comolli, Luis R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Allen, Frances I.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Allen, Frances I.; Ajo-Franklin, Caroline M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Allen, Frances I.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Wang, Y. Morris] Lawrence Livermore Natl Lab, Div Mat Sci, Livermore, CA 94550 USA; [Ajo-Franklin, Caroline M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Frolov, Vadim A.] Basque Fdn Sci, Ikerbasque, Bilbao 48011, Spain	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Basque Foundation for Science	Noy, A (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA.	noy1@llnl.gov	Geng, Jia/G-4332-2010; Ajo-Franklin, Caroline M/F-3405-2016; Frolov, Vadim/ABH-3889-2020; Geng, Jia/AAR-2192-2021; Wang, Yinmin (Morris)/F-2249-2010; Comolli, Luis Raul/C-5907-2017	Geng, Jia/0000-0003-4753-1039; Frolov, Vadim/0000-0002-0653-5669; Wang, Yinmin (MORRIS)/0000-0003-0393-5154; Grigoropoulos, Costas/0000-0002-8505-4037; Wang, Yinmin (Morris)/0000-0002-7161-2034; Allen, Frances/0000-0002-0311-8624; Noy, Aleksandr/0000-0003-4924-2652; Kim, Kyunghoon/0000-0001-8034-947X; Shnyrova, Anna/0000-0002-5329-348X; Comolli, Luis Raul/0000-0002-9313-6550; Cho, Kang Rae/0000-0003-1605-1032	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering; LDRD programme at LLNL [12-ERD-073]; LSP programme at LLNL; ROTC summer fellowship; Spanish Ministry of Economy and Competitiveness [BFU2012-34885]; European FEDER funds; Basque Government [IE12-332]; US Department of Energy [DE-AC52-07NA27344]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); LDRD programme at LLNL; LSP programme at LLNL; ROTC summer fellowship; Spanish Ministry of Economy and Competitiveness(Spanish Government); European FEDER funds(European Commission); Basque Government(Basque Government); US Department of Energy(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	Parts of this work were supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (characterization and transport studies), and the LDRD programme at LLNL, 12-ERD-073(synthesis). R. T. acknowledges support from the LSP programme at LLNL. D. M. acknowledges support from an ROTC summer fellowship. V. A. F. acknowledges partial support by the Spanish Ministry of Economy and Competitiveness, grant BFU2012-34885, co-financed with European FEDER funds, and the Basque Government, grant IE12-332. Work at LLNL was performed under the auspices of the US Department of Energy under contract DE-AC52-07NA27344. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract DE-AC02-05CH11231.	Buyukdagli S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158103; Dutt M, 2011, CURR NANOSCI, V7, P699, DOI 10.2174/157341311797483772; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Gu LQ, 2000, BIOPHYS J, V79, P1967, DOI 10.1016/S0006-3495(00)76445-9; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI [10.1038/nnano.2010.237, 10.1038/NNANO.2010.237]; Haque F, 2013, NAT PROTOC, V8, P373, DOI 10.1038/nprot.2013.001; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Lacerda L, 2013, NANOSCALE, V5, P10242, DOI 10.1039/c3nr03184e; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Le Duc Y, 2011, ANGEW CHEM INT EDIT, V50, P11366, DOI 10.1002/anie.201103312; Lee CY, 2010, SCIENCE, V329, P1320, DOI 10.1126/science.1193383; LEV AA, 1993, P ROY SOC B-BIOL SCI, V252, P187, DOI 10.1098/rspb.1993.0064; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liu HT, 2010, SCIENCE, V327, P64, DOI 10.1126/science.1181799; Liu L., 2013, NATURE COMMUN, V4; Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101; Majumder M, 2005, J AM CHEM SOC, V127, P9062, DOI 10.1021/ja043013b; NEHER E, 1978, J MEMBRANE BIOL, V40, P97, DOI 10.1007/BF01871143; Nestorovich EM, 2003, BIOPHYS J, V85, P3718, DOI 10.1016/S0006-3495(03)74788-2; Powell MR, 2008, NAT NANOTECHNOL, V3, P51, DOI 10.1038/nnano.2007.420; Powell MR, 2011, NAT NANOTECHNOL, V6, P798, DOI [10.1038/nnano.2011.189, 10.1038/NNANO.2011.189]; Shimizu S, 2013, J PHYS CHEM C, V117, P9641, DOI 10.1021/jp312659m; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Sun XM, 2008, J AM CHEM SOC, V130, P6551, DOI 10.1021/ja8006929; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Walther JH, 2013, NANO LETT, V13, P1910, DOI 10.1021/nl304000k; Zimmerli U, 2008, BIOPHYS J, V94, P2546, DOI 10.1529/biophysj.106.102467	33	287	291	27	541	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					612	+		10.1038/nature13817	http://dx.doi.org/10.1038/nature13817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355362				2022-12-28	WOS:000343801500045
J	Godefroit, P; Sinitsa, SM; Dhouailly, D; Bolotsky, YL; Sizov, AV; McNamara, ME; Benton, MJ; Spagna, P				Godefroit, Pascal; Sinitsa, Sofia M.; Dhouailly, Danielle; Bolotsky, Yuri L.; Sizov, Alexander V.; McNamara, Maria E.; Benton, Michael J.; Spagna, Paul			Response to Comment on "A Jurassic ornithischian dinosaur from Siberia with both feathers and scales"	SCIENCE			English	Editorial Material							INTEGUMENTARY STRUCTURES; CHINA	Lingham-Soliar questions our interpretation of integumentary structures in the Middle-Late Jurassic ornithischian dinosaur Kulindadromeus as feather-like appendages and alternatively proposes that the compound structures observed around the humerus and femur of Kulindadromeus are support fibers associated with badly degraded scales. We consider this hypothesis highly unlikely because of the taphonomy and morphology of the preserved structures.	[Godefroit, Pascal; Spagna, Paul] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium; [Sinitsa, Sofia M.] Inst Nat Resources Ecol & Cryol, Chita 672014, Russia; [Dhouailly, Danielle] Univ Grenoble 1, UJF CNRS FRE 3405, AGIM, F-38706 La Tronche, France; [Bolotsky, Yuri L.] FEB RAS, Inst Geol & Nat Management, Blagoveshchensk 675000, Russia; [Sizov, Alexander V.] SB RAS, Inst Earth Crust, Irkutsk 664033, Russia; [McNamara, Maria E.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [McNamara, Maria E.; Benton, Michael J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	Royal Belgian Institute of Natural Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institute of Geology & Nature Management FEB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; Institute of Earth's Crust of Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University College Cork; University of Bristol	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Rue Vautier 29, B-1000 Brussels, Belgium.	pascal.godefroit@naturalsciences.be	Benton, Michael J/A-5639-2008; McNamara, Maria E/C-8431-2014; Sizov, Alexander/ABH-9485-2020; Sinitsa, Sofia/J-3201-2018	Benton, Michael J/0000-0002-4323-1824; McNamara, Maria E/0000-0003-0968-4624; Sizov, Alexander/0000-0002-3029-9686; Sinitsa, Sofia/0000-0002-5074-787X				BJELLAND S, 1988, ARCH DERMATOL RES, V280, P50, DOI 10.1007/BF00412689; Brown T, 2011, P 2011 PART ACC C; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Buchwitz M, 2012, PALAEONTOL Z, V86, P313, DOI 10.1007/s12542-012-0135-3; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Godefroit P, 2014, SCIENCE, V345, P451, DOI 10.1126/science.1253351; Lingham-Soliar T, 2005, J MORPHOL, V263, P1, DOI 10.1002/jmor.10207; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P2207, DOI 10.1098/rspb.2008.0489; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; Lingham-Soliar T, 2014, SCIENCE, V346, DOI 10.1126/science.1259983; Lingham-Soliar T, 2007, NATURWISSENSCHAFTEN, V94, P65, DOI 10.1007/s00114-006-0160-8; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	16	2	2	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208								10.1126/science.1260146	http://dx.doi.org/10.1126/science.1260146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342796				2022-12-28	WOS:000343822900031
J	Vincent, ACJ; Harris, JM				Vincent, Amanda C. J.; Harris, Jean M.			Boundless no more	SCIENCE			English	Editorial Material									[Vincent, Amanda C. J.] Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V6T 1Z4, Canada; [Harris, Jean M.] Ezemvelo KwaZulu Natal Wildlife, Sci Serv, ZA-3202 Pietermaritzburg, South Africa	University of British Columbia	Vincent, ACJ (corresponding author), Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V6T 1Z4, Canada.	a.vincent@fisheries.ubc.ca						Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Davies TD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00561; Dupont DP, 2014, MAR POLICY, V44, P60, DOI 10.1016/j.marpol.2013.08.003; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Giles BG, 2006, BIODIVERS CONSERV, V15, P2497, DOI 10.1007/s10531-005-2432-6; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hansen GJA, 2011, BIOL CONSERV, V144, P1866, DOI 10.1016/j.biocon.2011.04.002; Harris JM., 2007, FISHERIES MANAGEMENT, P112; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Kleiber D, 2015, FISH FISH, V16, P547, DOI 10.1111/faf.12075; Kolding J, 2014, GOVERNANCE OF MARINE FISHERIES AND BIODIVERSITY CONSERVATION: INTERACTION AND COEVOLUTION, P317; Miller AMM, 2014, MAR POLICY, V45, P138, DOI 10.1016/j.marpol.2013.12.009; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Vincent ACJ, 2014, FISH FISH, V15, P563, DOI 10.1111/faf.12035	15	14	14	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					420	421		10.1126/science.1255923	http://dx.doi.org/10.1126/science.1255923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342785				2022-12-28	WOS:000343822900019
J	Howard, S				Howard, Sally			Taming the international commercial surrogacy industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												admin@sallyhoward.net						[Anonymous], 2012, BERKELEY J INT LAW, V30, P412; [Anonymous], 2014, AGENCE FRANCE PRESSE; [Anonymous], 2010, SOUTH EAST ASIA COUR; [Anonymous], 2014, THE DESIRABILITY AND; B, 2011, BBC NEWS; Central Adoption Resource Agency, 2011, GUIDELINES GOVERNING; Chaudhuri M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f475; Hague Conference on Private International law, 2012, PREL REP ISS AR INT; McGuirk R, 2014, AUSTRALIA MAY INTERV; Ministry of Health and Family Welfare, THE ASSISTED REPRODU; Sainsbury M, 2014, NEWS COM; UN, THAILAND ABORTION PO	12	4	4	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2014	349								g6334	10.1136/bmj.g6334	http://dx.doi.org/10.1136/bmj.g6334			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OH	25342063				2022-12-28	WOS:000343768600002
J	Izzo, S; Ahmed, M				Izzo, Sara; Ahmed, Muneer			Herpetic Whitlow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Izzo, Sara] Univ Rome, Rome, Italy; [Ahmed, Muneer] Kings Coll London, London WC2R 2LS, England	Sapienza University Rome; University of London; King's College London	Izzo, S (corresponding author), Univ Rome, Rome, Italy.	muneer.ahmed@kcl.ac.uk							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					E25	E25		10.1056/NEJMicm1311820	http://dx.doi.org/10.1056/NEJMicm1311820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337767				2022-12-28	WOS:000343648500001
J	Wu, WZ; Wang, L; Li, YL; Zhang, F; Lin, L; Niu, SM; Chenet, D; Zhang, X; Hao, YF; Heinz, TF; Hone, J; Wang, ZL				Wu, Wenzhuo; Wang, Lei; Li, Yilei; Zhang, Fan; Lin, Long; Niu, Simiao; Chenet, Daniel; Zhang, Xian; Hao, Yufeng; Heinz, Tony F.; Hone, James; Wang, Zhong Lin			Piezoelectricity of single-atomic-layer MoS2 for energy conversion and piezotronics	NATURE			English	Article							TRANSITION-METAL DICHALCOGENIDES; VALLEY POLARIZATION; GRAIN-BOUNDARIES; GRAPHENE; MONOLAYER; NANOWIRE; ELECTRONICS; STRENGTH	The piezoelectric characteristics of nanowires, thin films and bulk crystals have been closely studied for potential applications in sensors, transducers, energy conversion and electronics(1-3). With their high crystallinity and ability to withstand enormous strain(4-6), two-dimensional materials are of great interest as high-performance piezoelectric materials. Monolayer MoS2 is predicted to be strongly piezoelectric, an effect that disappears in the bulk owing to the opposite orientations of adjacent atomic layers(7,8). Here we report the first experimental study of the piezoelectric properties of two-dimensional MoS2 and show that cyclic stretching and releasing of thin MoS2 flakes with an odd number of atomic layers produces oscillating piezoelectric voltage and current outputs, whereas no output is observed for flakes with an even number of layers. A single monolayer flake strained by 0.53% generates a peak output of 15 mV and 20 pA, corresponding to a power density of 2 mW m(-2) and a 5.08% mechanical-to-electrical energy conversion efficiency. In agreement with theoretical predictions, the output increases with decreasing thickness and reverses sign when the strain direction is rotated by 90 degrees. Transport measurements show a strong piezotronic effect in single-layer MoS2, but not in bilayer and bulk MoS2. The coupling between piezoelectricity and semiconducting properties in two-dimensional nanomaterials may enable the development of applications in powering nanodevices, adaptive bioprobes and tunable/stretchable electronics/optoelectronics.	[Wu, Wenzhuo; Lin, Long; Niu, Simiao; Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Wang, Lei] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Li, Yilei; Heinz, Tony F.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Zhang, Fan; Chenet, Daniel; Zhang, Xian; Hao, Yufeng; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Wang, Zhong Lin] Chinese Acad Sci, Beijing Inst Nanoenergy & Nanosyst, Beijing 100083, Peoples R China	University System of Georgia; Georgia Institute of Technology; Columbia University; Columbia University; Columbia University; Chinese Academy of Sciences; Beijing Institute of Nanoenergy & Nanosystems, CAS	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	jh2228@columbia.edu; zhong.wang@mse.gatech.edu	Hone, James C/E-1879-2011; Wang, Zhong Lin/E-2176-2011; Wu, Wenzhuo/G-1334-2010; Niu, Simiao/D-3019-2012; hao, yufeng/B-9178-2013; Wang, Lei/K-1160-2012; wang, jie/GRS-0942-2022; Heinz, Tony/K-7797-2015	Hone, James C/0000-0002-8084-3301; Wang, Zhong Lin/0000-0002-5530-0380; Wu, Wenzhuo/0000-0003-0362-6650; Niu, Simiao/0000-0003-1973-2204; Wang, Lei/0000-0002-1919-9107; Heinz, Tony/0000-0003-1365-9464; Zhang, Xian/0000-0002-1088-4888	US Department of Energy, Office of Basic Energy Sciences [DE-FG02-07ER46394]; US National Science Foundation [DMR-1122594]; 'Thousands Talents' programme for pioneer researcher and his innovation team, National Natural Science Foundation of China [51432005]; China and Beijing City Committee of Science and Technology [Z131100006013004, Z131100006013005]	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); 'Thousands Talents' programme for pioneer researcher and his innovation team, National Natural Science Foundation of China; China and Beijing City Committee of Science and Technology	We thank C. Dean, P. Kim and K. Shepard for discussions, and K. Alexander and E. Reed for theoretical consultation. This research was supported by the US Department of Energy, Office of Basic Energy Sciences (DE-FG02-07ER46394) and US National Science Foundation (DMR-1122594). Z.L.W. acknowledges the 'Thousands Talents' programme for pioneer researcher and his innovation team, National Natural Science Foundation of China (51432005), and China and Beijing City Committee of Science and Technology (Z131100006013004 and Z131100006013005).	Bertolazzi S, 2011, ACS NANO, V5, P9703, DOI 10.1021/nn203879f; Chen JR, 2013, NANO LETT, V13, P3106, DOI 10.1021/nl4010157; Conley HJ, 2013, NANO LETT, V13, P3626, DOI 10.1021/nl4014748; Cooper RC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035423; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Duerloo KAN, 2012, J PHYS CHEM LETT, V3, P2871, DOI 10.1021/jz3012436; FERREN RA, 1991, NATURE, V350, P26; Gao Y, 2009, NANO LETT, V9, P1103, DOI 10.1021/nl803547f; He K, 2013, NANO LETT, V13, P2931, DOI 10.1021/nl4013166; Hu YF, 2013, NANO LETT, V13, P5026, DOI 10.1021/nl401702g; Hu YF, 2012, ADV MATER, V24, P110, DOI 10.1002/adma.201103727; Huang MY, 2011, NANO LETT, V11, P1241, DOI 10.1021/nl104227t; Hui YY, 2013, ACS NANO, V7, P7126, DOI 10.1021/nn4024834; Johari P, 2012, ACS NANO, V6, P5449, DOI 10.1021/nn301320r; Kingon AI, 2005, NAT MATER, V4, P233, DOI 10.1038/nmat1334; Kumar N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161403; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lauritsen JV, 2007, NAT NANOTECHNOL, V2, P53, DOI 10.1038/nnano.2006.171; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lee GH, 2013, SCIENCE, V340, P1073, DOI 10.1126/science.1235126; Li YL, 2013, NANO LETT, V13, P3329, DOI 10.1021/nl401561r; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Malard LM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.201401; Michel KH, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115328; Michel KH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224301; Neal A. T., 2012, DEV RES C DRC 18 20, P65, DOI DOI 10.1109/DRC.2012.6256928; Ong MT, 2012, ACS NANO, V6, P1387, DOI 10.1021/nn204198g; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656; Wang ZL, 2010, NANO TODAY, V5, P540, DOI 10.1016/j.nantod.2010.10.008; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Wu WZ, 2013, SCIENCE, V340, P952, DOI [10.1126/science.1234855, 10.1126/science.1237145]; Yang H, 2012, SCIENCE, V336, P1140, DOI 10.1126/science.1220527; Yang RS, 2009, NAT NANOTECHNOL, V4, P34, DOI [10.1038/nnano.2008.314, 10.1038/NNANO.2008.314]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang Y, 2011, ADV MATER, V23, P3004, DOI 10.1002/adma.201100906	37	1397	1415	98	1902	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					470	+		10.1038/nature13792	http://dx.doi.org/10.1038/nature13792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25317560				2022-12-28	WOS:000343775900035
J	Kroenke, K				Kroenke, Kurt			A Practical and Evidence-Based Approach to Common Symptoms A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							MEDICALLY UNEXPLAINED SYMPTOMS; PRIMARY-CARE; PHYSICAL-EXAMINATION; SOMATIC SYMPTOMS; HISTORY; DEPRESSION; PATIENT; EXPECTATIONS; EXERCISE; OUTCOMES	Physical symptoms account for more than half of all outpatient visits, yet the predominant disease-focused model of care is inadequate for many of these symptom-prompted encounters. Moreover, the amount of clinician training dedicated to understanding, evaluating, and managing common symptoms is disproportionally small relative to their prevalence, impairment, and health care costs. This narrative review regarding physical symptoms addresses 4 common epidemiologic questions: cause, diagnosis, prognosis, and therapy. Important findings include the following: First, at least one third of common symptoms do not have a clear-cut, disease-based explanation (5 studies in primary care, 1 in specialty clinics, and 2 in the general population). Second, the history and physical examination alone contribute 73% to 94% of the diagnostic information, with costly testing and procedures contributing much less (5 studies of multiple types of symptoms and 4 of specific symptoms). Third, physical and psychological symptoms commonly co-occur, making a dualistic approach impractical. Fourth, because most patients have multiple symptoms rather than a single symptom, focusing on 1 symptom and ignoring the others is unwise. Fifth, symptoms improve in weeks to several months in most patients but become chronic or recur in 20% to 25%. Sixth, serious causes that are not apparent after initial evaluation seldom emerge during long-term follow-up. Seventh, certain pharmacologic and behavioral treatments are effective across multiple types of symptoms. Eighth, measuring treatment response with valid scales can be helpful. Finally, communication has therapeutic value, including providing an explanation and probable prognosis without "normalizing" the symptom.	[Kroenke, Kurt] Indiana Univ, Vet Affairs Hlth Serv Res & Dev Ctr Hlth Informat, Indianapolis, IN 46204 USA; [Kroenke, Kurt] Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd,5th Floor, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org		Kroenke, Kurt/0000-0002-0114-4669				Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Abbass A, 2009, PSYCHOTHER PSYCHOSOM, V78, P265, DOI 10.1159/000228247; Aktas A, 2010, PALLIATIVE MED, V24, P373, DOI 10.1177/0269216310367842; Barsevick Andrea M, 2007, Semin Oncol Nurs, V23, P89, DOI 10.1016/j.soncn.2007.01.009; BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549; Costa LDM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3829; Daley A, 2008, J CLIN PSYCHOL MED S, V15, P140, DOI 10.1007/s10880-008-9105-z; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Dowrick CF, 2004, BRIT J GEN PRACT, V54, P165; Escobar JI, 2010, J PSYCHOSOM RES, V69, P1, DOI 10.1016/j.jpsychores.2010.01.001; Gardner JW, 2003, MIL MED, V168, P186, DOI 10.1093/milmed/168.3.186; Gask L, 2011, J PSYCHOSOM RES, V71, P325, DOI 10.1016/j.jpsychores.2011.05.008; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Gruppen L D, 1988, Res Med Educ, V27, P242; Hahn SR, 2001, ANN INTERN MED, V134, P897, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00014; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013; Hartman TCO, 2009, J PSYCHOSOM RES, V66, P363, DOI 10.1016/j.jpsychores.2008.09.018; HAWKINS CF, 1971, GUT, V12, P208, DOI 10.1136/gut.12.3.208; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Hoffman RM, 1999, AM J MED, V107, P468, DOI 10.1016/S0002-9343(99)00260-0; Jackson JL, 2006, CNS SPECTRUMS, V11, P212, DOI 10.1017/S1092852900014383; Jackson JL, 2005, J GEN INTERN MED, V20, P1032, DOI 10.1111/j.1525-1497.2005.0241.x; Jackson JL, 2001, ANN INTERN MED, V134, P889, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00013; Johns SA, 2011, J AMBUL CARE MANAG, V34, P126, DOI 10.1097/JAC.0b013e31820ef628; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Kelley GA, 2011, ARTHRIT CARE RES, V63, P79, DOI 10.1002/acr.20347; Khan AA, 2003, PSYCHOSOMATICS, V44, P471, DOI 10.1176/appi.psy.44.6.471; Kravitz RL, 2001, ANN INTERN MED, V134, P881, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00012; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; KROENKE K, 1988, JAMA-J AM MED ASSOC, V260, P929, DOI 10.1001/jama.260.7.929; Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; KROENKE K, 1994, J GEN INTERN MED, V9, P684, DOI 10.1007/BF02599010; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; Kroenke K, 2006, MED CLIN N AM, V90, P603, DOI 10.1016/j.mcna.2006.04.003; Kroenke K, 2013, JAMA INTERN MED, V173, P416, DOI 10.1001/jamainternmed.2013.11; Kroenke K, 2012, CAN MED ASSOC J, V184, P281, DOI 10.1503/cmaj.112004; Kroenke K, 2011, J PAIN, V12, P964, DOI 10.1016/j.jpain.2011.03.003; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lakhan SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071834; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Marple RL, 1997, ARCH INTERN MED, V157, P1482, DOI 10.1001/archinte.157.13.1482; Martina B, 1997, J GEN INTERN MED, V12, P459, DOI 10.1046/j.1525-1497.1997.00083.x; McMillan EM, 2011, APPL PHYSIOL NUTR ME, V36, P892, DOI [10.1139/h11-082, 10.1139/H11-082]; Morris DW, 2011, CURR PSYCHIAT REP, V13, P446, DOI 10.1007/s11920-011-0237-8; National Research Council, 2013, GULF WAR HLTH TREATM; PETERSON MC, 1992, WESTERN J MED, V156, P163; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Rao JK, 2000, ARCH FAM MED, V9, P1148, DOI 10.1001/archfami.9.10.1148; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; RICH EC, 1987, ARCH INTERN MED, V147, P1957, DOI 10.1001/archinte.147.11.1957; Rolfe A, 2013, JAMA INTERN MED, V173, P407, DOI 10.1001/jamainternmed.2013.2762; Salmon P, 2006, CNS SPECTRUMS, V11, P190, DOI 10.1017/S109285290001436X; SANDLER G, 1980, AM HEART J, V100, P928, DOI 10.1016/0002-8703(80)90076-9; SCHMITT BP, 1986, J GEN INTERN MED, V1, P386, DOI 10.1007/BF02596424; Skovenborg EL, 2014, GEN HOSP PSYCHIAT, V36, P38, DOI 10.1016/j.genhosppsych.2013.09.006; Smith RC, 2003, J GEN INTERN MED, V18, P478, DOI 10.1046/j.1525-1497.2003.20815.x; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Speckens AEM, 1996, PSYCHOL MED, V26, P745, DOI 10.1017/S0033291700037764; Steinbrecher N, 2011, PSYCHOSOMATICS, V52, P263, DOI 10.1016/j.psym.2011.01.007; Stone J, 2009, BRAIN, V132, P2878, DOI 10.1093/brain/awp220; Tan G, 2007, J REHABIL RES DEV, V44, P195, DOI 10.1682/JRRD.2006.06.0063; VONKORFF M, 1993, SPINE, V18, P855, DOI 10.1097/00007632-199306000-00008; Wasson J H, 1981, Med Decis Making, V1, P215, DOI 10.1177/0272989X8100100302; Weber BE, 1996, AM J MED, V100, P138, DOI 10.1016/S0002-9343(97)89451-X; YOUNG MJ, 1983, J MED EDUC, V58, P738; Zijlema WL, 2013, J PSYCHOSOM RES, V74, P459, DOI 10.1016/j.jpsychores.2013.03.093	72	75	78	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					579	U82		10.7326/M14-0461	http://dx.doi.org/10.7326/M14-0461			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9PL	25329205				2022-12-28	WOS:000343906800019
J	Tajeddine, R; Rambaux, N; Lainey, V; Charnoz, S; Richard, A; Rivoldini, A; Noyelles, B				Tajeddine, R.; Rambaux, N.; Lainey, V.; Charnoz, S.; Richard, A.; Rivoldini, A.; Noyelles, B.			Constraints on Mimas' interior from Cassini ISS libration measurements	SCIENCE			English	Article							REGULAR SATELLITES; GIANT PLANETS; MASSIVE RINGS; ACCRETION; PHOBOS; SYSTEMS; ORIGIN; MODEL	Like our Moon, the majority of the solar system's satellites are locked in a 1: 1 spin-orbit resonance; on average, these satellites show the same face toward the planet at a constant rotation rate equal to the satellite's orbital rate. In addition to the uniform rotational motion, physical librations (oscillations about an equilibrium) also occur. The librations may contain signatures of the satellite's internal properties. Using stereophotogrammetry on Cassini Image Science Subsystem (ISS) images, we measured longitudinal physical forced librations of Saturn's moon Mimas. Our measurements confirm all the libration amplitudes calculated from the orbital dynamics, with one exception. This amplitude depends mainly on Mimas' internal structure and has an observed value of twice the predicted one, assuming hydrostatic equilibrium. After considering various possible interior models of Mimas, we argue that the satellite has either a large nonhydrostatic interior, or a hydrostatic one with an internal ocean beneath a thick icy shell.	[Tajeddine, R.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Tajeddine, R.; Rambaux, N.; Lainey, V.; Richard, A.] Univ Lille 1, UPMC, UMR CNRS 8028, IMCCE Observ Paris, F-75014 Paris, France; [Tajeddine, R.; Rambaux, N.] Univ Paris 06, F-75005 Paris, France; [Charnoz, S.] Univ Paris Diderot CEA IRFU CNRS, Lab AIM, UMR 7158, Ctr Orme Merisiers, F-91191 Gif Sur Yvette, France; [Rivoldini, A.] Royal Observ Belgium, B-1180 Brussels, Belgium; [Noyelles, B.] Univ Namur, Dept Math, B-5000 Namur, Belgium; [Noyelles, B.] Univ Namur, Namur Ctr Complex Syst, B-5000 Namur, Belgium	Cornell University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA; Universite Paris Saclay; University of Namur; University of Namur	Tajeddine, R (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	tajeddine@astro.cornell.edu	Noyelles, Benoît/Q-1767-2015	Noyelles, Benoît/0000-0003-4106-8741	UPMC-EMERGENCE [EME0911]; Cassini mission; European Community [263466]; UnivEarthS Labex program at Sorbonne Paris Cite [ANR-10-LABX-0023, ANR-11-IDEX-0005-02]; RS/CNRS [2011/R1, IE110421]; European Space Agency; Belgian Federal Science Policy Office; FRS-FNRS	UPMC-EMERGENCE; Cassini mission; European Community(European Commission); UnivEarthS Labex program at Sorbonne Paris Cite; RS/CNRS; European Space Agency(European Space AgencyEuropean Commission); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	We thank the "ENCELADE" working group, J. A. Burns, N. J. Cooper, K Degiorgio, M. M. Hedman, C. D. Murray, P. D. Nicholson and T. Van Hooslt for fruitful discussions and suggestions; and the anonymous reviewers for their suggestions that improved the quality of the paper. The Cassini images that were used to obtain this paper's results are available on the Planetary Data System website, pds.nasa.gov. Supported by UPMC-EMERGENCE (contract EME0911), the Cassini mission (R.T.), the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement 263466 for the FP-ESPaCE project (R.T., N.R., and V.L.), the UnivEarthS Labex program at Sorbonne Paris Cite (ANR-10-LABX-0023 and ANR-11-IDEX-0005-02), RS/CNRS (2011/R1 ref. IE110421) (S.C.), the European Space Agency in collaboration with the Belgian Federal Science Policy Office (A.Riv.), and an FRS-FNRS postdoctoral research fellowship (B.N.).	ASPHAUG E, 1993, ICARUS, V101, P144, DOI 10.1006/icar.1993.1012; Asphaug E, 2013, ICARUS, V223, P544, DOI 10.1016/j.icarus.2012.12.009; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Charnoz S, 2011, ICARUS, V216, P535, DOI 10.1016/j.icarus.2011.09.017; Charnoz S, 2010, NATURE, V465, P752, DOI 10.1038/nature09096; Crida A, 2012, SCIENCE, V338, P1196, DOI 10.1126/science.1226477; DERMOTT SF, 1988, ICARUS, V73, P25, DOI 10.1016/0019-1035(88)90084-X; Durham WB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023484; DUXBURY TC, 1989, ICARUS, V77, P275, DOI 10.1016/0019-1035(89)90090-0; Lainey V, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/14; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; McKinnon WB, 2013, J GEOPHYS RES-PLANET, V118, P1775, DOI 10.1002/jgre.20122; Mosqueira I, 2003, ICARUS, V163, P198, DOI 10.1016/S0019-1035(03)00076-9; Mosqueira I, 2003, ICARUS, V163, P232, DOI 10.1016/S0019-1035(03)00077-0; Noyelles B, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117558; Ogihara M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/60; Rambaux N, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219710; Rambaux N, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041465; Richard A, 2014, PLANET SPACE SCI, V93-94, P22, DOI 10.1016/j.pss.2014.02.006; Roatsch T, 2009, PLANET SPACE SCI, V57, P83, DOI 10.1016/j.pss.2008.10.014; Sasaki T, 2010, ASTROPHYS J, V714, P1052, DOI 10.1088/0004-637X/714/2/1052; Schenk P. M., 2011, LUNAR PLANET SCI C, V42, P2729; Sekine Y, 2012, PLANET SPACE SCI, V63-64, P133, DOI 10.1016/j.pss.2011.05.015; Tajeddine R, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220831; Thomas PC, 2010, ICARUS, V208, P395, DOI 10.1016/j.icarus.2010.01.025; Willner K, 2010, EARTH PLANET SC LETT, V294, P541, DOI 10.1016/j.epsl.2009.07.033; Yseboodt M, 2013, ICARUS, V226, P41, DOI 10.1016/j.icarus.2013.05.011	28	46	47	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					322	324		10.1126/science.1255299	http://dx.doi.org/10.1126/science.1255299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324382				2022-12-28	WOS:000343041100036
J	Jackson, MG; Hart, SR; Konter, JG; Kurz, MD; Blusztajn, J; Farley, KA				Jackson, M. G.; Hart, S. R.; Konter, J. G.; Kurz, M. D.; Blusztajn, J.; Farley, K. A.			Helium and lead isotopes reveal the geochemical geometry of the Samoan plume	NATURE			English	Article							DEEP-MANTLE; OCEANIC BASALTS; ISLAND BASALTS; TRACE-ELEMENT; PB ISOTOPE; LAVAS; SR; ND; AGE; SYSTEMATICS	Hotspot lavas erupted at ocean islands exhibit tremendous isotopic variability, indicating that there are numerous mantle components(1,2) hosted in upwelling mantle plumes that generate volcanism at hotspots like Hawaii and Samoa(3). However, it is not known how the surface expression of the various geochemical components observed in hotspot volcanoes relates to their spatial distribution within the plume(4-10). Here we present a relationship between He and Pb isotopes in Samoan lavas that places severe constraints on the distribution of geochemical species within the plume. The Pb-isotopic compositions of the Samoan lavas reveal several distinct geochemical groups, each corresponding to a different geographic lineament of volcanoes. Each group has a signature associated with one of four mantle end members with low He-3/He-4:EMII(enriched mantle 2), EMI(enriched mantle 1), HIMU(high mu = U-238/Pb-204) and DM(depleted mantle). Critically, these four geochemical groups trend towards a common region of Pb-isotopic space with high He-3/He-4. This observation is consistent with several low-He-3/He-4 components in the plume mixing with a common high-He-3/He-4 component, but not mixing much with each other. The mixing relationships inferred from the new He and Pb isotopic data provide the clearest picture yet of the geochemical geometry of a mantle plume, and are best explained by a high-He-3/He-4 plume matrix that hosts, and mixes with, several distinct low-He-3/He-4 components.	[Jackson, M. G.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Hart, S. R.; Blusztajn, J.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Konter, J. G.] Univ Hawaii Manoa, Sch Earth & Ocean Sci & Technol SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Kurz, M. D.] Woods Hole Oceanog Inst, Dept Marine Chem, Woods Hole, MA 02543 USA; [Farley, K. A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of California System; University of California Santa Barbara; Woods Hole Oceanographic Institution; University of Hawaii System; University of Hawaii Manoa; Woods Hole Oceanographic Institution; California Institute of Technology	Jackson, MG (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	jackson@geol.ucsb.edu	Konter, Jasper/G-5206-2012; Farley, Kenneth/AAE-7735-2020	Konter, Jasper/0000-0002-4853-5456; Farley, Kenneth/0000-0002-7846-7546; Kurz, Mark/0000-0003-1745-2356	NSF [OCE-1061134, OCE-1153894, EAR-1348082, EAR-1145202]	NSF(National Science Foundation (NSF))	We thank J. Natland, P. Hall and M. Regelous for discussions, and R. Carlson for access to analytical facilities. Comments from B. Hanan and K. Harpp improved the manuscript. M.G.J. acknowledges grants from the NSF that funded this research: OCE-1061134, OCE-1153894, EAR-1348082 and EAR-1145202.	Abouchami W, 1999, GEOCHIM COSMOCHIM AC, V63, P1489, DOI 10.1016/S0016-7037(99)00068-X; Abouchami W, 2005, NATURE, V434, P851, DOI 10.1038/nature03402; Anderson T., 1910, Q J GEOL SOC LOND, V66, P621, DOI DOI 10.1144/GSL.JGS.1910.066.01-04.30; Bryce JG, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000809; Cabral RA, 2013, NATURE, V496, P490, DOI 10.1038/nature12020; Carlson RW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001342; Chauvel C, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004123; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Coltice N, 2011, EARTH PLANET SC LETT, V308, P193, DOI 10.1016/j.epsl.2011.05.045; Eisele J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000339; FARLEY KA, 1992, EARTH PLANET SC LETT, V111, P183, DOI 10.1016/0012-821X(92)90178-X; FARLEY KA, 1995, GEOLOGY, V23, P531, DOI 10.1130/0091-7613(1995)023<0531:RCOSSI>2.3.CO;2; Farnetani CG, 2012, EARTH PLANET SC LETT, V359, P240, DOI 10.1016/j.epsl.2012.09.057; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Galer S. J. H., 1986, THESIS U CAMBRIDGE; Garnero E. J., 2014, NATURE GEOSCI; GRAHAM DW, 1992, EARTH PLANET SC LETT, V110, P133, DOI 10.1016/0012-821X(92)90044-V; Hanan BB, 1996, SCIENCE, V272, P991, DOI 10.1126/science.272.5264.991; Hanyu T, 1997, NATURE, V390, P273, DOI 10.1038/36835; Hanyu T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003252; Hart SR, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000108; Hart S. R., 2004, GEOCHEM GEOPHYS GEOS, V6; Hart S. R., 2002, EOS, V83, pF20; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Hart SR, 2004, EARTH PLANET SC LETT, V227, P37, DOI 10.1016/j.epsl.2004.08.005; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Hart SR, 2014, GEOCHEM GEOPHY GEOSY, V15, P2301, DOI 10.1002/2013GC005221; Hauri EH, 1997, CHEM GEOL, V139, P185, DOI 10.1016/S0009-2541(97)00035-1; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; HAWKINS JW, 1975, EARTH PLANET SC LETT, V24, P427, DOI 10.1016/0012-821X(75)90150-8; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Honda M, 2005, EARTH PLANET SC LETT, V236, P597, DOI 10.1016/j.epsl.2005.05.038; Huang SC, 2011, NAT GEOSCI, V4, P874, DOI [10.1038/NGEO1263, 10.1038/ngeo1263]; Jackson M. G., GALAPAGOS N IN PRESS, P27; Jackson MG, 2007, EARTH PLANET SC LETT, V264, P360, DOI 10.1016/j.epsl.2007.09.023; Jackson MG, 2007, NATURE, V448, P684, DOI 10.1038/nature06048; Jackson MG, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003232; Jackson MG, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001876; Kear D., 1959, NZ GEOL SURV B, V63; Konter J. G., 2012, GEOCHEM GEOPHYS GEOS, V13; Koppers AAP, 2008, GEOLOGY, V36, P435, DOI 10.1130/G24630A.1; Koppers AAP, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003438; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Kurz MD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2002GC000439; MATSUDA JI, 1984, TECTONOPHYSICS, V104, P145, DOI 10.1016/0040-1951(84)90107-0; MCDONOUGH WF, 1991, EARTH PLANET SC LETT, V105, P397, DOI 10.1016/0012-821X(91)90180-P; MCDOUGALL I, 1985, PAC SCI, V39, P311; McDougall I, 2010, GEOL MAG, V147, P705, DOI 10.1017/S0016756810000038; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Natland J. H., 1985, EARTH SCI SERIES, V3, P139; NATLAND JH, 1980, AM J SCI, V280, P709; PALACZ ZA, 1986, EARTH PLANET SC LETT, V79, P270, DOI 10.1016/0012-821X(86)90185-8; Parai R, 2009, EARTH PLANET SC LETT, V277, P253, DOI 10.1016/j.epsl.2008.10.014; Payne JA, 2013, GEOLOGY, V41, P19, DOI 10.1130/G33273.1; Petrone CM, 2003, CHEM GEOL, V193, P1; Rohde J, 2013, GEOLOGY, V41, P335, DOI 10.1130/G33790.1; Sims KWW, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001651; Stolper EM, 1996, J GEOPHYS RES-SOL EA, V101, P11593, DOI 10.1029/96JB00332; TATSUMOTO M, 1978, EARTH PLANET SC LETT, V38, P63, DOI 10.1016/0012-821X(78)90126-7; Todt W., 1996, GEOPHYS MONOGR SER, V95, P429; Weis D, 2011, NAT GEOSCI, V4, P831, DOI [10.1038/ngeo1328, 10.1038/NGEO1328]; WHITE WM, 1982, NATURE, V296, P821, DOI 10.1038/296821a0; Workman RK, 2008, GEOLOGY, V36, P551, DOI 10.1130/G24558A.1; Workman RK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000623; WRIGHT E, 1987, EARTH PLANET SC LETT, V81, P151, DOI 10.1016/0012-821X(87)90152-X; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	68	73	74	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					355	+		10.1038/nature13794	http://dx.doi.org/10.1038/nature13794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318524				2022-12-28	WOS:000342988600049
J	Tarajia, M; Jaramillo, F; Pernett, A; Santamaria, N; Goodridge, A				Tarajia, Musharaf; Jaramillo, Fabio; Pernett, Amaranta; Santamaria, Nelson; Goodridge, Amador			Dyspnoea, weight loss, fever, and headache caused by extrapulmonary tuberculosis in a prison inmate	LANCET			English	Editorial Material									[Tarajia, Musharaf; Goodridge, Amador] Ctr Biol Mol & Celular Enfermedades, Inst Invest Cientificas, TB Biomarker Res Unit, Ciudad Del Saber, Panama; [Tarajia, Musharaf; Goodridge, Amador] Ctr Biol Mol & Celular Enfermedades, Inst Invest Cientificas, TB Biomarker Res Unit, Serv Alta Tecnol, Ciudad Del Saber, Panama; [Tarajia, Musharaf] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India; [Jaramillo, Fabio; Pernett, Amaranta; Santamaria, Nelson] Hosp Santo Tomas, Div Pulm Med, Panama City, Panama	Acharya Nagarjuna University	Tarajia, M (corresponding author), Ctr Biol Mol & Celular Enfermedades, Inst Invest Cientificas, TB Biomarker Res Unit, POB 0843-01103, Ciudad Del Saber, Panama.	drtarajia@me.com	Goodridge, Amador/Q-7109-2019; Goodridge, Amador/F-9026-2011	Goodridge, Amador/0000-0003-3910-0482; Tarajia, Musharaf/0000-0001-8313-3674				O'Grady J, 2011, EUR RESPIR J, V38, P752, DOI 10.1183/09031936.00041211; Porcel JM, 2006, AM FAM PHYSICIAN, V73, P1211; World Health Organization, 2014, AUT REAL TIM NUCL AC	3	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1400	1400		10.1016/S0140-6736(14)61456-2	http://dx.doi.org/10.1016/S0140-6736(14)61456-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25307843				2022-12-28	WOS:000343004000030
J	Liu, ZJ; Merkurjev, D; Yang, F; Li, WB; Oh, S; Friedman, MJ; Song, XY; Zhang, F; Ma, Q; Ohgi, KA; Krones, A; Rosenfeld, MG				Liu, Zhijie; Merkurjev, Daria; Yang, Feng; Li, Wenbo; Oh, Soohwan; Friedman, Meyer J.; Song, Xiaoyuan; Zhang, Feng; Ma, Qi; Ohgi, Kenneth A.; Krones, Anna; Rosenfeld, Michael G.			Enhancer Activation Requires trans-Recruitment of a Mega Transcription Factor Complex	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENOME-WIDE ANALYSIS; SUPER-ENHANCERS; DNA-BINDING; GENE-EXPRESSION; RETINOIC ACID; CELL IDENTITY; BREAST-CANCER; PHOSPHORYLATION; REGULATORS	Enhancers provide critical information directing cell-type-specific transcriptional programs, regulated by binding of signal-dependent transcription factors and their associated cofactors. Here, we report that the most strongly activated estrogen (E-2)-responsive enhancers are characterized by trans-recruitment and in situ assembly of a large 1-2 MDa complex of diverse DNA-binding transcription factors by ER alpha at ERE-containing enhancers. We refer to enhancers recruiting these factors as mega transcription factor-bound in trans (MegaTrans) enhancers. The MegaTrans complex is a signature of the most potent functional enhancers and is required for activation of enhancer RNA transcription and recruitment of co-activators, including p300 and Med1. The MegaTrans complex functions, in part, by recruiting specific enzymatic machinery, exemplified by DNA-dependent protein kinase. Thus, MegaTrans-containing enhancers represent a cohort of functional enhancers that mediate a broad and important transcriptional program and provide a molecular explanation for transcription factor clustering and hotspots noted in the genome.	[Liu, Zhijie; Merkurjev, Daria; Yang, Feng; Li, Wenbo; Oh, Soohwan; Friedman, Meyer J.; Song, Xiaoyuan; Zhang, Feng; Ma, Qi; Ohgi, Kenneth A.; Krones, Anna; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Merkurjev, Daria; Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Oh, Soohwan] Univ Calif San Diego, Grad Program Biol Sci, La Jolla, CA 92093 USA; [Song, Xiaoyuan] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230027, Peoples R China; [Song, Xiaoyuan] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liu, ZJ (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	z9liu@ucsd.edu; mrosenfeld@ucsd.edu	Yang, Feng/A-4770-2017; , songxy/P-1094-2014; li, wenbo/GZM-8930-2022; Ma, Qi/C-9716-2015	, songxy/0000-0002-9011-5033; Ma, Qi/0000-0002-8705-4460	NIH [DK018477, HL065445, NS034934, DK039949, CA173903]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R37DK039949, R01DK039949, T32DK007541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to Janet Hightower for assistance with figure preparation, to Rachel Pardee for proofreading, and to Dr. Majid Ghassemian (University of California, San Diego [UCSD]) for assistance in mass spectrometry. We thank Dr. Dimple Notani (UCSD) for critically reading the manuscript, and Drs. Namit Singh and Kevin Corbett (UCSD) for their experimental contributions on gel filtration studies. We thank Drs. Dorota Skowronska-Krawczyk and Bogdan Tanasa (UCSD) for critical comments and discussions on this paper. M.G.R. is an investigator with the Howard Hughes Medical Institute. This work was supported by NIH grants (DK018477, HL065445, NS034934, DK039949, and CA173903).	Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Foulds CE, 2013, MOL CELL, V51, P185, DOI 10.1016/j.molcel.2013.06.007; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	36	131	135	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					358	373		10.1016/j.cell.2014.08.027	http://dx.doi.org/10.1016/j.cell.2014.08.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303530	Green Accepted, Bronze			2022-12-28	WOS:000343095600017
J	Moro-Martin, A				Moro-Martin, Amaya			A call to those who care about Europe's science	NATURE			English	Editorial Material									STSI, Baltimore, MD 21218 USA	Space Telescope Science Institute	Moro-Martin, A (corresponding author), STSI, Baltimore, MD 21218 USA.	amayamoromartin@gmail.com		Moro Martin, Amaya/0000-0001-9504-8426					0	4	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					141	141		10.1038/514141a	http://dx.doi.org/10.1038/514141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3BG	25297399	Bronze			2022-12-28	WOS:000342663100005
J	Dowdy, DW				Dowdy, David W.			Healthy But Harmed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	ddowdy1@jhmi.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1399	1400		10.1001/jama.2014.7219	http://dx.doi.org/10.1001/jama.2014.7219			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291573				2022-12-28	WOS:000342630200012
J	Mulligan, MJ; Bernstein, DI; Winokur, P; Rupp, R; Anderson, E; Rouphael, N; Dickey, M; Stapleton, JT; Edupuganti, S; Spearman, P; Ince, D; Noah, DL; Hill, H; Bellamy, AR				Mulligan, Mark J.; Bernstein, David I.; Winokur, Patricia; Rupp, Richard; Anderson, Evan; Rouphael, Nadine; Dickey, Michelle; Stapleton, Jack T.; Edupuganti, Srilatha; Spearman, Paul; Ince, Dilek; Noah, Diana L.; Hill, Heather; Bellamy, Abbie R.		DMID 13-0032 H7N9 Vaccine Study Gr	Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							A H7N9 VIRUS; CELL RESPONSES; H5N1 INFLUENZA; IMMUNOGENICITY; SAFETY; CHILDREN; ADULTS; PROTECTION; INFECTION; ANTIBODY	IMPORTANCE Human infections with avian influenza A/H7N9 have resulted in high morbidity and mortality in China. OBJECTIVE To compare safety and immunogenicity of different doses of influenza A/Shanghai/2/13 (H7N9) vaccine mixed with or without the MF59 adjuvant. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind, phase 2 trial at 4 US sites enrolled 700 adults aged 19 to 64 years beginning in September 2013; 6-month follow-up was completed in May 2014. INTERVENTIONS The H7N9 inactivated virus vaccine was administered intramuscularly on days 0 and 21 at nominal doses of 3.75, 7.5, 15, or 45 mu g of hemagglutinin (actual doses approximately 50% higher) with or without the MF59 adjuvant. A total 99, 100, or 101 participants were randomized to each group (7 groups; N = 700). MAIN OUTCOMES AND MEASURES Proportions achieving day 42 antibody titer of 40 or greater or seroconversion (a minimum 4-fold increase to titer >= 40) with the hemagglutination inhibition assay; vaccine-related serious adverse events through month 13; and solicited postvaccination symptoms through day 7. RESULTS Hemagglutination inhibition antibodies were minimal after participants received an unadjuvanted vaccine. After receiving 2 doses of H7N9 vaccine at a dosage of 3.75 mu g plus the MF59 adjuvant, day 42 seroconversion occurred in 58 participants (59%; 95% CI, 48%-68%). The peak seroconversion occurred at day 29 in 62 participants (62%; 95% CI, 52%-72%). The day 42 geometric mean titer was 33.0 (95% CI, 24.7-44.1). Higher antigen doses were not associated with increased response. For the neutralizing antibody assays, after receiving 3.75 mu g of H7N9 vaccine plus the MF59 adjuvant, day 42 seroconversion occurred in 81 participants (82%; 95% CI, 73%-89%). The day 42 geometric mean titer was 81.4 (95% CI, 66.6-99.5). There was no statistically significant difference in day 42 hemagglutination inhibition seroconversion after mixing adjuvant with either the first or both 15 mu g doses (n = 34 [35%; 95% CI, 25%-45%] vs n = 47 [47%; 95% CI, 37%-58%], respectively; P = .10). Recent receipt of seasonal influenza vaccination and older age were associated with attenuated response. No vaccine-related serious adverse events occurred. Solicited postvaccination symptoms were generally mild with more local symptoms seen in participants who received the adjuvant. CONCLUSIONS AND RELEVANCE Point-of-use mixing and administration of 2 doses of H7N9 vaccine at the lowest tested antigen dose with MF59 adjuvant produced seroconversion in 59% of participants. Although these findings indicate potential value in this approach, the study is limited by the absence of antibody data beyond 42 days and the absence of clinical outcomes.	[Mulligan, Mark J.; Anderson, Evan; Rouphael, Nadine; Edupuganti, Srilatha] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Bernstein, David I.; Dickey, Michelle] Univ Cincinnati, Cincinnati Childrens Hosp & Med Ctr, Cincinnati, OH USA; [Winokur, Patricia; Stapleton, Jack T.; Ince, Dilek] Univ Iowa, Iowa City, IA USA; [Winokur, Patricia; Stapleton, Jack T.; Ince, Dilek] Iowa City VA Healthcare Syst, Iowa City, IA USA; [Rupp, Richard] Univ Texas Med Branch, Galveston, TX 77555 USA; [Anderson, Evan; Spearman, Paul] Emory Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis, Atlanta, GA USA; [Noah, Diana L.] So Res Inst, Birmingham, AL 35255 USA; [Hill, Heather; Bellamy, Abbie R.] EMMES Corp, Rockville, MD USA	Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Texas System; University of Texas Medical Branch Galveston; Emory University; Emmes Corporation	Mulligan, MJ (corresponding author), Emory Univ, Emory Vaccine Ctr, Hope Clin, 500 Irvin Court, Decatur, GA 30030 USA.	mark.mulligan@emory.edu	Mulligan, Mark/V-9275-2019; Ince, Dilek/AAW-4724-2021	Schilling, Margo/0000-0001-9684-9866; Ince, Dilek/0000-0001-5446-3789; Stapleton, Jack/0000-0002-2302-9055; McElroy, Anita/0000-0001-6764-7536; Meier, Jeffery/0000-0001-9491-1697; Rouphael, Nadine/0000-0002-2512-7919; Winokur, Patricia/0000-0002-4826-1790	National Institute of Allergy and Infectious Diseases; National Institutes of Health; US Department of Health and Human Services [HHSN272200800005C, HHSN272200800006C, HHSN272200800008C, HHSN272200800002C, HHSN272201200003I, HHSN27200003, HHSN272200800013C]; Georgia Research Alliance, Children's Healthcare of Atlanta; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454, UL1TR000442]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000442, UL1TR000454] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; Georgia Research Alliance, Children's Healthcare of Atlanta; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, and the US Department of Health and Human Services under contracts HHSN272200800005C (Emory University), HHSN272200800006C (Cincinnati Children's Hospital Medical Center), HHSN272200800008C (University of Iowa, Iowa City), HHSN272200800002C (Baylor University College of Medicine and subcontractor University of Texas Medical Branch), HHSN272201200003I and HHSN27200003 (Battelle and subcontractor Southern Research Inc), and HHSN272200800013C (EMMES Corporation). Additional support was provided by the Georgia Research Alliance, Children's Healthcare of Atlanta, and the National Center for Advancing Translational Sciences of the National Institutes of Health under awards UL1TR000454 and UL1TR000442. The authors and participating faculty and staff were compensated for their work on this project through the US government contracts to their institutions listed above. The vaccine and adjuvant provided by the US Department of Health and Human Services Biomedical Advanced Research and Development Authority from the National Pre-pandemic Influenza Vaccine Stockpile and were manufactured by Sanofi Pasteur (H7N9 vaccine) and Novartis Vaccines (M59 adjuvant).	Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Beyer WEP, 1998, VACCINE, V16, P1929, DOI 10.1016/S0264-410X(98)00123-6; Chen WH, 2012, VACCINE, V30, P4240, DOI 10.1016/j.vaccine.2012.04.044; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050830; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Frey SE, 2012, J INFECT DIS, V206, P828, DOI 10.1093/infdis/jis445; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; He XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002574; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kim JH, 2012, P NATL ACAD SCI USA, V109, P13751, DOI 10.1073/pnas.0912458109; Langley JM, 2010, J INFECT DIS, V201, P1644, DOI 10.1086/652701; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Neuzil KM, 2014, CLIN INFECT DIS, V58, P328, DOI 10.1093/cid/cit739; Ng S, 2013, J INFECT DIS, V208, P1320, DOI 10.1093/infdis/jit372; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0; Poland GA, 2009, J INFECT DIS, V200, P161, DOI 10.1086/599791; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2013, CLIN INFECT DIS, V56, P1370, DOI 10.1093/cid/cit064; US Centers for Disease Control and Prevention, 2003, AV INFL VIR INF HUM; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; World Health Organization, 2014, WHO RISK ASS HUM INF; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	45	111	114	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1409	1419		10.1001/jama.2014.12854	http://dx.doi.org/10.1001/jama.2014.12854			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291577	Bronze			2022-12-28	WOS:000342630200017
J	Farrell, RM; Falcone, T				Farrell, Ruth M.; Falcone, Tommaso			Uterine transplant: new medical and ethical considerations	LANCET			English	Editorial Material									[Farrell, Ruth M.; Falcone, Tommaso] Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH 44195 USA; [Farrell, Ruth M.] Cleveland Clin, Dept Bioeth, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Farrell, RM (corresponding author), Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH 44195 USA.	falcont@ccf.org						Brannstrom M, 2014, LANCET, DOI S0140-6736(14)61728-1; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Farrell RM, 2014, FERTIL STERIL, V101, P1244, DOI 10.1016/j.fertnstert.2014.03.022; Parikh LI, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.021; Raziel A, 2012, HUM REPROD, V27, P126, DOI 10.1093/humrep/der356	5	31	33	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					581	582		10.1016/S0140-6736(14)61792-X	http://dx.doi.org/10.1016/S0140-6736(14)61792-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25303786				2022-12-28	WOS:000349214000007
J	Inglis, T				Inglis, Tim			Developed nations must not fear sending Ebola help	NATURE			English	Editorial Material									Univ Western Australia, Nedlands, WA 6009, Australia	University of Western Australia	Inglis, T (corresponding author), Univ Western Australia, Nedlands, WA 6009, Australia.	tim.inglis@uwa.edu.au							0	4	4	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					537	537		10.1038/514537a	http://dx.doi.org/10.1038/514537a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25355324	Bronze			2022-12-28	WOS:000343801500013
J	Jullien, T; Roulleau, P; Roche, B; Cavanna, A; Jin, Y; Glattli, DC				Jullien, T.; Roulleau, P.; Roche, B.; Cavanna, A.; Jin, Y.; Glattli, D. C.			Quantum tomography of an electron	NATURE			English	Article							STATES; LIGHT; QUBIT	The complete knowledge of a quantum state allows the prediction of the probability of all possible measurement outcomes, a crucial step in quantum mechanics. It can be provided by tomographic methods(1) which have been applied to atomic(2,3), molecular(4), spin(5,6) and photonic states. For optical(7-9) or microwave(10-13) photons, standard tomography is obtained by mixing the unknown state with a large-amplitude coherent photon field. However, for fermions such as electrons in condensed matter, this approach is not applicable because fermionic fields are limited to small amplitudes (at most one particle per state), and so far no determination of an electron wavefunction has been made. Recent proposals involving quantum conductors suggest that the wavefunction can be obtained by measuring the time-dependent current of electronic wave interferometers(14) or the current noise of electronic Hanbury-Brown/Twiss interferometers(15-17). Here we show that such measurements are possible despite the extreme noise sensitivity required, and present the reconstructed wavefunction quasi-probability, or Wigner distribution function(17), of single electrons injected into a ballistic conductor. Many identical electrons are prepared in well-controlled quantum states called levitons(18) by repeatedly applying Lorentzian voltage pulses to a contact on the conductor(19-21). After passing through an electron beam splitter, the levitons are mixed with a weak-amplitude fermionic field formed by a coherent superposition of electron-hole pairs generated by a small alternating current with a frequency that is a multiple of the voltage pulse frequency(16). Antibunching of the electrons and holes with the levitons at the beam splitter changes the leviton partition statistics, and the noise variations provide the energy density matrix elements of the levitons. This demonstration of quantum tomography makes the developing field of electron quantum optics with ballistic conductors a new test-bed for quantum information with fermions(20,22-24). These results may find direct application in probing the entanglement of electron flying quantum bits(25), electron decoherence(17) and electron interactions. They could also be applied to cold fermionic (or spin-1/2) atoms(26).	[Jullien, T.; Roulleau, P.; Roche, B.; Glattli, D. C.] CEA Saclay, CNRS, URA 2464, Serv Phys Etat Condense,IRAMIS DSM, F-91191 Gif Sur Yvette, France; [Cavanna, A.; Jin, Y.] CNRS, Lab Photon & Nanostruct, F-91460 Marcoussis, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Glattli, DC (corresponding author), CEA Saclay, CNRS, URA 2464, Serv Phys Etat Condense,IRAMIS DSM, F-91191 Gif Sur Yvette, France.	christian.glattli@cea.fr	GLATTLI, D. Christian/A-3748-2019; roulleau, preden/F-1606-2019	GLATTLI, D. Christian/0000-0002-1457-0915; roulleau, preden/0000-0002-8397-5019	ERC [228273 MeQuaNo]	ERC(European Research Council (ERC)European Commission)	We acknowledge the ERC Advanced Grant 228273 MeQuaNo and thank P. Jacques for technical help, P. Pari, P. Forget and M. de Combarieu for cryogenic support, and P. Degiovanni and C. Grenier for discussions improving the manuscript.	Beenakker CWJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.186804; Beenakker CWJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147901; Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; Brantut JP, 2012, SCIENCE, V337, P1069, DOI 10.1126/science.1223175; Breitenbach G, 1997, NATURE, V387, P471, DOI 10.1038/387471a0; Dasenbrook D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.146801; Dubois J, 2013, NATURE, V502, P659, DOI 10.1038/nature12713; Dubois J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085301; DUNN TJ, 1995, PHYS REV LETT, V74, P884, DOI 10.1103/PhysRevLett.74.884; Eichler C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220503; Ferraro D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205303; Grenier C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093007; Haack G, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.201302; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Keeling J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116403; Kurtsiefer C, 1997, NATURE, V386, P150, DOI 10.1038/386150a0; Lebedev AV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245314; Levitov LS, 1996, J MATH PHYS, V37, P4845, DOI 10.1063/1.531672; Lvovsky AI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050402; Medford J, 2013, NAT NANOTECHNOL, V8, P654, DOI [10.1038/nnano.2013.168, 10.1038/NNANO.2013.168]; Pedersen MH, 1998, PHYS REV B, V58, P12993, DOI 10.1103/PhysRevB.58.12993; Polycarpou C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.053602; Samuelsson P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.041305; Sherkunov Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081108; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; VOGEL K, 1989, PHYS REV A, V40, P2847, DOI 10.1103/PhysRevA.40.2847; Yamamoto M, 2012, NAT NANOTECHNOL, V7, P247, DOI [10.1038/nnano.2012.28, 10.1038/NNANO.2012.28]	31	132	133	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					603	607		10.1038/nature13821	http://dx.doi.org/10.1038/nature13821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355360	Green Published			2022-12-28	WOS:000343801500043
J	Magda, GZ; Jin, XZ; Hagymasi, I; Vancso, P; Osvath, Z; Nemes-Incze, P; Hwang, CY; Biro, LP; Tapaszto, L				Magda, Gabor Zsolt; Jin, Xiaozhan; Hagymasi, Imre; Vancso, Peter; Osvath, Zoltan; Nemes-Incze, Peter; Hwang, Chanyong; Biro, Laszlo P.; Tapaszto, Levente			Room-temperature magnetic order on zigzag edges of narrow graphene nanoribbons	NATURE			English	Article							AUGMENTED-WAVE METHOD; POINT-DEFECTS; FERROMAGNETISM; STATE; SPIN	The possibility that non-magnetic materials such as carbon could exhibit a novel type of s-p electron magnetism has attracted much attention over the years, not least because such magnetic order is predicted to be stable at high temperatures(1). It has been demonstrated that atomic-scale structural defects of graphene can host unpaired spins(2,3), but it remains unclear under what conditions long-range magnetic order can emerge from such defect-bound magnetic moments. Here we propose that, in contrast to random defect distributions, atomic-scale engineering of graphene edges with specific crystallographic orientation-comprising edge atoms from only one sub-lattice of the bipartite graphene lattice-can give rise to a robust magnetic order. We use a nanofabrication technique(4) based on scanning tunnelling microscopy to define graphene nanoribbons with nanometre precision and well-defined crystallographic edge orientations. Although so-called 'armchair' ribbons display quantum confinement gaps, ribbons with the 'zigzag' edge structure that are narrower than 7 nanometres exhibit an electronic bandgap of about 0.2-0.3 electronvolts, which can be identified as a signature of interaction-induced spin ordering along their edges. Moreover, upon increasing the ribbon width, a semiconductor-to-metal transition is revealed, indicating the switching of the magnetic coupling between opposite ribbon edges from the antiferromagnetic to the ferromagnetic configuration. We found that the magnetic order on graphene edges of controlled zigzag orientation can be stable even at room temperature, raising hopes of graphene-based spintronic devices operating under ambient conditions.	[Magda, Gabor Zsolt; Vancso, Peter; Osvath, Zoltan; Nemes-Incze, Peter; Biro, Laszlo P.; Tapaszto, Levente] 2D Nanoelect Lendulet Res Grp, Inst Tech Phys & Mat Sci, Nanotechnol Dept, Res Ctr Nat Sci, H-1121 Budapest, Hungary; [Jin, Xiaozhan; Hwang, Chanyong] Korea Res Inst Stand & Sci, Ctr Nanometrol, Taejon 305340, South Korea; [Hagymasi, Imre] Strongly Correlated Syst Lendulet Res Grp, Inst Solid State Phys & Opt, Wigner Res Ctr Phys, H-1121 Budapest, Hungary; [Hagymasi, Imre] Univ Szeged, Dept Theoret Phys, H-6720 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Korea Research Institute of Standards & Science (KRISS); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Szeged University	Tapaszto, L (corresponding author), 2D Nanoelect Lendulet Res Grp, Inst Tech Phys & Mat Sci, Nanotechnol Dept, Res Ctr Nat Sci, H-1121 Budapest, Hungary.	tapaszto@mfa.kfki.hu	Osváth, Zoltán/E-7322-2011; Biró, László P/A-3057-2010; Tapaszto, Levente/B-4710-2011; Nemes - Incze, Péter/C-2298-2008; Biro, Laszlo/GRO-3819-2022; Vancsó, Péter/I-6893-2015	Osváth, Zoltán/0000-0003-0440-5446; Tapaszto, Levente/0000-0002-9377-8465; Nemes - Incze, Péter/0000-0002-1222-3020; Vancsó, Péter/0000-0003-4333-9787; Hagymasi, Imre/0000-0003-1245-4643	OTKA [K108753, K101599, K100908]; Bolyai Fellowship; Nano.Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2012M3A7B4049888]; European Union; State of Hungary; European Social Fund [TAMOP-4.2.4.A/2-11/1-2012-0001]; National Excellence Program	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Fellowship(Hungarian Academy of Sciences); Nano.Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); National Excellence Program	The experimental work was conducted within the framework of the Korea Hungary Joint Laboratory for Nanosciences through the Korean Research Council of Fundamental Science and Technology and the "Lendulet" programme of the Hungarian Academy of Sciences. L. T. acknowledges OTKA grant K108753 and the Bolyai Fellowship. L. P. B. acknowledges OTKA grant K101599. C. H. is supported in part by the Nano.Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2012M3A7B4049888). I. H. was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of the TAMOP-4.2.4.A/2-11/1-2012-0001 National Excellence Program and OTKA grant K100908. I. H. acknowledges discussions with K. Itai. L. T and P. V. acknowledge discussions with Y.-S. Kim.	BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cervenka J, 2009, NAT PHYS, V5, P840, DOI 10.1038/NPHYS1399; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Edwards DM, 2006, J PHYS-CONDENS MAT, V18, P7209, DOI 10.1088/0953-8984/18/31/016; Esquinazi P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.227201; Fujita M, 1996, J PHYS SOC JPN, V65, P1920, DOI 10.1143/JPSJ.65.1920; Golor M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155441; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Joly VLJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245428; Jung J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235433; Jung J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165415; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Li Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216804; Magnetism C.-B., 2005, OVERVIEW METAL FREE; Mashoff T, 2010, NANO LETT, V10, P461, DOI 10.1021/nl903133w; Mucciolo ER, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075407; Nair RR, 2012, NAT PHYS, V8, P199, DOI [10.1038/NPHYS2183, 10.1038/nphys2183]; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Palacios JJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195428; Ritter KA, 2009, NAT MATER, V8, P235, DOI [10.1038/NMAT2378, 10.1038/nmat2378]; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Tang MS, 1996, PHYS REV B, V53, P979, DOI 10.1103/PhysRevB.53.979; Tang MS, 1996, PHYS REV B, V54, P10982, DOI 10.1103/PhysRevB.54.10982; Tao CG, 2011, NAT PHYS, V7, P616, DOI [10.1038/NPHYS1991, 10.1038/nphys1991]; Tapaszto L, 2008, NAT NANOTECHNOL, V3, P397, DOI 10.1038/nnano.2008.149; Wang WL, 2008, NANO LETT, V8, P241, DOI 10.1021/nl072548a; WANG Y, 2009, NANO LETT, V9, P220, DOI DOI 10.1021/nl802810g; Wassmann T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096402; Yazyev OV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125408; Yazyev OV, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115406	35	552	558	20	571	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					608	+		10.1038/nature13831	http://dx.doi.org/10.1038/nature13831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355361	Green Submitted			2022-12-28	WOS:000343801500044
J	Wagner, JE; Eapen, M; Carter, S; Wang, YL; Schultz, KR; Wall, DA; Bunin, N; Delaney, C; Haut, P; Margolis, D; Peres, E; Verneris, MR; Walters, M; Horowitz, MM; Kurtzberg, J				Wagner, John E., Jr.; Eapen, Mary; Carter, Shelly; Wang, Yanli; Schultz, Kirk R.; Wall, Donna A.; Bunin, Nancy; Delaney, Colleen; Haut, Paul; Margolis, David; Peres, Edward; Verneris, Michael R.; Walters, Mark; Horowitz, Mary M.; Kurtzberg, Joanne		Blood Marrow Transplant Clinical T	One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; CLINICAL-OUTCOMES; UNRELATED DONORS; PLACENTAL-BLOOD; ACUTE-LEUKEMIA; ADULTS; ENGRAFTMENT; SINGLE; PREDICTOR; MARROW	BACKGROUND Umbilical-cord blood has been used as the source of hematopoietic stem cells in an estimated 30,000 transplants. The limited number of hematopoietic cells in a single cord-blood unit prevents its use in recipients with larger body mass and results in delayed hematopoietic recovery and higher mortality. Therefore, we hypothesized that the greater numbers of hematopoietic cells in two units of cord blood would be associated with improved outcomes after transplantation. METHODS Between December 1, 2006, and February 24, 2012, a total of 224 patients 1 to 21 years of age with hematologic cancer were randomly assigned to undergo double-unit (111 patients) or single-unit (113 patients) cord-blood transplantation after a uniform myeloablative conditioning regimen and immunoprophylaxis for graft-versus-host disease (GVHD). The primary end point was 1-year overall survival. RESULTS Treatment groups were matched for age, sex, self-reported race (white vs. nonwhite), performance status, degree of donor-recipient HLA matching, and disease type and status at transplantation. The 1-year overall survival rate was 65% (95% confidence interval [CI], 56 to 74) and 73% (95% CI, 63 to 80) among recipients of double and single cord-blood units, respectively (P = 0.17). Similar outcomes in the two groups were also observed with respect to the rates of disease-free survival, neutrophil recovery, transplantation-related death, relapse, infections, immunologic reconstitution, and grade II-IV acute GVHD. However, improved platelet recovery and lower incidences of grade III and IV acute and extensive chronic GVHD were observed among recipients of a single cord-blood unit. CONCLUSIONS We found that among children and adolescents with hematologic cancer, survival rates were similar after single-unit and double-unit cord-blood transplantation; however, a single-unit cord-blood transplant was associated with better platelet recovery and a lower risk of GVHD.	[Wagner, John E., Jr.; Verneris, Michael R.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Eapen, Mary; Margolis, David; Horowitz, Mary M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Carter, Shelly; Wang, Yanli] EMMES Corp, Rockville, MD USA; [Schultz, Kirk R.] BC Childrens Hosp, Vancouver, BC, Canada; [Wall, Donna A.] Univ Manitoba, Winnipeg, MB, Canada; [Bunin, Nancy] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Delaney, Colleen] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Haut, Paul] Indiana Univ, Indianapolis, IN 46204 USA; [Peres, Edward] Univ Michigan, Ann Arbor, MI 48109 USA; [Walters, Mark] Univ Calif San Francisco, Benioff Childrens Hosp Oakland, Oakland, CA USA; [Kurtzberg, Joanne] Duke Univ, Durham, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Medical College of Wisconsin; Emmes Corporation; BC Childrens Hospital; University of British Columbia; University of Manitoba; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fred Hutchinson Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Duke University	Wagner, JE (corresponding author), Univ Minnesota, Div Pediat Blood & Marrow Transplantat, Mayo Mail Code 366,420 Delaware St SE, Minneapolis, MN 55455 USA.	wagne002@umn.edu	horowitz, Mary/ABH-2173-2021; Schultz, Kirk R/AAA-3440-2022	Schultz, Kirk/0000-0002-0001-6438; Eapen, Mary/0000-0001-6193-4243	National Heart, Lung, and Blood Institute; National Cancer Institute [U10-HL069294, P01CA065493-21, U10CA098543]; NATIONAL CANCER INSTITUTE [U10CA180886, U24CA076518, P30CA077598, P01CA065493, U10CA098543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL069274, U10HL069330, U10HL069294, U10HL069246, U10HL069290, U01HL069246, U10HL069249] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grant from the National Heart, Lung, and Blood Institute and National Cancer Institute (U10-HL069294, to the Blood and Marrow Transplant Clinical Trials Network) and by grants from the National Cancer Institute (P01CA065493-21, to Dr. Wagner, and U10CA098543, to the Children's Oncology Group).	Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Barker JN, 2001, NEW ENGL J MED, V344, P1870, DOI 10.1056/NEJM200106143442417; Barker JN, 2010, BIOL BLOOD MARROW TR, V16, P1541, DOI 10.1016/j.bbmt.2010.08.011; Bart T, 2013, TRANSFUS MED HEMOTH, V40, P14, DOI 10.1159/000345690; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Cheuk Daniel Kl, 2013, World J Transplant, V3, P99, DOI 10.5500/wjt.v3.i4.99; Cornetta K, 2005, BIOL BLOOD MARROW TR, V11, P149, DOI 10.1016/j.bbmt.2004.11.020; COX DR, 1972, J R STAT SOC B, V34, P187; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Kurtzberg J, 2008, BLOOD, V112, P4318, DOI 10.1182/blood-2007-06-098020; Labopin M, 2014, HAEMATOLOGICA, V99, P535, DOI 10.3324/haematol.2013.092254; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; MacMillan ML, 2009, BLOOD, V113, P2410, DOI 10.1182/blood-2008-07-163238; Migliaccio AR, 2000, BLOOD, V96, P2717, DOI 10.1182/blood.V96.8.2717.h8002717_2717_2722; Page KM, 2011, BIOL BLOOD MARROW TR, V17, P1362, DOI 10.1016/j.bbmt.2011.01.011; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rocha V, 2010, BEST PRACT RES CL HA, V23, P223, DOI 10.1016/j.beha.2010.07.005; Rubinstein P, 1998, NEW ENGL J MED, V339, P1565, DOI 10.1056/NEJM199811263392201; Ruggeri A, 2014, LEUKEMIA, V28, P779, DOI 10.1038/leu.2013.259; Scaradavou A, 2013, BLOOD, V121, P752, DOI 10.1182/blood-2012-08-449108; Sideri A, 2011, HAEMATOL-HEMATOL J, V96, P1213, DOI 10.3324/haematol.2010.038836; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x; Spitzer TR, 2001, BONE MARROW TRANSPL, V27, P893, DOI 10.1038/sj.bmt.1703015; Verneris MR, 2009, BLOOD, V114, P4293, DOI 10.1182/blood-2009-05-220525; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Wagner JE, 1996, BLOOD, V88, P795; Weisdorf DJ, 2003, BIOL BLOOD MARROW TR, V9, P512, DOI 10.1016/S1083-8791(03)00162-9	31	194	195	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1685	1694		10.1056/NEJMoa1405584	http://dx.doi.org/10.1056/NEJMoa1405584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354103	Green Accepted			2022-12-28	WOS:000343768500006
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Dementiagate-how politicised pay diverts GPs from working for patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				British Medical Association, GENERAL PRACTICE CON; Kmietowicz Z, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6424; NHS England, 2014, ENHANCED SERVICE SPE; UK National Screening Committee, THE UK NSC POLICY ON	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g6446	10.1136/bmj.g6446	http://dx.doi.org/10.1136/bmj.g6446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OI	25344300	Green Published, Bronze			2022-12-28	WOS:000343768700010
J	Turner, W				Turner, Woody			Sensing biodiversity	SCIENCE			English	Editorial Material									NASA Headquarters, Div Earth Sci, Washington, DC 20546 USA	National Aeronautics & Space Administration (NASA)	Turner, W (corresponding author), NASA Headquarters, Div Earth Sci, Washington, DC 20546 USA.	woody.turner@nasa.gov						Asner GP, 2014, P NATL ACAD SCI USA, V111, P5604, DOI 10.1073/pnas.1401181111; Cord AF, 2013, J BIOGEOGR, V40, P2226, DOI 10.1111/jbi.12199; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Horning N., 2010, REMOTE SENSING ECOLO; Organelli E, 2013, APPL OPTICS, V52, P2257, DOI 10.1364/AO.52.002257; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Stoeger AS, 2014, BIOACOUSTICS, V23, P231, DOI 10.1080/09524622.2014.888375; Swatantran A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028922; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025	14	134	144	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					301	302		10.1126/science.1256014	http://dx.doi.org/10.1126/science.1256014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324372				2022-12-28	WOS:000343041100018
J	Hofling, S; Kavokin, A				Hoefling, Sven; Kavokin, Alexey			SOLID-STATE PHYSICS A historic experiment redesigned	NATURE			English	Editorial Material							CRYSTALS		[Hoefling, Sven] Univ St Andrews, Scottish Univ Phys Alliance, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Kavokin, Alexey] St Petersburg State Univ, St Petersburg 199034, Russia; [Kavokin, Alexey] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England	University of St Andrews; Saint Petersburg State University; University of Southampton	Hofling, S (corresponding author), Univ St Andrews, Scottish Univ Phys Alliance, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	sh222@st-andrews.ac.uk; a.kavokin@soton.ac.uk	Hofling, Sven/C-3140-2013; KAVOKINE, ALEXIS/C-3601-2016; Kavokin, Alexey V/J-8610-2013	Hofling, Sven/0000-0003-0034-4682; KAVOKINE, ALEXIS/0000-0003-2713-1062; 				Baldo M, 2009, NAT PHOTONICS, V3, P558, DOI 10.1038/nphoton.2009.178; GROSS EF, 1952, DOKL AKAD NAUK SSSR+, V84, P471; GROSS EF, 1956, DOKL AKAD NAUK SSSR+, V111, P564; HOPFIELD JJ, 1958, PHYS REV, V112, P1555, DOI 10.1103/PhysRev.112.1555; Kazimierczuk T, 2014, NATURE, V514, P343, DOI 10.1038/nature13832; Mott NF, 1938, T FARADAY SOC, V34, P0500, DOI 10.1039/tf9383400500; Pekar S. I., 1957, ZH EKSP TEOR FIZ+, V33, P1022; Wannier GH, 1937, PHYS REV, V52, P0191, DOI 10.1103/PhysRev.52.191	8	7	7	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					313	314		10.1038/514313a	http://dx.doi.org/10.1038/514313a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318520	Green Submitted			2022-12-28	WOS:000342988600039
J	Uluba, M; Dayi, S				Uluba, Munevver; Dayi, Sabriye			Tracheoesophageal Fistula in a Newborn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Uluba, Munevver] Bahar Med Hosp, Bursa, Turkey; [Dayi, Sabriye] Med Pk Hosp, Bursa, Turkey	Bahar Hospital; Medical Park Hospitals Group	Uluba, M (corresponding author), Bahar Med Hosp, Bursa, Turkey.	sabriyedayi@yahoo.com	DAYI, Sabriye/F-6568-2015	DAYI, Sabriye/0000-0002-0643-3785					0	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					E23	E23		10.1056/NEJMicm1314269	http://dx.doi.org/10.1056/NEJMicm1314269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317890				2022-12-28	WOS:000342994700011
J	Beaird, OE; Northway, C; Malani, PN				Beaird, Omer E.; Northway, Claire; Malani, Preeti N.			Facial Droop, Left-Sided Weakness, and Cystic Brain Lesions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULTS		[Beaird, Omer E.; Northway, Claire; Malani, Preeti N.] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Malani, PN (corresponding author), Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Vet Affairs Ann Arbor Healthcare Syst, 3119 Taubman Ctr, Ann Arbor, MI 48109 USA.	pmalani@umich.edu						Honda H, 2009, INFECT DIS CLIN N AM, V23, P609, DOI 10.1016/j.idc.2009.04.009; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; SEYDOUX C, 1992, CLIN INFECT DIS, V15, P394, DOI 10.1093/clind/15.3.394; van Crevel H, 2002, J NEUROL, V249, P129, DOI 10.1007/PL00007855; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126	6	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1581	1582		10.1001/jama.2014.5553	http://dx.doi.org/10.1001/jama.2014.5553			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321911				2022-12-28	WOS:000342983200022
J	Sedgwick, P				Sedgwick, Philip			Poisson regression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019; Day, Rosie/N-5733-2015	Sedgwick, Philip/0000-0001-8859-2175; Day, Rosie/0000-0003-1766-4068				Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Sedgwick P., 2010, BMJ-BRIT MED J, V341, pc4804, DOI DOI 10.1136/BMJ.C4804; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4488; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4373; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2340; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960	6	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2014	349								g6150	10.1136/bmj.g6150	http://dx.doi.org/10.1136/bmj.g6150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LQ	25304320				2022-12-28	WOS:000342999100003
J	Chen, JC; Alvarez, MJ; Talos, F; Dhruv, H; Rieckhof, GE; Iyer, A; Diefes, KL; Aldape, K; Berens, M; Shen, MM; Califano, A				Chen, James C.; Alvarez, Mariano J.; Talos, Flaminia; Dhruv, Harshil; Rieckhof, Gabrielle E.; Iyer, Archana; Diefes, Kristin L.; Aldape, Kenneth; Berens, Michael; Shen, Michael M.; Califano, Andrea			Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks	CELL			English	Article							B-CELL LYMPHOMA; UBIQUITIN LIGASE; MESENCHYMAL TRANSFORMATION; TUMOR-SUPPRESSOR; KAPPA-B; GLIOBLASTOMA; CANCER; PROGRESSION; PATHWAYS; GLIOMA	Identification of driver mutations in human diseases is often limited by cohort size and availability of appropriate statistical models. We propose a framework for the systematic discovery of genetic alterations that are causal determinants of disease, by prioritizing genes upstream of functional disease drivers, within regulatory networks inferred de novo from experimental data. We tested this framework by identifying the genetic determinants of the mesenchymal subtype of glioblastoma. Our analysis uncovered KLHL9 deletions as upstream activators of two previously established master regulators of the subtype, C/EBP beta and C/EBP delta. Rescue of KLHL9 expression induced proteasomal degradation of C/EBP proteins, abrogated the mesenchymal signature, and reduced tumor viability in vitro and in vivo. Deletions of KLHL9 were confirmed in > 50% of mesenchymal cases in an independent cohort, thus representing the most frequent genetic determinant of the subtype. The method generalized to study other human diseases, including breast cancer and Alzheimer's disease.	[Chen, James C.; Alvarez, Mariano J.; Rieckhof, Gabrielle E.; Iyer, Archana; Shen, Michael M.; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Chen, James C.; Alvarez, Mariano J.; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Chen, James C.; Talos, Flaminia; Shen, Michael M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Dhruv, Harshil; Berens, Michael] TGen, Canc & Cell Biol Div, Phoenix, AZ 85004 USA; [Diefes, Kristin L.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Toronto, Ontario Canc Inst, Adult Brain Tumor Ctr, Toronto, ON M5G 2M9, Canada; [Shen, Michael M.] Columbia Univ, Dept Urol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Shen, Michael M.; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Translational Genomics Research Institute; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, 1130 St Nicholas Ave, New York, NY 10032 USA.	califano@c2b2.columbia.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657; Califano, Andrea/0000-0003-4742-3679; Alfaro, Kristin/0000-0002-9870-8415; Chen, James/0000-0002-2629-1139; Shen, Mouquan/0000-0001-6448-4866	NCI CTD2 network [1RC2CA148308-01]; National Centers for Biomedical Computing NIH Roadmap Initiative [U54CA121852, R01 NS061776-05, P01CA154293]; Kirschstein NRSA training grant [T32GM082797]; CTDD grant [5U01CA16842603, W81XWH1210022]; Urology Care Foundation; NIH/NCI [P50CA127001]; Ben & Catherine IVY Foundation; NATIONAL CANCER INSTITUTE [U01CA168397, RC2CA148308, U54CA121852, P01CA154293, U01CA168426, P50CA127001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088, T32GM082797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	NCI CTD2 network; National Centers for Biomedical Computing NIH Roadmap Initiative; Kirschstein NRSA training grant; CTDD grant; Urology Care Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ben & Catherine IVY Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NCI CTD2 network 1RC2CA148308-01 (A.C.), National Centers for Biomedical Computing NIH Roadmap Initiative U54CA121852 (A.C., M.J.A.), R01 NS061776-05 (A.C.), P01CA154293 (M.M.S.), Kirschstein NRSA training grant T32GM082797 (J.C.C.), CTDD grant 5U01CA16842603 (G.E.R.), W81XWH1210022 (A.I.), a fellowship from the Urology Care Foundation (F.T.), and NIH/NCI P50CA127001 (K.A., K.L.D.). H.D. and M.B. were supported by the Ben & Catherine IVY Foundation.	Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Danussi C, 2013, CANCER RES, V73, P5140, DOI 10.1158/0008-5472.CAN-13-1168-T; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tamborero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055489; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	36	124	127	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					402	414		10.1016/j.cell.2014.09.021	http://dx.doi.org/10.1016/j.cell.2014.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303533	Green Accepted, Bronze			2022-12-28	WOS:000343095600020
J	Rakotoarivelo, R; Ratsarazaka, M				Rakotoarivelo, Rivo; Ratsarazaka, Mahaliana			Cutaneous Melanosis in Peripheral Cortisol Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rakotoarivelo, Rivo; Ratsarazaka, Mahaliana] Joseph Raseta Befelatanana Hosp, Antananarivo, Madagascar		Rakotoarivelo, R (corresponding author), Joseph Raseta Befelatanana Hosp, Antananarivo, Madagascar.	rakotoarivelo.rivo@gmail.com		Rakotoarivelo, Rivonirina Andry/0000-0003-3438-8624					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1446	1446		10.1056/NEJMicm1314564	http://dx.doi.org/10.1056/NEJMicm1314564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295503				2022-12-28	WOS:000342674800013
J	Rockholt, M; Cervera, C				Rockholt, Mika; Cervera, Carlos			Hypoglossal Nerve Palsy during Meningococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rockholt, Mika] Univ Barcelona, Barcelona, Spain; [Cervera, Carlos] Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Rockholt, M (corresponding author), Univ Barcelona, Barcelona, Spain.	ccervera@clinic.ub.es	Cervera, Carlos/U-4538-2018	Cervera, Carlos/0000-0002-0161-1749; Rockholt, Mika/0000-0002-8899-8551					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					E22	E22		10.1056/NEJMicm1315227	http://dx.doi.org/10.1056/NEJMicm1315227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295510				2022-12-28	WOS:000342674800002
J	Nelson-Sathi, S; Sousa, FL; Roettger, M; Lozada-Chavez, N; Thiergart, T; Janssen, A; Bryant, D; Landan, G; Schonheit, P; Siebers, B; McInerney, JO; Martin, WF				Nelson-Sathi, Shijulal; Sousa, Filipa L.; Roettger, Mayo; Lozada-Chavez, Nabor; Thiergart, Thorsten; Janssen, Arnold; Bryant, David; Landan, Giddy; Schoenheit, Peter; Siebers, Bettina; McInerney, James O.; Martin, William F.			Origins of major archaeal clades correspond to gene acquisitions from bacteria	NATURE			English	Article							CARBOHYDRATE-METABOLISM; MAXIMUM-LIKELIHOOD; PROTEIN FAMILIES; LIFE; TREE; EVOLUTION; GENOME; PHYLOGENY; DIVERSITY; ALGORITHM	The mechanisms that underlie the origin of major prokaryotic groups are poorly understood. In principle, the origin of both species and higher taxa among prokaryotes should entail similar mechanisms-ecological interactions with the environment paired with natural genetic variation involving lineage-specific gene innovations and lineage-specific gene acquisitions(1-4). To investigate the origin of higher taxa in archaea, we have determined gene distributions and gene phylogenies for the 267,568 protein-coding genes of 134 sequenced archaeal genomes in the context of their homologues from 1,847 reference bacterial genomes. Archaeal-specific gene families define 13 traditionally recognized archaeal higher taxa in our sample. Here we report that the origins of these 13 groups unexpectedly correspond to 2,264 group-specific gene acquisitions from bacteria. Interdomain gene transfer is highly asymmetric, transfers from bacteria to archaea are more than fivefold more frequent than vice versa. Gene transfers identified at major evolutionary transitions among prokaryotes specifically implicate gene acquisitions for metabolic functions from bacteria as key innovations in the origin of higher archaeal taxa.	[Nelson-Sathi, Shijulal; Sousa, Filipa L.; Roettger, Mayo; Lozada-Chavez, Nabor; Thiergart, Thorsten; Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Janssen, Arnold] Univ Dusseldorf, Math Inst, D-40225 Dusseldorf, Germany; [Bryant, David] Univ Otago, Dept Math & Stat, Dunedin 9054, New Zealand; [Landan, Giddy] Univ Kiel, Genom Microbiol Grp, Inst Microbiol, D-24118 Kiel, Germany; [Schoenheit, Peter] Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany; [Siebers, Bettina] Univ Duisburg Essen, Fac Chem, Biofilm Ctr, D-45117 Essen, Germany; [McInerney, James O.] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Martin, William F.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Otago; University of Kiel; University of Kiel; University of Duisburg Essen; Maynooth University; Universidade Nova de Lisboa	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany.	bill@hhu.de	Martin, William F./O-5446-2015; Sousa, Filipa/ACC-2848-2022; Sousa, Filipa L./H-6192-2012; Landan, Giddy/C-1086-2019; Mcinerney, James/AAF-7234-2020	Martin, William F./0000-0003-1478-6449; Sousa, Filipa/0000-0002-4084-1942; Sousa, Filipa L./0000-0002-4075-1701; Landan, Giddy/0000-0002-2502-8750; Nelson-Sathi, Shijulal/0000-0002-3346-0383; Siebers, Bettina/0000-0002-9905-541X	European Research Council (ERC) [232975, 281357]; graduate school E-Norm of the Heinrich-Heine University; DFG [Scho 316/11-1, SI 642/10-1]; BMBF [0316188A]	European Research Council (ERC)(European Research Council (ERC)European Commission); graduate school E-Norm of the Heinrich-Heine University; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	We gratefully acknowledge funding from European Research Council (ERC 232975 to W. F. M.), the graduate school E-Norm of the Heinrich-Heine University (W. F. M.), the DFG (Scho 316/11-1 to P. S.; SI 642/10-1 to B. S.), and BMBF (0316188A, B. S.). G. L. is supported by an ERC grant (281357 to Tal Dagan), D. B. thanks the Alexander von Humbold Foundation for a Fellowship. Computational support of the Zentrum fur Informations-und Medientechnologie (ZIM) at the Heinrich-Heine University is gratefully acknowledged.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hess WR, 2004, CURR OPIN BIOTECH, V15, P191, DOI 10.1016/j.copbio.2004.03.007; Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; Puigbo P, 2010, GENOME BIOL EVOL, V2, P745, DOI 10.1093/gbe/evq062; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Williams D, 2012, GENOME BIOL EVOL, V4, P1223, DOI 10.1093/gbe/evs098; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46	30	155	164	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					77	U185		10.1038/nature13805	http://dx.doi.org/10.1038/nature13805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25317564	Green Accepted			2022-12-28	WOS:000347178400038
J	Hol, FJH; Dekker, C				Hol, Felix J. H.; Dekker, Cees			Zooming in to see the bigger picture: Microfluidic and nanofabrication tools to study bacteria	SCIENCE			English	Review							SINGLE-CELL; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ELECTRON-TRANSFER; GENETIC-ANALYSIS; HIGH-THROUGHPUT; QUORUM; MICROORGANISMS; PERSISTENCE; DIFFUSION	The spatial structure of natural habitats strongly affects bacterial life, ranging from nanoscale structural features that individual cells exploit for surface attachment, to micro-and millimeter-scale chemical gradients that drive population-level processes. Nanofabrication and microfluidics are ideally suited to manipulate the environment at those scales and have emerged as powerful tools with which to study bacteria. Here, we review the new scientific insights gained by using a diverse set of nanofabrication and microfluidic techniques to study individual bacteria and multispecies communities. This toolbox is beginning to elucidate disparate bacterial phenomena-including aging, electron transport, and quorum sensing-and enables the dissection of environmental communities through single-cell genomics. A more intimate integration of microfluidics, nanofabrication, and microbiology will enable further exploration of bacterial life at the smallest scales.	[Hol, Felix J. H.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	c.dekker@tudelft.nl	Hol, Felix/AAL-3588-2021	Hol, Felix/0000-0001-8061-0826; Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]; Netherlands Organisation for Scientific Research (NWO/OCW) part of the Frontiers of Nanoscience program	European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research (NWO/OCW) part of the Frontiers of Nanoscience program	We acknowledge invaluable discussions with J. Keymer, P. Galajda, J. Mannik, F. Wu, S. van Vliet, M. Voges, and B. Beaumont. F.J.H.H. acknowledges J. Keymer for sage advice and mentoring. This work was supported by the European Research Council Advanced Grant 247072 and the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Ahmed T, 2010, NANO LETT, V10, P3379, DOI 10.1021/nl101204e; Amir A, 2014, P NATL ACAD SCI USA, V111, P5778, DOI 10.1073/pnas.1317497111; Baca HK, 2006, SCIENCE, V313, P337, DOI 10.1126/science.1126590; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Berke AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038102; Bigger JW, 1944, LANCET, V2, P497; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Caspi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083775; Chen PP, 2014, SMALL, V10, P3018, DOI 10.1002/smll.201303724; Connell JL, 2013, P NATL ACAD SCI USA, V110, P18380, DOI 10.1073/pnas.1309729110; Connell JL, 2012, NAT CHEM BIOL, V8, P10, DOI 10.1038/nchembio.749; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Di Leonardo R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038101; Di Leonardo R, 2010, P NATL ACAD SCI USA, V107, P9541, DOI 10.1073/pnas.0910426107; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Fadeeva E, 2011, LANGMUIR, V27, P3012, DOI 10.1021/la104607g; Flickinger ST, 2011, J AM CHEM SOC, V133, P5966, DOI 10.1021/ja111131f; Galajda P, 2007, J BACTERIOL, V189, P8704, DOI 10.1128/JB.01033-07; Galajda P, 2008, J MOD OPTIC, V55, P3413, DOI 10.1080/09500340802495826; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hiratsuka Y, 2006, P NATL ACAD SCI USA, V103, P13618, DOI 10.1073/pnas.0604122103; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Hol FJH, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0068-2; Hol FJH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077042; Hulme SE, 2008, LAB CHIP, V8, P1888, DOI 10.1039/b809892a; Ivanova EP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00165; Jeong HE, 2013, NANO LETT, V13, P2864, DOI 10.1021/nl401205b; Jiang XC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3751; Jiang XC, 2010, P NATL ACAD SCI USA, V107, P16806, DOI 10.1073/pnas.1011699107; Julou T, 2013, P NATL ACAD SCI USA, V110, P12577, DOI 10.1073/pnas.1301428110; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Koumakis N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3588; Leung K, 2012, P NATL ACAD SCI USA, V109, P7665, DOI 10.1073/pnas.1106752109; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Lovley DR, 2012, ANNU REV MICROBIOL, V66, P391, DOI 10.1146/annurev-micro-092611-150104; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Moolman MC, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-12; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Norman TM, 2013, NATURE, V503, P481, DOI 10.1038/nature12804; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Raynaud X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087217; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Renner LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084143; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Rusconi R, 2011, BIOPHYS J, V100, P1392, DOI 10.1016/j.bpj.2011.01.065; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Saragosti J, 2011, P NATL ACAD SCI USA, V108, P16235, DOI 10.1073/pnas.1101996108; Seymour JR, 2009, AM NAT, V173, pE15, DOI 10.1086/593004; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026803, 10.1371/journal.pone.0025029]; Smart AG, 2010, PHYS TODAY, V63, P18, DOI 10.1063/1.3529396; Sokolov A, 2010, P NATL ACAD SCI USA, V107, P969, DOI 10.1073/pnas.0913015107; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; van Vliet S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-116; Vigeant MAS, 2002, APPL ENVIRON MICROB, V68, P2794, DOI 10.1128/AEM.68.6.2794-2801.2002; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Weibel DB, 2005, P NATL ACAD SCI USA, V102, P11963, DOI 10.1073/pnas.0505481102; Weitz M, 2014, J AM CHEM SOC, V136, P72, DOI 10.1021/ja411132w; Wessel AK, 2013, NAT REV MICROBIOL, V11, P337, DOI 10.1038/nrmicro3010; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.11.010; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	112	135	138	9	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					438	+	1251821	10.1126/science.1251821	http://dx.doi.org/10.1126/science.1251821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YT	25342809				2022-12-28	WOS:000349773700001
J	Thomson, AR; Wood, CW; Burton, AJ; Bartlett, GJ; Sessions, RB; Brady, RL; Woolfson, DN				Thomson, Andrew R.; Wood, Christopher W.; Burton, Antony J.; Bartlett, Gail J.; Sessions, Richard B.; Brady, R. Leo; Woolfson, Derek N.			Computational design of water-soluble alpha-helical barrels	SCIENCE			English	Article							COILED-COIL STRUCTURES; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; REPEAT PROTEINS; SIDE-CHAINS; CHANNEL; ASSEMBLIES; PACKING	The design of protein sequences that fold into prescribed de novo structures is challenging. General solutions to this problem require geometric descriptions of protein folds and methods to fit sequences to these. The a-helical coiled coils present a promising class of protein for this and offer considerable scope for exploring hitherto unseen structures. For a-helical barrels, which have more than four helices and accessible central channels, many of the possible structures remain unobserved. Here, we combine geometrical considerations, knowledge-based scoring, and atomistic modeling to facilitate the design of new channel-containing a-helical barrels. X-ray crystal structures of the resulting designs match predicted in silico models. Furthermore, the observed channels are chemically defined and have diameters related to oligomer state, which present routes to design protein function.	[Thomson, Andrew R.; Wood, Christopher W.; Burton, Antony J.; Bartlett, Gail J.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Wood, Christopher W.; Sessions, Richard B.; Brady, R. Leo; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Thomson, AR (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	chzart@bristol.ac.uk; d.n.woolfson@bristol.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015	Wood, Christopher/0000-0003-1243-3105; Thomson, Andrew/0000-0002-1066-1369; Woolfson, Derek/0000-0002-0394-3202; Sessions, Richard/0000-0003-0320-0895	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) South West Doctoral Training Partnership; Engineering and Physical Sciences Research Council (EPSRC) Bristol Chemical Synthesis Centre for Doctoral Training; EPSRC [EP/J001430/1]; BBSRC [BB/J008990/1]; European Research Council [340764]; Royal Society Wolfson Research Merit Award; Diamond Light Source [MX8922]; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/K03927X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1228976, BB/L01386X/1, BB/J008990/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J001430/1, EP/K03927X/1, 1115150] Funding Source: researchfish	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) South West Doctoral Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC) Bristol Chemical Synthesis Centre for Doctoral Training(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Diamond Light Source; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C.W.W. and A.J.B. are supported by the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) South West Doctoral Training Partnership and the Engineering and Physical Sciences Research Council (EPSRC) Bristol Chemical Synthesis Centre for Doctoral Training, respectively. The work was funded by grants from the EPSRC (EP/J001430/1; D.N.W.), BBSRC (BB/J008990/1; D.N.W. and R.L.B.) and the European Research Council (340764; D.N.W.). D.N.W. holds a Royal Society Wolfson Research Merit Award. We thank the Diamond Light Source for access to beamlines I0-3 and I0-4 (award MX8922). We thank N. Zaccai for advice on protein x-ray crystallography, and members of the Brady and Woolfson groups for general discussions. A.R.T. and D.N.W. conceived the research program and approach; A.R.T. designed the peptide sequences; A.R.T., C.W.W., and A.J.B. synthesized the peptides and performed solution-phase characterizations; C.W.W., A.J.B., and R.L.B. solved the x-ray crystal structures; A.R.T., C.W.W., G.J.B., and R.B.S. wrote the computational design and modeling algorithms; A.R.T. and D.N.W. wrote the paper. All authors analyzed the data, and reviewed and contributed to the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank with the accession codes: CC-Pent, 4pn8; CC-Hex2, 4pn9; CC-Hex3, 4pnb; CC-Hept, 4pna; CC-Pent-variant, 4pnd.	Burton AJ, 2013, J AM CHEM SOC, V135, P12524, DOI 10.1021/ja4053027; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kopec KO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077074; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; McIntosh-Smith S, 2012, COMPUT J, V55, P192, DOI 10.1093/comjnl/bxr091; Meusch D, 2014, NATURE, V508, P61, DOI 10.1038/nature13015; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Reichen C, 2014, J STRUCT BIOL, V185, P147, DOI 10.1016/j.jsb.2013.07.012; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wood CW, 2014, BIOINFORMATICS, V30, P3029, DOI 10.1093/bioinformatics/btu502; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]	32	236	245	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					485	488		10.1126/science.1257452	http://dx.doi.org/10.1126/science.1257452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342807	Green Submitted			2022-12-28	WOS:000343822900047
J	Ranji, SR				Ranji, Sumant R.			What Gets Measured Gets (Micro)managed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY IMPROVEMENT; RESIDENTS; SAFETY		Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ranji, SR (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA 94143 USA.	sumantr@medicine.ucsf.edu						Farnan JM, 2009, AM J MED, V122, P784, DOI 10.1016/j.amjmed.2009.04.011; Fletcher KE, 2011, J GEN INTERN MED, V26, P907, DOI 10.1007/s11606-011-1657-1; Graber ML, 2012, JAMA-J AM MED ASSOC, V308, P1211, DOI 10.1001/2012.jama.11913; Kalanithi L, 2013, AM J MED QUAL, V28, P472, DOI 10.1177/1062860613478976; Neeman N, 2012, ACAD MED, V87, P168, DOI 10.1097/ACM.0b013e31823f3c2c; Plsek, 2001, CROSSING QUALITY CHA, P309; Rosenbaum L, 2012, NEW ENGL J MED, V367, P2044, DOI 10.1056/NEJMsr1210160; Vidyarthi AR, 2014, ACAD MED, V89, P460, DOI 10.1097/ACM.0000000000000159	8	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1637	1638		10.1001/jama.2014.11268	http://dx.doi.org/10.1001/jama.2014.11268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335143				2022-12-28	WOS:000343301400018
J	Attiah, MA				Attiah, Mark A.			The New Diversity in Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS; CARE; RACE		Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Attiah, MA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Marrast LM, 2014, JAMA INTERN MED, V174, P289, DOI 10.1001/jamainternmed.2013.12756; Nivet MA, 2011, ACAD MED, V86, P1487, DOI 10.1097/ACM.0b013e3182351f79; Rometty VM, IBMS COMMITMENT DIVE; Saha S, 2000, HEALTH AFFAIR, V19, P76, DOI 10.1377/hlthaff.19.4.76	5	7	7	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1474	1476		10.1056/NEJMp1408460	http://dx.doi.org/10.1056/NEJMp1408460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7KV	25317868				2022-12-28	WOS:000342994700003
J	Ahmed, S				Ahmed, Saifuddin			Challenges of achieving and tracking MDG 5	LANCET			English	Editorial Material									Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ahmed, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	sahmed@jhu.edu						AbouZahr C, 2010, LANCET, V375, P619, DOI 10.1016/S0140-6736(09)60004-0; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2014, LANCET, V383, P1792, DOI 10.1016/S0140-6736(14)60839-4; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Ronsmans C, 2002, B WORLD HEALTH ORGAN, V80, P317; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	8	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1329	1331		10.1016/S0140-6736(14)61096-5	http://dx.doi.org/10.1016/S0140-6736(14)61096-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25307833				2022-12-28	WOS:000343004000008
J	Laurance, J				Laurance, Jeremy			Julia Margaret Polak Obituary	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1342	1342		10.1016/S0140-6736(14)61809-2	http://dx.doi.org/10.1016/S0140-6736(14)61809-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25317447				2022-12-28	WOS:000343004000015
J	Dawson, RI; Chiang, E				Dawson, Rebekah I.; Chiang, Eugene			A class of warm Jupiters with mutually inclined, apsidally misaligned close friends	SCIENCE			English	Article							HOT JUPITERS; SECULAR RESONANCE; PLANETARY ORBITS; DYNAMICS; BINARY; PERTURBATIONS; CONSTRAINTS; COMPANIONS; SATELLITES; EVOLUTION	The orbits of giant extrasolar planets often have surprisingly small semimajor axes, large eccentricities, or severe misalignments between their orbit normals and their host stars' spin axes. In some formation scenarios invoking Kozai-Lidov oscillations, an external planetary companion drives a planet onto an orbit having these properties. The mutual inclinations for Kozai-Lidov oscillations can be large and have not been confirmed observationally. Here we present evidence that observed eccentric warm Jupiters with eccentric giant companions have mutual inclinations that oscillate between 35 degrees and 65 degrees. Our inference is based on the pairs' observed apsidal separations, which cluster near 90 degrees. The near-orthogonality of periapse directions is effected by the outer companion's quadrupolar and octupolar potentials. These systems may be undergoing a stalled version of tidal migration that produces warm Jupiters over hot Jupiters, and they provide evidence for a population of multiplanet systems that are not flat and have been sculpted by Kozai-Lidov oscillations.	[Dawson, Rebekah I.; Chiang, Eugene] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dawson, RI (corresponding author), Univ Calif Berkeley, Dept Astron, Hearst Field Annex 3411, Berkeley, CA 94720 USA.	rdawson@berkeley.edu			Miller Institute for Basic Research in Science; University of California (UC) Berkeley's Center for Integrative Planetary Science; National Science Foundation; National Aeronautics and Space Administration	Miller Institute for Basic Research in Science; University of California (UC) Berkeley's Center for Integrative Planetary Science(University of California System); National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	We gratefully acknowledge support from the Miller Institute for Basic Research in Science, the University of California (UC) Berkeley's Center for Integrative Planetary Science, the National Science Foundation, and the National Aeronautics and Space Administration. This research has made use of the Exoplanet Orbit Database at exoplanets.org. This research employed the SAVIO computational cluster provided by the Berkeley Research Computing program, which is supported by UC Berkeley's Chancellor, Vice Chancellor for Research, and Chief Information Officer. We thank four anonymous referees for constructive feedback and D. Fabrycky and J. Johnson for helpful comments.	Barnes R, 2007, ASTROPHYS J, V659, pL53, DOI 10.1086/516824; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chiang EI, 2001, ASTRON J, V122, P1607, DOI 10.1086/322115; Otto JC, 2010, MON NOT R ASTRON SOC, V402, P1959, DOI 10.1111/j.1365-2966.2009.16022.x; Cumming A, 2008, PUBL ASTRON SOC PAC, V120, P531, DOI 10.1086/588487; Dawson RI, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/89; Dawson RI, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/2/L24; Dong SB, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/1/L5; Fabrycky D., 2011, EXOPLANETS, P217; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Ford E. B., 2008, IAU S, V249, P441; Ford EB, 2000, ASTROPHYS J, V535, P385, DOI 10.1086/308815; Katz B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.181101; Kiseleva LG, 1998, MON NOT R ASTRON SOC, V300, P292, DOI 10.1046/j.1365-8711.1998.01903.x; Knutson HA, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/126; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Lee MH, 2002, ASTROPHYS J, V567, P596, DOI 10.1086/338504; Li GJ, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/86; Li GJ, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/116; LIDOV ML, 1962, PLANET SPACE SCI, V9, P719, DOI 10.1016/0032-0633(62)90129-0; Lithwick Y, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/94; McArthur BE, 2010, ASTROPHYS J, V715, P1203, DOI 10.1088/0004-637X/715/2/1203; Michtchenko TA, 2004, ICARUS, V168, P237, DOI 10.1016/j.icarus.2003.12.010; Morton TD, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/170; Nagasawa M, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/72; Naoz S, 2013, MON NOT R ASTRON SOC, V431, P2155, DOI 10.1093/mnras/stt302; Naoz S, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L36; Naoz S, 2011, NATURE, V473, P187, DOI 10.1038/nature10076; Petrovich C, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/101; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Rivera EJ, 2010, ASTROPHYS J, V719, P890, DOI 10.1088/0004-637X/719/1/890; Sanchis-Ojeda R, 2012, NATURE, V487, P449, DOI 10.1038/nature11301; Takeda G, 2005, ASTROPHYS J, V627, P1001, DOI 10.1086/430467; Tan XY, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/101; Veras D, 2010, ASTROPHYS J, V715, P803, DOI 10.1088/0004-637X/715/2/803; WHIPPLE AL, 1993, ICARUS, V101, P265, DOI 10.1006/icar.1993.1023; Wright JT, 2011, PUBL ASTRON SOC PAC, V123, P412, DOI 10.1086/659427; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598; Wu YQ, 2007, ASTROPHYS J, V670, P820, DOI 10.1086/521996; Wu YQ, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/109; Yokoyama T, 2003, ASTRON ASTROPHYS, V401, P763, DOI 10.1051/0004-6361:20030174	43	52	52	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					212	216		10.1126/science.1256943	http://dx.doi.org/10.1126/science.1256943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301622	Green Submitted			2022-12-28	WOS:000342721500042
J	Govindan, R				Govindan, Ramaswamy			Attack of the clones	SCIENCE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; LUNG-CANCER; EVOLUTION; ARCHITECTURE; THERAPY		[Govindan, Ramaswamy] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Govindan, Ramaswamy] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Govindan, R (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	rgovinda@dom.wustl.edu						Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	14	16	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					169	170		10.1126/science.1259926	http://dx.doi.org/10.1126/science.1259926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301605				2022-12-28	WOS:000342721500023
J	Howard, A				Howard, Ayanna			Building the Bionic Woman	SCIENCE			English	Editorial Material									Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Howard, A (corresponding author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.								0	1	1	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					274	274		10.1126/science.346.6206.274	http://dx.doi.org/10.1126/science.346.6206.274			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301632				2022-12-28	WOS:000342721500054
J	Smeeding, TM				Smeeding, Timothy M.			Adjusting to the fertility bust	SCIENCE			English	Editorial Material									Univ Wisconsin, Dept Publ Affairs & Econ, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Smeeding, TM (corresponding author), Univ Wisconsin, Dept Publ Affairs & Econ, Madison, WI 53706 USA.	smeeding@lafollette.wisc.edu			NICHD NIH HHS [P2C HD047873] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047873] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Elmendorf D. W., 2014, SHIFTING PRIORITIES; European Union, 2011, EUROPEAN EC, V4, DOI [10.2765/15373, DOI 10.2765/15373]; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Goldin C., 2008, RACE TECHNOLOGY ED; Goldin C, 2014, AM ECON REV, V104, P1091, DOI 10.1257/aer.104.4.1091; Gornick JC, 2014, LESSONS EUROPE WHAT, P17; Hamilton Brady E, 2014, NATL VITAL STAT REPO, V63; Lee R, 2014, SCIENCE, V346, P229, DOI 10.1126/science.1250542; Livingston Gretchen., 2014, BIRTH RATES LAG EURO; LUTZ W., 2006, VIENNA YB POPULATION, P167, DOI [10.1553/populationyearbook2006s167, DOI 10.1553/P0PULATI0NYEARB00K2006S167]; Parsons CA, 2006, IMMIGRATION AND THE TRANSFORMATION OF EUROPE, P1, DOI 10.1017/CBO9780511493577.001; Piketty T., 2014, CAPITAL SIGLO 21; Teitelbaum M. S., 2013, GLOBAL SPREAD FERTIL	13	10	10	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					163	164		10.1126/science.1260504	http://dx.doi.org/10.1126/science.1260504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301602	Green Accepted			2022-12-28	WOS:000342721500019
J	Buszczak, M; Signer, RAJ; Morrison, SJ				Buszczak, Michael; Signer, Robert A. J.; Morrison, Sean J.			Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis	CELL			English	Review							HEMATOPOIETIC STEM-CELLS; LINKED DYSKERATOSIS-CONGENITA; MESSENGER-RNA TRANSLATION; DIAMOND-BLACKFAN ANEMIA; RIBOSOMAL-RNA; SELF-RENEWAL; IN-VIVO; PROTEOTOXIC STRESS; MAMMALIAN-CELLS; P53 ACTIVATION	Although sometimes considered a "house-keeping" function, multiple aspects of protein synthesis are regulated differently among somatic cells, including stem cells, and can be modulated in a cell-type-specific manner. These differences are required to establish and maintain differences in cell identity, cell function, tissue homeostasis, and tumor suppression.	[Buszczak, Michael] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Signer, Robert A. J.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021	Buszczak, Michael/0000-0001-6361-3654; Morrison, Sean/0000-0003-1587-8329; Signer, Robert/0000-0003-3286-1334	National Institute on Aging [R37 AG024945]; National Institute of General Medical Sciences [R01 GM086647]; Leukemia and Lymphoma Society [5541-11]; Canadian Institutes of Health Research [MFE-106993]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024945, R37AG024945] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	S.J.M. is a Howard Hughes Medical Institute Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, director of the Hamon Laboratory for Stem Cells and Cancer, and a Cancer Research Scholar of the Cancer Prevention and Research Institute of Texas. This work was supported by the National Institute on Aging (R37 AG024945). M.B. was supported by the National Institute of General Medical Sciences (R01 GM086647). R.A.J.S. was supported by fellowships from the Leukemia and Lymphoma Society (5541-11) and the Canadian Institutes of Health Research (MFE-106993).	ABKOWITZ JL, 1991, BLOOD, V78, P2198; Armistead J, 2014, FEBS LETT, V588, P1491, DOI 10.1016/j.febslet.2014.03.024; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cormier P, 2001, DEV BIOL, V232, P275, DOI 10.1006/dbio.2001.0206; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Easley CA, 2010, CELL REPROGRAM, V12, P263, DOI 10.1089/cell.2010.0011; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; FRIEDLAND M, 1985, AM J HEMATOL, V20, P85, DOI 10.1002/ajh.2830200112; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Garlick P. J, 1972, BIOCH J, V126; GARLICK PJ, 1991, P NUTR SOC, V50, P217, DOI 10.1079/PNS19910031; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Han K, 2014, NAT METHODS, V11, P86, DOI [10.1038/NMETH.2729, 10.1038/nmeth.2729]; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Ivanov P, 2011, GENE DEV, V25, P2119, DOI 10.1101/gad.17838411; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kronja I, 2014, CELL REP, V7, P1495, DOI 10.1016/j.celrep.2014.05.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Le Bouteiller M, 2013, J EXP MED, V210, P2351, DOI 10.1084/jem.20122019; Lessard F, 2010, MOL CELL, V38, P539, DOI 10.1016/j.molcel.2010.03.015; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; LIPTON JM, 1986, BLOOD, V67, P962; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Logsdon CD, 2013, NAT REV GASTRO HEPAT, V10, P362, DOI 10.1038/nrgastro.2013.36; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; MARSH JCW, 1992, BLOOD, V79, P3138; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Salaun P, 2003, DEV BIOL, V255, P428, DOI 10.1016/S0012-1606(02)00099-4; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Taylor AM, 2012, EXP HEMATOL, V40, P228, DOI [10.1016/j.exphem.2011.11.007, 10.1016/j.exphem.2011.11.007.]; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Topisirovic I, 2011, COLD SH Q B, V76, P355, DOI 10.1101/sqb.2011.76.010785; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wilkins BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077670; Xiao GG, 2008, J APPL PHYSIOL, V104, P828, DOI 10.1152/japplphysiol.00976.2007; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384; Zhang Y, 2014, NATURE; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	107	120	120	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					242	251		10.1016/j.cell.2014.09.016	http://dx.doi.org/10.1016/j.cell.2014.09.016			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303523	Green Accepted, Bronze			2022-12-28	WOS:000343095600008
J	Wang, JC; Xie, GC; Singh, M; Ghanbarian, AT; Rasko, T; Szvetnik, A; Cai, HQ; Besser, D; Prigione, A; Fuchs, NV; Schumann, GG; Chen, W; Lorincz, MC; Ivics, Z; Hurst, LD; Izsvak, Z				Wang, Jichang; Xie, Gangcai; Singh, Manvendra; Ghanbarian, Avazeh T.; Rasko, Tamas; Szvetnik, Attila; Cai, Huiqiang; Besser, Daniel; Prigione, Alessandro; Fuchs, Nina V.; Schumann, Gerald G.; Chen, Wei; Lorincz, Matthew C.; Ivics, Zoltan; Hurst, Laurence D.; Izsvak, Zsuzsanna			Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells	NATURE			English	Article							SLEEPING-BEAUTY; RNA-SEQ; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; PLURIPOTENCY; CHROMATIN; INDUCTION; PROGRAM; NETWORK; DIFFERENTIATION	Naive embryonic stem cells hold great promise for research and therapeutics as they have broad and robust developmental potential. While such cells are readily derived from mouse blastocysts it has not been possible to isolate human equivalents easily(1,2), although human naive-like cells have been artificially generated (rather than extracted) by coercion of human primed embryonic stem cells by modifying culture conditions(2-4) or through transgenic modification(5). Here we show that a sub-population within cultures of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) manifests key properties of naive state cells. These naive-like cells can be genetically tagged, and are associated with elevated transcription of HERVH, a primate-specific endogenous retrovirus. HERVH elements provide functional binding sites for a combination of naive pluripotency transcription factors, including LBP9, recently recognized as relevant to naivety inmice(6). LBP9-HERVH drives hESC-specific alternative and chimaeric transcripts, including pluripotency-modulating long non-coding RNAs. Disruption of LBP9, HERVH and HERVH-derived transcripts compromises self-renewal. These observations define HERVH expression as a hallmark of naive-like hESCs, and establish novel primate-specific transcriptional circuitry regulating pluripotency.	[Wang, Jichang; Xie, Gangcai; Singh, Manvendra; Rasko, Tamas; Szvetnik, Attila; Cai, Huiqiang; Besser, Daniel; Prigione, Alessandro; Fuchs, Nina V.; Chen, Wei; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Xie, Gangcai] CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Ghanbarian, Avazeh T.; Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Fuchs, Nina V.; Schumann, Gerald G.; Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; University of Bath; Paul Ehrlich Institute; University of British Columbia	Izsvak, Z (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	l.d.hurst@bath.ac.uk; zizsvak@mdc-berlin.de	Xie, Gangcai/AAN-9197-2021; Prigione, Alessandro/ABA-1584-2021; Besser, Daniel/A-8304-2012; Ghanbarian, Avazeh/H-7310-2019; Chen, Wei/C-1273-2011; Alessandro, Prigione/B-2959-2013; Hurst, Laurence/F-9215-2010	Xie, Gangcai/0000-0002-8286-2987; Besser, Daniel/0000-0002-4958-9624; Ghanbarian, Avazeh/0000-0003-3920-5807; Fuchs, Nina/0000-0003-4175-0740; Wang, Jichang/0000-0002-7027-0298; Lorincz, Matthew/0000-0003-0885-0467; Alessandro, Prigione/0000-0001-9457-1952; Izsvak, Zsuzsanna/0000-0002-2053-2384; Hurst, Laurence/0000-0002-1002-1054; Singh, Manvendra/0000-0002-8626-5418	University of Bath; DFG [SCHU1014/8-1]; LOEWE Center for Cell and Gene Therapy Frankfurt/Hessian Ministry of Higher Education, Research and the Arts [III L 4-518/17.004];  [ERC-2011-AdG 294742]	University of Bath; DFG(German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy Frankfurt/Hessian Ministry of Higher Education, Research and the Arts; 	L.D.H. is Wolfson Royal Society Research Merit Award Holder. A.T.G. is funded by a scholarship from the University of Bath. Z.Iz. is funded by ERC-2011-AdG 294742. G.G.S. is funded by DFG grant SCHU1014/8-1 and LOEWE Center for Cell and Gene Therapy Frankfurt/Hessian Ministry of Higher Education, Research and the Arts (ref. number III L 4-518/17.004). We thank U. Martin and S. Merkert (Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover Medical School, Hannover, Germany) for providing the cell lines hCBEC, hCBiPS1, hCBiPS2 and hFF-iPS4. We thank G. Klein for the inspiration of working with ERVs and Z. Cseresnyes for his assistance in imaging.	Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Grabundzija I, 2013, NUCLEIC ACIDS RES, V41, P1829, DOI 10.1093/nar/gks1305; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Kaufman Christopher D, 2005, J RNAi Gene Silencing, V1, P97; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishiyama A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01390; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Theunissen T.W., 2014, CELL STEM CELL; To S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011702; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Volders P.-J., 2012, NUCLEIC ACIDS RES, V41, P246; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Welling M, 2013, TRENDS CELL BIOL, V23, P442, DOI 10.1016/j.tcb.2013.04.004; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000	56	258	273	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					405	+		10.1038/nature13804	http://dx.doi.org/10.1038/nature13804			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25317556	Green Accepted			2022-12-28	WOS:000346484800049
J	Azim, E				Azim, Eiman			Shortcuts and checkpoints on the road to skilled movement	SCIENCE			English	Editorial Material							OPTIMAL FEEDBACK-CONTROL; MOTOR CONTROL; CIRCUITS		[Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA; [Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Biochem & Mol Biophys,Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Azim, E (corresponding author), Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA.			Azim, Eiman/0000-0002-1015-1772	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS088193] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [K99 NS088193] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Frank K, 1957, FED PROC, V16, P49; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Miri A, 2013, NEURON, V80, P827, DOI 10.1016/j.neuron.2013.10.049; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; STEIN RB, 1976, BIOL CYBERN, V22, P147, DOI 10.1007/BF00365525; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; WHISHAW IQ, 1992, BEHAV BRAIN RES, V47, P59, DOI 10.1016/S0166-4328(05)80252-9; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	17	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		554	555		10.1126/science.1260778	http://dx.doi.org/10.1126/science.1260778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359954				2022-12-28	WOS:000343799700025
J	Hall, JW; Grey, D; Garrick, D; Fung, F; Brown, C; Dadson, SJ; Sadoff, CW				Hall, J. W.; Grey, D.; Garrick, D.; Fung, F.; Brown, C.; Dadson, S. J.; Sadoff, C. W.			Coping with the curse of freshwater variability	SCIENCE			English	Editorial Material							CLIMATE-CHANGE		[Hall, J. W.; Grey, D.; Dadson, S. J.] Univ Oxford, Oxford OX1 3QY, England; [Garrick, D.] McMaster Univ, Dept Polit Sci, Hamilton, ON L8S 0A3, Canada; [Garrick, D.] McMaster Univ, Walter G Booth Sch Engn Practice, Hamilton, ON L8S 0A3, Canada; [Fung, F.] Environm Agcy, Bristol BS1 5AH, Avon, England; [Brown, C.] Univ Massachusetts, Dept Civil & Environm Engn, Amherst, MA 01003 USA; [Sadoff, C. W.] World Bank, Washington, DC 20433 USA	University of Oxford; McMaster University; McMaster University; University of Massachusetts System; University of Massachusetts Amherst; The World Bank	Hall, JW (corresponding author), Univ Oxford, S Parks Rd, Oxford OX1 3QY, England.	jim.hall@eci.ox.ac.uk	Hall, Jim W/ABF-1407-2020; Dadson, Simon J/D-2370-2010	Hall, Jim W/0000-0002-2024-9191; GARRICK, DUSTIN/0000-0001-6504-6550; Fung, Fai/0000-0003-4367-151X; Sadoff, Claudia/0000-0002-7354-563X; Dadson, Simon/0000-0002-6144-4639	Engineering and Physical Sciences Research Council [EP/I01344X/2] Funding Source: researchfish; Natural Environment Research Council [NE/L010364/1, NE/I01277X/2] Funding Source: researchfish; EPSRC [EP/I01344X/2] Funding Source: UKRI; NERC [NE/I01277X/2, NE/L010364/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2013, SEV WEATH AS PER RIS; Briscoe J., 2006, INDIAS WATER EC BRAC; Brown C, 2006, NAT RESOUR FORUM, V30, P306, DOI 10.1111/j.1477-8947.2006.00118.x; Flooding of Rojana Industrial Park Ayutthaya Thailand, 2011, DEFENSE VIDEO IMAGER; Gleick PH, 2014, WEATHER CLIM SOC, V6, P331, DOI 10.1175/WCAS-D-13-00059.1; Grafton RQ, 2013, NAT CLIM CHANGE, V3, P315, DOI [10.1038/NCLIMATE1746, 10.1038/nclimate1746]; Grey D., 2013, PHILOS T R SOC LONDO, V371, P1471; Hall JW, 2012, NAT CLIM CHANGE, V2, P833, DOI 10.1038/nclimate1749; IPCC, 2012, MAN RISKS EXTR EV DI; Janssen MA, 2007, SOC NATUR RESOUR, V20, P307, DOI 10.1080/08941920601161320; Lorenz C, 2012, J HYDROMETEOROL, V13, P1397, DOI 10.1175/JHM-D-11-088.1; Moody P, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012497; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; World Bank, 2006, ETH MAN WAT RES MAX	14	121	123	5	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					429	430		10.1126/science.1257890	http://dx.doi.org/10.1126/science.1257890			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342791				2022-12-28	WOS:000343822900025
J	Coombes, R; Arie, S				Coombes, Rebecca; Arie, Sophie			BRIEFING Ebola: How well is the UK prepared?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Center for Disease Control, DET HOSP CHECKL EB P; Mabey D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6202; Public Health England, ENH EB SCREEN PROC; Public Health England, 2014, EB Q A; Public Health England, 2014, VIR HAEM FEV RISK AS; Public Health England, 2014, EB ADV RISK ASS U FU; Public Health England, RET W AFR INF EB; The College of Emergency Medicine, 2014, EB GUID EM DEP	8	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6288	10.1136/bmj.g6288	http://dx.doi.org/10.1136/bmj.g6288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25354397	Bronze, Green Published			2022-12-28	WOS:000343767700009
J	De Pontieu, B; Title, A; Carlsson, M				De Pontieu, Bart; Title, Alan; Carlsson, Mats			PROBING THE SOLAR INTERFACE REGION	SCIENCE			English	Editorial Material									[De Pontieu, Bart; Title, Alan] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [Carlsson, Mats] Univ Oslo, Inst Theoret Astrophys, N-0316 Oslo, Norway	Lockheed Martin; University of Oslo	De Pontieu, B (corresponding author), Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA.								0	17	17	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					315	315						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324380	Bronze			2022-12-28	WOS:000343041100029
J	Ma, ZQ; Wang, XL; Wang, X; Rodriguez, RA; Moore, CE; Gao, SH; Tan, XH; Ma, YY; Rheingold, AL; Baran, PS; Chen, C				Ma, Zhiqiang; Wang, Xiaolei; Wang, Xiao; Rodriguez, Rodrigo A.; Moore, Curtis E.; Gao, Shuanhu; Tan, Xianghui; Ma, Yuyong; Rheingold, Arnold L.; Baran, Phil S.; Chen, Chuo			Asymmetric syntheses of sceptrin and massadine and evidence for biosynthetic enantiodivergence	SCIENCE			English	Article							PYRROLE-IMIDAZOLE ALKALOIDS; VISIBLE-LIGHT PHOTOCATALYSIS; AGELAS-CONIFERA; ENERGY-TRANSFER; CORE SKELETONS; NAGELAMIDE-E; SPONGE; AGELIFERIN; PALAUAMINE; CYCLOADDITIONS	Cycloaddition is an essential tool in chemical synthesis. Instead of using light or heat as a driving force, marine sponges promote cycloaddition with a more versatile but poorly understood mechanism in producing pyrrole-imidazole alkaloids sceptrin, massadine, and ageliferin. Through de novo synthesis of sceptrin and massadine, we show that sponges may use single-electron oxidation as a central mechanism to promote three different types of cycloaddition. Additionally, we provide surprising evidence that, in contrast to previous reports, sceptrin, massadine, and ageliferin have mismatched chirality. Therefore, massadine cannot be an oxidative rearrangement product of sceptrin or ageliferin, as is commonly believed. Taken together, our results demonstrate unconventional chemical approaches to achieving cycloaddition reactions in synthesis and uncover enantiodivergence as a new biosynthetic paradigm for natural products.	[Ma, Zhiqiang; Wang, Xiaolei; Wang, Xiao; Gao, Shuanhu; Tan, Xianghui; Ma, Yuyong; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rodriguez, Rodrigo A.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Moore, Curtis E.; Rheingold, Arnold L.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; University of California System; University of California San Diego	Chen, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chuo.chen@utsouthwestern.edu	Rheingold, Arnold/U-4735-2019; Ma, Yuyong/I-2678-2016; wang, xiaolei/K-6888-2014; Wang, Xiao/F-4535-2015	Rheingold, Arnold/0000-0003-4472-8127; Ma, Yuyong/0000-0001-9591-6465; Chen, Chuo/0000-0002-3118-4901; wang, xiaolei/0000-0002-8867-6528	NIH [NIGMS R01-GM079554, R01-GM073949]; Welch Foundation [I-1596]; UT Southwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079554, R01GM073949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UT Southwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kock (Alfred Wegener Institute) for providing the natural samples of sceptrin and massadine, and J. Munoz (Alfred Wegener Institute) for providing a copy of the CD spectrum of natural sceptrin center dot TFA. We also thank V. Lynch (University of Texas at Austin), J. Clardy (Harvard University), and T. Molinski (University of California, San Diego) for helpful discussions. The CD experiments were performed by H. Shi [University of Texas (UT) Southwestern]. Financial support was provided by NIH (NIGMS R01-GM079554 and R01-GM073949), the Welch Foundation (I-1596), and UT Southwestern. Metrical parameters for the structures of natural sceptrin (1a) and 21 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-995387 (1a), 1014159 (21), and 1016848 (21).	Al-Mourabit A, 2011, NAT PROD REP, V28, P1229, DOI 10.1039/c0np00013b; Baran PS, 2006, ANGEW CHEM INT EDIT, V45, P249, DOI 10.1002/anie.200503374; Baran PS, 2004, ANGEW CHEM INT EDIT, V43, P2674, DOI 10.1002/anie.200453937; Baran PS, 2004, J AM CHEM SOC, V126, P3726, DOI 10.1021/ja049648s; BAULD NL, 1989, TETRAHEDRON, V45, P5307, DOI 10.1016/S0040-4020(01)89486-2; Birman VB, 2004, ORG LETT, V6, P2369, DOI 10.1021/ol049283g; Chen FC, 2003, J POLYM SCI POL PHYS, V41, P2681, DOI 10.1002/polb.10648; Dilley AS, 2001, ORG LETT, V3, P1535, DOI 10.1021/ol015864j; Ding H, 2013, CHEM SCI, V4, P303, DOI 10.1039/c2sc21651e; Finefield JM, 2012, ANGEW CHEM INT EDIT, V51, P4802, DOI 10.1002/anie.201107204; Gautschi JT, 2004, J NAT PROD, V67, P1256, DOI 10.1021/np0340495; Grube A, 2007, ANGEW CHEM INT EDIT, V46, P6721, DOI 10.1002/anie.200701935; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; KEIFER PA, 1991, J ORG CHEM, V56, P2965, DOI 10.1021/jo00009a008; Kinnel RB, 1998, J ORG CHEM, V63, P3281, DOI 10.1021/jo971987z; KOBAYASHI J, 1990, TETRAHEDRON, V46, P5579, DOI 10.1016/S0040-4020(01)87756-5; Kock M, 2007, ANGEW CHEM INT EDIT, V46, P6586, DOI 10.1002/anie.200701798; Lovely CJ, 2004, ORG LETT, V6, P735, DOI 10.1021/ol036403w; Lu Z, 2012, ANGEW CHEM INT EDIT, V51, P10329, DOI 10.1002/anie.201204835; Ma ZQ, 2011, CHEM COMMUN, V47, P427, DOI 10.1039/c0cc02214d; Munoz J, 2012, TETRAHEDRON LETT, V53, P5828, DOI 10.1016/j.tetlet.2012.07.110; Nishimura S, 2003, ORG LETT, V5, P2255, DOI 10.1021/ol034564u; Northrop BH, 2006, ANGEW CHEM INT EDIT, V45, P4126, DOI 10.1002/anie.200600514; O'Malley DP, 2008, ANGEW CHEM INT EDIT, V47, P3581, DOI 10.1002/anie.200801138; O'Malley DP, 2007, J AM CHEM SOC, V129, P4762, DOI 10.1021/ja069035a; Overman LE, 1997, J AM CHEM SOC, V119, P7159, DOI 10.1021/ja9712985; Seiple IB, 2011, J AM CHEM SOC, V133, P14710, DOI 10.1021/ja2047232; Seiple IB, 2010, ANGEW CHEM INT EDIT, V49, P1095, DOI 10.1002/anie.200907112; Starr JT, 2000, J AM CHEM SOC, V122, P8793, DOI 10.1021/ja0019575; Stout EP, 2012, ANGEW CHEM INT EDIT, V51, P4877, DOI 10.1002/anie.201108119; Su S, 2011, J AM CHEM SOC, V133, P13922, DOI 10.1021/ja206191g; Su S, 2008, J AM CHEM SOC, V130, P16490, DOI 10.1021/ja8074852; Tan XH, 2006, ANGEW CHEM INT EDIT, V45, P4345, DOI 10.1002/anie.200601208; VALENTINE D, 1972, J AM CHEM SOC, V94, P3449, DOI 10.1021/ja00765a032; WALKER RP, 1981, J AM CHEM SOC, V103, P6772, DOI 10.1021/ja00412a052; Wang X, 2012, J AM CHEM SOC, V134, P18834, DOI 10.1021/ja309172t; Wang X, 2011, J AM CHEM SOC, V133, P15350, DOI 10.1021/ja207386q; Yamaguchi J, 2008, ANGEW CHEM INT EDIT, V47, P3578, DOI 10.1002/anie.200705913; Yoon TP, 2013, ACS CATAL, V3, P895, DOI 10.1021/cs400088e	39	85	85	2	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					219	224		10.1126/science.1255677	http://dx.doi.org/10.1126/science.1255677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301624	Green Accepted			2022-12-28	WOS:000342721500044
J	Skands, P				Skands, Peter			PARTICLE PHYSICS The mass of a top	NATURE			English	Editorial Material									[Skands, Peter] CERN, CH-1211 Geneva 23, Switzerland; [Skands, Peter] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia	European Organization for Nuclear Research (CERN); Monash University	Skands, P (corresponding author), CERN, CH-1211 Geneva 23, Switzerland.	peter.skands@monash.edu						Aad G, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2046-6; Aaltonen T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.152003; Abachi, 1995, Phys Rev Lett, V74, P2632, DOI 10.1103/PhysRevLett.74.2638; Abazov VM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.032002; ABE F, 1995, PHYS REV LETT, V74, P2626, DOI 10.1103/PhysRevLett.74.2638; Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; Elias-Miro J, 2012, PHYS LETT B, V709, P222, DOI 10.1016/j.physletb.2012.02.013; The CMS collaboration, 2012, J HIGH ENERGY PHYS, V105, P1212	9	0	0	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					174	176		10.1038/514174a	http://dx.doi.org/10.1038/514174a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297430				2022-12-28	WOS:000342663100028
J	Masters, PA				Masters, Philip A.			Insomnia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; SLEEP DISORDERS; OLDER-ADULTS; LONG-TERM; POPULATION; EPIDEMIOLOGY; LIFE; ASSOCIATION; ESZOPICLONE											[Anonymous], 2014, INT CLASS SLEEP DIS; Arnedt JT, 2013, SLEEP, V36, P353, DOI 10.5665/sleep.2448; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barion A, 2007, SLEEP MED, V8, P566, DOI 10.1016/j.sleep.2006.11.017; Bonnet MH, 2014, SLEEP MED REV, V18, P111, DOI 10.1016/j.smrv.2013.02.003; Brzezinski A, 2005, SLEEP MED REV, V9, P41, DOI 10.1016/j.smrv.2004.06.004; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Dikeos D, 2011, CURR OPIN PSYCHIATR, V24, P346, DOI 10.1097/YCO.0b013e3283473375; Ebben MR, 2009, J BEHAV MED, V32, P244, DOI 10.1007/s10865-008-9198-8; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; Espie CA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004183; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Gellis LA, 2005, J ABNORM PSYCHOL, V114, P111, DOI 10.1037/0021-843X.114.1.111; Holmqvist M, 2014, SLEEP MED, V15, P187, DOI 10.1016/j.sleep.2013.10.013; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Kessler RC, 2012, SLEEP, V35, P725, DOI 10.5665/sleep.1844; Kessler RC, 2011, SLEEP, V34, P1608, DOI 10.5665/sleep.1408; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Krystal AD, 2008, SLEEP, V31, P79, DOI 10.1093/sleep/31.1.79; Krystal AD, 2009, SLEEP MED REV, V13, P265, DOI 10.1016/j.smrv.2008.08.001; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Miller CB, 2014, SLEEP MED REV; Minkel J, 2013, SLEEP MED CLIN, V8, P333, DOI 10.1016/j.jsmc.2013.06.002; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2011, CAN J PSYCHIAT, V56, P540, DOI 10.1177/070674371105600905; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Morin CM, 1999, J PSYCHOSOM RES, V46, P103, DOI 10.1016/S0022-3999(98)00077-4; Morphy H, 2007, SLEEP, V30, P274; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2001, J PSYCHOSOM RES, V51, P745, DOI 10.1016/S0022-3999(01)00285-9; Paine SJ, 2004, SLEEP, V27, P1163, DOI 10.1093/sleep/27.6.1163; Perlis ML, 2004, J CLIN PSYCHIAT, V65, P1128; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Roth T, 2005, SLEEP MED, V6, P487, DOI 10.1016/j.sleep.2005.06.004; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Sarris J, 2011, SLEEP MED REV, V15, P99, DOI 10.1016/j.smrv.2010.04.001; Sarsour K, 2011, SLEEP, V34, P443, DOI 10.1093/sleep/34.4.443; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0364-5; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Taylor DJ, 2007, SLEEP, V30; Troxel WM, 2010, SLEEP, V33, P1633, DOI 10.1093/sleep/33.12.1633; van Straten A, 2013, PSYCHOL MED, P1; Vande Griend JP, 2012, J AM PHARM ASSOC, V52, pE210, DOI 10.1331/JAPhA.2012.12051; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Walsh JK, 2007, SLEEP, V30, P959, DOI 10.1093/sleep/30.8.959; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Yang PY, 2012, J PHYSIOTHER, V58, P157, DOI 10.1016/S1836-9553(12)70106-6; Young J, 2009, BRIT J CRIMINOL, V49, P4, DOI 10.1093/bjc/azn074; Young JS, 2008, J HOSP MED, V3, P473, DOI 10.1002/jhm.372	57	10	10	4	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7							ITC1	10.7326/0003-4819-161-7-201410070-01004	http://dx.doi.org/10.7326/0003-4819-161-7-201410070-01004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9LU	25285559				2022-12-28	WOS:000343896700003
J	Liu, D; Xu, HP; Shih, CM; Wan, ZR; Ma, XP; Ma, WW; Luo, D; Qi, H				Liu, Dan; Xu, Heping; Shih, Changming; Wan, Zurong; Ma, Xiaopeng; Ma, Weiwei; Luo, Dan; Qi, Hai			T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction	NATURE			English	Article							FOLLICULAR HELPER-CELL; AFFINITY MATURATION; MEMORY; DIFFERENTIATION; ACTIVATION; SELECTION; EFFECTOR; SURFACE; LIGAND	The germinal centre(GC) reaction supports affinity-based B-cell competition and generates high-affinity bone-marrow plasma cells (BMPCs)(1,2). How follicular T-helper (T-FH) cells regulate GC selection is not clear(3,4). Using competitive mixed chimaera, we show here that, beyond the role in promoting T-FH development(5-7), ICOSL (inducible T-cell co-stimulator ligand, also known as ICOSLG) is important for individual B cells to competitively participate in the GC reaction and to develop into BMPCs. Using intravital imaging aided by a calcium reporter, we further show that ICOSL promotes an 'entangled' mode of T-FH-B-cell interactions, characterized by brief but extensive surface engagement, productive T-cell calcium spikes, and B-cell acquisition of CD40 signals. Reiterated entanglement promotes outer-zone co-localization of outcompeting GC B cells together with T-FH cells, affording the former increased access to T-cell help. ICOSL on GC B cells is upregulated by CD40 signals. Such an intercellular positive feedback between contact-dependent help and ICOSL-controlled entanglement promotes positive selection and BMPC development, as evidenced by observations that higher-affinity B-cell receptor variants are enriched in the ICOSLhigh fraction, that numerically disadvantaged ICOSL-deficient GC B cells or BMPCs exhibit strong affinity compensation in competitive chimaera, and that when GC competition proceeds without ICOSL, selection of high-affinity variants in otherwise normal GC reactions is impaired. By demonstrating entanglement as the basic form of GC T-FH-B-cell interactions, identifying ICOSL as a molecular linkage between T-B interactional dynamics and positive selection for high-affinity BMPC formation, our study reveals a pathway by which T-FH cells control the quality of long-lived humoral immunity.	[Liu, Dan; Xu, Heping; Shih, Changming; Wan, Zurong; Ma, Weiwei; Luo, Dan; Qi, Hai] Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Ma, Xiaopeng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Qi, H (corresponding author), Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	qihai@tsinghua.edu.cn		Qi, Hai/0000-0001-5475-3989; Xu, Heping/0000-0003-2149-7004	Ministry of Science and Technology '973' program [2014CB542501]; National Natural Science Foundation of China [81330070, 81361120397]; Tsinghua University Initiative Scientific Research Program [20131089224]; Institut Merieux; Tsinghua-Peking Center for Life Sciences	Ministry of Science and Technology '973' program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Institut Merieux; Tsinghua-Peking Center for Life Sciences	We thank L. and M. McHeyzer-Williams for providing the V<INF>H</INF> gene analysis protocol, T. Nagai for YC-Nano reporter constructs<SUP>9</SUP>, and H. Wekerle for the Twitch-1<SUP>CD</SUP> reporter construct<SUP>10</SUP>. H.Q. is indebted to Y. Hong for support. H.Q. was a Tsinghua-Bayer Investigator and a Tsinghua-Janssen Investigator. This work was funded in part by the Ministry of Science and Technology '973' program (2014CB542501), National Natural Science Foundation of China (81330070 and 81361120397), Tsinghua University Initiative Scientific Research Program (20131089224), Institut Merieux, and the Tsinghua-Peking Center for Life Sciences.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mues M, 2013, NAT MED, V19, P778, DOI 10.1038/nm.3180; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weinstein JS, 2014, J IMMUNOL, V192, P3166, DOI 10.4049/jimmunol.1302617; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	19	242	256	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					214	U241		10.1038/nature13803	http://dx.doi.org/10.1038/nature13803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25317561				2022-12-28	WOS:000347477600039
J	Rugge, JB; Bougatsos, C; Chou, R				Rugge, J. Bruin; Bougatsos, Christina; Chou, Roger			Screening and Treatment of Thyroid Dysfunction: An Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; MILD SUBCLINICAL HYPOTHYROIDISM; PLACEBO-CONTROLLED TRIAL; INTIMA-MEDIA THICKNESS; L-THYROXINE THERAPY; DOUBLE-BLIND; ENDOTHELIAL FUNCTION; SERUM THYROTROPIN; CROSSOVER TRIAL; OLDER-ADULTS	Background: In 2004, the U.S. Preventive Services Task Force found insufficient evidence to recommend thyroid screening. Purpose: To update the 2004 U.S. Preventive Services Task Force review on the benefits and harms of screening and treatment of subclinical and undiagnosed overt hypothyroidism and hyperthyroidism in adults without goiter or thyroid nodules. Data Sources: MEDLINE and Cochrane databases through July 2014. Study Selection: Randomized, controlled trials and observational studies of screening and treatment. Data Extraction: One investigator abstracted data, and a second investigator confirmed; 2 investigators independently assessed study quality. Data Synthesis: No study directly assessed benefits and harms of screening versus no screening. For subclinical hypothyroidism (based on thyroid-stimulating hormone levels of 4.1 to 11.0 mIU/L), 1 fair-quality cohort study found that treatment of subclinical hypothyroidism was associated with decreased risk for coronary heart disease events versus no treatment. No study found that treatment was associated with improved quality of life, cognitive function, blood pressure, or body mass index versus no treatment. Effects of treatment versus no treatment showed potential beneficial effects on lipid levels, but effects were inconsistent, not statistically significant in most studies, and of uncertain clinical significance (difference, -0.7 to 0 mmol/L [-28 to 0 mg/dL] for total cholesterol levels and -0.6 to 0.1 mmol/L [-22 to 2 mg/dL] for low-density lipoprotein cholesterol levels). Treatment harms were poorly studied and sparsely reported. Two poorquality studies evaluated treatment of subclinical hyperthyroidism but examined intermediate outcomes. No study evaluated treatment versus no treatment of screen-detected, undiagnosed overt thyroid dysfunction. Limitation: English-language articles only, no treatment study performed in the United States, and small trials with short duration that used different dosage protocols. Conclusion: More research is needed to determine the clinical benefits associated with thyroid screening.	[Rugge, J. Bruin; Bougatsos, Christina; Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Oregon Health & Science University	Rugge, JB (corresponding author), Oregon Hlth & Sci Univ, Mail Code FM,3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	ruggeb@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Abu-Helalah M, 2010, J MED SCREEN, V17, P164, DOI 10.1258/jms.2010.010057; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P1251, DOI 10.1210/jc.2008-2325; Buscemi S, 2007, J ENDOCRINOL INVEST, V30, P230, DOI 10.1007/BF03347430; Cabral MD, 2011, CLINICS, V66, P1321, DOI 10.1590/S1807-59322011000800003; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Caraccio N, 2002, J CLIN ENDOCR METAB, V87, P1533, DOI 10.1210/jc.87.4.1533; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Diez JJ, 2004, J CLIN ENDOCR METAB, V89, P4890, DOI 10.1210/jc.2003-032061; Teixeira PDD, 2008, TRANSL RES, V151, P224, DOI 10.1016/j.trsl.2007.12.006; Duman D, 2007, HEART VESSELS, V22, P88, DOI 10.1007/s00380-006-0950-0; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Helfand M., 2004, PREPARED BY THE OREG; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; IMS Institute for Healthcare Informatics, 2011, THE USE OF MEDICINES; Iqbal A, 2006, J INTERN MED, V260, P53, DOI 10.1111/j.1365-2796.2006.01652.x; Jaeschke R, 1996, J GEN INTERN MED, V11, P744, DOI 10.1007/BF02598988; Jameson J.L., 2008, HARRISONS PRINCIPLES; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; Meier C, 2001, J CLIN ENDOCR METAB, V86, P4860, DOI 10.1210/jc.86.10.4860; Michalopoulou G, 1998, EUR J ENDOCRINOL, V138, P141, DOI 10.1530/eje.0.1380141; Mikhail George S, 2008, Endocr Pract, V14, P570; Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669; Nagasaki T, 2009, EUR J ENDOCRINOL, V160, P409, DOI 10.1530/EJE-08-0742; NYSTROM E, 1988, CLIN ENDOCRINOL, V29, P63, DOI 10.1111/j.1365-2265.1988.tb00250.x; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Pollock MA, 2001, BRIT MED J, V323, P891, DOI 10.1136/bmj.323.7318.891; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Rugge B., 2011, AHRQ PUBLICATION, V11; Rugge JB, 2014, SCREENING AND TREATM; Simonsick EM, 2009, ARCH INTERN MED, V169, P2011, DOI 10.1001/archinternmed.2009.392; Somwaru LL, 2011, J GERONTOL A-BIOL, V66, P809, DOI 10.1093/gerona/glr063; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Surks MI, 2010, J CLIN ENDOCR METAB, V95, P496, DOI 10.1210/jc.2009-1845; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Teixeira PFS, 2008, HORM METAB RES, V40, P50, DOI 10.1055/s-2007-993216; U.S. Preventive Services Task Force, PROCEDURE MANUAL; Wirth CD, 2014, ANN INTERN MED, V161, P189, DOI 10.7326/M14-0125; Yonem O, 2002, ENDOCR J, V49, P307, DOI 10.1507/endocrj.49.307	47	101	108	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					35	45		10.7326/M14-1456	http://dx.doi.org/10.7326/M14-1456			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25347444				2022-12-28	WOS:000350103000005
J	Ryskina, KL; Korenstein, D; Weissman, A; Masters, P; Alguire, P; Smith, CD				Ryskina, Kira L.; Korenstein, Deborah; Weissman, Arlene; Masters, Philip; Alguire, Patrick; Smith, Cynthia D.			Development of a High-Value Care Subscore on the Internal Medicine In-Training Examination	ANNALS OF INTERNAL MEDICINE			English	Article							COST-CONSCIOUS CARE; TEACHING HIGH-VALUE; RESIDENTS; COMPETENCE; PHYSICIANS; VIGNETTES	Background: Although high-value care (HVC) that balances benefits of tests or treatments against potential harms and costs has been a recently emphasized competency for internal medicine (IM) residents, few tools to assess residents' knowledge of HVC are available. Objective: To describe the development and initial results of an HVC subscore of the Internal Medicine In-Training Examination (IM-ITE). Design: The HVC concepts were introduced to IM-ITE authors during question development. Three physicians independently reviewed each examination question for selection in the HVC subscore according to 6 HVC principles. The final subscore was determined by consensus. Data from the IM-ITE administered in October 2012 were analyzed at the program level. Setting: U.S. IM residency programs. Participants: 362 U.S. IM residency programs with IM-ITE data for at least 10 residents. Measurements: Program-level performance on the HVC subscore was compared with performance on the overall IM-ITE, the Dartmouth Atlas hospital care intensity (HCI) index of the program's primary training hospital, and residents' attitudes about HVC assessed with a voluntary survey. Results: The HVC subscore comprised 38 questions, including 21 (55%) on managing conservatively when appropriate and 14 (37%) on identifying low-value care. Of the 362 U.S. IM programs in the sample, 41% were in a different quartile when ranked based on the HVC subscore compared with overall IM-ITE performance. Rankings by HVC subscore and HCI index were modestly inversely associated, with 30% of programs ranked in the same quartile based on both measures. Limitation: Knowledge of HVC assessed from examination vignettes may not reflect practice of HVC. Conclusion: Although the HVC subscore has face validity and can contribute to evaluation of residents' HVC knowledge, additional tools are needed to accurately measure residents' proficiency in HVC.	[Ryskina, Kira L.] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Amer Coll Physicians, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; American College of Physicians	Ryskina, KL (corresponding author), Univ Penn, Div Gen Internal Med, 13-30B4,13th Floor,Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	ryskina@mail.med.upenn.edu			National Research Service Award	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Ryskina is supported by a National Research Service Award. Drs. Korenstein, Weissman, Masters, Alguire, and Smith are employees of the ACP.	American College of Physicians Alliance for Academic Internal Medicine, 2014, ACP INT MED INTR EX; [Anonymous], 2014, DARTMOUTH ATLAS HLTH; Arora A, 2012, DARTMOUTH ATLAS HLTH; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Bernabeo EC, 2013, ADV HEALTH SCI EDUC, V18, P463, DOI 10.1007/s10459-012-9384-x; Caverzagie KJ, 2013, ANN INTERN MED, V158, P557, DOI 10.7326/0003-4819-158-7-201304020-00593; Moriates C, 2013, JAMA INTERN MED, V173, P308, DOI 10.1001/jamainternmed.2013.2286; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Post J, 2013, AM J MED, V126, P838, DOI 10.1016/j.amjmed.2013.05.015; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; Wallenstein J, 2010, ACAD EMERG MED, V17, pS67, DOI 10.1111/j.1553-2712.2010.00894.x; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007	15	11	11	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					733	U187		10.7326/M14-0444	http://dx.doi.org/10.7326/M14-0444			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25321871				2022-12-28	WOS:000347245600030
J	Durdu, S; Iskar, M; Revenu, C; Schieber, N; Kunze, A; Bork, P; Schwab, Y; Gilmour, D				Durdu, Sevi; Iskar, Murat; Revenu, Celine; Schieber, Nicole; Kunze, Andreas; Bork, Peer; Schwab, Yannick; Gilmour, Darren			Luminal signalling links cell communication to tissue architecture during organogenesis	NATURE			English	Article							LUMEN FORMATION; FGF; MIGRATION; MORPHOGENESIS; MECHANISM; DYNAMICS	Morphogenesis is the process whereby cell collectives are shaped into differentiated tissues and organs(1). The self-organizing nature of morphogenesis has been recently demonstrated by studies showing that stem cells in three-dimensional culture can generate complex organoids, such as mini-guts(2), optic-cups(3) and even mini-brains(4). To achieve this, cell collectives must regulate the activity of secreted signalling molecules that control cell differentiation, presumably through the self-assembly of microenvironments or niches. However, mechanisms that allow changes in tissue architecture to feedback directly on the activity of extracellular signals have not been described. Here we investigate how the process of tissue assembly controls signalling activity during organogenesis in vivo, using the migrating zebrafish lateral line primordium(5). We show that fibroblast growth factor (FGF) activity within the tissue controls the frequency at which it deposits rosette-like mechanosensory organs. Live imaging reveals that FGF becomes specifically concentrated in microluminal structures that assemble at the centre of these organs and spatially constrain its signalling activity. Genetic inhibition of microlumen assembly and laser micropuncture experiments demonstrate that microlumina increase signalling responses in participating cells, thus allowing FGF to coordinate the migratory behaviour of cell groups at the tissue rear. As the formation of a central lumen is a self-organizing property of many cell types, such as epithelia(6) and embryonic stem cells(7), luminal signalling provides a potentially general mechanism to locally restrict, coordinate and enhance cell communication within tissues.	[Durdu, Sevi; Iskar, Murat; Revenu, Celine; Schieber, Nicole; Kunze, Andreas; Bork, Peer; Schwab, Yannick; Gilmour, Darren] European Mol Biol Lab Heidelberg, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Gilmour, D (corresponding author), European Mol Biol Lab Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gilmour@embl.de	Bork, Peer/F-1813-2013	Bork, Peer/0000-0002-2627-833X; Schwab, Yannick/0000-0001-8027-1836; Schieber, Nicole L./0000-0002-3212-5057; Gilmour, Darren/0000-0001-7613-090X; Durdu, Sevi/0000-0001-9746-6779; Iskar, Murat/0000-0001-8603-4313; Kunze, Andreas/0000-0002-4955-1052; Revenu des Courtils, Celine/0000-0003-3697-3739; Iskar, Murat/0000-0001-6448-8779	European Molecular Biology Organization; EMBL Interdisciplinary Postdocs (EIPOD); Deutsche Forschungsgemeinschaft [SFB 488]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EMBL Interdisciplinary Postdocs (EIPOD); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to J. Ellenberg, S. de Renzis and F. Peri for suggestions and comments on the manuscript, A. Aulehla for advice about timing, and E. Karsenti and the Gilmour laboratory for discussion. We thank M. Brand for advice about FGF tagging, the EMBL Advanced Light Microscopy Facility, in particular Y. Belyaev, for imaging assistance, the European Molecular Biology Laboratory (EMBL) Monoclonal Antibody (MACF) and Protein Expression Facilities for Fgfr1a antibody, K. Miura from the EMBL Centre for Cell and Molecular Imaging for advice with data analysis, E. Dona and T. Gregor for advice with the smFISH protocol, and A. Gruia for fish care. We acknowledge funding from the European Molecular Biology Organization and EMBL Interdisciplinary Postdocs (EIPOD) (to C. R.) and the Deutsche Forschungsgemeinschaft SFB 488 (to D.G.).	Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bokel C., 2014, COLD SPRING HARB PER, V6; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eklund A., beeswarm: the bee swarm plot, an alternative to stripchart; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Ernst S, 2012, DEVELOPMENT, V139, P4571, DOI 10.1242/dev.083253; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kolotuev I, 2010, BIOL CELL, V102, P121, DOI 10.1042/BC20090096; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Kwon HJ, 2009, DEV DYNAM, V238, P1582, DOI 10.1002/dvdy.21955; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morhac M., 2012, PEAKS PEAKS R PACKAG; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Revenu C, 2014, DEVELOPMENT, V141, P1282, DOI 10.1242/dev.101675; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Wand M., 1995, KERNSMOOTH FUNCTIONS; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938; Westerfield M, 2007, ZEBRAFISH BOOK; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	42	99	100	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					120	+		10.1038/nature13852	http://dx.doi.org/10.1038/nature13852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25337877				2022-12-28	WOS:000344187500042
J	Sarafian, AR; Nielsen, SG; Marschall, HR; McCubbin, FM; Monteleone, BD				Sarafian, Adam R.; Nielsen, Sune G.; Marschall, Horst R.; McCubbin, Francis M.; Monteleone, Brian D.			Early accretion of water in the inner solar system from a carbonaceous chondrite-like source	SCIENCE			English	Article							U-PB; HYDROGEN; DELIVERY; HISTORY; SURFACE; ZIRCONS; ORIGIN; OXYGEN; VESTA	Determining the origin of water and the timing of its accretion within the inner solar system is important for understanding the dynamics of planet formation. The timing of water accretion to the inner solar system also has implications for how and when life emerged on Earth. We report in situ measurements of the hydrogen isotopic composition of the mineral apatite in eucrite meteorites, whose parent body is the main-belt asteroid 4 Vesta. These measurements sample one of the oldest hydrogen reservoirs in the solar system and show that Vesta contains the same hydrogen isotopic composition as that of carbonaceous chondrites. Taking into account the old ages of eucrite meteorites and their similarity to Earth's isotopic ratios of hydrogen, carbon, and nitrogen, we demonstrate that these volatiles could have been added early to Earth, rather than gained during a late accretion event.	[Sarafian, Adam R.; Nielsen, Sune G.; Marschall, Horst R.; Monteleone, Brian D.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Marschall, Horst R.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Marschall, Horst R.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [McCubbin, Francis M.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA	Woods Hole Oceanographic Institution; American Museum of Natural History (AMNH); University of Bristol; University of New Mexico	Sarafian, AR (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	asarafian@whoi.edu	Marschall, Horst/E-1661-2011; McCubbin, Francis/AAG-1095-2020; Nielsen, Sune/P-3983-2019; Facility, NENIMF/B-8811-2015	Marschall, Horst/0000-0002-0609-682X; Nielsen, Sune/0000-0002-0458-3739; 	NASA [NNX13AR90H]; Andrew W. Mellon Foundation Award for Innovative Research; NASA Cosmochemistry Program [NNX11AG76G]; NSF Instrumentation and Facilities Program, Division of Earth Sciences; WHOI	NASA(National Aeronautics & Space Administration (NASA)); Andrew W. Mellon Foundation Award for Innovative Research; NASA Cosmochemistry Program(National Aeronautics & Space Administration (NASA)); NSF Instrumentation and Facilities Program, Division of Earth Sciences(National Science Foundation (NSF)); WHOI	We thank the anonymous reviewers; K. Righter, D. Ebel, C. Agee, and T. McCoy for sample allocations; and N. Shimizu and G. Gaetani for their immense help. Supported by NASA graduate fellowship NNX13AR90H (A. R. S.), an Andrew W. Mellon Foundation Award for Innovative Research (S. G. N.), and NASA Cosmochemistry Program award NNX11AG76G (F. M. M.). Secondary ion mass spectrometry analyses were made at the Northeast National Ion Microprobe Facility (NENIMF) at the Woods Hole Oceanographic Institution (WHOI). NENIMF acknowledges support from the NSF Instrumentation and Facilities Program, Division of Earth Sciences, and from WHOI. Data are presented in the main text of the manuscript and the supplementary materials.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; CAMPBELL IH, 1983, GEOPHYS RES LETT, V10, P1061, DOI 10.1029/GL010i011p01061; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; Chacko T, 2001, REV MINERAL GEOCHEM, V43, P1, DOI 10.2138/gsrmg.43.1.1; CLAYTON RN, 1976, EARTH PLANET SC LETT, V30, P10, DOI 10.1016/0012-821X(76)90003-0; Hallis LJ, 2012, EARTH PLANET SC LETT, V359, P84, DOI 10.1016/j.epsl.2012.09.049; King HE, 2010, EARTH PLANET SC LETT, V300, P11, DOI 10.1016/j.epsl.2010.10.019; Lucey P, 2006, REV MINERAL GEOCHEM, V60, P83, DOI 10.2138/rmg.2006.60.2; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween Jr HY, 2012, DAWN MISSION MINOR P, P141; Misawa K, 2005, GEOCHIM COSMOCHIM AC, V69, P5847, DOI 10.1016/j.gca.2005.08.009; Miura Y., 1993, ANTARCTIC METEOR RES, V6, P338; Papike J. J., 1998, REV MINERAL, V43, P7; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Saal AE, 2013, SCIENCE, V340, P1317, DOI 10.1126/science.1235142; Sarafian AR, 2013, METEORIT PLANET SCI, V48, P2135, DOI 10.1111/maps.12124; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Sharp ZD, 2013, EARTH PLANET SC LETT, V380, P88, DOI 10.1016/j.epsl.2013.08.015; Tartese R, 2014, GEOLOGY, V42, P363, DOI 10.1130/G35288.1; Zhou Q, 2013, GEOCHIM COSMOCHIM AC, V110, P152, DOI 10.1016/j.gca.2013.02.016	25	91	93	6	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		623	626		10.1126/science.1256717	http://dx.doi.org/10.1126/science.1256717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359971				2022-12-28	WOS:000343799700046
J	Sokol, DK				Sokol, Daniel K.			Defending the sophisticated consent attack What can doctors do to protect themselves against allegations that they failed when obtaining consent to ensure that the patient understood information?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									12 Kings Bench Walk, London, England		Sokol, DK (corresponding author), 12 Kings Bench Walk, London, England.	daniel.sokol@talk21.com						General Medical Council, CONS GUID DISC SID E	1	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2014	349								g6432	10.1136/bmj.g6432	http://dx.doi.org/10.1136/bmj.g6432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DB	25351423				2022-12-28	WOS:000344155300005
J	Chen, BC; Legant, WR; Wang, K; Shao, L; Milkie, DE; Davidson, MW; Janetopoulos, C; Wu, XFS; Hammer, JA; Liu, Z; English, BP; Mimori-Kiyosue, Y; Romero, DP; Ritter, AT; Lippincott-Schwartz, J; Fritz-Laylin, L; Mullins, RD; Mitchell, DM; Bembenek, JN; Reymann, AC; Bohme, R; Grill, SW; Wang, JT; Seydoux, G; Tulu, US; Kiehart, DP; Betzig, E				Chen, Bi-Chang; Legant, Wesley R.; Wang, Kai; Shao, Lin; Milkie, Daniel E.; Davidson, Michael W.; Janetopoulos, Chris; Wu, Xufeng S.; Hammer, John A., III; Liu, Zhe; English, Brian P.; Mimori-Kiyosue, Yuko; Romero, Daniel P.; Ritter, Alex T.; Lippincott-Schwartz, Jennifer; Fritz-Laylin, Lillian; Mullins, R. Dyche; Mitchell, Diana M.; Bembenek, Joshua N.; Reymann, Anne-Cecile; Boehme, Ralph; Grill, Stephan W.; Wang, Jennifer T.; Seydoux, Geraldine; Tulu, U. Serdar; Kiehart, Daniel P.; Betzig, Eric			Lattice light-sheet microscopy: Imaging molecules to embryos at high spatiotemporal resolution	SCIENCE			English	Article							FLUORESCENCE MICROSCOPY; HIGH-SPEED; DYNAMICS; CELLS; PROTEIN; ORGANIZATION; CYTOKINESIS; STRATEGIES; MIGRATION; TRACKING	Although fluorescence microscopy provides a crucial window into the physiology of living specimens, many biological processes are too fragile, are too small, or occur too rapidly to see clearly with existing tools. We crafted ultrathin light sheets from two-dimensional optical lattices that allowed us to image three-dimensional (3D) dynamics for hundreds of volumes, often at subsecond intervals, at the diffraction limit and beyond. We applied this to systems spanning four orders of magnitude in space and time, including the diffusion of single transcription factor molecules in stem cell spheroids, the dynamic instability of mitotic microtubules, the immunological synapse, neutrophil motility in a 3D matrix, and embryogenesis in Caenorhabditis elegans and Drosophila melanogaster. The results provide a visceral reminder of the beauty and the complexity of living systems.	[Chen, Bi-Chang; Legant, Wesley R.; Wang, Kai; Shao, Lin; Liu, Zhe; English, Brian P.; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Milkie, Daniel E.] Coleman Technol Inc, Newtown Sq, PA 19073 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Janetopoulos, Chris] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA; [Wu, Xufeng S.; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Mimori-Kiyosue, Yuko] RIKEN Ctr Dev Biol, Opt Image Anal Unit, Kobe, Hyogo 6500047, Japan; [Romero, Daniel P.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Ritter, Alex T.; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Ritter, Alex T.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Fritz-Laylin, Lillian; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Mitchell, Diana M.; Bembenek, Joshua N.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Reymann, Anne-Cecile; Boehme, Ralph; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Reymann, Anne-Cecile; Boehme, Ralph; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01307 Dresden, Germany; [Wang, Jennifer T.; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Tulu, U. Serdar; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Howard Hughes Medical Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); RIKEN; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Knoxville; Max Planck Society; Max Planck Society; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Duke University	Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	betzige@janelia.hhmi.org	SEYDOUX, Geraldine/AAA-2005-2020; Chen, Bi-Chang/F-3480-2014; Mimori-Kiyosue, Yuko/K-9158-2015; English, Brian P/O-8156-2016; Grill, Stephan/D-9427-2012	Chen, Bi-Chang/0000-0002-1876-7432; Mimori-Kiyosue, Yuko/0000-0003-3513-9072; English, Brian P/0000-0002-4037-6294; Bembenek, Joshua/0000-0002-0966-2268; Seydoux, Geraldine/0000-0001-8257-0493; Wang, Kai/0000-0001-7858-944X; Fritz-Laylin, Lillian/0000-0002-9237-9403; Reymann, Anne-Cecile/0000-0002-0517-5083; Wang, Jennifer/0000-0002-8506-5182	Howard Hughes Medical Institute (HHMI); Janelia Visitor Program; NIH [R01GM080370, RM01-GM61010, R01HD37047, GM033830]; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; Japan Society for the Promotion of Science-NEXT program [LS128]; Uehara Memorial Foundation; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; RIKEN Center for Developmental Biology; HHMI; Human Frontier Science Program [LT000926/2012]; European Research Council [281903]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047, ZIAHD008850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL000514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080370, R01GM061010, T32GM007445, R01GM033830] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Janelia Visitor Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japan Society for the Promotion of Science-NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; RIKEN Center for Developmental Biology; HHMI(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Gao, now at Stony Brook University, for technical expertise; the Shared Resource teams at Janelia for their skill and dedication in specimen handling and preparation; and the Instrument Design and Fabrication team for their manufacturing expertise. B.-C.C., W.R.L., K.W., L.S., Z.L., B.P.E., and E.B. are funded by the Howard Hughes Medical Institute (HHMI). We also gratefully acknowledge the support of the Janelia Visitor Program. C.J. is supported by NIH grant R01GM080370. X.S.W. and J.A.H. are funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH. Y.M.-K. is supported by the Japan Society for the Promotion of Science-NEXT program LS128, the Uehara Memorial Foundation, the Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, and an intramural grant from the RIKEN Center for Developmental Biology. A.T.R. and J.L.S. acknowledge G. M. Griffiths of the University of Cambridge as the doctoral cosupervisor of A. T. R., who provided technical expertise with CTL experiments. These experiments are a collaboration with GMG. L.F.L. and R.D.M. were supported by NIH grant RM01-GM61010 and HHMI. A.-C. R. is supported by the Human Frontier Science Program LT000926/2012. S.W.G. acknowledges support from the European Research Council starting grant 281903. J.T.W. and G.S. are supported by NIH R01HD37047. G.S. is also an HHMI Investigator. U.S.T. and D.P.K. are supported by NIH grant GM033830. All data in the manuscript are available upon request. Researchers can apply to access the microscope as visitors through the Advanced Imaging Center at Janelia Farm (www.janelia.org/aic). Documentation for the construction of a copy of the microscope is available after execution of a research license with HHMI. Portions of the technology described herein are covered by U.S. Patent 7,894,136 issued to E.B. and assigned to Lattice Light, LLC of Ashburn, VA; U.S. Patent 8,711,211 issued to E.B. and assigned to HHMI; and U.S. Patent application 13/844,405 filed by E.B. and K.W. and assigned to HHMI.	Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bembenek JN, 2013, CURR BIOL, V23, P937, DOI 10.1016/j.cub.2013.04.028; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2005, OPT EXPRESS, V13, P3021, DOI 10.1364/OPEX.13.003021; Betzig E, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.063406; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Coelho M, 2013, INTEGR BIOL-UK, V5, P748, DOI 10.1039/c3ib40018b; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Dormann D, 2006, EMBO J, V25, P3480, DOI 10.1038/sj.emboj.7601227; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Graf R, 2005, ADV BIOCHEM ENG BIOT, V95, P57, DOI 10.1007/b102210; Grill SW, 2011, CURR OPIN GENET DEV, V21, P647, DOI 10.1016/j.gde.2011.09.005; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Khodjakov A, 2006, METHODS, V38, P2, DOI 10.1016/j.ymeth.2005.07.007; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Murphy D. B., 2013, FUNDAMENTALS OF LIGH; PETSAS KI, 1994, PHYS REV A, V50, P5173, DOI 10.1103/PhysRevA.50.5173; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Ritter AT, 2013, IMMUNOL REV, V256, P107, DOI 10.1111/imr.12117; Ritter JG, 2008, OPT EXPRESS, V16, P7142, DOI 10.1364/OE.16.007142; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Sokolow A, 2012, BIOPHYS J, V102, P969, DOI 10.1016/j.bpj.2012.01.027; Speidel M, 2003, OPT LETT, V28, P69, DOI 10.1364/OL.28.000069; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tikhonenko I, 2009, EUKARYOT CELL, V8, P723, DOI 10.1128/EC.00018-09; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Wloga D, 2012, METHOD CELL BIOL, V109, P83, DOI 10.1016/B978-0-12-385967-9.00005-0; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	58	1066	1103	62	732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					439	+	1257998	10.1126/science.1257998	http://dx.doi.org/10.1126/science.1257998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YT	25342811	Green Accepted			2022-12-28	WOS:000349773700002
J	Davis, SJ; Shearer, C				Davis, Steven J.; Shearer, Christine			A crack in the natural-gas bridge	NATURE			English	Editorial Material									[Davis, Steven J.; Shearer, Christine] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Davis, SJ (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	sjdavis@uci.edu; cesheare@uci.edu	Davis, Steven/Y-2838-2019; Davis, Steven J/F-9968-2010	Davis, Steven/0000-0002-9338-0844; Davis, Steven J/0000-0002-9338-0844; Shearer, Christine/0000-0002-6003-7310				AUSUBEL JH, 1988, CLIMATIC CHANGE, V12, P245, DOI 10.1007/BF00139432; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Channell J, 2012, SHALE RENEWABLES SYM; Davis SJ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084018; Huntington H., 2013, EMF26 CHANGING GAME; International Energy Agency, 2012, GOLD RUL GOLD AG GAS; McJeon H, 2014, NATURE, V514, P482, DOI 10.1038/nature13837; Newell RG, 2014, ENVIRON SCI TECHNOL, V48, P8360, DOI 10.1021/es4046154; Podesta J., 2009, NATURAL GAS BRIDGE F; Shearer C, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/094008	10	21	21	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					436	437		10.1038/nature13927	http://dx.doi.org/10.1038/nature13927			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25317563				2022-12-28	WOS:000343775900024
J	Richeldi, L; du Bois, RM; Raghu, G				Richeldi, L.; du Bois, R. M.; Raghu, G.			Nintedanib reduced decline in FVC in idiopathic pulmonary fibrosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Richeldi, L.] Univ Hosp Southamptom NHS Fdn Trust, Southampton, Hants, England		Richeldi, L (corresponding author), Univ Hosp Southamptom NHS Fdn Trust, Southampton, Hants, England.	l.richeldi@soton.ac.uk	Richeldi, Luca/B-6243-2019; Richeldi, Luca/ABF-2486-2020	Richeldi, Luca/0000-0001-8594-1448					0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC5	10.7326/0003-4819-161-8-201410210-02005	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329222				2022-12-28	WOS:000343906800004
J	Tian, H; DeLuca, EE; Cranmer, SR; De Pontieu, B; Peter, H; Martinez-Sykora, J; Golub, L; McKillop, S; Reeves, KK; Miralles, MP; McCauley, P; Saar, S; Testa, P; Weber, M; Murphy, N; Lemen, J; Title, A; Boerner, P; Hurlburt, N; Tarbell, TD; Wuelser, JP; Kleint, L; Kankelborg, C; Jaeggli, S; Carlsson, M; Hansteen, V; McIntosh, SW				Tian, H.; DeLuca, E. E.; Cranmer, S. R.; De Pontieu, B.; Peter, H.; Martinez-Sykora, J.; Golub, L.; McKillop, S.; Reeves, K. K.; Miralles, M. P.; McCauley, P.; Saar, S.; Testa, P.; Weber, M.; Murphy, N.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Kleint, L.; Kankelborg, C.; Jaeggli, S.; Carlsson, M.; Hansteen, V.; McIntosh, S. W.			Prevalence of small-scale jets from the networks of the solar transition region and chromosphere	SCIENCE			English	Article							ALFVENIC WAVES; II SPICULES; WIND; CORONA; ENERGY; RECONNECTION; ORIGIN; SUMER; POWER	As the interface between the Sun's photosphere and corona, the chromosphere and transition region play a key role in the formation and acceleration of the solar wind. Observations from the Interface Region Imaging Spectrograph reveal the prevalence of intermittent small-scale jets with speeds of 80 to 250 kilometers per second from the narrow bright network lanes of this interface region. These jets have lifetimes of 20 to 80 seconds and widths of = 300 kilometers. They originate from small-scale bright regions, often preceded by footpoint brightenings and accompanied by transverse waves with amplitudes of similar to 20 kilometers per second. Many jets reach temperatures of at least similar to 10(5) kelvin and constitute an important element of the transition region structures. They are likely an intermittent but persistent source of mass and energy for the solar wind.	[Tian, H.; DeLuca, E. E.; Cranmer, S. R.; Golub, L.; McKillop, S.; Reeves, K. K.; Miralles, M. P.; McCauley, P.; Saar, S.; Testa, P.; Weber, M.; Murphy, N.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [De Pontieu, B.; Martinez-Sykora, J.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Kleint, L.] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [Peter, H.] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany; [Martinez-Sykora, J.; Kleint, L.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Kankelborg, C.; Jaeggli, S.] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA; [Carlsson, M.; Hansteen, V.] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; [McIntosh, S. W.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Lockheed Martin; Max Planck Society; Montana State University System; Montana State University Bozeman; University of Oslo; National Center Atmospheric Research (NCAR) - USA	Tian, H (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	hui.tian@cfa.harvard.edu	McCauley, Patrick/P-7747-2015; Reeves, Katharine/P-9163-2014	McCauley, Patrick/0000-0002-1450-7350; Golub, Leon/0000-0001-9638-3082; Murphy, Nicholas/0000-0001-6628-8033; Tian, Hui/0000-0002-1369-1758; Reeves, Katharine/0000-0002-6903-6832	Norwegian Space Center (Norway) through European Space Agency PRODEX; NASA [NNG09FA40C, NNX11AO98G]; Lockheed Martin Independent Research Program; European Research Council from LMSAL [291058, 8100002705]; Div Atmospheric & Geospace Sciences [1540094] Funding Source: National Science Foundation	Norwegian Space Center (Norway) through European Space Agency PRODEX; NASA(National Aeronautics & Space Administration (NASA)); Lockheed Martin Independent Research Program; European Research Council from LMSAL; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	IRIS is a NASA Small Explorer mission developed and operated by the Lockheed Martin Solar and Astrophysics Laboratory (LMSAL), with mission operations executed at the NASA Ames Research Center and major contributions to downlink communications funded by the Norwegian Space Center (Norway) through a European Space Agency PRODEX contract. This work is supported by NASA contract NNG09FA40C (IRIS), the Lockheed Martin Independent Research Program, European Research Council grant agreement no. 291058, contract 8100002705 from LMSAL to the Smithsonian Astrophysical Observatory, and NASA grant NNX11AO98G. The publicly available IRIS data (including the data used in this study) are archived at http://iris.lmsal.com/data.html.	Archontis V, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913752; Chae J, 1998, ASTROPHYS J, V505, P957, DOI 10.1086/306179; Chandran BDG, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/197; Cranmer SR, 2010, ASTROPHYS J, V720, P824, DOI 10.1088/0004-637X/720/1/824; Cranmer SR, 2009, LIVING REV SOL PHYS, V6, DOI 10.12942/lrsp-2009-3; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; De Pontieu B, 2014, SCIENCE, V346, DOI 10.1126/science.1255732; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; De Pontieu B, 2011, SCIENCE, V331, P55, DOI 10.1126/science.1197738; De Pontieu B, 2007, PUBL ASTRON SOC JPN, V59, pS655, DOI 10.1093/pasj/59.sp3.S655; De Pontieu B, 2010, ASTROPHYS J, V722, P1013, DOI 10.1088/0004-637X/722/2/1013; De Pontieu B, 2009, ASTROPHYS J LETT, V701, pL1, DOI 10.1088/0004-637X/701/1/L1; Goodman ML, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/87; Hahn M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/36; HAMMER R, 1982, ASTROPHYS J, V259, P767, DOI 10.1086/160213; Hansteen VH, 2012, SPACE SCI REV, V172, P89, DOI 10.1007/s11214-012-9887-z; Hassler DM, 1999, SCIENCE, V283, P810, DOI 10.1126/science.283.5403.810; Ji HS, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L25; Martinez-Sykora J, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/9; Matsumoto T, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/8; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; McIntosh SW, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/7; Pereira TMD, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/18; REEVES EM, 1976, SOL PHYS, V46, P53, DOI 10.1007/BF00157554; Shibata K, 2007, SCIENCE, V318, P1591, DOI 10.1126/science.1146708; Tu CY, 2005, SCIENCE, V308, P519, DOI 10.1126/science.1109447; van Ballegooijen AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/3; van der Voort LR, 2009, ASTROPHYS J, V705, P272, DOI 10.1088/0004-637X/705/1/272; Wilhelm K, 1995, SOL PHYS, V162, P189, DOI 10.1007/BF00733430; Yang LP, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/6; Zhang YZ, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/16	31	193	199	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207							1255711	10.1126/science.1255711	http://dx.doi.org/10.1126/science.1255711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324395	Green Submitted			2022-12-28	WOS:000343041100031
J	Johnson, RW; Rice, ASC				Johnson, Robert W.; Rice, Andrew S. C.			Postherpetic Neuralgia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROPATHIC PAIN; HERPES-ZOSTER; INTRATHECAL METHYLPREDNISOLONE; PHARMACOLOGICAL MANAGEMENT; DOUBLE-BLIND; PLACEBO; GUIDELINES; ACYCLOVIR; THERAPY; EFFICACY	A 73-year-old woman presents with persistent pain and itching in the right T10 dermatome from just above the thoracolumbar junction to the umbilicus since a documented episode of herpes zoster in the same region 1 year earlier. She describes a severe, continuous "burning" pain, unpredictable paroxysms of lancinating pain lasting a few seconds, and intense hypersensitivity to light tactile stimulation, such as clothing brushing against the skin. On physical examination, there are signs of cutaneous scarring throughout the right T10 dermatome, with areas of excoriation caused by scratching. She has patchy loss of tactile perception in this distribution as well as areas of pain provoked by a light brush. Acetaminophen did not help her pain. How would you manage this patient's condition?	[Johnson, Robert W.] Univ Bristol, Bristol Royal Infirm, Bristol, Avon, England; [Johnson, Robert W.] Univ Bristol, Dept Clin Sci, Bristol, Avon, England; [Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, London, England; [Rice, Andrew S. C.] Chelsea & Westminster Hosp NHS Fdn Trust, London, England	Bristol Royal Infirmary; University of Bristol; University of Bristol; Imperial College London; Imperial College London	Johnson, RW (corresponding author), Univ Bristol, Bristol Royal Infirm, Bristol, Avon, England.	rwjbristol@doctors.org.uk; a.rice@imperial.ac.uk			Sanofi Pasteur Merck; GlaxoSmith-Kline; Merck Frosst Canada; Merck; Pfizer; Astellas Pharma through the EuroPain Private-Public Partnership under the European Union Innovative Medicines Initiative Joint Undertaking; Pfizer through the London Pain Consortium; Spinifex Pharmaceuticals; Medivir; Astellas Pharma; Relmada Therapeutics; Asahi Kasei; Nektar Therapeutics through Imperial College Consultants	Sanofi Pasteur Merck; GlaxoSmith-Kline(GlaxoSmithKline); Merck Frosst Canada; Merck(Merck & Company); Pfizer(Pfizer); Astellas Pharma through the EuroPain Private-Public Partnership under the European Union Innovative Medicines Initiative Joint Undertaking; Pfizer through the London Pain Consortium; Spinifex Pharmaceuticals; Medivir; Astellas Pharma(Astellas Pharmaceuticals); Relmada Therapeutics; Asahi Kasei(Asahi Kasei Corporation); Nektar Therapeutics through Imperial College Consultants	Dr. Johnson reports receiving consulting fees and lecture fees from Sanofi Pasteur Merck, consulting fees from GlaxoSmith-Kline, and lecture fees from Merck Frosst Canada and Merck. Dr. Rice reports receiving grant support from Pfizer and Astellas Pharma through the EuroPain Private-Public Partnership under the European Union Innovative Medicines Initiative Joint Undertaking and from Pfizer through the London Pain Consortium, share options from Spinifex Pharmaceuticals, and consulting and advisory-board fees from Spinifex Pharmaceuticals, Medivir, Astellas Pharma, Relmada Therapeutics, Asahi Kasei, and Nektar Therapeutics through Imperial College Consultants. In addition, Dr. Rice reports having a patent pending related to methods using N-(2-propenyl) hexadecanamide and related amides to relieve pain (WO 2005/079771), licensed to Imperial Innovations. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2013, NEUR PHARM MAN PHARM; Attal N, 2006, EUR J NEUROL, V13, P1153, DOI 10.1111/j.1468-1331.2006.01511.x; BALFOUR HH, 1988, AM J MED, V85, P68; Ballantyne JC, 2013, PAIN, V1; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Binder A, 2009, CLIN DRUG INVEST, V29, P393, DOI 10.2165/00044011-200929060-00003; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Coplan PM, 2004, J PAIN, V5, P344, DOI 10.1016/j.jpain.2004.06.001; Daniel HC, 2008, EUR J PAIN, V12, P731, DOI 10.1016/j.ejpain.2007.11.006; Demant DT, 2014, PAIN, V155, P2263, DOI 10.1016/j.pain.2014.08.014; DERRY S, 2013, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD007393.PUB3, 10.1002/14651858.CD007393.pub3]; Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010111; Drolet M, 2010, J PAIN, V11, P1211, DOI 10.1016/j.jpain.2010.02.020; Drolet M, 2010, CLIN J PAIN, V26, P656, DOI 10.1097/AJP.0b013e3181eef686; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; Dworkin RH, 2010, PAIN, V150, P12, DOI 10.1016/j.pain.2010.02.002; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Fields HL, 1998, NEUROBIOL DIS, V5, P209, DOI 10.1006/nbdi.1998.0204; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Haanpaa ML, 2009, AM J MED, V122, pS13, DOI 10.1016/j.amjmed.2009.04.006; Hempenstall K, 2005, PLOS MED, V2, P628, DOI 10.1371/journal.pmed.0020164; Insinga RP, 2005, J GEN INTERN MED, V20, P748, DOI 10.1111/j.1525-1497.2005.0150.x; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; LEWITH GT, 1983, PAIN, V17, P361, DOI 10.1016/0304-3959(83)90167-7; McNicol ED, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146.pub2; Moore R Andrew, 2014, Cochrane Database Syst Rev, pCD007938, DOI 10.1002/14651858.CD007938.pub3; Moore RA, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008242.PUB2; Moulin DE, 2007, PAIN RES MANAG, V12, P13; Nelson DA, 2001, NEW ENGL J MED, V344, P1019; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Petersen KL, 2007, PAIN, V131, P214, DOI 10.1016/j.pain.2007.03.004; Rijsdijk M, 2013, EUR J PAIN, V17, P714, DOI 10.1002/j.1532-2149.2012.00233.x; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Schmader KE, 2010, MAYO CLIN PROC, V85, pS26, DOI 10.4065/mcp.2009.0646; Stannard C., 2010, OPIOIDS PERSISTENT P; Thomas BM, 2013, THER CLIN RISK MANAG, V9, P469, DOI 10.2147/TCRM.S50212; van Wijck AJM, 2006, LANCET, V367, P219, DOI 10.1016/S0140-6736(06)68032-X; Vo T, 2009, PAIN, V143, P169, DOI 10.1016/j.pain.2009.03.013; WATSON CPN, 1991, PAIN, V44, P105, DOI 10.1016/0304-3959(91)90124-G; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; Wiffen PJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010567.pub2; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341	49	253	291	9	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1526	1533		10.1056/NEJMcp1403062	http://dx.doi.org/10.1056/NEJMcp1403062			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317872				2022-12-28	WOS:000342994700009
J	Stewart, L				Stewart, Lorna			Will you still need me, will you still feed me?	NATURE			English	Editorial Material																		Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269	4	6	6	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					S14	S15		10.1038/514S14a	http://dx.doi.org/10.1038/514S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25317591	Bronze			2022-12-28	WOS:000342988600009
J	Zhang, JJ; Fujimoto, J; Zhang, JH; Wedge, DC; Song, XZ; Zhang, JX; Seth, S; Chow, CW; Cao, Y; Gumbs, C; Gold, KA; Kalhor, N; Little, L; Mahadeshwar, H; Moran, C; Protopopov, A; Sun, HD; Tang, JB; Wu, XF; Ye, YQ; William, WN; Lee, JJ; Heymach, JV; Hong, WK; Swisher, S; Wistuba, II; Futreal, A				Zhang, Jianjun; Fujimoto, Junya; Zhang, Jianhua; Wedge, David C.; Song, Xingzhi; Zhang, Jiexin; Seth, Sahil; Chow, Chi-Wan; Cao, Yu; Gumbs, Curtis; Gold, Kathryn A.; Kalhor, Neda; Little, Latasha; Mahadeshwar, Harshad; Moran, Cesar; Protopopov, Alexei; Sun, Huandong; Tang, Jiabin; Wu, Xifeng; Ye, Yuanqing; William, William N.; Lee, J. Jack; Heymach, John V.; Hong, Waun Ki; Swisher, Stephen; Wistuba, Ignacio I.; Futreal, Andrew			Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing	SCIENCE			English	Article							21 BREAST CANCERS; SOMATIC MUTATIONS; EVOLUTION; PATTERNS; GENOMES; SMOKERS	Cancers are composed of populations of cells with distinct molecular and phenotypic features, a phenomenon termed intratumor heterogeneity (ITH). ITH in lung cancers has not been well studied. We applied multiregion whole-exome sequencing (WES) on 11 localized lung adenocarcinomas. All tumors showed clear evidence of ITH. On average, 76% of all mutations and 20 out of 21 known cancer gene mutations were identified in all regions of individual tumors, which suggested that single-region sequencing may be adequate to identify the majority of known cancer gene mutations in localized lung adenocarcinomas. With a median follow-up of 21 months after surgery, three patients have relapsed, and all three patients had significantly larger fractions of subclonal mutations in their primary tumors than patients without relapse. These data indicate that a larger subclonal mutation fraction may be associated with increased likelihood of postsurgical relapse in patients with localized lung adenocarcinomas.	[Zhang, Jianjun; Cao, Yu; Gumbs, Curtis; Little, Latasha; Futreal, Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Zhang, Jianjun; Gold, Kathryn A.; William, William N.; Heymach, John V.; Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Fujimoto, Junya; Chow, Chi-Wan; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Zhang, Jianhua; Song, Xingzhi; Seth, Sahil; Mahadeshwar, Harshad; Protopopov, Alexei; Sun, Huandong; Tang, Jiabin] Univ Texas MD Anderson Canc Ctr, Appl Canc Sci Inst, Houston, TX 77030 USA; [Wedge, David C.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Zhang, Jiexin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Kalhor, Neda; Moran, Cesar] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wu, Xifeng; Ye, Yuanqing] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Swisher, Stephen] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Futreal, Andrew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Wellcome Trust Sanger Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Wellcome Trust Sanger Institute	Futreal, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	afutreal@mdanderson.org	Wedge, David/AAC-4977-2021; Lee, Jack/P-7331-2019; Zhang, Jianjun/AAH-1943-2020; Seth, Sahil/I-5809-2019; William, William/GRX-5352-2022; Heymach, John/AAG-2361-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019	Lee, Jack/0000-0002-4584-929X; Seth, Sahil/0000-0003-4579-3959; Heymach, John/0000-0001-9068-8942; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Wedge, David/0000-0002-7572-3196	Cancer Prevention and Research Institute of Texas [R120501]; University of Texas (UT) Systems Stars Award [PS100149]; Welch Foundation Robert A. Welch Distinguished University Chair Award [G-0040]; Department of Defense PROSPECT grant [W81XWH-07-1-0306]; UT Lung Specialized Programs of Research Excellence grant [P50CA70907]; MD Anderson Cancer Center Support grant [CA016672]; NIH [CA-009666]; MD Anderson Institutional Support for the Center for Translational and Public Health Genomics; A. Lavoy Moore Endowment Fund; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA016672, T32CA009666] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; University of Texas (UT) Systems Stars Award; Welch Foundation Robert A. Welch Distinguished University Chair Award; Department of Defense PROSPECT grant(United States Department of Defense); UT Lung Specialized Programs of Research Excellence grant; MD Anderson Cancer Center Support grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Institutional Support for the Center for Translational and Public Health Genomics; A. Lavoy Moore Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Cancer Prevention and Research Institute of Texas (R120501), the University of Texas (UT) Systems Stars Award (PS100149), the Welch Foundation Robert A. Welch Distinguished University Chair Award (G-0040), Department of Defense PROSPECT grant (W81XWH-07-1-0306), the UT Lung Specialized Programs of Research Excellence grant (P50CA70907), the MD Anderson Cancer Center Support grant (CA016672), NIH T32 Research Training in Academic Medical Oncology grant (CA-009666), the MD Anderson Institutional Support for the Center for Translational and Public Health Genomics, and the A. Lavoy Moore Endowment Fund. The authors thank L. Chin and R. Verhaak for constructive discussions. Sequence data have been deposited at the European Genome-phenome Archive (EGA, www.ebi.ac.uk/ega/), which is hosted by the European Bioinformatics Institute, under accession number EGAS00001000930.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; BULZEBRUCK H, 1992, CANCER-AM CANCER SOC, V70, P1102, DOI 10.1002/1097-0142(19920901)70:5<1102::AID-CNCR2820700514>3.0.CO;2-5; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Horswell S, 2013, CANCER LETT, V340, P220, DOI 10.1016/j.canlet.2012.10.031; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Swanton C, 2010, GENOME MED, V2, DOI 10.1186/gm174; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854	30	650	670	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					256	259		10.1126/science.1256930	http://dx.doi.org/10.1126/science.1256930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301631	Green Accepted			2022-12-28	WOS:000342721500053
J	Brydson, R				Brydson, Rik			MATERIALS ANALYSIS Good vibrations	NATURE			English	Editorial Material							SPECTROSCOPY		Univ Leeds, Inst Mat Res, Sch Chem & Proc Engn, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Brydson, R (corresponding author), Univ Leeds, Inst Mat Res, Sch Chem & Proc Engn, Leeds LS2 9JT, W Yorkshire, England.	r.m.drummond-brydson@leeds.ac.uk	Brydson, Rik/AAP-5531-2020	Drummond-Brydson, Richard/0000-0003-2003-7612	Engineering and Physical Sciences Research Council [EP/J021156/1] Funding Source: researchfish; EPSRC [EP/J021156/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bleloch A, 2011, ABERRATION CORRECTED, P55; Dwyer C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054103; Egerton R. F., 2011, ELECTRON ENERGY LOSS; Hermann P, 2011, ANALYST, V136, P1148, DOI 10.1039/c0an00531b; Krivanek OL, 2014, NATURE, V514, P209, DOI 10.1038/nature13870; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Krivanek OL, 2009, PHILOS T R SOC A, V367, P3683, DOI 10.1098/rsta.2009.0087; Mahan G. D., 2010, CONDENSED MATTER IN; Williams D.B., 2009, TRANSMISSION ELECT M, V32, P91	9	4	4	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					177	178		10.1038/514177a	http://dx.doi.org/10.1038/514177a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297431	Green Submitted			2022-12-28	WOS:000342663100030
J	Thill, Z; Abare, M; Fox, A				Thill, Zoey; Abare, Marce; Fox, Aaron			Thinking Outside the Box: Hospitals Promoting Employment for Formerly Incarcerated Persons	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Albert Einstein Coll Med, Bronx, NY 10467 USA; [Abare, Marce] Montefiore Med Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Abare, M (corresponding author), Montefiore Med Ctr, 111 East 210th St, Bronx, NY 10467 USA.	marce.abare@gmail.com						[Anonymous], 2013, SENT PROJ UN HUM RIG; Atkinson DV, 2011, BAN BOX FELLOW MEMBE; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Glaze L. E., 2013, BULLETIN; Henry Jessica S., 2007, CRIMINOL PUBLIC POL, V6, P755; National Employment Law Project, 2014, BAN BOX MAJ US CIT C; Pager D, 2003, AM J SOCIOL, V108, P937, DOI 10.1086/374403; Schnittker J, 2007, J HEALTH SOC BEHAV, V48, P115, DOI 10.1177/002214650704800202; Stoll Michael A., 2008, CRIMINOL PUBLIC POL, V7, P371, DOI DOI 10.1111/J.1745-9133.2008.00516.X	9	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					524	+		10.7326/M14-1674	http://dx.doi.org/10.7326/M14-1674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9LU	25285544				2022-12-28	WOS:000343896700013
J	Zhang, XQ; Bogunovic, D; Payelle-Brogard, B; Francois-Newton, V; Speer, SD; Yuan, C; Volpi, S; Li, Z; Sanal, O; Mansouri, D; Tezcan, I; Rice, GI; Chen, CY; Mansouri, N; Mahdaviani, SA; Itan, Y; Boisson, B; Okada, S; Zeng, L; Wang, X; Jiang, H; Liu, WQ; Han, TT; Liu, DL; Ma, T; Wang, B; Liu, MG; Liu, JY; Wang, QK; Yalnizoglu, D; Radoshevich, L; Uze, G; Gros, P; Rozenberg, F; Zhang, SY; Jouanguy, E; Bustamante, J; Garcia-Sastre, A; Abel, L; Lebon, P; Notarangelo, LD; Crow, YJ; Boisson-Dupuis, S; Casanova, JL; Pellegrini, S				Zhang, Xianqin; Bogunovic, Dusan; Payelle-Brogard, Beatrice; Francois-Newton, Veronique; Speer, Scott D.; Yuan, Chao; Volpi, Stefano; Li, Zhi; Sanal, Ozden; Mansouri, Davood; Tezcan, Ilhan; Rice, Gillian I.; Chen, Chunyuan; Mansouri, Nahal; Mahdaviani, Seyed Alireza; Itan, Yuval; Boisson, Bertrand; Okada, Satoshi; Zeng, Lu; Wang, Xing; Jiang, Hui; Liu, Wenqiang; Han, Tiantian; Liu, Delin; Ma, Tao; Wang, Bo; Liu, Mugen; Liu, Jing-Yu; Wang, Qing K.; Yalnizoglu, Dilek; Radoshevich, Lilliana; Uze, Gilles; Gros, Philippe; Rozenberg, Flore; Zhang, Shen-Ying; Jouanguy, Emmanuelle; Bustamante, Jacinta; Garcia-Sastre, Adolfo; Abel, Laurent; Lebon, Pierre; Notarangelo, Luigi D.; Crow, Yanick J.; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Pellegrini, Sandra			Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation	NATURE			English	Article							AICARDI-GOUTIERES SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BASAL GANGLIA CALCIFICATION; INTRACRANIAL CALCIFICATION; EXPRESSION SIGNATURE; GENE; MUTATIONS; IMMUNITY; AUTOIMMUNITY; PROTEOLYSIS	Intracellular ISG15 is an interferon (IFN)-alpha/beta-inducible ubiquitin-like modifier which can covalently bind other proteins in a process called ISGylation; it is an effector of IFN-alpha/beta-dependent antiviral immunity in mice(1-4). We previously published a study describing humans with inherited ISG15deficiency but without unusually severe viral diseases(5). We showed that these patients were prone to mycobacterial disease and that human ISG15 was non-redundant as an extracellular IFN-gamma-inducing molecule. We show here that ISG15-deficient patients also display unanticipated cellular, immunological and clinical signs of enhanced IFN-alpha/beta immunity, reminiscent of the Mendelian autoinflammatory interferonopathies Aicardi-Goutieres syndrome and spondyloenchondrodysplasia(6-9). We further show that an absence of intracellular ISG15 in the patients' cells prevents the accumulation of USP18(10,11), a potent negative regulator of IFN-alpha/beta signalling, resulting in the enhancement and amplification of IFN-alpha/beta responses. Human ISG15, therefore, is not only redundant for antiviral immunity, but is a key negative regulator of IFN-alpha/beta immunity. In humans, intracellular ISG15 is IFN-alpha/beta-inducible not to serve as a substrate for ISGylation-dependent antiviral immunity, but to ensure USP18-dependent regulation of IFN-alpha/beta and prevention of IFN-alpha/beta-dependent autoinflammation.	[Zhang, Xianqin; Yuan, Chao; Zeng, Lu; Wang, Xing; Liu, Wenqiang; Han, Tiantian; Ma, Tao; Liu, Mugen; Liu, Jing-Yu; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Bogunovic, Dusan; Itan, Yuval; Boisson, Bertrand; Okada, Satoshi; Zhang, Shen-Ying; Abel, Laurent; Boisson-Dupuis, Stephanie] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Bogunovic, Dusan; Speer, Scott D.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Payelle-Brogard, Beatrice; Francois-Newton, Veronique; Li, Zhi; Pellegrini, Sandra] Inst Pasteur, Cytokine Signaling Unit, CNRS URA 1961, F-75724 Paris, France; [Speer, Scott D.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Speer, Scott D.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Microbiol Training Area, New York, NY 10029 USA; [Volpi, Stefano; Notarangelo, Luigi D.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Volpi, Stefano] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy; [Sanal, Ozden; Tezcan, Ilhan; Yalnizoglu, Dilek] Hacettepe Univ, Childrens Hosp, Div Immunol, TR-06100 Ankara, Turkey; [Sanal, Ozden; Tezcan, Ilhan; Yalnizoglu, Dilek] Hacettepe Univ, Childrens Hosp, Pediat Neurol Dept, TR-06100 Ankara, Turkey; [Mansouri, Davood; Mansouri, Nahal; Mahdaviani, Seyed Alireza] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Pediat Resp Dis Res Ctr, Div Infect Dis & Clin Immunol, Tehran 4739, Iran; [Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Chen, Chunyuan] Cent S Univ, Xiangya Hosp 3, Dept Pediat, Changsha 410013, Hunan, Peoples R China; [Jiang, Hui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Liu, Delin] Sangzhi Cty Peoples Hosp, Sangzhi 427100, Peoples R China; [Wang, Bo] Hubei Maternal & Child Hlth Hosp, Genet Lab, Wuhan 430070, Peoples R China; [Wang, Qing K.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; [Radoshevich, Lilliana] Inst Pasteur, Bacteria Cell Interact Unit, F-75724 Paris, France; [Uze, Gilles] Univ Montpellier 2, CNRS UMR5235, F-34095 Montpellier, France; [Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ H3A 0G4, Canada; [Rozenberg, Flore; Lebon, Pierre] Paris Descartes Univ, F-75006 Paris, France; [Jouanguy, Emmanuelle; Bustamante, Jacinta; Abel, Laurent; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Jouanguy, Emmanuelle; Bustamante, Jacinta; Abel, Laurent; Crow, Yanick J.; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Bustamante, Jacinta] Necker Hosp Sick Children, Ctr Study Primary Immunodeficiencies, F-75015 Paris, France; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Crow, Yanick J.] Imagine Inst, Lab Neurogenet & Neuroinflammat, INSERM UMR 1163, F-75006 Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France	Huazhong University of Science & Technology; Rockefeller University; Icahn School of Medicine at Mount Sinai; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital; University of Genoa; Hacettepe University; Hacettepe University; Shahid Beheshti University Medical Sciences; University of Manchester; Central South University; Beijing Genomics Institute (BGI); Cleveland Clinic Foundation; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; McGill University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bogunovic, D (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	Dusan.Bogunovic@mssm.edu	Uzé, Gilles/O-6383-2019; mansouri, davood/G-6471-2017; Zhang, Shen-Ying/I-2685-2017; Jouanguy, Emmanuelle/H-7901-2017; Rozenberg, Flore/O-8854-2017; Pellegrini, Sandra/Y-6351-2019; Abel, Laurent/H-8888-2017; Boisson-Dupuis, Stéphanie/I-2040-2017; Boisson, Bertrand/AAC-6058-2019; Rice, Gillian I/G-3128-2015; mahdaviani, alireza/G-3256-2017; Notarangelo, Luigi D/F-9718-2016; LI, Zhi/Q-4790-2018; Bustamante, Jacinta/H-7877-2017; Boisson, Bertrand/I-2485-2017; Crow, Yanick J/N-6120-2014; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Pellegrini, Sandra -/G-5546-2015; Okada, Satoshi/B-8901-2011; Volpi, Stefano/O-3717-2014	mansouri, davood/0000-0002-0564-8282; Zhang, Shen-Ying/0000-0002-9449-3672; Jouanguy, Emmanuelle/0000-0002-7358-9157; Pellegrini, Sandra/0000-0001-5837-7589; Abel, Laurent/0000-0001-7016-6493; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Boisson, Bertrand/0000-0001-5240-3555; Rice, Gillian I/0000-0002-4223-0571; mahdaviani, alireza/0000-0001-6224-4797; Notarangelo, Luigi D/0000-0002-8335-0262; LI, Zhi/0000-0003-4422-4914; Bustamante, Jacinta/0000-0002-3439-2482; Boisson, Bertrand/0000-0001-5240-3555; Crow, Yanick J/0000-0001-7211-7564; Pellegrini, Sandra -/0000-0001-5837-7589; Okada, Satoshi/0000-0002-4622-5657; Volpi, Stefano/0000-0002-7129-868X; Uze, Gilles/0000-0002-4150-5772; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Radoshevich, Lilliana/0000-0003-0294-9300; Casanova, Jean-Laurent/0000-0002-7782-4169; Chao, Yuan/0000-0003-1315-0166; Wang, Qing/0000-0002-5639-8519	European Research Council [309449] Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000043, 8UL1TR000043] Funding Source: Medline; NIAID NIH HHS [U19 AI083025, R00 AI106942, U19AI083025, R01 AI035237, P01 AI076210, R00AI106942-02, P01AI090935, R37AI095983, R37 AI095983, P01 AI090935, 1P01AI076210-01A1] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI106942, U19AI083025, R37AI095983, P01AI090935, R01AI035237, P01AI076210] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bogunovic D, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.36; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Broering R, 2010, GUT, V59, P1111, DOI 10.1136/gut.2009.195545; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chua PK, 2009, J GEN VIROL, V90, P2929, DOI 10.1099/vir.0.013128-0; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; KENDALL B, 1986, NEURORADIOLOGY, V28, P324, DOI 10.1007/BF00333438; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Livingston JH, 2013, DEV MED CHILD NEUROL, V55, P46, DOI 10.1111/j.1469-8749.2012.04437.x; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Raymond AA, 1996, LUPUS, V5, P123, DOI 10.1177/096120339600500207; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Tokarz S, 2004, J BIOL CHEM, V279, P46424, DOI 10.1074/jbc.M403189200; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	31	316	325	0	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					89	U229		10.1038/nature13801	http://dx.doi.org/10.1038/nature13801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25307056	Green Accepted			2022-12-28	WOS:000347178400041
J	Velasco-Velez, JJ; Wu, CH; Pascal, TA; Wan, LWF; Guo, JH; Prendergast, D; Salmeron, M				Velasco-Velez, Juan-Jesus; Wu, Cheng Hao; Pascal, Tod A.; Wan, Liwen F.; Guo, Jinghua; Prendergast, David; Salmeron, Miquel			The structure of interfacial water on gold electrodes studied by x-ray absorption spectroscopy	SCIENCE			English	Article							FREQUENCY VIBRATIONAL SPECTROSCOPY; AU(111) SURFACE; MOLECULES; ADSORPTION; RU(0001); FORCE; LAYER	The molecular structure of the electrical double layer determines the chemistry in all electrochemical processes. Using x-ray absorption spectroscopy (XAS), we probed the structure of water near gold electrodes and its bias dependence. Electron yield XAS detected at the gold electrode revealed that the interfacial water molecules have a different structure from those in the bulk. First principles calculations revealed that similar to 50% of the molecules lie flat on the surface with saturated hydrogen bonds and another substantial fraction with broken hydrogen bonds that do not contribute to the XAS spectrum because their core-excited states are delocalized by coupling with the gold substrate. At negative bias, the population of flat-lying molecules with broken hydrogen bonds increases, producing a spectrum similar to that of bulk water.	[Velasco-Velez, Juan-Jesus; Wu, Cheng Hao; Salmeron, Miquel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Wu, Cheng Hao] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Pascal, Tod A.; Wan, Liwen F.; Prendergast, David] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Joint Ctr Energy Storage Res, Berkeley, CA 94720 USA; [Guo, Jinghua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Guo, Jinghua] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Salmeron, Miquel] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	mbsalmeron@lbl.gov	Velasco-Velez, Juan J./AAZ-1159-2020; Wu, Cheng Hao/C-9565-2014; Guo, Jinghua/AAZ-6492-2020; Prendergast, David/E-4437-2010; Wu, Cheng Hao/AAG-2521-2020; Vélez, Juan Jesús Velasco/AAA-1573-2020	Wu, Cheng Hao/0000-0002-6515-0988; Guo, Jinghua/0000-0002-8576-2172; Prendergast, David/0000-0003-0598-1453; Wu, Cheng Hao/0000-0002-6515-0988; Vélez, Juan Jesús Velasco/0000-0002-6595-0168; Wan, Liwen/0000-0002-5391-0804	Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; Alexander von Humboldt Foundation, Germany; Joint Center for Energy Storage Research, an Energy Innovation Hub - U.S. DOE; DOE-BES; DOE-Advanced Scientific Computing Research; DOE Office of Science [DE-AC02-05CH11231]	Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, of the U.S. Department of Energy (DOE); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation); Joint Center for Energy Storage Research, an Energy Innovation Hub - U.S. DOE; DOE-BES(United States Department of Energy (DOE)); DOE-Advanced Scientific Computing Research; DOE Office of Science(United States Department of Energy (DOE))	This work was supported by the Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231 (through the Chemical and Mechanical Properties of Surfaces, Interfaces and Nanostructures program). J.-J.V.-V. acknowledges financial support from the Alexander von Humboldt Foundation, Germany. C.H.W. acknowledges the Advanced Light Source (ALS) Doctoral Fellowship in Residence. Theory and simulations by T.A.P., L.F.W., and D.P. were supported by the Joint Center for Energy Storage Research, an Energy Innovation Hub funded by the U.S. DOE and facilitated by a user project at the Molecular Foundry. Computations were performed with the computing resources of the National Energy Research Scientific Computing Center (NERSC). The ALS and Molecular Foundry (supported by DOE-BES) and NERSC (supported by DOE-Advanced Scientific Computing Research) are DOE Office of Science User Facilities, supported by the DOE Office of Science under contract no. DE-AC02-05CH11231. We thank C.-H. Chuang, B.-Y. Wang, D. Zhang, X. Feng, and M. W. West for support at the beamline. We also thank J. Zhang for help with AFM imaging and C. Das Pemmaraju, C. Schwartz, P. Ross, J. Colchero, G. Thornton, H. Fang, and S. Harris for useful discussions.	Ataka K, 1996, J PHYS CHEM-US, V100, P10664, DOI 10.1021/jp953636z; Bard A. J., 1980, ELECTROCHEMICAL METH; Bergmann U, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.092107; Bluhm H, 2002, J PHYS-CONDENS MAT, V14, pL227, DOI 10.1088/0953-8984/14/8/108; Braun A, 2012, J PHYS CHEM C, V116, P16870, DOI 10.1021/jp304254k; Brown MA, 2009, ANNU REP PROG CHEM C, V105, P174, DOI 10.1039/b803023p; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cicero G, 2011, J PHYS CHEM LETT, V2, P2582, DOI 10.1021/jz200989n; Cicero G, 2008, J AM CHEM SOC, V130, P1871, DOI 10.1021/ja074418+; Drisdell WS, 2013, J AM CHEM SOC, V135, P18183, DOI 10.1021/ja408972f; England AH, 2011, CHEM PHYS LETT, V514, P187, DOI 10.1016/j.cplett.2011.08.063; Feibelman PJ, 2002, SCIENCE, V295, P99, DOI 10.1126/science.1065483; Fenter P, 2000, J COLLOID INTERF SCI, V225, P154, DOI 10.1006/jcis.2000.6756; FLEISCHMANN M, 1981, J ELECTROANAL CHEM, V117, P243, DOI 10.1016/S0022-0728(81)80086-1; Fuchs O, 2008, NUCL INSTRUM METH A, V585, P172, DOI 10.1016/j.nima.2007.10.029; Ghosal S, 2005, SCIENCE, V307, P563, DOI 10.1126/science.1106525; Guo JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157401; Guo JH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137402; Jiang P, 2010, ELECTROCHEM COMMUN, V12, P820, DOI 10.1016/j.elecom.2010.03.042; LIU GY, 1994, LANGMUIR, V10, P367, DOI 10.1021/la00014a006; Michaelides A, 2003, J AM CHEM SOC, V125, P2746, DOI 10.1021/ja028855u; Nadler R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4752235; Nilsson A, 2004, SURF SCI REP, V55, P49, DOI 10.1016/j.surfrep.2004.06.002; Nilsson A, 2010, J ELECTRON SPECTROSC, V177, P99, DOI 10.1016/j.elspec.2010.02.005; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Prendergast D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.215502; Shen YR, 2006, CHEM REV, V106, P1140, DOI 10.1021/cr040377d; Stacchiola D, 2009, J PHYS CHEM C, V113, P15102, DOI 10.1021/jp904875h; Sung JH, 2011, J PHYS CHEM C, V115, P13887, DOI 10.1021/jp2046596; Tatarkhanov M, 2009, J AM CHEM SOC, V131, P18425, DOI 10.1021/ja907468m; Tokushima T, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3678443; TONEY MF, 1994, NATURE, V368, P444, DOI 10.1038/368444a0; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Zhang L, 2008, J AM CHEM SOC, V130, P7686, DOI 10.1021/ja8011116	34	287	288	35	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					831	834		10.1126/science.1259437	http://dx.doi.org/10.1126/science.1259437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25342657				2022-12-28	WOS:000344659900039
J	Holtz, TR				Holtz, Thomas R., Jr.			Mystery of the horrible hands solved	NATURE			English	Editorial Material									[Holtz, Thomas R., Jr.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Holtz, Thomas R., Jr.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History	Holtz, TR (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	tholtz@umd.edu		Holtz, Thomas/0000-0002-2906-4900				Bell PR, 2012, CRETACEOUS RES, V37, P186, DOI 10.1016/j.cretres.2012.03.018; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Jerzykiewicz Tom, 2000, P279; Lee YN, 2014, NATURE, V515, P257, DOI 10.1038/nature13874; Makovicky P. J., 2003, DINOSAURIA, P137; Osmolski H., 1969, Palaeontologia Polonica, V21, P5; Ostrom J.H., 1972, MCGRAW HILL YB SCI T, P176; Rozhdestvensky A. K., 1970, PALEONTOL J, V4, P117; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108	12	1	1	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					203	+		10.1038/nature13930	http://dx.doi.org/10.1038/nature13930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25337885				2022-12-28	WOS:000344631400034
J	Boozary, AS; Farmer, PE; Jha, AK				Boozary, Andrew S.; Farmer, Paul E.; Jha, Ashish K.			The Ebola Outbreak, Fragile Health Systems, and Quality as a Cure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Boozary, Andrew S.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Farmer, Paul E.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Garrett L., 2000, BETRAYAL TRUST COLLA; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; KLEINMAN A, 1991, CULT MED PSYCHIAT, V15, P275, DOI 10.1007/BF00046540; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310; Rid A, 2014, JAMA-J AM MED ASSOC, V312, P1297, DOI 10.1001/jama.2014.12869; World Health Organization, UN MISS EB EM RESP A; World Health Organization, 2012, MARB HEM FEV FACT SH	10	76	78	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1859	1860		10.1001/jama.2014.14387	http://dx.doi.org/10.1001/jama.2014.14387			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25285459	Bronze			2022-12-28	WOS:000344532600011
J	Munro, JB; Gorman, J; Ma, XC; Zhou, Z; Arthos, J; Burton, DR; Koff, WC; Courter, JR; Smith, AB; Kwong, PD; Blanchard, SC; Mothes, W				Munro, James B.; Gorman, Jason; Ma, Xiaochu; Zhou, Zhou; Arthos, James; Burton, Dennis R.; Koff, Wayne C.; Courter, Joel R.; Smith, Amos B., III; Kwong, Peter D.; Blanchard, Scott C.; Mothes, Walther			Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions	SCIENCE			English	Article							NEUTRALIZING ANTIBODY PG9; RECEPTOR-BINDING; STRUCTURAL BASIS; CD4 RECEPTOR; GP120; GLYCOPROTEIN; RECOGNITION; VACCINE; FUSION; BROAD	The HIV-1 envelope (Env) mediates viral entry into host cells. To enable the direct imaging of conformational dynamics within Env, we introduced fluorophores into variable regions of the glycoprotein gp120 subunit and measured single-molecule fluorescence resonance energy transfer within the context of native trimers on the surface of HIV-1 virions. Our observations revealed unliganded HIV-1 Env to be intrinsically dynamic, transitioning between three distinct prefusion conformations, whose relative occupancies were remodeled by receptor CD4 and antibody binding. The distinct properties of neutralization-sensitive and neutralization-resistant HIV-1 isolates support a dynamics-based mechanism of immune evasion and ligand recognition.	[Munro, James B.; Ma, Xiaochu; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Gorman, Jason; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Zhou, Zhou; Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Koff, Wayne C.] IAVI, New York, NY 10004 USA; [Courter, Joel R.; Smith, Amos B., III] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; University of Pennsylvania	Mothes, W (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	james.munro@tufts.edu; scb2005@med.cornell.edu; walther.mothes@yale.edu	Gorman, Jason/AGG-9417-2022; Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Gorman, Jason/0000-0002-3775-6560	NIH [R21 AI100696, P01 56550, R01 GM098859]; Cancer Research Institute; China Scholarship Council; International AIDS Vaccine Initiative's (IAVI) Neutralizing Antibody Consortium; NIH Intramural Research Program (Vaccine Research Center); Bill & Melinda Gates Foundation; U.S. Agency for International Development (USAID); American people through USAID; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005023, R21AI100696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550, R01GM098859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; China Scholarship Council(China Scholarship Council); International AIDS Vaccine Initiative's (IAVI) Neutralizing Antibody Consortium; NIH Intramural Research Program (Vaccine Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); American people through USAID(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jin, L. Agosto, T. Wang, R. B. Altman, and M. R. Wasserman for assistance; C. Walsh, J. Binely, A. Trkola, and M. Krystal for reagents; and members of the Structural Biology Section, Vaccine Research Center, for critically reading the manuscript. We thank I. Wilson and J. Sodroski for encouraging us to extend our approach to a R5-tropic Env. The data presented in this paper are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants R21 AI100696 to W. M. and S. C. B; P01 56550 to W. M., S. C. B., and A. B. S.; and R01 GM098859 to S. C. B.; by the Irvington Fellows Program of the Cancer Research Institute to J. B. M; by a fellowship from the China Scholarship Council-Yale World Scholars to X. M.; by grants from the International AIDS Vaccine Initiative's (IAVI) Neutralizing Antibody Consortium to D. R. B., W. C. K., and P. D. K.; and by funding from the NIH Intramural Research Program (Vaccine Research Center) to P. D. K. IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation and the U.S. Agency for International Development (USAID). This study is made possible by the generous support of the American people through USAID. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. government. Reagents from the NIH are subject to nonrestrictive material transfer agreements. Patent applications pertaining to this work are the U.S. and World Application US2009/006049 and WO/2010/053583, Synthesis of JRC-II-191 (A. B. S., J.R.C.), U.S. Patent Application 13/202,351, Methods and Compositions for Altering Photopysical Properties of Fluorophores via Proximal Quenching (S. C. B., Z.Z.); U. S. Patent Application 14/373,402 Dye Compositions, Methods of Preparation, Conjugates Thereof, and Methods of Use (S. C. B., Z.Z.); and International and US Patent Application PCT/US13/42249 Reagents and Methods for Identifying Anti-HIV Compounds (S. C. B., J.B.M., W. M.). S. C. B. is a co-founder of Lumidyne Corporation.	Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; DeVico AL, 2007, CURR HIV RES, V5, P561, DOI 10.2174/157016207782418560; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Li ZF, 2013, ANTIMICROB AGENTS CH, V57, P4172, DOI 10.1128/AAC.00513-13; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; Mukherjee NG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065103; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	42	325	331	9	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					759	763		10.1126/science.1254426	http://dx.doi.org/10.1126/science.1254426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25298114	Green Accepted			2022-12-28	WOS:000344690100044
J	Campbell, C; Shea, K; Albert, R				Campbell, Colin; Shea, Katriona; Albert, Reka			Comment on "Control profiles of complex networks"	SCIENCE			English	Editorial Material								Ruths and Ruths (Reports, 21 March 2014, p. 1373) find that existing synthetic random network models fail to generate control profiles that match those found in real network models. Here, we show that a straightforward extension to the Barabasi-Albert model allows the control profile to be "tuned" across the control profile space, permitting more meaningful control profile analyses of real networks.	[Campbell, Colin; Albert, Reka] Penn State Univ, Dept Phys, Davey Lab 122, University Pk, PA 16802 USA; [Campbell, Colin; Shea, Katriona; Albert, Reka] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Campbell, C (corresponding author), Penn State Univ, Dept Phys, Davey Lab 122, University Pk, PA 16802 USA.	cec220@psu.edu	Albert, Reka/E-2195-2011; Shea, Katriona/B-7954-2008	Albert, Reka/0000-0002-9485-0828; Shea, Katriona/0000-0002-7607-8248; Campbell, Colin/0000-0003-3770-7432				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063	2	10	10	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI					10.1126/science.1256492	http://dx.doi.org/10.1126/science.1256492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359960				2022-12-28	WOS:000343799700031
J	Sedgwick, P				Sedgwick, Philip			Sample size: how many participants are needed in a cohort study?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6051; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6726; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2839; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Wang K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3668	5	5	5	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2014	349								g6557	10.1136/bmj.g6557	http://dx.doi.org/10.1136/bmj.g6557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DM	25361576	Green Published			2022-12-28	WOS:000344156600006
J	Gilbert, LA; Horlbeck, MA; Adamson, B; Villalta, JE; Chen, Y; Whitehead, EH; Guimaraes, C; Panning, B; Ploegh, HL; Bassik, MC; Qi, LS; Kampmann, M; Weissman, JS				Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Whitehead, Evan H.; Guimaraes, Carla; Panning, Barbara; Ploegh, Hidde L.; Bassik, Michael C.; Qi, Lei S.; Kampmann, Martin; Weissman, Jonathan S.			Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation	CELL			English	Article							HUMAN-CELLS; MAMMALIAN-CELLS; TRANSCRIPTION FACTORS; SHRNA LIBRARIES; CHOLERA-TOXIN; EXPRESSION; RNA; BINDING; SCREENS; DIFFERENTIATION	While the catalog of mammalian transcripts and their expression levels in different cell types and disease states is rapidly expanding, our understanding of transcript function lags behind. We present a robust technology enabling systematic investigation of the cellular consequences of repressing or inducing individual transcripts. We identify rules for specific targeting of transcriptional repressors (CRISPRi), typically achieving 90%-99% knockdown with minimal off-target effects, and activators (CRISPRa) to endogenous genes via endonuclease-deficient Cas9. Together they enable modulation of gene expression over a similar to 1,000-fold range. Using these rules, we construct genome-scale CRISPRi and CRISPRa libraries, each of which we validate with two pooled screens. Growth-based screens identify essential genes, tumor suppressors, and regulators of differentiation. Screens for sensitivity to a cholera-diphtheria toxin provide broad insights into the mechanisms of pathogen entry, retrotranslocation and toxicity. Our results establish CRISPRi and CRISPRa as powerful tools that provide rich and complementary information for mapping complex pathways.	[Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Whitehead, Evan H.; Bassik, Michael C.; Qi, Lei S.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Bassik, Michael C.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Whitehead, Evan H.; Bassik, Michael C.; Qi, Lei S.; Kampmann, Martin; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Bassik, Michael C.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Whitehead, Evan H.; Qi, Lei S.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Guimaraes, Carla; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; [Guimaraes, Carla; Ploegh, Hidde L.] MIT, Cambridge, MA 02142 USA; [Panning, Barbara] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco	Kampmann, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	martin.kampmann@ucsf.edu; jonathan.weissman@ucsf.edu	Gilbert, Luke/AAC-5300-2019; Qi, Lei S/AAC-5088-2019	Whitehead, Evan/0000-0002-4132-2140; Kampmann, Martin/0000-0002-3819-7019; Qi, Lei S/0000-0002-3965-3223; Weissman, Jonathan/0000-0003-2445-670X; Gilbert, Luke/0000-0001-5854-0825	NIH [P50 GM102706, P50 GM081879, U01 CA168370, R01 DA036858]; Howard Hughes Medical Institute; UCSF Medical Scientist Training Program; NCI/NIH Pathway to Independence Award [K99CA181494];  [DRG-[2182-14]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD084069] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA168370, K99CA181494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100341, P50GM081879, T32GM008284, P50GM102706, R01GM100518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); UCSF Medical Scientist Training Program; NCI/NIH Pathway to Independence Award; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank M. Tanenbaum, J. Tsai, K. Kostova, J. Zalatan, W. Lim, S. Weissman, J. Doudna, and R. Vale for unpublished reagents, technical advice and helpful discussion. L.S.Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology. This work was supported by NIH P50 GM102706 (J.S.W.), NIH P50 GM081879 (L.S.Q., E.H.W.), NIH U01 CA168370 and NIH R01 DA036858 (J.S.W.), as well as the Howard Hughes Medical Institute (J.E.V., Y.C., M.K., M.A.H., J.S.W.). B.A. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-[2182-14]). L.A.G. is a Fellow of the Leukemia and Lymphoma Society. M.A.H. is supported by the UCSF Medical Scientist Training Program. M.K. is supported by NCI/NIH Pathway to Independence Award K99CA181494.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Alberich-Jorda M, 2012, J CLIN INVEST, V122, P4490, DOI 10.1172/JCI65102; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; SMITH R, 2009, CONSUM REP, V74, P6; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; VANNESS BG, 1980, J BIOL CHEM, V255, P717; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang P, 2000, BLOOD, V96, P2641; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	49	1435	1538	40	443	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					647	661		10.1016/j.cell.2014.09.029	http://dx.doi.org/10.1016/j.cell.2014.09.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25307932	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000344521700019
J	Kiefer, F; des Etangs, AL; Boissier, J; Vidal-Madjar, A; Beust, H; Lagrange, AM; Hebrard, G; Ferlet, R				Kiefer, F.; des Etangs, A. Lecavelier; Boissier, J.; Vidal-Madjar, A.; Beust, H.; Lagrange, A-M.; Hebrard, G.; Ferlet, R.			Two families of exocomets in the beta Pictoris system	NATURE			English	Article							INFALLING EVAPORATING BODIES; YOUNG PLANETARY SYSTEM; CIRCUMSTELLAR DISK; CA-II; HST-GHRS; COMETS; MODEL	The young planetary system surrounding the star beta Pictoris harbours active minor bodies(1-6). These asteroids and comets produce a large amount of dust and gas through collisions and evaporation, as happened early in the history of our Solar System(7). Spectroscopic observations of beta Pictoris reveal a high rate of transits of small evaporating bodies(8-11), that is, exocomets. Here we report an analysis of more than 1,000 archival spectra gathered between 2003 and 2011, which provides a sample of about 6,000 variable absorption signatures arising from exocomets transiting the disk of the parent star. Statistical analysis of the observed properties of these exocomets allows us to identify two populations with different physical properties. One family consists of exocomets producing shallow absorption lines, which can be attributed to old exhausted (that is, strongly depleted in volatiles) comets trapped in a mean motion resonance with a massive planet. Another family consists of exocomets producing deep absorption lines, which may be related to the recent fragmentation of one or a few parent bodies. Our results show that the evaporating bodies observed for decades in the beta Pictoris system are analogous to the comets in our own Solar System.	[Kiefer, F.; des Etangs, A. Lecavelier; Vidal-Madjar, A.; Hebrard, G.; Ferlet, R.] CNRS, Inst Astrophys Paris, UMR 7095, F-75014 Paris, France; [Kiefer, F.; des Etangs, A. Lecavelier; Vidal-Madjar, A.; Hebrard, G.; Ferlet, R.] Univ Paris 06, Inst Astrophys Paris, UMR 7095, F-75014 Paris, France; [Kiefer, F.] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Boissier, J.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Beust, H.; Lagrange, A-M.] Univ Grenoble 1, CNRS, Inst Natl Sci Univers, Inst Planetol & Astrophys Grenoble,UMR 5274, F-38400 St Martin Dheres, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Kiefer, F (corresponding author), CNRS, Inst Astrophys Paris, UMR 7095, 98 Bis Blvd Arago, F-75014 Paris, France.	kiefer@iap.fr; lecaveli@iap.fr	Lecavelier des Etangs, Alain/GLU-6503-2022	Lecavelier des Etangs, Alain/0000-0002-5637-5253	Fondation Simone et Cino Del Duca; French Agence Nationale de la Recherche (ANR) [ANR-12-13505-0012 Exo-Atmos, ANR-2010 BLAN-0505-01]	Fondation Simone et Cino Del Duca; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was based on observations made with ESO telescopes at the La Silla Observatory and data obtained from the ESO Science Archive Facility. This work has been supported by an award from the Fondation Simone et Cino Del Duca. We also acknowledge support from the French Agence Nationale de la Recherche (ANR), under programmes ANR-12-13505-0012 Exo-Atmos and ANR-2010 BLAN-0505-01 (EXOZODI). We thank P. A. Wilson for his comments on the manuscript.	BEUST H, 1990, ASTRON ASTROPHYS, V236, P202; BEUST H, 1991, ASTRON ASTROPHYS, V241, P488; Beust H, 1996, ASTRON ASTROPHYS, V310, P181; BEUST H, 1989, ASTRON ASTROPHYS, V223, P304; BEUST H, 1993, ICARUS, V106, P42, DOI 10.1006/icar.1993.1157; Beust H, 2000, ICARUS, V143, P170, DOI 10.1006/icar.1999.6238; Beust H, 1996, ICARUS, V120, P358, DOI 10.1006/icar.1996.0056; de Vries BL, 2012, NATURE, V490, P74, DOI 10.1038/nature11469; des Etangs AL, 2009, ASTRON ASTROPHYS, V497, P557, DOI 10.1051/0004-6361/200811528; des Etangs AL, 2001, NATURE, V412, P706, DOI 10.1038/35089006; Everitt B. S., 1993, CLUSTER ANAL; FERLET R, 1987, ASTRON ASTROPHYS, V185, P267; Huebner W. F., 1990, PHYS CHEM COMETS; Lagrange AM, 2009, ASTRON ASTROPHYS, V493, pL21, DOI 10.1051/0004-6361:200811325; Lagrange AM, 1996, ASTRON ASTROPHYS, V310, P547; LALLEMENT R, 1995, ASTRON ASTROPHYS, V304, P461; MARSDEN BG, 1967, ASTRON J, V72, P1170, DOI 10.1086/110396; Okamoto YK, 2004, NATURE, V431, P660, DOI 10.1038/nature02948; Pepe F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117055; Roberge A, 2000, ASTROPHYS J, V538, P904, DOI 10.1086/309157; Roberge A, 2006, NATURE, V441, P724, DOI 10.1038/nature04832; Telesco CM, 2005, NATURE, V433, P133, DOI 10.1038/nature03255; Thehault P., 2001, ASTRON ASTROPHYS, V376, P621; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; VIDALMADJAR A, 1994, ASTRON ASTROPHYS, V290, P245	25	75	75	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					462	+		10.1038/nature13849	http://dx.doi.org/10.1038/nature13849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341784				2022-12-28	WOS:000343775900033
J	Sarpatwari, A; Kesselheim, AS; Malin, BA; Gagne, JJ; Schneeweiss, S				Sarpatwari, Ameet; Kesselheim, Aaron S.; Malin, Bradley A.; Gagne, Joshua J.; Schneeweiss, Sebastian			Ensuring Patient Privacy in Data Sharing for Postapproval Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLINICAL-TRIALS; HEALTH DATA; SAFETY; RISK; RULE		[Sarpatwari, Ameet; Kesselheim, Aaron S.; Gagne, Joshua J.; Schneeweiss, Sebastian] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, Boston, MA 02115 USA; [Sarpatwari, Ameet; Kesselheim, Aaron S.; Gagne, Joshua J.; Schneeweiss, Sebastian] Harvard Univ, Sch Med, Boston, MA USA; [Malin, Bradley A.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Malin, Bradley A.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA.		Schneeweiss, Sebastian/C-2125-2013; Kesselheim, Aaron/R-6793-2017	Schneeweiss, Sebastian/0000-0003-2575-467X; Kesselheim, Aaron/0000-0002-8867-2666				[Anonymous], 2009, ENC US RETH PROT DEI; Arbuckle L., 2013, ANONYMIZING HLTH DAT; Benitez K, 2010, J AM MED INFORM ASSN, V17, P169, DOI 10.1136/jamia.2009.000026; Boulos MNK, 2006, J BIOMED INFORM, V39, P160, DOI 10.1016/j.jbi.2005.06.003; Brownstein JS, 2010, PHARMACOEPIDEM DR S, V19, P627, DOI 10.1002/pds.1939; Burmester GR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4452; Candela S, 2013, VACCINE, V31, P1431, DOI 10.1016/j.vaccine.2012.06.030; Cohen IG, 2014, HEALTH AFFAIR, V33, P1139, DOI 10.1377/hlthaff.2014.0048; Darrow JJ, 2014, MINN LAW REV, V98, P805; Department of Health and Human Services Office of Civil Rights, CAS EX RES AGR; Department of Health and Human Services Office of Civil Rights, GUID REG METH ID PRO; El Emam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028071; Evans BJ, 2013, UC DAVIS L REV, V46, P1175; Food and Drug Administration, 2013, FED REGISTER, V78, P58786; Funch D, 2014, DIABETES OBES METAB, V16, P273, DOI 10.1111/dom.12230; Geller SE, 2011, J WOMENS HEALTH, V20, P315, DOI 10.1089/jwh.2010.2469; Glover John, 2004, Int J Health Geogr, V3, P30, DOI 10.1186/1476-072X-3-30; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Malin B, 2011, J AM MED INFORM ASSN, V18, P3, DOI 10.1136/jamia.2010.004622; McGraw D, 2012, PHARMACOEPIDEM DR S, V21, P18, DOI 10.1002/pds.2319; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Psaty BM, 2014, NEW ENGL J MED, V370, P2165, DOI 10.1056/NEJMp1401664; Reisz LP, 2012, STATE ATTORNEYS GEN; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rosenbaum S, 2007, BNA HLTH CARE POLICY, V15, P1; Sun LH, 2011, WASHINGTON POST; US Census Bureau, GEOGR TERMS CONC CEN; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	28	9	9	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1644	1649		10.1056/NEJMsb1405487	http://dx.doi.org/10.1056/NEJMsb1405487			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR5UF	25337755	Bronze			2022-12-28	WOS:000343648500014
J	Trkola, A				Trkola, Alexandra			HIV Potency needs constancy	NATURE			English	Editorial Material							NEUTRALIZING ANTIBODIES; NONNEUTRALIZING ANTIBODIES; IN-VIVO; INFECTION; BINDING; PROTECTION; THERAPY		Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland	University of Zurich	Trkola, A (corresponding author), Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland.	trkola.alexandra@virology.uzh.ch	Trkola, Alexandra/K-2115-2012	Trkola, Alexandra/0000-0003-1013-876X				Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Ackerman ME, 2013, CURR HIV RES, V11, P365, DOI 10.2174/1570162X113116660058; Ackerman ME, 2012, ANNU REV MED, V63, P113, DOI 10.1146/annurev-med-050310-085221; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko S.Y., 2014, NATURE; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Platt EJ, 2012, P NATL ACAD SCI USA, V109, P7829, DOI 10.1073/pnas.1109728109; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	19	3	3	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					442	443		10.1038/514442a	http://dx.doi.org/10.1038/514442a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341782				2022-12-28	WOS:000343775900029
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			Association Between Hospital Conversions to For-Profit Status and Clinical and Economic Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; MEDICARE BENEFICIARIES; CARE; OWNERSHIP; MARGINS	IMPORTANCE An increasing number of hospitals have converted to for-profit status, prompting concerns that these hospitals will focus on payer mix and profits, avoiding disadvantaged patients and paying less attention to quality of care. OBJECTIVE To examine characteristics of US acute care hospitals associated with conversion to for-profit status and changes following conversion. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study conducted among 237 converting hospitals and 631 matched control hospitals. Participants were 1 843 764 Medicare fee-for-service beneficiaries at converting hospitals and 4 828 138 at control hospitals. EXPOSURES Conversion to for-profit status, 2003-2010. MAIN OUTCOMES AND MEASURES Financial performance measures, quality process measures, mortality rates, Medicare volume, and patient population for the 2 years prior and the 2 years after conversion, excluding the conversion year, assessed using difference-in-difference models. RESULTS Hospitals that converted to for-profit status were more often small or medium in size, located in the south, in an urban or suburban location, and were less often teaching institutions. Converting hospitals improved their total margins (ratio of net income to net revenue plus other income) more than controls (2.2% vs 0.4% improvement; difference in differences, 1.8%[95% CI, 0.5% to 3.1%]; P = .007). Converting hospitals and controls both improved their process qualitymetrics (6.0% vs 5.6%; difference in differences, 0.4% [95% CI, -1.1% to 2.0%]; P = .59). Mortality rates did not change at converting hospitals relative to controls for Medicare patients overall (increase of 0.1% vs 0.2%; difference in differences, -0.2%[95% CI, -0.5% to 0.2%], P = .42) or for dual-eligible or disabled patients. There was no change in converting hospitals relative to controls in annual Medicare volume (-111 vs -74 patients; difference in differences, -37 [95% CI, -224 to 150]; P = .70), Disproportionate Share Hospital Index (1.7% vs 0.4%; difference in differences, 1.3%[95% CI, -0.9% to 3.4%], P = .26), the proportion of patients with Medicaid (-0.2% vs 0.4%; difference in differences, -0.6%[95% CI, -2.0% to 0.8%]; P = .38) or the proportion of patients who were black (-0.4% vs -0.1%; difference in differences, -0.3%[95% CI, -1.9% to 1.3%]; P = .72) or Hispanic (0.1% vs -0.1%; difference in differences, 0.2%[95% CI, -0.3% to 0.7%]; P = .50). CONCLUSIONS AND RELEVANCE Hospital conversion to for-profit status was associated with improvements in financial margins but not associated with differences in quality or mortality rates or with the proportion of poor or minority patients receiving care.Copyright 2014 American Medical Association. All rights reserved.	[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Joynt, KE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Heart, Lung, and Blood Institute, National Institutes of Health [1K23HL109177-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Joynt was supported by grant 1K23HL109177-01 from the National Heart, Lung, and Blood Institute, National Institutes of Health.	[Anonymous], 2008, MED PAYM POL; Cutler DM, 1998, NBER WORKING PAPER S; Desai M, 2009, MEASURES MAINTENANCE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Hospital Safety Score, SAF IS YOUR LOC HOSP; Jha AK, 2008, JT COMM J QUAL PATIE, V34, P318, DOI 10.1016/S1553-7250(08)34040-9; Joynt KE, 2014, JAMA INTERN MED, V174, P61, DOI 10.1001/jamainternmed.2013.11537; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Ly DP, 2011, J GEN INTERN MED, V26, P1291, DOI 10.1007/s11606-011-1815-5; Picone G, 2002, RAND J ECON, V33, P507, DOI 10.2307/3087470; Shen YC, 2002, J HEALTH ECON, V21, P901, DOI 10.1016/S0167-6296(02)00058-9; Silber JH, 2010, HEALTH SERV RES, V45, P1148, DOI 10.1111/j.1475-6773.2010.01130.x; Sloan FA, 2003, MED CARE, V41, P1193, DOI 10.1097/01.MLR.0000088569.50763.15; Studdert DM, 2007, NEW ENGL J MED, V356, P625, DOI 10.1056/NEJMhpr063800; Thorpe KE, 2000, HEALTH AFFAIR, V19, P187, DOI 10.1377/hlthaff.19.6.187; United States Department of Agriculture (USDA) Economic Research Service, 2005, MEAS RUR RUR URB COM; *US DEP HHS, HOSP COMP; Young GJ, 1999, HEALTH AFFAIR, V18, P146, DOI 10.1377/hlthaff.18.5.146	18	32	32	4	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1644	1652		10.1001/jama.2014.13336	http://dx.doi.org/10.1001/jama.2014.13336			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335146	Bronze			2022-12-28	WOS:000343301400021
J	Juthani-Mehta, M; Datunashvili, A; Tinetti, M				Juthani-Mehta, Manisha; Datunashvili, Ann; Tinetti, Mary			Tests for Urinary Tract Infection in Nursing Home Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIPSTICK		[Juthani-Mehta, Manisha] Yale Univ, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Datunashvili, Ann; Tinetti, Mary] Yale Univ, Dept Internal Med, Sect Geriatr, New Haven, CT 06520 USA	Yale University; Yale University	Juthani-Mehta, M (corresponding author), Yale Univ, Dept Internal Med, Infect Dis Sect, POB 208022, New Haven, CT 06520 USA.	manisha.juthani@yale.edu						Centers for Medicare & Medicaid Services, CLIN LAB FEE SCH; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Ducharme James, 2007, CJEM, V9, P87; Juthani-Mehta M, 2007, INFECT CONT HOSP EP, V28, P889, DOI 10.1086/518752; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; LACHS MS, 1992, ANN INTERN MED, V117, P135, DOI 10.7326/0003-4819-117-2-135; Lammers RL, 2001, ANN EMERG MED, V38, P505, DOI 10.1067/mem.2001.119427; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; Nicolle LE, 2009, J AM GERIATR SOC, V57, P1113, DOI 10.1111/j.1532-5415.2009.02277.x; Sundvall PD, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-36	10	8	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1687	1688		10.1001/jama.2014.13554	http://dx.doi.org/10.1001/jama.2014.13554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335152				2022-12-28	WOS:000343301400027
J	Kelly, J; Granger, CB				Kelly, Jacob; Granger, Christopher B.			Spironolactone did not reduce cardiac outcomes in symptomatic heart failure with preserved ejection fraction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kelly, Jacob; Granger, Christopher B.] Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Kelly, J (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.							McMurray JJV, 2014, NEW ENGL J MED, V370, P1453, DOI 10.1056/NEJMe1401231; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	2	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC6	10.7326/0003-4819-161-8-201410210-02006	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329223				2022-12-28	WOS:000343906800005
J	Testa, P; De Pontieu, B; Allred, J; Carlsson, M; Reale, F; Daw, A; Hansteen, V; Martinez-Sykora, J; Liu, W; DeLuca, EE; Golub, L; McKillop, S; Reeves, K; Saar, S; Tian, H; Lemen, J; Title, A; Boerner, P; Hurlburt, N; Tarbell, TD; Wuelser, JP; Kleint, L; Kankelborg, C; Jaeggli, S				Testa, P.; De Pontieu, B.; Allred, J.; Carlsson, M.; Reale, F.; Daw, A.; Hansteen, V.; Martinez-Sykora, J.; Liu, W.; DeLuca, E. E.; Golub, L.; McKillop, S.; Reeves, K.; Saar, S.; Tian, H.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Kleint, L.; Kankelborg, C.; Jaeggli, S.			Evidence of nonthermal particles in coronal loops heated impulsively by nanoflares	SCIENCE			English	Article							X-RAY OBSERVATIONS; SOLAR-FLARES; FREQUENCY-DISTRIBUTIONS; ELECTRON ACCELERATION; WAVES; CHROMOSPHERE; PROPAGATION; STATISTICS; EMISSION; PLASMA	The physical processes causing energy exchange between the Sun's hot corona and its cool lower atmosphere remain poorly understood. The chromosphere and transition region (TR) form an interface region between the surface and the corona that is highly sensitive to the coronal heating mechanism. High-resolution observations with the Interface Region Imaging Spectrograph (IRIS) reveal rapid variability (similar to 20 to 60 seconds) of intensity and velocity on small spatial scales (less than or similar to 500 kilometers) at the footpoints of hot and dynamic coronal loops. The observations are consistent with numerical simulations of heating by beams of nonthermal electrons, which are generated in small impulsive (less than or similar to 30 seconds) heating events called "coronal nanoflares." The accelerated electrons deposit a sizable fraction of their energy (less than or similar to 10(25) erg) in the chromosphere and TR. Our analysis provides tight constraints on the properties of such electron beams and new diagnostics for their presence in the nonflaring corona.	[Testa, P.; DeLuca, E. E.; Golub, L.; McKillop, S.; Reeves, K.; Saar, S.; Tian, H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [De Pontieu, B.; Liu, W.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Kleint, L.] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [De Pontieu, B.; Carlsson, M.; Hansteen, V.] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; [Allred, J.; Daw, A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Reale, F.] Univ Palermo, Dipartimento Fis & Chim, I-90134 Palermo, Italy; [Reale, F.] Ist Nazl Astrofis INAF, Osservatorio Astron Palermo, I-90134 Palermo, Italy; [Martinez-Sykora, J.; Kleint, L.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Liu, W.] Stanford Univ, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Kankelborg, C.; Jaeggli, S.] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Lockheed Martin; University of Oslo; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Palermo; Istituto Nazionale Astrofisica (INAF); Stanford University; Montana State University System; Montana State University Bozeman	Testa, P (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	ptesta@cfa.harvard.edu	Reeves, Katharine/P-9163-2014	Reeves, Katharine/0000-0002-6903-6832; Reale, Fabio/0000-0002-1820-4824; Golub, Leon/0000-0001-9638-3082; Tian, Hui/0000-0002-1369-1758	Norwegian Space Center (NSC, Norway) through European Space Agency PRODEX; NASA [NNG09FA40C, NNX13AF79G]; Lockheed Martin Independent Research Program; European Research Council from Lockheed-Martin [291058, 8100002705]; Research Council of Norway	Norwegian Space Center (NSC, Norway) through European Space Agency PRODEX; NASA(National Aeronautics & Space Administration (NASA)); Lockheed Martin Independent Research Program; European Research Council from Lockheed-Martin; Research Council of Norway(Research Council of Norway)	IRIS is a NASA Small Explorer mission, developed and operated by Lockheed Martin Solar and Astrophysics Laboratory with mission operations executed at NASA Ames Research Center and major contributions to downlink communications funded by the Norwegian Space Center (NSC, Norway) through an European Space Agency PRODEX contract. The IRIS data can be accessed at http://iris.lmsal.com/search/, and the AIA data at www.lmsal.com/get_aia_data/. This work is supported by NASA under contract NNG09FA40C (IRIS) and the Lockheed Martin Independent Research Program, the European Research Council grant agreement no.291058, and contract 8100002705 from Lockheed-Martin to the Smithsonian Astrophysical Observatory. M.C. acknowledges funding from the Research Council of Norway. W.L. is supported by NASA Living with a Star-Targeted Research and Technology grant NNX13AF79G.	Allred JC, 2006, ASTROPHYS J, V644, P484, DOI 10.1086/503314; Bell AR, 2004, MON NOT R ASTRON SOC, V353, P550, DOI 10.1111/j.1365-2966.2004.08097.x; BLANDFORD RD, 1978, ASTROPHYS J, V221, pL29, DOI 10.1086/182658; Brown JC, 2009, ASTRON ASTROPHYS, V508, P993, DOI 10.1051/0004-6361/200913145; Carlsson M, 1997, ASTROPHYS J, V481, P500, DOI 10.1086/304043; Christe S, 2008, ASTROPHYS J, V677, P1385, DOI 10.1086/529011; Cirtain JW, 2013, NATURE, V493, P501, DOI 10.1038/nature11772; CROSBY NB, 1993, SOL PHYS, V143, P275, DOI 10.1007/BF00646488; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; Feldman U, 1996, ASTROPHYS J, V460, P1034, DOI 10.1086/177030; Fletcher L, 2008, ASTROPHYS J, V675, P1645, DOI 10.1086/527044; Fletcher L, 1999, ASTROPHYS J, V520, pL135, DOI 10.1086/312157; Hannah IG, 2011, SPACE SCI REV, V159, P263, DOI 10.1007/s11214-010-9705-4; Holman GD, 2011, SPACE SCI REV, V159, P107, DOI 10.1007/s11214-010-9680-9; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; KOCH HW, 1959, REV MOD PHYS, V31, P920, DOI 10.1103/RevModPhys.31.920; Kontar EP, 2011, SPACE SCI REV, V159, P301, DOI 10.1007/s11214-011-9804-x; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Martens PCH, 2000, ASTROPHYS J, V537, P471, DOI 10.1086/309000; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Petrosian V, 2008, SPACE SCI REV, V134, P207, DOI 10.1007/s11214-008-9315-6; Petrosian V, 2004, ASTROPHYS J, V610, P550, DOI 10.1086/421486; Priest ER, 2002, ASTROPHYS J, V576, P533, DOI 10.1086/341539; Reale F, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-5; Russell AJB, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/81; Testa P, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/1/L1; van Ballegooijen AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/3; Varady M, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322391; Zharkova VV, 2011, SPACE SCI REV, V159, P357, DOI 10.1007/s11214-011-9803-y	30	125	127	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207							1255724	10.1126/science.1255724	http://dx.doi.org/10.1126/science.1255724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324396	Green Submitted			2022-12-28	WOS:000343041100032
J	Hsia, RY; Nath, JB; Baker, LC				Hsia, Renee Y.; Nath, Julia Brownell; Baker, Laurence C.			Emergency Department Visits by Children, Adolescents, and Young Adults in California by Insurance Status, 2005-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TRENDS		[Hsia, Renee Y.; Nath, Julia Brownell] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Baker, Laurence C.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Hsia, RY (corresponding author), San Francisco Gen Hosp, UCSF Dept Emergency Med, 1001 Potrero Ave, San Francisco, CA 94110 USA.	renee.hsia@emergency.ucsf.edu		Baker, Laurence/0000-0001-5032-794X	NCATS NIH HHS [KL2 TR000143] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adams JG, 2013, JAMA-J AM MED ASSOC, V309, P1173, DOI 10.1001/jama.2013.2476; Burt C W, 2001, Vital Health Stat 13, P1; Hsia RY, 2013, JAMA-J AM MED ASSOC, V310, P1181, DOI 10.1001/jama.2013.228331; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	6	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1587	1588		10.1001/jama.2014.9905	http://dx.doi.org/10.1001/jama.2014.9905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321913	Green Accepted			2022-12-28	WOS:000342983200024
J	Huang, H; Sabari, BR; Garcia, BA; Allis, CD; Zhao, YM				Huang, He; Sabari, Benjamin R.; Garcia, Benjamin A.; Allis, C. David; Zhao, Yingming			SnapShot: Histone Modifications	CELL			English	Editorial Material							POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN; CODE		[Huang, He; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Sabari, Benjamin R.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Chicago; Rockefeller University; University of Pennsylvania	Huang, H (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.				NATIONAL CANCER INSTITUTE [U24CA160036] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174, R01GM105933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NCI NIH HHS [CA160036, U24 CA160036] Funding Source: Medline; NCRR NIH HHS [RR020839, U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [R01 GM105933, R01 GM110174, GM105933] Funding Source: Medline; NIH HHS [DP2OD007447, DP2 OD007447] Funding Source: Medline; NIMH NIH HHS [P50 MH096890] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; Fierz B, 2012, NAT CHEM BIOL, V8, P417, DOI [10.1038/NCHEMBIO.938, 10.1038/nchembio.938]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Young NL, 2010, CELL MOL LIFE SCI, V67, P3983, DOI 10.1007/s00018-010-0475-7	9	273	282	8	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					458	+	458.e1	10.1016/j.cell.2014.09.037	http://dx.doi.org/10.1016/j.cell.2014.09.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303536	Green Accepted, Bronze			2022-12-28	WOS:000343095600025
J	Malik, ZA; Stein, IS; Navedo, MF; Hell, JW				Malik, Zulfiqar A.; Stein, Ivar S.; Navedo, Manuel F.; Hell, Johannes W.			Mission CaMKII gamma: Shuttle Calmodulin from Membrane to Nucleus	CELL			English	Editorial Material							CHANNEL ACTIVITY; CA2+ CHANNELS; FACILITATION	Neuronal plasticity depends on plasma membrane Ca2+ influx, resulting in activity-dependent gene transcription. Calmodulin (CaM) activated by Ca2+ initiates the nuclear events, but how CaM makes its way to the nucleus has remained elusive. Ma et al. now show that CaMKII gamma transports CaM from cell surface Ca2+ channels to the nucleus.	[Malik, Zulfiqar A.; Stein, Ivar S.; Navedo, Manuel F.; Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95615 USA	University of California System; University of California Davis	Hell, JW (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95615 USA.	jwhell@ucdavis.edu	Hell, Johannes W./P-5085-2019		NHLBI NIH HHS [R01 HL098200] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041	10	9	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					235	237		10.1016/j.cell.2014.09.023	http://dx.doi.org/10.1016/j.cell.2014.09.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303520	Green Accepted, Bronze			2022-12-28	WOS:000343095600005
J	Wieder, S; Levitt, J				Wieder, Shira; Levitt, Jacob			Intensely Pruritic Eruption in a College Student	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CUTANEOUS LARVA MIGRANS; IVERMECTIN; TRAVELERS; THERAPY		[Wieder, Shira] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Levitt, Jacob] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Levitt, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Dermatol, 5 E 98th St,Fifth Floor, New York, NY 10029 USA.	jacob.levitt@mssm.edu						Bouchaud O, 2000, CLIN INFECT DIS, V31, P493, DOI 10.1086/313942; Caumes E, 2003, FUND CLIN PHARMACOL, V17, P213, DOI 10.1046/j.1472-8206.2003.00172.x; Criado Paulo Ricardo, 2012, Dermatol Online J, V18, P11; Feldmeier H, 2012, EUR J CLIN MICROBIOL, V31, P915, DOI 10.1007/s10096-011-1404-x; Hochedez P, 2007, J TRAVEL MED, V14, P326, DOI 10.1111/j.1708-8305.2007.00148.x; James WD, 2011, ANDREWS DISEASES OF, P27; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Sunderkotter C, 2014, J DTSCH DERMATOL GES, V12, P86, DOI 10.1111/ddg.12250; Vanhaecke C, 2014, J EUR ACAD DERMATOL, V28, P655, DOI 10.1111/jdv.12097	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1458	1459		10.1001/jama.2014.7086	http://dx.doi.org/10.1001/jama.2014.7086			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291582				2022-12-28	WOS:000342630200023
J	Snyder, A				Snyder, Alison			Jesse Steinfeld Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu						STEINFELD J, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1258	1258		10.1016/S0140-6736(14)61760-8	http://dx.doi.org/10.1016/S0140-6736(14)61760-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	25289423				2022-12-28	WOS:000343003400018
J	Mello, MM; Studdert, DM; Kachalia, A				Mello, Michelle M.; Studdert, David M.; Kachalia, Allen			The Medical Liability Climate and Prospects for Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PRACTITIONER DATA-BANK; MALPRACTICE CLAIMS; RESOLUTION PROGRAMS; PATIENT SAFETY; ADMINISTRATIVE COMPENSATION; INJURY COMPENSATION; HEALTH COURTS; DISCLOSURE; IMPACT; CARE	For many physicians, the prospect of being sued for medical malpractice is a singularly disturbing aspect of modern clinical practice. State legislatures have enacted tort reforms, such as caps on damages, in an effort to reduce the volume and costs of malpractice litigation. Attempts to introduce similar traditional reform measures at the federal level have so far failed. Much less prominent, but potentially more important, are proposed alternative approaches for resolving medical injuries; a number of these efforts are currently being tested in federally sponsored demonstration projects. These nontraditional reforms have considerable promise for addressing some of the system's most challenging issues, including high costs and barriers to accessing compensation. In this Special Communication, we review recent national trends in medical liability claims and costs, which indicate a sharp reduction in the rate of paid claims and flat or declining levels in compensation payments and liability insurance costs over the last 7 to 10 years. We discuss a number of nontraditional reform approaches-communication-and-resolution programs, presuit notification and apology laws, safe harbor legislation, judge-directed negotiation, and administrative compensation systems-and we conclude by describing several forces likely to shape change in the medical liability environment over the next decade.	[Mello, Michelle M.; Studdert, David M.] Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.; Studdert, David M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Kachalia, Allen] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mello, MM (corresponding author), Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA.	mmello@law.stanford.edu	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270	AHRQ [1R18HS019531-01, 1R18 HS019505-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS019531, R18HS019505] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Mello's work on this article was supported by grants from the AHRQ (grant numbers 1R18HS019531-01 and 1R18 HS019505-01)	Abraham R, DATABASE OF STATE TO; American College of Physicians, 2014, MEDICAL LIABILITY RE; American Medical Association, 1994, PHYSICIAN CHARACTERI; American Medical Association Advocacy Resource Center, 2012, APOLOGY INADMISSIBIL; [Anonymous], 2007, MEDICAL LIABILITY MO, V32, P1; [Anonymous], 2013, MEDICAL LIABILITY MO, V38, P1; [Anonymous], 2009, MEDICAL LIABILITY MO, V34, P1; [Anonymous], 2010, MEDICAL LIABILITY MO, V35, P1; [Anonymous], 2006, MEDICAL LIABILITY MO, V31, P1; [Anonymous], 2005, MEDICAL LIABILITY MO, V30, P1; [Anonymous], MEDICAL LIABILITY RE; [Anonymous], EARLY DISCUSSION AND; [Anonymous], 2004, MEDICAL LIABILITY MO, V29, P1; [Anonymous], 2011, MEDICAL LIABILITY MO, V36, P1; [Anonymous], MEDICAL LIABILITY ME; [Anonymous], 2008, MEDICAL LIABILITY MO, V33, P1; [Anonymous], 2012, MEDICAL LIABILITY MO, V37, P1; Avraham R, 1980, DATABASE OF STATE TO; Barringer PJ, 2008, J HEALTH POLIT POLIC, V33, P725, DOI 10.1215/03616878-2008-014; Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; Boothman Richard C, 2012, Front Health Serv Manage, V28, P13; Boothman Richard C, 2009, J Health Life Sci Law, V2, P125; Bovbjerg RR, 2012, THE VALUE OF CLINICA; Bureau of Labor Statistics, 2013, CPI DETAILED REPORT; Conway J, 2011, RESPECTFUL MANAGEMEN; DeVito S, 2011, DM-DIS MON, V57, P291, DOI 10.1016/j.disamonth.2011.05.008; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Espersson C, 2000, THE SWEDISH PATIENT; Etchegaray JM, 2014, HEALTH AFFAIR, V33, P46, DOI 10.1377/hlthaff.2013.0831; Glaberson, 2011, NEW YORK TIMES; Greenberg MD, 2009, CHANGE MEDICAL LIABI; Harvey HB, 2013, JAMA-J AM MED ASSOC, V310, P141, DOI 10.1001/jama.2013.7339; Hendrich A, 2014, HEALTH AFFAIR, V33, P39, DOI 10.1377/hlthaff.2013.1009; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; HICKSON GB, 1994, JAMA-J AM MED ASSOC, V272, P1583, DOI 10.1001/jama.272.20.1583; Hultgren R., 2014, FOX NEWS; Kachalia A, 2014, HEALTH AFFAIR, V33, P59, DOI 10.1377/hlthaff.2013.0834; Kachalia A, 2013, NEW ENGL J MED, V369, P1677, DOI 10.1056/NEJMp1303960; Kachalia A, 2011, NEW ENGL J MED, V364, P1564, DOI 10.1056/NEJMhpr1012821; Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Kachalia AB, 2008, SOC SCI MED, V66, P387, DOI 10.1016/j.socscimed.2007.08.020; Kirchhoff SM, 2013, PHYS PRACTICES BACKG, P1; Kraman SS, 1999, ANN INTERN MED, V131, P963, DOI 10.7326/0003-4819-131-12-199912210-00010; Lizza Ryan, 2012, NEW YORKER, P27; Manning JM, 2006, MEDICAL LAW IN NEW Z; Mason Melanie, 2014, LOS ANGELES TIMES; Mastroianni AC, 2010, HEALTH AFFAIR, V29, P1611, DOI 10.1377/hlthaff.2009.0134; McDonnell WM, 2008, ANN INTERN MED, V149, P811, DOI 10.7326/0003-4819-149-11-200812020-00007; Mello MA, 2008, HARVARD J LEGIS, V45, P59; Mello MM, 2008, GEORGETOWN LAW J, V96, P599; Mello MM, 2006, MILBANK Q, V84, P459, DOI 10.1111/j.1468-0009.2006.00455.x; Mello MM, 2014, HEALTH AFFAIR, V33, P30, DOI 10.1377/hlthaff.2013.0849; Mello MM, 2014, HEALTH AFFAIR, V33, P20, DOI 10.1377/hlthaff.2013.0828; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mello MM, 2010, NEW ENGL J MED, V362, P1353, DOI 10.1056/NEJMp1001603; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mello MM, 2002, TEX LAW REV, V80, P1595; Mello MM, 2001, U PENN LAW REV, V149, P645, DOI 10.2307/3312867; Mello MM, 2011, MEDICAL MALPRACTICE; Mello MM, 2011, ADMINISTRATIVE COMPE; Mello MM, 2010, EVALUATION OF OPTION; Mello MM., 2006, UNDERSTANDING MEDICA; Nelson LJ, 2007, MILBANK Q, V85, P259, DOI 10.1111/j.1468-0009.2007.00486.x; Paik M, 2013, J EMPIR LEGAL STUD, V10, P612, DOI 10.1111/jels.12021; Public Citizen, 2012, MEDICAL MALPRACTICE; Rubin JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002985; Sage WM, 2014, HEALTH AFFAIR, V33, P11, DOI 10.1377/hlthaff.2013.0930; Sage WM, 2006, MEDICAL MALPRACTICE AND THE U.S. HEALTH CARE SYSTEM, P1, DOI 10.2277/ 0521614112; Sebelius K, 2014, MEMORANDUM DECISION; Siegal G, 2008, AM J LAW MED, V34, P493, DOI 10.1177/009885880803400402; Sorrel AL, 2008, AMERICAN MEDICAL NEW; Studdert DM, 2010, MED J AUSTRALIA, V193, P273, DOI 10.5694/j.1326-5377.2010.tb03906.x; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Tehrani ASS, 2013, BMJ QUAL SAF, V22, P672, DOI 10.1136/bmjqs-2012-001550; Teninbaum GH, 2011, CHAPMAN LAW REV, V15, P307; Waters TM, 2007, HEALTH AFFAIR, V26, P500, DOI 10.1377/hlthaff.26.2.500; Waters TM, 2003, INQUIRY-J HEALTH CAR, V40, P283, DOI 10.5034/inquiryjrnl_40.3.283	77	62	63	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2146	2155		10.1001/jama.2014.10705	http://dx.doi.org/10.1001/jama.2014.10705			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU5DG	25358122				2022-12-28	WOS:000345626800018
J	Akagi, T; Henry, IM; Tao, R; Comai, L				Akagi, Takashi; Henry, Isabelle M.; Tao, Ryutaro; Comai, Luca			A Y-chromosome-encoded small RNA acts as a sex determinant in persimmons	SCIENCE			English	Article							SILENE-LATIFOLIA; FLOWERING PLANTS; EVOLUTION; PAPAYA; EBENACEAE; MODEL; DIVERGENCE; EXPANSION; MARKERS; SYSTEM	In plants, multiple lineages have evolved sex chromosomes independently, providing a powerful comparative framework, but few specific determinants controlling the expression of a specific sex have been identified. We investigated sex determinants in the Caucasian persimmon, Diospyros lotus, a dioecious plant with heterogametic males (XY). Male-specific short nucleotide sequences were used to define a male-determining region. A combination of transcriptomics and evolutionary approaches detected a Y-specific sex-determinant candidate, OGI, that displays male-specific conservation among Diospyros species. OGI encodes a small RNA targeting the autosomal MeGI gene, a homeodomain transcription factor regulating anther fertility in a dosage-dependent fashion. This identification of a feminizing gene suppressed by a Y-chromosome-encoded small RNA contributes to our understanding of the evolution of sex chromosome systems in higher plants.	[Akagi, Takashi; Henry, Isabelle M.; Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Akagi, Takashi; Henry, Isabelle M.; Comai, Luca] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Akagi, Takashi; Tao, Ryutaro] Kyoto Univ, Lab Pomol, Grad Sch Agr, Kyoto, Japan	University of California System; University of California Davis; University of California System; University of California Davis; Kyoto University	Tao, R (corresponding author), Kyoto Univ, Lab Pomol, Grad Sch Agr, Kyoto, Japan.	rtao@kais.kyoto-u.ac.jp; lcomai@ucdavis.edu	Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619; Henry, Isabelle/0000-0002-6796-1119	Japan Society for the Promotion of Science (JSPS); JSPS [26712005, 26660025]; University of California Davis Genome Center seed grant; Office of Science (Biology and Environmental Research) of the U.S. Department of Energy [DE-SC0007183]; BioProject [PRJNA261435]; Transcriptome Shotgun Assembly (TSA) project [GBSJ00000000]; Division Of Integrative Organismal Systems [1457230] Funding Source: National Science Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of California Davis Genome Center seed grant; Office of Science (Biology and Environmental Research) of the U.S. Department of Energy; BioProject; Transcriptome Shotgun Assembly (TSA) project; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Lieberman and K. Ngo for bioinformatics support, the University of California Davis Genome Center DNA Technologies Core for sequencing support, and the U.S. Department of Agriculture's Agricultural Research Service for providing plant samples from various Diospyros species. Supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) fellows (to T. A.); a Grant-in-Aid for Young Scientists (A) (no. 26712005 to T. A.) and for Challenging Exploratory Research (no. 26660025 to R. T.) from JSPS; a University of California Davis Genome Center seed grant (to I. M. H.); and the Office of Science (Biology and Environmental Research) of the U.S. Department of Energy (grant DE-SC0007183 to L. C.). All sequence data generated in the context of this manuscript have been deposited in the appropriate NCBI database: Illumina and PacBio reads in the Short Read Archives (SRA) database (SRA ID SRP045872), RNA-Seq reads and associated statistics in the Gene Expression Omnibus (GEO: GSE61386) database (BioProject ID PRJNA261435), and the OGI and MeGI genomic sequences obtained from various Diospyros species were submitted to GenBank (IDs KM408638 to KM408642). The Whole Genome Shotgun (WGS) project has been deposited at DDBJ/EMBL/GenBank under the accession no. JRBH00000000. The version described in this paper is version JRBH01000000. The Transcriptome Shotgun Assembly (TSA) project has been deposited at DDBJ/EMBL/GenBank under the accession no. GBSJ00000000. The version described in this paper is the first version, GBSJ01000000. The authors declare no competing financial interests. T. A., I. M. H., and L. C. designed the experiments. T. A. performed the experiments. T. A. and I. M. H. analyzed the data. R. T. initiated the study and maintained the KK persimmon sib-family. T. A. drafted the manuscript. All authors participated in data interpretation, edited the manuscript, and approved the final manuscript. Correspondence and requests for materials should be addressed to R. T. (rtao@kais.kyoto-u.ac.jp) and L.C. (lcomai@udavis.edu).	Ainsworth C, 2000, ANN BOT-LONDON, V86, P211, DOI 10.1006/anbo.2000.1201; Akagi T, 2014, J JPN SOC HORTIC SCI, V83, P214, DOI 10.2503/jjshs1.CH-109; Aryal R, 2014, PLANT SCI, V217, P56, DOI 10.1016/j.plantsci.2013.10.018; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bergero R, 2013, GENETICS, V194, P673, DOI 10.1534/genetics.113.150755; Blavet N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-226; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Cherif E, 2013, NEW PHYTOL, V197, P409, DOI 10.1111/nph.12069; CHRISTOPHEL DC, 1982, NATURE, V296, P439, DOI 10.1038/296439a0; Duangjai S, 2006, AM J BOT, V93, P1808, DOI 10.3732/ajb.93.12.1808; Gschwend AR, 2012, P NATL ACAD SCI USA, V109, P13716, DOI 10.1073/pnas.1121096109; Kejnovsky E, 2010, CYTOGENET GENOME RES, V129, P250, DOI 10.1159/000314285; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Ming R, 2007, AM J BOT, V94, P141, DOI 10.3732/ajb.94.2.141; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Quinn AE, 2011, BIOL LETTERS, V7, P443, DOI 10.1098/rsbl.2010.1126; Sakuma S, 2013, NEW PHYTOL, V197, P939, DOI 10.1111/nph.12068; Turner B, 2013, MOL PHYLOGENET EVOL, V69, P740, DOI 10.1016/j.ympev.2013.07.002; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1	25	233	257	11	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		646	650		10.1126/science.1257225	http://dx.doi.org/10.1126/science.1257225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359977				2022-12-28	WOS:000343799700053
J	Brown, DL				Brown, David L.			Review: CABG or stents compared with medical therapy in stable coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Brown, DL (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.								0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC10	10.7326/0003-4819-161-8-201410210-02010	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329215				2022-12-28	WOS:000343906800009
J	Masaoutis, P; Koutsandrea, C; Paraskevopoulos, T; Georgalas, I				Masaoutis, Panos; Koutsandrea, Chryssanthi; Paraskevopoulos, Theodore; Georgalas, Ilias			White pupillary reflex in a 3 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIFFUSE ANTERIOR RETINOBLASTOMA; TRILATERAL RETINOBLASTOMA; RETINAL INVOLVEMENT; CHEMOREDUCTION; CHEMOTHERAPY; GUIDELINES; LESIONS; TUMORS		[Masaoutis, Panos; Koutsandrea, Chryssanthi; Paraskevopoulos, Theodore; Georgalas, Ilias] Univ Athens, Dept Ophthalmol, Athens, Greece	National & Kapodistrian University of Athens	Masaoutis, P (corresponding author), 154 Mesogeion Ave, Athens 15400, Greece.	lekiat37@gmail.com	Georgalas, Ilias/AAD-5946-2019	Georgalas, Ilias/0000-0002-6171-5865				Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030; Abramson DH, 2001, OPHTHALMOLOGY, V108, P1868, DOI 10.1016/S0161-6420(01)00713-8; Abramson DH, 1998, J PEDIATR-US, V132, P505, DOI 10.1016/S0022-3476(98)70028-9; Aerts I, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-31; Balmer A, 2007, CLIN OPHTHALMOL, V1, P431; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Chakraborty S, 2007, GENOMICS, V90, P344, DOI 10.1016/j.ygeno.2007.05.002; Crosby MB, 2009, ARCH PATHOL LAB MED, V133, P1215, DOI 10.1043/1543-2165-133.8.1215; de Graaf P, 2012, PEDIATR RADIOL, V42, P2, DOI 10.1007/s00247-011-2201-5; de Jong MC, 2014, OPHTHALMOLOGY, V121, P1109, DOI 10.1016/j.ophtha.2013.11.021; Ganguly A, 2009, RETINA-J RET VIT DIS, V29, P1002, DOI 10.1097/IAE.0b013e3181a0be05; GARNER A, 1987, BRIT J OPHTHALMOL, V71, P858, DOI 10.1136/bjo.71.11.858; Ghassemi F, 2012, ARCH OPHTHALMOL-CHIC, V130, P1268, DOI 10.1001/archophthalmol.2012.1983; Graeber CP, 2011, OPEN OPHTHALMOL J, V5, P1, DOI 10.2174/1874364101105010001; Grossniklaus HE, 1998, RETINA-J RET VIT DIS, V18, P238, DOI 10.1097/00006982-199803000-00008; Honavar Santosh G, 2005, Ophthalmol Clin North Am, V18, P65, DOI 10.1016/j.ohc.2004.09.001; Honavar SG, 2002, ARCH OPHTHALMOL-CHIC, V120, P923, DOI 10.1001/archopht.120.7.923; Honavar SG, 2005, OPHTHALMOL CLIN N AM, V18, pviii; Kaufman LM, 1998, RADIOL CLIN N AM, V36, P1101, DOI 10.1016/S0033-8389(05)70234-7; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Linn Murphree A, 2005, Ophthalmol Clin North Am, V18, P41; Longmuir SQ, 2010, OPHTHALMOLOGY, V117, P2034, DOI 10.1016/j.ophtha.2010.02.010; Mahajan A, 2011, SEMIN ULTRASOUND CT, V32, P28, DOI 10.1053/j.sult.2010.12.001; Mastrangelo D, 2007, EUR J CANCER, V43, P1596, DOI 10.1016/j.ejca.2007.04.019; Murphree AL, 2005, OPHTHALMOL CLIN N AM, V18, pviii; Palma J, 2012, BONE MARROW TRANSPL, V47, P522, DOI 10.1038/bmt.2011.108; REESE A B, 1963, Trans Am Acad Ophthalmol Otolaryngol, V67, P164; Rodjan F, 2012, J NEURO-ONCOL, V109, P535, DOI 10.1007/s11060-012-0922-4; Rodriguez-Galindo C, 2003, J CLIN ONCOL, V21, P2019, DOI 10.1200/JCO.2003.09.103; Shields Carol L, 2004, Cancer Control, V11, P317; Shields CL, 2013, OPHTHALMOLOGY, V120, P311, DOI 10.1016/j.ophtha.2012.07.067; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; Shields CL, 1999, ARCH OPHTHALMOL-CHIC, V117, P885; Shields CL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1269; Shields JA, 1992, OCULAR TUMORS TEXT A, P311; Simpson ER, 2014, BRACHYTHERAPY, V13, P1, DOI 10.1016/j.brachy.2013.11.008; Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665; Villegas VM, 2013, CURR OPIN OPHTHALMOL, V24, P581, DOI 10.1097/ICU.0000000000000002; Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6	41	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2014	349								g6081	10.1136/bmj.g6081	http://dx.doi.org/10.1136/bmj.g6081			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OD	25336274				2022-12-28	WOS:000343768200002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: What use is mass flu vaccination?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD005187.PUB4; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000364.pub4; Demicheli V, 2014, COCHRANE DB SYST REV, V3; Department of Health, 2014, NAT FLU IMM PROGR; Department of Health Social Services and Public Safety (Northern Ireland), 2013, SEAS INFL PROGR 2013; Jefferson T, 2012, COCHRANE DB SYST REV, V2; JEFFERSON T, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004876.PUB3; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Poole PJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002733.PUB2; Scottish Government, 2013, SEAS INFL VACC PROGR; Welsh Government, 2014, SEAS FLU VCC PROGR 2	11	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2014	349								g6182	10.1136/bmj.g6182	http://dx.doi.org/10.1136/bmj.g6182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OC	25331457	Green Published, hybrid			2022-12-28	WOS:000343768100003
J	Ford, AT; Goheen, JR; Otieno, TO; Bidner, L; Isbell, LA; Palmer, TM; Ward, D; Woodroffe, R; Pringle, RM				Ford, Adam T.; Goheen, Jacob R.; Otieno, Tobias O.; Bidner, Laura; Isbell, Lynne A.; Palmer, Todd M.; Ward, David; Woodroffe, Rosie; Pringle, Robert M.			Large carnivores make savanna tree communities less thorny	SCIENCE			English	Article							POPULATION-CONTROL; COMPETITION; PREY	Understanding how predation risk and plant defenses interactively shape plant distributions is a core challenge in ecology. By combining global positioning system telemetry of an abundant antelope (impala) and its main predators (leopards and wild dogs) with a series of manipulative field experiments, we showed that herbivores' risk-avoidance behavior and plants' antiherbivore defenses interact to determine tree distributions in an African savanna. Well-defended thorny Acacia trees (A. etbaica) were abundant in low-risk areas where impala aggregated but rare in high-risk areas that impala avoided. In contrast, poorly defended trees (A. brevispica) were more abundant in high-than in low-risk areas. Our results suggest that plants can persist in landscapes characterized by intense herbivory, either by defending themselves or by thriving in risky areas where carnivores hunt.	[Ford, Adam T.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Ford, Adam T.; Goheen, Jacob R.; Otieno, Tobias O.; Bidner, Laura; Isbell, Lynne A.; Palmer, Todd M.; Woodroffe, Rosie; Pringle, Robert M.] Mpala Res Ctr, Nanyuki, Kenya; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Bidner, Laura; Isbell, Lynne A.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL USA; [Ward, David] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa; [Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of British Columbia; University of Wyoming; University of California System; University of California Davis; State University System of Florida; University of Florida; University of Kwazulu Natal; Zoological Society of London; Princeton University	Ford, AT (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	atford@zoology.ubc.ca	Palmer, Todd/GRS-0639-2022	Palmer, Todd/0000-0001-5710-9750	Canada's Natural Sciences and Engineering Research Council; University of British Columbia; University of Wyoming; American Society of Mammalogists; Keren Keyemet I'Israel; U.S. National Science Foundation; Wenner-Gren Foundation; Direct For Social, Behav & Economic Scie [1266389] Funding Source: National Science Foundation	Canada's Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia; University of Wyoming; American Society of Mammalogists; Keren Keyemet I'Israel; U.S. National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by grants from Canada's Natural Sciences and Engineering Research Council (A.T.F., J.R.G.), the University of British Columbia (A.T.F.) the University of Wyoming (J.R.G.), the American Society of Mammalogists (A.T.F.), Keren Keyemet I'Israel (D.W.) the U.S. National Science Foundation (L.A.I.), and the Wenner-Gren Foundation (L.B.). We thank S. Lima, M. Kinnaird, M. Littlewood, B. Agwanda, C. Forbes, J. Estes, M. Kauffman, R. Ostfeld, S. Buskirk, C. Martinez del Rio, C. Riginos, and the Kenya Wildlife Service. Comments from three anonymous reviewers greatly improved the manuscript.	Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Augustine DJ, 2004, J WILDLIFE MANAGE, V68, P916, DOI 10.2193/0022-541X(2004)068[0916:IOCMOH]2.0.CO;2; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Goheen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055192; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; MURDOCH WW, 1966, AM NAT, V100, P219, DOI 10.1086/282415; Orrock JL, 2010, ECOL LETT, V13, P11, DOI 10.1111/j.1461-0248.2009.01412.x; Pimm SL, 1991, BALANCE NATURE ECOLO; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schmitz O. J., 2010, MONOGR POPUL BIOL, V47; SCHMITZ OJ, 1994, P NATL ACAD SCI USA, V91, P5364, DOI 10.1073/pnas.91.12.5364; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Veblen KE, 2012, J ARID ENVIRON, V78, P119, DOI 10.1016/j.jaridenv.2011.10.016; YOUNG TP, 1995, ECOL APPL, V5, P97, DOI 10.2307/1942055	18	140	141	8	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					346	349		10.1126/science.1252753	http://dx.doi.org/10.1126/science.1252753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324387				2022-12-28	WOS:000343041100043
J	Eisenstein, M				Eisenstein, Michael			Remove, reuse, recycle	NATURE			English	Editorial Material							AUTOPHAGY; BECLIN-1											Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2012, EMBO REP, V13, P173, DOI 10.1038/embor.2012.5; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362	7	13	16	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					S2	S4		10.1038/514S2a	http://dx.doi.org/10.1038/514S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25317592	Bronze			2022-12-28	WOS:000342988600002
J	Van Calster, B; Van Hoorde, K; Valentin, L; Testa, AC; Fischerova, D; Van Holsbeke, C; Savelli, L; Franchi, D; Epstein, E; Kaijser, J; Van Belle, V; Czekierdowski, A; Guerriero, S; Fruscio, R; Lanzani, C; Scala, F; Bourne, T; Timmerman, D				Van Calster, Ben; Van Hoorde, Kirsten; Valentin, Lil; Testa, Antonia C.; Fischerova, Daniela; Van Holsbeke, Caroline; Savelli, Luca; Franchi, Dorella; Epstein, Elisabeth; Kaijser, Jeroen; Van Belle, Vanya; Czekierdowski, Artur; Guerriero, Stefano; Fruscio, Robert; Lanzani, Chiara; Scala, Felice; Bourne, Tom; Timmerman, Dirk		Int Ovarian Tumour Anal IOTA Grp	Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOGISTIC-REGRESSION MODELS; MATHEMATICAL-MODELS; PROSPECTIVE VALIDATION; EXTERNAL VALIDATION; PREDICTION; ULTRASOUND; SURVIVAL; DISTINGUISH; MASSES; CA-125	Objectives To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours. Design Observational diagnostic study using prospectively collected clinical and ultrasound data. Setting 24 ultrasound centres in 10 countries. Participants Women with an ovarian (including para-ovarian and tubal) mass and who underwent a standardised ultrasound examination before surgery. The model was developed on 3506 patients recruited between 1999 and 2007, temporally validated on 2403 patients recruited between 2009 and 2012, and then updated on all 5909 patients. Main outcome measures Histological classification and surgical staging of the mass. Results The Assessment of Different NEoplasias in the adneXa (ADNEX) model contains three clinical and six ultrasound predictors: age, serum CA-125 level, type of centre (oncology centres v other hospitals), maximum diameter of lesion, proportion of solid tissue, more than 10 cyst locules, number of papillary projections, acoustic shadows, and ascites. The area under the receiver operating characteristic curve (AUC) for the classic discrimination between benign and malignant tumours was 0.94 (0.93 to 0.95) on temporal validation. The AUC was 0.85 for benign versus borderline, 0.92 for benign versus stage I cancer, 0.99 for benign versus stage II-IV cancer, and 0.95 for benign versus secondary metastatic. AUCs between malignant subtypes varied between 0.71 and 0.95, with an AUC of 0.75 for borderline versus stage I cancer and 0.82 for stage II-IV versus secondary metastatic. Calibration curves showed that the estimated risks were accurate. Conclusions The ADNEX model discriminates well between benign and malignant tumours and offers fair to excellent discrimination between four types of ovarian malignancy. The use of ADNEX has the potential to improve triage and management decisions and so reduce morbidity and mortality associated with adnexal pathology.	[Van Calster, Ben; Kaijser, Jeroen; Bourne, Tom; Timmerman, Dirk] Katholieke Univ Leuven, Dept Dev & Regenerat, B-3000 Leuven, Belgium; [Van Hoorde, Kirsten; Van Belle, Vanya] Katholieke Univ Leuven, Dept Elect Engn, B-3000 Leuven, Belgium; [Van Hoorde, Kirsten; Van Belle, Vanya] Katholieke Univ Leuven, iMinds Med Informat Technol, B-3000 Leuven, Belgium; [Valentin, Lil] Lund Univ, Skane Univ Hosp Malmo, Dept Obstet & Gynaecol, Malmo, Sweden; [Testa, Antonia C.] Univ Cattolica Sacro Cuore, Dept Oncol, I-00168 Rome, Italy; [Fischerova, Daniela] Charles Univ Prague, Dept Obstet & Gynaecol, Gynaecol Oncol Ctr, Prague, Czech Republic; [Van Holsbeke, Caroline] Ziekenhuis Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium; [Savelli, Luca] Univ Bologna, S Orsola Malpighi Hosp, Gynaecol & Reprod Med Unit, Bologna, Italy; [Franchi, Dorella] European Inst Oncol, Div Gynaecol, Prevent Gynaecol Unit, Milan, Italy; [Epstein, Elisabeth] Karolinska Univ Hosp, Dept Obstet & Gynaecol, Stockholm, Sweden; [Kaijser, Jeroen; Bourne, Tom; Timmerman, Dirk] Univ Hosp Leuven, Dept Obstet & Gynaecol, Leuven, Belgium; [Czekierdowski, Artur] Med Univ Lublin, Dept Gynaecol Oncol & Gynaecol 1, Lublin, Poland; [Guerriero, Stefano] Azienda Osped Univ Cagliari, Dept Obstet & Gynaecol, Cagliari, Italy; [Fruscio, Robert] Univ Milano Bicocca, San Gerardo Hosp, Clin Obstet & Gynaecol, Monza, Italy; [Lanzani, Chiara] Univ Milan, Biol & Clin Sch Med, Buzzi Childrens Hosp, Dept Woman Mother & Neonate, Milan, Italy; [Scala, Felice] Ist Nazl Tumori, Dept Gynaecol Oncol, Naples, Italy; [Bourne, Tom] Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, London, England	KU Leuven; KU Leuven; IMEC; KU Leuven; Lund University; Skane University Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Charles University Prague; East Limburg Hospital; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS European Institute of Oncology (IEO); Karolinska Institutet; Karolinska University Hospital; KU Leuven; University Hospital Leuven; Medical University of Lublin; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Florence; Azienda Ospedaliero Universitaria Careggi; San Gerardo Hospital; University of Milano-Bicocca; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Imperial College London	Van Calster, B (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Herestr 49 Box 7003, B-3000 Leuven, Belgium.	ben.vancalster@med.kuleuven.be	Fischerova, Daniela/D-2857-2017; Van Calster, Ben/F-9150-2010; Guerriero, Stefano/AAL-3252-2020; TESTA, Antonia Carla/AAC-2582-2019; Epstein, Elisabeth/GRO-7235-2022; Timmerman, Dirk/AAD-2363-2019; epstein, elisabeth/F-4586-2014; Bourne, Tom/I-6478-2012; Fruscio, Robert/F-8542-2011	Fischerova, Daniela/0000-0002-7224-3218; Van Calster, Ben/0000-0003-1613-7450; Guerriero, Stefano/0000-0002-1359-7155; TESTA, Antonia Carla/0000-0003-2217-8726; Timmerman, Dirk/0000-0002-3707-6645; epstein, elisabeth/0000-0003-2298-7785; Bourne, Tom/0000-0003-1421-6059; Savelli, Luca/0000-0003-0961-7296; Fruscio, Robert/0000-0001-5688-2194; Czekierdowski, Artur/0000-0001-6481-4271; Valentin, Lil/0000-0002-3830-6414	Flemish government: Research Foundation-Flanders (FWO) [G049312N]; Flanders' Agency for Innovation by Science and Technology (IWT) project [IWT-TBM 070706-IOTA3]; iMinds; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust; Imperial College London; Swedish Medical Research Council [K2001-72X-11605-06A, K2002-72X-11605-07B, K2004-73X-11605-09A, K2006-73X-11605-11-3]; Swedish governmental grants (ALF-medel and Landstingsfinansierad Regional Forskning)	Flemish government: Research Foundation-Flanders (FWO)(FWO); Flanders' Agency for Innovation by Science and Technology (IWT) project; iMinds; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust; Imperial College London(General Electric); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish governmental grants (ALF-medel and Landstingsfinansierad Regional Forskning)	This study was supported by the Flemish government: Research Foundation-Flanders (FWO) project G049312N, Flanders' Agency for Innovation by Science and Technology (IWT) project IWT-TBM 070706-IOTA3, and iMinds 2013. BVC and VVB are postdoctoral fellows of FWO. KVH is a doctoral fellow of IWT. TB is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the authors and not necessarily those of the NHS, NIHR or Department of Health. LV is supported by the Swedish Medical Research Council (grants K2001-72X-11605-06A, K2002-72X-11605-07B, K2004-73X-11605-09A, and K2006-73X-11605-11-3), funds administered by Malmo University Hospital and Skane University Hospital, Allmanna Sjukhusets i Malmo Stiftelse for bekampande av cancer (the Malmo General Hospital Foundation for fighting against cancer), and two Swedish governmental grants (ALF-medel and Landstingsfinansierad Regional Forskning). The sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the work for publication. The researchers performed this work independently of the funding sources.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bristow RE, 2014, GYNECOL ONCOL, V132, P403, DOI 10.1016/j.ygyno.2013.12.017; Bristow RE, 2013, OBSTET GYNECOL, V121, P1226, DOI 10.1097/AOG.0b013e3182922a17; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Darai E, 2013, HUM REPROD UPDATE, V19, P151, DOI 10.1093/humupd/dms047; Davelaar EM, 1998, CLIN CHEM, V44, P1417; Earle CC, 2006, J NATL CANCER I, V98, P172, DOI 10.1093/jnci/djj019; Education and Practical Standards Committee European Federation of Societies for Ultrasound in Medicine and Biology, 2006, Ultraschall Med, V27, P79; Engelen MJA, 2006, CANCER-AM CANCER SOC, V106, P589, DOI 10.1002/cncr.21616; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howlader N, 2014, SEER CANC STAT REV 1; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kaijser J, 2013, ULTRASOUND OBST GYN, V41, P9, DOI 10.1002/uog.12323; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Kuss O, 2007, COMPUT METH PROG BIO, V87, P262, DOI 10.1016/j.cmpb.2007.06.002; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Nunes N, 2013, INT J GYNECOL CANCER, V23, P1583, DOI 10.1097/IGC.0b013e3182a6171a; Royal College of Obstetrics and Gynaecology, 2011, MAN SUSP OV MASS PRE; Royston P., 2008, MULTIVARIABLE MODEL; Sayasneh A, 2013, BRIT J CANCER, V108, P2448, DOI 10.1038/bjc.2013.224; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Testa A, 2014, BRIT J CANCER, V111, P680, DOI 10.1038/bjc.2014.333; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 2010, ULTRASOUND OBST GYN, V36, P226, DOI 10.1002/uog.7636; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Timmerman D, 2010, BMJ-BRIT MED J, V341, pc6839, DOI [DOI 10.1136/BMJ.C6839, 10.1136/bmj.c6839]; Timmerman D, 2007, J CLIN ONCOL, V25, P4194, DOI 10.1200/JCO.2006.09.5943; Van Calster B, 2012, EUR J EPIDEMIOL, V27, P761, DOI 10.1007/s10654-012-9733-3; Van Calster B, 2012, STAT MED, V31, P2610, DOI 10.1002/sim.5321; Van Calster B, 2011, CANCER EPIDEM BIOMAR, V20, P2420, DOI 10.1158/1055-9965.EPI-11-0422; Van Calster B, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-96; Van Holsbeke C, 2009, CLIN CANCER RES, V15, P684, DOI 10.1158/1078-0432.CCR-08-0113; Van Hoorde K, 2014, STAT MED, V33, P2585, DOI 10.1002/sim.6114; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vergote I, 2001, LANCET, V357, P176, DOI 10.1016/S0140-6736(00)03590-X; Verleye L, 2010, Eur J Surg Oncol, V36 Suppl 1, pS108, DOI 10.1016/j.ejso.2010.06.006; Vernooij F, 2008, JNCI-J NATL CANCER I, V100, P399, DOI 10.1093/jnci/djn033; Woo YL, 2012, GYNECOL ONCOL, V126, P286, DOI 10.1016/j.ygyno.2012.04.012; Wynants L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-128	48	204	210	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2014	349								g5920	10.1136/bmj.g5920	http://dx.doi.org/10.1136/bmj.g5920			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NU	25320247	Green Published, hybrid			2022-12-28	WOS:000343767400002
J	Walker, AMN; Parviz, Y; Heppenstall, J; Best, J; Grech, ED				Walker, Andrew M. N.; Parviz, Yasir; Heppenstall, James; Best, James; Grech, Ever D.			PICTURE QUIZ A 16 year old boy with chest pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CORONARY; CLOPIDOGREL		[Walker, Andrew M. N.; Parviz, Yasir; Heppenstall, James; Best, James; Grech, Ever D.] No Gen Hosp, South Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Walker, AMN (corresponding author), No Gen Hosp, South Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England.	a.m.n.walker@leeds.ac.uk		Walker, Andrew/0000-0003-0380-7283; Best, James/0000-0001-5269-8605				Cabello JB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007160.pub3; Carano N, 2004, PEDIATRICS, V114, P255; Cutri N, 2011, INT J CARDIOL, V146, P457, DOI 10.1016/j.ijcard.2010.10.120; Falcone M Wayne, 2004, Proc (Bayl Univ Med Cent), V17, P363; Gautschi M, 2012, JIMD REP, V2, P45, DOI 10.1007/8904_2011_45; Gersony DR, 2001, J AM SOC ECHOCARDIOG, V14, P1227, DOI 10.1067/mje.2001.114138; Katsimagklis G, 2014, INT J CARDIOL, V172, pE307, DOI 10.1016/j.ijcard.2013.12.186; Lluri G, 2014, CLIN CARDIOL, V37, P126, DOI 10.1002/clc.22237; Ayman AE, 2006, J POSTGRAD MED, V52, P51; National Institute for Health and Care Excellence, 2013, MYOC INF ST SEGM EL; Patra Soumya, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-200799; Pineault J, 2011, INT J GEN MED, V4, P889, DOI 10.2147/IJGM.S22906; Pinto DS, 2006, CIRCULATION, V114, P2019, DOI 10.1161/CIRCULATIONAHA.106.638353; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	16	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2014	349								g6172	10.1136/bmj.g6172	http://dx.doi.org/10.1136/bmj.g6172			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NU	25319730				2022-12-28	WOS:000343767400004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Does the GMC deserve its current powers?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				General Medical Council, 2014, REV WE DEAL CONC DOC; General Medical Council, 2013, GOOD MED PRACT EXPL; Hammond P., 2014, PRIVATE EYE     0703; Moberly T, 2014, BMJ CAREERS	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2014	349								g5959	10.1136/bmj.g5959	http://dx.doi.org/10.1136/bmj.g5959			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NR	25313191	Green Published, Bronze			2022-12-28	WOS:000343767100001
J	Watts, G				Watts, Geoff			Janet Hemingway: putting the bite back into insect vector biology	LANCET			English	Biographical-Item																			0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1339	1339		10.1016/S0140-6736(14)61807-9	http://dx.doi.org/10.1016/S0140-6736(14)61807-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25307835				2022-12-28	WOS:000343004000013
J	Laland, K; Uller, T; Feldman, M; Sterelny, K; Muller, GB; Moczek, A; Jablonka, E; Odling-Smee, J				Laland, Kevin; Uller, Tobias; Feldman, Marc; Sterelny, Kim; Mueller, Gerd B.; Moczek, Armin; Jablonka, Eva; Odling-Smee, John			Does evolutionary theory need a rethink? - POINT Yes, urgently	NATURE			English	Editorial Material									[Laland, Kevin] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Laland, K (corresponding author), Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland.	knl1@st-andrews.ac.uk	Krammel, Vera/N-4826-2014; Hoekstra, Hopi/I-6690-2012	Krammel, Vera/0000-0002-8273-8396; Strassmann, Joan/0000-0003-0638-8440; Hoekstra, Hopi/0000-0003-1431-1769; Lenski, Richard/0000-0002-1064-8375; Sterelny, Kim/0000-0003-3159-6698; Laland, Kevin/0000-0002-2457-0900; Schluter, Dolph/0000-0003-1683-7836				Arthur W., 2004, BIASED EMBRYOS EVOLU; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Erwin D. H., 2013, CAMBRIAN EXPLOSION; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; Jablonka E, 2014, LIFE MIND-PHILOS ISS, P1; Noble D, 2014, J PHYSIOL-LONDON, V592, P2237, DOI 10.1113/jphysiol.2014.273151; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci Massimo, 2010, EVOLUTION EXTENDED S, DOI DOI 10.1016/j.tree.2008.04.005; West-Eberhard Mary Jane, 2003, pi	10	418	444	7	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					161	164		10.1038/514161a	http://dx.doi.org/10.1038/514161a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3BG	25297418	Green Submitted, Bronze			2022-12-28	WOS:000342663100014
J	Yore, MM; Syed, I; Moraes-Vieira, PM; Zhang, TJ; Herman, MA; Homan, EA; Patel, RT; Lee, J; Chen, SL; Peroni, OD; Dhaneshwar, AS; Hammarstedt, A; Smith, U; McGraw, TE; Saghatelian, A; Kahn, BB				Yore, Mark M.; Syed, Ismail; Moraes-Vieira, Pedro M.; Zhang, Tejia; Herman, Mark A.; Homan, Edwin A.; Patel, Rajesh T.; Lee, Jennifer; Chen, Shili; Peroni, Odile D.; Dhaneshwar, Abha S.; Hammarstedt, Ann; Smith, Ulf; McGraw, Timothy E.; Saghatelian, Alan; Kahn, Barbara B.			Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects	CELL			English	Article							FREE FATTY-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OBESITY; GPR120; OVEREXPRESSION; MACROPHAGES; LIPOGENESIS; ADIPOCYTES	Increased adipose tissue lipogenesis is associated with enhanced insulin sensitivity. Mice overexpressing the Glut4 glucose transporter in adipocytes have elevated lipogenesis and increased glucose tolerance despite being obese with elevated circulating fatty acids. Lipidomic analysis of adipose tissue revealed the existence of branched fatty acid esters of hydroxy fatty acids (FAHFAs) that were elevated 16- to 18-fold in these mice. FAHFA isomers differ by the branched ester position on the hydroxy fatty acid (e.g., palmitic-acid-9-hydroxy-stearic-acid, 9-PAHSA). PAHSAs are synthesized in vivo and regulated by fasting and high-fat feeding. PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. PAHSA administration in mice lowers ambient glycemia and improves glucose tolerance while stimulating GLP-1 and insulin secretion. PAHSAs also reduce adipose tissue inflammation. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes.	[Yore, Mark M.; Syed, Ismail; Moraes-Vieira, Pedro M.; Herman, Mark A.; Lee, Jennifer; Peroni, Odile D.; Dhaneshwar, Abha S.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Yore, Mark M.; Syed, Ismail; Moraes-Vieira, Pedro M.; Herman, Mark A.; Lee, Jennifer; Peroni, Odile D.; Dhaneshwar, Abha S.; Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Patel, Rajesh T.; McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Zhang, Tejia; Homan, Edwin A.; Chen, Shili; Saghatelian, Alan] Harvard Univ, Dept Mol & Clin Med, Cambridge, MA 02138 USA; [Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University; Harvard University; University of Gothenburg	Saghatelian, A (corresponding author), Salk Inst Biol Studies, Torrey Pines Rd, La Jolla, CA 92037 USA.	asaghatelian@salk.edu; bkahn@bidmc.harvard.edu	Moraes-Vieira, Pedro/C-8701-2014; Mo, Xiulei/A-1616-2017	Moraes-Vieira, Pedro/0000-0002-8263-786X; Herman, Mark/0000-0001-6979-103X; SYED, ISMAIL/0000-0002-1941-5957	NIH [R37DK43051, P30 DK57521, R01 DK098002]; JPB foundation; Searle Scholars Award; Burroughs Welcome Fund CABS; Sloan Foundation Fellowship; Harvard Training Program in Nutrition and Metabolism [2T32HD052961, 5T32DK007516, K08 DK076726, P30 DK046200]; Novo Nordisk Fonden [NNF14OC0009795] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, T32DK007516, P30DK057521, R37DK043051, K08DK076726, R01DK098002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Searle Scholars Award; Burroughs Welcome Fund CABS(Burroughs Wellcome Fund); Sloan Foundation Fellowship(Alfred P. Sloan Foundation); Harvard Training Program in Nutrition and Metabolism; Novo Nordisk Fonden(Novo Nordisk Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Thue Schwartz for stimulating discussions; Drs. Anna Greka and Dequan Tian for performing functional assays; Pratik Aryal, Marlee Jackson, Kerry Wellenstein, and Peter Dwyer for technical assistance; and Dr. Douglas Hanahan for the STC1 cells. Supported by grants from the NIH R37DK43051 and P30 DK57521 (B.B.K.); R01 DK098002 (B.B.K. and T.E.M.); a grant from the JPB foundation (B.B.K.). Searle Scholars Award, Burroughs Welcome Fund CABS, and Sloan Foundation Fellowship (A.S.); Harvard Training Program in Nutrition and Metabolism, 2T32HD052961 (M.M.Y.); 5T32DK007516 (B.B.K., M.M.Y., and J.L.); K08 DK076726 (M.A.H.); P30 DK046200 (M.A.H.). B.B.K., M.A.H., A.S., and E.A.H. are inventors on a patent related to the fatty acid hydroxy-fatty acids.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Mo XL, 2013, PROG MOL BIOL TRANSL, V114, P251, DOI 10.1016/B978-0-12-386933-3.00007-8; Moe MK, 2004, RAPID COMMUN MASS SP, V18, P1731, DOI 10.1002/rcm.1545; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Virtanen JK, 2014, DIABETES CARE, V37, P189, DOI 10.2337/dc13-1504	30	471	484	11	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					318	332		10.1016/j.cell.2014.09.035	http://dx.doi.org/10.1016/j.cell.2014.09.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303528	Green Accepted, Bronze			2022-12-28	WOS:000343095600014
J	Lamb, SE; Williamson, EM; Heine, PJ; Adams, J; Dosanjh, S; Dritsaki, M; Glover, MJ; Lord, J; McConkey, C; Nichols, V; Rahman, A; Underwood, M; Williams, MA				Lamb, Sarah E.; Williamson, Esther M.; Heine, Peter J.; Adams, Jo; Dosanjh, Sukhdeep; Dritsaki, Melina; Glover, Matthew J.; Lord, Joanne; McConkey, Christopher; Nichols, Vivien; Rahman, Anisur; Underwood, Martin; Williams, Mark A.		Strengthening & Stretching Rheumat	Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial	LANCET			English	Article							DISEASE-ACTIVITY; HIGH-INTENSITY; FOLLOW-UP; CLINICAL-TRIALS; ARTHRITIS; PROGRAM; PEOPLE; DISABILITY; THERAPY	Background Disease-modifying biological agents and other drug regimens have substantially improved control of disease activity and joint damage in people with rheumatoid arthritis of the hand. However, commensurate changes in function and quality of life are not always noted. Tailored hand exercises might provide additional improvements, but evidence is lacking. We estimated the effectiveness and cost-effectiveness of tailored hand exercises in addition to usual care during 12 months. Methods In this pragmatic, multicentre, parallel-group trial, at 17 National Health Service sites across the UK we randomly assigned 490 adults with rheumatoid arthritis who had pain and dysfunction of the hands and had been on a stable drug regimen for at least 3 months, to either usual care or usual care plus a tailored strengthening and stretching hand exercise programme. Participants were randomly assigned with stratification by centre. Allocation was computer generated and unmasked to participants and therapists delivering treatment after randomisation. Outcome assessors and all investigators were masked to allocation. Physiotherapists or occupational therapists gave the treatments. The primary outcome was the Michigan Hand Outcomes Questionnaire overall hand function score at 12 months. The analysis was by intention to treat. We calculated cost per quality-adjusted life-year. This trial is registered as ISRCTN 89936343. Findings Between Oct 5, 2009, and May 10, 2011, we screened 1606 people, of whom 490 were randomly assigned to usual care (n=244) or tailored exercises (n=246). 438 of 490 participants (89%) provided 12 month follow-up data. Improvements in overall hand function were 3.6 points (95% CI 1.5-5.7) in the usual care group and 7.9 points (6.0-9.9) in the exercise group (mean difference between groups 4.3, 95% CI 1.5-7.1; p=0.0028). Pain, drug regimens, and health-care resource use were stable for 12 months, with no difference between the groups. No serious adverse events associated with the treatment were recorded. The cost of tailored hand exercise was 156 pound per person; cost per quality-adjusted life-year was 9549 pound with the EQ-5D (17941 pound with imputation for missing data). Interpretation We have shown that a tailored hand exercise programme is a worthwhile, low-cost intervention to provide as an adjunct to various drug regimens. Maximisation of the benefits of biological and DMARD regimens in terms of function, disability, and health-related quality of life should be an important treatment aim.	[Lamb, Sarah E.; Williamson, Esther M.; Williams, Mark A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford OX3 7LD, England; [Lamb, Sarah E.; Heine, Peter J.; Dosanjh, Sukhdeep; Dritsaki, Melina; McConkey, Christopher; Nichols, Vivien; Underwood, Martin] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Adams, Jo] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Glover, Matthew J.; Lord, Joanne] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Rahman, Anisur] UCL, London, England	University of Oxford; University of Warwick; University of Southampton; Brunel University; University of London; University College London	Lamb, SE (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Windmill Rd, Oxford OX3 7LD, England.	sarah.lamb@ndorms.ox.ac.uk	Jansen, Victoria/K-1046-2019; Lord, Joanne/H-1417-2011; Glover, Matthew/ABG-3969-2021; Evans, David/Q-2278-2019; Underwood, Martin/D-6364-2015	Jansen, Victoria/0000-0002-0700-7462; Lord, Joanne/0000-0003-1086-1624; Evans, David/0000-0002-9073-5558; Underwood, Martin/0000-0002-0309-1708; Lamb, Sarah/0000-0003-4349-7195; Williamson, Esther/0000-0003-0638-0406; Glover, Matthew/0000-0001-9454-2668; Adams, Jo/0000-0003-1765-7060; Frost, Helen/0000-0001-9241-8970	UK National Institute of Health Research Health Technology Assessment Programme (NIHR HTA) [07/32/05]; National Institute for Health Research [07/32/05, NF-SI-0512-10103] Funding Source: researchfish	UK National Institute of Health Research Health Technology Assessment Programme (NIHR HTA); National Institute for Health Research(National Institute for Health Research (NIHR))	UK National Institute of Health Research Health Technology Assessment Programme (NIHR HTA), project number 07/32/05.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Adams J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-230; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Boers M, 2013, ANN RHEUM DIS, V72, P406, DOI 10.1136/annrheumdis-2012-202333; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chung KC, 1998, J HAND SURG-AM, V23A, P575, DOI 10.1016/S0363-5023(98)80042-7; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Jong Z, 2009, CLIN RHEUMATOL, V28, P663, DOI 10.1007/s10067-009-1125-z; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FUCHS HA, 1989, ARTHRITIS RHEUM, V32, P531, DOI 10.1002/anr.1780320504; Heine PJ, 2012, PHYSIOTHERAPY, V98, P122, DOI 10.1016/j.physio.2011.03.001; Horsten NCA, 2010, J REHABIL MED, V42, P916, DOI 10.2340/16501977-0619; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Lemmey AB, 2012, ARTHRIT CARE RES, V64, P71, DOI 10.1002/acr.20523; Lineker SC, 2000, ARTHRIT CARE RES, V13, P62, DOI 10.1002/1529-0131(200002)13:1<62::AID-ART9>3.0.CO;2-J; Lorig K., 1996, OUTCOME MEASURES HLT, VVol. 2019; Manning VL, 2013, RHEUMATOLOGY, V52, P147; McGuigan MR, 2004, J SPORT SCI MED, V3, P8; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; NICE, RHEUM ARTHR MAN RHEU; NICE, 2010, RHEUM ARTHR DRUGS TR; O'Brien AV, 2006, RHEUMATOLOGY, V45, P577, DOI 10.1093/rheumatology/kei215; Parsons S, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-34; Perneger TV, 2005, J CLIN EPIDEMIOL, V58, P142, DOI 10.1016/j.jclinepi.2004.06.005; Seto Y, 2013, MOD RHEUMATOL, V23, P1179, DOI [10.1007/s10165-012-0816-5, 10.3109/s10165-012-0816-5]; Toyama S, 2014, MOD RHEUMATOL, V24, P69, DOI 10.3109/14397595.2013.854054; UK Department of Health, 2012, NHS REF COSTS FIN YE; Vlieland TPMV, 2003, BEST PRACT RES CL RH, V17, P847, DOI 10.1016/S1521-6942(03)00043-3; Ware J.E., 2002, SF 12V2 SCORE VERSIO; Weinblatt Michael E, 2013, Trans Am Clin Climatol Assoc, V124, P16; Wessel Jean, 2004, J Hand Ther, V17, P174, DOI 10.1197/j.jht.2004.02.006	32	74	75	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					421	429		10.1016/S0140-6736(14)60998-3	http://dx.doi.org/10.1016/S0140-6736(14)60998-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25308290	Green Accepted, Bronze			2022-12-28	WOS:000348509900029
J	Strom, BL; Buyse, M; Hughes, J; Knoppers, BM				Strom, Brian L.; Buyse, Marc; Hughes, John; Knoppers, Bartha M.			Data Sharing, Year 1-Access to Data from Industry-Sponsored Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCESS		[Strom, Brian L.] Rutgers Biomed & Hlth Sci, Newark, NJ 07107 USA; [Buyse, Marc] Hasselt Univ, Hasselt, Belgium; [Buyse, Marc] Int Inst Drug Dev, Louvain, Belgium; [Hughes, John] United Kingdom Clin Res Collaborat Board, London, England; [Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada	Rutgers State University New Brunswick; Rutgers State University Medical Center; Hasselt University; International Drug Development Institute; McGill University	Strom, BL (corresponding author), Rutgers Biomed & Hlth Sci, Newark, NJ 07107 USA.		Buyse, Marc/J-4658-2013	Buyse, Marc/0000-0002-4559-0994				Christakis DA, 2013, JAMA-J AM MED ASSOC, V310, P2499, DOI 10.1001/jama.2013.281337; Ebrahim S, 2014, JAMA-J AM MED ASSOC, V312, P1024, DOI 10.1001/jama.2014.9646; Krumholz HM, 2013, ANN INTERN MED, V158, P910, DOI 10.7326/0003-4819-158-12-201306180-00009; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541	4	83	85	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2052	2054		10.1056/NEJMp1411794	http://dx.doi.org/10.1056/NEJMp1411794			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25317745	Bronze			2022-12-28	WOS:000345580000002
J	Baud, MGJ; Lin-Shiao, E; Cardote, T; Tallant, C; Pschibul, A; Chan, KH; Zengerle, M; Garcia, JR; Kwan, TTL; Ferguson, FM; Ciulli, A				Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T. -L.; Ferguson, Fleur M.; Ciulli, Alessio			A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes	SCIENCE			English	Article							INHIBITION; TARGET	Small molecules are useful tools for probing the biological function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins. The Bromo and Extra-Terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer. The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors, but these inhibitors lack selectivity for individual family members. We developed an ethyl derivative of an existing small-molecule inhibitor, I-BET/JQ1, and showed that it binds leucine/alanine mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains. Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BETprotein, Brd4, from chromatin. Expansion of this approach could help identify the individual roles of single BETproteins in human physiology and disease.	[Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Ciulli, Alessio] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, James Black Ctr, Dundee DD1 5EH, Scotland; [Baud, Matthias G. J.; Lin-Shiao, Enrique; Tallant, Cynthia; Kwan, Terence T. -L.; Ferguson, Fleur M.; Ciulli, Alessio] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Dundee; University of Cambridge	Ciulli, A (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, James Black Ctr, Dow St, Dundee DD1 5EH, Scotland.	a.ciulli@dundee.ac.uk	Ferguson, Fleur M/L-2639-2019	Ferguson, Fleur M/0000-0003-4091-7617; Baud, Matthias/0000-0003-3714-4350; Lin Shiao, Enrique/0000-0001-5396-9614; Chan, Kwok Ho/0000-0002-6693-2682	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J001201/1, BB/G023123/1]; European Commission; Wellcome Trust [097945/Z/11/Z, 100476/Z/12/Z]; Biotechnology and Biological Sciences Research Council [BB/G023123/2, BB/J001201/2, 980607, BB/G023123/1, BB/J001201/1] Funding Source: researchfish; BBSRC [BB/J001201/2, BB/G023123/2, BB/G023123/1, BB/J001201/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Knapp, O. Fedorov, and their team for constructs, assistance with BLI, and discussions; S. Swift for assistance with the Light Microscopy Facility; C. Conte, E. Griffis, V. Cowling, and M. Peggie for materials and discussions; and D. Chirgadze for assistance with the Crystallographic X-ray Facility. This work was supported by awards to A. C. from the UK Biotechnology and Biological Sciences Research Council (BBSRC, grant BB/J001201/1 and David Phillips Fellowship BB/G023123/1). E. L. S. and A. P. were supported by European Commission Erasmus work placement grants. Microscopy and biophysics were supported by Wellcome Trust strategic awards to the University of Dundee (097945/Z/11/Z and 100476/Z/12/Z, respectively). The University of Dundee and the authors have filed patent applications (GB1320994.5 and GB1401001.1) related to the use of the bump-and-hole BET bromodomain chemical probes and mutant pairs for examining the biological function of BET bromodomain proteins. Coordinates and structure factors have been deposited with the Protein Data Bank (PDB) under accession code 4QEU [Brd2(2)<INF>L383A</INF> apo], 4QEV (in complex with ME), and 4QEW (in complex with ET).	Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GlaxoSmithKline, STUD INV SAF PHARM P; Lamoureux F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4511; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	17	111	129	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		638	641		10.1126/science.1249830	http://dx.doi.org/10.1126/science.1249830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25323695	Green Accepted			2022-12-28	WOS:000343799700051
J	McInerney, JO; O'Connell, MJ				McInerney, James O.; O'Connell, Mary J.			EVOLUTIONARY DEVELOPMENTAL BIOLOGY Ghost locus appears	NATURE			English	Editorial Material							PORIFERA; ANIMALS; ORIGINS		[McInerney, James O.] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [O'Connell, Mary J.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland	Maynooth University; Dublin City University	McInerney, JO (corresponding author), Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland.	james.o.mcinerney@nuim.ie; mary.oconnell@dcu.ie	Mcinerney, James/AAF-7234-2020	O'Connell, Mary/0000-0002-1877-1001				Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Fortunato SAV, 2014, NATURE, V514, P620, DOI 10.1038/nature13881; Gazave E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014290; GEHRING WJ, 1992, TRENDS BIOCHEM SCI, V17, P277, DOI 10.1016/0968-0004(92)90434-B; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Ramos OM, 2012, CURR BIOL, V22, P1951, DOI 10.1016/j.cub.2012.08.023; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Scotland RW, 2010, BIOESSAYS, V32, P438, DOI 10.1002/bies.200900175	10	1	1	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					570	571		10.1038/514570a	http://dx.doi.org/10.1038/514570a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355355				2022-12-28	WOS:000343801500032
J	Sukhija, J; Kaur, S				Sukhija, Jaspreet; Kaur, Savleen			Congenital Sutural Cataract	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sukhija, Jaspreet; Kaur, Savleen] Post Grad Inst Med Educ & Res, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sukhija, J (corresponding author), Post Grad Inst Med Educ & Res, Chandigarh, India.	jaspreetsukhija@rediffmail.com	Kaur, Savleen/AAH-6415-2020	Kaur, Savleen/0000-0003-1929-4451					0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					E27	E27		10.1056/NEJMicm1311616	http://dx.doi.org/10.1056/NEJMicm1311616			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354117				2022-12-28	WOS:000343768500012
J	Banerjee, I; Miyake, Y; Nobs, SP; Schneider, C; Horvath, P; Kopf, M; Matthias, P; Helenius, A; Yamauchi, Y				Banerjee, Indranil; Miyake, Yasuyuki; Nobs, Samuel Philip; Schneider, Christoph; Horvath, Peter; Kopf, Manfred; Matthias, Patrick; Helenius, Ari; Yamauchi, Yohei			Influenza A virus uses the aggresome processing machinery for host cell entry	SCIENCE			English	Article							HISTONE DEACETYLASE-6; CYTOPLASMIC DYNEIN; NUCLEAR IMPORT; PROTEIN; TRANSPORT; HDAC6; RIBONUCLEOPROTEINS; INHIBITOR; STRESS	During cell entry, capsids of incoming influenza A viruses (IAVs) must be uncoated before viral ribonucleoproteins (vRNPs) can enter the nucleus for replication. After hemagglutinin-mediated membrane fusion in late endocytic vacuoles, the vRNPs and the matrix proteins dissociate from each other and disperse within the cytosol. Here, we found that for capsid disassembly, IAV takes advantage of the host cell's aggresome formation and disassembly machinery. The capsids mimicked misfolded protein aggregates by carrying unanchored ubiquitin chains that activated a histone deacetylase 6 (HDAC6)-dependent pathway. The ubiquitin-binding domain was essential for recruitment of HDAC6 to viral fusion sites and for efficient uncoating and infection. That other components of the aggresome processing machinery, including dynein, dynactin, and myosin II, were also required suggested that physical forces generated by microtubule-and actin-associated motors are essential for IAV entry.	[Banerjee, Indranil; Helenius, Ari; Yamauchi, Yohei] Eidgenoss Tech Hsch ETH Zurich, Inst Biochem, Zurich, Switzerland; [Miyake, Yasuyuki; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Nobs, Samuel Philip; Schneider, Christoph; Kopf, Manfred] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland; [Horvath, Peter] Biol Res Ctr, Synthet & Syst Biol Unit, H-6701 Szeged, Hungary; [Matthias, Patrick] Univ Basel, Fac Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Basel	Helenius, A (corresponding author), Eidgenoss Tech Hsch ETH Zurich, Inst Biochem, Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch; yohei.yamauchi@bc.biol.ethz.ch	Miyake, Yasuyuki/AAS-1504-2021; Nobs, Samuel Philip/N-4819-2019; Kopf, Manfred/B-6907-2009	Miyake, Yasuyuki/0000-0001-6250-0260; Nobs, Samuel Philip/0000-0003-0627-892X; Kopf, Manfred/0000-0002-0628-7140; Yamauchi, Yohei/0000-0002-8233-9133; Schneider, Christoph/0000-0002-0452-2960	ETH Zurich; European Research Council; Swiss National Science Foundation (SNSF); SNSF; NIH; Novartis Research Foundation	ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation	We thank many current and former members of the Helenius laboratory for helpful discussions, T. Heger for providing us the infection counter algorithm, and ScopeM of ETH Zurich for assistance in microscopy. This work was supported by grants to A.H. from ETH Zurich, the European Research Council, and the Swiss National Science Foundation (SNSF); to C.S. and M.K. from the SNSF and NIH; and to Y.M. and P.M. from the Novartis Research Foundation. The findings of this work are filed under patent no. 14172323.9-1464 "New treatment against influenza virus."	Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Myers KA, 2006, TRAFFIC, V7, P1333, DOI 10.1111/j.1600-0854.2006.00476.x; Noda T, 2012, P NATL ACAD SCI USA, V109, P8797, DOI 10.1073/pnas.1206736109; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Stauffer S, 2014, J VIROL; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	26	158	160	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					473	477		10.1126/science.1257037	http://dx.doi.org/10.1126/science.1257037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342804				2022-12-28	WOS:000343822900044
J	Chu, L; Xiao, KJ; Yu, JQ				Chu, Ling; Xiao, Kai-Jiong; Yu, Jin-Quan			Room-temperature enantioselective C-H iodination via kinetic resolution	SCIENCE			English	Article							BETA-AMINO ACIDS; MOLECULAR-OXYGEN; CHIRAL LIGANDS; AMINATION; INDOLINES; DIARYLMETHYLAMINES; FUNCTIONALIZATION; ACTIVATION; CATALYSTS; ALCOHOLS	Asymmetric carbon-hydrogen (C-H) activation reactions often rely on desymmetrization of prochiral C-H bonds on the same achiral molecule, using a chiral catalyst. Here, we report a kinetic resolution via palladium-catalyzed enantioselective C-H iodination in which one of the enantiomers of a racemic benzylic amine substrates undergoes faster aryl C-H insertion with the chiral catalysts than the other. The resulting enantioenriched C-H functionalization products would not be accessible through desymmetrization of prochiral C-H bonds. The exceedingly high relative rate ratio (k(fast)/k(slow) up to 244), coupled with the subsequent iodination of the remaining enantiomerically enriched starting material using a chiral ligand with the opposite configuration, enables conversion of both substrate enantiomers into enantiomerically pure iodinated products.	[Chu, Ling; Xiao, Kai-Jiong; Yu, Jin-Quan] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu		Chu, Ling/0000-0002-4418-6850	Scripps Research Institute; NIH (National Institute of General Medical Sciences) [2R01GM084019]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute and NIH (National Institute of General Medical Sciences, 2R01GM084019) for financial support. J.-Q. Y. and L. C. conceived the concept. L.C. developed the enantioselective C-H iodination. L.C. and K.-J.X. synthesized the amine substrates. J.-Q.Y. directed the project. We thank J. Spangler for constructive suggestions. Metrical parameters for the structures of 3l are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC-1021096.	Anas S, 2011, CHEM COMMUN, V47, P11483, DOI 10.1039/c1cc14292e; Arai S, 2001, ANGEW CHEM INT EDIT, V40, P234, DOI 10.1002/1521-3773(20010105)40:1<234::AID-ANIE234>3.0.CO;2-K; Berkessel A, 2005, ANGEW CHEM INT EDIT, V44, P7466, DOI 10.1002/anie.200502003; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Bumbu VD, 2011, J AM CHEM SOC, V133, P13902, DOI 10.1021/ja2058633; Chu L, 2013, J AM CHEM SOC, V135, P16344, DOI 10.1021/ja408864c; De CK, 2009, J AM CHEM SOC, V131, P17060, DOI 10.1021/ja9079435; Doyle MP, 2010, CHEM REV, V110, P704, DOI 10.1021/cr900239n; Ferreira EM, 2001, J AM CHEM SOC, V123, P7725, DOI 10.1021/ja015791z; Fowler BS, 2010, J AM CHEM SOC, V132, P2870, DOI 10.1021/ja9107897; Gao DW, 2014, ACS CATAL, V4, P2741, DOI 10.1021/cs500813z; Giri R, 2009, CHEM SOC REV, V38, P3242, DOI 10.1039/b816707a; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Jensen DR, 2001, J AM CHEM SOC, V123, P7475, DOI 10.1021/ja015827n; Kakiuchi F, 2000, TETRAHEDRON-ASYMMETR, V11, P2647, DOI 10.1016/S0957-4166(00)00244-5; Katayev D, 2012, CHEM SCI, V3, P1422, DOI 10.1039/c2sc20111a; Liang CG, 2006, ANGEW CHEM INT EDIT, V45, P4641, DOI 10.1002/anie.200601248; Milczek E, 2008, ANGEW CHEM INT EDIT, V47, P6825, DOI 10.1002/anie.200801445; Nakanishi M, 2011, ANGEW CHEM INT EDIT, V50, P7438, DOI 10.1002/anie.201102639; Paetzold J, 2005, J AM CHEM SOC, V127, P17620, DOI 10.1021/ja056306t; Reddy RP, 2006, ORG LETT, V8, P5013, DOI 10.1021/ol061742l; Robak MT, 2010, CHEM REV, V110, P3600, DOI 10.1021/cr900382t; Saget T, 2012, ANGEW CHEM INT EDIT, V51, P2238, DOI 10.1002/anie.201108511; Schmidt F, 2006, CHEM SOC REV, V35, P454, DOI 10.1039/b600091f; Shi BF, 2008, ANGEW CHEM INT EDIT, V47, P4882, DOI 10.1002/anie.200801030; Song J, 2006, J AM CHEM SOC, V128, P6048, DOI 10.1021/ja060716f; Tokunaga M, 1997, SCIENCE, V277, P936, DOI 10.1126/science.277.5328.936; Ye BH, 2012, SCIENCE, V338, P504, DOI 10.1126/science.1226938; Zalatan DN, 2008, J AM CHEM SOC, V130, P9220, DOI 10.1021/ja8031955; Zhou SB, 2014, ANGEW CHEM INT EDIT, V53, P7883, DOI 10.1002/anie.201403556	30	156	156	5	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					451	455		10.1126/science.1258538	http://dx.doi.org/10.1126/science.1258538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342799	Green Accepted			2022-12-28	WOS:000343822900038
J	Liu, D; Gu, XW; Zhu, J; Zhang, XX; Han, Z; Yan, WJ; Cheng, Q; Hao, J; Fan, HM; Hou, RQ; Chen, ZQ; Chen, YL; Li, CYT				Liu, Ding; Gu, Xiaowei; Zhu, Jia; Zhang, Xiaoxing; Han, Zhe; Yan, Wenjun; Cheng, Qi; Hao, Jiang; Fan, Hongmei; Hou, Ruiqing; Chen, Zhaoqin; Chen, Yulei; Li, Chengyu T.			Medial prefrontal activity during delay period contributes to learning of a working memory task	SCIENCE			English	Article							SHORT-TERM-MEMORY; NEURAL MECHANISMS; CORTICAL ACTIVITY; CORTEX; DYNAMICS; DECISION; RAT; INFORMATION; ACQUISITION; LESIONS	Cognitive processes require working memory (WM) that involves a brief period of memory retention known as the delay period. Elevated delay-period activity in the medial prefrontal cortex (mPFC) has been observed, but its functional role in WM tasks remains unclear. We optogenetically suppressed or enhanced activity of pyramidal neurons in mouse mPFC during the delay period. Behavioral performance was impaired during the learning phase but not after the mice were well trained. Delay-period mPFC activity appeared to be more important in memory retention than in inhibitory control, decision-making, or motor selection. Furthermore, endogenous delay-period mPFC activity showed more prominent modulation that correlated with memory retention and behavioral performance. Thus, properly regulated mPFC delay-period activity is critical for information retention during learning of a WM task.	[Liu, Ding; Gu, Xiaowei; Zhu, Jia; Zhang, Xiaoxing; Han, Zhe; Yan, Wenjun; Cheng, Qi; Hao, Jiang; Fan, Hongmei; Hou, Ruiqing; Chen, Zhaoqin; Chen, Yulei; Li, Chengyu T.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Liu, Ding; Gu, Xiaowei; Zhu, Jia; Zhang, Xiaoxing; Han, Zhe; Yan, Wenjun; Cheng, Qi; Hao, Jiang; Fan, Hongmei; Hou, Ruiqing; Chen, Zhaoqin; Chen, Yulei; Li, Chengyu T.] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Primate Neurobiol, Shanghai 200031, Peoples R China; [Liu, Ding; Gu, Xiaowei; Zhu, Jia; Han, Zhe; Yan, Wenjun; Cheng, Qi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CYT (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	tonylicy@ion.ac.cn	Zhang, Xiaoxing/AAL-8549-2021	, Xiaowei/0000-0003-2906-6348; Zhu, Jia/0000-0003-2240-7007; Zhang, Xiaoxing/0000-0001-5229-6091	Chinese 973 Program [2011CBA00406]; State Key Laboratory of Neuroscience; Chinese Academy of Sciences Hundreds of Talents Program	Chinese 973 Program(National Basic Research Program of China); State Key Laboratory of Neuroscience; Chinese Academy of Sciences Hundreds of Talents Program(Chinese Academy of Sciences)	We thank M. P. Stryker for communication on head-fixed mice preparation; Z. F. Mainen and N. Uchida for communication on behavioral design; G. Laurent for communication on population analysis; L. P. Wang for help in optogenetics; L. N. Lin for help in tetrode drive manufacturing; H. L. Hu for help in electrophysiological recordings; Y. Dan and J. F. Erlich for communication on spike sorting; H. Y. Zoghbi for VGAT-Cre mice; B. L. Roth for DREADD vectors; Z. L. Qiu, H. L. Hu, and X. Yu for help on AAV virus packaging and transgenic mice; A. K. Guo for help in PID experiments; Q. Hu for help in imaging experiments; Y. G. Sun for histochemistry experiments; Y. F. Li for help in drawing diagrams; and M. M. Poo and R. Desimone for critical comments on the manuscript. The work was supported by Chinese 973 Program (2011CBA00406), the State Key Laboratory of Neuroscience, and Chinese Academy of Sciences Hundreds of Talents Program (to C.T.L.). All the behavioral, optogenetic, electrophysiological, and histochemical data are archived in Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Baddeley A.D., 1986, WORKING MEMORY THOUG; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; LU XCM, 1993, PHYSIOL BEHAV, V53, P795, DOI 10.1016/0031-9384(93)90191-H; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Meyers EM, 2012, P NATL ACAD SCI USA, V109, P4651, DOI 10.1073/pnas.1201022109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; Passingham REP, 2012, NEUROBIOLOGY PREFRON; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Sobotka S, 2005, J NEUROPHYSIOL, V93, P128, DOI 10.1152/jn.01002.2003; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009	30	122	127	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					458	463		10.1126/science.1256573	http://dx.doi.org/10.1126/science.1256573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342800				2022-12-28	WOS:000343822900040
J	Sun, TP				Sun, Tai-ping			Sex and the single fern	SCIENCE			English	Editorial Material							PLANTS		Duke Univ, Dept Biol, Durham, NC 27705 USA	Duke University	Sun, TP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27705 USA.	tps@duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100051] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM100051] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DOPP W., 1950, BER DEUTSCHE BOT GES, V63, P139; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Tanaka J, 2014, SCIENCE, V346, P469, DOI 10.1126/science.1259923; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamane H, 1998, INT REV CYTOL, V184, P1, DOI 10.1016/S0074-7696(08)62177-4	8	1	2	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					423	424		10.1126/science.1260948	http://dx.doi.org/10.1126/science.1260948			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342787	Green Accepted			2022-12-28	WOS:000343822900021
J	Fu, QM; Li, H; Moorjani, P; Jay, F; Slepchenko, SM; Bondarev, AA; Johnson, PLF; Aximu-Petri, A; Prufer, K; de Filippo, C; Meyer, M; Zwyns, N; Salazar-Garcia, DC; Kuzmin, YV; Keates, SG; Kosintsev, PA; Razhev, DI; Richards, MP; Peristov, NV; Lachmann, M; Douka, K; Higham, TFG; Slatkin, M; Hublin, JJ; Reich, D; Kelso, J; Viola, TB; Paabo, S				Fu, Qiaomei; Li, Heng; Moorjani, Priya; Jay, Flora; Slepchenko, Sergey M.; Bondarev, Aleksei A.; Johnson, Philip L. F.; Aximu-Petri, Ayinuer; Pruefer, Kay; de Filippo, Cesare; Meyer, Matthias; Zwyns, Nicolas; Salazar-Garcia, Domingo C.; Kuzmin, Yaroslav V.; Keates, Susan G.; Kosintsev, Pavel A.; Razhev, Dmitry I.; Richards, Michael P.; Peristov, Nikolai V.; Lachmann, Michael; Douka, Katerina; Higham, Thomas F. G.; Slatkin, Montgomery; Hublin, Jean-Jacques; Reich, David; Kelso, Janet; Viola, T. Bence; Paeaebo, Svante			Genome sequence of a 45,000-year-old modern human from western Siberia	NATURE			English	Article							HUMAN-EVOLUTION; HUMAN DISPERSALS; HISTORY; ASIA; DIVERGENCE; ADMIXTURE; EUROPE	We present the high-quality genome sequence of a similar to 45,000-year-old modern human male from Siberia. This individual derives from a population that lived before-or simultaneously with-the separation of the populations in western and eastern Eurasia and carries a similar amount of Neanderthal ancestry as present-day Eurasians. However, the genomic segments of Neanderthal ancestry are substantially longer than those observed in present-day individuals, indicating that Neanderthal gene flow into the ancestors of this individual occurred 7,000-13,000 years before he lived. We estimate an autosomal mutation rate of 0.4 x 10(-9) to 0.6 x 10(-9) per site per year, a Y chromosomal mutation rate of 0.7 x 10(-9) to 0.9 x 10(-9) per site per year based on the additional substitutions that have occurred in present-day non-Africans compared to this genome, and a mitochondrial mutation rate of 1.8 x 10(-8) to 3.2 x 10(-8) per site per year based on the age of the bone.	[Fu, Qiaomei] Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Fu, Qiaomei; Aximu-Petri, Ayinuer; Pruefer, Kay; de Filippo, Cesare; Meyer, Matthias; Lachmann, Michael; Kelso, Janet; Viola, T. Bence; Paeaebo, Svante] Max Planck Inst Evolutionare Anthropol, Dept EvolutionaryGenet, D-04103 Leipzig, Germany; [Li, Heng; Moorjani, Priya; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Moorjani, Priya] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jay, Flora; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Slepchenko, Sergey M.; Razhev, Dmitry I.] Russian Acad Sci, Siberian Branch, Inst Problems Dev North, Tyumen 625026, Russia; [Bondarev, Aleksei A.] Minist Internal Affairs, Omsk Div, Expert Criminalist Ctr, Omsk 644007, Russia; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Zwyns, Nicolas; Salazar-Garcia, Domingo C.; Richards, Michael P.; Hublin, Jean-Jacques; Viola, T. Bence] Max Planck Inst Evolutionare Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Zwyns, Nicolas] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Salazar-Garcia, Domingo C.] Univ Cape Town, Dept Archaeol, ZA-7701 Cape Town, South Africa; [Salazar-Garcia, Domingo C.] Univ Valencia, Dept Prehist & Arqueol, Valencia 46010, Spain; [Salazar-Garcia, Domingo C.] Max Planck Inst Evolutionare Anthropol, Res Grp Plant Foods Hominin Dietary Ecol, D-04103 Leipzig, Germany; [Kuzmin, Yaroslav V.; Keates, Susan G.] Russian Acad Sci, Siberian Branch, Inst Geol & Mineral, Novosibirsk 630090, Russia; [Kosintsev, Pavel A.] Russian Acad Sci, Urals Branch, Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Lab Archaeol, Vancouver, BC V6T 1Z1, Canada; [Peristov, Nikolai V.] Siberian Cultural Ctr, Omsk 644010, Russia; [Lachmann, Michael] Santa Fe Inst, Santa Fe, NM 87501 USA; [Douka, Katerina; Higham, Thomas F. G.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QY, England; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Columbia University; University of California System; University of California Berkeley; Russian Academy of Sciences; Tyumen Scientific Center of the Russian Academy of Sciences; Emory University; Max Planck Society; University of California System; University of California Davis; University of Cape Town; University of Valencia; Max Planck Society; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of British Columbia; The Santa Fe Institute; University of Oxford; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Fu, QM (corresponding author), Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.	qiaomei_fu@eva.mpg.de; reich@genetics.med.harvard.edu; kelso@eva.mpg.de; bence_viola@eva.mpg.de	Slepchenko, Sergey M/H-3454-2017; Douka, Katerina/L-3287-2014; Salazar-García, Domingo C./AAB-1115-2019; Razhev, Dmitry/AAD-3668-2019; Slepchenko, Sergey/AAN-5737-2020; Yaroslav, Kuzmin/GVT-7991-2022; Li, Heng/D-9344-2011; Kelso, Janet/N-1812-2019; Kuzmin, Yaroslav/A-5286-2014; Higham, Tom/Y-2707-2019; Richards, Michael/O-3717-2016	Slepchenko, Sergey M/0000-0002-9365-3849; Douka, Katerina/0000-0002-0558-0011; Li, Heng/0000-0003-4874-2874; Kelso, Janet/0000-0002-3618-322X; Higham, Tom/0000-0002-5949-598X; Richards, Michael/0000-0001-5274-8887; jay, flora/0000-0001-5884-4730; Salazar-Garcia, Domingo C./0000-0002-8017-0194	Chinese Academy of Sciences [XDA05130202]; Ministry of Science and Technology of China [2007FY110200]; Urals Branch, Russian Academy of Sciences [12-C-4-1014]; Russian Foundation for Basic Sciences [12-06-00045]; National Institutes of Health of the USA [R01-GM40282]; NIH [K99-GM104158, GM100233]; ERC [324139]; National Science Foundation [1032255]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM115006, R01GM100233, K99GM104158, R01GM040282] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Urals Branch, Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Sciences; National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to P. Gunz, M. Kircher, A. I. Krivoshapkin, P. Nigst, M. Ongyerth, N. Patterson, G. Renaud, U. Stenzel, M. Stoneking and S. Talamo for valuable input, comments and help; T. Pfisterer and H. Temming for technical assistance. Q.F. is funded in part by the Chinese Academy of Sciences (XDA05130202) and the Ministry of Science and Technology of China (2007FY110200); P.A.K. by Urals Branch, Russian Academy of Sciences (12-C-4-1014) and Y.V.K. by the Russian Foundation for Basic Sciences (12-06-00045); F.J. and M.S. by the National Institutes of Health of the USA (R01-GM40282); P.J. by the NIH (K99-GM104158); and T.F.G.H. by ERC advanced grant 324139. D.R. is a Howard Hughes Medical Institute Investigator and supported by the National Science Foundation (1032255) and the NIH (GM100233). Major funding for this work was provided by the Presidential Innovation Fund of the Max Planck Society.	Brock F, 2012, RADIOCARBON, V54, P879, DOI 10.1017/S0033822200047524; Ellis N, 2002, GENOME RES, V12, P339; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; GOEBEL T, 1993, CURR ANTHROPOL, V34, P452, DOI 10.1086/204192; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kuhn S. L., 2014, QUAT INT; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McCown T, 1939, STONE AGE MOUNT CARM, V2; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P409, DOI 10.1006/jasc.1998.0343; Vandermeersch B., 1981, HOMMES FOSSILES QAFZ, V319; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	36	551	578	12	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					445	+		10.1038/nature13810	http://dx.doi.org/10.1038/nature13810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341783	Green Accepted, Green Published			2022-12-28	WOS:000343775900030
J	Loupakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Salvatore, L; Cortesi, E; Tomasello, G; Ronzoni, M; Spadi, R; Zaniboni, A; Tonini, G; Buonadonna, A; Amoroso, D; Chiara, S; Carlomagno, C; Boni, C; Allegrini, G; Boni, L; Falcone, A				Loupakis, Fotios; Cremolini, Chiara; Masi, Gianluca; Lonardi, Sara; Zagonel, Vittorina; Salvatore, Lisa; Cortesi, Enrico; Tomasello, Gianluca; Ronzoni, Monica; Spadi, Rosella; Zaniboni, Alberto; Tonini, Giuseppe; Buonadonna, Angela; Amoroso, Domenico; Chiara, Silvana; Carlomagno, Chiara; Boni, Corrado; Allegrini, Giacomo; Boni, Luca; Falcone, Alfredo			Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST-LINE TREATMENT; INFUSIONAL FLUOROURACIL; PHASE-III; OXALIPLATIN; IRINOTECAN; LEUCOVORIN; FOLFIRI; CHEMOTHERAPY; GUIDELINES; MANAGEMENT	BACKGROUND A fluoropyrimidine plus irinotecan or oxaliplatin, combined with bevacizumab (a monoclonal antibody against vascular endothelial growth factor), is standard first-line treatment for metastatic colorectal cancer. Before the introduction of bevacizumab, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) showed superior efficacy as compared with fluorouracil, leucovorin, and irinotecan (FOLFIRI). In a phase 2 study, FOLFOXIRI plus bevacizumab showed promising activity and an acceptable rate of adverse effects. METHODS We randomly assigned 508 patients with untreated metastatic colorectal cancer to receive either FOLFIRI plus bevacizumab (control group) or FOLFOXIRI plus bevacizumab (experimental group). Up to 12 cycles of treatment were administered, followed by fluorouracil plus bevacizumab until disease progression. The primary end point was progression-free survival. RESULTS The median progression-free survival was 12.1 months in the experimental group, as compared with 9.7 months in the control group (hazard ratio for progression, 0.75; 95% confidence interval [CI], 0.62 to 0.90; P = 0.003). The objective response rate was 65% in the experimental group and 53% in the control group (P = 0.006). Overall survival was longer, but not significantly so, in the experimental group (31.0 vs. 25.8 months; hazard ratio for death, 0.79; 95% CI, 0.63 to 1.00; P = 0.054). The incidences of grade 3 or 4 neurotoxicity, stomatitis, diarrhea, and neutropenia were significantly higher in the experimental group. CONCLUSIONS FOLFOXIRI plus bevacizumab, as compared with FOLFIRI plus bevacizumab, improved the outcome in patients with metastatic colorectal cancer and increased the incidence of some adverse events. (Funded by the Gruppo Oncologico Nord Ovest and others; ClinicalTrials.gov number, NCT00719797.)	[Loupakis, Fotios; Cremolini, Chiara; Masi, Gianluca; Salvatore, Lisa; Falcone, Alfredo] Univ Pisana, Azienda Osped, I-56126 Pisa, Italy; [Loupakis, Fotios; Cremolini, Chiara; Masi, Gianluca; Salvatore, Lisa; Falcone, Alfredo] Univ Pisa, Pisa, Italy; [Lonardi, Sara; Zagonel, Vittorina] IRCCS, Ist Oncol Veneto, Padua, Italy; [Cortesi, Enrico] Univ Roma La Sapienza, I-00185 Rome, Italy; [Tonini, Giuseppe] Univ Campus Biomed, Rome, Italy; [Tomasello, Gianluca] Azienda Ist Ospitalieri, Cremona, Italy; [Ronzoni, Monica] IRCCS, Osped San Raffaele, Milan, Italy; [Spadi, Rosella] Univ Citta Salute & Sci, Azienda Osped, Turin, Italy; [Zaniboni, Alberto] Fdn Poliambulanza, Brescia, Italy; [Buonadonna, Angela] IRCCS, Ctr Riferimento Oncol, Aviano, Italy; [Amoroso, Domenico] Osped Versilia, Lido Di Camaiore, Italy; [Chiara, Silvana] IRCCS, Osped San Martino, Genoa, Italy; [Carlomagno, Chiara] Azienda Osped Univ Federico II, Naples, Italy; [Boni, Corrado] IRCCS, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; [Allegrini, Giacomo] Osped Felice Lotti, Pontedera, Italy; [Boni, Luca] Univ Careggi, Azienda Osped, Florence, Italy; [Boni, Luca] Ist Toscano Tumori, Florence, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; IRCCS Istituto Oncologico Veneto (IOV); Sapienza University Rome; University Campus Bio-Medico - Rome Italy; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; A.O.U. Citta della Salute e della Scienza di Torino; IRCCS Aviano (CRO); Ospedale Versilia; University of Genoa; IRCCS AOU San Martino IST; IRCCS Arcispedale S. Maria Nuova; University of Florence; Azienda Ospedaliero Universitaria Careggi; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Falcone, A (corresponding author), Univ Pisana, Azienda Osped, Via Roma 67, I-56126 Pisa, Italy.	alfredo.falcone@med.unipi.it	Boni, Luca/ABI-6243-2020; Masi, Gianluca/AAD-1637-2021; Lonardi, Sara/F-4228-2014; Cortesi, Enrico/AAA-2983-2019; Buonadonna, Angela/ABE-2374-2020; Cremolini, Chiara/AAC-1889-2019; Masi, Gianluca/AAJ-8388-2020; Falcone, Alfredo/G-5217-2013; zagonel, vittorina/F-4226-2014; Loupakis, Fotios/I-7243-2012; Spadi, Rosella/AHD-6311-2022; Salvatore, Lisa/L-7746-2019	Boni, Luca/0000-0003-2217-4047; Lonardi, Sara/0000-0002-7593-8138; Buonadonna, Angela/0000-0002-1930-0308; zagonel, vittorina/0000-0002-0829-2525; Loupakis, Fotios/0000-0001-9651-0395; Ronzoni, Monica/0000-0002-2845-275X; MASI, GIANLUCA/0000-0001-8329-8989; Salvatore, Lisa/0000-0003-3864-0719; Falcone, Alfredo/0000-0001-5840-2529; Tonini, Giuseppe/0000-0003-4442-8677; CREMOLINI, CHIARA/0000-0002-0520-4841	Gruppo Oncologico Nord Ovest; ARCO Foundation; F. Hoffmann-La Roche	Gruppo Oncologico Nord Ovest; ARCO Foundation; F. Hoffmann-La Roche(Hoffmann-La Roche)	Supported by the Gruppo Oncologico Nord Ovest and the ARCO Foundation. A research grant was provided by F. Hoffmann-La Roche.	[Anonymous], 2006, COMM TERM CRIT ADV E; Falcone A, 2002, J CLIN ONCOL, V20, P4006, DOI 10.1200/JCO.2002.12.075; Falcone A, 2007, J CLIN ONCOL, V25, P1670, DOI 10.1200/JCO.2006.09.0928; Goldberg RM, 2007, ONCOLOGIST, V12, P38, DOI 10.1634/theoncologist.12-1-38; Hedrick E, 2006, J CLIN ONCOL, V24, p155S; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Koopman M, 2014, J CLIN ONCOL, V32, P388; Masi G, 2004, ANN ONCOL, V15, P1766, DOI 10.1093/annonc/mdh470; Masi G, 2010, LANCET ONCOL, V11, P845, DOI 10.1016/S1470-2045(10)70175-3; National Comprehensive Cancer Network, 2014, COL CANC VERS 3 2014; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113	16	688	711	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2014	371	17					1609	1618		10.1056/NEJMoa1403108	http://dx.doi.org/10.1056/NEJMoa1403108			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5UF	25337750	Green Published, Bronze			2022-12-28	WOS:000343648500009
J	Landon, BE				Landon, Bruce E.			Structuring Payments to Patient-Centered Medical Homes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; HEALTH-CARE; QUALITY		[Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	landon@hcp.med.harvard.edu						Ash AS, 2012, MED CARE, V50, P643, DOI 10.1097/MLR.0b013e3182549c74; Berenson RA, 2010, J GEN INTERN MED, V25, P619, DOI 10.1007/s11606-010-1290-4; Edwards STBA, 2014, AC HLTH 2014 ANN RES; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Phillips RL, 2010, HEALTH AFFAIR, V29, P806, DOI 10.1377/hlthaff.2010.0020; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063	8	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1633	1634		10.1001/jama.2014.9529	http://dx.doi.org/10.1001/jama.2014.9529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335142				2022-12-28	WOS:000343301400016
J	Harra, LK				Harra, Louise K.			Looking closer at the Sun	SCIENCE			English	Editorial Material									Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England	University of London; University College London	Harra, LK (corresponding author), Univ Coll London, Mullard Space Sci Lab, Holmbury St Mary, Dorking RH5 6NT, Surrey, England.	l.harra@ucl.ac.uk		Harra, Louise/0000-0001-9457-6200	STFC [ST/K000977/1, PP/D002907/1, ST/H000429/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1, ST/K000977/1, ST/H000429/1, ST/L006383/1] Funding Source: researchfish; UK Space Agency [ST/J001732/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency		De Pontieu B, 2014, SCIENCE, V346, DOI 10.1126/science.1255732; Hansteen V, 2014, SCIENCE, V346, DOI 10.1126/science.1255757; Peter H, 2014, SCIENCE, V346, DOI 10.1126/science.1255726; Testa P, 2014, SCIENCE, V346, DOI 10.1126/science.1255724; Tian H, 2014, SCIENCE, V346, DOI 10.1126/science.1255711	5	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					305	306		10.1126/science.1260828	http://dx.doi.org/10.1126/science.1260828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324375				2022-12-28	WOS:000343041100021
J	Long, P; Corfas, G				Long, Patrick; Corfas, Gabriel			To learn is to myelinate	SCIENCE			English	Editorial Material									[Long, Patrick; Corfas, Gabriel] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Long, P (corresponding author), Univ Michigan, Kresge Hearing Res Inst, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	corfas@med.umich.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	NICHD NIH HHS [P30 HD018655] Funding Source: Medline; NIDCD NIH HHS [R01 DC004820, T32 DC000011] Funding Source: Medline; NINDS NIH HHS [R01 NS035884] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011, R01DC004820] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Long P, 2014, JAMA PSYCHIAT, V71, P1296, DOI 10.1001/jamapsychiatry.2014.1049; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zuo H, 2013, NEUROSCI BULL, V29, P165, DOI 10.1007/s12264-013-1320-4	12	13	13	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					298	299		10.1126/science.1261127	http://dx.doi.org/10.1126/science.1261127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ7ZY	25324370	Green Accepted			2022-12-28	WOS:000343041100016
J	Bryant, PA; Noronha, J				Bryant, Penelope A.; Noronha, Jesuina			Acute Neck Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bryant, Penelope A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Noronha, Jesuina] Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Bryant, PA (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	penelope.bryant@rch.org.au							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1534	1534		10.1056/NEJMicm1313981	http://dx.doi.org/10.1056/NEJMicm1313981			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317873				2022-12-28	WOS:000342994700010
J	Kazimierczuk, T; Frohlich, D; Scheel, S; Stolz, H; Bayer, M				Kazimierczuk, T.; Froehlich, D.; Scheel, S.; Stolz, H.; Bayer, M.			Giant Rydberg excitons in the copper oxide Cu2O	NATURE			English	Article							ABSORPTION; POSITRONIUM; SPECTRA; ATOMS	A highly excited atom having an electron that has moved into a level with large principal quantum number is a hydrogen-like object, termed a Rydberg atom. The giant size of Rydberg atoms(1) leads to huge interaction effects. Monitoring these interactions has provided in-sights into atomic and molecular physics on the single-quantum level. Excitons-the fundamental optical excitations in semiconductors(2), consisting of an electron and a positively charged hole-are the condensed-matter analogues of hydrogen. Highly excited excitons with extensions similar to those of Rydberg atoms are of interest because they can be placed and moved in a crystal with high precision using microscopic energy potential landscapes. The interaction of such Rydberg excitons may allow the formation of ordered exciton phases or the sensing of elementary excitations in their surroundings on a quantum level. Here we demonstrate the existence of Rydberg excitons in the copper oxide Cu2O, with principal quantum numbers as large as n = 25. These states have giant wavefunction extensions (that is, the average distance between the electron and the hole) of more than two micrometres, compared to about a nanometre for the ground state. The strong dipole-dipole interaction between such excitons is indicated by a blockade effect in which the presence of one exciton prevents the excitation of another in its vicinity.	[Kazimierczuk, T.; Froehlich, D.; Bayer, M.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [Scheel, S.; Stolz, H.] Univ Rostock, Inst Phys, D-18051 Rostock, Germany; [Bayer, M.] Russian Acad Sci, AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia	Dortmund University of Technology; University of Rostock; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute	Frohlich, D (corresponding author), Tech Univ Dortmund, D-44221 Dortmund, Germany.	dietmar.froehlich@tu-dortmund.de	Bayer, Manfred/I-7947-2013	Scheel, Stefan/0000-0001-7011-2663; Bayer, Manfred/0000-0002-0893-5949; Kazimierczuk, Tomasz/0000-0001-6545-4167	Deutsche Forschungsgemeinschaft [BA 1549/18-1, SFB 652]; Russian Ministry of Science and Education [14.Z50.31.0021]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	We thank R. Honig for experimental support with the first measurements. We acknowledge financial support by the Deutsche Forschungsgemeinschaft (BA 1549/18-1 and SFB 652 Strong correlations and collective effects in radiation fields). M.B. acknowledges support from the Russian Ministry of Science and Education (contract number 14.Z50.31.0021).	Balewski JB, 2013, NATURE, V502, P664, DOI 10.1038/nature12592; BASSANI F, 1976, SOLID STATE COMMUN, V19, P887, DOI 10.1016/0038-1098(76)90678-5; Bendkowsky V, 2009, NATURE, V458, P1005, DOI 10.1038/nature07945; Boisseau C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.133004; Cassidy DB, 2007, NATURE, V449, P195, DOI 10.1038/nature06094; ELLIOTT RJ, 1961, PHYS REV, V124, P340, DOI 10.1103/PhysRev.124.340; ELLIOTT RJ, 1957, PHYS REV, V108, P1384, DOI 10.1103/PhysRev.108.1384; FRIEDRICH H, 1989, PHYS REP, V183, P37, DOI 10.1016/0370-1573(89)90121-X; GALLAGHER TF, 1988, REP PROG PHYS, V51, P143, DOI 10.1088/0034-4885/51/2/001; Gross E. F., 1956, NUOVO CIM, V3, P672; GROSS EF, 1952, DOKL AKAD NAUK SSSR+, V84, P471; Jolk A, 1998, PHYS STATUS SOLIDI B, V206, P841, DOI 10.1002/(SICI)1521-3951(199804)206:2<841::AID-PSSB841>3.0.CO;2-N; Kavoulakis GM, 1997, PHYS REV B, V55, P7593, DOI 10.1103/PhysRevB.55.7593; Kiffner M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.031401; Knox R., 1963, SOLID STATE PHYS S, V5; Matsumoto H, 1996, SOLID STATE COMMUN, V97, P125, DOI 10.1016/0038-1098(95)00601-X; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Stolz H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105007; TOYOZAWA Y, 1964, J PHYS CHEM SOLIDS, V25, P59, DOI 10.1016/0022-3697(64)90162-3; TOYOZAWA Y, 1958, PROG THEOR PHYS, V20, P53, DOI 10.1143/PTP.20.53; UENO T, 1969, J PHYS SOC JPN, V26, P438, DOI 10.1143/JPSJ.26.438; Varga K, 1998, PHYS REV LETT, V80, P1876, DOI 10.1103/PhysRevLett.80.1876	22	209	212	7	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					343	347		10.1038/nature13832	http://dx.doi.org/10.1038/nature13832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318523	Green Submitted			2022-12-28	WOS:000342988600046
J	McCarthy, FP; O'Brien, U; Kenny, LC				McCarthy, Fergus P.; O'Brien, Una; Kenny, Louise C.			The management of teenage pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACTING REVERSIBLE CONTRACEPTION; YOUNG MATERNAL AGE; ADOLESCENT MOTHERS; PRENATAL-CARE; OUTCOMES; BIRTH; RISK; ASSOCIATION; CHILDHOOD; WEIGHT		[McCarthy, Fergus P.; Kenny, Louise C.] Cork Univ, Matern Hosp, Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [McCarthy, Fergus P.] St Thomas Hosp, Kings Hlth Partners, Womens Hlth Acad Ctr, London, England; [O'Brien, Una] Our Lady Lourdes Hosp, Matern Unit, Parentcraft Dept, Drogheda, Louth, Ireland	University College Cork; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	McCarthy, FP (corresponding author), Cork Univ, Matern Hosp, Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland.	Fergus.mccarthy@ucc.ie	Kenny, Louise/X-6329-2019; Kenny, Louise C/G-1112-2011	Kenny, Louise/0000-0002-9011-759X; Kenny, Louise C/0000-0002-9011-759X; McCarthy, Fergus/0000-0001-5062-6851				Abortion Statistics, 2013, ABORTION STAT ENGLAN; Alio AP, 2011, J PEDIATR ADOL GYNEC, V24, P404, DOI 10.1016/j.jpag.2011.07.002; [Anonymous], 2010, PREGN COMPL SOC FACT; [Anonymous], 2013, HLTH PROTECTION REPO, V7; Santos MMAD, 2013, NUTR HOSP, V28, P1943, DOI [10.3305/nutr hosp.v28in06.6860, 10.3305/nh.2013.28.6.6860]; Balayla J, 2011, AM J PERINAT, V28, P643, DOI 10.1055/s-0031-1276739; Baldwin MK, 2013, J ADOLESCENT HEALTH, V52, pS47, DOI 10.1016/j.jadohealth.2012.10.278; Barnet B, 2007, ANN FAM MED, V5, P224, DOI 10.1370/afm.629; Berthoud R, 2001, Popul Trends, P12; Bitzer J, 2013, BEST PRACT RES CL EN, V27, P77, DOI 10.1016/j.beem.2012.09.005; Botting B, 1998, Popul Trends, P19; Carr S, 2013, J ADOLESCENT HEALTH, V52, pS22, DOI 10.1016/j.jadohealth.2013.01.017; Causey AL, 1997, AM J EMERG MED, V15, P125, DOI 10.1016/S0735-6757(97)90081-4; CMACE, 2011, CTR MAT CHILD ENQ CM; Department of Health, 2009, GETT MAT SERV RIGHT; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Fleming N, 2013, J OBSTET GYNAECOL CA, V35, P234, DOI 10.1016/S1701-2163(15)30995-6; Francisco MA, 2008, J SPEC PEDIATR NURS, V13, P237, DOI 10.1111/j.1744-6155.2008.00160.x; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Gavin L, 2013, MMWR-MORBID MORTAL W, V62, P249; Hall KS, 2014, SOC SCI MED, V100, P62, DOI 10.1016/j.socscimed.2013.10.037; HARDEN A, 2006, YOUNG PEOPLE PREGNAN; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Hardy JB, 1998, DEV PSYCHOL, V34, P1220, DOI 10.1037/0012-1649.34.6.1220; Health and Social Care Information Centre, SMOK DRINK DRUG US Y; Iacobelli S, 2014, INT J GYNECOL OBSTET, V125, P44, DOI 10.1016/j.ijgo.2013.09.029; Khashan AS, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-36; Leppalahti S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003225; Liran D, 2013, J MATERN-FETAL NEO M, V26, P469, DOI 10.3109/14767058.2012.738262; Malabarey OT, 2012, J PEDIATR ADOL GYNEC, V25, P98, DOI 10.1016/j.jpag.2011.09.004; McNicholas C, 2012, CURR OPIN OBSTET GYN, V24, P293, DOI 10.1097/GCO.0b013e32835686d5; Moran VH, 2007, BRIT J NUTR, V97, P411, DOI 10.1017/S0007114507381373; Office for National Statistics, 2014, TEEN CONC RAT HIGH M; OH MK, 1993, SEX TRANSM DIS, V20, P45, DOI 10.1097/00007435-199301000-00009; Olausson PO, 2004, BJOG-INT J OBSTET GY, V111, P793, DOI 10.1111/j.1471-0528.2004.00248.x; Oringanje C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005215.pub2; Patel PH, 2012, MATERN CHILD HLTH J, V16, P1063, DOI 10.1007/s10995-011-0829-2; Phipps MG, 2002, J WOMEN HEALTH GEN-B, V11, P889, DOI 10.1089/154099902762203722; Quinlivan JA, 2003, LANCET, V361, P893, DOI 10.1016/S0140-6736(03)12770-5; Schmidt RM, 2006, J ADOLESCENT HEALTH, V38, P712, DOI 10.1016/j.jadohealth.2005.05.023; Shah MK, 2014, J PEDIATR ADOL GYNEC, V27, P14, DOI 10.1016/j.jpag.2013.08.002; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Social Exclusion Unit, 1999, TEEN PREGN REP SOC E; UNICEF Office of Research, 2013, CHILD WELL BEING RIC; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; Uzun AK, 2013, J MATERN-FETAL NEO M, V26, P454, DOI 10.3109/14767058.2012.733748; Vieira CL, 2012, J PEDIATR ADOL GYNEC, V25, P185, DOI 10.1016/j.jpag.2011.12.070; Vigod SN, 2014, PEDIATRICS, V133, pE585, DOI 10.1542/peds.2013-1761; Wiemann C.M., 2005, J ADOLESCENT HEALTH, V36, p352.; World Health Organization, AD PREGN	51	9	9	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2014	349								g5887	10.1136/bmj.g5887	http://dx.doi.org/10.1136/bmj.g5887			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NU	25319232				2022-12-28	WOS:000343767400001
J	Gostin, LO; Friedman, EA				Gostin, Lawrence O.; Friedman, Eric A.			Ebola: a crisis in global health leadership	LANCET			English	Editorial Material									[Gostin, Lawrence O.; Friedman, Eric A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Gostin, Lawrence O.] WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, INT HLTH REG; Callimachi N, 2014, NY TIMES; CDC, 2014, BUDG REQ SUMM FISC Y; Cooper H., 2014, NY TIMES; Fink S., 2014, NY TIMES; Gostin L.O., 2014, GLOBAL HLTH LAW; Gostin LO, 2014, LANCET; McNeil D., 2014, NY TIMES; Medecins sans Frontieres, 2014, GLOB BIOD RESP URG N; Nossiter Adam, 2014, NEW YORK TIMES; Ooms G, 2014, FINANCING HLTH GLOBA; Painter K, 2014, US TODAY; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; United Nations, 2014, EB VIR DIS OUTBR OV; WHO, 2014, ANN FIN REP AUD FIN; World Health Organisation, 1946, WHO CONST; World Health Organization, 2011, REP REV COMM FUNCT I; World Health Organization, 2013, PROP PROGR BUDG 2014; World Health Organization, 2014, EB VIR DIS OUTBR RES; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2014, WHO STAT M INT HLTH	21	62	66	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1323	1325		10.1016/S0140-6736(14)61791-8	http://dx.doi.org/10.1016/S0140-6736(14)61791-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7NH	25306563	Green Submitted			2022-12-28	WOS:000343004000005
J	Gil, Y; Greaves, M; Hendler, J; Hirsh, H				Gil, Yolanda; Greaves, Mark; Hendler, James; Hirsh, Haym			Amplify scientific discovery with artificial intelligence	SCIENCE			English	Editorial Material									[Gil, Yolanda] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Greaves, Mark] Pacific NW Natl Lab, Richland, WA 99354 USA; [Hendler, James] Rensselaer Polytech Inst, Troy, NY 12203 USA; [Hirsh, Haym] Cornell Univ, Ithaca, NY 14850 USA	University of Southern California; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Rensselaer Polytechnic Institute; Cornell University	Gil, Y (corresponding author), Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA.	hendler@cs.rpi.edu		Hendler, James/0000-0003-3056-1960; Greaves, Mark/0000-0002-6239-9999; Gil, Yolanda/0000-0001-8465-8341				Aragon CR, 2008, J PHYS CONF SER, V125, P12091, DOI 10.1088/1742-6596/125/1/012091; Caetano C, 2011, INT J QUANTUM CHEM, V111, P2732, DOI 10.1002/qua.22572; Deepa S. N., 2011, INDIAN J SCI TECHNOL, V4, P1583; Gil Y, 2011, IEEE INTELL SYST, V26, P62, DOI 10.1109/MIS.2010.9; Hendler J, 2003, SCIENCE, V299, P520, DOI 10.1126/science.1078874; Kelly III John E., 2013, SMART MACHINES; Langley P., 1987, SCI DISCOVERY COMPUT; Leach SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000215; Lindsay R.K., 1980, APPL ARTIF INTELL, V1st ed.; Martialay M., CITIZEN SCI; Waltz D, 2009, SCIENCE, V324, P43, DOI 10.1126/science.1172781	11	66	74	10	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					171	172		10.1126/science.1259439	http://dx.doi.org/10.1126/science.1259439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301606				2022-12-28	WOS:000342721500024
J	Wagle, N; Grabiner, BC; Van Allen, EM; Amin-Mansour, A; Taylor-Weiner, A; Rosenberg, M; Gray, N; Barletta, JA; Guo, YN; Swanson, SJ; Ruan, DT; Hanna, GJ; Haddad, RI; Getz, G; Kwiatkowski, DJ; Carter, SL; Sabatini, DM; Janne, PA; Garraway, LA; Lorch, JH				Wagle, Nikhil; Grabiner, Brian C.; Van Allen, Eliezer M.; Amin-Mansour, Ali; Taylor-Weiner, Amaro; Rosenberg, Mara; Gray, Nathanael; Barletta, Justine A.; Guo, Yanan; Swanson, Scott J.; Ruan, Daniel T.; Hanna, Glenn J.; Haddad, Robert I.; Getz, Gad; Kwiatkowski, David J.; Carter, Scott L.; Sabatini, David M.; Jaenne, Pasi A.; Garraway, Levi A.; Lorch, Jochen H.			Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MTOR MUTATIONS; GENE-PRODUCTS; ACTIVATION; SIROLIMUS; PROTEIN; LYMPHANGIOLEIOMYOMATOSIS; ANGIOMYOLIPOMA; SENSITIVITY; INHIBITION	Everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), is effective in treating tumors harboring alterations in the mTOR pathway. Mechanisms of resistance to everolimus remain undefined. Resistance developed in a patient with metastatic anaplastic thyroid carcinoma after an extraordinary 18-month response. Whole-exome sequencing of pretreatment and drug-resistant tumors revealed a nonsense mutation in TSC2, a negative regulator of mTOR, suggesting a mechanism for exquisite sensitivity to everolimus. The resistant tumor also harbored a mutation in MTOR that confers resistance to allosteric mTOR inhibition. The mutation remains sensitive to mTOR kinase inhibitors.	[Wagle, Nikhil; Van Allen, Eliezer M.; Gray, Nathanael; Haddad, Robert I.; Kwiatkowski, David J.; Jaenne, Pasi A.; Garraway, Levi A.; Lorch, Jochen H.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wagle, Nikhil; Van Allen, Eliezer M.; Gray, Nathanael; Guo, Yanan; Haddad, Robert I.; Kwiatkowski, David J.; Jaenne, Pasi A.; Garraway, Levi A.; Lorch, Jochen H.] Harvard Univ, Sch Med, Boston, MA USA; [Wagle, Nikhil; Van Allen, Eliezer M.; Guo, Yanan; Haddad, Robert I.; Kwiatkowski, David J.; Jaenne, Pasi A.; Garraway, Levi A.; Lorch, Jochen H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Barletta, Justine A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Swanson, Scott J.; Ruan, Daniel T.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Hanna, Glenn J.] Brigham & Womens Hosp, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA; [Wagle, Nikhil; Van Allen, Eliezer M.; Amin-Mansour, Ali; Taylor-Weiner, Amaro; Rosenberg, Mara; Getz, Gad; Kwiatkowski, David J.; Carter, Scott L.; Sabatini, David M.; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Grabiner, Brian C.; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Grabiner, Brian C.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA USA; [Grabiner, Brian C.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lorch, JH (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,D1542, Boston, MA 02115 USA.	jochen_lorch@dfci.harvard.edu	Wagle, Nikhil/Q-7428-2019	Haddad, Robert/0000-0003-1413-0079; /0000-0002-1446-7256; Rosenberg, Mara/0000-0001-6400-3161	Next Generation Fund at the Broad Institute of Massachusetts Institute of Technology and Harvard; Novartis Pharmaceuticals; Starr Cancer Consortium; National Cancer Institute; NATIONAL CANCER INSTITUTE [R33CA155554, T32CA009172] Funding Source: NIH RePORTER	Next Generation Fund at the Broad Institute of Massachusetts Institute of Technology and Harvard; Novartis Pharmaceuticals(Novartis); Starr Cancer Consortium; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Next Generation Fund at the Broad Institute of Massachusetts Institute of Technology and Harvard (to Dr. Wagle), Novartis Pharmaceuticals (to Dr. Lorch), the Starr Cancer Consortium (to Dr. Garraway), and the National Cancer Institute (to Drs. Kwiatkowski and Garraway).	Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Corver WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038287; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerlinger M, 2013, NEW ENGL J MED, V369, P1172, DOI 10.1056/NEJMc1309091; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hoogeveen-Westerveld M, 2013, HUM MUTAT, V34, P167, DOI 10.1002/humu.22202; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Klumpen HJ, 2011, J CLIN ONCOL, V29, pE150, DOI 10.1200/JCO.2010.32.7825; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Rosove MH, 2013, NEW ENGL J MED, V368, P684, DOI 10.1056/NEJMc1215697; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wagner AJ, 2010, J CLIN ONCOL, V28, P835, DOI 10.1200/JCO.2009.25.2981	24	222	228	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1426	1433		10.1056/NEJMoa1403352	http://dx.doi.org/10.1056/NEJMoa1403352			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295501	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000342674800011
J	Raithatha, N; Mehrtens, S; Mouyis, M; Manson, J				Raithatha, Nisha; Mehrtens, Sarah; Mouyis, Maria; Manson, Jessica			PICTURE QUIZ Rash and fever after sulfasalazine use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTEMIC SYMPTOMS DRESS; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; DRUG REACTION; COMPLEX INTERACTION; EOSINOPHILIA; MANAGEMENT		[Raithatha, Nisha; Mehrtens, Sarah; Mouyis, Maria; Manson, Jessica] Univ Coll Hosp, Dept Rheumatol, London NW1 2BU, England	University of London; University College London	Raithatha, N (corresponding author), Univ Coll Hosp, Dept Rheumatol, London NW1 2BU, England.	nisharaithatha@gmail.com						Abe R, 2008, J DERMATOL SCI, V52, P151, DOI 10.1016/j.jdermsci.2008.06.003; Bachot N, 2003, AM J CLIN DERMATOL, V4, P561, DOI 10.2165/00128071-200304080-00006; Barbaud A, 2001, CONTACT DERMATITIS, V45, P321, DOI 10.1034/j.1600-0536.2001.450601.x; Bocquet H, 1996, SEMIN CUTAN MED SURG, V15, P250, DOI 10.1016/S1085-5629(96)80038-1; Borroni G, 2014, GIORN ITAL DERMAT V, V149, P291; Chen YC, 2010, ARCH DERMATOL, V146, P1373, DOI 10.1001/archdermatol.2010.198; Cheng CY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/565320; Chopra S, 1996, BRIT J DERMATOL, V134, P1109; Criado PR, 2012, ISR MED ASSOC J, V14, P577; Descamps V, 2010, ANN DERMATOL VENER, V137, P703, DOI 10.1016/j.annder.2010.04.024; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; GUPTA A, 1992, CLIN PHARMACOL THER, V51, P56, DOI 10.1038/clpt.1992.8; Kano Y, 2010, MED CLIN N AM, V94, P743, DOI 10.1016/j.mcna.2010.03.004; Kim DH, 2014, ALLERGY ASTHMA IMMUN, V6, P216, DOI 10.4168/aair.2014.6.3.216; Moling O, 2012, MED SCI MONITOR, V18, pCS57, DOI 10.12659/MSM.883198; Shiohara T, 2007, CLIN REV ALLERG IMMU, V33, P124, DOI 10.1007/s12016-007-8010-9; Shiohara Tetsuo, 2006, Allergol Int, V55, P1, DOI 10.2332/allergolint.55.1; Sultan SJ, 2014, INT J DERMATOL; Tas S, 2003, DERMATOLOGY, V206, P353, DOI 10.1159/000069956	19	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2014	349								g5655	10.1136/bmj.g5655	http://dx.doi.org/10.1136/bmj.g5655			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LP	25296685				2022-12-28	WOS:000342998900001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Have we given guidelines too much power?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEOPLE					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Diener L, 2013, J NUTR HEALTH AGING, V17, P625, DOI 10.1007/s12603-013-0340-0; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Palmer SC, 2012, ANN INTERN MED, V156, P445, DOI 10.7326/0003-4819-156-6-201203200-00007; Steel N, 2014, J CLIN EPIDEMIOL, V67, P1251, DOI 10.1016/j.jclinepi.2014.05.020	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2014	349								g6027	10.1136/bmj.g6027	http://dx.doi.org/10.1136/bmj.g6027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LM	25288140	Green Published, Bronze			2022-12-28	WOS:000342998500004
J	Krishnaswamy, S; Spitzer, MH; Mingueneau, M; Bendall, SC; Litvin, O; Stone, E; Pe'er, D; Nolan, GP				Krishnaswamy, Smita; Spitzer, Matthew H.; Mingueneau, Michael; Bendall, Sean C.; Litvin, Oren; Stone, Erica; Pe'er, Dana; Nolan, Garry P.			Conditional density-based analysis of T cell signaling in single-cell data	SCIENCE			English	Article							MASS CYTOMETRY; MUTUAL INFORMATION; CD4; ACTIVATION; GENERATION; RESPONSES; PATHWAYS; IMMUNE; NAIVE	Cellular circuits sense the environment, process signals, and compute decisions using networks of interacting proteins. To model such a system, the abundance of each activated protein species can be described as a stochastic function of the abundance of other proteins. High-dimensional single-cell technologies, such as mass cytometry, offer an opportunity to characterize signaling circuit-wide. However, the challenge of developing and applying computational approaches to interpret such complex data remains. Here, we developed computational methods, based on established statistical concepts, to characterize signaling network relationships by quantifying the strengths of network edges and deriving signaling response functions. In comparing signaling between naive and antigen-exposed CD4(+) T lymphocytes, we find that although these two cell subtypes had similarly wired networks, naive cells transmitted more information along a key signaling cascade than did antigen-exposed cells. We validated our characterization on mice lacking the extracellular-regulated mitogen-activated protein kinase (MAPK) ERK2, which showed stronger influence of pERK on pS6 (phosphorylated-ribosomal protein S6), in naive cells as compared with antigen-exposed cells, as predicted. We demonstrate that by using cell-to-cell variation inherent in single-cell data, we can derive response functions underlying molecular circuits and drive the understanding of how cells process signals.	[Krishnaswamy, Smita; Litvin, Oren; Pe'er, Dana] Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA; [Spitzer, Matthew H.; Bendall, Sean C.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Mingueneau, Michael] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA USA; [Stone, Erica] Univ Calif San Diego, Dept Cellular & Mol Med, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	Columbia University; Stanford University; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Bendall, Sean/AGG-0126-2022; Mingueneau, Michael/O-5313-2019; Krishnaswamy, Smita/D-8089-2016; Nolan, Garry/AAE-7903-2019	Mingueneau, Michael/0000-0002-3873-7329; Krishnaswamy, Smita/0000-0001-5823-1985; Spitzer, Matthew/0000-0002-5291-3819; Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453	National Science Foundation CAREER award [MCB-1149728]; National Centers for Biomedical Computing Grant [1U54CA121852-01A1]; NIH S10 Shared instrumentation grant [NIH S10 SIG S10RR027582-01]; Packard Fellowship for Science and Engineering; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; NIH K01 award [1K01DK095008]; Rachford and Carlota A. Harris Endowed Professorship; NCI [RFA CA 09-011, NHLBIHV-10-05 (2)]; European Commission [HEALTH.2010.1.2-1]; Bill and Melinda Gates Foundation [GF12141-137101];  [U19 AI057229];  [P01 CA034233];  [HHSN272200700038C];  [1R01CA130826];  [CIRM DR1-01477];  [RB2-01592]; Direct For Biological Sciences [1149728] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P01CA034233, U54CA121852, F32CA009011, R01CA130826, U54CA149145] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM104148] Funding Source: NIH RePORTER	National Science Foundation CAREER award(National Science Foundation (NSF)); National Centers for Biomedical Computing Grant; NIH S10 Shared instrumentation grant; Packard Fellowship for Science and Engineering; Damon Runyon Cancer Research Foundation Fellowship; NIH K01 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rachford and Carlota A. Harris Endowed Professorship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; ; ; ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Bodenmiller, N. Friedman, N. HaCohen, I. Pe'er, A. Regev, and S. Reiner for valuable comments. We respectfully appreciate the provision of mouse samples and key mechanistic discussions with C. Benoist and S. Hedrick. This research was supported by the National Science Foundation CAREER award through grant MCB-1149728 and National Centers for Biomedical Computing Grant 1U54CA121852-01A1 and the NIH S10 Shared instrumentation grant NIH S10 SIG S10RR027582-01. D. P. holds a Packard Fellowship for Science and Engineering. S. C. B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). E. S. is supported by NIH K01 award 1K01DK095008. G. P. N. is supported by the Rachford and Carlota A. Harris Endowed Professorship and grants from U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, CIRM DR1-01477, and RB2-01592, NCI RFA CA 09-011, NHLBIHV-10-05 (2), European Commission HEALTH.2010.1.2-1, and the Bill and Melinda Gates Foundation (GF12141-137101). S. K., G. P. N., and D. P. conceived the study. S. K. and D. P. designed and developed DREVI, DREMI, and additional computational methods in this manuscript. S. K. wrote all computer programs used in this manuscript. M. H. S. and S. C. B. developed reagents. M. M. stimulated the mice and collected the biological samples. M. H. S., M. M., and S. C. B. designed mouse experiments and performed cognate data acquisition. E. S. developed the inducible ERK-knockdown mouse. S. K. and O.L. performed statistical analysis. S. K. and D. P. performed the biological analysis and interpretation. S. K., G. P. N., and D. P. wrote the manuscript.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Angelo M, 2014, LAB INVEST, V94, p518A; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Baaten Bas Jg, 2010, Commun Integr Biol, V3, P508, DOI 10.4161/cib.3.6.13495; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chandok MR, 2004, SEMIN IMMUNOL, V16, P285, DOI 10.1016/j.smim.2004.08.009; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Darbellay GA, 1999, IEEE T INFORM THEORY, V45, P1315, DOI 10.1109/18.761290; DeGroot MH., 2012, PROBABILITY STAT PEA; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Hall P, 2004, J AM STAT ASSOC, V99, P1015, DOI 10.1198/016214504000000548; Hastie T., 2001, THE ELEMENTS OF STAT; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jang IS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0011; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Koller D., 2009, PROBABILISTIC GRAPHI; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Mingueneau M, 2014, P NATL ACAD SCI USA, V111, P16466, DOI 10.1073/pnas.1419337111; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rosenblatt M., 1969, MULTIVARIATE ANALYSI, P25; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Thomas MC, 2006, ELEMENTS INFORM THEO; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	127	132	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1079	+	1250689	10.1126/science.1250689	http://dx.doi.org/10.1126/science.1250689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25342659	Green Accepted			2022-12-28	WOS:000345763400033
J	Baidal, JAW; Taveras, EM				Baidal, Jennifer A. Woo; Taveras, Elsie M.			Protecting Progress against Childhood Obesity - The National School Lunch Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STANDARDS		[Baidal, Jennifer A. Woo] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Baidal, Jennifer A. Woo; Taveras, Elsie M.] MassGeneral Hosp Children, Dept Pediat, Boston, MA USA; [Taveras, Elsie M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Baidal, JAW (corresponding author), Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA.							Cohen JFW, 2014, AM J PREV MED, V46, P388, DOI 10.1016/j.amepre.2013.11.013; Committee on Nutrition Standards for National School Lunch and Breakfast Programs, 2010, SCH MEALS BUILD BLOC; Forestell CA, 2007, PEDIATRICS, V120, P1247, DOI 10.1542/peds.2007-0858; Government Accountability Office, 2014, SCH LUNCH IMPL NUTR; Turner L, 2014, CHILD OBES, V10, P349, DOI 10.1089/chi.2014.0038	5	23	23	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1862	1865		10.1056/NEJMp1409353	http://dx.doi.org/10.1056/NEJMp1409353			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25353967				2022-12-28	WOS:000344709800003
J	Valyavin, G; Shulyak, D; Wade, GA; Antonyuk, K; Zharikov, SV; Galazutdinov, GA; Plachinda, S; Bagnulo, S; Machado, LF; Alvarez, M; Clark, DM; Lopez, JM; Hiriart, D; Han, I; Jeon, YB; Zurita, C; Mujica, R; Burlakova, T; Szeifert, T; Burenkov, A				Valyavin, G.; Shulyak, D.; Wade, G. A.; Antonyuk, K.; Zharikov, S. V.; Galazutdinov, G. A.; Plachinda, S.; Bagnulo, S.; Machado, L. Fox; Alvarez, M.; Clark, D. M.; Lopez, J. M.; Hiriart, D.; Han, Inwoo; Jeon, Young-Beom; Zurita, C.; Mujica, R.; Burlakova, T.; Szeifert, T.; Burenkov, A.			Suppression of cooling by strong magnetic fields in white dwarf stars	NATURE			English	Article							TURBULENT CONVECTION; BROADENING TABLES; SPACE MOTIONS; EVOLUTION; WD-1953-011; HYDROGEN; MODEL; FEIGE-7; SEARCH	Isolated cool white dwarf stars more often have strong magnetic fields than young, hotter white dwarfs(1-4), which has been a puzzle because magnetic fields are expected to decay with time(5,6) but a cool surface suggests that the star is old. In addition, some white dwarfs with strong fields vary in brightness as they rotate(7-10), which has been variously attributed to surface brightness inhomogeneities similar to sunspots(8-12), chemical inhomogeneities(13,14) and other magneto-optical effects(15-17). Here we describe optical observations of the brightness and magnetic field of the cool white dwarf WD 1953-011 taken over about eight years, and the results of an analysis of its surface temperature and magnetic field distribution. We find that the magnetic field suppresses atmospheric convection, leading to dark spots in the most magnetized areas. We also find that strong fields are sufficient to suppress convection over the entire surface in cool magnetic white dwarfs, which inhibits their cooling evolution relative to weakly magnetic and non-magnetic white dwarfs, making them appear younger than they truly are. This explains the long-standing mystery of why magnetic fields are more common amongst cool white dwarfs, and implies that the currently accepted ages of strongly magnetic white dwarfs are systematically too young.	[Valyavin, G.; Burlakova, T.; Burenkov, A.] Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz 369167, Zelenchukskiy R, Russia; [Shulyak, D.] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; [Wade, G. A.] Royal Mil Coll Canada, Dept Phys, Kingston, ON K7K 7B4, Canada; [Antonyuk, K.; Plachinda, S.] Crimean Astrophys Observ, UA-98409 Nauchnyi, Crimea, Ukraine; [Zharikov, S. V.; Machado, L. Fox; Alvarez, M.; Clark, D. M.; Lopez, J. M.; Hiriart, D.] Univ Nacl Autonoma Mexico, Inst Astron, Observ Astron Nacl San Pedro Martir SPM, Ensenada 22860, Baja California, Mexico; [Galazutdinov, G. A.] Univ Catolica Norte, Inst Astron, Antofagasta, Chile; [Galazutdinov, G. A.] Pulkovo Observ, St Petersburg 196140, Russia; [Bagnulo, S.] Armagh Observ, Armagh BT61 9DG, North Ireland; [Han, Inwoo; Jeon, Young-Beom] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Zurita, C.] Inst Astrofis Canarias, Tenerife 38200, Spain; [Zurita, C.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Mujica, R.] Inst Nacl Astrofis Opt & Electr, Tonantzintla 72000, Pueblo, Mexico; [Szeifert, T.] European So Observ, Santiago 19, Chile	Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; University of Gottingen; Royal Military College - Canada; Russian Academy of Sciences; Crimean Astrophysical Observatory; Universidad Nacional Autonoma de Mexico; Universidad Catolica del Norte; Pulkovo Observatory; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Korea Astronomy & Space Science Institute (KASI); Instituto de Astrofisica de Canarias; Universidad de la Laguna; Instituto Nacional de Astrofisica, Optica y Electronica; European Southern Observatory	Valyavin, G (corresponding author), Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz 369167, Zelenchukskiy R, Russia.	gvalyavin@sao.ru	Galazutdinov, Gazinur/AAU-8934-2020; Burenkov, Alexander/Y-2248-2019; Galazutdinov, Gazinur/AAV-5144-2020; Plachinda, Sergei/AAD-3187-2020; Antoniuk, Kirill/AAX-9102-2021; Fox-Machado, Lester/L-5746-2019; ZHARIKOV, SERGEY/AAR-2577-2020	Plachinda, Sergei/0000-0002-9975-0789; Fox-Machado, Lester/0000-0002-2781-873X; ZHARIKOV, SERGEY/0000-0003-2526-2683; Shulyak, Denis/0000-0001-8496-2482; Hiriart, David/0000-0002-4711-7658; , Antoniuk/0000-0003-2754-8925	Chilean fund FONDECYT [1120190]; CONACyT, Mexico [180817]; ministry of science and education of the Russian Federation [14.518.11.7070, 16.518.11.7073]; CRC963 Astrophysical Flow Instabilities and Turbulence [A16-A17]; Natural Sciences and Engineering Research Council (NSERC Canada); DGAPA/PAPIIT [IN100614]; CONACYT [151858]; Universidad Nacional Autonoma de Mexico [PAPIIT IN104612]	Chilean fund FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ministry of science and education of the Russian Federation(Ministry of Education and Science, Russian Federation); CRC963 Astrophysical Flow Instabilities and Turbulence; Natural Sciences and Engineering Research Council (NSERC Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); DGAPA/PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	G.V. thanks J. Landstreet and S. Fabrika for discussions and practical help in interpreting the results. G. V. also thanks E. Kaisina for help in the preparation of the manuscript. G. V. and G. A. G. acknowledge the support of Chilean fund FONDECYT-regular (project 1120190). G. V. and D. H. acknowledge financial support from CONACyT, Mexico (grant 180817). G. V., T. B. and A. B. acknowledge financial support from the ministry of science and education of the Russian Federation (contracts 14.518.11.7070 and 16.518.11.7073). D. S. acknowledges financial support from CRC963 Astrophysical Flow Instabilities and Turbulence (project A16-A17). G. A. W. is supported by a Natural Sciences and Engineering Research Council (NSERC Canada) Discovery Grant. S.V.Z. acknowledges support from DGAPA/PAPIIT IN100614 and CONACYT 151858 projects. L. F. M. acknowledges financial support from the Universidad Nacional Autonoma de Mexico under grant PAPIIT IN104612.	ACHILLEOS N, 1992, ASTROPHYS J, V396, P273, DOI 10.1086/171715; ANGEL JRP, 1981, ASTROPHYS J SUPPL S, V45, P457, DOI 10.1086/190720; Anselowitz T, 1999, PUBL ASTRON SOC PAC, V111, P702, DOI 10.1086/316381; BARSTOW MA, 1995, MON NOT R ASTRON SOC, V277, P971, DOI 10.1093/mnras/277.3.971; Bergeron P, 2001, ASTROPHYS J SUPPL S, V133, P413, DOI 10.1086/320356; Bohm-Vitense E., 1958, Z ASTROPHYS, V46, P108; Brinkworth CS, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/47; Brinkworth CS, 2005, MON NOT R ASTRON SOC, V357, P333, DOI 10.1111/j.1365-2966.2005.08649.x; CANUTO VM, 1992, ASTROPHYS J, V389, P724, DOI 10.1086/171245; CANUTO VM, 1991, ASTROPHYS J, V370, P295, DOI 10.1086/169815; CHANDRASEKHAR S, 1952, PHILOS MAG, V43, P501; Cowling T. G., 1965, COMP ASTRON ASTROPHY, V8, P425; DANTONA F, 1979, ASTRON ASTROPHYS, V74, P161; Ferrario L, 1997, MON NOT R ASTRON SOC, V292, P205, DOI 10.1093/mnras/292.2.205; HUMMER DG, 1988, ASTROPHYS J, V331, P794, DOI 10.1086/166600; Kawka A, 2007, ASTROPHYS J, V654, P499, DOI 10.1086/509072; Kepler SO, 2013, MON NOT R ASTRON SOC, V429, P2934, DOI 10.1093/mnras/sts522; Koester D, 1998, ASTRON ASTROPHYS, V338, P612; Landstreet JD, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219829; Lemke M, 1997, ASTRON ASTROPHYS SUP, V122, P285, DOI 10.1051/aas:1997134; Liebert J, 2003, ASTRON J, V125, P348, DOI 10.1086/345573; LIEBERT J, 1977, ASTROPHYS J, V214, P457, DOI 10.1086/155271; MARTIN B, 1979, MON NOT R ASTRON SOC, V189, P69, DOI 10.1093/mnras/189.1.69; Maxted PFL, 2000, MON NOT R ASTRON SOC, V315, pL41, DOI 10.1046/j.1365-8711.2000.03636.x; MUSLIMOV AG, 1995, ASTROPHYS J, V442, P758, DOI 10.1086/175481; Parker E. N., 1979, COSMICAL MAGNETIC FI, P207; SCHMIDT GD, 1995, ASTROPHYS J, V448, P305, DOI 10.1086/175962; Shapiro S. L., 1983, BLACK HOLES WHITE DW, P82; Shulyak D, 2004, ASTRON ASTROPHYS, V428, P993, DOI 10.1051/0004-6361:20034169; Sion EM, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/129; SION EM, 1977, ASTROPHYS J, V213, P468, DOI 10.1086/155178; SION EM, 1988, ASTRON J, V96, P251, DOI 10.1086/114807; Solanki SK, 2003, ASTRON ASTROPHYS REV, V11, P153, DOI 10.1007/s00159-003-0018-4; Valyavin G, 2008, ASTROPHYS J, V683, P466, DOI 10.1086/589234; Valyavin G, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/17; Valyavin G, 1999, ASTR SOC P, V169, P206; VIDAL CR, 1973, ASTROPHYS J SUPPL S, V25, P37, DOI 10.1086/190264; Wade GA, 2003, ASTR SOC P, V307, P569; WENDELL CE, 1987, ASTROPHYS J, V313, P284, DOI 10.1086/164968; WICKRAMASINGHE DT, 1986, MON NOT R ASTRON SOC, V223, P323, DOI 10.1093/mnras/223.2.323	40	45	54	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					88	+		10.1038/nature13836	http://dx.doi.org/10.1038/nature13836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25327247				2022-12-28	WOS:000344187500034
J	Charlton, BM; Rich-Edwards, JW; Colditz, GA; Missmer, SA; Rosner, BA; Hankinson, SE; Speizer, FE; Michels, KB				Charlton, Brittany M.; Rich-Edwards, Janet W.; Colditz, Graham A.; Missmer, Stacey A.; Rosner, Bernard A.; Hankinson, Susan E.; Speizer, Frank E.; Michels, Karin B.			Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; HORMONAL CONTRACEPTION; ROYAL-COLLEGE; RISK; WOMEN	Objective To determine whether use of oral contraceptives is associated with all cause and cause specific mortality. Design Prospective cohort study. Setting Nurses' Health Study, data collected between 1976 and 2012. Population 121 701 participants were prospectively followed for 36 years; lifetime oral contraceptive use was recorded biennially from 1976 to 1982. Main outcome measures Overall and cause specific mortality, assessed throughout follow-up until 2012. Cox proportional hazards models were used to calculate the relative risks of all cause and cause specific mortality associated with use of oral contraceptives. Results In our population of 121 577 women with information on oral contraceptive use, 63 626 were never users (52%) and 57 951 were ever users (48%). After 3.6 million person years, we recorded 31 286 deaths. No association was observed between ever use of oral contraceptives and all cause mortality. However, violent or accidental deaths were more common among ever users (hazard ratio 1.20, 95% confidence interval 1.04 to 1.37). Longer duration of use was more strongly associated with certain causes of death, including premature mortality due to breast cancer (test for trend P<0.0001) and decreased mortality rates of ovarian cancer (P=0.002). Longer time since last use was also associated with certain outcomes, including a positive association with violent or accidental deaths (P=0.005). Conclusions All cause mortality did not differ significantly between women who had ever used oral contraceptives and never users. Oral contraceptive use was associated with certain causes of death, including increased rates of violent or accidental death and deaths due to breast cancer, whereas deaths due to ovarian cancer were less common among women who used oral contraceptives. These results pertain to earlier oral contraceptive formulations with higher hormone doses rather than the now more commonly used third and fourth generation formulations with lower estrogen doses.	[Charlton, Brittany M.; Rich-Edwards, Janet W.; Missmer, Stacey A.; Hankinson, Susan E.; Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Charlton, Brittany M.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA; [Charlton, Brittany M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Rich-Edwards, Janet W.] Harvard Univ, Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, Sch Med, Boston, MA 02115 USA; [Rich-Edwards, Janet W.; Missmer, Stacey A.; Rosner, Bernard A.; Hankinson, Susan E.; Speizer, Frank E.; Michels, Karin B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Rich-Edwards, Janet W.; Missmer, Stacey A.; Rosner, Bernard A.; Hankinson, Susan E.; Speizer, Frank E.; Michels, Karin B.] Harvard Univ, Sch Med, Boston, MA USA; [Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Missmer, Stacey A.] Brigham & Womens Hosp, Div Reprod Med, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Speizer, Frank E.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Michels, Karin B.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Michels, KB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	kmichels@research.bwh.harvard.edu	Colditz, Graham/A-3963-2009; Charlton, Brittany/AAH-9334-2021	Colditz, Graham/0000-0002-7307-0291; 	National Institutes of Health [P01CA87969, R01HL034594, R01HL088521]; National Institute of Child Health and Human Development [T32HD060454]; National Cancer Institute, National Institutes of Health [T32CA09001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969, T32CA009001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL088521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Nurses' Health Study was supported by research grants P01CA87969, R01HL034594, and R01HL088521 of the National Institutes of Health. BMC was supported by the training grant T32HD060454 in reproductive, perinatal, and pediatric epidemiology from the National Institute of Child Health and Human Development, and the training program in cancer epidemiology under grant T32CA09001 from the National Cancer Institute, National Institutes of Health. The funding sources had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Annegers J F, 1989, Br J Rheumatol, V28 Suppl 1, P48; [Anonymous], 1974, JAMA, V228, P68; [Anonymous], SAS STAT SOFTW REL 9; Baer HJ, 2011, AM J EPIDEMIOL, V173, P319, DOI 10.1093/aje/kwq368; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; Bosetti C, 2009, HUM REPROD UPDATE, V15, P489, DOI 10.1093/humupd/dmp017; Brind J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2523; CAILLOUETTE JC, 1987, AM J OBSTET GYNECOL, V156, P1538, DOI 10.1016/0002-9378(87)90028-7; Calle EE, 1996, CONTRACEPTION, V54, pS1; Cogliano V, 2005, LANCET ONCOL, V6, P552, DOI 10.1016/S1470-2045(05)70273-4; COLDITZ GA, 1994, ANN INTERN MED, V120, P821, DOI 10.7326/0003-4819-120-10-199405150-00002; EGARTER C, 1995, CONTRACEPTION, V51, P329, DOI 10.1016/0010-7824(95)00096-S; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P83, DOI 10.1111/j.1479-828X.2007.00805.x; Gillum LA, 2000, JAMA-J AM MED ASSOC, V284, P72, DOI 10.1001/jama.284.1.72; Graff-Iversen S, 2006, SCAND J PUBLIC HEALT, V34, P11, DOI 10.1080/14034940510032239; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hankinson SE, 1997, CANCER CAUSE CONTROL, V8, P65, DOI 10.1023/A:1018435205695; Hannaford PC, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c927; Hunter DJ, 2010, CANCER EPIDEM BIOMAR, V19, P2496, DOI 10.1158/1055-9965.EPI-10-0747; Hunter DJ, 1997, CONTRACEPTION, V56, P373, DOI 10.1016/S0010-7824(97)00172-8; Kahlenborn C, 2006, MAYO CLIN PROC, V81, P1290, DOI 10.4065/81.10.1290; Kahn L S, 2001, Expert Opin Pharmacother, V2, P1367, DOI 10.1517/14656566.2.9.1367; KAY CR, 1984, CLIN OBSTET GYNAECOL, V11, P759; KAY CR, 1981, LANCET, V1, P541; Keyes KM, 2013, AM J EPIDEMIOL, V178, P1378, DOI 10.1093/aje/kwt188; Khader YS, 2003, CONTRACEPTION, V68, P11, DOI 10.1016/S0010-7824(03)00073-8; LANES SF, 1992, AM J OBSTET GYNECOL, V166, P956, DOI 10.1016/0002-9378(92)91371-G; Maguire K, 2011, AM J OBSTET GYNECOL, V205, pS4, DOI 10.1016/j.ajog.2011.06.056; Mosher William D, 2010, Vital Health Stat 23, P1; Mueck AO, 2010, ENDOCR-RELAT CANCER, V17, pR263, DOI 10.1677/ERC-10-0076; Oinonen KA, 2002, J AFFECT DISORDERS, V70, P229, DOI 10.1016/S0165-0327(01)00356-1; Pasqualini JR, 2007, GYNECOL ENDOCRINOL, V23, P32, DOI 10.1080/09513590701585003; PIPER JM, 1987, INT J EPIDEMIOL, V16, P215, DOI 10.1093/ije/16.2.215; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; ROOKUS MA, 1994, LANCET, V344, P844, DOI 10.1016/S0140-6736(94)92826-6; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; THOMAS DB, 1990, BRIT J CANCER, V61, P110; Toffol E, 2011, HUM REPROD, V26, P3085, DOI 10.1093/humrep/der269; Vessey M, 2003, LANCET, V362, P185, DOI 10.1016/S0140-6736(03)13907-4; Vessey M, 2010, CONTRACEPTION, V82, P221, DOI 10.1016/j.contraception.2010.04.006; Vessey MP, 1998, BRIT J GEN PRACT, V48, P1639; VESSEY MP, 1989, BMJ-BRIT MED J, V299, P1487, DOI 10.1136/bmj.299.6714.1487; YOUNG RL, 1992, AM J OBSTET GYNECOL, V167, P678, DOI 10.1016/S0002-9378(11)91570-1; Zhu H, 2012, EUR J CONTRACEP REPR, V17, P402, DOI 10.3109/13625187.2012.715357	47	46	48	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2014	349								g6356	10.1136/bmj.g6356	http://dx.doi.org/10.1136/bmj.g6356			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DM	25361731	hybrid, Green Published			2022-12-28	WOS:000344156600001
J	Johns-Krull, CM				Johns-Krull, Christopher M.			ASTROPHYSICS Secret ingredient exposed	NATURE			English	Editorial Material							T-TAURI STARS; DISK		Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University	Johns-Krull, CM (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.	cmj@rice.edu						Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; Gullbring E, 1998, ASTROPHYS J, V492, P323, DOI 10.1086/305032; Lazarian A, 2007, J QUANT SPECTROSC RA, V106, P225, DOI 10.1016/j.jqsrt.2007.01.038; Rao R, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L6; Stephens IW, 2014, NATURE, V514, P597, DOI 10.1038/nature13850; VALENTI JA, 1993, ASTRON J, V106, P2024, DOI 10.1086/116783	6	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					571	572		10.1038/nature13932	http://dx.doi.org/10.1038/nature13932			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25337884				2022-12-28	WOS:000343801500033
J	Thibert, RL; Duhaime, AC; Caruso, PA; Stemmer-Rachamimov, A				Thibert, Ronald L.; Duhaime, Ann-Christine; Caruso, Paul A.; Stemmer-Rachamimov, Anat			Case 34-2014: A 7-Year-Old Boy with Focal Seizures and Progressive Weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPILEPSIA-PARTIALIS-CONTINUA; RASMUSSENS ENCEPHALITIS; CORTICAL DYSPLASIA; DIAGNOSIS; PATHOLOGY; ETIOLOGY; FEATURES		[Thibert, Ronald L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Caruso, Paul A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stemmer-Rachamimov, Anat] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Thibert, Ronald L.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Duhaime, Ann-Christine] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA; [Caruso, Paul A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stemmer-Rachamimov, Anat] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Thibert, RL (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.							Bien CG, 2005, BRAIN, V128, P454, DOI 10.1093/brain/awh415; Bien CG, 2002, NEUROLOGY, V58, P250, DOI 10.1212/WNL.58.2.250; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Firlik KS, 1999, PEDIATR NEUROSURG, V30, P278, DOI 10.1159/000028811; Hart YM, 1998, NEUROLOGY, V50, P731, DOI 10.1212/WNL.50.3.731; Harvey S, 2008, EPILEPSIA, V49, P146, DOI 10.1111/j.1528-1167.2007.01421.x; Kravljanac R, 2013, EPILEPSY RES, V104, P112, DOI 10.1016/j.eplepsyres.2012.09.003; Longaretti F, 2012, EPILEPSIA, V53, P1539, DOI 10.1111/j.1528-1167.2012.03565.x; MISCHEL PS, 1995, J NEUROPATH EXP NEUR, V54, P137, DOI 10.1097/00005072-199503000-00001; Palmer CA, 1999, EPILEPSIA, V40, P242, DOI 10.1111/j.1528-1157.1999.tb02082.x; Pandian JD, 2002, SEIZURE-EUR J EPILEP, V11, P437, DOI 10.1053/seiz.2001.0646; Phabphal K, 2012, EPILEPSY RES, V100, P179, DOI 10.1016/j.eplepsyres.2012.02.009; Prayson RA, 2012, CASE REP PATHOL, V2012, DOI 10.1155/2012/569170; Robitaille Y, 1991, CHRONIC ENCEPHALITIS, P79; Rowland NC, 2012, J NEUROSURG, V116, P1035, DOI 10.3171/2012.1.JNS111105; Schachter SC, 1998, EPILEPSIA, V39, P677, DOI 10.1111/j.1528-1157.1998.tb01151.x; SCHRAMM J, 1995, NEUROSURGERY, V36, P509, DOI 10.1227/00006123-199503000-00010; Schramm J, 2001, NEUROSURGERY, V49, P891, DOI 10.1097/00006123-200110000-00021; Sinha S, 2007, EPILEPSY RES, V74, P55, DOI 10.1016/j.eplepsyres.2006.12.003; Takei H, 2010, NEUROPATHOLOGY, V30, P381, DOI 10.1111/j.1440-1789.2009.01079.x; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; THOMAS JE, 1977, ARCH NEUROL-CHICAGO, V34, P266, DOI 10.1001/archneur.1977.00500170020003; VILLEMURE JG, 1995, NEUROSURGERY, V37, P975, DOI 10.1227/00006123-199511000-00018; Vinters HV, 2002, INT REV NEUROBIOL, V49, P63	24	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1737	1746		10.1056/NEJMcpc1305993	http://dx.doi.org/10.1056/NEJMcpc1305993			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354108				2022-12-28	WOS:000343768500013
J	Roberge, A				Roberge, Aki			ASTRONOMY Hurling comets around a planetary nursery	NATURE			English	Editorial Material							BETA-PICTORIS; CIRCUMSTELLAR DISK; BODIES		NASA, Goddard Space Flight Ctr, Exoplunets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Roberge, A (corresponding author), NASA, Goddard Space Flight Ctr, Exoplunets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA.	aki.roberge@nasa.gov	Roberge, Aki/D-2782-2012	Roberge, Aki/0000-0002-2989-3725				BEUST H, 1990, ASTRON ASTROPHYS, V236, P202; Dent WRF, 2014, SCIENCE, V343, P1490, DOI 10.1126/science.1248726; Kiefer F, 2014, NATURE, V514, P462, DOI 10.1038/nature13849; Mamajek E E., PREPRINT; Mamajek E E., MON NOT R A IN PRESS; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Vidal-Madjar A., 1987, ASTRON ASTROPHYS, V173, P239	8	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					440	441		10.1038/514440a	http://dx.doi.org/10.1038/514440a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341780				2022-12-28	WOS:000343775900027
J	Hoge, CW; Castro, CA				Hoge, Charles W.; Castro, Carl A.			Treatment of Generalized War-Related Health Concerns Placing TBI and PTSD in Context	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-GUARD; OUTCOMES; COMBAT; ASSOCIATION; RISK		[Hoge, Charles W.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Castro, Carl A.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Southern California	Hoge, CW (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	charles.hoge@us.army.mil		Yurgil, Kate/0000-0003-0651-5219; Nievergelt, Caroline/0000-0001-5766-8923; Schork, Nicholas/0000-0003-0920-5013				Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW., 2012, HARRISONS PRINCIPLES, P1; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	9	26	26	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1685	1686		10.1001/jama.2014.6670	http://dx.doi.org/10.1001/jama.2014.6670			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335151				2022-12-28	WOS:000343301400026
J	Rubin, R				Rubin, Rita			Analysis Reveals Large Increase in Hospitalizations in Recent Years Among Older Patients Prescribed Opioids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item							COMPARATIVE SAFETY; ADULTS; PAIN						Rubin, Rita/AAD-1259-2020					Colliver JD, 2006, ANN EPIDEMIOL, V16, P257, DOI 10.1016/j.annepidem.2005.08.003; Hanlon JT, 2009, PAIN MED, V10, P959, DOI 10.1111/j.1526-4637.2009.00698.x; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391	4	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1621	1623		10.1001/jama.2014.13249	http://dx.doi.org/10.1001/jama.2014.13249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335129				2022-12-28	WOS:000343301400002
J	Brooks, HE; Carbin, GW; Marsh, PT				Brooks, Harold E.; Carbin, Gregory W.; Marsh, Patrick T.			Increased variability of tornado occurrence in the United States	SCIENCE			English	Article							SEVERE THUNDERSTORM; REANALYSIS; ENVIRONMENTS; PARAMETERS	Whether or not climate change has had an impact on the occurrence of tornadoes in the United States has become a question of high public and scientific interest, but changes in how tornadoes are reported have made it difficult to answer it convincingly. We show that, excluding the weakest tornadoes, the mean annual number of tornadoes has remained relatively constant, but their variability of occurrence has increased since the 1970s. This is due to a decrease in the number of days per year with tornadoes combined with an increase in days with many tornadoes, leading to greater variability on annual and monthly time scales and changes in the timing of the start of the tornado season.	[Brooks, Harold E.] NOAA, Natl Severe Storms Lab, Norman, OK 73072 USA; [Carbin, Gregory W.; Marsh, Patrick T.] NOAA, Natl Weather Serv Storm Predict Ctr, Norman, OK 73072 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Brooks, HE (corresponding author), NOAA, Natl Severe Storms Lab, Norman, OK 73072 USA.	harold.brooks@noaa.gov						Brooks HE, 2013, ATMOS RES, V123, P129, DOI 10.1016/j.atmosres.2012.04.002; Brooks HE, 2003, ATMOS RES, V67-8, P73, DOI 10.1016/S0169-8095(03)00045-0; Compo GP, 2006, B AM METEOROL SOC, V87, P175, DOI 10.1175/BAMS-87-2-175; Craven J.P., 2004, NATL WEA DIG, V28, P13; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Doswell CA, 2009, ATMOS RES, V93, P554, DOI 10.1016/j.atmosres.2008.11.003; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Myhre G., 2013, CONTRIBUTION WORKING; Rasmussen EN, 1998, WEATHER FORECAST, V13, P1148, DOI 10.1175/1520-0434(1998)013<1148:ABCOSD>2.0.CO;2; Shafer CM, 2012, WEATHER FORECAST, V27, P809, DOI 10.1175/WAF-D-11-00142.1; Shafer CM, 2009, MON WEATHER REV, V137, P1250, DOI 10.1175/2008MWR2597.1; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1	15	101	103	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					349	352		10.1126/science.1257460	http://dx.doi.org/10.1126/science.1257460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324388				2022-12-28	WOS:000343041100044
J	Hummer, G				Hummer, Gerhard			Potassium ions line up	SCIENCE			English	Editorial Material							CONDUCTION; CHANNEL; FILTER; SELECTIVITY; MECHANISM; FILE		Max Planck Inst Biophys, Dept Theoret Biophys, D-60438 Frankfurt, Germany	Max Planck Society	Hummer, G (corresponding author), Max Planck Inst Biophys, Dept Theoret Biophys, D-60438 Frankfurt, Germany.	gehummer@biophys.mpg.de	Hummer, Gerhard/A-2546-2013	Hummer, Gerhard/0000-0001-7768-746X				Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000	10	15	15	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					303	303		10.1126/science.1260555	http://dx.doi.org/10.1126/science.1260555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324373				2022-12-28	WOS:000343041100019
J	Medford, JI; Prasad, A				Medford, June I.; Prasad, Ashok			Plant synthetic biology takes root	SCIENCE			English	Editorial Material							ARABIDOPSIS; SYSTEM		[Medford, June I.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Prasad, Ashok] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Medford, JI (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	june.medford@colostate.edu	Prasad, Ashok/HDN-5956-2022					Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Antunes MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016292; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Lyons SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003533; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Morey KJ, 2011, METHOD ENZYMOL, V497, P581, DOI 10.1016/B978-0-12-385075-1.00025-1; Sainsbury F, 2014, CURR OPIN PLANT BIOL, V19, P1, DOI 10.1016/j.pbi.2014.02.003; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stewart CN, 2011, PLANT TRANSFORMATION; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	15	12	12	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					162	163		10.1126/science.1261140	http://dx.doi.org/10.1126/science.1261140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301601				2022-12-28	WOS:000342721500018
J	Pappas, L; Foglierini, M; Piccoli, L; Kallewaard, NL; Turrini, F; Silacci, C; Fernandez-Rodriguez, B; Agatic, G; Giacchetto-Sasselli, I; Pellicciotta, G; Sallusto, F; Zhu, Q; Vicenzi, E; Corti, D; Lanzavecchia, A				Pappas, Leontios; Foglierini, Mathilde; Piccoli, Luca; Kallewaard, Nicole L.; Turrini, Filippo; Silacci, Chiara; Fernandez-Rodriguez, Blanca; Agatic, Gloria; Giacchetto-Sasselli, Isabella; Pellicciotta, Gabriele; Sallusto, Federica; Zhu, Qing; Vicenzi, Elisa; Corti, Davide; Lanzavecchia, Antonio			Rapid development of broadly influenza neutralizing antibodies through redundant mutations	NATURE			English	Article							MEMORY B-CELLS; MONOCLONAL-ANTIBODIES; AFFINITY MATURATION; SEQUENCE-ANALYSIS; GERMINAL-CENTERS; IMMUNE-RESPONSE; VIRUS; GENERATION; HEMAGGLUTININ; EXPRESSION	The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem(1-6). Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region(HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals(6,7), suggesting that several somatic mutations may be required for their development(8,9). To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.	[Pappas, Leontios; Foglierini, Mathilde; Piccoli, Luca; Silacci, Chiara; Fernandez-Rodriguez, Blanca; Giacchetto-Sasselli, Isabella; Sallusto, Federica; Corti, Davide; Lanzavecchia, Antonio] Univ Svizzera Italiana, Insitute Res Biomed, CH-6500 Bellinzona, Switzerland; [Kallewaard, Nicole L.; Zhu, Qing] Dis & Vaccines MedImmune LLC, Dept Infect, Gaithersburg, MD 20878 USA; [Vicenzi, Elisa] Ist Sci San Raffaele, Viral Pathogens & Biosafety Unit, I-20132 Milan, Italy; [Agatic, Gloria; Corti, Davide] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Pellicciotta, Gabriele] Ist Sci San Raffaele, Unit Prevent Med, I-20132 Milan, Italy; [Lanzavecchia, Antonio] ETH, Insitute Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; AstraZeneca; Medimmune; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Insitute Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.usi.ch	Turrini, Filippo/I-3677-2018; Vicenzi, Elisa/AAL-3980-2020	Turrini, Filippo/0000-0002-9121-9117; Vicenzi, Elisa/0000-0003-0051-3968; Piccoli, Luca/0000-0002-1085-6502; Foglierini, Mathilde/0000-0001-7538-4262	European Research Council IMMUNExplore [250348]; Swiss National Science Foundation [141254]; Fondazione Cariplo Vaccine Program [2009-3594]; Human Frontiers Science Program [RGP0009/2007-C]; European Commission ADITEC [FP7-HEALTH-2011-280873]; National Institutes of Health [AI-057266]; Helmut Horten Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER	European Research Council IMMUNExplore; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Cariplo Vaccine Program; Human Frontiers Science Program(Human Frontier Science Program); European Commission ADITEC(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmut Horten Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the European Research Council (grant number 250348) IMMUNExplore, the Swiss National Science Foundation (grant number 141254), Fondazione Cariplo Vaccine Program (grant number 2009-3594), the Human Frontiers Science Program (grant number RGP0009/2007-C), the European Commission (grant number FP7-HEALTH-2011-280873) ADITEC and the National Institutes of Health (U19 grant number AI-057266). A.L. is supported by the Helmut Horten Foundation.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Avnir Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004103; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Ghezzi S, 2013, AIDS, V27, P2335, DOI 10.1097/01.aids.0000432474.76873.5f; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hassantoufighi A, 2010, VACCINE, V28, P790, DOI 10.1016/j.vaccine.2009.10.066; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kaji T, 2013, INT IMMUNOL, V25, P683, DOI 10.1093/intimm/dxt030; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Sangster MY, 2013, CLIN VACCINE IMMUNOL, V20, P867, DOI 10.1128/CVI.00735-12; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vencovsky J, 2002, RHEUMATOLOGY, V41, P401, DOI 10.1093/rheumatology/41.4.401; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	39	204	209	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					418	+		10.1038/nature13764	http://dx.doi.org/10.1038/nature13764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25296253				2022-12-28	WOS:000346484800052
J	Sharpe, J				Sharpe, James			DEVELOPMENTAL BIOLOGY Cells unite by trapping a signal	NATURE			English	Editorial Material							GRADIENT	Gradients of fibroblast growth factors often induce cells to adopt different fates. A study in zebrafish embryos reveals another, unexpected role when the factors are trapped in small spaces by a special arrangement of cells. SEE LETTER P.120	[Sharpe, James] Ctr Genom Regulat, Syst Biol Program, Barcelona 08003, Spain; [Sharpe, James] Univ Pompeu Fabra, Barcelona, Spain; [Sharpe, James] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Sharpe, J (corresponding author), Ctr Genom Regulat, Syst Biol Program, Barcelona 08003, Spain.	james.sharpe@crg.eu	Sharpe, James/L-1150-2014; Sharpe, James/AAB-7948-2019	Sharpe, James/0000-0002-1434-9743; 	ICREA Funding Source: Custom	ICREA(ICREA)		Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Durdu S, 2014, NATURE, V515, P120, DOI 10.1038/nature13852; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547	7	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					41	42		10.1038/nature13933	http://dx.doi.org/10.1038/nature13933			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25337875				2022-12-28	WOS:000344187500023
J	Shafto, MA; Tyler, LK				Shafto, Meredith A.; Tyler, Lorraine K.			Language in the aging brain: The network dynamics of cognitive decline and preservation	SCIENCE			English	Review							AGE-RELATED-CHANGES; OF-THE-TONGUE; VERBAL WORKING-MEMORY; WORD-FINDING FAILURES; ADULT LIFE-SPAN; OLDER-ADULTS; SENTENCE COMPREHENSION; SPEECH; RETRIEVAL; TIP	Language is a crucial and complex lifelong faculty, underpinned by dynamic interactions within and between specialized brain networks. Whereas normal aging impairs specific aspects of language production, most core language processes are robust to brain aging. We review recent behavioral and neuroimaging evidence showing that language systems remain largely stable across the life span and that both younger and older adults depend on dynamic neural responses to linguistic demands. Although some aspects of network dynamics change with age, there is no consistent evidence that core language processes are underpinned by different neural networks in younger and older adults.	[Shafto, Meredith A.; Tyler, Lorraine K.] Univ Cambridge, Dept Psychol, Ctr Speech Language & Brain, Cambridge CB2 3EB, England	University of Cambridge	Shafto, MA (corresponding author), Univ Cambridge, Dept Psychol, Ctr Speech Language & Brain, Cambridge CB2 3EB, England.	mshafto@csl.psychol.cam.ac.uk		Tyler, Lorraine/0000-0002-9943-118X	Biotechnology and Biological Sciences Research Council [BB/H008217/1]; European Research Council under the European Community [249640]; BBSRC [BB/H008217/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council under the European Community(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Preparation of this review was supported by grants to L. K. T. from the Biotechnology and Biological Sciences Research Council (grant number BB/H008217/1) and the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 249640. The authors thank W. Marslen-Wilson, M. G. Shafto, and S. Shafto for helpful comments on an early draft and D. Samu and D. Meunier for help with figure preparation.	Abel S, 2009, NEUROSCI LETT, V463, P167, DOI 10.1016/j.neulet.2009.07.077; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Bozic M, 2010, P NATL ACAD SCI USA, V107, P17439, DOI 10.1073/pnas.1000531107; Burke D.M., 2008, HDB AGING COGNITION, V3rd ed, P373, DOI DOI 10.1016/B978-0-12-809324-5.01889-7; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2000, DEBATES PSYCHOL, P204; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R., 2012, PRINCIPLES FRONTAL L, P628, DOI [DOI 10.1093/ACPROF:OSO/9780195134971.001.0001, 10.1093/med/9780199837755.001.0001]; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Cross ES, 2004, BRAIN LANG, V89, P174, DOI 10.1016/S0093-934X(03)00363-8; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Davis SW, 2014, NEUROPSYCHOLOGIA, V63, P107, DOI 10.1016/j.neuropsychologia.2014.08.017; DeDe G, 2004, PSYCHOL AGING, V19, P601, DOI 10.1037/0882-7974.19.4.601; Federmeier KD, 2003, PSYCHOL AGING, V18, P858, DOI 10.1037/0882-7974.18.4.858; Foygel D, 2000, J MEM LANG, V43, P182, DOI 10.1006/jmla.2000.2716; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grossman M, 2002, NEUROIMAGE, V15, P302, DOI 10.1006/nimg.2001.0971; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; La Tourette TR, 2000, J LANG SOC PSYCHOL, V19, P463, DOI 10.1177/0261927X00019004004; Levelt WJM, 1998, J COGNITIVE NEUROSCI, V10, P553, DOI 10.1162/089892998562960; Lindin M, 2010, NEUROPSYCHOLOGIA, V48, P1757, DOI 10.1016/j.neuropsychologia.2010.02.025; LOVELACE EA, 1990, B PSYCHONOMIC SOC, V28, P115; Maril A, 2001, NEURON, V31, P653, DOI 10.1016/S0896-6273(01)00396-8; Meunier D, 2014, NEUROBIOL AGING, V35, P42, DOI 10.1016/j.neurobiolaging.2013.07.003; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Neumann Y, 2009, APHASIOLOGY, V23, P1028, DOI 10.1080/02687030802661630; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Peelle JE, 2010, CEREB CORTEX, V20, P773, DOI 10.1093/cercor/bhp142; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Rolheiser T, 2011, J NEUROSCI, V31, P16949, DOI 10.1523/JNEUROSCI.2725-11.2011; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Shafto MA, 2010, J COGNITIVE NEUROSCI, V22, P1530, DOI 10.1162/jocn.2009.21321; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Taylor JK, 2002, PSYCHOL AGING, V17, P662, DOI 10.1037//0882-7974.17.4.662; Thornton R, 2006, HDB PSYCHOL AGING, P261; Tun PA, 1998, PSYCHOL AGING, V13, P424, DOI 10.1037/0882-7974.13.3.424; TYLER LK, 1992, SPOKEN LANGUAGE COMP; Tyler LK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00271; Tyler LK, 2011, BRAIN, V134, P415, DOI 10.1093/brain/awq369; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Verhaeghen P, 2003, PSYCHOL AGING, V18, P332, DOI 10.1037/0882-7974.18.2.332; Waters GS, 2001, PSYCHOL AGING, V16, P128, DOI 10.1037/0882-7974.16.1.128; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; WILSON WM, 1973, NATURE, V244, P522, DOI 10.1038/244522a0; Wright P, 2012, J NEUROSCI, V32, P8149, DOI 10.1523/JNEUROSCI.0485-12.2012; Wright P, 2011, J COGNITIVE NEUROSCI, V23, P404, DOI 10.1162/jocn.2010.21450; Zhuang J, 2014, CEREB CORTEX, V24, P908, DOI 10.1093/cercor/bhs366	58	127	139	8	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		583	587		10.1126/science.1254404	http://dx.doi.org/10.1126/science.1254404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359966	Green Accepted			2022-12-28	WOS:000343799700037
J	Stern, P; Hines, PJ; Travis, J				Stern, Peter; Hines, Pamela J.; Travis, John			THE AGING Brain	SCIENCE			English	Editorial Material																			0	1	1	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		566	567		10.1126/science.346.6209.566	http://dx.doi.org/10.1126/science.346.6209.566			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359962				2022-12-28	WOS:000343799700033
J	Wong, M; Munro, S				Wong, Mie; Munro, Sean			The specificity of vesicle traffic to the Golgi is encoded in the golgin coiled-coil proteins	SCIENCE			English	Article							MATRIX PROTEIN; MEMBRANE-PROTEIN; COMPLEXES; SIGNALS; LACKING; SNARES; GCC185; DOMAIN; GM130; ER	The Golgi apparatus is a multicompartment central sorting station at the intersection of secretory and endocytic vesicular traffic. The mechanisms that permit cargo-loaded transport vesicles from different origins to selectively access different Golgi compartments are incompletely understood. We developed a rerouting and capture assay to investigate systematically the vesicle-tethering activities of 10 widely conserved golgin coiled-coil proteins. We find that subsets of golgins with distinct localizations on the Golgi surface have capture activities toward vesicles of different origins. These findings demonstrate that golgins act as tethers in vivo, and hence the specificity we find to be encoded in this tethering is likely to make a major contribution to the organization of membrane traffic at the Golgi apparatus.	[Wong, Mie; Munro, Sean] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Munro, S (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	sean@mrc-lmb.cam.ac.uk		Munro, Sean/0000-0001-6160-5773; Wong, Mie/0000-0001-8664-6651	UK Medical Research Council (MRC) [U105178783]; Medical Research Council [MC_U105178783] Funding Source: researchfish; MRC [MC_U105178783] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Akhmanova, F. Barr, H. Clausen, P. Gleeson, A. Linstedt, M. Lowe, U. Mandel, M. Robinson, and M. Seaman for generous provision of reagents; G. Howard for help with electron microscopy; and A. Gillingham, R. Hegde, B. Nichols, and K. Roper for comments on the manuscript. Supported by the UK Medical Research Council (MRC file reference no. U105178783). The data are presented in the main manuscript and the supplementary materials.	Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Elkis Y, 2013, MOL CELL ENDOCRINOL, V365, P52, DOI 10.1016/j.mce.2012.09.003; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; MITOMA J, 1992, J BIOCHEM-TOKYO, V111, P20, DOI 10.1093/oxfordjournals.jbchem.a123712; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; PONNAMBALAM S, 1994, J CELL BIOL, V125, P253, DOI 10.1083/jcb.125.2.253; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whyte JRC, 2002, J CELL SCI, V115, P2627; Willett R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2535; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	41	172	173	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		601	+	1256898	10.1126/science.1256898	http://dx.doi.org/10.1126/science.1256898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359980	Green Accepted			2022-12-28	WOS:000343799700040
J	Orenstein, W; Seib, K				Orenstein, Walter; Seib, Katherine			Mounting a Good Offense against Measles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								More measles cases have been reported in the United States so far in 2014 - 592 cases from January 1 to August 29 - than during any year in the past two decades (see graph) (www.cdc.gov/measles/	[Orenstein, Walter; Seib, Katherine] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University	Orenstein, W (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.							[Anonymous], 2014, Public Health Rep, V129 Suppl 3, P12; [Anonymous], 2012, VACCINES; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Orenstein WA, 2006, PEDIATR INFECT DIS J, V25, P1093, DOI 10.1097/01.inf.0000246840.13477.28; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P103	5	31	31	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1661	1663		10.1056/NEJMp1408696	http://dx.doi.org/10.1056/NEJMp1408696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354100	Bronze			2022-12-28	WOS:000343768500001
J	Lundeberg, MB; Folk, JA				Lundeberg, Mark B.; Folk, Joshua A.			Harnessing chirality for valleytronics	SCIENCE			English	Editorial Material									[Lundeberg, Mark B.] Inst Photon Sci ICFO, Barcelona 08860, Spain; [Folk, Joshua A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of British Columbia	Lundeberg, MB (corresponding author), Inst Photon Sci ICFO, Mediterranean Technol Pk, Barcelona 08860, Spain.	jfolk@physics.ubc.ca	Folk, Joshua A/E-6287-2017	Folk, Joshua A/0000-0003-4455-5609				Gorbachev RV, 2014, SCIENCE, V346, P448, DOI 10.1126/science.1254966; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mecklenburg M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.116803; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959	6	27	27	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					422	423		10.1126/science.1260989	http://dx.doi.org/10.1126/science.1260989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342786				2022-12-28	WOS:000343822900020
J	Tanaka, J; Yano, K; Aya, K; Hirano, K; Takehara, S; Koketsu, E; Ordonio, RL; Park, SH; Nakajima, M; Ueguchi-Tanaka, M; Matsuoka, M				Tanaka, Junmu; Yano, Kenji; Aya, Koichiro; Hirano, Ko; Takehara, Sayaka; Koketsu, Eriko; Ordonio, Reynante Lacsamana; Park, Seung-Hyun; Nakajima, Masatoshi; Ueguchi-Tanaka, Miyako; Matsuoka, Makoto			Antheridiogen determines sex in ferns via a spatiotemporally split gibberellin synthesis pathway	SCIENCE			English	Article							LYGODIUM-JAPONICUM; IDENTIFICATION; RECEPTORS; SYSTEM	Some ferns possess the ability to control their sex ratio to maintain genetic variation in their colony with the aid of antheridiogen pheromones, antheridium (male organ)-inducing compounds that are related to gibberellin. We determined that ferns have evolved an antheridiogen-mediated communication system to produce males by modifying the gibberellin biosynthetic pathway, which is split between two individuals of different developmental stages in the colony. Antheridiogen acts as a bridge between them because it is more readily taken up by prothalli than bioactive gibberellin. The pathway initiates in early-maturing prothalli (gametophytes) within a colony, which produce antheridiogens and secrete them into the environment. After the secreted antheridiogen is absorbed by neighboring late-maturing prothalli, it is modified in to bioactive gibberellin to trigger male organ formation.	[Tanaka, Junmu; Yano, Kenji; Aya, Koichiro; Hirano, Ko; Takehara, Sayaka; Koketsu, Eriko; Ordonio, Reynante Lacsamana; Ueguchi-Tanaka, Miyako; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Park, Seung-Hyun; Nakajima, Masatoshi] Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan	Nagoya University; University of Tokyo	Ueguchi-Tanaka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	mueguchi@nuagr1.agr.nagoya-u.ac.jp; makoto@nuagr1.agr.nagoya-u.ac.jp		Yano, Kenji/0000-0002-2428-9748	JSPS through the Funding Program for Next Generation World-Leading Researchers;  [23113005]	JSPS through the Funding Program for Next Generation World-Leading Researchers; 	We thank M. Kawamura and W. Takase (Nagoya University) for technical assistance and H. Yamane (Teikyo University), M. Hasebe (National Institute for Basic Biology), S. Ooe (Osaka Prefectural Education Center), and T. Yoshimura (Kumiai Chemical Industry Co., Ltd.) for helpful discussions. Supported by Grant-in-Aid for Scientific Research on Innovative Areas no. 23113005 (M.M. and M.N.) and by JSPS through the Funding Program for Next Generation World-Leading Researchers (M.U.-T.). Additional data are in the supplement. DNA Data Bank of Japan (DDBJ) accession numbers: Lj_CPS/KS, AB915786; Lj_KO, AB915787; Lj_KAO, AB915788; Lj_GA20ox, AB915789; Lj_GA3ox1, AB915790; Lj_GA3ox2, AB915791; Lj_GID1-1, AB915792; Lj_GID1-2, AB915793; Lj_GID1-3, AB915794; Lj_DELLA1, AB915795; Lj_DELLA2, AB915796; Lj_GID2, AB915797.	Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Hanson L, 2002, BOT J LINN SOC, V140, P169, DOI 10.1046/j.1095-8339.2002.00083.x; Hedden P, 2008, NATURE, V456, P455, DOI 10.1038/456455a; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; IZUMI K, 1985, PLANT CELL PHYSIOL, V26, P821; Manton I., 1965, NEW PHYTOL, V64, P286; Naf U, 1979, EXPT BIOL FERNS, P436; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; NAKAYAMA I, 1990, PLANT CELL PHYSIOL, V31, P1183; Schneller JJ, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P134, DOI 10.1017/CBO9780511541827.006; TAKENO K, 1980, BOT MAG TOKYO, V93, P67, DOI 10.1007/BF02489487; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Voeller B. R., 1969, CURRENT TOPICS PLANT, P77; Williams J, 1998, PLANT PHYSIOL, V117, P559, DOI 10.1104/pp.117.2.559; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamamoto Y, 2010, PLANT CELL, V22, P3589, DOI 10.1105/tpc.110.074542; Yamane H, 1998, INT REV CYTOL, V184, P1, DOI 10.1016/S0074-7696(08)62177-4; YAMANE H, 1979, PLANTA, V147, P251, DOI 10.1007/BF00388747; Yoon JM, 2013, BIOORG MED CHEM LETT, V23, P1096, DOI 10.1016/j.bmcl.2012.12.007	20	47	53	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					469	473		10.1126/science.1259923	http://dx.doi.org/10.1126/science.1259923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342803				2022-12-28	WOS:000343822900043
J	Acton, SE; Farrugia, AJ; Astarita, JL; Mourao-Sa, D; Jenkins, RP; Nye, E; Hooper, S; van Blijswijk, J; Rogers, NC; Snelgrove, KJ; Rosewell, I; Moita, LF; Stamp, G; Turley, SJ; Sahai, E; Sousa, CRE				Acton, Sophie E.; Farrugia, Aaron J.; Astarita, Jillian L.; Mourao-Sa, Diego; Jenkins, Robert P.; Nye, Emma; Hooper, Steven; van Blijswijk, Janneke; Rogers, Neil C.; Snelgrove, Kathryn J.; Rosewell, Ian; Moita, Luis F.; Stamp, Gordon; Turley, Shannon J.; Sahai, Erik; Reis e Sousa, Caetano			Dendritic cells control fibroblastic reticular network tension and lymph node expansion	NATURE			English	Article							T-CELLS; IN-VIVO; B-CELLS; ACTIVATION; INVASION; RHO; MIGRATION; PROTEINS; MOTILITY; CLEC-2	After immunogenic challenge, infiltrating and dividing lymphocytes markedly increase lymph node cellularity, leading to organ expansion(1,2). Here we report that the physical elasticity of lymph nodes is maintained in part by podoplanin (PDPN) signalling in stromal fibroblastic reticular cells (FRCs) and its modulation by CLEC-2 expressed on dendritic cells. We show in mouse cells that PDPN induces actomyosin contractility in FRCs via activation of RhoA/C and downstream Rho-associated protein kinase (ROCK). Engagement by CLEC-2 causes PDPN clustering and rapidly uncouples PDPN from RhoA/C activation, relaxing the actomyosin cytoskeleton and permitting FRC stretching. Notably, administration of CLEC-2 protein to immunized mice augments lymph node expansion. In contrast, lymph node expansion is significantly constrained in mice selectively lacking CLEC-2 expression in dendritic cells. Thus, the same dendritic cells that initiate immunity by presenting antigens to T lymphocytes(3) also initiate remodelling of lymph nodes by delivering CLEC-2 to FRCs. CLEC-2 modulation of PDPN signalling permits FRC network stretching and allows for the rapid lymph node expansion-driven by lymphocyte influx and proliferation-that is the critical hallmark of adaptive immunity.	[Acton, Sophie E.; Farrugia, Aaron J.; Mourao-Sa, Diego; van Blijswijk, Janneke; Rogers, Neil C.; Snelgrove, Kathryn J.; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Immunobiol Lab, London WC2A 3LY, England; [Acton, Sophie E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Farrugia, Aaron J.; Jenkins, Robert P.; Hooper, Steven; Sahai, Erik] Canc Res UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3LY, England; [Astarita, Jillian L.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Nye, Emma; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, Transgen Lab, Potters Bar EN6 3LD, Herts, England; [Moita, Luis F.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Moita, Luis F.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal; [Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Cancer Research UK; University of London; University College London; Cancer Research UK; Harvard University; Dana-Farber Cancer Institute; Cancer Research UK; Cancer Research UK; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Roche Holding; Genentech	Acton, SE (corresponding author), Canc Res UK London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	sophie.acton@cancer.org.uk; caetano@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Moita, Luis F./L-1296-2013; Moita, Luis/HCI-2793-2022; Acton, Sophie/G-9784-2012	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Moita, Luis F./0000-0003-0707-315X; Moita, Luis/0000-0003-0707-315X; Acton, Sophie/0000-0003-2704-716X; Mourao, Diego/0000-0001-6618-6969; Rogers, Neil/0000-0001-8977-7585; Farrugia, Aaron J/0000-0003-0448-5896; Sahai, Erik/0000-0002-3932-5086	Henry Wellcome Postdoctoral fellowship; Cancer Research UK; Cancer Research UK [15154, 15689] Funding Source: researchfish	Henry Wellcome Postdoctoral fellowship; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank B. Reizis for CD11c-Cre mice, the LRI Biological Resources staff for animal care and assistance with experiments and R. Horton-Harpin for production of CLEC-2-Fc. We are grateful to M. Y. Gerner and R. N. Germain for critical reading of the manuscript and to all the members of the Immunobiology Laboratory and Tumour Cell Biology Laboratory for helpful discussions and comments. This work was supported by a Henry Wellcome Postdoctoral fellowship (S.E.A.) and core funding from Cancer Research UK (I.R., G.S., E.S. and C.R.S.).	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Fernandez Munoz B., 2011, INT J BIOCHEM CELL B, V43, P886; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	28	178	188	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					498	+		10.1038/nature13814	http://dx.doi.org/10.1038/nature13814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341788	Green Submitted, Green Accepted			2022-12-28	WOS:000343775900042
J	McCarthy, M				McCarthy, Michael			US revamps domestic Ebola response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mxmc@mac.com						McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6418; US Centers for Disease Control and Prevention, EBOLA EBOLA VIRUS DI	2	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2014	349								g6417	10.1136/bmj.g6417	http://dx.doi.org/10.1136/bmj.g6417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OE	25338759	Bronze, Green Published			2022-12-28	WOS:000343768300007
J	Reiling, J				Reiling, Jennifer			How the Opium Habit Is Acquired	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1597	1597		10.1001/jama.2013.279734	http://dx.doi.org/10.1001/jama.2013.279734			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321925				2022-12-28	WOS:000342983200033
J	Nguyen, PA; Groen, AC; Loose, M; Ishihara, K; Wuhr, M; Field, CM; Mitchison, TJ				Nguyen, Phuong A.; Groen, Aaron C.; Loose, Martin; Ishihara, Keisuke; Wuehr, Martin; Field, Christine M.; Mitchison, Timothy J.			Spatial organization of cytokinesis signaling reconstituted in a cell-free system	SCIENCE			English	Article							SPINDLE; SPECIFICATION; MICROTUBULES; EMBRYOS; ACTIN	During animal cell division, the cleavage furrow is positioned by microtubules that signal to the actin cortex at the cell midplane. We developed a cell-free system to recapitulate cytokinesis signaling using cytoplasmic extract from Xenopus eggs. Microtubules grew out as asters from artificial centrosomes and met to organize antiparallel overlap zones. These zones blocked the interpenetration of neighboring asters and recruited cytokinesis midzone proteins, including the chromosomal passenger complex (CPC) and centralspindlin. The CPC was transported to overlap zones, which required two motor proteins, Kif4A and a Kif20A paralog. Using supported lipid bilayers to mimic the plasma membrane, we observed the recruitment of cleavage furrow markers, including an active RhoA reporter, at microtubule overlaps. This system opens further approaches to understanding the biophysics of cytokinesis signaling.	[Nguyen, Phuong A.; Groen, Aaron C.; Loose, Martin; Ishihara, Keisuke; Wuehr, Martin; Field, Christine M.; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Nguyen, Phuong A.; Groen, Aaron C.; Ishihara, Keisuke; Field, Christine M.; Mitchison, Timothy J.] Marine Biol Lab, Woods Hole, MA 02543 USA	Harvard University; Harvard Medical School; Marine Biological Laboratory - Woods Hole	Field, CM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Christine_Field@hms.harvard.edu	Wühr, Martin/A-2447-2009; Ishihara, Keisuke/I-5656-2019	Wühr, Martin/0000-0002-0244-8947; Ishihara, Keisuke/0000-0002-8481-8680; Loose, Martin/0000-0001-7309-9724	NIH [GM39565, GM103785]; Evans Foundation; MBL Associates; Colwin Fund; HFSP fellowship [LT000466/2012-L]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039565, R01GM103785, R37GM039565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evans Foundation; MBL Associates; Colwin Fund; HFSP fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Ohi, D. Burgess, D. Miyamoto, and E. Tan for reagents; H. Basu for preliminary work; the Nikon Imaging Center at Harvard Medical School and Nikon at the Woods Hole Marine Biological Laboratory (MBL) for microscopy support; and the National Xenopus Resource at MBL for Xenopus animals and care. This work was supported by NIH grant GM39565 (T.J.M.); MBL fellowships from the Evans Foundation, MBL Associates, and the Colwin Fund (T.J.M. and C. M. F.); HFSP fellowship LT000466/2012-L (M. L.); and NIH grant GM103785 (M.W.).	Argiros H, 2012, CYTOSKELETON, V69, P840, DOI 10.1002/cm.21061; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Danilchik MV, 2006, DEVELOPMENT, V133, P4517, DOI 10.1242/dev.02642; Field CM, 2014, METHOD ENZYMOL, V540, P399, DOI 10.1016/B978-0-12-397924-7.00022-4; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mitchison TJ, 2013, MOL BIOL CELL, V24, P1559, DOI 10.1091/mbc.E12-12-0850; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	20	83	83	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					244	247		10.1126/science.1256773	http://dx.doi.org/10.1126/science.1256773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301629	Green Accepted			2022-12-28	WOS:000342721500050
J	Christensen, H; Trotter, CL; Hickman, M; Edmunds, WJ				Christensen, Hannah; Trotter, Caroline L.; Hickman, Matthew; Edmunds, W. John			Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							B MENINGOCOCCAL VACCINES; BACTERICIDAL ANTIBODY; 4CMENB VACCINE; OPEN-LABEL; DISEASE; IMMUNOGENICITY; IMMUNIZATION; MULTICOMPONENT; ADOLESCENTS; RECOMBINANT	Objective To use mathematical and economic models to predict the epidemiological and economic impact of vaccination with Bexsero, designed to protect against group B meningococcal disease, to help inform vaccine policy in the United Kingdom. Design Modelling study. Setting England. Population People aged 0-99. Interventions Incremental impact of introductory vaccine strategies simulated with a transmission dynamic model of meningococcal infection and vaccination including potential herd effects. Model parameters included recent evidence on the vaccine characteristics, disease burden, costs of care, litigation costs, and loss of quality of life from disease, including impacts on family and network members. The health impact of vaccination was assessed through cases averted and quality adjusted life years (QALYs) gained. Main outcome measures Cases averted and cost per QALY gained through vaccination; programmes were deemed cost effective against a willingness to pay of pound 20 000 ((sic)25 420, $ 32 677) per QALY gained from an NHS and personal and social services perspective. Results In the short term, case reduction is greatest with routine infant immunisation (26.3% of cases averted in the first five years). This strategy could be cost effective at pound 3 ((sic) 3.8, $ 4.9) a vaccine dose, given several favourable assumptions and the use of a quality of life adjustment factor. If the vaccine can disrupt meningococcal transmission more cases are prevented in the long term with an infant and adolescent combined programme (51.8% after 30 years), which could be cost effective at pound 4 a vaccine dose. Assuming the vaccine reduces acquisition by 30%, adolescent vaccination alone is the most favourable strategy economically, but takes more than 20 years to substantially reduce the number of cases. Conclusions Routine infant vaccination is the most effective short term strategy and could be cost effective with a low vaccine price. Critically, if the vaccine reduces carriage acquisition in teenagers, the combination of infant and adolescent vaccination could result in substantial long term reductions in cases and be cost effective with competitive vaccine pricing.	[Christensen, Hannah; Hickman, Matthew] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Trotter, Caroline L.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge CB3 0ES, England; [Edmunds, W. John] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Bristol; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Christensen, H (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	hannah.christensen@bristol.ac.uk	Trotter, Caroline L/H-5077-2013; Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Trotter, Caroline/0000-0003-4000-2708	Department of Health; National Institute for Health Research (NIHR) [RDA/03/07/014, PDF-2012-05-245, PDA/02/06/088]; NIHR; MRC [MR/K023233/1] Funding Source: UKRI; Medical Research Council [MR/K023233/1] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-245, RDA/03/07/014] Funding Source: researchfish	Department of Health; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health and the National Institute for Health Research (NIHR) (RDA/03/07/014 and PDF-2012-05-245 to HC, PDA/02/06/088 to CT). This work is produced by the authors under the terms of these research training fellowships issued by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. MH is a member of the NIHR School of Public Health Research; HC and MH are members of the NIHR Health Protection Research Unit Evaluation of Interventions. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Al-Janabi H, 2013, MEN RES FDN BIENN C; [Anonymous], 2013, JCVI INT POS STAT US; Black S, 2013, VACCINE, V31, P6046, DOI 10.1016/j.vaccine.2013.08.008; Blewitt J, 2013, LANCET, V382, P857, DOI 10.1016/S0140-6736(13)61861-9; Buysse CMP, 2008, ARCH PEDIAT ADOL MED, V162, P1036, DOI 10.1001/archpedi.162.11.1036; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Committee on Immunisation Programmes and Registries, 2013, CRIT ASS CHANG IMM P; Curtis L, 2015, UNIT COSTS HLTH SOCI; Delbos V, 2013, VACCINE, V31, P4416, DOI 10.1016/j.vaccine.2013.06.080; Department of Health, 2012, 201112 NSRC01 DOH; Department of Health, 2013, ANN HPV VACC COV ENG; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Erickson L, 1998, CLIN INFECT DIS, V26, P1159, DOI 10.1086/520303; Esposito S, 2014, HUM VACC IMMUNOTHER, V10, P2005, DOI 10.4161/hv.29218; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Health and Social Care Information Centre, 2012, NHS IMM STAT ENGL 20; Health Protection Agency, 2012, INV MEN INF LAB REP; Hong AT, 2013, 35 ANN M SOC MED DEC; Huels J, 2014, EPIDEMIOL INFECT, V142, P2000, DOI 10.1017/S095026881300294X; Jit M, 2007, VACCINE, V25, P3971, DOI 10.1016/j.vaccine.2007.02.070; Joint Committee on Vaccination and Immunistion, 2013, COD PRACT; Kind P., 1999, 172 U YORK YORK HLTH; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Le Haut Conseil de la sante publique, 2013, VACC SER B INV MEN D; McIntosh D., 2012, NORD VACC M 2012; McNicholas A, 2007, HUM VACCINES, V3, P196, DOI 10.4161/hv.3.5.4458; McQuaid F, 2014, PEDIATR INFECT DIS J, V33, P760, DOI 10.1097/INF.0000000000000327; Moxon R, 2013, LANCET, V382, P369, DOI 10.1016/S0140-6736(13)61572-X; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence, 2012, METH DEV NICE PUBL H; Office for National Statistics, 2010, CERT INF PAR DIS TAB; Office for National Statistics, 2012, CERT INF PAR DIS TAB; Office for National Statistics, 2006, CERT INF PAR DIS MOR; Office for National Statistics, 2009, CERT INF PAR DIS MOR; Office for National Statistics, 2004, CERT INF PAR DIS MOR; Office for National Statistics, 2010, NAT POP PROJ ENGL PO; Office for National Statistics, 2009, CERT INF PAR DIS TAB; Office for National Statistics, 2012, MID 2011 POP EST ENG; Office for National Statistics, 2008, CERT INF PAR DIS MOR; Office for National Statistics, 2005, CERT INF PAR DIS MOR; Pouwels KB, 2013, HUM VACC IMMUNOTHER, V9, P1129, DOI 10.4161/hv.23888; Prosser LA, 2004, PEDIATRICS, V113, P283, DOI 10.1542/peds.113.2.283; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Public Health England, 2013, STAT NOT INF DIS NOI; Ramsay M, 2004, USE MLST EPIDEMIOLOG; Read RC, 2013, 31 ANN M EUR SOC PAE; Roed C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009662; Ruedin HJ, 2003, VACCINE, V21, P4145, DOI 10.1016/S0264-410X(03)00562-0; Snape MD, 2013, PEDIATR INFECT DIS J, V32, P1116, DOI 10.1097/INF.0b013e31829cfff2; Song J, 2010, FAM RELAT, V59, P269, DOI 10.1111/j.1741-3729.2010.00601.x; Trotter C L, 2002, Commun Dis Public Health, V5, P220; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1	59	78	79	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2014	349								g5725	10.1136/bmj.g5725	http://dx.doi.org/10.1136/bmj.g5725			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LK	25301037	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000342998200009
J	Meisel, JD; Panda, O; Mahanti, P; Schroeder, FC; Kim, DH				Meisel, Joshua D.; Panda, Oishika; Mahanti, Parag; Schroeder, Frank C.; Kim, Dennis H.			Chemosensation of Bacterial Secondary Metabolites Modulates Neuroendocrine Signaling and Behavior of C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; TGF-BETA; LARVAL DEVELOPMENT; G-PROTEINS; GENE; EXPRESSION; RECEPTOR; NEURONS; PATHWAY; AVOIDANCE	Discrimination between pathogenic and beneficial microbes is essential for host organism immunity and homeostasis. Here, we show that chemosensory detection of two secondary metabolites produced by Pseudomonas aeruginosa modulates a neuroendocrine signaling pathway that promotes avoidance behavior in the simple animal host Caenorhabditis elegans. Secondary metabolites phenazine-1-carboxamide and pyochelin activate a G-protein-signaling pathway in the ASJ chemosensory neuron pair that induces expression of the neuromodulator DAF-7/TGF-beta. DAF-7, in turn, activates a canonical TGF-beta signaling pathway in adjacent interneurons to modulate aerotaxis behavior and promote avoidance of pathogenic P. aeruginosa. Our data provide a chemical, genetic, and neuronal basis for how the behavior and physiology of a simple animal host can be modified by the microbial environment and suggest that secondary metabolites produced by microbes may provide environmental cues that contribute to pathogen recognition and host survival.	[Meisel, Joshua D.; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Panda, Oishika; Mahanti, Parag; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; [Panda, Oishika; Mahanti, Parag; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Massachusetts Institute of Technology (MIT); Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Kim, DH (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dhkim@mit.edu	Mahanti, Parag/AAK-8974-2021	Schroeder, Frank/0000-0002-4420-0237; Panda, Oishika/0000-0002-1217-8231	NIH [GM084477, GM088290]; National Science Foundation; Ellison New Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084477, R01GM088290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ellison New Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Alcedo, K. Ashrafi, F. Ausubel, H.R. Horvitz, the C. elegans Knockout Consortium, and the Caenorhabditis Genetics Center (which is supported by the NIH, Office of the Director) for providing strains and reagents. We thank N. Bhatla, C. Engert, C. Pender, and S. Sando for technical assistance. J.D.M. was supported by a Graduate Research Fellowship from the National Science Foundation. This study was supported by the NIH (GM084477 to D.H.K. and GM088290 to F.C.S.) and an Ellison New Scholar Award (to D.H.K.).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Bargmann Cornelia I, 2006, WormBook, P1; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chang HC, 2011, NATURE, V480, P525, DOI 10.1038/nature10643; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fierro-Gonzalez JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016561; Gallagher T, 2013, J NEUROSCI, V33, P9716, DOI 10.1523/JNEUROSCI.4493-12.2013; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Gunther CV, 2000, DEVELOPMENT, V127, P3337; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kim K, 2010, DEVELOPMENT, V137, P963, DOI 10.1242/dev.044719; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Korsager S, 2013, J AM CHEM SOC, V135, P2891, DOI 10.1021/ja3114032; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Mehnaz S, 2013, J NAT PROD, V76, P135, DOI 10.1021/np3005166; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nakata K, 2013, ORG LETT, V15, P1170, DOI 10.1021/ol303453j; Niu DF, 2008, TETRAHEDRON, V64, P10517, DOI 10.1016/j.tet.2008.08.093; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reddy KC, 2011, P NATL ACAD SCI USA, V108, P12887, DOI 10.1073/pnas.1108265108; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Taggi AE, 2004, J AM CHEM SOC, V126, P10364, DOI 10.1021/ja047416n; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang XD, 2012, P NATL ACAD SCI USA, V109, P17081, DOI 10.1073/pnas.1205982109; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700; Zwaal RR, 1997, GENETICS, V145, P715	65	139	152	0	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					267	280		10.1016/j.cell.2014.09.011	http://dx.doi.org/10.1016/j.cell.2014.09.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303524	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000343095600010
J	Ofri, D				Ofri, Danielle			The Little Things	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10012 USA; [Ofri, Danielle] Bellevue Hosp, New York, NY USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10012 USA.			Ofri, Danielle/0000-0001-9865-7104					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1378	1379		10.1056/NEJMp1408761	http://dx.doi.org/10.1056/NEJMp1408761			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295499				2022-12-28	WOS:000342674800006
J	Cooke, CR; Iwashyna, TJ				Cooke, Colin R.; Iwashyna, Theodore J.			Sepsis Mandates Improving Inpatient Care While Advancing Quality Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cooke, Colin R.; Iwashyna, Theodore J.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Cooke, Colin R.; Iwashyna, Theodore J.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Cooke, Colin R.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Cooke, Colin R.; Iwashyna, Theodore J.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] VA Ann Arbor Hlth Syst, Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Cooke, CR (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Room 127W, Ann Arbor, MI 48109 USA.	cookecr@umich.edu		Iwashyna, Theodore/0000-0002-4226-9310; Cooke, Colin/0000-0001-9713-5371	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044752] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berenson R, 2014, ACHIEVING POTENTIAL; Centers for Medicare and Medicaid Services (CMS) HHS, 2014, Fed Regist, V79, P49853; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Miller RR, 2013, AM J RESP CRIT CARE, V188, P77, DOI 10.1164/rccm.201212-2199OC; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	9	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1397	1398		10.1001/jama.2014.11350	http://dx.doi.org/10.1001/jama.2014.11350			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291572	Green Accepted			2022-12-28	WOS:000342630200011
J	Vespa, PM				Vespa, Paul M.			Fever in Critical Neurologic Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIAC-ARREST; HYPOTHERMIA; MANAGEMENT	IMPORTANCE Fever is common in critically ill neurologic patients. Knowledge of the indicators of central fever may allow greater antibiotic stewardship in this era of rapidly developing super-resistant microorganisms. OBJECTIVE To develop a model to differentiate central from infectious fever in critically ill neurologic patients with fever of an undetermined cause. DESIGN, SETTING, AND PARTICIPANTS Retrospective data collection from January 1, 2006, through December 31, 2010, at a 20-bed neurologic intensive care unit of a large teaching hospital. Consecutive patients 18 years and older admitted for 48 hours or longer with a core body temperature higher than 38.3 degrees C on at least 1 measurement for 2 consecutive days. Patients with alternative identified causes of noninfectious fever were excluded. In total, 526 patients were included in the final analysis. MAIN OUTCOMES AND MEASURES Percentage incidence and odds ratios of variables associated with central fever. Fever was classified as infectious if there was culture growth of a pathogenic species or documented clinical diagnosis of infection treated with antibiotics. Remaining patients were considered to have central fever. Continuous fever lasting longer than 6 hours for 2 or more consecutive days was considered persistent. RESULTS Fever was central in 246 patients (46.8%). Patients with infectious fever were older (mean, 57.4 vs 53.5 years; P = .01) and had a longer length of stay in the neurologic intensive care unit (mean, 12.1 vs 8.8 days; P < .001). Central fever was more likely to occur within 72 hours of admission to the neurologic intensive care unit (76.4% vs 60.7%; P < .001) and tended to be persistent (26.4% vs 18.6%; P = .04). Blood transfusion (odds ratio [OR], 3.06; 95% CI, 1.63-5.76); absence of infiltrate on chest x-ray (3.02; 1.81-5.05); diagnosis of subarachnoid hemorrhage, intraventricular hemorrhage, or tumor (6.33; 3.72-10.77); and onset of fever within 72 hours of hospital admission (2.20; 1.23-3.94) were independent predictors of central fever on multivariable analysis. The combination of negative cultures; absence of infiltrate on chest radiographs; diagnosis of subarachnoid hemorrhage, intraventricular hemorrhage, or tumor; and onset of fever within 72 hours of admission predicted central fever with a probability of .90. CONCLUSIONS AND RELEVANCE We provide a reliable model to differentiate central fever from infectious fever in critically ill neurologic patients, allowing clinicians to select patients in whom antibiotics may be safely discontinued despite ongoing fever.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 757Westwood Blvd,Room 6236A, Los Angeles, CA 90095 USA.	pvespa@mednet.ucla.edu						Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Flint AC, 2007, NEUROCRIT CARE, V7, P109, DOI 10.1007/s12028-007-0068-y; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; Scaravilli V, 2011, NEUROCRIT CARE, V15, P287, DOI 10.1007/s12028-011-9588-6	8	2	2	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1456	1457		10.1001/jama.2014.12492	http://dx.doi.org/10.1001/jama.2014.12492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291581				2022-12-28	WOS:000342630200022
J	De Robertis, EM				De Robertis, Edward M.			Yoshiki Sasai 1962-2014 Obituary	CELL			English	Biographical-Item									[De Robertis, Edward M.] Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [De Robertis, Edward M.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Howard Hughes Med Inst, 675 C Young Dr South, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		De Robertis, Edward/0000-0002-7843-1869					0	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 11	2014	158	6					1233	1235		10.1016/j.cell.2014.08.024	http://dx.doi.org/10.1016/j.cell.2014.08.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QK	25349875	Bronze			2022-12-28	WOS:000343094200004
J	Colver, A; Rapp, M; Eisemann, N; Ehlinger, V; Thyen, U; Dickinson, HO; Parkes, J; Parkinson, K; Nystrand, M; Fauconnier, J; Marcelli, M; Michelsen, SI; Arnaud, C				Colver, Allan; Rapp, Marion; Eisemann, Nora; Ehlinger, Virginie; Thyen, Ute; Dickinson, Heather O.; Parkes, Jackie; Parkinson, Kathryn; Nystrand, Malin; Fauconnier, Jerome; Marcelli, Marco; Michelsen, Susan I.; Arnaud, Catherine			Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysis	LANCET			English	Article							8-12-YEAR-OLD CHILDREN; YOUNG-PEOPLE; PARTICIPATION; HEALTH; PAIN; INTERVENTIONS; DIFFICULTIES; ENVIRONMENT; PREDICTORS; CHILDHOOD	Background Children with cerebral palsy who can self-report have similar quality of life (QoL) to their able-bodied peers. Is this similarity also found in adolescence? We examined how self-reported QoL of adolescents with cerebral palsy varies with impairment and compares with the general population, and how factors in childhood predict adolescent QoL. Methods We report QoL outcomes in a longitudinal follow-up and cross-sectional analysis of individuals included in the SPARCLE1 (childhood) and SPARCLE2 (adolescent) studies. In 2004 (SPARCLE1), a cohort of 818 children aged 8-12 years were randomly selected from population-based cerebral palsy registers in nine European regions. We gathered data from 500 participants about QoL with KIDSCREEN (ten domains); frequency of pain; child psychological problems (Strengths and Difficulties Questionnaire); and parenting stress (Parenting Stress Index). At follow-up in 2009 (SPARCLE2), 355 (71%) adolescents aged 13-17 years remained in the study and self-reported QoL (longitudinal sample). 76 additional adolescents self-reported QoL in 2009, providing data for 431 adolescents in the cross-sectional sample. Researchers gathered data at home visits. We compared QoL against matched controls in the general population. We used multivariable regression to relate QoL of adolescents with cerebral palsy to impairments (cross-sectional analysis) and to childhood QoL, pain, psychological problems, and parenting stress (longitudinal analysis). Findings Severity of impairment was significantly associated (p<0.01) with reduced adolescent QoL on only three domains (Moods and emotions, Autonomy, and Social support and peers); average differences in QoL between the least and most able groups were generally less than 0.5 SD. Adolescents with cerebral palsy had significantly lower QoL than did those in the general population in only one domain (Social support and peers; mean difference -2.7 [0.25 SD], 95% CI -4.3 to -1.4). Pain in childhood or adolescence was strongly associated with low adolescent QoL on eight domains. Childhood QoL was a consistent predictor of adolescent QoL. Child psychological problems and parenting stress in childhood or their worsening between childhood and adolescence predicted only small reductions in adolescent QoL. Interpretation Individual and societal attitudes should be affected by the similarity of the QoL of adolescents with and without cerebral palsy. Adolescents with cerebral palsy need particular help to maintain and develop peer relationships. Interventions in childhood to alleviate psychological difficulties, parenting stress, and especially pain, are justified for their intrinsic value and for their longer term effect on adolescent QoL. Copyright (C) Colver et al. Open Access article distributed under the terms of CC BY.	[Colver, Allan; Dickinson, Heather O.; Parkinson, Kathryn] Newcastle Univ, Royal Victoria Infirm, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Rapp, Marion; Thyen, Ute] Univ Lubeck, Klin Kinder & Jugendmed, Lubeck, Germany; [Eisemann, Nora] Univ Lubeck, Inst Canc Epidemiol, Lubeck, Germany; [Ehlinger, Virginie; Arnaud, Catherine] Univ Toulouse 3, INSERM, UMR 1027, F-31062 Toulouse, France; [Parkes, Jackie] Queens Univ Belfast, Ctr Med Biol, Sch Nursing & Midwifery, Belfast BT7 1NN, Antrim, North Ireland; [Nystrand, Malin] Univ Gothenburg, Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Fauconnier, Jerome] CHU Grenoble, UJF Grenoble 1, CNRS, TIMC IMAG UMR 5525, Grenoble, France; [Marcelli, Marco] AUSL, Viterbo, Italy; [Michelsen, Susan I.] Natl Publ Hlth Inst, Copenhagen, Denmark; [Arnaud, Catherine] Clin Epidemiol Unit, Toulouse, France	Newcastle University - UK; University of Lubeck; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Queens University Belfast; Queen Silvia Children's Hospital; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Colver, A (corresponding author), Newcastle Univ, Royal Victoria Infirm, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	allan.colver@ncl.ac.uk	ARNAUD, Catherine/AAC-5646-2019; marcelli, marco/AGR-6853-2022	ARNAUD, Catherine/0000-0002-4002-802X; Eisemann, Nora/0000-0002-8521-6497; Michelsen, Susan I/0000-0002-6291-8031	European Union Research Framework 5 Program [QLG5-CT-2002-00636]; German Ministry of Health [GRR-58640-2/14]; German Foundation for the Disabled Child; Wellcome Trust WT [086315 A1A]; Medical Faculty of the University of Lubeck (Germany) [E40-2009, E26-2010]; CNSA (France); INSERM (France); MiRe-DREES (France); IRESP (France); Ludvig and Sara Elsass Foundation; Spastics Society (Denmark); Vanforefonden (Denmark); Cooperativa Sociale "Gli Anni in Tasca"; Fondazione Carivit, Viterbo (Italy); Goteborg University-Riksforbundet for Rorelsehindrade Barn och Ungdomar and the Folke Bernadotte Foundation (Sweden)	European Union Research Framework 5 Program; German Ministry of Health; German Foundation for the Disabled Child; Wellcome Trust WT(Wellcome Trust); Medical Faculty of the University of Lubeck (Germany); CNSA (France); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); MiRe-DREES (France); IRESP (France); Ludvig and Sara Elsass Foundation; Spastics Society (Denmark); Vanforefonden (Denmark); Cooperativa Sociale "Gli Anni in Tasca"; Fondazione Carivit, Viterbo (Italy); Goteborg University-Riksforbundet for Rorelsehindrade Barn och Ungdomar and the Folke Bernadotte Foundation (Sweden)	SPARCLE1 was funded by the European Union Research Framework 5 Program (grant number QLG5-CT-2002-00636), the German Ministry of Health GRR-58640-2/14, and the German Foundation for the Disabled Child. SPARCLE2 was funded by: Wellcome Trust WT 086315 A1A (UK and Ireland); Medical Faculty of the University of Lubeck E40-2009 and E26-2010 (Germany); CNSA, INSERM, MiRe-DREES, and IRESP (France); Ludvig and Sara Elsass Foundation, The Spastics Society and Vanforefonden (Denmark); Cooperativa Sociale "Gli Anni in Tasca" and Fondazione Carivit, Viterbo (Italy); Goteborg University-Riksforbundet for Rorelsehindrade Barn och Ungdomar and the Folke Bernadotte Foundation (Sweden).	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Arnaud C, 2008, PEDIATRICS, V121, P54, DOI 10.1542/peds.2007-0854; BARAKAT LP, 1992, J PEDIATR PSYCHOL, V17, P725, DOI 10.1093/jpepsy/17.6.725; Barlow JH, 2004, CHILD CARE HLTH DEV, V30, P637, DOI 10.1111/j.1365-2214.2004.00474.x; Beale IL, 2006, J PEDIATR PSYCHOL, V31, P437, DOI 10.1093/jpepsy/jsj079; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Bisegger C, 2005, SOZ PRAVENTIV MED, V50, P281, DOI 10.1007/s00038-005-4094-2; Bjornson KF, 2008, ARCH PHYS MED REHAB, V89, P121, DOI 10.1016/j.apmr.2007.09.016; Brossard-Racine M, 2013, J CHILD NEUROL, V28, P27, DOI 10.1177/0883073812461942; Brossard-Racine M, 2012, EUR J PAEDIATR NEURO, V16, P35, DOI 10.1016/j.ejpn.2011.10.001; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Colver A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-105; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Colver AF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-280; Cussen A, 2012, DISABIL REHABIL, V34, P2103, DOI 10.3109/09638288.2012.672540; Davis E, 2009, DEV MED CHILD NEUROL, V51, P193, DOI 10.1111/j.1469-8749.2008.03194.x; Dickinson H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-273; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; DICKINSON HO, 2012, BMC RES NOTES, V5, pNIL25, DOI DOI 10.1186/1756-0500-5-300; DIMDI, 2005, INT CLASS FUNCT DIS; Engel-Yeger B, 2009, AM J OCCUP THER, V63, P96, DOI 10.5014/ajot.63.1.96; Erhart M, 2009, VALUE HEALTH, V12, P782, DOI 10.1111/j.1524-4733.2009.00508.x; Fauconnier J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1458; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Janssen CGC, 2010, DISABIL REHABIL, V32, P344, DOI 10.3109/09638280903166345; Jensen MP, 2006, PAIN MED, V7, P30, DOI 10.1111/j.1526-4637.2006.00086.x; Korn EL., 1999, ANAL HLTH SURVEYS; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Livingston MH, 2008, DEV MED CHILD NEUROL, V50, P696, DOI 10.1111/j.1469-8749.2008.03053.x; Magill-Evans J, 2001, DEV MED CHILD NEUROL, V43, P466, DOI 10.1017/S0012162201000858; Maher Carol A, 2008, Phys Occup Ther Pediatr, V28, P41; Manuel J, 2003, J PEDIATR PSYCHOL, V28, P197, DOI 10.1093/jpepsy/jsg007; McCullough N, 2013, INT J NURS STUD, V50, P747, DOI 10.1016/j.ijnurstu.2011.01.011; Michelsen SI, 2014, EUR J PAEDIATR NEURO, V18, P282, DOI 10.1016/j.ejpn.2013.12.003; Michelsen SI, 2009, EUR J PAEDIATR NEURO, V13, P165, DOI 10.1016/j.ejpn.2008.03.005; Orlin MN, 2010, DEV MED CHILD NEUROL, V52, P160, DOI 10.1111/j.1469-8749.2009.03363.x; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Parkes J, 2008, J CHILD PSYCHOL PSYC, V49, P405, DOI 10.1111/j.1469-7610.2007.01845.x; Parkes J, 2011, DEV MED CHILD NEUROL, V53, P815, DOI 10.1111/j.1469-8749.2011.04014.x; Parkinson KN, 2010, ACTA PAEDIATR, V99, P446, DOI 10.1111/j.1651-2227.2009.01626.x; Parkinson KN, 2013, ARCH DIS CHILD, V98, P434, DOI 10.1136/archdischild-2012-303482; Ravens-Sieberer Ulrike, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P353, DOI 10.1586/14737167.5.3.353; Rosenbaum PL, 2007, DEV MED CHILD NEUROL, V49, P516, DOI 10.1111/j.1469-8749.2007.00516.x; Schenker R, 2005, DISABIL REHABIL, V27, P539, DOI 10.1080/09638280400018437; Shakespeare T, 1999, L129251047 ESRC; Shikako-Thomas K, 2009, QUAL LIFE RES, V18, P825, DOI 10.1007/s11136-009-9501-3; Soyupek F, 2010, DISABIL REHABIL, V32, P1109, DOI 10.3109/09638280903391120; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stine R, 1990, MODERN METHODS DATA, P353; Streiner D. L., 2003, HLTH MEASUREMENT SCA; The KIDSCREEN Group Europe, 2006, KIDSCREEN QUEST QUAL; Tsoi WSE, 2012, CHILD CARE HLTH DEV, V38, P21, DOI 10.1111/j.1365-2214.2011.01255.x; Tukey J. W., 1977, EXPLORATORY DATA ANA; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vargus-Adams J, 2006, DEV MED CHILD NEUROL, V48, P343, DOI 10.1017/S0012162206000752; Varni JW, 2005, DEV MED CHILD NEUROL, V47, P592, DOI 10.1017/S0012162205001179; White-Koning M, 2005, DEV MED CHILD NEUROL, V47, P281, DOI 10.1017/S0012162205000526; Young NL, 2010, ARCH PHYS MED REHAB, V91, P143, DOI 10.1016/j.apmr.2009.08.152	59	98	107	2	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					705	716		10.1016/S0140-6736(14)61229-0	http://dx.doi.org/10.1016/S0140-6736(14)61229-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB7ED	25301503	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000349788300027
J	Gauer, CC; Michelena, HI				Gauer, Cassandra C.; Michelena, Hector I.			Blue-black eyes and legs	LANCET			English	Editorial Material									[Gauer, Cassandra C.; Michelena, Hector I.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Michelena, HI (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	michelena.hector@mayo.edu							0	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					452	452		10.1016/S0140-6736(14)61800-6	http://dx.doi.org/10.1016/S0140-6736(14)61800-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25308289				2022-12-28	WOS:000348509900032
J	Wang, DS; Cai, CG; Dong, XB; Yu, QC; Zhang, XO; Yang, L; Zeng, YA				Wang, Daisong; Cai, Cheguo; Dong, Xiaobing; Yu, Qing Cissy; Zhang, Xiao-Ou; Yang, Li; Zeng, Yi Arial			Identification of multipotent mammary stemcells by protein C receptor expression	NATURE			English	Article							STEM-CELLS; WNT PROTEINS; GLAND; LINEAGES; MOUSE; BASAL; GENE	The mammary gland is composed of multiple types of epithelial cells, which are generated by mammary stem cells (MaSCs) residing at the top of the hierarchy(1,2). However, the existence of these multi-potent MaSCs remains controversial and the nature of such cells is unknown(3,4). Here we demonstrate that protein C receptor (Procr), a novel Wnt target in the mammary gland, marks a unique population of multipotent mouse MaSCs. Procr-positive cells localize to the basal layer, exhibit epithelial-to-mesenchymal transition characteristics, and express low levels of basal keratins. Procr-expressing cells have a high regenerative capacity in transplantation assays and differentiate into all lineages of the mammary epithelium by lineage tracing. These results define a novel multipotent mammary stem cell population that could be important in the initiation of breast cancer.	[Wang, Daisong; Cai, Cheguo; Dong, Xiaobing; Yu, Qing Cissy; Zeng, Yi Arial] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhang, Xiao-Ou; Yang, Li] Chinese Acad Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Zeng, YA (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	yzeng@sibcb.ac.cn	Cai, Cheguo/K-3747-2019; Kessenbrock, Kai/B-6936-2011; Zhang, Xiao-Ou/J-6229-2014	yang, li/0000-0001-8833-7473; Zhang, Xiao-Ou/0000-0002-2027-1313; cai, cheguo/0000-0002-3712-1696				Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beaulieu LM, 2007, EXP CELL RES, V313, P677, DOI 10.1016/j.yexcr.2006.11.019; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Gu JM, 2002, J BIOL CHEM, V277, P43335, DOI 10.1074/jbc.M207538200; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Schaffner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061071; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Spek CA, 2012, THROMB RES, V129, pS80, DOI 10.1016/S0049-3848(12)70022-1; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	27	229	240	7	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					81	U201		10.1038/nature13851	http://dx.doi.org/10.1038/nature13851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25327250				2022-12-28	WOS:000347178400039
J	Al Jord, A; Lemaitre, AI; Delgehyr, N; Faucourt, M; Spassky, N; Meunier, A				Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice			Centriole amplification by mother and daughter centrioles differs in multiciliated cells	NATURE			English	Article							PRIMARY CILIUM; CENTROSOME; CILIOGENESIS; BIOGENESIS; TUBULIN; MORPHOGENESIS; EPITHELIUM; INTERACTS; CYCLE; CPAP	The semi-conservative centrosome duplication in cycling cells gives rise to a centrosome composed of a mother and a newly formed daughter centriole(1). Both centrioles are regarded as equivalent in their ability to form new centrioles and their symmetric duplication is crucial for cell division homeostasis(2,4). Multiciliated cells do not use the archetypal duplication program and instead form more than a hundred centrioles that are required for the growth of motile cilia and the efficient propelling of physiological fluids(5). The majority of these new centrioles are thought to appear de novo, that is, independently from the centrosome, around electron-dense structures called deuterosomes(5,9). Their origin remains unknown. Using live imaging combined with correlative super-resolution light and electron microscopy, we show that all new centrioles derive from the pre-existing progenitor cell centrosome through multiple rounds of procentriole seeding. Moreover, we establish that only the daughter centrosomal centriole contributes to deuterosome formation, and thus to over ninety per cent of the final centriole population. This unexpected centriolar asymmetry grants new perspectives when studying cilia-related diseases and pathological centriole amplification observed in cycling cells and associated with microcephaly and cancer(2-4,10).	[Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice] Ecole Normale Super, ENS, IBENS, Inst Biol, F-75005 Paris, France; [Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice] INSERM, U1024, F-75005 Paris, France; [Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice] CNRS, UMR 8197, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Spassky, N (corresponding author), Ecole Normale Super, ENS, IBENS, Inst Biol, F-75005 Paris, France.	nathalie.spassky@ens.fr; alice.meunier@ens.fr	Spassky, Nathalie/E-3932-2016	Delgehyr, Nathalie/0000-0001-9870-0475; Al Jord, Adel/0000-0002-5075-3014; Meunier, Alice/0000-0001-6131-7747; spassky, nathalie/0000-0003-4722-6464	Federation pour la Recherche sur le Cerveau; Region Ile de France DIM NeRF; France-BioImaging; CNRS; ENS; INSERM; FPGG; ANR [ANR-12-BSV4-0006 CILIASTEM, ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02 PSL]; ARC [PJA-20131200184]; La ligue contre le cancer-comite de Paris [RS14/75-88]; 'Investissements d'Avenir' program of the French Government; City of Paris; FRM; French Ministry of Higher Education and Research	Federation pour la Recherche sur le Cerveau; Region Ile de France DIM NeRF(Region Ile-de-France); France-BioImaging(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FPGG; ANR(French National Research Agency (ANR)); ARC(Australian Research Council); La ligue contre le cancer-comite de Paris; 'Investissements d'Avenir' program of the French Government(French National Research Agency (ANR)); City of Paris(Region Ile-de-France); FRM(Fondation pour la Recherche Medicale); French Ministry of Higher Education and Research	We thank P. Rostaing of the IBENS Electron microscopy facility for making the correlative 3D-SIM and electron microscopy experiments possible. We also thank the Imaging Facility of IBENS, which is supported by grants from Federation pour la Recherche sur le Cerveau, Region Ile de France DIM NeRF 2009 and 2011 and France-BioImaging. We wish to thank L. Sengmanivong from the Nikon Imaging Centre at Institut Curie-CNRS. We are grateful to L. Goldstein for providing us with the Kif3a mutant mice. We thank C. Janke for the GT335 antibody, E. A. Nigg for the Cep164 and Plk4 antibodies, T. K. Tang for Cep120 and Cpap antibodies, X. Yan and X. Zhu for Deup1 and Cep152 antibodies, J.Azimzadeh for the Poc5 antibody and X. Morin for his gift of the pCAAGS-Cen2-GFP-mCherry plasmid. We also thank M. Bornens, B. Guirao, J. B. Boule, C. Janke and J.-F. Brunet for their comments on the manuscript and all the members of the Spassky laboratory for discussions. This study was supported by the CNRS, the ENS, INSERM, an FPGG grant, ANR award ANR-12-BSV4-0006 CILIASTEM, ARC award PJA-20131200184, La ligue contre le cancer-comite de Paris RS14/75-88, the 'Investissements d'Avenir' program of the French Government and implemented by the ANR (referenced ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University), a start-up grant from the City of Paris and a start-up grant from the FRM. A.A.J. and A-I.L. received fellowships from the French Ministry of Higher Education and Research.	Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; DIRKSEN ER, 1971, J CELL BIOL, V51, P286, DOI 10.1083/jcb.51.1.286; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Grau MB, 2013, J CELL BIOL, V202, P441, DOI 10.1083/jcb.201305041; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; LOOTS GP, 1989, CELL TISSUE RES, V255, P589; Ma LN, 2014, GENE DEV, V28, P1461, DOI 10.1101/gad.243832.114; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Tan FE, 2013, DEVELOPMENT, V140, P4277, DOI 10.1242/dev.094102; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Zhao HJ, 2013, NAT CELL BIOL, V15, P1434, DOI 10.1038/ncb2880	38	83	84	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					104	U259		10.1038/nature13770	http://dx.doi.org/10.1038/nature13770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25307055				2022-12-28	WOS:000346310800048
J	Schieffelin, JS; Shaffer, JG; Goba, A; Gbakie, M; Gire, SK; Colubri, A; Sealfon, RSG; Kanneh, L; Moigboi, A; Momoh, M; Fullah, M; Moses, LM; Brown, BL; Andersen, KG; Winnicki, S; Schaffner, SF; Park, DJ; Yozwiak, NL; Jiang, PP; Kargbo, D; Jalloh, S; Fonnie, M; Sinnah, V; French, I; Kovoma, A; Kamara, FK; Tucker, V; Konuwa, E; Sellu, J; Mustapha, I; Foday, M; Yillah, M; Kanneh, F; Saffa, S; Massally, JLB; Boisen, ML; Branco, LM; Vandi, MA; Grant, DS; Happi, C; Gevao, SM; Fletcher, TE; Fowler, RA; Bausch, DG; Sabeti, PC; Khan, SH; Garry, RF				Schieffelin, J. S.; Shaffer, J. G.; Goba, A.; Gbakie, M.; Gire, S. K.; Colubri, A.; Sealfon, R. S. G.; Kanneh, L.; Moigboi, A.; Momoh, M.; Fullah, M.; Moses, L. M.; Brown, B. L.; Andersen, K. G.; Winnicki, S.; Schaffner, S. F.; Park, D. J.; Yozwiak, N. L.; Jiang, P. -P.; Kargbo, D.; Jalloh, S.; Fonnie, M.; Sinnah, V.; French, I.; Kovoma, A.; Kamara, F. K.; Tucker, V.; Konuwa, E.; Sellu, J.; Mustapha, I.; Foday, M.; Yillah, M.; Kanneh, F.; Saffa, S.; Massally, J. L. B.; Boisen, M. L.; Branco, L. M.; Vandi, M. A.; Grant, D. S.; Happi, C.; Gevao, S. M.; Fletcher, T. E.; Fowler, R. A.; Bausch, D. G.; Sabeti, P. C.; Khan, S. H.; Garry, R. F.		Viral Hemorrhagic Fever Consortium; WHO Clinical Response Team	Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; VIRUS; TRANSMISSION; FEATURES; MONKEYS; CONGO	BACKGROUND Limited clinical and laboratory data are available on patients with Ebola virus disease (EVD). The Kenema Government Hospital in Sierra Leone, which had an existing infrastructure for research regarding viral hemorrhagic fever, has received and cared for patients with EVD since the beginning of the outbreak in Sierra Leone in May 2014. METHODS We reviewed available epidemiologic, clinical, and laboratory records of patients in whom EVD was diagnosed between May 25 and June 18, 2014. We used quantitative reverse-transcriptase-polymerase-chain-reaction assays to assess the load of Ebola virus (EBOV, Zaire species) in a subgroup of patients. RESULTS Of 106 patients in whom EVD was diagnosed, 87 had a known outcome, and 44 had detailed clinical information available. The incubation period was estimated to be 6 to 12 days, and the case fatality rate was 74%. Common findings at presentation included fever (in 89% of the patients), headache (in 80%), weakness (in 66%), dizziness (in 60%), diarrhea (in 51%), abdominal pain (in 40%), and vomiting (in 34%). Clinical and laboratory factors at presentation that were associated with a fatal outcome included fever, weakness, dizziness, diarrhea, and elevated levels of blood urea nitrogen, aspartate aminotransferase, and creatinine. Exploratory analyses indicated that patients under the age of 21 years had a lower case fatality rate than those over the age of 45 years (57% vs. 94%, P = 0.03), and patients presenting with fewer than 100,000 EBOV copies per milliliter had a lower case fatality rate than those with 10 million EBOV copies per milliliter or more (33% vs. 94%, P = 0.003). Bleeding occurred in only 1 patient. CONCLUSIONS The incubation period and case fatality rate among patients with EVD in Sierra Leone are similar to those observed elsewhere in the 2014 outbreak and in previous outbreaks. Although bleeding was an infrequent finding, diarrhea and other gastrointestinal manifestations were common.	[Schieffelin, J. S.; Moses, L. M.; Garry, R. F.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Shaffer, J. G.; Bausch, D. G.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Goba, A.; Gbakie, M.; Kanneh, L.; Moigboi, A.; Momoh, M.; Fullah, M.; Kargbo, D.; Jalloh, S.; Fonnie, M.; Sinnah, V.; French, I.; Kovoma, A.; Kamara, F. K.; Tucker, V.; Konuwa, E.; Sellu, J.; Mustapha, I.; Foday, M.; Yillah, M.; Kanneh, F.; Saffa, S.; Massally, J. L. B.; Grant, D. S.; Khan, S. H.] Kenema Govt Hosp, Kenema, Sierra Leone; [Momoh, M.; Fullah, M.] Eastern Polytech Coll, Kenema, Sierra Leone; [Vandi, M. A.] Minist Hlth & Sanitat, Kenema Dist Hlth Management Team, Kenema, Sierra Leone; [Gevao, S. M.] Univ Sierra Leone, Freetown, Sierra Leone; [Gire, S. K.; Colubri, A.; Andersen, K. G.; Winnicki, S.; Schaffner, S. F.; Yozwiak, N. L.; Jiang, P. -P.; Sabeti, P. C.] Harvard Univ, Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Gire, S. K.; Sealfon, R. S. G.; Andersen, K. G.; Winnicki, S.; Schaffner, S. F.; Park, D. J.; Yozwiak, N. L.; Jiang, P. -P.; Sabeti, P. C.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Sealfon, R. S. G.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Brown, B. L.; Boisen, M. L.] Corgenix Med, Broomfield, CO USA; [Branco, L. M.] Zalgen Labs, Germantown, MD USA; [Happi, C.] Redeemers Univ, Redemption City, Nigeria; [Fletcher, T. E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Fowler, R. A.] Univ Toronto, Toronto, ON, Canada; [Bausch, D. G.] US Naval Med Res Unit 6, Lima, Peru	Tulane University; Tulane University; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Redeemers University; Liverpool School of Tropical Medicine; University of Liverpool; University of Toronto; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Schieffelin, JS (corresponding author), Tulane Univ, Sch Med, Dept Med, 1430 Tulane Ave,TB 8, New Orleans, LA 70112 USA.	jschieff@tulane.edu; pardis@broadinstitute.org	Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011	Garry, Robert/0000-0002-5683-3250; Fletcher, Tom/0000-0002-3712-415X; Moses, Lina/0000-0003-4292-647X; Branco, Luis/0000-0001-8161-0182; Happi, Christian/0000-0002-3056-6705; Melnik, Lilia/0000-0002-3247-3158; Boisen, Matthew/0000-0001-6043-8459; Schaffner, Stephen/0000-0001-6699-3568	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI088843, U19AI109762, U19AI115589, R01AI099699, R01AI104621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177, P20GM103501] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the National Institutes of Health and others.	Adesunkanmi ARK, 2003, ANZ J SURG, V73, P275, DOI 10.1046/j.1445-2197.2003.t01-1-02608.x; Adesunkanmi ARK, 2005, INDIAN J SURG, V67, P29; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; FISHERHOCH SP, 1983, LANCET, V2, P1055; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Kasolo F, 2010, TECHNICAL GUIDELINES, P270; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Kuhn JH, 2011, BIOSECUR BIOTERROR, V9, P361, DOI 10.1089/bsp.2011.0051; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5980; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Sadek RF, 1999, J INFECT DIS, V179, pS24, DOI 10.1086/514311; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; World Health Organization, 2014, EB RESP ROADM SIT RE; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	24	379	405	1	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2092	2100		10.1056/NEJMoa1411680	http://dx.doi.org/10.1056/NEJMoa1411680			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25353969	Green Published, Green Accepted			2022-12-28	WOS:000345580000008
J	Kyrgiou, M; Mitra, A; Arbyn, M; Stasinou, SM; Martin-Hirsch, P; Bennett, P; Paraskevaidis, E				Kyrgiou, Maria; Mitra, Anita; Arbyn, Marc; Stasinou, Sofia Melina; Martin-Hirsch, Pierre; Bennett, Phillip; Paraskevaidis, Evangelos			Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LARGE-LOOP EXCISION; PRETERM BIRTH; WOMEN; RISK; CONIZATION; CANCER; CONE; COMPLICATIONS; COLPOSCOPY; MORTALITY	Objective To determine the impact of cervical excision for cervical intraepithelial neoplasia on fertility and early pregnancy outcomes. Design Systematic review and meta-analysis of cohort studies. Data sources Medline and Embase. Eligibility criteria Studies assessing fertility and early pregnancy outcomes in women with a history of treatment for cervical intraepithelial neoplasia versus untreated women. We classified the included studies according to treatment type and fertility or early pregnancy endpoint. Analysis Pooled relative risks and 95% confidence intervals using a random effect model, and interstudy heterogeneity with I-2 statistics. Results 15 studies fulfilled the inclusion criteria and were included. The meta-analysis did not provide any evidence that treatment for cervical intraepithelial neoplasia adversely affected the chances of conception. The overall pregnancy rate was higher for treated women than for untreated women (four studies; 43% v 38%, pooled relative risk 1.29, 95% confidence interval 1.02 to 1.64), although the heterogeneity between studies was high (P<0.0001). Pregnancy rates did not differ between women with an intention to conceive (two studies; 88% v 95%, 0.93, 0.80 to 1.08) and the number requiring more than 12 months to conceive (three studies, 15% v 9%, 1.45, 0.89 to 2.37). Although the rates for total miscarriages (10 studies; 4.6% v 2.8%, 1.04, 0.90 to 1.21) and miscarriage in the first trimester (four studies; 9.8% v 8.4%, 1.16, 0.80 to 1.69) was similar for treated and untreated women, cervical treatment was associated with a significantly increased risk of miscarriage in the second trimester. The rate was higher for treated women than for untreated women (eight studies; 1.6% v 0.4%, 16 558 women; 2.60, 1.45 to 4.67). The number of ectopic pregnancies (1.6% v 0.8%; 1.89, 1.50 to 2.39) and terminations (12.2% v 7.4%; 1.71, 1.31 to 2.22) was also higher for treated women. Conclusion There is no evidence suggesting that treatment for cervical intraepithelial neoplasia adversely affects fertility, although treatment was associated with a significantly increased risk of miscarriages in the second trimester. Research should explore mechanisms that may explain this increase in risk and stratify the impact that treatment may have on fertility and early pregnancy outcomes by the size of excision and treatment method used.	[Kyrgiou, Maria; Mitra, Anita; Bennett, Phillip] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Dept Surg & Canc, Fac Med, London W12 0NN, England; [Arbyn, Marc] Sci Inst Publ Hlth, Unit Canc Epidemiol, Brussels, Belgium; [Stasinou, Sofia Melina] Create Infertil Clin, London, England; [Stasinou, Sofia Melina; Paraskevaidis, Evangelos] Univ Hosp Ioannina, Dept Obstet & Gynaecol, Ioannina, Greece; [Martin-Hirsch, Pierre] Lancashire Teaching Hosp, Dept Gynaecol Oncol, Preston, Lancs, England; [Martin-Hirsch, Pierre] Univ Lancaster, Dept Biophoton, Lancaster, England	Imperial College London; University Hospital Ioannina; Lancaster University	Kyrgiou, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Dept Surg & Canc, Fac Med, London W12 0NN, England.	m.kyrgiou@imperial.ac.uk	Paraskevaidis, Evangelos/ABH-4990-2020	Bennett, Phillip/0000-0002-6253-4919	Imperial Healthcare NHS Trust Biomedical Research Centre [P45272]; British Society of Colposcopy and Cervical Pathology; Imperial College Healthcare Charity Fellowship; DG research of the European Commission through the COHEAHR Network [603019]; Institut national du Cancer (Paris, France) through the COSPCC study (Consequences obstetricales du (sur)traitement des precurseurs du cancer du col uterin); European Federation of Colposcopy; National Institute for Health Research [ACF-2014-21-012] Funding Source: researchfish	Imperial Healthcare NHS Trust Biomedical Research Centre; British Society of Colposcopy and Cervical Pathology; Imperial College Healthcare Charity Fellowship; DG research of the European Commission through the COHEAHR Network; Institut national du Cancer (Paris, France) through the COSPCC study (Consequences obstetricales du (sur)traitement des precurseurs du cancer du col uterin); European Federation of Colposcopy; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the Imperial Healthcare NHS Trust Biomedical Research Centre grant P45272. MK received support and a research award from the British Society of Colposcopy and Cervical Pathology. AM and MK were supported by the Imperial College Healthcare Charity Fellowship. MA was supported by seventh framework programme of DG research of the European Commission, through the COHEAHR Network (grant No 603019); the Institut national du Cancer (Paris, France) through the COSPCC study (Consequences obstetricales du (sur)traitement des precurseurs du cancer du col uterin) and by European Federation of Colposcopy.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Arbyn M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7700; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; BIGRIGG A, 1994, LANCET, V343, P32, DOI 10.1016/S0140-6736(94)90881-8; BLOMFIELD PI, 1993, AM J OBSTET GYNECOL, V169, P620, DOI 10.1016/0002-9378(93)90633-T; Bruinsma F, 2007, BJOG-INT J OBSTET GY, V114, P70, DOI 10.1111/j.1471-0528.2006.01107.x; BULLER RE, 1982, AM J OBSTET GYNECOL, V142, P506, DOI 10.1016/0002-9378(82)90752-9; Castanon A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5174; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; CRUICKSHANK ME, 1995, BRIT J OBSTET GYNAEC, V102, P467, DOI 10.1111/j.1471-0528.1995.tb11319.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Founta C, 2010, BJOG-INT J OBSTET GY, V117, P1468, DOI 10.1111/j.1471-0528.2010.02709.x; Frega A, 2013, INT J GYNECOL OBSTET, V122, P145, DOI 10.1016/j.ijgo.2013.03.013; HAMMOND RH, 1990, BRIT MED J, V301, P1344, DOI 10.1136/bmj.301.6765.1344; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; Jimenez B, 2013, J PROTEOME RES, V12, P959, DOI 10.1021/pr3010106; Kalliala I, 2012, BJOG-INT J OBSTET GY, V119, P227, DOI 10.1111/j.1471-0528.2011.03042.x; KENNEDY S, 1993, BRIT J OBSTET GYNAEC, V100, P965, DOI 10.1111/j.1471-0528.1993.tb15123.x; Khalid S, 2012, BJOG-INT J OBSTET GY, V119, P685, DOI 10.1111/j.1471-0528.2011.03252.x; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Kyrgiou M, 2014, INT J GYNAE IN PRESS; LARSSON G, 1982, ACTA OBSTET GYN SCAN, V61, P461, DOI 10.3109/00016348209156591; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; LUESLEY DM, 1985, BRIT J OBSTET GYNAEC, V92, P158, DOI 10.1111/j.1471-0528.1985.tb01068.x; Moher David, 2009, Open Med, V3, pe123; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Paraskevaidis E, 2007, BJOG-INT J OBSTET GY, V114, P3, DOI 10.1111/j.1471-0528.2006.01178.x; Phadnis SV, 2011, BJOG-INT J OBSTET GY, V118, P1585, DOI 10.1111/j.1471-0528.2011.03085.x; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; SAGOT P, 1995, EUR J OBSTET GYN R B, V58, P53, DOI 10.1016/0028-2243(94)01986-H; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; SPITZER M, 1995, OBSTET GYNECOL, V86, P504, DOI 10.1016/0029-7844(95)00237-L; Spracklen CN, 2013, BJOG-INT J OBSTET GY, V120, P960, DOI 10.1111/1471-0528.12209; Strander B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7361; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tan Linda, 2004, J Obstet Gynaecol, V24, P25; Turlington WT, 1996, J REPROD MED, V41, P815; WEBER T, 1979, ACTA OBSTET GYN SCAN, V58, P259, DOI 10.3109/00016347909154045	48	88	96	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2014	349								g6192	10.1136/bmj.g6192	http://dx.doi.org/10.1136/bmj.g6192			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DB	25352501	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000344155300002
J	Michaelsson, K; Wolk, A; Langenskiold, S; Basu, S; Warensjo, E; Melhus, H; Byberg, L				Michaelsson, Karl; Wolk, Alicja; Langenskiold, Sophie; Basu, Samar; Warensjo, Eva Lemming; Melhus, Hakan; Byberg, Liisa			Milk intake and risk of mortality and fractures in women and men: cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; HIGH-TRAUMA FRACTURES; BONE-MINERAL DENSITY; OXIDATIVE STRESS; D-GALACTOSE; DROSOPHILA-MELANOGASTER; MYOCARDIAL-INFARCTION; DAIRY CONSUMPTION; CALCIUM INTAKE; CANCER RISK	Objective To examine whether high milk consumption is associated with mortality and fractures in women and men. Design Cohort studies. Setting Three counties in central Sweden. Participants Two large Swedish cohorts, one with 61 433 women (39-74 years at baseline 1987-90) and one with 45 339 men (45-79 years at baseline 1997), were administered food frequency questionnaires. The women responded to a second food frequency questionnaire in 1997. Main outcome measure Multivariable survival models were applied to determine the association between milk consumption and time to mortality or fracture. Results During a mean follow-up of 20.1 years, 15 541 women died and 17 252 had a fracture, of whom 4259 had a hip fracture. In the male cohort with a mean follow-up of 11.2 years, 10 112 men died and 5066 had a fracture, with 1166 hip fracture cases. In women the adjusted mortality hazard ratio for three or more glasses of milk a day compared with less than one glass a day was 1.93 (95% confidence interval 1.80 to 2.06). For every glass of milk, the adjusted hazard ratio of all cause mortality was 1.15 (1.13 to 1.17) in women and 1.03 (1.01 to 1.04) in men. For every glass of milk in women no reduction was observed in fracture risk with higher milk consumption for any fracture (1.02, 1.00 to 1.04) or for hip fracture (1.09, 1.05 to 1.13). The corresponding adjusted hazard ratios in men were 1.01 (0.99 to 1.03) and 1.03 (0.99 to 1.07). In subsamples of two additional cohorts, one in males and one in females, a positive association was seen between milk intake and both urine 8-iso-PGF2 alpha (a biomarker of oxidative stress) and serum interleukin 6 (a main inflammatory biomarker). Conclusions High milk intake was associated with higher mortality in one cohort of women and in another cohort of men, and with higher fracture incidence in women. Given the observational study designs with the inherent possibility of residual confounding and reverse causation phenomena, a cautious interpretation of the results is recommended.	[Michaelsson, Karl; Warensjo, Eva Lemming; Byberg, Liisa] Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Langenskiold, Sophie; Basu, Samar] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Warensjo, Eva Lemming] Swedish Natl Food Agcy, Uppsala, Sweden; [Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University; Swedish National Food Agency; Uppsala University	Michaelsson, K (corresponding author), Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden.	karl.michaelsson@surgsci.uu.sem	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Research Council. EWL is employed by the Swedish National Food Agency. The views in this article do not necessarily represent those of the agency.	Abargouei AS, 2012, INT J OBESITY, V36, P1485, DOI 10.1038/ijo.2011.269; ALM L, 1982, J DAIRY SCI, V65, P346, DOI 10.3168/jds.S0022-0302(82)82198-X; Astrup A, 2014, AM J CLIN NUTR, V99, p1235S, DOI 10.3945/ajcn.113.073015; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Batey LA, 2013, OSTEOPOROSIS INT, V24, P501, DOI 10.1007/s00198-012-1983-0; Bergstrom L., 1991, Var Foda, V43, P439; Bischoff-Ferrari HA, 2011, J BONE MINER RES, V26, P833, DOI 10.1002/jbmr.279; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Ceapa C, 2013, BEST PRACT RES CL GA, V27, P139, DOI 10.1016/j.bpg.2013.04.004; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen M, 2012, AM J CLIN NUTR, V96, P735, DOI 10.3945/ajcn.112.037119; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Corella D, 2011, OBESITY, V19, P1707, DOI 10.1038/oby.2010.320; Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3; Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845; Gaucheron F, 2011, J AM COLL NUTR, V30, p400S, DOI 10.1080/07315724.2011.10719983; Gedeborg R, 2008, EPIDEMIOLOGY, V19, P860, DOI 10.1097/EDE.0b013e318181319e; GROSS KC, 1991, J INHERIT METAB DIS, V14, P253, DOI 10.1007/BF01800599; Hao L, 2014, NEUROSCI LETT, V571, P45, DOI 10.1016/j.neulet.2014.04.038; Heaney RP, 2009, J AM COLL NUTR, V28, p82S, DOI 10.1080/07315724.2009.10719808; Hegsted DM, 2001, AM J CLIN NUTR, V74, P571; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Huth PJ, 2012, ADV NUTR, V3, P266, DOI 10.3945/an.112.002030; Jiang J, 1999, AM J CLIN NUTR, V70, P21; Jumbo-Lucioni PP, 2013, DIS MODEL MECH, V6, P84, DOI 10.1242/dmm.010207; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kumar M, 2010, INT J FOOD SCI NUTR, V61, P473, DOI 10.3109/09637480903455971; Lai K, 2009, IUBMB LIFE, V61, P1063, DOI 10.1002/iub.262; Lampe JW, 2011, J AM COLL NUTR, V30, p464S, DOI 10.1080/07315724.2011.10719991; Larsson SC, 2008, AM J CLIN NUTR, V88, P1083, DOI 10.1093/ajcn/88.4.1083; Larsson SC, 2009, AM J CLIN NUTR, V89, P277, DOI 10.3945/ajcn.2008.26704; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Michaelsson Karl, 2013, BMJ, V346, pf228, DOI 10.1136/bmj.f228; Michaelsson K, 2014, AM J CLIN NUTR, V99, P107, DOI 10.3945/ajcn.113.064691; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nestel PJ, 2013, BRIT J NUTR, V110, P2242, DOI 10.1017/S0007114513001621; Orsini N, 2008, EUR J EPIDEMIOL, V23, P661, DOI 10.1007/s10654-008-9273-z; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; Patterson E, 2013, J NUTR, V143, P74, DOI 10.3945/jn.112.166330; Portnoi PA, 2009, J HUM NUTR DIET, V22, P400, DOI 10.1111/j.1365-277X.2009.00948.x; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Segall JJ, 2008, INT J EPIDEMIOL, V37, P1204, DOI 10.1093/ije/dyn169; SIMOONS FJ, 1978, AM J DIG DIS, V23, P963, DOI 10.1007/BF01263095; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Song Y, 2013, J NUTR, V143, P189, DOI 10.3945/jn.112.168484; [STATA Corporation Stata Corporation], 2009, STAT REF MAN REL 11; TAHVONEN R, 1995, FOOD ADDIT CONTAM, V12, P789, DOI 10.1080/02652039509374371; Thomas LDK, 2011, J BONE MINER RES, V26, P1601, DOI 10.1002/jbmr.386; Timpson NJ, 2010, CANCER EPIDEM BIOMAR, V19, P1341, DOI 10.1158/1055-9965.EPI-09-1019; Tornkvist A, 2011, CHEMOSPHERE, V83, P193, DOI 10.1016/j.chemosphere.2010.12.042; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; VanderWeele TJ, 2008, EPIDEMIOLOGY, V19, P720, DOI 10.1097/EDE.0b013e3181810e29; Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751; Warensjo E, BMJ, V342, pd1473; Weaver CM, 2014, AM J CLIN NUTR, V99, p1217S, DOI 10.3945/ajcn.113.073007; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291	70	171	172	5	91	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2014	349								g6015	10.1136/bmj.g6015	http://dx.doi.org/10.1136/bmj.g6015			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DB	25352269	Green Published, hybrid			2022-12-28	WOS:000344155300001
J	McJeon, H; Edmonds, J; Bauer, N; Clarke, L; Fisher, B; Flannery, BP; Hilaire, J; Krey, V; Marangoni, G; Mi, R; Riahi, K; Rogner, H; Tavoni, M				McJeon, Haewon; Edmonds, Jae; Bauer, Nico; Clarke, Leon; Fisher, Brian; Flannery, Brian P.; Hilaire, Jerome; Krey, Volker; Marangoni, Giacomo; Mi, Raymond; Riahi, Keywan; Rogner, Holger; Tavoni, Massimo			Limited impact on decadal-scale climate change from increased use of natural gas	NATURE			English	Article							SHALE GAS; CHANGE MITIGATION; EMISSIONS; MODEL; TECHNOLOGIES; SCENARIOS; ECONOMICS; METHANE; STABILIZATION; UNCERTAINTY	The most important energy development of the past decade has been the wide deployment of hydraulic fracturing technologies that enable the production of previously uneconomic shale gas resources in North America(1). If these advanced gas production technologies were to be deployed globally, the energy market could see a large influx of economically competitive unconventional gas resources(2). The climate implications of such abundant natural gas have been hotly debated. Some researchers have observed that abundant natural gas substituting for coal could reduce carbon dioxide (CO2) emissions(3-6). Others have reported that the non-CO2 greenhouse gas emissions associated with shale gas production make its lifecycle emissions higher than those of coal(7,8). Assessment of the full impact of abundant gas on climate change requires an integrated approach to the global energyeconomyclimate systems, but the literature has been limited in either its geographic scope(9,10) or its coverage of greenhouse gases(2). Here we show that market-driven increases in global supplies of unconventional natural gas do not discernibly reduce the trajectory of greenhouse gas emissions or climate forcing. Our results, based on simulations from five state-of-the-art integrated assessment models(11) of energyeconomyclimate systems independently forced by an abundant gas scenario, project large additional natural gas consumption of up to +170 per cent by 2050. The impact on CO2 emissions, however, is found to be much smaller (from -2 per cent to +11 per cent), and a majority of the models reported a small increase in climate forcing (from -0.3 per cent to +7 per cent) associated with the increased use of abundant gas. Our results show that although market penetration of globally abundant gas may substantially change the future energy system, it is not necessarily an effective substitute for climate change mitigation policy(9,10).	[McJeon, Haewon; Edmonds, Jae; Clarke, Leon] Pacific NW Natl Lab, JGCRI, College Pk, MD 20740 USA; [Bauer, Nico; Hilaire, Jerome] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Fisher, Brian; Mi, Raymond] BAEconomics, Kingston, ACT 2604, Australia; [Flannery, Brian P.] Resources Future Inc, Washington, DC 20036 USA; [Krey, Volker; Riahi, Keywan; Rogner, Holger] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Marangoni, Giacomo; Tavoni, Massimo] Ctr Euromediterraneo Cambiamenti Climat, I-20156 Milan, Italy; [Marangoni, Giacomo; Tavoni, Massimo] Politecn Milan, I-20156 Milan, Italy	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Potsdam Institut fur Klimafolgenforschung; Resources for the Future; International Institute for Applied Systems Analysis (IIASA); Polytechnic University of Milan	McJeon, H (corresponding author), Pacific NW Natl Lab, JGCRI, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	haewon.mcjeon@pnnl.gov	Krey, Volker/ABD-5070-2021; Riahi, Keywan/B-6426-2011; Marangoni, Giacomo/AAV-1668-2021	Riahi, Keywan/0000-0001-7193-3498; Marangoni, Giacomo/0000-0003-3994-380X; Flannery, Brian/0000-0002-3318-8068; Krey, Volker/0000-0003-0307-3515; McJeon, Haewon/0000-0003-0348-5704; tavoni, massimo/0000-0001-5069-4707; Hilaire, Jerome/0000-0002-9879-6339	BAEconomics; Global Technology Strategy Project; International Institute for Applied Systems Analysis; German Federal Ministry of Education and Research; Italian Ministry of Education, University and Research; Italian Ministry of Environment, Land and Sea under the GEMINA project	BAEconomics; Global Technology Strategy Project; International Institute for Applied Systems Analysis; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Environment, Land and Sea under the GEMINA project(Ministry of Environment (ME), Republic of Korea)	B.F. and R.M. and their development of BAEGEM were supported by BAEconomics with assistance for special applications to the resource sector from Rio Tinto (Australia). H.M., L.C.,J.E. and B.P.F. were supported by the Global Technology Strategy Project. V.K., K.R. and H.R. were supported by the International Institute for Applied Systems Analysis cross-cutting project on unconventional natural gas. N.B. and J.H. were supported by funding from the German Federal Ministry of Education and Research in the project 'Economics of Climate Change'. G.M. and M.T. were supported by the Italian Ministry of Education, University and Research and the Italian Ministry of Environment, Land and Sea under the GEMINA project. We thank M. Jeong and E. Golman for research assistance. The views and opinions expressed in this paper are those of the authors alone.	Aguiar A., 2012, GLOBAL TRADE ASSISTA; [Anonymous], 2008, MAGICC SCENGEN 5 3 U; [Anonymous], CO2 EM FUEL COMB 201; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; Bauer N., CLIM CHANGE IN PRESS; Bauer N., TECHNOL FORECAST SOC; Bauer N, 2012, P NATL ACAD SCI USA, V109, P16805, DOI 10.1073/pnas.1201264109; Bauer N, 2008, COMPUT MANAG SCI, V5, P95, DOI 10.1007/s10287-007-0042-3; Boden T. A., 2009, GLOBAL REGIONAL NATL; Bosetti V, 2008, ENERG ECON, V30, P2912, DOI 10.1016/j.eneco.2008.04.008; Bosetti V, 2006, ENERG J, P13; Bosetti V, 2011, ENERG ECON, V33, P1313, DOI 10.1016/j.eneco.2011.02.010; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Brown Stephen P.A., 2009, NATURAL GAS BRIDGE L; Burnham A, 2012, ENVIRON SCI TECHNOL, V46, P619, DOI 10.1021/es201942m; Calvin K., 2011, GCAM WIKI DOCUMENTAT; Calvin K, 2012, ENERG ECON, V34, pS251, DOI 10.1016/j.eneco.2012.09.003; CLARKE JF, 1993, ENERG ECON, V15, P123, DOI 10.1016/0140-9883(93)90031-L; Edenhofer O, 2010, ENERG J, V31, P11; EDMONDS J, 1983, ENERG ECON, V5, P74, DOI 10.1016/0140-9883(83)90014-2; EDMONDS J, 1983, ENERGY, V8, P419, DOI 10.1016/0360-5442(83)90064-6; Edmonds J., 1983, ENERGY J, V4, DOI [10.5547/ISSN0195-6574-EJ-Vol4-No3-3, DOI 10.5547/ISSN0195-6574-EJ-VOL4-NO3-3]; Edmonds J. A., 2012, CLIMATE CHANGE MODEL, P169; Energy Modeling Forum, 2013, 26 EMF; Environmental Protection Agency, 2012, GLOB ANTHR NONCO2 GR; Environmental Protection Agency, 2011, EPA PUBL, V430-R-11-005; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Global Energy Assessment, 2012, GEA SCEN DAT; HANOCH G, 1971, ECONOMETRICA, V39, P695, DOI 10.2307/1909573; Harrison J., 2012, GEMPACK MANUAL; Hertel TW, 1999, GLOBAL TRADE ANAL MO; Howarth RW, 2011, NATURE, V477, P271, DOI 10.1038/477271a; Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5; Hultman N, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044008; Integrated Assessment Modeling Consortium, 2014, IPCC AR5 SCEN DAT; Intergovernmental Panel on Climate Change, 2000, GUID UNC MAN NAT GRE; Intergovernmental Panel on Climate Change, 2006, IPPC GUID NAT GREENH; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; International Energy Agency, 2012, CO2 EM FUEL COMB 197; International Energy Agency, 2012, EM CO2 CH4 N2O HFCS; International Energy Agency, 2008, WORLD EN OUTL 2008; International Energy Agency, 2011, AR WE ENT GOLD AG GA; International Energy Agency, 2013, EN BAL NONOECD COUNT; International Energy Agency, 2013, EN BAL OECD COUNTR; International Institute for Applied Systems Analysis, 2014, GLOB BIOSPH MAN MOD; Joos F, 2001, GLOBAL BIOGEOCHEM CY, V15, P891, DOI 10.1029/2000GB001375; Klein D, 2014, CLIMATIC CHANGE, V123, P705, DOI 10.1007/s10584-013-0940-z; Kriegler E, 2014, CLIMATIC CHANGE, V123, P353, DOI 10.1007/s10584-013-0953-7; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Laurenzi IJ, 2013, ENVIRON SCI TECHNOL, V47, P4896, DOI 10.1021/es305162w; Leimbach M, 2010, ENERG J, V31, P109; Levi M, 2013, CLIMATIC CHANGE, V118, P609, DOI 10.1007/s10584-012-0658-3; Liu GJ, 2011, ENRGY PROCED, V4, P1989, DOI 10.1016/j.egypro.2011.02.080; Liu GJ, 2011, ENERG FUEL, V25, P415, DOI 10.1021/ef101184e; Luderer G., 2011, DESCRIPTION REMIND R; Luderer G, 2012, CLIMATIC CHANGE, V114, P9, DOI 10.1007/s10584-011-0105-x; MANNE A, 1995, ENERG POLICY, V23, P17, DOI 10.1016/0301-4215(95)90763-W; McCollum D, 2014, CLIMATIC CHANGE, V123, P413, DOI 10.1007/s10584-013-0939-5; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Messner S, 2000, ENERGY, V25, P267, DOI 10.1016/S0360-5442(99)00063-8; Messner S., 1995, USERS GUIDE MESSAGE; Mi R., 2014, BAEGEM MODEL DOCUMEN; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Moniz E., 2011, FUTURE NATURAL GAS I; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Newell RG, 2014, ENVIRON SCI TECHNOL, V48, P8360, DOI 10.1021/es4046154; Nordhaus WD, 1996, AM ECON REV, V86, P741; Nordhaus WD, 1999, ENERG J, P93; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P1011, DOI 10.1073/pnas.0903797106; Patwardhan A. P., 2012, GLOBAL ENERGY ASSESS; Ramage M., 2009, LIQUID TRANSPORTATIO; Rao S, 2006, ENERG J, P177; Reilly J., 1987, ENERGY J, V8, P1; Riahi K, 2004, ENERGY, V29, P1309, DOI 10.1016/j.energy.2004.03.089; Riahi K., 2012, GLOBAL ENERGY ASSESS, P1203; Riahi K., TECHNOL FOR IN PRESS; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rogner H., 2012, GLOBAL ENERGY ASSESS, P425, DOI [10.1017/CBO9780511793677.013, DOI 10.1017/CBO9780511793677.013]; Rogner HH, 1997, ANNU REV ENERG ENV, V22, P217, DOI 10.1146/annurev.energy.22.1.217; Schwanitz VJ, 2014, ENERG POLICY, V67, P882, DOI 10.1016/j.enpol.2013.12.015; Scott MJ, 1999, ENERG POLICY, V27, P855, DOI 10.1016/S0301-4215(99)00057-9; Skone T. J., 2010, LIFE CYCLE ANAL NATU; Sovacool BK, 2014, RENEW SUST ENERG REV, V37, P249, DOI 10.1016/j.rser.2014.04.068; Strefler J., 2008, CLIM CHANGE IN PRESS; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; United Nations Framework Convention on Climate Change, 2012, 2012 ANN 1 PART GHG; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Venkatesh A, 2011, ENVIRON SCI TECHNOL, V45, P8182, DOI 10.1021/es200930h; Weber CL, 2012, ENVIRON SCI TECHNOL, V46, P5688, DOI 10.1021/es300375n; Weyant JR, 2006, ENERG J, P1; WIGLEY TML, 1987, NATURE, V330, P127, DOI 10.1038/330127a0; Wigley TML, 2002, J CLIMATE, V15, P2690, DOI 10.1175/1520-0442(2002)015<2690:RFDTRG>2.0.CO;2; WIGLEY TML, 1992, NATURE, V357, P293, DOI 10.1038/357293a0; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	96	143	144	6	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					482	+		10.1038/nature13837	http://dx.doi.org/10.1038/nature13837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25317557	Green Published			2022-12-28	WOS:000343775900038
J	Vaahtomeri, K; Sixt, M				Vaahtomeri, Kari; Sixt, Michael			PHYSIOLOGY Relax and come in	NATURE			English	Editorial Material							LYMPH-NODES; LYMPHOCYTES; GROWTH; CELLS		[Vaahtomeri, Kari; Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Vaahtomeri, K (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	michael.sixt@ist.ac.at		Sixt, Michael/0000-0002-6620-9179				Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Cabanac A, 1997, J APPL PHYSIOL, V82, P1989, DOI 10.1152/jappl.1997.82.6.1989; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Luther SA, 2011, IMMUNOL LETT, V138, P9, DOI 10.1016/j.imlet.2011.02.006; MCHALE NG, 1990, EXP PHYSIOL, V75, P847, DOI 10.1113/expphysiol.1990.sp003467; Mionnet C, 2011, BLOOD, V118, P6115, DOI 10.1182/blood-2011-07-367409; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	8	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					441	442		10.1038/514441a	http://dx.doi.org/10.1038/514441a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341781				2022-12-28	WOS:000343775900028
J	Latif, SR; Bommer, W				Latif, Syed R.; Bommer, William			In older patients with hypertension, newly prescribed thiazides were linked to metabolic adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Latif, Syed R.; Bommer, William] UC Davis Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Latif, SR (corresponding author), UC Davis Med Ctr, Sacramento, CA 95817 USA.							Ernst ME, 2009, NEW ENGL J MED, V361, P2153, DOI 10.1056/NEJMra0907219; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC11	10.7326/0003-4819-161-8-201410210-02011	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329216				2022-12-28	WOS:000343906800010
J	Calegari, F; Ayuso, D; Trabattoni, A; Belshaw, L; De Camillis, S; Anumula, S; Frassetto, F; Poletto, L; Palacios, A; Decleva, P; Greenwood, JB; Martin, F; Nisoli, M				Calegari, F.; Ayuso, D.; Trabattoni, A.; Belshaw, L.; De Camillis, S.; Anumula, S.; Frassetto, F.; Poletto, L.; Palacios, A.; Decleva, P.; Greenwood, J. B.; Martin, F.; Nisoli, M.			Ultrafast electron dynamics in phenylalanine initiated by attosecond pulses	SCIENCE			English	Article							REAL-TIME OBSERVATION; CHARGE MIGRATION; PEPTIDE CATIONS	In the past decade, attosecond technology has opened up the investigation of ultrafast electronic processes in atoms, simple molecules, and solids. Here, we report the application of isolated attosecond pulses to prompt ionization of the amino acid phenylalanine and the subsequent detection of ultrafast dynamics on a sub-4.5-femtosecond temporal scale, which is shorter than the vibrational response of the molecule. The ability to initiate and observe such electronic dynamics in polyatomic molecules represents a crucial step forward in attosecond science, which is progressively moving toward the investigation of more and more complex systems.	[Calegari, F.; Nisoli, M.] CNR, Inst Photon & Nanotechnol IFN, I-20133 Milan, Italy; [Ayuso, D.; Palacios, A.; Martin, F.] Univ Autonoma Madrid, Dept Quim, E-28049 Madrid, Spain; [Trabattoni, A.; Anumula, S.; Nisoli, M.] Politecn Milan, Dept Phys, I-20133 Milan, Italy; [Belshaw, L.; De Camillis, S.; Greenwood, J. B.] Queens Univ Belfast, Sch Maths & Phys, Ctr Plasma Phys, Belfast BT7 1NN, Antrim, North Ireland; [Frassetto, F.; Poletto, L.] CNR, IFN, I-35131 Padua, Italy; [Decleva, P.] Univ Trieste, Dipartimento Sci Chim & Farmaceut, I-34127 Trieste, Italy; [Decleva, P.] CNR, Ist Officina Mat, I-34127 Trieste, Italy; [Martin, F.] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Autonomous University of Madrid; Polytechnic University of Milan; Queens University Belfast; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR)	Martin, F (corresponding author), Univ Autonoma Madrid, Dept Quim, Modulo 13, E-28049 Madrid, Spain.	fernando.martin@uam.es; mauro.nisoli@polimi.it	Frassetto, Fabio/AAY-3281-2020; Calegari, Francesca/H-8881-2012; Nisoli, Mauro/K-8563-2017; Greenwood, Jason B/L-4799-2014; Martin, Fernando/C-3972-2014; Palacios, Alicia/V-4525-2019; Ayuso, David/M-7330-2016	Calegari, Francesca/0000-0003-3234-7298; Nisoli, Mauro/0000-0003-2309-732X; Greenwood, Jason B/0000-0001-9470-7223; Martin, Fernando/0000-0002-7529-925X; Palacios, Alicia/0000-0001-6531-9926; Ayuso, David/0000-0002-5394-5361; Trabattoni, Andrea/0000-0002-0187-9075; De Camillis, Simone/0000-0002-9392-5197; Poletto, Luca/0000-0002-0914-0531; De Camillis, Simone/0000-0002-8823-9643	European Research Council under ERC [227355 ELYCHE, 290853 XCHEM]; LASERLAB-EUROPE (European Commission) [284464]; European COST Action [CM1204 XLIC]; Ministerio de Ciencia e Innovacion [FIS2010-15127]; ERA-Chemistry project [PIM2010EEC-00751]; European grant MC-ITN CORINF [268284]; European grant MC-RG ATTOTREND [268284]; UK's Science and Technology Facilities Council; Engineering and Physical Sciences Research Council [EP/J007048/1]; Leverhulme Trust [RPG-2012-735]; Northern Ireland Department of Employment and Learning; EPSRC [EP/G03088X/1, EP/J007048/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G03088X/1] Funding Source: researchfish	European Research Council under ERC(European Research Council (ERC)); LASERLAB-EUROPE (European Commission)(European Commission); European COST Action; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ERA-Chemistry project; European grant MC-ITN CORINF; European grant MC-RG ATTOTREND; UK's Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Northern Ireland Department of Employment and Learning; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge support from the European Research Council under ERC grant nos. 227355 ELYCHE and 290853 XCHEM, LASERLAB-EUROPE (grant agreement no. 284464, European Commission's Seventh Framework Programme), European COST Action CM1204 XLIC, the Ministerio de Ciencia e Innovacion project FIS2010-15127, the ERA-Chemistry project PIM2010EEC-00751, European grants MC-ITN CORINF and MC-RG ATTOTREND 268284, UK's Science and Technology Facilities Council Laser Loan Scheme, the Engineering and Physical Sciences Research Council (grant EP/J007048/1), the Leverhulme Trust (grant RPG-2012-735), and the Northern Ireland Department of Employment and Learning.	Belshaw L, 2012, J PHYS CHEM LETT, V3, P3751, DOI 10.1021/jz3016028; Breidbach J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033901; Breidbach J, 2003, J CHEM PHYS, V118, P3983, DOI 10.1063/1.1540618; Calvert CR, 2012, PHYS CHEM CHEM PHYS, V14, P6289, DOI 10.1039/c2cp23840c; Canton SE, 2011, P NATL ACAD SCI USA, V108, P7302, DOI 10.1073/pnas.1018534108; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Cederbaum LS, 1999, CHEM PHYS LETT, V307, P205, DOI 10.1016/S0009-2614(99)00508-4; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Hennig H, 2005, J PHYS CHEM A, V109, P409, DOI 10.1021/jp046232s; Huang ZJ, 2006, J MOL STRUC-THEOCHEM, V758, P195, DOI 10.1016/j.theochem.2005.10.043; Kelkensberg F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.043002; Klunder K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143002; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kuleff AI, 2007, CHEM PHYS, V338, P320, DOI 10.1016/j.chemphys.2007.04.012; Lepine F, 2014, NAT PHOTONICS, V8, P195, DOI 10.1038/nphoton.2014.25; Lunnemann S, 2008, CHEM PHYS LETT, V450, P232, DOI 10.1016/j.cplett.2007.11.031; Mendive-Tapia D, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4815914; Plesiat E, 2012, PHYS CHEM CHEM PHYS, V14, P10853, DOI 10.1039/c2cp40693d; Ranitovic P, 2014, P NATL ACAD SCI USA, V111, P912, DOI 10.1073/pnas.1321999111; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Siu W, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063412; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; WALS J, 1994, PHYS REV LETT, V72, P3783, DOI 10.1103/PhysRevLett.72.3783; Weinkauf R, 1996, J PHYS CHEM-US, V100, P18567, DOI 10.1021/jp960926m; WEINKAUF R, 1995, J PHYS CHEM-US, V99, P11255, DOI 10.1021/j100028a029	30	504	511	3	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					336	339		10.1126/science.1254061	http://dx.doi.org/10.1126/science.1254061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324385	Green Submitted, Green Accepted			2022-12-28	WOS:000343041100040
J	Rosenbaum, L				Rosenbaum, Lisa			Invisible Risks, Emotional Choices - Mammography and Medical Decision Making	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCREENING MAMMOGRAPHY; CANCER; BENEFITS											Allen JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1169; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Kahneman D., 2011, THINKING FAST SLOW; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Ransohoff DF, 2002, AM J MED, V113, P663, DOI 10.1016/S0002-9343(02)01235-4; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 2002, HEURISTICS BIASES PS, P297; Sunstein C, 2005, LAWS FEAR PRECAUTION, V1st; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	14	31	32	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1549	1552		10.1056/NEJMms1409003	http://dx.doi.org/10.1056/NEJMms1409003			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317876				2022-12-28	WOS:000342994700015
J	de Bruin, EC; McGranahan, N; Mitter, R; Salm, M; Wedge, DC; Yates, L; Jamal-Hanjani, M; Shafi, S; Murugaesu, N; Rowan, AJ; Gronroos, E; Muhammad, MA; Horswell, S; Gerlinger, M; Varela, I; Jones, D; Marshall, J; Voet, T; Van Loo, P; Rassl, DM; Rintoul, RC; Janes, SM; Lee, SM; Forster, M; Ahmad, T; Lawrence, D; Falzon, M; Capitanio, A; Harkins, TT; Lee, CC; Tom, W; Teefe, E; Chen, SC; Begum, S; Rabinowitz, A; Phillimore, B; Spencer-Dene, B; Stamp, G; Szallasi, Z; Matthews, N; Stewart, A; Campbell, P; Swanton, C				de Bruin, Elza C.; McGranahan, Nicholas; Mitter, Richard; Salm, Max; Wedge, David C.; Yates, Lucy; Jamal-Hanjani, Mariam; Shafi, Seema; Murugaesu, Nirupa; Rowan, Andrew J.; Groenroos, Eva; Muhammad, Madiha A.; Horswell, Stuart; Gerlinger, Marco; Varela, Ignacio; Jones, David; Marshall, John; Voet, Thierry; Van Loo, Peter; Rassl, Doris M.; Rintoul, Robert C.; Janes, Sam M.; Lee, Siow-Ming; Forster, Martin; Ahmad, Tanya; Lawrence, David; Falzon, Mary; Capitanio, Arrigo; Harkins, Timothy T.; Lee, Clarence C.; Tom, Warren; Teefe, Enock; Chen, Shann-Ching; Begum, Sharmin; Rabinowitz, Adam; Phillimore, Benjamin; Spencer-Dene, Bradley; Stamp, Gordon; Szallasi, Zoltan; Matthews, Nik; Stewart, Aengus; Campbell, Peter; Swanton, Charles			Spatial and temporal diversity in genomic instability processes defines lung cancer evolution	SCIENCE			English	Article							CHROMOSOMAL INSTABILITY; MUTATIONS; ADENOCARCINOMA; REARRANGEMENTS; HETEROGENEITY; MUTAGENESIS; RESISTANCE; SIGNATURES; PATTERNS	Spatial and temporal dissection of the genomic changes occurring during the evolution of human non-small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.	[de Bruin, Elza C.; Jamal-Hanjani, Mariam; Shafi, Seema; Murugaesu, Nirupa; Muhammad, Madiha A.; Lee, Siow-Ming; Forster, Martin; Swanton, Charles] UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, London WC1E 6BT, England; [McGranahan, Nicholas; Mitter, Richard; Salm, Max; Rowan, Andrew J.; Groenroos, Eva; Horswell, Stuart; Gerlinger, Marco; Begum, Sharmin; Rabinowitz, Adam; Phillimore, Benjamin; Spencer-Dene, Bradley; Stamp, Gordon; Matthews, Nik; Stewart, Aengus; Swanton, Charles] Canc Res UK London Res Inst, London WC2A 3LY, England; [McGranahan, Nicholas] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Wedge, David C.; Yates, Lucy; Jones, David; Marshall, John; Voet, Thierry; Van Loo, Peter; Campbell, Peter] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Yates, Lucy] Univ Cambridge, Cambridge CB2 1TN, England; [Varela, Ignacio] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria, CSIC UC Sodercan, E-39005 Santander, Spain; [Voet, Thierry; Van Loo, Peter] Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Rassl, Doris M.; Rintoul, Robert C.] Papworth Hosp NHS Fdn Trust, Cambridge CB23 3RE, England; [Janes, Sam M.] UCL, Lungs Living Res Ctr, London WC1E 6BT, England; [Lee, Siow-Ming; Forster, Martin; Ahmad, Tanya; Lawrence, David; Falzon, Mary; Capitanio, Arrigo] Univ Coll London Hosp, London NW1 2BU, England; [Harkins, Timothy T.; Lee, Clarence C.; Tom, Warren; Teefe, Enock; Chen, Shann-Ching] Thermo Fisher Sci, Carlsbad, CA 92008 USA; [Szallasi, Zoltan] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Szallasi, Zoltan] Harvard Univ, Sch Med, Childrens Hosp Informat Program, Boston, MA 02115 USA	Cancer Research UK; University of London; University College London; Cancer Research UK; University of London; University College London; Wellcome Trust Sanger Institute; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); KU Leuven; Papworth Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Thermo Fisher Scientific; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard Medical School	Swanton, C (corresponding author), UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, Mortimer St, London WC1E 6BT, England.	charles.swanton@cancer.org.uk	Varela, Ignacio/G-1699-2016; Voet, Thierry/E-8877-2017; Gronroos, Eva/P-6951-2015; Varela, Ignacio/AAA-7680-2021; McGranahan, Nicholas/ABD-6561-2021; wang, edwin/G-5372-2010; Rintoul, Robert Campbell/Q-1727-2015; Wedge, David/AAC-4977-2021	Varela, Ignacio/0000-0002-0969-506X; Voet, Thierry/0000-0003-1204-9963; Varela, Ignacio/0000-0002-0969-506X; McGranahan, Nicholas/0000-0001-9537-4045; Rintoul, Robert Campbell/0000-0003-3875-3780; Horswell, Stuart/0000-0003-2787-1933; Gerlinger, Marco/0000-0003-2719-299X; Mitter, Richard/0000-0002-1279-3760; Lee, Siow Ming/0000-0002-1741-6235; Teefe, Enock/0000-0001-9063-7707; Szallasi, Zoltan/0000-0001-5395-7509; Yates, Lucy/0000-0003-4519-7794; Wedge, David/0000-0002-7572-3196; Gronroos, Eva/0000-0001-8303-5409; Salm, Max/0000-0002-5742-3376; Janes, Sam/0000-0002-6634-5939; Swanton, Charles/0000-0002-4299-3018; Van Loo, Peter/0000-0003-0292-1949	Cancer Research UK; Rosetrees Trust; UK Medical Research Council; Spanish Ministerio de Economia y Competitividad; Cambridge Biomedical Research Centre; Cancer Research UK Cancer Centre; European Union [259303]; Prostate Cancer Foundation; European Research Council; Breast Cancer Research Foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Servicio Santander Supercomputacion; 14M Genomics Ltd; MRC [G0902275] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL7-Murugaesu] Funding Source: researchfish; Cancer Research UK [17786, 18377] Funding Source: researchfish; Medical Research Council [G0902275] Funding Source: researchfish; National Institute for Health Research [CL-2011-18-001] Funding Source: researchfish; Rosetrees Trust [M35-F1-CD1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Cambridge Biomedical Research Centre(General Electric); Cancer Research UK Cancer Centre(Cancer Research UK); European Union(European Commission); Prostate Cancer Foundation; European Research Council(European Research Council (ERC)European Commission); Breast Cancer Research Foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Servicio Santander Supercomputacion; 14M Genomics Ltd; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	E.B. is a Rosetrees Trust fellow; M.J.H. has a Cancer Research UK fellowship; N. Mu. received funding from the Rosetrees Trust; M. G. is funded by the UK Medical Research Council; I. V. is funded by Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal; R. C. R. and D. M. R. are partly funded by the Cambridge Biomedical Research Centre and Cancer Research UK Cancer Centre; P. V. L. is a postdoctoral researcher of the Research Foundation-Flanders (FWO); S.M.J. is a Wellcome Senior Fellow in Clinical Science; and C. S. is a senior Cancer Research UK clinical research fellow and is funded by Cancer Research UK, the Rosetrees Trust, European Union Framework Programme 7 (projects PREDICT and RESPONSIFY, ID: 259303), the Prostate Cancer Foundation, the European Research Council and the Breast Cancer Research Foundation. This research is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. We would like to thank Servicio Santander Supercomputacion for their support. P. C. is a paid consultant for and holds equity in 14M Genomics Ltd. The results published here are in part based upon data generated by the Cancer Genome Atlas pilot project established by the National Cancer Institute and National Human Genome Research Institute, NIH. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/. The data were retrieved through dbGaP authorization (accession no. phs000178.v5.p5). Sequence data have been deposited at the European Genome-Phenome Archive (EGA, www.ebi.ac.uk/ega/), which is hosted by the European Bionformatics Institute (EBI), under accession numbers EGAS00001000809, EGAS00001000888 and EGAS00001000889.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pfeifer GP, 2003, MUTAT RES-FUND MOL M, V526, P39, DOI 10.1016/S0027-5107(03)00013-7; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soria JC, 2013, EUR J CANCER, V49, pS798; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	35	733	758	4	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					251	256		10.1126/science.1253462	http://dx.doi.org/10.1126/science.1253462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301630	Green Accepted, Green Submitted			2022-12-28	WOS:000342721500052
J	Nakajima, M; Gorlich, A; Heintz, N				Nakajima, Miho; Goerlich, Andreas; Heintz, Nathaniel			Oxytocin Modulates Female Sociosexual Behavior through a Specific Class of Prefrontal Cortical Interneurons	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; GABAERGIC NEURONS; ESTROUS-CYCLE; GENE-EXPRESSION; DRIVER LINES; CELL-TYPES; VASOPRESSIN; INHIBITION; SYSTEM; NUCLEUS	Human imaging studies have revealed that intranasal administration of the "prosocial" hormone oxytocin (OT) activates the frontal cortex, and this action of OT correlates with enhanced brain function in autism. Here, we report the discovery of a population of somatostatin (Sst)-positive, regular spiking interneurons that express the oxytocin receptor (OxtrINs). Silencing of OxtrINs in the medial prefrontal cortex (mPFC) of female mice resulted in loss of social interest in male mice specifically during the sexually receptive phase of the estrous cycle. This sociosexual deficit was also present in mice in which the Oxtr gene was conditionally deleted from the mPFC and in control mice infused with an Oxtr antagonist. Our data demonstrate a gender-, cell type-, and state-specific role for OT/Oxtr signaling in the mPFC and identify a latent cortical circuit element that may modulate other complex social behaviors in response to OT.	[Nakajima, Miho; Goerlich, Andreas; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@rockefeller.edu	Nakajima, Miho/AAU-3731-2020; Core, Vector/CAF-4832-2022		Howard Hughes Medical Institute; NIH PHS [MH090963 P2]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute and NIH PHS MH090963 P2 (N.H. is an HHMI Investigator). We wish to thank Guojun Ma and Clint Earnheart for their contributions to the initial characterization of bacTRAP lines targeting cortical interneuron populations and the GENSAT Project for the Htr3a Cre mice used in this study. We would also like to thank Jie Xing, Paola Emhardt, and Beatriz Lopez for their skilled assistance, Soohyun Lee, Robin Tremblay, Eric Schmidt, Joseph Doughterty, Jodi Gresack, Hirofumi Nakayama, Awni Mousa and all other Heintz lab members for their excellent advice, and Wenxiang Zhang from the Rockefeller University Genomics Resource Center for help with the TRAP data production.	Anacker AMJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00185; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; CROWLEY WR, 1978, LIFE SCI, V23, P2579, DOI 10.1016/0024-3205(78)90373-9; deLecea L, 1997, J NEUROSCI, V17, P5868; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dumais KM, 2013, HORM BEHAV, V64, P693, DOI 10.1016/j.yhbeh.2013.08.012; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Gorski JA, 2002, J NEUROSCI, V22, P6309; Graustella AJ, 2012, HORM BEHAV, V61, P410, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; GREER ER, 1986, LIFE SCI, V38, P2311, DOI 10.1016/0024-3205(86)90638-7; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Knobloch HS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00031; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; Leng G, 2008, CURR OPIN PHARMACOL, V8, P731, DOI 10.1016/j.coph.2008.07.001; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; MacDonald E, 2011, PSYCHONEUROENDOCRINO, V36, P1114, DOI 10.1016/j.psyneuen.2011.02.015; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McCarthy MM, 1997, MOL MED TODAY, V3, P269, DOI 10.1016/S1357-4310(97)01058-7; Moscovice LR, 2012, HORM BEHAV, V62, P592, DOI 10.1016/j.yhbeh.2012.08.011; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Oblak AL, 2011, BRAIN RES, V1380, P218, DOI 10.1016/j.brainres.2010.09.021; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; PERLOW MJ, 1982, SCIENCE, V216, P1416, DOI 10.1126/science.7201163; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; RICHARD S, 1990, J BIOL CHEM, V265, P6098; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Scheele D, 2012, J NEUROSCI, V32, P16074, DOI 10.1523/JNEUROSCI.2755-12.2012; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Takahashi S, 2013, SCHIZOPHR RES, V146, P238, DOI 10.1016/j.schres.2013.02.033; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; VANTOL HHM, 1988, ENDOCRINOLOGY, V122, P945, DOI 10.1210/endo-122-3-945; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Watanabe T, 2014, JAMA PSYCHIAT, V71, P166, DOI 10.1001/jamapsychiatry.2013.3181; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	69	163	165	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					295	305		10.1016/j.cell.2014.09.020	http://dx.doi.org/10.1016/j.cell.2014.09.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303526	Green Accepted, Bronze			2022-12-28	WOS:000343095600012
J	Powell, J; O'Hara, J; Wilson, JA				Powell, Jason; O'Hara, James; Wilson, Janet A.			Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXTRA-ESOPHAGEAL REFLUX; GASTROESOPHAGEAL-REFLUX; LARYNGOPHARYNGEAL REFLUX; CHRONIC LARYNGITIS; DISEASE; METAANALYSIS; THERAPY; MANAGEMENT; EFFICACY; PEPSIN		[Powell, Jason] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [O'Hara, James] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Wilson, Janet A.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK	Powell, J (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jason.powell@doctors.org.uk		wilson, janet/0000-0002-6416-5870; O'Hara, James/0000-0002-4096-3296	National Institute for Health Research [12/01/04] Funding Source: researchfish; Department of Health [12/01/04] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Ah-See K, 2012, CLIN OTOLARYNGOL, V37, P9, DOI 10.1111/j.1749-4486.2012.02443.x; Bredenoord AJ, 2013, LANCET, V381, P1933, DOI 10.1016/S0140-6736(12)62171-0; Bulmer DM, 2010, LARYNGOSCOPE, V120, P777, DOI 10.1002/lary.20665; Chang AB, 2011, COCHRANE DB SYST REV, V1; Cremonini F, 2010, ALIMENT PHARM THER, V32, P29, DOI 10.1111/j.1365-2036.2010.04315.x; Ford CN, 2005, JAMA-J AM MED ASSOC, V294, P1534, DOI 10.1001/jama.294.12.1534; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Gatta L, 2007, ALIMENT PHARM THER, V25, P385, DOI 10.1111/j.1365-2036.2006.03213.x; Gibson PG, 2014, CURR OPIN ALLERGY CL, V14, P55, DOI 10.1097/ACI.0000000000000027; Gupta R, 2009, CURR OPIN OTOLARYNGO, V17, P143, DOI 10.1097/MOO.0b013e32832b2581; HANSON DG, 1995, ANN OTO RHINOL LARYN, V104, P550, DOI 10.1177/000348949510400709; Hopkins C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005054.pub2; Karkos PD, 2007, EUR ARCH OTO-RHINO-L, V264, P513, DOI 10.1007/s00405-006-0222-8; Karkos PD, 2006, LARYNGOSCOPE, V116, P144, DOI 10.1097/01.mlg.0000191463.67692.36; Khalil H S, 2003, Rev Laryngol Otol Rhinol (Bord), V124, P187; KIBBLEWHITE DJ, 1990, J OTOLARYNGOL, V19, P103; Koufman JA, 2011, ANN OTO RHINOL LARYN, V120, P281, DOI 10.1177/000348941112000501; Lowden M, 2009, LOGOP PHONIATR VOCO, V34, P32, DOI 10.1080/14015430902735847; MacKenzie K, 2001, BRIT MED J, V323, P658, DOI 10.1136/bmj.323.7314.658; Mazzini Gda S, 2012, INT J OTOLARYNGOL, V2012; McGlashan JA, 2009, EUR ARCH OTO-RHINO-L, V266, P243, DOI 10.1007/s00405-008-0708-7; Moore JM, 2010, CURR OPIN GASTROEN, V26, P389, DOI 10.1097/MOG.0b013e32833adc8d; National Institute for Health and Care Excellence, 2011, REF GUID SUSP CANC; Ndukwe N, 2012, INT J HEALTH CARE Q, V25, P75, DOI 10.1108/09526861211192421; Pearson JP, 2011, ALIMENT PHARM THER, V33, P2, DOI 10.1111/j.1365-2036.2011.04581.x; Powell J, 2013, LARYNGOSCOPE, V123, P985, DOI 10.1002/lary.23693; Qadeer MA, 2006, AM J GASTROENTEROL, V101, P2646, DOI 10.1111/j.1572-0241.2006.00844.x; Toohill RJ, 2005, ANN OTO RHINOL LARYN, V114, P177, DOI 10.1177/000348940511400302; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wilhelm SM, 2013, EXPERT REV CLIN PHAR, V6, P443, DOI 10.1586/17512433.2013.811206; Wood JM, 2011, J LARYNGOL OTOL, V125, P1218, DOI 10.1017/S0022215111002234; Yamamichi N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-45; Yuksel ES, 2012, LARYNGOSCOPE, V122, P1312, DOI 10.1002/lary.23252	33	7	8	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2014	349								g5813	10.1136/bmj.g5813	http://dx.doi.org/10.1136/bmj.g5813			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LK	25300569				2022-12-28	WOS:000342998200010
J	Ruan, HB; Dietrich, MO; Liu, ZW; Zimmer, MR; Li, MD; Singh, JP; Zhang, KS; Yin, RN; Wu, J; Horvath, TL; Yang, XY				Ruan, Hai-Bin; Dietrich, Marcelo O.; Liu, Zhong-Wu; Zimmer, Marcelo R.; Li, Min-Dian; Singh, Jay Prakash; Zhang, Kaisi; Yin, Ruonan; Wu, Jing; Horvath, Tamas L.; Yang, Xiaoyong			O-GlcNAc Transferase Enables AgRP Neurons to Suppress Browning of White Fat	CELL			English	Article							AGOUTI-RELATED PROTEIN; NPY/AGRP NEURONS; MELANOCORTIN SYSTEM; N-ACETYLGLUCOSAMINE; ENERGY HOMEOSTASIS; GENETIC-CONTROL; NEUROPEPTIDE-Y; MESSENGER-RNA; ADIPOSE ORGAN; GLUCOSE	Induction of beige cells causes the browning of white fat and improves energy metabolism. However, the central mechanism that controls adipose tissue browning and its physiological relevance are largely unknown. Here, we demonstrate that fasting and chemical-genetic activation of orexigenic AgRP neurons in the hypothalamus suppress the browning of white fat. O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of cytoplasmic and nuclear proteins regulates fundamental cellular processes. The levels of O-GlcNAc transferase (OGT) and O-GlcNAc modification are enriched in AgRP neurons and are elevated by fasting. Genetic ablation of OGT in AgRP neurons inhibits neuronal excitability through the voltage-dependent potassium channel, promotes white adipose tissue browning, and protects mice against diet-induced obesity and insulin resistance. These data reveal adipose tissue browning as a highly dynamic physiological process under central control, in which O-GlcNAc signaling in AgRP neurons is essential for suppressing thermogenesis to conserve energy in response to fasting.	[Ruan, Hai-Bin; Dietrich, Marcelo O.; Liu, Zhong-Wu; Zimmer, Marcelo R.; Li, Min-Dian; Singh, Jay Prakash; Zhang, Kaisi; Yin, Ruonan; Wu, Jing; Horvath, Tamas L.; Yang, Xiaoyong] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Ruan, Hai-Bin; Dietrich, Marcelo O.; Liu, Zhong-Wu; Zimmer, Marcelo R.; Li, Min-Dian; Singh, Jay Prakash; Zhang, Kaisi; Yin, Ruonan; Wu, Jing; Horvath, Tamas L.; Yang, Xiaoyong] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Li, Min-Dian; Zhang, Kaisi; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Zimmer, Marcelo R.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-93042 Porto Alegre, RS, Brazil	Yale University; Yale University; Yale University; Yale University; Yale University; Universidade Federal do Rio Grande do Sul	Horvath, TL (corresponding author), Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu; xiaoyong.yang@yale.edu	Ruan, Hai-Bin/AAN-7777-2021; Zimmer, Marcelo Rigon/ABB-7993-2020; Li, Min-Dian/F-1721-2015; Dietrich, Marcelo/A-9928-2009; Ruan, Hai-Bin/G-9907-2012	Ruan, Hai-Bin/0000-0002-3858-1272; Zimmer, Marcelo Rigon/0000-0001-9628-8915; Li, Min-Dian/0000-0002-3650-1507; Dietrich, Marcelo/0000-0001-9781-2221; Ruan, Hai-Bin/0000-0002-3858-1272	NIH [R01 DK089098, DP1 DK098058]; American Diabetes Association; Ellison Medical Foundation; American Heart Association Scientist Development Grant; ADA Mentor-Based Fellowship; CNPq/Brazil	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association Scientist Development Grant(American Heart Association); ADA Mentor-Based Fellowship; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank Dr. Steven Jones from University of Louisville for providing Ogt-flox mice and Dr. Alison Xu from University of California at San Francisco for donating AgRP-Cre mice. This work was supported by NIH R01 DK089098, American Diabetes Association, and Ellison Medical Foundation to X.Y., American Heart Association Scientist Development Grant to H.-B.R., NIH DP1 DK098058 and ADA Mentor-Based Fellowship to T.L.H., and CNPq/Brazil to M.O.D. and M.R.Z.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; APFELBAUM M, 1971, AM J CLIN NUTR, V24, P1405; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Kajimura S., 2013, ANN REV PHYSL; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Nogueiras R, 2008, REGUL PEPTIDES, V149, P26, DOI 10.1016/j.regpep.2007.09.034; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; SHIBATA H, 1987, J APPL PHYSIOL, V63, P465, DOI 10.1152/jappl.1987.63.2.465; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; WELLE S, 1983, J CLIN INVEST, V71, P916, DOI 10.1172/JCI110846; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Wiedmer P, 2011, PHYSIOL BEHAV, V105, P43, DOI 10.1016/j.physbeh.2011.03.027; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WU J, 2013, CELL, V27, P234; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yasuda T, 2004, EXP BIOL MED, V229, P235, DOI 10.1177/153537020422900303	66	178	178	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					306	317		10.1016/j.cell.2014.09.010	http://dx.doi.org/10.1016/j.cell.2014.09.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303527	Green Accepted, Bronze			2022-12-28	WOS:000343095600013
J	Hantel, A; Olopade, CO				Hantel, Andrew; Olopade, Christopher Olusola			Drug and Vaccine Access in the Ebola Epidemic: Advising Caution in Compassionate Usec	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFORMED-CONSENT		[Hantel, Andrew; Olopade, Christopher Olusola] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Hantel, A (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 7082, Chicago, IL 60637 USA.		Hantel, Andrew/AAV-5385-2021	Hantel, Andrew/0000-0001-9612-3643				Adebamowo C., 2014, STATEMENT USE INNOVA; Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474; Dennis B., 2014, WASHINGTON POST; Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674; Gallagher J, 2014, BBC NEWS; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; U.S. Department of Health and Human Services, 2013, GUID IND EXP ACC INV; WHO, 2014, ETH CONS US UNR INT; WHO, 2014, EB SIT LIB NONC INT	9	11	11	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					141	+		10.7326/M14-2002	http://dx.doi.org/10.7326/M14-2002			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25322080				2022-12-28	WOS:000350106600020
J	Kanapathipillai, R; Restrepo, AMH; Fast, P; Wood, D; Dye, C; Kieny, MP; Moorthy, V				Kanapathipillai, Rupa; Restrepo, Ana Maria Henao; Fast, Patricia; Wood, David; Dye, Christopher; Kieny, Marie-Paule; Moorthy, Vasee			Ebola Vaccine - An Urgent International Priority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Restrepo, Ana Maria Henao; Fast, Patricia; Wood, David; Dye, Christopher; Kieny, Marie-Paule; Moorthy, Vasee] WHO, Geneva, Switzerland	World Health Organization			Dye, Christopher/AIC-4659-2022; Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; Dye, Christopher/0000-0002-2957-1793; Moorthy, Vasee/0000-0002-6535-2854	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2014, EXPT EB VACC WHO CON; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Stanley D.A., 2014, NAT MED	3	72	77	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2249	2251		10.1056/NEJMp1412166	http://dx.doi.org/10.1056/NEJMp1412166			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25289888				2022-12-28	WOS:000346048800004
J	Lindenberger, U				Lindenberger, Ulman			Human cognitive aging: Corriger la fortune?	SCIENCE			English	Review							ADULT AGE-DIFFERENCES; LIFE-SPAN; WORKING-MEMORY; HEALTHY-ADULTS; VASCULAR RISK; GENETIC CONTRIBUTIONS; EPISODIC MEMORY; BRAIN; INTELLIGENCE; PLASTICITY	Human cognitive aging differs between and is malleable within individuals. In the absence of a strong genetic program, it is open to a host of hazards, such as vascular conditions, metabolic syndrome, and chronic stress, but also open to protective and enhancing factors, such as experience-dependent cognitive plasticity. Longitudinal studies suggest that leading an intellectually challenging, physically active, and socially engaged life may mitigate losses and consolidate gains. Interventions help to identify contexts and mechanisms of successful cognitive aging and give science and society a hint about what would be possible if conditions were different.	[Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Lindenberger, Ulman] Max Planck Univ Coll London Ctr Computat Psychiat, London WC1B 5EH, England	Max Planck Society	Lindenberger, U (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Lentzeallee 94, D-14195 Berlin, Germany.	seklindenberger@mpib-berlin.mpg.de			German Research Foundation (DFG); Federal Ministry of Education and Research	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	U.L. thanks R. Dolan, M. Lovden, N. Raz, and F. Schmiedek for providing valuable comments on an earlier version of this article, and the Max Planck Society for continued research support. Parts of the research described in this article were financed by a Gottfried Wilhelm Leibniz Award 2010 of the German Research Foundation (DFG) to U.L. and a grant from the Federal Ministry of Education and Research ("The Berlin Aging Study II").	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; BACKMAN L, 1992, PSYCHOL BULL, V112, P259, DOI 10.1037/0033-2909.112.2.259; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Baltes P. B., 2006, HDB CHILD PSYCHOL, V1, P569, DOI [10.1002/9780470147658.chpsy0111, DOI 10.1002/9780470147658.CHPSY0111]; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Bosman E. A., 1996, PERSPECTIVES COGNITI, P428; Brose A, 2012, EMOTION, V12, P605, DOI 10.1037/a0024436; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Burzynska AZ, 2013, J NEUROSCI, V 33, P17150, DOI 10.1523/JNEUROSCI.1426-13.2013; Cabeza R., 2012, PRINCIPLES FRONTAL L, P628, DOI [DOI 10.1093/ACPROF:OSO/9780195134971.001.0001, 10.1093/med/9780199837755.001.0001]; Carstensen L.L., 2006, HDB PSYCHOL AGING, P343, DOI DOI 10.1016/B978-012101264-9/50018-5; Chowdhury R, 2013, NAT NEUROSCI, V16, P648, DOI 10.1038/nn.3364; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Colzato LS, 2013, NEUROPSYCHOLOGIA, V51, P1377, DOI 10.1016/j.neuropsychologia.2013.01.014; Corley J, 2012, J PSYCHOSOM RES, V73, P132, DOI 10.1016/j.jpsychores.2012.03.006; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; de Frias CM, 2007, INTELLIGENCE, V35, P381, DOI 10.1016/j.intell.2006.07.011; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Duzel E, 2011, HIPPOCAMPUS, V21, P803, DOI 10.1002/hipo.20834; Duncan J, 2013, PRINCIPLES FRONTAL L, P292; Duverne S, 2009, CEREB CORTEX, V19, P733, DOI 10.1093/cercor/bhn122; Edelman G. M., 1987, THEORY NEURONAL GROU; Falkstedt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082031; Fandakova Y, 2014, CEREB CORTEX, V24, P1832, DOI 10.1093/cercor/bht034; FINKEL D, 1995, PSYCHOL AGING, V10, P437, DOI 10.1037/0882-7974.10.3.437; Freund AM, 2000, CONTROL OF HUMAN BEHAVIOR, MENTAL PROCESSES, AND CONSCIOUSNESS, P35; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Gazzaley A., 2013, PRINCIPLES FRONTAL L, P593; Geryain J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00102; Ghisletta P, 2012, INTELLIGENCE, V40, P260, DOI 10.1016/j.intell.2012.02.008; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Haberman RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083674; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hernandez MDV, 2013, NEUROBIOL AGING, V34, P2740, DOI 10.1016/j.neurobiolaging.2013.05.032; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hofer SM, 2006, MULTIVAR BEHAV RES, V41, P165, DOI 10.1207/s15327906mbr4102_4; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; LAUTREY J, 2003, MODELS INTELLIGENCE, P117; LAVOIE D, 1994, PSYCHOL AGING, V9, P539, DOI 10.1037/0882-7974.9.4.539; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Li SC, 2010, J COGNITIVE NEUROSCI, V22, P2164, DOI 10.1162/jocn.2009.21374; Lindenberger U, 2002, J GERONTOL B-PSYCHOL, V57, pP474, DOI 10.1093/geronb/57.6.P474; Lindenberger U., 2013, PRINCIPLES FRONTAL L, P609, DOI DOI 10.1093/MED/9780199837755.003.0043; Lindenberger U., 2001, INT ENCYCLOP SOC BEH, P8848, DOI [DOI 10.1016/B0-08-043076-7/01572-2, 10.1016/b0-08-043076-7/01572-2]; LINDENBERGER U, 2014, SCI ENG ETHICS, V18, P7, DOI DOI 10.1016/J.TICS.2013.10.006; Lindenberger U, 2008, GERONTOLOGY, V54, P59, DOI 10.1159/000116114; Lindenberger U, 2011, PSYCHOL AGING, V26, P34, DOI 10.1037/a0020525; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Lovden M, 2012, NEUROBIOL AGING, V33; Marioni RE, 2014, INTELLIGENCE, V44, P26, DOI 10.1016/j.intell.2014.02.006; McArdle JJ, 2008, PSYCHOL AGING, V23, P702, DOI 10.1037/a0014349; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; MOLENAAR PCM, 1993, BEHAV GENET, V23, P519, DOI 10.1007/BF01068142; Moran RJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003422; Morrison JH, 2014, JAMA PSYCHIAT, V71, P835, DOI 10.1001/jamapsychiatry.2014.380; Mottus R, 2013, J PSYCHOSOM RES, V75, P275, DOI 10.1016/j.jpsychores.2013.06.032; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; NESSELROADE JR, 1991, VISIONS OF AESTHETICS, THE ENVIRONMENT & DEVELOPMENT : THE LEGACY OF JOACHIM F WOHLWILL, P213; Nevalainen N, 2015, BRAIN RES, V1612, P83, DOI 10.1016/j.brainres.2014.09.010; Noack H, 2014, PSYCHOL RES-PSYCH FO, V78, P773, DOI 10.1007/s00426-014-0564-6; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Papenberg G, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.11.014; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park J, 2010, J NEUROSCI, V30, P9253, DOI 10.1523/JNEUROSCI.0853-10.2010; Persson J, 2012, CEREB CORTEX, V22, P2297, DOI 10.1093/cercor/bhr306; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N, 2008, CEREB CORTEX, V18, P718, DOI 10.1093/cercor/bhm108; Raz N, 2007, NEUROPSYCHOLOGY, V21, P676, DOI 10.1037/0894-4105.21.6.676; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Raz N, 2013, BRAIN COGNITION, V82, P171, DOI 10.1016/j.bandc.2013.04.002; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Raz N, 2011, PSYCHOL BULL, V137, P790, DOI 10.1037/a0024503; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Salthouse TA, 1985, THEORY COGNITIVE AGI; Sander MC, 2012, NEUROSCI BIOBEHAV R, V36, P2007, DOI 10.1016/j.neubiorev.2012.06.004; Schaie K. W., 1996, INTELLECTUAL DEV ADU; Schmiedek F, 2014, DEV PSYCHOL, V50, P2304, DOI 10.1037/a0037388; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Shing YL, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00002; Shing YL, 2010, NEUROSCI BIOBEHAV R, V34, P1080, DOI 10.1016/j.neubiorev.2009.11.002; Small B. J., 2011, J GERONTOL B S1, V66B, pi153; Spieler DH, 2006, PSYCHON B REV, V13, P787, DOI 10.3758/BF03193998; Stephan KE, 2014, CURR OPIN NEUROBIOL, V25, P85, DOI 10.1016/j.conb.2013.12.007; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Tan ZS, 2011, DIABETES CARE, V34, P1766, DOI 10.2337/dc11-0308; Touron DR, 2007, J GERONTOL B-PSYCHOL, V62, pP149, DOI 10.1093/geronb/62.3.P149; Tucker-Drob EM, 2011, DEV PSYCHOL, V47, P331, DOI 10.1037/a0021361; Turkheimer E, 2011, RES HUM DEV, V8, P227, DOI 10.1080/15427609.2011.625321; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Voelkle MC, 2014, MULTIVAR BEHAV RES, V49, P193, DOI 10.1080/00273171.2014.889593; Walhovd KB, 2014, NEUROBIOL AGING, V35, P1055, DOI 10.1016/j.neurobiolaging.2013.11.011; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Wenger E, 2012, NEUROIMAGE, V59, P3389, DOI 10.1016/j.neuroimage.2011.11.015; Werkle-Bergner M, 2012, NEUROIMAGE, V60, P71, DOI 10.1016/j.neuroimage.2011.11.071; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31	120	209	215	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		572	578		10.1126/science.1254403	http://dx.doi.org/10.1126/science.1254403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359964	Green Published			2022-12-28	WOS:000343799700035
J	Binzel, RP				Binzel, Richard P.			Find asteroids to get to Mars	NATURE			English	Editorial Material																			0	8	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					559	560		10.1038/514559a	http://dx.doi.org/10.1038/514559a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355345	Bronze			2022-12-28	WOS:000343801500023
J	Greenfield, G				Greenfield, Geva			PERSONAL VIEW GPs should be rewarded for patient experience to encourage a person centred NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; UK; MANAGEMENT; CONTRACT; OUTCOMES; QUALITY; WOMEN		Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London W6 8RP, England	Imperial College London	Greenfield, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London W6 8RP, England.							Aarts JWM, 2012, HUM REPROD, V27, P488, DOI 10.1093/humrep/der386; Campbell J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-57; Coulter A, 2002, BMJ-BRIT MED J, V324, P648, DOI 10.1136/bmj.324.7338.648; Department of Health, 2012, LIB NHS NO DEC ME ME; Dusheiko M, 2011, HEALTH SERV RES, V46, P27, DOI 10.1111/j.1475-6773.2010.01184.x; Hudon C, 2011, ANN FAM MED, V9, P155, DOI 10.1370/afm.1226; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; McGovern MP, 2008, DIABETIC MED, V25, P1083, DOI 10.1111/j.1464-5491.2008.02544.x; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; Richards N, 2007, IS NHS BECOMING MORE; Stewart M, 2000, J FAM PRACTICE, V49, P796; WHO, 2002, INNOVATIVE CARE CHRO	12	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2014	349								g6422	10.1136/bmj.g6422	http://dx.doi.org/10.1136/bmj.g6422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3CT	25348331	Green Published			2022-12-28	WOS:000344154600008
J	Robinson, JC; Miller, K				Robinson, James C.; Miller, Kelly			Total Expenditures per Patient in Hospital-Owned and Physician-Owned Physician Organizations in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VERTICAL INTEGRATION	IMPORTANCE Hospitals are rapidly acquiring medical groups and physician practices. This consolidation may foster cooperation and thereby reduce expenditures, but also may lead to higher expenditures through greater use of hospital-based ambulatory services and through greater hospital pricing leverage against health insurers. OBJECTIVE To determine whether total expenditures per patient were higher in physician organizations (integrated medical groups and independent practice associations) owned by local hospitals or multihospital systems compared with groups owned by participating physicians. DESIGN AND SETTING Data were obtained on total expenditures for the care provided to 4.5 million patients treated by integrated medical groups and independent practice associations in California between 2009 and 2012. The patients were covered by commercial health maintenance organization (HMO) insurance and the data did not include patients covered by commercial preferred provider organization (PPO) insurance, Medicare, or Medicaid. MAIN OUTCOMES AND MEASURES Total expenditures per patient annually, measured in terms of what insurers paid to the physician organizations for professional services, to hospitals for inpatient and outpatient procedures, to clinical laboratories for diagnostic tests, and to pharmaceutical manufacturers for drugs and biologics. EXPOSURES Annual expenditures per patient were compared after adjusting for patient illness burden, geographic input costs, and organizational characteristics. RESULTS Of the 158 organizations, 118 physician organizations (75%) were physician-owned and provided care for 3 065 551 patients, 19 organizations (12%) were owned by local hospitals and provided care for 728 608 patients, and 21 organizations (13%) were owned by multihospital systems and provided care for 693 254 patients. In 2012, physician-owned physician organizations had mean expenditures of $3066 per patient (95% CI, $2892 to $3240), hospital-owned physician organizations had mean expenditures of $4312 per patient (95% CI, $3768 to $4857), and physician organizations owned by multihospital systems had mean expenditures of $4776 (95% CI, $4349 to $5202) per patient. After adjusting for patient severity and other factors over the period, local hospital-owned physician organizations incurred expenditures per patient 10.3%(95% CI, 1.7% to 19.7%) higher than did physician-owned organizations (adjusted difference, $435 [95% CI, $105 to $766], P = .02). Organizations owned by multihospital systems incurred expenditures 19.8%(95% CI, 13.9% to 26.0%) higher (adjusted difference, $704 [95% CI,$512 to $895], P < .001) than physician-owned organizations. The largest physician organizations incurred expenditures per patient 9.2%(95% CI, 3.8% to 15.0%, P = .001) higher than the smallest organizations (adjusted difference, $130 [95% CI, $-32 to $292]). CONCLUSIONS AND RELEVANCE From the perspective of the insurers and patients, between 2009 and 2012, hospital-owned physician organizations in California incurred higher expenditures for commercial HMO enrollees for professional, hospital, laboratory, pharmaceutical, and ancillary services than physician-owned organizations. Although organizational consolidation may increase some forms of care coordination, it may be associated with higher total expenditures. Copyright 2014 American Medical Association. All rights reserved.	[Robinson, James C.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Miller, Kelly] Integrated Healthcare Assoc, Oakland, CA USA	University of California System; University of California Berkeley	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 50 Univ Hall, Berkeley, CA 94720 USA.	james.robinson@berkeley.edu		Robinson, James/0000-0003-0056-3017	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Support for this research was obtained from the Robert Wood Johnson Foundation.	Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Berenson RA, 2010, HEALTH AFFAIR, V29, P699, DOI 10.1377/hlthaff.2009.0715; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Burns LR, 2013, ADV HEALTH CARE MANA, V15, P39, DOI 10.1108/S1474-8231(2013)0000015009; Centers for Medicare & Medicaid Services, MED AC INP PPS WAG I; Centers for Medicare & Medicaid Services, SHAR SAV PROGR FREQ; Correia EW, 2011, AM J MANAG CARE, V17, P560; Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Gaynor M, 2012, HBK ECON, P499, DOI 10.1016/B978-0-444-53592-4.00009-8; Integrated Healthcare Association, PAY FOR PERF FACT SH; Medicare Payment Advisory Commission, PAYM BAS HOSP AC INP; Porter E, HLTH LAW GOALS FACE; Robinson JC, 2009, HEALTH AFFAIR, V28, P1438, DOI 10.1377/hlthaff.28.5.1438; Town R, IMPACT HOSP CONSOLID; Vogt W.B., 2006, 9 RW JOHNS FDN; Yegian J, VALUE BASED PAY FOR	17	63	63	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1663	1669		10.1001/jama.2014.14072	http://dx.doi.org/10.1001/jama.2014.14072			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335148	Green Published			2022-12-28	WOS:000343301400023
J	Bradley, P; Beasley, N; Au-Yong, I				Bradley, Paula; Beasley, Nigel; Au-Yong, Iain			RATIONAL IMAGING Imaging of neck lumps	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; ORAL-CAVITY; HEAD; CANCER; MRI; CT; METAANALYSIS		[Bradley, Paula] Northern Deanery, Newcastle Upon Tyne, Tyne & Wear, England; [Beasley, Nigel] Queens Med Ctr, Nottingham NG7 2UH, England; [Au-Yong, Iain] Kings Mill Hosp, Sutton NG17 4JL, Surrey, England	University of Nottingham	Au-Yong, I (corresponding author), Kings Mill Hosp, Sutton NG17 4JL, Surrey, England.	iauyong@doctors.org.uk	Bradley, Paula T/W-4630-2019	Bradley, Paula T/0000-0002-1908-1053				[Anonymous], EV BAS IND US PET CT; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; Becker M, 2008, EUR J RADIOL, V66, P460, DOI 10.1016/j.ejrad.2008.03.027; CAMPBELL RSD, 1995, CLIN RADIOL, V50, P533, DOI 10.1016/S0009-9260(05)83187-3; de Bondt RBJ, 2007, EUR J RADIOL, V64, P266, DOI 10.1016/j.ejrad.2007.02.037; Lee YYP, 2008, EUR J RADIOL, V66, P419, DOI 10.1016/j.ejrad.2008.01.027; Leslie A, 1999, J COMPUT ASSIST TOMO, V23, P43, DOI 10.1097/00004728-199901000-00010; Mehanna H, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4684; Mehanna H, 2010, BMJ-BRIT MED J, V341, pc4690; National Institute of Health and Care Excellence, 2005, REF GUID SUSP CANC; Public Health England, 2011, DOS COMP ION RAD; Roland NJ, 2011, HEAD NECK CANC MULTI; Ryan WR, 2005, LARYNGOSCOPE, V115, P645, DOI 10.1097/01.mlg.0000161345.23128.d4; Sievers KW, 2000, EUR J RADIOL, V33, P185, DOI 10.1016/S0720-048X(99)00142-4; Wu LM, 2012, ACAD RADIOL, V19, P331, DOI 10.1016/j.acra.2011.10.027; Wu MX, 2011, DIAGN CYTOPATHOL, V39, P743, DOI 10.1002/dc.21460	16	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2014	349								g6136	10.1136/bmj.g6136	http://dx.doi.org/10.1136/bmj.g6136			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OD	25336332				2022-12-28	WOS:000343768200003
J	Hansteen, V; De Pontieu, B; Carlsson, M; Lemen, J; Title, A; Boerner, P; Hurlburt, N; Tarbell, TD; Wuelser, JP; Pereira, TMD; De Luca, EE; Golub, L; McKillop, S; Reeves, K; Saar, S; Testa, P; Tian, H; Kankelborg, C; Jaeggli, S; Kleint, L; Martinez-Sykora, J				Hansteen, V.; De Pontieu, B.; Carlsson, M.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Pereira, T. M. D.; De Luca, E. E.; Golub, L.; McKillop, S.; Reeves, K.; Saar, S.; Testa, P.; Tian, H.; Kankelborg, C.; Jaeggli, S.; Kleint, L.; Martinez-Sykora, J.			The unresolved fine structure resolved: IRIS observations of the solar transition region	SCIENCE			English	Article							TEMPERATURE REGION; UPPER-ATMOSPHERE; LOOPS; CORONA; INTERNETWORK; INTERFACE; DYNAMICS; NETWORK; FLUX	The heating of the outer solar atmospheric layers, i.e., the transition region and corona, to high temperatures is a long-standing problem in solar (and stellar) physics. Solutions have been hampered by an incomplete understanding of the magnetically controlled structure of these regions. The high spatial and temporal resolution observations with the Interface Region Imaging Spectrograph (IRIS) at the solar limb reveal a plethora of short, low-lying loops or loop segments at transition-region temperatures that vary rapidly, on the time scales of minutes. We argue that the existence of these loops solves a long-standing observational mystery. At the same time, based on comparison with numerical models, this detection sheds light on a critical piece of the coronal heating puzzle.	[Hansteen, V.; De Pontieu, B.; Carlsson, M.; Pereira, T. M. D.] Univ Oslo, Inst Theoret Astrophys, NO-0315 Oslo, Norway; [De Pontieu, B.; Lemen, J.; Title, A.; Boerner, P.; Hurlburt, N.; Tarbell, T. D.; Wuelser, J. P.; Kleint, L.; Martinez-Sykora, J.] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [De Luca, E. E.; Golub, L.; McKillop, S.; Reeves, K.; Saar, S.; Testa, P.; Tian, H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kankelborg, C.; Jaeggli, S.] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA; [Kleint, L.; Martinez-Sykora, J.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA	University of Oslo; Lockheed Martin; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Montana State University System; Montana State University Bozeman	Hansteen, V (corresponding author), Univ Oslo, Inst Theoret Astrophys, POB 1029, NO-0315 Oslo, Norway.	viggoh@astro.uio.no	Reeves, Katharine/P-9163-2014; Pereira, Tiago/G-4079-2014	Pereira, Tiago/0000-0003-4747-4329; Golub, Leon/0000-0001-9638-3082; Reeves, Katharine/0000-0002-6903-6832; Tian, Hui/0000-0002-1369-1758	Norwegian Space Center (NSC, Norway) through European Space Agency PRODEX; Research Council of Norway; NASA [NNG09FA40C]; Lockheed Martin Independent Research Program; European Research Council [291058]; LMSAL [8100002705]	Norwegian Space Center (NSC, Norway) through European Space Agency PRODEX; Research Council of Norway(Research Council of Norway); NASA(National Aeronautics & Space Administration (NASA)); Lockheed Martin Independent Research Program; European Research Council(European Research Council (ERC)European Commission); LMSAL	IRIS is a NASA Small Explorer mission developed and operated by the Lockheed Martin Solar and Astrophysics Laboratory (LMSAL), with mission operations executed at NASA Ames Research Center and major contributions to downlink communications funded by the Norwegian Space Center (NSC, Norway) through a European Space Agency PRODEX contract. This research was supported by the Research Council of Norway through the grant "Solar Atmospheric Modelling" and through grants of computing time from the Programme for Supercomputing. This work is supported by NASA contract NNG09FA40C (IRIS), the Lockheed Martin Independent Research Program, and European Research Council grant agreement no. 291058. Authors from the Smithsonian Astrophysical Observatory are supported by LMSAL contract 8100002705. The data presented in this paper may be found on the Hinode Science Data Centre Europe (www.sdc.uio.no).	Almeida JS, 2007, ASTRON ASTROPHYS, V475, P1101, DOI 10.1051/0004-6361:20078124; ANTIOCHOS SK, 1986, ASTROPHYS J, V301, P440, DOI 10.1086/163912; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; DOWDY JF, 1986, SOL PHYS, V105, P35, DOI 10.1007/BF00156374; DOWDY JF, 1993, ASTROPHYS J, V411, P406, DOI 10.1086/172842; Feldman U, 1999, ASTROPHYS J, V522, P1133, DOI 10.1086/307682; FELDMAN U, 1987, ASTROPHYS J, V320, P426, DOI 10.1086/165556; FELDMAN U, 1983, ASTROPHYS J, V275, P367, DOI 10.1086/161539; Feldman U, 2001, ASTROPHYS J, V558, P423, DOI 10.1086/322471; Gonzalez MJM, 2007, ASTRON ASTROPHYS, V469, pL39, DOI 10.1051/0004-6361:20077505; Guerreiro N, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/47; Hansteen VH, 2010, ASTROPHYS J, V718, P1070, DOI 10.1088/0004-637X/718/2/1070; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; KLIMCHUK JA, 1987, ASTROPHYS J, V320, P409, DOI 10.1086/165554; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Lites BW, 2008, ASTROPHYS J, V672, P1237, DOI 10.1086/522922; Mariska J. T., 1992, CAMBRIDGE ASTROPHYSI; Martinez-Sykora J, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/23; Martinez-Sykora J, 2009, ASTROPHYS J, V702, P129, DOI 10.1088/0004-637X/702/1/129; Oluseyi HM, 2007, SOL PHYS, V245, P69, DOI 10.1007/s11207-007-9023-5; Patsourakos S, 2007, ASTROPHYS J, V664, P1214, DOI 10.1086/518645; Schrijver CJ, 2003, ASTROPHYS J, V597, pL165, DOI 10.1086/379870; Spadaro D, 2006, ASTROPHYS J, V642, P579, DOI 10.1086/500963; Warren HP, 2000, ASTROPHYS J, V535, pL63, DOI 10.1086/312690; Wikstol O, 1998, ASTROPHYS J, V501, P895, DOI 10.1086/305854	25	70	72	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207							1255757	10.1126/science.1255757	http://dx.doi.org/10.1126/science.1255757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324399	Green Published, Green Submitted			2022-12-28	WOS:000343041100034
J	McKenzie, IA; Ohayon, D; Li, HL; de Faria, JP; Emery, B; Tohyama, K; Richardson, WD				McKenzie, Ian A.; Ohayon, David; Li, Huiliang; de Faria, Joana Paes; Emery, Ben; Tohyama, Koujiro; Richardson, William D.			Motor skill learning requires active central myelination	SCIENCE			English	Article							GENE REGULATORY FACTOR; CELLS; PROGENITORS; PROLIFERATION; NEURONS	Myelin-forming oligodendrocytes (OLs) are formed continuously in the healthy adult brain. In this work, we study the function of these late-forming cells and the myelin they produce. Learning a new motor skill (such as juggling) alters the structure of the brain's white matter, which contains many OLs, suggesting that late-born OLs might contribute to motor learning. Consistent with this idea, we show that production of newly formed OLs is briefly accelerated in mice that learn a new skill (running on a "complex wheel" with irregularly spaced rungs). By genetically manipulating the transcription factor myelin regulatory factor in OL precursors, we blocked production of new OLs during adulthood without affecting preexisting OLs or myelin. This prevented the mice from mastering the complex wheel. Thus, generation of new OLs and myelin is important for learning motor skills.	[McKenzie, Ian A.; Ohayon, David; Li, Huiliang; de Faria, Joana Paes; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Emery, Ben] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Emery, Ben] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Tohyama, Koujiro] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Morioka, Iwate 0208505, Japan	University of London; University College London; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Iwate Medical University	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk	de Faria, Joana Paes/M-8815-2014; Richardson FMedSci FRS, William D/C-1762-2008	de Faria, Joana Paes/0000-0001-7046-6197; OHAYON, David/0000-0003-3545-3774; Richardson FMedSci FRS, William D/0000-0001-7261-2485	European Research Council [293544]; UK Medical Research Council; Wellcome Trust; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for Promotion of Science; Royal Society USA/Canada Exchange Fellowship; Portuguese Fundacao para a Ciencia e a Tecnologia; Australian National Health and Medical Research Council; BBSRC [BB/L003236/1] Funding Source: UKRI; MRC [G0800575] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L003236/1] Funding Source: researchfish; Medical Research Council [G0800575] Funding Source: researchfish; Wellcome Trust [100269/Z/12/Z] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Society USA/Canada Exchange Fellowship; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the staff of the Center for Electron, Microscopy and Bio-Imaging Research, Iwate Medical University, and U. Dennehy and M. Grist (University College London) for technical help and our colleagues in the Wolfson Institute for Biomedical Research for encouragement and suggestions. W.D.R. thanks T. Richardson for stimulating discussions. The study was supported by the European Research Council (grant agreement 293544), the UK Medical Research Council, the Wellcome Trust, and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. W.D.R. and K.T. acknowledge an Invitation Fellowship from the Japan Society for Promotion of Science. I.M. was supported by a Royal Society USA/Canada Exchange Fellowship, J.P.d.F. by a fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia, and B.E. by a Career Development Fellowship from the Australian National Health and Medical Research Council. Pdgfra-CreER<SUP>T2</SUP> and Sox10-CreER<SUP>T2</SUP> mice can be obtained by request through www.e-lucid.com/ with a material transfer agreement. Myrf(flox) mice can be obtained from Jackson Laboratories, strain 010607. The supplementary materials include additional data.	Bakiri Y, 2009, NEUROSCIENCE, V158, P266, DOI 10.1016/j.neuroscience.2008.01.015; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fields RD, 2011, SEMIN CELL DEV BIOL, V22, P214, DOI 10.1016/j.semcdb.2011.02.009; Gallo V, 2008, J PHYSIOL-LONDON, V586, P3767, DOI 10.1113/jphysiol.2008.158436; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hibbits N, 2009, ASN NEURO, V1, DOI 10.1042/AN20090032; HILDEBRAND M, 1989, BIOSCIENCE, V39, P766, DOI 10.2307/1311182; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Liebetanz D, 2007, EXP NEUROL, V205, P207, DOI 10.1016/j.expneurol.2007.01.030; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Maldonado PP, 2011, J ANAT, V219, P8, DOI 10.1111/j.1469-7580.2011.01350.x; Mangin JM, 2012, NAT NEUROSCI, V15, P1192, DOI 10.1038/nn.3190; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schalomon PM, 2002, BRAIN RES BULL, V57, P27, DOI 10.1016/S0361-9230(01)00633-5; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	34	635	643	7	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					318	322		10.1126/science.1254960	http://dx.doi.org/10.1126/science.1254960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324381	Green Accepted			2022-12-28	WOS:000343041100035
J	Zhang, J				Zhang, Jie			Chinese university reform in three steps	NATURE			English	Editorial Material									[Zhang, Jie] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Zhang, Jie] Chinese Acad Sci, Beijing 100864, Peoples R China; [Zhang, Jie] US Natl Acad Sci, Washington, DC USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; National Academies of Sciences, Engineering & Medicine	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China.	jzhang1@sjtu.edu.cn	Zhang, Jie/O-8767-2014						0	13	13	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					295	296		10.1038/514295a	http://dx.doi.org/10.1038/514295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ7JH	25318507	Bronze			2022-12-28	WOS:000342988600026
J	Blumberg, HM; Kempker, RR				Blumberg, Henry M.; Kempker, Russell R.			Interferon-gamma Release Assays for the Evaluation of Tuberculosis Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIAGNOSIS		[Blumberg, Henry M.; Kempker, Russell R.] Emory Univ, Div Infect Dis, Sch Med, Atlanta, GA 30303 USA	Emory University	Blumberg, HM (corresponding author), Emory Univ, Div Infect Dis, Sch Med, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	henry.m.blumberg@emory.edu	Blumberg, Henry/W-2156-2019	Blumberg, Henry/0000-0002-3110-2443	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000454, UL1TR000454] Funding Source: Medline; NIAID NIH HHS [K23 AI103044, K23AI103044] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Talati NJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-264	9	6	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1460	1461		10.1001/jama.2014.4928	http://dx.doi.org/10.1001/jama.2014.4928			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291583	Green Accepted			2022-12-28	WOS:000342630200024
J	Epstein, L; Hunter, JC; Arwady, MA; Tsai, V; Stein, L; Gribogiannis, M; Frias, M; Guh, AY; Laufer, AS; Black, S; Pacilli, M; Moulton-Meissner, H; Rasheed, JK; Avillan, JJ; Kitchel, B; Limbago, BM; MacCannell, D; Lonsway, D; Noble-Wang, J; Conway, J; Conover, C; Vernon, M; Kallen, AJ				Epstein, Lauren; Hunter, Jennifer C.; Arwady, M. Allison; Tsai, Victoria; Stein, Linda; Gribogiannis, Marguerite; Frias, Mabel; Guh, Alice Y.; Laufer, Alison S.; Black, Stephanie; Pacilli, Massimo; Moulton-Meissner, Heather; Rasheed, J. Kamile; Avillan, Johannetsy J.; Kitchel, Brandon; Limbago, Brandi M.; MacCannell, Duncan; Lonsway, David; Noble-Wang, Judith; Conway, Judith; Conover, Craig; Vernon, Michael; Kallen, Alexander J.			New Delhi Metallo-beta-Lactamase-Producing Carbapenem-Resistant Escherichia coli Associated With Exposure to Duodenoscopes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FIELD GEL-ELECTROPHORESIS; PSEUDOMONAS-AERUGINOSA; ENTEROBACTERIACEAE; OUTBREAK; EPIDEMIOLOGY; ACQUISITION; PREVENTION; GUIDELINE	IMPORTANCE Carbapenem-resistant Enterobacteriaceae (CRE) producing the New Delhi metallo-beta-lactamase (NDM) are rare in the United States, but have the potential to add to the increasing CRE burden. Previous NDM-producing CRE clusters have been attributed to person-to-person transmission in health care facilities. OBJECTIVE To identify a source for, and interrupt transmission of, NDM-producing CRE in a northeastern Illinois hospital. DESIGN, SETTING, AND PARTICIPANTS Outbreak investigation among 39 case patients at a tertiary care hospital in northeastern Illinois, including a case-control study, infection control assessment, and collection of environmental and device cultures; patient and environmental isolate relatedness was evaluated with pulsed-field gel electrophoresis (PFGE). Following identification of a likely source, targeted patient notification and CRE screening cultures were performed. MAIN OUTCOMES AND MEASURES Association between exposure and acquisition of NDM-producing CRE; results of environmental cultures and organism typing. RESULTS In total, 39 case patients were identified from January 2013 through December 2013, 35 with duodenoscope exposure in 1 hospital. No lapses in duodenoscope reprocessing were identified; however, NDM-producing Escherichia coli was recovered from a reprocessed duodenoscope and shared more than 92% similarity to all case patient isolates by PFGE. Based on the case-control study, case patients had significantly higher odds of being exposed to a duodenoscope (odds ratio [OR], 78 [95% CI, 6.0-1008], P < .001). After the hospital changed its reprocessing procedure from automated high-level disinfection with ortho-phthalaldehyde to gas sterilization with ethylene oxide, no additional case patients were identified. CONCLUSIONS AND RELEVANCE In this investigation, exposure to duodenoscopes with bacterial contamination was associated with apparent transmission of NDM-producing E coli among patients at 1 hospital. Bacterial contamination of duodenoscopes appeared to persist despite the absence of recognized reprocessing lapses. Facilities should be aware of the potential for transmission of bacteria including antimicrobial-resistant organisms via this route and should conduct regular reviews of their duodenoscope reprocessing procedures to ensure optimal manual cleaning and disinfection.	[Epstein, Lauren; Hunter, Jennifer C.; Guh, Alice Y.; Laufer, Alison S.; Moulton-Meissner, Heather; Rasheed, J. Kamile; Avillan, Johannetsy J.; Kitchel, Brandon; Limbago, Brandi M.; MacCannell, Duncan; Lonsway, David; Noble-Wang, Judith; Kallen, Alexander J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Epstein, Lauren; Hunter, Jennifer C.; Arwady, M. Allison] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA; [Arwady, M. Allison; Tsai, Victoria; Conway, Judith; Conover, Craig] Illinois Dept Publ Hlth, Chicago, IL USA; [Stein, Linda; Gribogiannis, Marguerite] Advocate Lutheran Gen Hosp, Park Ridge, IL USA; [Frias, Mabel; Vernon, Michael] Cook Cty Dept Publ Hlth, Oak Forest, IL USA; [Black, Stephanie; Pacilli, Massimo] Chicago Dept Publ Hlth, Chicago, IL USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health	Epstein, L (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,Mailstop A-24, Atlanta, GA 30333 USA.	xdd0@cdc.gov		Epstein, Lauren/0000-0002-1175-1112; Moulton-Meissner, Heather/0000-0002-0728-2552				Alfa MJ, 2013, AM J INFECT CONTROL, V41, pS56, DOI 10.1016/j.ajic.2012.12.006; Alfa MJ, 2013, AM J INFECT CONTROL, V41, P249, DOI 10.1016/j.ajic.2012.03.015; Aumeran C, 2011, ENDOSKOPIE HEUTE, V24, P124, DOI 10.1055/s-0030-1255647; Beilenhoff U, 2007, ENDOSCOPY, V39, P175, DOI 10.1055/s-2006-945181; Bommarito M, 2013, AM J INFECT CONTROL, V41, pS24; Bond WW, 2004, CLINICAL MICROBIOLOG; Carbonne A, 2009, CONTROL OF A MULTI H; Centers for Disease Control and Prevention, STANDARD OPERATING P; Centers for Disease Control and Prevention, 2012 CRE TOOLKIT GUI; Centers for Disease Control and Prevention, MULTIPLEX REAL TIME; DOHERTY DE, 1982, DIGEST DIS SCI, V27, P169, DOI 10.1007/BF01311712; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Fraser TG, 2004, INFECT CONT HOSP EP, V25, P856, DOI 10.1086/502309; Frias M, 2014, MMWR-MORBID MORTAL W, V62, P1051; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; Gastmeier P, 2014, INFECTION, V42, P15, DOI 10.1007/s15010-013-0544-6; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hennekinne JA, 2003, J APPL MICROBIOL, V94, P321, DOI 10.1046/j.1365-2672.2003.01837.x; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kovaleva J, 2009, ENDOSCOPY, V41, P913, DOI 10.1055/s-0029-1215086; Lin MY, 2013, CLIN INFECT DIS, V57, P1246, DOI 10.1093/cid/cit500; LOW DE, 1980, ARCH INTERN MED, V140, P1076, DOI 10.1001/archinte.140.8.1076; Miner N, 2007, GASTROENTEROL NURS, V30, P285, DOI 10.1097/01.SGA.0000287201.98483.43; Muscarella LF, 2010, ENDOSCOPY, V42, P957, DOI 10.1055/s-0030-1255871; Nelson DB, 2003, J LAB CLIN MED, V141, P159, DOI 10.1067/mlc.2003.24; Ofstead CL, 2010, GASTROENTEROL NURS, V33, P304, DOI 10.1097/SGA.0b013e3181e9431a; Petersen BT, 2011, GASTROINTEST ENDOSC, V73, P1075, DOI 10.1016/j.gie.2011.03.1183; RUTALA WA, 2008, GUIDELINE FOR DISINF; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; STRUELENS MJ, 1993, AM J MED, V95, P489, DOI 10.1016/0002-9343(93)90331-I; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Taylor A, INFECTION CONTROL IN; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thornhill G, 2012, AM J INFECT CONTROL, V40, pe184; US Food and Drug Administration, 2009, FDA CLEARED STERILAN; Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482	36	267	281	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1447	1455		10.1001/jama.2014.12720	http://dx.doi.org/10.1001/jama.2014.12720			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291580	Bronze			2022-12-28	WOS:000342630200021
J	Keklikoglou, I; De Palma, M				Keklikoglou, Ioanna; De Palma, Michele			CANCER Metastasis risk after anti-macrophage therapy	NATURE			English	Editorial Material							TUMOR-ASSOCIATED MACROPHAGES; ANTIBODY; CCL2	Blocking the activity of macrophages may delay the spread of cancer. But new findings show that these immune cells can rapidly rebound to tumours after therapy withdrawal, accelerating lethal metastasis in mice. See Letter p. 130	[Keklikoglou, Ioanna; De Palma, Michele] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Keklikoglou, I (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland.	michele.depalma@epfl.ch	De Palma, Michele/L-5350-2016	De Palma, Michele/0000-0001-9128-5459; Keklikoglou, Ioanna/0000-0003-1219-6912				Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Swierczak A, 2014, CANCER IMMUNOL RES, V2, P765, DOI 10.1158/2326-6066.CIR-13-0190; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	12	19	20	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					46	47		10.1038/nature13931	http://dx.doi.org/10.1038/nature13931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25337881				2022-12-28	WOS:000344187500027
J	Jaxybulatov, K; Shapiro, NM; Koulakov, I; Mordret, A; Landes, M; Sens-Schonfelder, C				Jaxybulatov, K.; Shapiro, N. M.; Koulakov, I.; Mordret, A.; Landes, M.; Sens-Schoenfelder, C.			A large magmatic sill complex beneath the Toba caldera	SCIENCE			English	Article							SURFACE-WAVE TOMOGRAPHY; SNAKE RIVER PLAIN; SEISMIC ANISOTROPY; VELOCITY STRUCTURE; NOISE; RESERVOIRS	An understanding of the formation of large magmatic reservoirs is a key issue for the evaluation of possible strong volcanic eruptions in the future. We estimated the size and level of maturity of one of the largest volcanic reservoirs, based on radial seismic anisotropy. We used ambient-noise seismic tomography below the Toba caldera (in northern Sumatra) to observe the anisotropy that we interpret as the expression of a fine-scale layering caused by the presence of many partially molten sills in the crust below 7 kilometers. This result demonstrates that the magmatic reservoirs of present (non-eroded) supervolcanoes can be formed as large sill complexes and supports the concept of the long-term incremental evolution of magma bodies that lead to the largest volcanic eruptions.	[Jaxybulatov, K.; Koulakov, I.] Russian Acad Sci, Trofimuk Inst Petr Geol & Geophys, Siberian Branch, Novosibirsk 630090, Russia; [Jaxybulatov, K.; Koulakov, I.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Jaxybulatov, K.; Shapiro, N. M.; Mordret, A.; Landes, M.] CNRS, UMR 7154, Sorbonne Paris Cite, Inst Phys Globe Paris, F-75238 Paris 5, France; [Sens-Schoenfelder, C.] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany	Russian Academy of Sciences; Trofimuk Institute of Petroleum Geology & Geophysics; Novosibirsk State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Shapiro, NM (corresponding author), CNRS, UMR 7154, Sorbonne Paris Cite, Inst Phys Globe Paris, 1 Rue Jussieu, F-75238 Paris 5, France.	nshapiro@ipgp.fr	Mordret, Aurelien/HGB-2775-2022; Koulakov, Ivan/AAT-6109-2021; Koulakov, Ivan/C-1942-2018; Shapiro, Nikolai M/G-1049-2010	Mordret, Aurelien/0000-0002-7998-5417; Shapiro, Nikolai M/0000-0002-0144-723X	European Union through the European Research Council [227507]; Federal Ministry of Education and Research (BMBF) project MIIC [03G0736A]; Russian Science Foundation [14-17-00430]; French project DataScale	European Union through the European Research Council; Federal Ministry of Education and Research (BMBF) project MIIC; Russian Science Foundation(Russian Science Foundation (RSF)); French project DataScale	All of the data used in this study (doi:10.14470/2N934755) were acquired with instruments from the GFZ instrument pool (GIPP) and distributed by the GFZ-GEOFON data center. Computations in this study were performed using the High-Performance Computing infrastructure S-CAPAD at the Institute de Physique du Globe de Paris, which is supported by the Ile-de-France region (via the SEASAME program), France-Grille (http://www.france-grilles.fr), and the CNRS MASTODONS program. The work of K.J., A.M., and N.M.S. was supported by the European Union through the European Research Council advanced grant project 227507 Whisper and for C.S.-S. by the Federal Ministry of Education and Research (BMBF) project MIIC (grant no. 03G0736A). I. K. was supported by the Russian Science Foundation (grant no. 14-17-00430). M. L. was supported by the French project DataScale. We acknowledge C. Jaupart (Institut de Physique du Globe de Paris) for helpful discussions.	Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Annen C, 2009, EARTH PLANET SC LETT, V284, P409, DOI 10.1016/j.epsl.2009.05.006; Bachmann O, 2008, ELEMENTS, V4, P17, DOI 10.2113/GSELEMENTS.4.1.17; Barmin MP, 2001, PURE APPL GEOPHYS, V158, P1351, DOI 10.1007/PL00001225; Bensen GD, 2007, GEOPHYS J INT, V169, P1239, DOI 10.1111/j.1365-246X.2007.03374.x; Brocher TM, 2008, B SEISMOL SOC AM, V98, P950, DOI 10.1785/0120060403; Chaussard E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053817; Chesner CA, 2012, QUATERN INT, V258, P5, DOI 10.1016/j.quaint.2011.09.025; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; Gardner JE, 2002, GEOLOGY, V30, P347, DOI 10.1130/0091-7613(2002)030<0347:PVXITY>2.0.CO;2; Gathorne-Hardy FJ, 2003, J HUM EVOL, V45, P227, DOI 10.1016/S0047-2484(03)00105-2; Gudmundsson A, 2011, TECTONOPHYSICS, V500, P50, DOI 10.1016/j.tecto.2009.10.015; Hill GJ, 2009, NAT GEOSCI, V2, P785, DOI 10.1038/NGEO661; Koulakov I, 2009, GEOPHYS J INT, V177, P1121, DOI [10.1111/j.1365-246X.2009.04114.x, 10.1111/J.1365-246X.2009.04114.x]; Koulakov I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002109; Lees JM, 2007, J VOLCANOL GEOTH RES, V167, P37, DOI 10.1016/j.jvolgeores.2007.06.008; Masturyono R., 2001, GEOCHEM GEOPHY GEOSY, V2, P1014, DOI [10.1029/2000GC000096, DOI 10.1029/2000GC000096]; Michaut C, 2011, TECTONOPHYSICS, V500, P34, DOI 10.1016/j.tecto.2009.08.019; Mordret A, 2014, GEOPHYS J INT, V198, P1514, DOI 10.1093/gji/ggu217; Moschetti MP, 2010, NATURE, V464, P885, DOI 10.1038/nature08951; Peng XH, 1998, J GEOPHYS RES-SOL EA, V103, P7171, DOI 10.1029/97JB03615; Postma, 1955, GEOPHYSICS, V20, P780; Sakaguchi K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027397; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Shapiro NM, 2004, SCIENCE, V305, P233, DOI 10.1126/science.1098276; Shervais JW, 2006, GEOLOGY, V34, P365, DOI 10.1130/G22226.1; Stankiewicz J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044211; Taisne B, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006228; Wang ZJ, 2002, GEOPHYSICS, V67, P1423, DOI 10.1190/1.1512743; Wohletz K., 1992, VOLCANOLOGY GEOTHERM	30	116	120	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		617	619		10.1126/science.1258582	http://dx.doi.org/10.1126/science.1258582			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359969				2022-12-28	WOS:000343799700044
J	Ko, H				Ko, Ho			Functional organization of synaptic connections in the neocortex	SCIENCE			English	Editorial Material							STIMULUS FEATURE SELECTIVITY; VISUAL CORTICAL-NEURONS; IN-VIVO; DIRECTION-SELECTIVITY; WIRING SPECIFICITY; EXCITATORY NEURONS; INHIBITORY NEURONS; RECEPTIVE-FIELDS; CORTEX; INTERNEURONS		[Ko, Ho] Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Shatin, Hong Kong, Peoples R China; [Ko, Ho] Chinese Univ Hong Kong, Fac Med, Chow Yuk Ho Technol Ctr Innovat Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ko, H (corresponding author), Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Shatin, Hong Kong, Peoples R China.		Ko, Ho/I-7513-2016; Ko, Ho/AAH-2755-2020	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274				Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Ko H, 2014, J NEUROSCI, V34, P9812, DOI 10.1523/JNEUROSCI.0875-14.2014; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee SH, 2014, NATURE, V508, pE1, DOI 10.1038/nature13128; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Poggio T., 1977, NEUROSCI RES PROGRAM, V3, P470; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	35	1	1	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209								10.1126/science.1260780	http://dx.doi.org/10.1126/science.1260780			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7VH	25359956				2022-12-28	WOS:000349836100002
J	Miyake, T; Kalluri, R				Miyake, Toru; Kalluri, Raghu			CARDIAC BIOLOGY Cell plasticity helps hearts to repair	NATURE			English	Editorial Material							FIBROBLAST; FIBROSIS		[Miyake, Toru; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Rice University	Miyake, T (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	NCI NIH HHS [P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	7	7	7	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					575	576		10.1038/nature13928	http://dx.doi.org/10.1038/nature13928			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25317554				2022-12-28	WOS:000343801500036
J	Swoboda, KJ				Swoboda, Kathryn J.			Romancing the Spliceosome to Fight Spinal Muscular Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Swoboda, KJ (corresponding author), Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA.			Swoboda, Kathryn/0000-0002-4593-6342	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD069045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Lah GJE, 2014, NEURON, V83, P1376, DOI 10.1016/j.neuron.2014.08.002; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	5	4	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1752	1754		10.1056/NEJMcibr1409795	http://dx.doi.org/10.1056/NEJMcibr1409795			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354110	Green Accepted			2022-12-28	WOS:000343768500016
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: After Rotherham-pattern spotting and child abuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Jay A., 2014, INDEPENDENT INQUIRY	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2014	349								g6347	10.1136/bmj.g6347	http://dx.doi.org/10.1136/bmj.g6347			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS3CT	25347985	Bronze			2022-12-28	WOS:000344154600007
J	Hall, MA; Lord, R				Hall, Mark A.; Lord, Richard			Obamacare: what the Affordable Care Act means for patients and physicians	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEALTH-INSURANCE COVERAGE; OUT-OF-POCKET; MEDICARE; REFORM; PROTECTION; EXCHANGES; EXPANSION; GROWTH; PLANS; HALF	The Affordable Care Act's core achievement is to make all Americans insurable, by requiring insurers to accept all applicants at rates based on population averages regardless of health status. The act also increases coverage by allowing states to expand Medicaid (the social healthcare program for families and people with low income and resources) to cover everyone near the poverty line, and by subsidizing private insurance for people who are not poor but who do not have workplace coverage. The act allows most people to keep the same kind of insurance that they currently have, and it does not change how private insurance pays physicians and hospitals. Although the act falls short of achieving truly universal coverage, nine million uninsured people have received coverage so far. Market reforms have not hurt the insurance industry's profitability, prices for individual insurance have been lower than expected, and government costs so far have been less than initially projected. The act expands several ongoing pilot programs in Medicare that reform how doctors and hospitals are paid, but it does not directly change how private insurers pay healthcare providers. Nevertheless, it has set into motion market dynamics that are affecting medical practice, such as limiting insurance networks to fewer providers and requiring patients to pay for more treatment costs out of pocket. In response, many hospitals and physicians are forming closer and larger affiliations. Further time and study are needed to learn whether these evolutionary changes will achieve their goals without harming the doctor-patient relationship.	[Hall, Mark A.; Lord, Richard] Wake Forest Univ, Ctr Bioeth Hlth & Soc, Winston Salem, NC 27157 USA	Wake Forest University	Hall, MA (corresponding author), Wake Forest Univ, Ctr Bioeth Hlth & Soc, Winston Salem, NC 27157 USA.	mhall@wakehealth.edu		Hall, Mark A./0000-0001-6277-144X				Berenson RA, 2010, NEW ENGL J MED, V363, P101, DOI 10.1056/NEJMp1005588; Bernasek A, 2013, NY TIMES; Bhardwaj A, 2014, INDIVIDUAL MARKET EN; Blumberg LJ, 2012, INQUIRY-J HEALTH CAR, V49, P116, DOI 10.5034/inquiryjrnl_49.02.05; Blumberg LJ, 2011, NEW ENGL J MED, V364, DOI [10.1056/NEJMP1100112, 10.1056/NEJMp1100112]; Blumberg LJ, 2014, MEASURING MARKETPLAC; Blumberg LJ, 2013, WHY ACAS LIMITS AGE; Blumenthal D, 2014, NEW ENGL J MED, V371, P275, DOI 10.1056/NEJMhpr1405667; Buchmueller T, 2013, HEALTH AFFAIR, V32, P1522, DOI 10.1377/hlthaff.2013.0526; Buettgens M, 2010, AM AFF CAR ACT; Buettgens M, 2011, WHO WILL BE UN HLTH; Buettgens M, 2011, CONSIDER SAVINGS WEL; Carman KG, 2014, CHANGES HLTH INSURAN; Cohn J, 2014, MILBANK Q, V92, P177, DOI 10.1111/1468-0009.12048; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Congress of the United States Congressional Budget Office, 2014, UPD EST EFF INS COV; Congressional Budget Office, 2013, CBOS MAY 2013 EST EF; Corlette S, 2013, MOVING HIGH QUALITY; Cox C, 2013, EARLY LOOK PREMIUMS; Cuckler GA, 2013, HEALTH AFFAIR, V32, P1820, DOI 10.1377/hlthaff.2013.0721; Davis K, 2011, J GEN INTERN MED, V26, P1201, DOI 10.1007/s11606-011-1720-y; Delisle DR, 2013, AM J MED QUAL, V28, P339, DOI 10.1177/1062860612462740; Department of Health and Human Services, 2014, HLTH INS MARK SUMM E; Department of Health and Human Services ASPE Office of Health Policy, 2013, HLTH INS MARK PREM 2; Dorn S, 2013, MEDICAID EXPANSION A; Eibner C, 2010, NEW ENGL J MED, V363, P1393, DOI 10.1056/NEJMp1008047; Families USA, 2013, DOES AFF CAR ACT AFF; Fronstin P., 2012, PRIVATE HLTH INSURAN; Gabel JR, 2013, HEALTH AFFAIR, V32, P2032, DOI 10.1377/hlthaff.2013.0861; Gabel JR, 2012, HEALTH AFFAIR, V31, P1339, DOI 10.1377/hlthaff.2011.1082; Glesa K, 2013, MY GENERATION AGE BA; Gottlieb S, 2013, NY TIMES; Gray J., 2014, ACAVIEW MEASURING IM; Hall MA, 2000, HEALTH AFFAIR, V19, P173, DOI 10.1377/hlthaff.19.2.173; Hall MA., 2012, HLTH CARE SAFETY NET; Hall MA, 2009, J FAM PRACTICE, V58, pE1; Haviland AM, 2012, HEALTH AFFAIR, V31, P1009, DOI 10.1377/hlthaff.2011.0369; Henry J, 2009, ROL MED STAT EC LOOK; Henry J Kaiser Family Foundation, 2014, MED ENR OV CMS APR 2; Hofer AN, 2011, MILBANK Q, V89, P69, DOI 10.1111/j.1468-0009.2011.00620.x; Holahan J, 2013, CROSS CUTTING ISSUES; Holahan J., 2014, LAUNCH AFFORDABLE CA; Holahan J, 2013, COST NOT EXPANDING M; Iglehart JK, 2013, NEW ENGL J MED, V368, P1935, DOI 10.1056/NEJMhpr1301084; Jacobs Lawrence, 2012, HLTH CARE REFORM AM; Jost TS, 2014, HEALTH AFFAIR, V33, P7, DOI 10.1377/hlthaff.2013.1355; Kocher R, 2011, NEW ENGL J MED, V364, P1790, DOI 10.1056/NEJMp1101959; Koff Stephen, 2013, CLEVELAND PLAIN DEAL; Ku L, 2013, EXPLAINING RECENT CH; Levey NN., 2014, LOS ANGELES TIMES; Levitt L, 2013, QUANTIFYING TAX CRED; Linda Blumberg, 2013, AFFORDABLE CARE ACT; McCue M. J., 2014, FEDERAL MED LOSS RAT; MCCUE MICHAEL J., 2012, INSURERS RESPONSES R; McKinsey Center for US Health System Reform, 2014, HOSP NETW UPD NAT VI; McKinsey Center for US Health System Reform, 2013, EM EXCH DYN TEMP TUR; McKinsey Center for US Health System Reform, 2013, HOSP NETW CONF EXCH; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886; Mechanic R, 2010, NEW ENGL J MED, V362, P772, DOI 10.1056/NEJMp1001013; Neumann PJ, 2010, NEW ENGL J MED, V363, P1495, DOI 10.1056/NEJMp1007168; NIHCM Foundation, 2012, CONC HLTH CAR SPEND; Oberlander J, 2013, NEW ENGL J MED, V369, P2469, DOI 10.1056/NEJMp1314861; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571; Pauly MV, 2013, HLTH MANAG POLICY IN, V1, P61; PWC Health Research Institute, 2014, HLTH INS PREM COMP A; Quadagno J, 2014, J HEALTH POLIT POLIC, V39, P35, DOI 10.1215/03616878-2395172; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Schoen C, 2013, HEALTH AFFAIR, V32, P2205, DOI 10.1377/hlthaff.2013.0879; Skopec L., 2013, MARKET COMPETITION W; Sommers BD, 2013, NEW ENGL J MED, V368, P496, DOI 10.1056/NEJMp1215785; Sood N, 2011, HEALTH AFFAIR, V30, P1708, DOI 10.1377/hlthaff.2010.0394; Spiro T., 2013, AFFORDABLE CARE ACTS; Tanner MD, 2011, BAD MED GUIDE REAL C; Ubel PA, 2013, NEW ENGL J MED, V369, P1484, DOI 10.1056/NEJMp1306826; Weeks WB, 2013, ANN INTERN MED, V158, P62, DOI 10.7326/0003-4819-158-1-201301010-00012; Wharam JF, 2013, NEW ENGL J MED, V369, P1481, DOI 10.1056/NEJMp1309490	77	19	19	0	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2014	349								g5376	10.1136/bmj.g5376	http://dx.doi.org/10.1136/bmj.g5376			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OE	25338761				2022-12-28	WOS:000343768300001
J	[Anonymous]				[Anonymous]			The Cost of Medical Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1699	1699		10.1001/jama.2013.279804	http://dx.doi.org/10.1001/jama.2013.279804			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335163				2022-12-28	WOS:000343301400037
J	Bhaumik, S				Bhaumik, Soumyadeep			NON-COMMUNICABLE DISEASE The public health threat from sugary drinks in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWEETENED BEVERAGES; METABOLIC SYNDROME; WEIGHT-GAIN; CONSUMPTION; RISK					soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Bhusan R., 2012, EC TIMES        0213; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; ET Bureau, 2014, EC TIMES        0710; Euromonitor, 2014, SOFT DRINKS IND; Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HAZRA N, 2013, NAT MED J INDIA, V26, P125; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Prabhakaran D, 2010, INDIAN J MED RES, V132, P529; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; United Nations Human Rights Council General Assembly, 2014, UNH FOODS NONC DIS R; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	17	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2014	349								g6216	10.1136/bmj.g6216	http://dx.doi.org/10.1136/bmj.g6216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OD	25336402				2022-12-28	WOS:000343768200005
J	Herrington, W; Haynes, R				Herrington, William; Haynes, Richard			Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Herrington, William; Haynes, Richard] Univ Oxford, Clin Trials Serv Unit, Oxford, England	University of Oxford	Herrington, W (corresponding author), Univ Oxford, Clin Trials Serv Unit, Oxford, England.							BAIGENT C, 2010, J GERONTOL B-PSYCHOL, V376, P1670, DOI DOI 10.1016/S0140-6736(10)61350-5; Haynes R, 2014, J AM SOC NEPHROL, V25, P1825, DOI 10.1681/ASN.2013090965	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8							JC8	10.7326/0003-4819-161-8-201410210-02008	http://dx.doi.org/10.7326/0003-4819-161-8-201410210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329225				2022-12-28	WOS:000343906800007
J	Brosnan, SF; de Waal, FBM				Brosnan, Sarah F.; de Waal, Frans B. M.			Evolution of responses to (un)fairness	SCIENCE			English	Review							TUFTED CAPUCHIN MONKEYS; INEQUITY AVERSION; PAN-TROGLODYTES; TOKEN-EXCHANGE; SELF-CONTROL; CHIMPANZEES; COOPERATION; CEBUS; BEHAVIOR; INEQUALITY	The human sense of fairness is an evolutionary puzzle. To study this, we can look to other species, in which this can be translated empirically into responses to reward distribution. Passive and active protest against receiving less than a partner for the same task is widespread in species that cooperate outside kinship and mating bonds. There is less evidence that nonhuman species seek to equalize outcomes to their own detriment, yet the latter has been documented in our closest relatives, the apes. This reaction probably reflects an attempt to forestall partner dissatisfaction with obtained outcomes and its negative impact on future cooperation. We hypothesize that it is the evolution of this response that allowed the development of a complete sense of fairness in humans, which aims not at equality for its own sake but for the sake of continued cooperation.	[Brosnan, Sarah F.] Georgia State Univ, Dept Psychol, Inst Neurosci, Atlanta, GA 30303 USA; [Brosnan, Sarah F.] Georgia State Univ, Dept Philosophy, Inst Neurosci, Atlanta, GA 30303 USA; [Brosnan, Sarah F.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [de Waal, Frans B. M.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University; Emory University	Brosnan, SF (corresponding author), Georgia State Univ, Dept Psychol, Inst Neurosci, Univ Plaza, Atlanta, GA 30303 USA.	sarah.brosnan@gmail.com			NSF [SES 0847351, SES 1123897]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.F.B. was funded by NSF CAREER grant SES 0847351 and NSF SES 1123897.	[Anonymous], 2013, 2 MONKEYS WERE PAID; Barclay P, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0213; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brandstatter H, 2001, EUR J PERSONALITY, V15, pS53, DOI 10.1002/per.424; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Brosnan SF, 2012, SOC JUSTICE RES, V25, P336, DOI 10.1007/s11211-012-0165-8; Brosnan SF, 2011, FOLIA PRIMATOL, V82, P56, DOI 10.1159/000328142; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2593, DOI 10.1098/rstb.2010.0155; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 2004, ROUNDTABLE SER BEHAV, P3; Chapais B., 2004, KINSHIP BEHAV PRIMAT; CLARK MS, 2003, HDB PSYCHOL PERSONAL, V5, P447; De Waal F., 2013, BONOBO ATHEIST SEARC; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; de Waal FBM, 2003, NEUROPSYCHOLOGIA, V41, P221, DOI 10.1016/S0028-3932(02)00152-5; de Waal Frans B.M., 1992, P37; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; De Waal Frans B. M., 1992, P233; Dindo M, 2007, AM J PRIMATOL, V69, P448, DOI 10.1002/ajp.20362; Drayton LA, 2014, BEHAV SCI-BASEL, V4, P87, DOI 10.3390/bs4020087; Dugatkin L.A., 1997, COOPERATION ANIMALS; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Evans TA, 2006, J COMP PSYCHOL, V120, P163, DOI 10.1037/0735-7036.120.2.163; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fletcher GE, 2008, AM J PRIMATOL, V70, P901, DOI 10.1002/ajp.20576; Fontenot MB, 2007, ANIM BEHAV, V74, P487, DOI 10.1016/j.anbehav.2007.01.015; Frank R.H., 2001, EVOLUTION CAPACITY C, P57; Freeman HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076297; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Heidary F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003705; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J., 2005, FDN HUMAN SOCIALITY; Hopper L. M., 2013, J PRIMATOL, V2, P109, DOI DOI 10.4172/2167-6801.1000109; Hopper LM, 2014, ANIM COGN, V17, P1303, DOI 10.1007/s10071-014-0765-9; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Horowitz A, 2012, SOC JUSTICE RES, V25, P195, DOI 10.1007/s11211-012-0158-7; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kaiser I, 2012, BIOL LETTERS, V8, P942, DOI 10.1098/rsbl.2012.0519; Kappeler P. M., 2005, COOPERATION PRIMATES; Koyama NF, 1996, PRIMATES, V37, P79, DOI 10.1007/BF02382923; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Massen JJM, 2012, AM J PRIMATOL, V74, P145, DOI 10.1002/ajp.21014; McAuliffe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080966; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2011, ANIM BEHAV, V82, P485, DOI 10.1016/j.anbehav.2011.05.024; Melis AP, 2009, EVOL HUM BEHAV, V30, P381, DOI 10.1016/j.evolhumbehav.2009.05.003; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Mesterton-Gibbons M, 2011, J THEOR BIOL, V274, P187, DOI 10.1016/j.jtbi.2010.12.031; Mitani JC, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P107, DOI 10.1007/3-540-28277-7_6; Neiworth JJ, 2009, J COMP PSYCHOL, V123, P10, DOI 10.1037/a0012662; Nissen HW, 1936, J COMP PSYCHOL, V22, P383, DOI 10.1037/h0062234; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Proctor D, 2013, P NATL ACAD SCI USA, V110, P2070, DOI 10.1073/pnas.1220806110; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Range F, 2012, SOC JUSTICE RES, V25, P170, DOI 10.1007/s11211-012-0155-x; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Roma PG, 2006, J COMP PSYCHOL, V120, P67, DOI 10.1037/0735-7036.120.1.67; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Semmann D, 2004, BEHAV ECOL SOCIOBIOL, V56, P248, DOI 10.1007/s00265-004-0782-9; Shaw A, 2014, J EXP CHILD PSYCHOL, V119, P40, DOI 10.1016/j.jecp.2013.10.007; Sheskin M, 2014, COGNITION, V130, P152, DOI 10.1016/j.cognition.2013.10.008; Silberberg A, 2009, ANIM COGN, V12, P505, DOI 10.1007/s10071-009-0211-6; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; SOMMER R, 1967, PSYCHOL BULL, V67, P145, DOI 10.1037/h0024201; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Surbeck M, 2008, CURR BIOL, V18, pR906, DOI 10.1016/j.cub.2008.08.040; Takimoto A, 2011, ANIM COGN, V14, P715, DOI 10.1007/s10071-011-0406-5; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Talbot CF, 2011, BIOL LETTERS, V7, P680, DOI 10.1098/rsbl.2011.0211; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Wascher CAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056885; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Yamagishi T, 2009, P NATL ACAD SCI USA, V106, P11520, DOI 10.1073/pnas.0900636106	95	178	182	11	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					314	+	1251776	10.1126/science.1251776	http://dx.doi.org/10.1126/science.1251776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324394	Green Accepted			2022-12-28	WOS:000343041100028
J	Yang, TT; Liu, Q; Kloss, B; Bruni, R; Kalathur, RC; Guo, YZ; Kloppmann, E; Rost, B; Colecraft, HM; Hendrickson, WA				Yang, Tingting; Liu, Qun; Kloss, Brian; Bruni, Renato; Kalathur, Ravi C.; Guo, Youzhong; Kloppmann, Edda; Rost, Burkhard; Colecraft, Henry M.; Hendrickson, Wayne A.			Structure and selectivity in bestrophin ion channels	SCIENCE			English	Article							VITELLIFORM MACULAR DYSTROPHY; CHLORIDE CHANNEL; BEST-DISEASE; MOUSE BESTROPHIN-2; VMD2 GENE; DEGENERATION; MEMBRANE; FAMILY; IDENTIFICATION; MUTATIONS	Human bestrophin-1 (hBest1) is a calcium-activated chloride channel from the retinal pigment epithelium, where mutations are associated with vitelliform macular degeneration, or Best disease. We describe the structure of a bacterial homolog (KpBest) of hBest1 and functional characterizations of both channels. KpBest is a pentamer that forms a five-helix transmembrane pore, closed by three rings of conserved hydrophobic residues, and has a cytoplasmic cavern with a restricted exit. From electrophysiological analysis of structure-inspired mutations in KpBest and hBest1, we find a sensitive control of ion selectivity in the bestrophins, including reversal of anion/cation selectivity, and dramatic activation by mutations at the cytoplasmic exit. A homology model of hBest1 shows the locations of disease-causing mutations and suggests possible roles in regulation.	[Yang, Tingting; Guo, Youzhong; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Liu, Qun; Hendrickson, Wayne A.] Brookhaven Natl Lab, New York Struct Biol Ctr, Upton, NY 11973 USA; [Kloss, Brian; Bruni, Renato; Kalathur, Ravi C.; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Dept Informat Bioinformat & Computat Biol, D-85748 Garching, Germany; [Colecraft, Henry M.; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory; Technical University of Munich; Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@xtl.cumc.columbia.edu	Rost, Burkhard/A-1908-2016; Guo, Youzhong/AAW-3010-2021; Liu, Qun/A-8757-2011; Kalathur, Ravi/L-7696-2016	Rost, Burkhard/0000-0003-0179-8424; Liu, Qun/0000-0002-1179-290X; Kalathur, Ravi/0000-0003-1669-9277; Bruni, Renato/0000-0002-2312-0254; kalathur, ravi/0000-0002-4889-8003; Kloss, Brian/0000-0003-0130-8739	NIH [GM095315, GM107462]; NATIONAL EYE INSTITUTE [R00EY025290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, R01GM107462, U54GM095315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Clarke for help in the diffraction analysis; A. Marks for use of planar lipid instrumentation; W. Xie for help in planar lipid experiments; Q. Fan, Y. Geng, and members of the Hendrickson laboratory for discussions; and J. Schwanof and R. Abramowitz at National Synchrotron Light Source (NSLS) beamlines X4A and X4C and F. Murphy at the Advanced Photon Source beamline 24-ID-E for their assistance in data collection. This work was supported in part by NIH grants GM095315 and GM107462 to W.A.H. X4 beamlines are supported by the New York Structural Biology Center at the NSLS of Brookhaven National Laboratory, a Department of Energy facility. The data reported in this paper are tabulated in the supplementary materials and deposited to the Protein Data Bank with access codes listed in table S2. Author contributions: T.Y. and W.A.H. designed research, analyzed data, and wrote the paper; T.Y. performed experiments; Q.L. analyzed, diffraction data; B.K., R.C.K., and R.B. performed expression tests: Y.G. advised on protein production and analyzed diffraction data; E.K. and B.R. performed bioinformatics analyses; and H.M.C. designed and analyzed electrophysiology experiments. The authors declare no conflicts of interest.	Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Kramer Franziska, 2003, Hum Mutat, V22, P418, DOI 10.1002/humu.9189; Kranjc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004672; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Maia-Lopes Susana, 2008, Hum Genet, V123, P112; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Milenkovic VM, 2007, J BIOL CHEM, V282, P1313, DOI 10.1074/jbc.M607383200; Neussert R, 2010, PFLUG ARCH EUR J PHY, V460, P163, DOI 10.1007/s00424-010-0840-2; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Yu K, 2006, INVEST OPHTH VIS SCI, V47, P4956, DOI 10.1167/iovs.06-0524	33	86	86	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					355	359		10.1126/science.1259723	http://dx.doi.org/10.1126/science.1259723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324390	Green Submitted, Green Accepted			2022-12-28	WOS:000343041100046
J	Watson-Capps, JJ; Cech, TR				Watson-Capps, Jana J.; Cech, Thomas R.			Companies on campus	NATURE			English	Editorial Material							INDUSTRY		[Watson-Capps, Jana J.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Cech, Thomas R.] Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Watson-Capps, JJ (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.	jana.watson-capps@colorado.edu						D'Este P, 2011, J TECHNOL TRANSFER, V36, P316, DOI 10.1007/s10961-010-9153-z; Grimaldi R, 2011, RES POLICY, V40, P1045, DOI 10.1016/j.respol.2011.04.005; Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007; Schachter B, 2012, NAT BIOTECHNOL, V30, P944, DOI 10.1038/nbt.2385; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814	5	6	6	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					297	298		10.1038/514297a	http://dx.doi.org/10.1038/514297a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318508	Bronze			2022-12-28	WOS:000342988600027
J	Dowen, JM; Fan, ZP; Hnisz, D; Ren, G; Abraham, BJ; Zhang, LN; Weintraub, AS; Schuijers, J; Lee, TI; Zhao, KJ; Young, RA				Dowen, Jill M.; Fan, Zi Peng; Hnisz, Denes; Ren, Gang; Abraham, Brian J.; Zhang, Lyndon N.; Weintraub, Abraham S.; Schuijers, Jurian; Lee, Tong Ihn; Zhao, Keji; Young, Richard A.			Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes	CELL			English	Article							TRANSCRIPTIONAL REGULATION; DEVELOPMENTAL REGULATORS; TOPOLOGICAL DOMAINS; GENOME ORGANIZATION; SUPER-ENHANCERS; BINDING SITES; PROTEIN CTCF; CHROMATIN; COHESIN; POLYCOMB	The pluripotent state of embryonic stem cells (ESCs) is produced by active transcription of genes that control cell identity and repression of genes encoding lineage-specifying developmental regulators. Here, we use ESC cohesin ChIA-PET data to identify the local chromosomal structures at both active and repressed genes across the genome. The results produce a map of enhancer-promoter interactions and reveal that super-enhancer-driven genes generally occur within chromosome structures that are formed by the looping of two interacting CTCF sites co-occupied by cohesin. These looped structures form insulated neighborhoods whose integrity is important for proper expression of local genes. We also find that repressed genes encoding lineage-specifying developmental regulators occur within insulated neighborhoods. These results provide insights into the relationship between transcriptional control of cell identity genes and control of local chromosome structure.	[Dowen, Jill M.; Fan, Zi Peng; Hnisz, Denes; Abraham, Brian J.; Zhang, Lyndon N.; Weintraub, Abraham S.; Schuijers, Jurian; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Ren, Gang; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Ren, Gang] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Lyndon N.; Weintraub, Abraham S.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwest A&F University - China; Massachusetts Institute of Technology (MIT)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; young@wi.mit.edu	Abraham, Brian/C-2230-2019; Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012	Abraham, Brian/0000-0001-8085-3027; Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647; REN, GANG/0000-0001-9690-5995; Schuijers, Jurian/0000-0003-2531-3516	National Institutes of Health [HG002668]; Division of Intramural Research, NHLBI; Ruth L. Kirschstein National Research Service Award [CA168263-01A1]; Austrian Science Fund (FWF) [J3490]; Rubicon Fellowship for the Life Sciences, Netherlands Organization for Scientific Research (NWO); Austrian Science Fund (FWF) [J 3490] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F32CA168263] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Rubicon Fellowship for the Life Sciences, Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Warren Whyte for generating the H3K27me3 ChIP-seq data set, Chikdu Shivalila for help with genome editing experiments, Alla Sigova for help with experiment design, Rudolf Jaenisch for sharing CRISPR reagents, and the Whitehead Institute Genome Technology Core and NHLBI DNA Sequencing Core for Illumina sequencing. We also thank members of the Young lab for helpful discussions. This work was supported by the National Institutes of Health grant HG002668 (R.A.Y.), Division of Intramural Research, NHLBI (K.Z.), a Ruth L. Kirschstein National Research Service Award (CA168263-01A1) (J.M.D.), an Erwin Schrodinger Fellowship (J3490) from the Austrian Science Fund (FWF) (D.H.), and a Rubicon Fellowship for the Life Sciences, Netherlands Organization for Scientific Research (NWO) (J.S.). R.A.Y. is a founder of Syros Pharmaceuticals.	Baranello L, 2014, P NATL ACAD SCI USA, V111, P889, DOI 10.1073/pnas.1321957111; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Goh YF, 2012, JOVE-J VIS EXP, DOI 10.3791/3770; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaspi H, 2013, STEM CELLS, V31, P2266, DOI 10.1002/stem.1465; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003560; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	69	560	574	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					374	387		10.1016/j.cell.2014.09.030	http://dx.doi.org/10.1016/j.cell.2014.09.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303531	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000343095600018
J	Negro, R; Stagnaro-Green, A				Negro, Roberto; Stagnaro-Green, Alex			Diagnosis and management of subclinical hypothyroidism in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MATERNAL THYROID-FUNCTION; 1ST TRIMESTER; STIMULATING HORMONE; IODINE STATUS; NEUROPSYCHOLOGICAL DEVELOPMENT; INCREASED RISK; UNITED-STATES; TSH LEVELS; SERUM TSH; WOMEN	In prospective studies, the prevalence of undiagnosed subclinical hypothyroidism in pregnant women ranges from 3% to 15%. Subclinical hypothyroidism is associated with multiple adverse outcomes in the mother and fetus, including spontaneous abortion, pre-eclampsia, gestational hypertension, gestational diabetes, preterm delivery, and decreased IQ in the offspring. Only two prospective studies have evaluated the impact of levothyroxine therapy in pregnant women with subclinical hypothyroidism, and the results were mixed. Subclinical hypothyroidism is defined as raised thyrotropin combined with a normal serum free thyroxine level. The normal range of thyrotropin varies according to geographic region and ethnic background. In the absence of local normative data, the recommended upper limit of thyrotropin in the first trimester of pregnancy is 2.5 mIU/L, and 3.0 mIU/L in the second and third trimester. The thyroid gland needs to produce 50% more thyroid hormone during pregnancy to maintain a euthyroid state. Consequently, most women on levothyroxine therapy before pregnancy require an increase in dose when pregnant to maintain euthyroidism. Ongoing prospective trials that are evaluating the impact of levothyroxine therapy on adverse outcomes in the mother and fetus in women with subclinical hypothyroidism will provide crucial data on the role of thyroid hormone replacement in pregnancy.	[Negro, Roberto] V Fazzi Hosp, Div Endocrinol, Dept Internal Med, I-73100 Lecce, Italy; [Stagnaro-Green, Alex] Univ Illinois, Coll Med Rockford, Rockford, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Negro, R (corresponding author), V Fazzi Hosp, Div Endocrinol, Dept Internal Med, I-73100 Lecce, Italy.	dr.negro@libero.it		Negro, Roberto/0000-0001-9282-4530				Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Abalovich M, 2013, THYROID, V23, P1479, DOI 10.1089/thy.2013.0024; Abalovich M, 2010, THYROID, V20, P1175, DOI 10.1089/thy.2009.0457; Aguayo A, 2013, J TRACE ELEM MED BIO, V27, P302, DOI 10.1016/j.jtemb.2013.07.002; Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; American College of Obstetrics and Gynecology, 2002, Int J Gynaecol Obstet, V79, P171; Anckaert E, 2010, CLIN CHIM ACTA, V411, P1348, DOI 10.1016/j.cca.2010.05.032; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; Ashoor G, 2011, OBSTET GYNECOL, V117, P293, DOI 10.1097/AOG.0b013e318205152c; Bannerman CG, 2011, CLIN OBSTET GYNECOL, V54, P488, DOI 10.1097/GRF.0b013e3182272fca; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Benhadi N, 2009, EUR J ENDOCRINOL, V160, P985, DOI 10.1530/EJE-08-0953; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777, DOI 10.1210/jc.2011-2038; Bliddal S, 2014, EUR J ENDOCRINOL, V170, P329, DOI 10.1530/EJE-13-0672; Burch HB, 2014, J CLIN ENDOCR METAB, V99, P2077, DOI 10.1210/jc.2014-1046; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Chang DLF, 2011, J CLIN ENDOCR METAB, V96, pE1452, DOI 10.1210/jc.2011-0360; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; DAFNIS E, 1992, AM J MED SCI, V303, P184, DOI 10.1097/00000441-199203000-00011; Dashe JS, 2005, OBSTET GYNECOL, V106, P753, DOI 10.1097/01.AOG.0000175836.41390.73; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Dosiou C, 2012, J CLIN ENDOCR METAB, V97, P334; Escobar GM, 2000, J CLIN ENDOCR METAB, V85, P3975; Food and Nutrition Board, 2006, DIET REF INT, P320; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Glinoer D, 1999, THYROID, V9, P631, DOI 10.1089/thy.1999.9.631; GLINOER D, 1994, J CLIN ENDOCR METAB, V79, P197, DOI 10.1210/jcem.79.1.8027226; Goel P, 2012, GYNECOL OBSTET INVES, V74, P89, DOI 10.1159/000337715; Haddow JE, 2008, J CLIN ENDOCR METAB, V93, P3341, DOI 10.1210/jc.2008-0568; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hallengren B, 2009, THYROID, V19, P391, DOI 10.1089/thy.2008.0206; Haymart MR, 2010, THYROID, V20, P301, DOI 10.1089/thy.2009.0321; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horacek J, 2010, EUR J ENDOCRINOL, V163, P645, DOI 10.1530/EJE-10-0516; JONES WS, 1969, AM J OBSTET GYNECOL, V104, P909, DOI 10.1016/0002-9378(69)90645-0; Kahric-Janicic N, 2007, THYROID, V17, P303, DOI 10.1089/thy.2006.0303; Karagiannis G, 2011, THYROID, V21, P1127, DOI 10.1089/thy.2010.0445; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; Kharb S, 2013, ANN MED HEALTH SCI R, V3, P43, DOI 10.4103/2141-9248.109478; Korevaar TIM, 2013, J CLIN ENDOCR METAB, V98, P4382, DOI 10.1210/jc.2013-2855; Korevaar TIM, 2013, J CLIN ENDOCR METAB, V98, P3678, DOI 10.1210/jc.2013-2005; Kothari A, 2008, BJOG-INT J OBSTET GY, V115, P1704, DOI 10.1111/j.1471-0528.2008.01901.x; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Kuppens SMI, 2010, CLIN ENDOCRINOL, V72, P820, DOI 10.1111/j.1365-2265.2009.03729.x; Lambert-Messerlian G, 2008, AM J OBSTET GYNECOL, V199; Laurberg P, 2013, CLIN ENDOCRINOL, V79, P297, DOI 10.1111/cen.12232; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; LEUNG AS, 1993, OBSTET GYNECOL, V81, P349; Li CY, 2014, J CLIN ENDOCR METAB, V99, P73, DOI 10.1210/jc.2013-1674; Li Y, 2010, CLIN ENDOCRINOL, V72, P825, DOI 10.1111/j.1365-2265.2009.03743.x; Lockwood CM, 2009, THYROID, V19, P863, DOI 10.1089/thy.2009.0079; Mannisto T, 2013, AM J EPIDEMIOL, V178, P731, DOI 10.1093/aje/kwt031; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; MANDEL SJ, 1990, NEW ENGL J MED, V323, P91, DOI 10.1056/NEJM199007123230204; Mandel SJ, 2005, THYROID, V15, P44, DOI 10.1089/thy.2005.15.44; Mannisto T, 2010, J CLIN ENDOCR METAB, V95, P1084, DOI 10.1210/jc.2009-1904; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Marwaha RK, 2008, BJOG-INT J OBSTET GY, V115, P602, DOI 10.1111/j.1471-0528.2008.01673.x; Moleti M, 2008, J CLIN ENDOCR METAB, V93, P2616, DOI 10.1210/jc.2008-0352; Moreno-Reyes R, 2013, J CLIN ENDOCR METAB, V98, P3694, DOI 10.1210/jc.2013-2149; Negro R, 2010, J CLIN ENDOCR METAB, V95, pE44, DOI 10.1210/jc.2010-0340; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Nelson DB, 2014, AM J PERINAT, V31, P77, DOI 10.1055/s-0033-1334457; Potlukova E, 2012, J CLIN ENDOCR METAB, V97, P1945, DOI 10.1210/jc.2011-3275; Reid SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007752.pub3; Rinaldi MD, 2007, THYROID, V17, P747, DOI 10.1089/thy.2007.0080; ROTI E, 1981, J CLIN ENDOCR METAB, V53, P498, DOI 10.1210/jcem-53-3-498; Sahu MT, 2010, ARCH GYNECOL OBSTET, V281, P215, DOI 10.1007/s00404-009-1105-1; Schneuer FJ, 2012, J CLIN ENDOCR METAB, V97, P3115, DOI 10.1210/jc.2012-1193; Shields BM, 2013, J CLIN ENDOCR METAB, V98, pE1941, DOI 10.1210/jc.2013-2768; Smit BJ, 2000, ACTA PAEDIATR, V89, P291; Soldin OP, 2007, THER DRUG MONIT, V29, P553, DOI 10.1097/FTD.0b013e31815709ac; Soldin OP, 2006, THER DRUG MONIT, V28, P8, DOI 10.1097/01.ftd.0000194498.32398.7b; Stagnaro-Green A, 2005, THYROID, V15, P351, DOI 10.1089/thy.2005.15.351; Stagnaro- Green A, 2012, JAMA-J AM MED ASSOC, V23, p:; Stagnaro-Green A, 2012, J CLIN ENDOCR METAB, V97, P2619, DOI 10.1210/jc.2012-2380; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Stagnaro-Green A, 2011, CLIN OBSTET GYNECOL, V54, P478, DOI 10.1097/GRF.0b013e3182272f32; Stricker R, 2007, EUR J ENDOCRINOL, V157, P509, DOI 10.1530/EJE-07-0249; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Teng W, THYROID, V21, P1053; Thangaratinam S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2616; Tierney K, 2009, CLIN ENDOCRINOL, V71, P892, DOI 10.1111/j.1365-2265.2009.03569.x; Trumpff C, 2013, J TRACE ELEM MED BIO, V27, P174, DOI 10.1016/j.jtemb.2013.01.002; Tudela CM, 2012, OBSTET GYNECOL, V119, P983, DOI 10.1097/AOG.0b013e318250aeeb; Unuane D, 2013, THYROID, V23, P1022, DOI 10.1089/thy.2012.0562; Vadiveloo T, 2013, CLIN ENDOCRINOL, V78, P466, DOI 10.1111/j.1365-2265.2012.04426.x; Vaidya B, 2007, J CLIN ENDOCR METAB, V92, P203, DOI 10.1210/jc.2006-1748; Vaidya B, 2012, EUR J ENDOCRINOL, V166, P49, DOI 10.1530/EJE-11-0729; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; Velasco I, 2009, J CLIN ENDOCR METAB, V94, P3234, DOI 10.1210/jc.2008-2652; Wang WW, 2011, EUR J ENDOCRINOL, V164, P263, DOI 10.1530/EJE-10-0660; Wikner BN, 2008, ACTA OBSTET GYN SCAN, V87, P617, DOI 10.1080/00016340802075103; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a; Yan YQ, 2011, CLIN ENDOCRINOL, V74, P262, DOI 10.1111/j.1365-2265.2010.03910.x; Yassa L, 2010, J CLIN ENDOCR METAB, V95, P3234, DOI 10.1210/jc.2010-0013; Yu XH, 2013, ENDOCRINE, V44, P710, DOI 10.1007/s12020-013-9913-2; Zigman JM, 2003, THYROID, V13, P1169, DOI 10.1089/10507250360731587	101	76	82	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2014	349								g4929	10.1136/bmj.g4929	http://dx.doi.org/10.1136/bmj.g4929			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LM	25288580				2022-12-28	WOS:000342998500001
J	Buffie, CG; Bucci, V; Stein, RR; McKenney, PT; Ling, LL; Gobourne, A; No, D; Liu, H; Kinnebrew, M; Viale, A; Littmann, E; van den Brink, MRM; Jenq, RR; Taur, Y; Sander, C; Cross, JR; Toussaint, NC; Xavier, JB; Pamer, EG				Buffie, Charlie G.; Bucci, Vanni; Stein, Richard R.; McKenney, Peter T.; Ling, Lilan; Gobourne, Asia; No, Daniel; Liu, Hui; Kinnebrew, Melissa; Viale, Agnes; Littmann, Eric; van den Brink, Marcel R. M.; Jenq, Robert R.; Taur, Ying; Sander, Chris; Cross, Justin R.; Toussaint, Nora C.; Xavier, Joao B.; Pamer, Eric G.			Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile	NATURE			English	Article							INTESTINAL MICROBIOTA; METABOLISM; DOMINATION; PHYLOGENY; SCINDENS; PROPOSAL; SALTS; MICE	The gastrointestinal tracts of mammals are colonized by hundreds of microbial species that contribute to health, including colonization resistance against intestinal pathogens(1). Many antibiotics destroy intestinal microbial communities and increase susceptibility to intestinal pathogens(2). Among these, Clostridium difficile, a major cause of antibiotic-induced diarrhoea, greatly increases morbidity and mortality in hospitalized patients(3). Which intestinal bacteria provide resistance to C. difficile infection and their in vivo inhibitory mechanisms remain unclear. Here we correlate loss of specific bacterial taxa with development of infection, by treating mice with different antibiotics that result in distinct microbiota changes and lead to varied susceptibility to C. difficile. Mathematical modelling augmented by analyses of the microbiota of hospitalized patients identifies resistance-associated bacteria common to mice and humans. Using these platforms, we determine that Clostridium scindens, a bile acid 7 alpha-dehydroxylating intestinal bacterium, is associated with resistance to C. difficile infection and, upon administration, enhances resistance to infection in a secondary bile acid dependent fashion. Using a workflow involving mouse models, clinical studies, metagenomic analyses, and mathematical modelling, we identify a probiotic candidate that corrects a clinically relevant microbiome deficiency. These findings have implications for the rational design of targeted antimicrobials as well as microbiome-based diagnostics and therapeutics for individuals at risk of C. difficile infection.	[Buffie, Charlie G.; McKenney, Peter T.; Kinnebrew, Melissa; Taur, Ying; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Buffie, Charlie G.; McKenney, Peter T.; Ling, Lilan; Gobourne, Asia; No, Daniel; Kinnebrew, Melissa; Littmann, Eric; Taur, Ying; Toussaint, Nora C.; Xavier, Joao B.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10065 USA; [Bucci, Vanni; Stein, Richard R.; Sander, Chris; Toussaint, Nora C.; Xavier, Joao B.] Sloan Kettering Inst, Computat Biol Program, New York, NY 10065 USA; [Bucci, Vanni] Univ Massachusetts Dartmouth, Dept Biol, N Dartmouth, MA 02747 USA; [Liu, Hui; Cross, Justin R.] Sloan Kettering Inst, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Lab, New York, NY 10065 USA; [van den Brink, Marcel R. M.; Jenq, Robert R.] Mem Sloan Kettering Canc Ctr, Dept Med, Bone Marrow Transplant Serv, New York, NY 10065 USA; [van den Brink, Marcel R. M.; Pamer, Eric G.] Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University Massachusetts Dartmouth; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	pamere@mskcc.org	Xavier, Joao/H-5471-2011; van den Brink, Marcel R. M./HGB-9434-2022; Bucci, Vanni/B-4558-2011	Xavier, Joao/0000-0003-3592-1689; Toussaint, Nora/0000-0001-7911-7647; Bucci, Vanni/0000-0002-3257-2922; Stein, Richard/0000-0002-5110-6863; Ling, Lilan/0000-0001-6961-7787; Cross, Justin/0000-0002-6356-057X; Taur, Ying/0000-0002-6601-8284	US National Institutes of Health (NIH) [RO1 AI42135, AI95706]; Tow Foundation; NIH Office of the Director [DP2OD008440]; NCI [U54 CA148967]; Lucille Castori Center for Microbes, Inflammation, and Cancer; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH [T32GM07739]; NATIONAL CANCER INSTITUTE [T32CA009149, P30CA008748, P01CA023766, U54CA148967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095398, R01AI042135, R01AI095706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tow Foundation; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lucille Castori Center for Microbes, Inflammation, and Cancer; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	E.G.P. received funding from US National Institutes of Health (NIH) grants RO1 AI42135 and AI95706, and from the Tow Foundation. J.B.X. received funding from the NIH Office of the Director (DP2OD008440), NCI (U54 CA148967), and from a seed grant from the Lucille Castori Center for Microbes, Inflammation, and Cancer. C.G.B. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH (award number T32GM07739, awarded to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program).	Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008; Kinnebrew MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090158; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000; Wells JE, 2003, CLIN CHIM ACTA, V331, P127, DOI 10.1016/S0009-8981(03)00115-3; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	40	1046	1132	15	410	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					205	U207		10.1038/nature13828	http://dx.doi.org/10.1038/nature13828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25337874	Green Accepted			2022-12-28	WOS:000347477600037
J	DaRosa, PA; Wang, ZZ; Jiang, XM; Pruneda, JN; Cong, F; Klevit, RE; Xu, WQ				DaRosa, Paul A.; Wang, Zhizhi; Jiang, Xiaomo; Pruneda, Jonathan N.; Cong, Feng; Klevit, Rachel E.; Xu, Wenqing			Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal	NATURE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX REVEALS; E3 LIGASE; RECOGNITION; MECHANISM; AXIN; PROTEINS; INSIGHTS; SYSTEM	Protein poly(ADP-ribosyl)ation (PARylation) has a role in diverse cellular processes such as DNA repair, transcription, Wnt signalling, andcell death(1-6). Recent studies have shown that PARylation can serve as a signal for the polyubiquitination and degradation of several crucial regulatory proteins, including Axin and 3BP2 (refs 7-9). The RING-type E3 ubiquitin ligase RNF146 (also known as Iduna) is responsible for PARylation-dependent ubiquitination (PARdU)(10-12). Here we provide a structural basis for RNF146-catalysed PARdU and how PARdU specificity is achieved. First, we show that iso-ADP-ribose (iso-ADPr), the smallest internal poly(ADP-ribose) (PAR) structural unit, binds between the WWE and RING domains of RNF146 and functions as an allosteric signal that switches the RING domain from a catalytically inactive state to an active one. In the absence of PAR, the RING domain is unable to bind and activate a ubiquitin-conjugating enzyme (E2) efficiently. Binding of PAR or iso-ADPr induces a major conformational change that creates a functional RING structure. Thus, RNF146 represents a new mechanistic class of RING E3 ligases, the activities of which are regulated by non-covalent ligand binding, and that may provide a template for designing inducible protein-degradation systems. Second, we find that RNF146 directly interacts with the PAR polymerase tankyrase (TNKS). Disruption of the RNF146-TNKS interaction inhibits turnover of the substrate Axin in cells. Thus, both substrate PARylation and PARdU are catalysed by enzymes within the same protein complex, and PARdU substrate specificity may be primarily determined by the substrate-TNKS interaction. We propose that the maintenance of unliganded RNF146 in an inactive state may serve to maintain the stability of the RNF146-TNKS complex, which in turn regulates the homeostasis of PARdU activity in the cell.	[DaRosa, Paul A.; Pruneda, Jonathan N.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [DaRosa, Paul A.; Wang, Zhizhi; Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Jiang, Xiaomo; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Novartis	Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	klevit@uw.edu; wxu@uw.edu	Klevit, Rachel/AAI-7038-2021; Wang, Zhizhi/K-3271-2016	Klevit, Rachel/0000-0002-3476-969X; Wang, Zhizhi/0000-0003-4948-925X; Da Rosa, Paul/0000-0001-7214-8758; Pruneda, Jonathan/0000-0002-0304-4418; Xu, Wenqing/0000-0002-2884-3101	National Institutes of Health (NIH) [R01 GM099766, T32 GM07270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099766, T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Brzovic and N. Zheng for discussions and editorial comments. We are grateful to the staff at Advanced Light Source (ALS) beamlines BL 8.2.1 and 8.2.2 for assistance with synchrotron data collection. This work was supported by National Institutes of Health (NIH) grant R01 GM099766 to W.X. and R.E.K. and NIH T32 GM07270 to P.A.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELANO WL, 1994, PROTEINS, V20, P105, DOI 10.1002/prot.340200202; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085377; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Virag L, 2013, MOL ASPECTS MED, V34, P1043, DOI 10.1016/j.mam.2013.05.002; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	38	127	135	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					223	U275		10.1038/nature13826	http://dx.doi.org/10.1038/nature13826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25327252	Green Accepted			2022-12-28	WOS:000347477600041
J	Gutchess, A				Gutchess, Angela			Plasticity of the aging brain: New directions in cognitive neuroscience	SCIENCE			English	Review							DIRECT-CURRENT STIMULATION; MEDIAL PREFRONTAL CORTEX; AGE-RELATED-CHANGES; EPISODIC MEMORY; SKILL ACQUISITION; OLDER-ADULTS; MOTOR; TASK; ENHANCEMENT; HIPPOCAMPUS	Cognitive neuroscience has revealed aging of the human brain to be rich in reorganization and change. Neuroimaging results have recast our framework around cognitive aging from one of decline to one emphasizing plasticity. Current methods use neurostimulation approaches to manipulate brain function, providing a direct test of the ways that the brain differently contributes to task performance for younger and older adults. Emerging research into emotional, social, and motivational domains provides some evidence for preservation with age, suggesting potential avenues of plasticity, alongside additional evidence for reorganization. Thus, we begin to see that aging of the brain, amidst interrelated behavioral and biological changes, is as complex and idiosyncratic as the brain itself, qualitatively changing over the life span.	[Gutchess, Angela] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Gutchess, Angela] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA USA; [Gutchess, Angela] Massachussetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Brandeis University; Brandeis University; Harvard University; Massachusetts General Hospital	Gutchess, A (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	gutchess@brandeis.edu						Berryhill ME, 2012, NEUROSCI LETT, V521, P148, DOI 10.1016/j.neulet.2012.05.074; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Cassidy BS, 2013, SOC NEUROSCI-UK, V8, P462, DOI 10.1080/17470919.2013.832373; Cassidy BS, 2012, SOC NEUROSCI-UK, V7, P552, DOI 10.1080/17470919.2012.674057; Coffman BA, 2014, NEUROIMAGE, V85, P895, DOI 10.1016/j.neuroimage.2013.07.083; Cotelli M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00038; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fertonani A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00131; Floel A, 2012, NEUROBIOL AGING, V33, P1682, DOI 10.1016/j.neurobiolaging.2011.05.007; Freitas C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00042; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Harty S, 2014, J NEUROSCI, V34, P3646, DOI 10.1523/JNEUROSCI.5308-13.2014; Jackson J, 2011, NEUROBIOL AGING, V32, P2162, DOI 10.1016/j.neurobiolaging.2009.12.009; Kremen WS, 2012, J GERONTOL A-BIOL, V67, P760, DOI 10.1093/gerona/gls125; Leclerc CM, 2010, SOC NEUROSCI-UK, V5, P560, DOI 10.1080/17470910903512296; Luber B, 2014, NEUROIMAGE, V85, P961, DOI 10.1016/j.neuroimage.2013.06.007; Manenti R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00049; Manenti R, 2011, BEHAV BRAIN RES, V216, P153, DOI 10.1016/j.bbr.2010.07.027; Mata R, 2011, ANN NY ACAD SCI, V1235, P18, DOI 10.1111/j.1749-6632.2011.06200.x; Meinzer M, 2013, J NEUROSCI, V33, P12470, DOI 10.1523/JNEUROSCI.5743-12.2013; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Moran JM, 2012, J NEUROSCI, V32, P5553, DOI 10.1523/JNEUROSCI.5511-11.2012; Nashiro K, 2012, GERONTOLOGY, V58, P156, DOI 10.1159/000328465; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Ross LA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00016; Samanez-Larkin GR, 2012, J NEUROSCI, V32, P5333, DOI 10.1523/JNEUROSCI.5756-11.2012; St Jacques PL, 2009, J INT NEUROPSYCH SOC, V15, P819, DOI 10.1017/S1355617709990439; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Vidal-Pineiro D, 2014, BRAIN STIMUL, V7, P287, DOI 10.1016/j.brs.2013.12.016; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zimerman M, 2014, CEREB CORTEX, V24, P1030, DOI 10.1093/cercor/bhs385; Zimerman M, 2013, ANN NEUROL, V73, P10, DOI 10.1002/ana.23761; Zimerman M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00149	40	109	115	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		579	582		10.1126/science.1254604	http://dx.doi.org/10.1126/science.1254604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359965				2022-12-28	WOS:000343799700036
J	Fralick, M; Macdonald, EM; Gomes, T; Antoniou, T; Hollands, S; Mamdani, MM; Juurlink, DN				Fralick, Michael; Macdonald, Erin M.; Gomes, Tara; Antoniou, Tony; Hollands, Simon; Mamdani, Muhammad M.; Juurlink, David N.		CDSERN	Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING ENZYME-INHIBITOR; INDUCED HYPERKALEMIA; ADMINISTRATIVE DATA; TRIMETHOPRIM; CIPROFLOXACIN; COMBINATION; MECHANISM; ONTARIO; RATES	Objective To determine whether the prescription of co-trimoxazole with an angiotensin converting enzyme inhibitor or angiotensin receptor blocker is associated with sudden death. Design Population based nested case-control study. Setting Ontario, Canada, from 1 April 1994 to 1 January 2012. Participants Ontario residents aged 66 years or older treated with an angiotensin converting enzyme inhibitor or angiotensin receptor blocker. Cases were those who died suddenly shortly after receiving an outpatient prescription for one of co-trimoxazole, amoxicillin, ciprofloxacin, norfloxacin, or nitrofurantoin. Each case was matched with up to four controls on age, sex, chronic kidney disease, and diabetes. Main outcome measure Odds ratio for the association between sudden death and exposure to each antibiotic relative to amoxicillin, after adjustment for predictors of sudden death according to a disease risk index. Results Of 39 879 sudden deaths, 1027 occurred within seven days of exposure to an antibiotic and were matched to 3733 controls. Relative to amoxicillin, co-trimoxazole was associated with an increased risk of sudden death (adjusted odds ratio 1.38, 95% confidence interval 1.09 to 1.76). The risk was marginally higher at 14 days (adjusted odds ratio 1.54, 1.29 to 1.84). This corresponds to approximately three sudden deaths within 14 days per 1000 co-trimoxazole prescriptions. Ciprofloxacin (a known cause of QT interval prolongation) was also associated with an increased risk of sudden death (adjusted odds ratio 1.29, 1.03 to 1.62), but no such risk was observed with nitrofurantoin or norfloxacin. Conclusions In older patients receiving angiotensin converting enzyme inhibitors or angiotensin receptor blockers, co-trimoxazole is associated with an increased risk of sudden death. Unrecognized severe hyperkalemia may underlie this finding. When appropriate, alternative antibiotics should be considered in such patients.	[Fralick, Michael] Univ Toronto, Dept Internal Med, Toronto, ON M5G 2C4, Canada; [Macdonald, Erin M.; Gomes, Tara; Antoniou, Tony; Hollands, Simon; Mamdani, Muhammad M.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON M5N 4M5, Canada; St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Antoniou, Tony; Mamdani, Muhammad M.; Juurlink, David N.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M7, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] King Saud Univ, Riyadh, Saudi Arabia; [Juurlink, David N.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave G106, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca		Gomes, Tara/0000-0002-1468-1965	Canadian Drug Safety and Effectiveness Research Network (CDSERN); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institute for Health Research; Ontario HIV Treatment Network	Canadian Drug Safety and Effectiveness Research Network (CDSERN); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network	This study was supported in part by a grant from the Canadian Drug Safety and Effectiveness Research Network (CDSERN) and by the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute sponsored by the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. TA is supported by a new investigator award from the Canadian Institute for Health Research and Ontario HIV Treatment Network.	Alappan R, 1999, AM J NEPHROL, V19, P389, DOI 10.1159/000013483; Antoniou T, 2010, ARCH INTERN MED, V170, P1045, DOI 10.1001/archinternmed.2010.142; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bugge JF, 1996, J INTERN MED, V240, P249, DOI 10.1046/j.1365-2796.1996.43869000.x; Canaday D, 2013, ARCH INTERN MED, V120, P437; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; EiamOng S, 1996, KIDNEY INT, V49, P1372, DOI 10.1038/ki.1996.193; Eschmann E, 2014, EUR J CLIN PHARMACOL, V70, P215, DOI 10.1007/s00228-013-1597-2; Flanagan MC, 2006, INT J CARDIOL, V113, P239, DOI 10.1016/j.ijcard.2005.08.048; Frothingham R, 2001, PHARMACOTHERAPY, V21, P1468, DOI 10.1592/phco.21.20.1468.34482; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Health and Social Care Information Centre, 2013, PRESCR DIS COMM ENGL; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Ibrahim M, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.09.039; IMS Institute for Healthcare Informatics, 2012, NAT PRESCR AUD, P46; Izzo JL, 2011, J CLIN HYPERTENS, V13, P667, DOI 10.1111/j.1751-7176.2011.00508.x; Jolobe OMP, 1997, J INTERN MED, V242, P88; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kang JS, 2001, MOL PHARMACOL, V59, P122, DOI 10.1124/mol.59.1.122; Knorr JP, 2008, AM J HEALTH-SYST PH, V65, P547, DOI 10.2146/ajhp070081; Lam N, 2011, AM J KIDNEY DIS, V57, P521, DOI 10.1053/j.ajkd.2010.11.006; Margassery S, 2001, J NEPHROL, V14, P410; Marinella MA, 1999, GERONTOLOGY, V45, P209, DOI 10.1159/000022089; Motiwala SS, 2006, CAN J AGING, V25, P363, DOI 10.1353/cja.2007.0019; National Health Services Business Association, 2009, ANT PRESCR EXCL TOP; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Prabhakar M, 2004, HEART RHYTHM, V1, P624, DOI 10.1016/j.hrthm.2004.06.020; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Schaefer TJ, 2005, EMERG MED CLIN N AM, V23, P723, DOI 10.1016/j.emc.2005.03.016; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; van Walraven C, 2013, CAN MED ASSOC J, V185, pE755, DOI 10.1503/cmaj.130875; VELAZQUEZ H, 1993, ANN INTERN MED, V119, P296, DOI 10.7326/0003-4819-119-4-199308150-00008; World Health Organization, 2013, WHO MOD LIST ESS MED; Wright AJ, 2011, CAN MED ASSOC J, V183, P303, DOI 10.1503/cmaj.100702	38	47	48	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2014	349								g6196	10.1136/bmj.g6196	http://dx.doi.org/10.1136/bmj.g6196			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DI	25359996	Green Published, hybrid			2022-12-28	WOS:000344156100002
J	Marcott, SA; Bauska, TK; Buizert, C; Steig, EJ; Rosen, JL; Cuffey, KM; Fudge, TJ; Severinghaus, JP; Ahn, J; Kalk, ML; McConnell, JR; Sowers, T; Taylor, KC; White, JWC; Brook, EJ				Marcott, Shaun A.; Bauska, Thomas K.; Buizert, Christo; Steig, Eric J.; Rosen, Julia L.; Cuffey, Kurt M.; Fudge, T. J.; Severinghaus, Jeffery P.; Ahn, Jinho; Kalk, Michael L.; McConnell, Joseph R.; Sowers, Todd; Taylor, Kendrick C.; White, James W. C.; Brook, Edward J.			Centennial-scale changes in the global carbon cycle during the last deglaciation	NATURE			English	Article							VOSTOK ICE CORE; ATMOSPHERIC CO2; ANTARCTIC ICE; POLAR ICE; CHRONOLOGY AICC2012; GREENLAND; CLIMATE; AIR; OCEAN; AGE	Global climate and the concentration of atmospheric carbon dioxide (CO2) are correlated over recent glacial cycles(1,2). The combination of processes responsible for a rise in atmospheric CO2 at the last glacial termination(1,3) (23,000 to 9,000 years ago), however, remains uncertain(1-3). Establishing the timing and rate of CO2 changes in the past provides critical insight into the mechanisms that influence the carbon cycle and helps put present and future anthropogenic emissions in context. Here we present CO2 and methane (CH4) records of the last deglaciation from a new high-accumulation West Antarctic ice core with unprecedented temporal resolution and precise chronology. We show that although low-frequency CO2 variations parallel changes in Antarctic temperature, abrupt CO2 changes occur that have a clear relationship with abrupt climate changes in the Northern Hemisphere. A significant proportion of the direct radiative forcing associated with the rise in atmospheric CO2 occurred in three sudden steps, each of 10 to 15 parts per million. Every step took place in less than two centuries and was followed by no notable change in atmospheric CO2 for about 1,000 to 1,500 years. Slow, millennial-scale ventilation of Southern Ocean CO2-rich, deep-ocean water masses is thought to have been fundamental to the rise in atmospheric CO2 associated with the glacial termination(4), given the strong covariance of CO2 levels and Antarctic temperatures(5). Our data establish a contribution from an abrupt, centennial-scale mode of CO2 variability that is not directly related to Antarctic temperature. We suggest that processes operating on centennial timescales, probably involving the Atlantic meridional overturning circulation, seem to be influencing global carbon-cycle dynamics and are at present not widely considered in Earth system models.	[Marcott, Shaun A.; Bauska, Thomas K.; Buizert, Christo; Rosen, Julia L.; Kalk, Michael L.; Brook, Edward J.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Marcott, Shaun A.] Univ Wisconsin Madison, Dept Geosci, Madison, WI 53706 USA; [Steig, Eric J.; Fudge, T. J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Cuffey, Kurt M.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Severinghaus, Jeffery P.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92037 USA; [Ahn, Jinho] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul 151742, South Korea; [McConnell, Joseph R.; Taylor, Kendrick C.] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Sowers, Todd] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [White, James W. C.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA	Oregon State University; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California San Diego; Scripps Institution of Oceanography; Seoul National University (SNU); Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Boulder	Marcott, SA (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	smarcott@wisc.edu	White, James W.C./A-7845-2009; Taylor, Kendrick/A-3469-2016; Brook, Edward/AAB-7807-2021; Marcott, Shaun A/L-7098-2015; Steig, Eric J/G-9088-2015	White, James W.C./0000-0001-6041-4684; Taylor, Kendrick/0000-0001-8535-1261; Marcott, Shaun A/0000-0003-3264-0523; Steig, Eric J/0000-0002-8191-5549; Fudge, Tyler/0000-0002-6818-7479; Buizert, Christo/0000-0002-2227-1747; Bauska, Thomas/0000-0003-1901-0367	US National Science Foundation (NSF) [0739766-ANT, 1043518-ANT, 1043092-ANT, 0839093-ANT, 1142166-ANT]; NSF [0230396, 0440817, 0944348, 0944266]; NSF Office of Polar Programs through Ice Drilling Program Office; NSF Office of Polar Programs through Ice Drilling Design and Operations group; Korea Meteorological Administration Research and Development Program [CATER 2012-7030]; Directorate For Geosciences [1043092, 0944197, 1246465, 1142166, 0944348] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1043518, 1043167, 1043522] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NSF Office of Polar Programs through Ice Drilling Program Office; NSF Office of Polar Programs through Ice Drilling Design and Operations group; Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by the US National Science Foundation (NSF) (grants 0739766-ANT, 1043518-ANT, 1043092-ANT, 0839093-ANT and 1142166-ANT). We appreciate the support of the WAIS Divide Science Coordination Office at the Desert Research Institute (DRI) of Reno, Nevada, and the University of New Hampshire for the collection and distribution of the WAIS Divide ice core and related tasks (NSF grants 0230396, 0440817, 0944348 and 0944266). Additional support for this research came from the NSF Office of Polar Programs through their support of the Ice Drilling Program Office and the Ice Drilling Design and Operations group; the US National Ice Core Laboratory, for curation of the core; Raytheon Polar Services, for logistics support in Antarctica; the 109th New York Air National Guard, for airlift to Antarctica; and the Korea Meteorological Administration Research and Development Program(CATER 2012-7030). We thank T. Alig, J. Edwards and J. Lee for assisting with CO<INF>2</INF> and CH<INF>4</INF> measurements; the DRI ultratrace ice-core lab, including D. Pasteris, M. Sigl and O. Maselli for their contribution to the aerosol records; and I. Fung for discussions and providing software for carbon uptake calculations.	Ahn J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004415; Ahn J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004247; Ahn JH, 2009, J GLACIOL, V55, P499, DOI 10.3189/002214309788816731; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; BARNOLA JM, 1991, TELLUS B, V43, P83, DOI 10.1034/j.1600-0889.1991.t01-1-00002.x; Battle MO, 2011, ATMOS CHEM PHYS, V11, P11007, DOI 10.5194/acp-11-11007-2011; Bazin L, 2013, CLIM PAST, V9, P1715, DOI 10.5194/cp-9-1715-2013; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Buizert C., 2011, ATMOS CHEM PHYS DISC, V11, P15975, DOI DOI 10.5194/ACPD-11-15975-2011; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; HERRON MM, 1980, J GLACIOL, V25, P373, DOI 10.3189/S0022143000015239; Horhold MW, 2012, EARTH PLANET SC LETT, V325, P93, DOI 10.1016/j.epsl.2011.12.022; Kaspers KA, 2004, ATMOS CHEM PHYS, V4, P1365, DOI 10.5194/acp-4-1365-2004; KHALIL MAK, 1983, J GEOPHYS RES-OCEANS, V88, P5131, DOI 10.1029/JC088iC09p05131; Kohler P, 2011, CLIM PAST, V7, P473, DOI 10.5194/cp-7-473-2011; Kohler P, 2005, CLIM DYNAM, V25, P689, DOI 10.1007/s00382-005-0058-8; Lamarque JF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045992; Legrand M. R., 1988, ANN GLACIOL, V10, P116; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Lourantou A, 2010, QUATERNARY SCI REV, V29, P1983, DOI 10.1016/j.quascirev.2010.05.002; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Mudelsee M, 2009, EUR PHYS J-SPEC TOP, V174, P49, DOI 10.1140/epjst/e2009-01089-3; Mudelsee M, 2000, COMPUT GEOSCI, V26, P293, DOI 10.1016/S0098-3004(99)00141-7; OESCHGER H, 1975, TELLUS, V27, P168, DOI 10.1111/j.2153-3490.1975.tb01671.x; Parrenin F, 2013, SCIENCE, V339, P1060, DOI 10.1126/science.1226368; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Petrenko VV, 2006, QUATERNARY SCI REV, V25, P865, DOI 10.1016/j.quascirev.2005.09.005; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P349; Rasmussen SO, 2013, CLIM PAST, V9, P2713, DOI 10.5194/cp-9-2713-2013; Sachs JP, 2005, NATURE, V434, P1118, DOI 10.1038/nature03544; Schilt A, 2010, EARTH PLANET SC LETT, V300, P33, DOI 10.1016/j.epsl.2010.09.027; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Scholze M, 2003, HOLOCENE, V13, P327, DOI 10.1191/0959683603hl625rp; SCHWANDER J, 1984, NATURE, V311, P45, DOI 10.1038/311045a0; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Siegenthaler U, 2005, TELLUS B, V57, P51, DOI 10.1111/j.1600-0889.2005.00131.x; Sigman D.M., 2007, OCEAN CIRCULATION ME, V173, P335, DOI [10.1029/173GM21, DOI 10.1029/173GM21]; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith HJ, 1997, J GEOPHYS RES-OCEANS, V102, P26577, DOI 10.1029/97JC00163; Sofen E. D., 2013, ATMOS CHEM PHYS DISC, V13, P23089, DOI [10.5194/acpd-13-23089-2013, DOI 10.5194/ACPD-13-23089-2013]; SOWERS T, 1992, J GEOPHYS RES-ATMOS, V97, P15683, DOI 10.1029/92JD01297; SOWERS T, 1989, J GEOPHYS RES-ATMOS, V94, P5137, DOI 10.1029/JD094iD04p05137; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Steig EJ, 2013, NAT GEOSCI, V6, P372, DOI [10.1038/ngeo1778, 10.1038/NGEO1778]; Stern JV, 2013, GEOPHYS RES LETT, V40, P3693, DOI 10.1002/grl.50679; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Tschumi J, 2000, J GLACIOL, V46, P45, DOI 10.3189/172756500781833359; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Weber ME, 2014, NATURE, V510, P134, DOI 10.1038/nature13397; Wu JY, 2009, SCI CHINA SER D, V52, P360, DOI 10.1007/s11430-009-0031-1	59	281	288	14	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					616	+		10.1038/nature13799	http://dx.doi.org/10.1038/nature13799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355363	Green Published			2022-12-28	WOS:000343801500046
J	McGinty, RK; Henrici, RC; Tan, S				McGinty, Robert K.; Henrici, Ryan C.; Tan, Song			Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome	NATURE			English	Article							CENTROMERIC NUCLEOSOME; H2A UBIQUITYLATION; CORE PARTICLE; E3 LIGASE; COMPLEX; MECHANISMS; PROTEINS; REVEALS; SYSTEM; DOMAIN	The Polycomb group of epigenetic enzymes represses expression of developmentally regulated genes in many eukaryotes. This group includes the Polycomb repressive complex 1 (PRC1), which ubiquitylates nucleosomal histone H2A Lys 119 using its E3 ubiquitin ligase subunits, Ring1B and Bmi1, together with an E2 ubiquitin-conjugating enzyme, UbcH5c. However, the molecular mechanism of nucleosome substrate recognition by PRC1 or other chromatin enzymes is unclear. Here we present the crystal structure of the human Ring1B-Bmi1-UbcH5c E3-E2 complex (the PRC1 ubiquitylation module) bound to its nucleosome core particle substrate. The structure shows how a chromatin enzyme achieves substrate specificity by interacting with several nucleosome surfaces spatially distinct from the site of catalysis. Our structure further reveals an unexpected role for the ubiquitin E2 enzyme in substrate recognition, and provides insight into how the related histone H2A E3 ligase, BRCA1, interacts with and ubiquitylates the nucleosome.	[McGinty, Robert K.; Henrici, Ryan C.; Tan, Song] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Henrici, Ryan C.] Penn State Univ, Schreyer Honors Coll, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tan, S (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	sxt30@psu.edu			NIGMS [GM060489-09S1, GM088236, GM111651]; Damon Runyon Post-doctoral fellowship [DRG 2107-12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111651, R01GM088236, R01GM060489] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Post-doctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the staff of APS NE-CAT beamlines 24ID-E and 24ID-C for their assistance during synchrotron data collection; H. Yennawar, N. Yennawar and J. Fecko at the Penn State Huck Institute X-ray core facility; A. Minns, M. Moore and J. Malloy for reagent preparation; T. Girish and J. Huang for assistance with data collection; S. Wang for providing U2OS cDNA; R. Makde and members of the Tan laboratory and the Penn State Center for Eukaryotic Gene Regulation for discussions. This work was supported by NIGMS grants GM060489-09S1, GM088236 and GM111651 to S. T. R. K. M. is supported by a Damon Runyon Post-doctoral fellowship (DRG 2107-12).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Arnaudo N, 2013, NAT STRUCT MOL BIOL, V20, P1119, DOI 10.1038/nsmb.2641; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; D'Arcy A, 2004, METHODS, V34, P323, DOI 10.1016/j.ymeth.2004.03.023; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shrodinger L. L. C, 2014, PYMOL MOL GRAPH SYST; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	54	200	201	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					591	+		10.1038/nature13890	http://dx.doi.org/10.1038/nature13890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355358	Green Accepted, Green Submitted			2022-12-28	WOS:000343801500040
J	Szpiro, G				Szpiro, George			John Napier: Life, Logarithms, and Legacy	NATURE			English	Book Review												georgeszpiro@gmail.com						[No title captured]	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					566	566		10.1038/514566a	http://dx.doi.org/10.1038/514566a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355349	Bronze			2022-12-28	WOS:000343801500026
J	Koschowitz, MC; Fischer, C; Sander, M				Koschowitz, Marie-Claire; Fischer, Christian; Sander, Martin			Beyond the rainbow	SCIENCE			English	Editorial Material							EVOLUTION; DINOSAUR; FEATHERS		[Koschowitz, Marie-Claire; Sander, Martin] Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, D-53115 Bonn, Germany; [Koschowitz, Marie-Claire; Fischer, Christian] Univ Gottingen, Zool Museum, Dept Morphol Systemat & Evolutionary Biol, Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Sander, Martin] Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	University of Bonn; University of Gottingen	Koschowitz, MC (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, Nussallee 8, D-53115 Bonn, Germany.	m.koschowitz@uni-bonn.de						Angielczyk KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1642; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Chang BSW, 2003, INTEGR COMP BIOL, V43, P500, DOI 10.1093/icb/43.4.500; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Clarke J, 2013, SCIENCE, V340, P690, DOI 10.1126/science.1235463; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Godefroit P, 2014, SCIENCE, V345, P451, DOI 10.1126/science.1253351; Hill G. E., 2006, BIRD COLORATION, V2; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; ROWE MP, 2000, PALAEONTOL ELECTRON, V3, P43; Wilts BD, 2014, P NATL ACAD SCI USA, V111, P4363, DOI 10.1073/pnas.1323611111; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	15	13	14	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					416	418		10.1126/science.1258957	http://dx.doi.org/10.1126/science.1258957			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342783				2022-12-28	WOS:000343822900017
J	Rademaker, K; Hodgins, G; Moore, K; Zarrillo, S; Miller, C; Bromley, GRM; Leach, P; Reid, DA; Alvarez, WY; Sandweiss, DH				Rademaker, Kurt; Hodgins, Gregory; Moore, Katherine; Zarrillo, Sonia; Miller, Christopher; Bromley, Gordon R. M.; Leach, Peter; Reid, David A.; Yepez Alvarez, Willy; Sandweiss, Daniel H.			Paleoindian settlement of the high-altitude Peruvian Andes	SCIENCE			English	Article							EARLY HUMAN OCCUPATION; C-14; CALIBRATION; ADAPTATION; CHILE	Study of human adaptation to extreme environments is important for understanding our cultural and genetic capacity for survival. The Pucuncho Basin in the southern Peruvian Andes contains the highest-altitude Pleistocene archaeological sites yet identified in the world, about 900 meters above confidently dated contemporary sites. The Pucuncho workshop site [4355 meters above sea level (masl)] includes two fishtail projectile points, which date to about 12.8 to 11.5 thousand years ago (ka). Cuncaicha rock shelter (4480 masl) has a robust, well-preserved, and well-dated occupation sequence spanning the past 12.4 thousand years (ky), with 21 dates older than 11.5 ka. Our results demonstrate that despite cold temperatures and low-oxygen conditions, hunter-gatherers colonized extremehigh-altitudeAndean environments in the Terminal Pleistocene, within about 2 ky of the initial entry of humans to South America.	[Rademaker, Kurt; Sandweiss, Daniel H.] Univ Maine, Dept Anthropol, Orono, ME 04469 USA; [Rademaker, Kurt] Schloss Hohentubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany; [Hodgins, Gregory] Univ Arizona, Dept Phys, Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA; [Hodgins, Gregory] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Moore, Katherine] Univ Penn Museum, Philadelphia, PA 19104 USA; [Zarrillo, Sonia] Dept Anthropol & Archaeol, Calgary, BC, Canada; [Miller, Christopher] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Miller, Christopher] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, D-72070 Tubingen, Germany; [Rademaker, Kurt; Bromley, Gordon R. M.; Sandweiss, Daniel H.] Univ Maine, Climate Change Inst, Bryand Global Sci Ctr, Orono, ME 04469 USA; [Leach, Peter] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Reid, David A.] Univ Illinois, Dept Anthropol, Chicago, IL 60607 USA	University of Maine System; University of Maine Orono; Eberhard Karls University of Tubingen; University of Arizona; University of Arizona; University of Pennsylvania; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Maine System; University of Maine Orono; University of Connecticut; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rademaker, K (corresponding author), Univ Maine, Dept Anthropol, South Stevens Hall, Orono, ME 04469 USA.	kurt.rademaker@umit.maine.edu	Hodgins, Gregory/GVT-3022-2022; Hodgins, Gregory/D-9730-2018; Sandweiss, Daniel/K-5808-2019; Rademaker, Kurt/AAH-1075-2021	Rademaker, Kurt/0000-0001-5676-4884	National Science Foundation Dissertation Grant [1208748]	National Science Foundation Dissertation Grant	Field work was supported by the Churchill Exploration Fund, National Geographic Society Waitt Foundation, Foundation for Exploration and Research on Cultural Origins, American Philosophical Society, and Lambda Alpha. B. Robinson and B. Hall funded pilot AMS dates. National Science Foundation Dissertation Grant no. 1208748 funded the AMS chronology. Pucuncho Basin pastoralists graciously allowed field work on their lands. A. Chu, R. Hintz, C. Mauricio, A. Ramos, A. Saenz, and E. Zuniga provided invaluable logistical support. We thank field assistants W. Beckwith, K. Gardella, M. Koehler, T. Labanowski, O. McGlamery, E. Olson, and J. Wertheim and the staff of the Arizona AMS Laboratory. E. Cooper created Fig. 2. T. Koffman and P. Strand calibrated C-II <SUP>3</SUP>He ages for Fig. 3. Two anonymous reviewers provided helpful comments on the manuscript. Additional data are available in the supplementary materials. Artifact collections are curated at the Ministry of Culture in Arequipa, Peru.	Aldenderfer M, 2006, WORLD ARCHAEOL, V38, P357, DOI 10.1080/00438240600813285; Aldenderfer MS, 2005, ADV TITICACA BASIN A, P25; Baker PT, 1976, MAN ANDES MULTIDISCI; Bigham AW, 2013, AM J HUM BIOL, V25, P190, DOI 10.1002/ajhb.22358; Blard PH, 2011, QUATERNARY SCI REV, V30, P3973, DOI 10.1016/j.quascirev.2011.11.001; Brantingham PJ, 2013, GEOARCHAEOLOGY, V28, P413, DOI 10.1002/gea.21448; Bromley GRM, 2009, QUATERNARY SCI REV, V28, P2514, DOI 10.1016/j.quascirev.2009.05.012; deFrance SD, 2009, J FIELD ARCHAEOL, V34, P227, DOI 10.1179/009346909791070853; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Dornbusch U., 1998, ERDKUNDE, V52, P41, DOI [10.3112/erdkunde.1998.01.04, DOI 10.3112/ERDKUNDE.1998.01.04]; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; Franklin W. L., 1981, SPECIAL PUBLICATION, V6, P457; Frisancho AR, 2013, AM J HUM BIOL, V25, P151, DOI 10.1002/ajhb.22367; Grosjean M, 2005, J QUATERNARY SCI, V20, P643, DOI 10.1002/jqs.969; Hather J. G., 2000, ARCHAEOLOGICAL PAREN; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Jackson D, 2007, CURR ANTHROPOL, V48, P725, DOI 10.1086/520965; Jackson L., 2006, PALEOINDIAN ARCHAEOL, P105; Jolie EA, 2011, CURR ANTHROPOL, V52, P285, DOI 10.1086/659336; Lynch Thomas F., 1980, GUITARRERO CAVE EARL; MARRIOT BM, 1996, NUTR NEEDS COLD HIGH; Melgar CM, 2013, QUATERN INT, V301, P60, DOI 10.1016/j.quaint.2012.04.003; NUNEZ L., 1987, ANDEAN PAST, V1, P57; Perry L, 2006, NATURE, V440, P76, DOI 10.1038/nature04294; Prates L, 2013, QUATERN INT, V301, P104, DOI 10.1016/j.quaint.2013.03.011; Rademaker K., 2012, THESIS U MAINE ORONO; Rademaker K., 2012, LEAST COST ANAL SOCI, P32; Rademaker K, 2013, GEOLOGY, V41, P779, DOI 10.1130/G34313.1; Rademaker K, 2013, QUATERN INT, V301, P34, DOI 10.1016/j.quaint.2012.08.2052; Rick J. W., 1999, B ARQUEOLOGIA PUCP, V3, P263; Rick John, 1980, PREHISTORIC HUNTERS; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Steele J, 2009, J ARCHAEOL SCI, V36, P419, DOI 10.1016/j.jas.2008.09.024; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Weiss KM, 2007, EVOL ANTHROPOL, V16, P164, DOI 10.1002/evan.20140; Zhou D, 2013, AM J HUM GENET, V93, P452, DOI 10.1016/j.ajhg.2013.07.011	38	128	136	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					466	469		10.1126/science.1258260	http://dx.doi.org/10.1126/science.1258260			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AR8KB	25342802				2022-12-28	WOS:000343822900042
J	Fokkens, WJ; Hoffmans, R; Thomas, M				Fokkens, Wytske J.; Hoffmans, Ruth; Thomas, Mike			CHANGE PAGE Avoid prescribing antibiotics in acute rhinosinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESPIRATORY-TRACT INFECTIONS; PRIMARY-CARE; COMPLICATIONS; RESISTANCE; SINUSITIS		[Fokkens, Wytske J.; Hoffmans, Ruth] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands; [Thomas, Mike] Univ Southampton, Dept Primary Care Res, Southampton SO9 5NH, Hants, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Southampton	Fokkens, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.j.fokkens@amc.nl	Fokkens, Wytske WJ/ABF-2185-2020					Ahovuo-Saloranta A, 2008, COCHRANE DB SYST REV, V16; Babar-Craig H, 2010, RHINOLOGY, V48, P344, DOI 10.4193/Rhino09.130; Brookes-Howell L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000796; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Desrosiers M, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-2; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hansen FS, 2012, FAM PRACT, V29, P147, DOI 10.1093/fampra/cmr062; HANSEN JG, 1995, BRIT MED J, V311, P233, DOI 10.1136/bmj.311.6999.233; Hoffmans R, 2011, PRIM CARE RESP J, V20, P64, DOI 10.4104/pcrj.2010.00064; Jorgensen LC, 2013, SCAND J PRIM HEALTH, V31, P101, DOI 10.3109/02813432.2013.788270; Lemiengre MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006089.pub4; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Sastre J, 2012, J INVEST ALLERG CLIN, V22, P1; Schafer T, 2011, RHINOLOGY, V49, P272, DOI [10.4193/Rhin10.170, 10.4193/Rhino10.170]; Shaikh N, 2010, COCHRANE DB SYST REV, V12; Shintani Smith S, 2014, LARYNGOSCOPE; Smith SS, 2013, J ALLERGY CLIN IMMUN, V132, P1230, DOI 10.1016/j.jaci.2013.07.009; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; Wang DY, 2011, RHINOLOGY, V49, P264, DOI 10.4193/Rhino10.169; WILLIAMS JW, 1992, ANN INTERN MED, V117, P705, DOI 10.7326/0003-4819-117-9-705; Wood F, 2013, J ANTIMICROB CHEMOTH, V68, P237, DOI 10.1093/jac/dks338; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X; Zalmanovici A, 2009, COCHRANE DB SYST REV, V4	24	11	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g5703	10.1136/bmj.g5703	http://dx.doi.org/10.1136/bmj.g5703			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25353368				2022-12-28	WOS:000343767700001
J	Hoffman, JR; Kanzaria, HK				Hoffman, Jerome R.; Kanzaria, Hemal K.			Intolerance of error and culture of blame drive medical excess	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFENSIVE MEDICINE; HEALTH; PHYSICIANS; ASSOCIATION; SERVICES; CLAIMS; COSTS; RISK	Jerome R Hoffman and Hemal K Kanzaria argue that efforts to reduce overdiagnosis and overtreatment should focus on changing professional and public attitudes towards medical error and uncertainty	[Hoffman, Jerome R.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Kanzaria, Hemal K.] Univ Calif Los Angeles, Robert Wood Johnson Fdn Clin Scholars Program, US Dept Vet Affairs, Ctr Emergency Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; US Department of Veterans Affairs	Hoffman, JR (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.	jrh@ucla.edu						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; BAICKER K, 2005, FORUM HLTH EC POLICY, V8; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Baker DW, 2013, ANN INTERN MED, V158, P55, DOI 10.7326/0003-4819-158-1-201301010-00560; Carrier ER, 2010, HEALTH AFFAIR, V29, P1585, DOI 10.1377/hlthaff.2010.0135; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Cunningham Wayne, 2006, N Z Med J, V119, pU2283; Elshaug AG, 2013, JAMA-J AM MED ASSOC, V309, P775, DOI 10.1001/jama.2013.828; Elshaug AG, 2012, MED J AUSTRALIA, V197, P556, DOI 10.5694/mja12.11083; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Garner S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4519; Hermer LD, 2010, J GEN INTERN MED, V25, P470, DOI 10.1007/s11606-010-1259-3; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kachalia A, 2007, ANN EMERG MED, V49, P196, DOI 10.1016/j.annemergmed.2006.06.035; Kanzaria HK, 2014, ACAD EMERG MED S1, V21; KASSIRER JP, 1989, NEW ENGL J MED, V320, P1489, DOI 10.1056/NEJM198906013202211; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kessler DP, 2011, J ECON PERSPECT, V25, P93, DOI 10.1257/jep.25.2.93; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mitchell JM, 2008, MED CARE, V46, P460, DOI 10.1097/MLR.0b013e31815dc5ae; Mitchell JM, 2012, HEALTH AFFAIR, V31, P741, DOI 10.1377/hlthaff.2011.1372; Mitchell JM, 2010, ARCH SURG-CHICAGO, V145, P732, DOI 10.1001/archsurg.2010.149; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7141; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; National Institute for Health and Clinical Excellence, DO NOT DO REC; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Sloan FA, 2009, J HEALTH ECON, V28, P481, DOI 10.1016/j.jhealeco.2008.12.006; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Studdert DM, 2004, NEW ENGL J MED, V350, P283, DOI 10.1056/NEJMhpr035470	36	56	56	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2014	349								g5702	10.1136/bmj.g5702	http://dx.doi.org/10.1136/bmj.g5702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7NT	25315302	Green Published			2022-12-28	WOS:000343767300001
J	Yawar, A				Yawar, Athar			The art of medicine In praise of Muswell Hillbillies	LANCET			English	Editorial Material												athar.yawar@doctors.org.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1340	1341		10.1016/S0140-6736(14)61808-0	http://dx.doi.org/10.1016/S0140-6736(14)61808-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AQ7NH	25317446				2022-12-28	WOS:000343004000014
J	Roebroeks, W				Roebroeks, Wil			Art on the move	NATURE			English	Editorial Material							CAVE; NEANDERTHAL; PLEISTOCENE; EVOLUTION; HOMININ		Leiden Univ, Fac Archaeol, Human Origins Grp, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Roebroeks, W (corresponding author), Leiden Univ, Fac Archaeol, Human Origins Grp, NL-2300 RA Leiden, Netherlands.	w.roebroeks@arch.leidenuniv.nl		Roebroeks, Wil/0000-0002-5075-6899				Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Barker G., 2013, RAINFOREST FORAGING; Broglio A, 2009, ANTHROPOLOGIE, V113, P753, DOI 10.1016/j.anthro.2009.09.016; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Callaway E., 2014, NATURE; Dalen L, 2012, MOL BIOL EVOL, V29, P1893, DOI 10.1093/molbev/mss074; David B, 2013, J ARCHAEOL SCI, V40, P3, DOI 10.1016/j.jas.2012.08.019; Dennell R. W., 2014, SO ASIA AUSTR SEARCH; Fage L-H., 2010, BORNEO MEMORY CAVES; Gibbons A, 2014, SCIENCE, V343, P1417, DOI 10.1126/science.343.6178.1417; Hawks J, 2013, ANNU REV ANTHROPOL, V42, P433, DOI 10.1146/annurev-anthro-092412-155548; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; O'Connell JF, 2012, AUST ARCHAEOL, P5; OConnell J.F., 2010, GLOBAL ORIGINS DEV S, P57; Pettitt P, 2008, J HUM EVOL, V55, P908, DOI 10.1016/j.jhevol.2008.04.003; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rodriguez-Vidal J., 2014, P NATL ACAD SCI US; Valladas H, 2001, NATURE, V413, P479, DOI 10.1038/35097160	20	5	5	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					170	171		10.1038/514170a	http://dx.doi.org/10.1038/514170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AQ3BG	25297428				2022-12-28	WOS:000342663100025
J	Goldman, LE; Sarkar, U; Kessell, E; Guzman, D; Schneidermann, M; Pierluissi, E; Walter, B; Vittinghoff, E; Critchfield, J; Kushel, M				Goldman, L. Elizabeth; Sarkar, Urmimala; Kessell, Eric; Guzman, David; Schneidermann, Michelle; Pierluissi, Edgar; Walter, Barbara; Vittinghoff, Eric; Critchfield, Jeff; Kushel, Margot			Support From Hospital to Home for Elders A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							VULNERABLE PATIENTS; PRIMARY-CARE; FOLLOW-UP; DISCHARGE; READMISSIONS; UTILITY; REHOSPITALIZATION; RELIABILITY; PROGRAM; BOOST	Background: Hospitals are implementing discharge support programs to reduce readmissions, and these programs have had mixed success. Objective: To examine whether a peridischarge, nurse-led intervention decreased emergency department (ED) visits or readmissions among ethnically and linguistically diverse older patients admitted to a safety-net hospital. Design: Randomized, controlled trial using computer-generated randomization with 1: 1 allocation, stratified by language. (Clinical Trials.gov: NCT01221532) Setting: Publicly funded urban hospital in Northern California. Patients: Hospitalized adults aged 55 years or older with anticipated discharge to the community who spoke English, Spanish, or Chinese (Mandarin or Cantonese). Intervention: Usual care versus in-hospital, one-on-one, self-management education given by a dedicated language-concordant registered nurse combined with a telephone follow-up after discharge from a nurse practitioner. Measurements: Staff blinded to the study groups determined ED visits or readmissions to any facility at 30, 90, and 180 days after initial hospital discharge using administrative data from several hospitals. Results: There were 700 low-income, ethnically and linguistically diverse patients with a mean age of 66.2 years (SD, 9.0). The primary outcome of ED visits or readmissions did not differ between the intervention and usual care groups (hazard ratio, 1.26 [95% CI, 0.89 to 1.78] at 30 days, 1.21 [ CI, 0.91 to 1.62] at 90 days, and 1.11 [ CI, 0.86 to 1.43] at 180 days). Limitations: This study was done at a single acute-care hospital. There were fewer outcomes than expected, which may have caused the study to be underpowered. Conclusion: A nurse-led, in-hospital discharge support intervention did not show a reduction in readmissions or ED visits among diverse, low-income older adults at a safety-net hospital. Although wide CIs preclude firm conclusions, the intervention may have increased ED visits. Alternative readmission prevention strategies should be tested in this population.	[Goldman, L. Elizabeth; Sarkar, Urmimala; Kessell, Eric; Guzman, David; Schneidermann, Michelle; Pierluissi, Edgar; Walter, Barbara; Vittinghoff, Eric; Critchfield, Jeff; Kushel, Margot] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Goldman, LE (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Med, Dept Internal Med, 1001 Potrero Ave,Box 1364, San Francisco, CA 94110 USA.	legoldman@medsfgh.ucsf.edu		Kushel, Margot/0000-0002-1361-6889	Gordon and Betty Moore Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018090] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Primary Funding Source: Gordon and Betty Moore Foundation.	Ali R, 2002, ADDICTION, V97, P1183; Balaban RB, 2008, J GEN INTERN MED, V23, P1228, DOI 10.1007/s11606-008-0618-9; Brown-Williams H., 2006, HOSP HOME IMPROVING; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Centers for Disease Control and Prevention, 2009, 2008 NAT HLTH INT SU; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chew LD, 2004, FAM MED, V36, P588; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Cunningham PJ, 2008, HEALTH AFFAIR, V27, pW374, DOI 10.1377/hlthaff.27.5.w374; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Debling D, 2005, Z GERONTOL GERIATR, V38, P360, DOI 10.1007/s00391-005-0299-5; Dudas V, 2002, DM-DIS MON, V48, P239, DOI 10.1016/S0011-5029(02)90031-3; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gerhardt G, 2013, DATA SHOWS REDUCTION, V3; Hansen LO, 2013, J HOSP MED, V8, P421, DOI 10.1002/jhm.2054; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; Huang L, 2006, J MED LIBR ASSOC, V94, P234; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jha AK, 2013, J HOSP MED, V8, P470, DOI 10.1002/jhm.2069; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lewin ME, 2000, AM HLTH CARE SAFETY; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; McCarthy D, 2013, JAMA-J AM MED ASSOC, V309, P351, DOI 10.1001/jama.2013.1; Naylor Mary D, 2002, Annu Rev Nurs Res, V20, P127; Naylor Mary D, 2004, LDI Issue Brief, V9, P1; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Ness D, 2013, REDUCING HOSP READMI; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098; Project BOOST Team, 2014, OV PROJ BOOST IMPL T; Reuland DS, 2009, ANN FAM MED, V7, P455, DOI 10.1370/afm.981; Sarkar U, 2011, J GEN INTERN MED, V26, P265, DOI 10.1007/s11606-010-1552-1; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Schillinger D, 2009, DIABETES CARE, V32, P559, DOI 10.2337/dc08-0787; Searight HR, 2007, PRIMARY CARE, V34, P551, DOI 10.1016/j.pop.2007.05.012; Shepperd S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub3; SHIN HB, 2003, LANGUAGE USE ENGLISH; Society of Hospital Medicine, 2014, USE PROJ BOOST IMPL; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sudore RL, 2006, J GEN INTERN MED, V21, P867, DOI 10.1111/j.1525-1497.2006.00535.x; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; Volz A, 2011, J BEHAV MED, V34, P13, DOI 10.1007/s10865-010-9282-8; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams MV, 2002, FAM MED, V34, P383	53	49	49	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					472	+		10.7326/M14-0094	http://dx.doi.org/10.7326/M14-0094			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9LU	25285540				2022-12-28	WOS:000343896700006
J	Lennox, JL; Landovitz, RJ; Ribaudo, HJ; Ofotokun, I; Na, LH; Godfrey, C; Kuritzkes, DR; Sagar, M; Brown, TT; Cohn, SE; McComsey, GA; Aweeka, F; Fichtenbaum, CJ; Presti, RM; Koletar, SL; Haas, DW; Patterson, KB; Benson, CA; Baugh, BP; Leavitt, RY; Rooney, JF; Seekins, D; Currier, JS				Lennox, Jeffrey L.; Landovitz, Raphael J.; Ribaudo, Heather J.; Ofotokun, Ighovwerha; Na, Lumine H.; Godfrey, Catherine; Kuritzkes, Daniel R.; Sagar, Manish; Brown, Todd T.; Cohn, Susan E.; McComsey, Grace A.; Aweeka, Francesca; Fichtenbaum, Carl J.; Presti, Rachel M.; Koletar, Susan L.; Haas, David W.; Patterson, Kristine B.; Benson, Constance A.; Baugh, Bryan P.; Leavitt, Randi Y.; Rooney, James F.; Seekins, Daniel; Currier, Judith S.		ACTG A5257 Team	Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1	ANNALS OF INTERNAL MEDICINE			English	Article							DISOPROXIL FUMARATE; RITONAVIR; THERAPY; INDIVIDUALS; COBICISTAT; TRIAL; RISK	Background: Nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy is not suitable for all treatment-naive HIV-infected persons. Objective: To evaluate 3 nonnucleoside reverse transcriptase inhibitor-sparing initial antiretroviral regimens to show equivalence for virologic efficacy and tolerability. Design: A phase 3, open-label study randomized in a 1: 1: 1 ratio with follow-up for at least 96 weeks. (ClinicalTrials.gov: NCT00811954) Setting: 57 sites in the United States and Puerto Rico. Patients: Treatment-naive persons aged 18 years or older with HIV-1 RNA levels greater than 1000 copies/mL without resistance to nucleoside reverse transcriptase inhibitors or protease inhibitors. Intervention: Atazanavir, 300 mg/d, with ritonavir, 100 mg/d; raltegravir, 400 mg twice daily; or darunavir, 800 mg/d, with ritonavir, 100 mg/d, plus combination emtricitabine, 200 mg/d, and tenofovir disoproxil fumarate, 300 mg/d. Measurements: Virologic failure, defined as a confirmed HIV-1 RNA level greater than 1000 copies/mL at or after 16 weeks and before 24 weeks or greater than 200 copies/mL at or after 24 weeks, and tolerability failure, defined as discontinuation of atazanavir, raltegravir, or darunavir for toxicity. A secondary end point was a combination of virologic efficacy and tolerability. Results: Among 1809 participants, all pairwise comparisons of incidence of virologic failure over 96 weeks showed equivalence within a margin of equivalence defined as -10% to 10%. Raltegravir and ritonavir-boosted darunavir were equivalent for tolerability, whereas ritonavir-boosted atazanavir resulted in a 12.7% and 9.2% higher incidence of tolerability discontinuation than raltegravir and ritonavir-boosted darunavir, respectively, primarily because of hyperbilirubinemia. For combined virologic efficacy and tolerability, ritonavir-boosted darunavir was superior to ritonavir-boosted atazanavir, and raltegravir was superior to both protease inhibitors. Antiretroviral resistance at the time of virologic failure was rare but more frequent with raltegravir. Limitation: The trial was open-label, and ritonavir was not provided. Conclusion: Over 2 years, all 3 regimens attained high and equivalent rates of virologic control. Tolerability of regimens containing raltegravir or ritonavir-boosted darunavir was superior to that of the ritonavir-boosted atazanavir regimen.	Grady Mem Hosp, Atlanta, GA USA; [Lennox, Jeffrey L.] Emory Univ, Sch Med, Atlanta, GA 30303 USA; Ctr Clin AIDS Res & Educ, Los Angeles, CA USA; Univ Calif Los Angeles, Los Angeles, CA 90035 USA; Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; [Godfrey, Catherine] NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD 21287 USA; [Cohn, Susan E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; [Aweeka, Francesca] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; [Fichtenbaum, Carl J.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Presti, Rachel M.] Washington Univ, Sch Med, St Louis, MO 63110 USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Baugh, Bryan P.] Janssen Sci Affairs, Titusville, NJ 08560 USA; Merck, Whitehouse Stn, NJ USA; [Rooney, James F.] Gilead Sci, Foster City, CA 94404 USA; Bristol Myers Squibb Co, New York, NY 10154 USA	Emory University; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Northwestern University; Feinberg School of Medicine; Case Western Reserve University; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; Washington University (WUSTL); University System of Ohio; Ohio State University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Diego; Johnson & Johnson; Janssen Pharmaceuticals; Merck & Company; Gilead Sciences; Bristol-Myers Squibb	Lennox, JL (corresponding author), Emory Univ, Sch Med, Div Infect Dis, 69 Jesse Hill Jr Dr SE,Suite 202, Atlanta, GA 30303 USA.	jlennox@emory.edu	Sagar, Manish/ABB-3816-2020; Sagar, Manish/Y-2611-2019; Ofotokun, Ighovwerha/L-6545-2015; Cohn, Susan E/ABB-3629-2020	Sagar, Manish/0000-0001-9803-6594; Ofotokun, Ighovwerha/0000-0003-2735-1903; Presti, Rachel/0000-0002-5469-0727; Fichtenbaum, Carl/0000-0002-6778-7253	National Institute of Allergy and Infectious Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, UL1TR000004, UL1TR000445, UL1TR000439, UL1TR000457, UL1TR001082, UL1TR000124, UL1TR001079, UL1TR000454, UL1TR001111, UL1TR000170] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156, UL1RR024160, S10RR002415, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069503, U01AI069432, UM1AI069471, U01AI069418, P30AI045008, U01AI069424, U01AI069447, P30AI060354, UM1AI069496, UM1AI106701, UM1AI069472, P30AI050409, UM1AI069470, U01AI069481, U01AI069501, P30AI027763, UM1AI069481, UM1AI069465, UM1AI068636, UM1AI069494, U01AI069471, UM1AI069511, UM1AI069439, UM1AI069452, UM1AI069419, P30AI050410, P30AI028697, U01AI069477, U01AI069494, UM1AI069484, UM1AI069423, U01AI069556, UM1AI069532, UM1AI069534, UM1AI069412, UM1AI068634, U01AI069439, U01AI068636, UM1AI069501, UM1AI069424, UM1AI069556, UM1AI069432, UM1AI069418, UM1AI069415, UM1AI069477] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary Funding Source: National Institute of Allergy and Infectious Diseases.	Aberg JA, 2012, AIDS RES HUM RETROV, V28, P1184, DOI 10.1089/aid.2011.0327; Boyd SD, 2011, ANTIVIR THER, V16, P257, DOI 10.3851/IMP1749; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Currier J, 2009, 16 C RETR OPP INF MO; Currier J, 2010, ANN INTERN MED, V153, P349, DOI 10.7326/0003-4819-153-6-201009210-00002; D'Ascenzo F, 2012, EUR HEART J, V33, P875, DOI 10.1093/eurheartj/ehr456; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Elion R, 2011, AIDS, V25, P1881, DOI 10.1097/QAD.0b013e32834b4d48; Gallant JE, 2013, J INFECT DIS, V208, P32, DOI 10.1093/infdis/jit122; Monteiro P, 2013, J ANTIMICROB CHEMOTH, V68, P404, DOI 10.1093/jac/dks416; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Periard D, 1999, CIRCULATION, V100, P700, DOI 10.1161/01.CIR.100.7.700; PRENTICE RL, 1979, BIOMETRICS, V35, P25, DOI 10.2307/2529934; Stein JH, 2013, AIDS, V27, P929, DOI 10.1097/QAD.0b013e32835ce27e; U.S. Department of Health and Human Services; U.S. Food and Drug Administration; Center for Drug Evaluation and Research, 2013, GUID IND HU IN PRESS; US Department of Health and Human Services, 2014, GUID US ANT AG HIV 1; US Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER), 2002, GUID IND ANT DRUGS U; Wiens BL, 2000, CONTROL CLIN TRIALS, V21, P127, DOI 10.1016/S0197-2456(99)00052-5; World Health Organization, 2013, CONS GUID US ANT ROV; Worm SW, 2012, J INFECT DIS, V205, P535, DOI 10.1093/infdis/jir788; Young B, 2011, ANTIVIR THER, V16, P253, DOI 10.3851/IMP1748	21	198	201	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					461	+		10.7326/M14-1084	http://dx.doi.org/10.7326/M14-1084			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25285539	Green Accepted			2022-12-28	WOS:000343896700004
J	Tilman, D; Snell-Rood, E				Tilman, David; Snell-Rood, Emilie			ECOLOGY Diversity breeds complementarity	NATURE			English	Editorial Material							COMMUNITIES	Evolutionary and ecosystem processes have long been treated as distinct. The finding that interactions among plant species cause rapid evolutionary changes that affect ecosystem function suggests that it is time for unification. SEE LETTER P.108	[Tilman, David; Snell-Rood, Emilie] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu; emilies@umn.edu	Tilman, David/ABD-5309-2021		Direct For Biological Sciences [1234162] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 2011, AM NAT, V178, P355, DOI 10.1086/661245; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	9	23	23	7	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					44	45		10.1038/nature13929	http://dx.doi.org/10.1038/nature13929			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25317559				2022-12-28	WOS:000344187500025
J	Adams, WM				Adams, W. M.			The value of valuing nature	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY; CONSERVATION; CHALLENGE; BENEFITS; FOREST		Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England	University of Cambridge	Adams, WM (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	wa12@cam.ac.uk		Adams, William/0000-0002-1559-0379				Abson DJ, 2011, CONSERV BIOL, V25, P250, DOI 10.1111/j.1523-1739.2010.01623.x; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Birch JC, 2014, ECOSYST SERV, V8, P118, DOI 10.1016/j.ecoser.2014.03.005; Cimon-Morin J, 2013, BIOL CONSERV, V166, P144, DOI 10.1016/j.biocon.2013.06.023; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Kallis G, 2013, ECOL ECON, V94, P97, DOI 10.1016/j.ecolecon.2013.07.002; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Lopez-Hoffman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087912; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Moller I, 2011, ESTUAR COAST SHELF S, V92, P424, DOI 10.1016/j.ecss.2011.01.016; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Muradian R, 2012, ECOSYST SERV, V1, P93, DOI 10.1016/j.ecoser.2012.07.009; Palmer MA, 2014, ECOL ENG, V65, P62, DOI 10.1016/j.ecoleng.2013.07.059; Redford KH, 2014, ORYX, V48, P330, DOI 10.1017/S0030605314000040; Redford KH, 2009, CONSERV BIOL, V23, P785, DOI 10.1111/j.1523-1739.2009.01271.x; Simonit S, 2013, P NATL ACAD SCI USA, V110, P9326, DOI 10.1073/pnas.1112242110	16	71	74	2	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		549	551		10.1126/science.1255997	http://dx.doi.org/10.1126/science.1255997			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359952				2022-12-28	WOS:000343799700023
J	Friedman, RA				Friedman, Richard A.			Antidepressants' Black-Box Warning-10 Years Later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FDA WARNINGS; DEPRESSION		[Friedman, Richard A.] Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA; [Friedman, Richard A.] Cornell Univ, Psychopharmacol Clin, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Friedman, RA (corresponding author), Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA.							[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P321; Hamad T, RELATIONSHIP PSYCHOT; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007	5	69	72	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1666	1668		10.1056/NEJMp1408480	http://dx.doi.org/10.1056/NEJMp1408480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354101				2022-12-28	WOS:000343768500003
J	McWilliams, JM; Landon, BE; Chernew, ME; Zaslavsky, AM				McWilliams, J. Michael; Landon, Bruce E.; Chernew, Michael E.; Zaslavsky, Alan M.			Changes in Patients' Experiences in Medicare Accountable Care Organizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MANAGED CARE; PERFORMANCE	BACKGROUND Incentives for accountable care organizations (ACOs) to limit health care use and improve quality may enhance or hurt patients' experiences with care. METHODS Using Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey data covering 3 years before and 1 year after the start of Medicare ACO contracts in 2012 as well as linked Medicare claims, we compared patients' experiences in a group of 32,334 fee-for-service beneficiaries attributed to ACOs (ACO group) with those in a group of 251,593 beneficiaries attributed to other providers (control group), before and after the start of ACO contracts. We used linear regression and a difference-in-differences analysis to estimate changes in patients' experiences in the ACO group that differed from concurrent changes in the control group, with adjustment for the sociodemographic and clinical characteristics of the patients. RESULTS After ACO contracts began, patients' reports of timely access to care and their primary physicians' being informed about specialty care differentially improved in the ACO group, as compared with the control group (P = 0.01 and P = 0.006, respectively), whereas patients' ratings of physicians, interactions with physicians, and overall care did not differentially change. Among patients with multiple chronic conditions and high predicted Medicare spending, overall ratings of care differentially improved in the ACO group as compared with the control group (P = 0.02). Differential improvements in timely access to care and overall ratings were equivalent to moving from average performance among ACOs to the 86th to 98th percentile (timely access to care) and to the 82nd to 96th percentile (overall ratings) and were robust to adjustment for group differences in trends during the preintervention period. CONCLUSIONS In the first year, ACO contracts were associated with meaningful improvements in some measures of patients' experience and with unchanged performance in others.	[McWilliams, J. Michael; Landon, Bruce E.; Chernew, Michael E.; Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [McWilliams, J. Michael] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu			National Institute on Aging [P01 AG032952]; Laura and John Arnold Foundation; Doris Duke Charitable Foundation [2010053]; Paul B. Beeson Career Development Program of the National Institute on Aging [K08 AG038354]; American Federation for Aging Research; NATIONAL INSTITUTE ON AGING [P01AG032952, K08AG038354] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Laura and John Arnold Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Paul B. Beeson Career Development Program of the National Institute on Aging; American Federation for Aging Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (P01 AG032952) and the Laura and John Arnold Foundation, a Clinical Scientist Development Award from the Doris Duke Charitable Foundation (2010053), and a grant (K08 AG038354) from the Paul B. Beeson Career Development Program of the National Institute on Aging and the American Federation for Aging Research.	Agency for Healthcare Research and Quality, 2008, CRAT NEW RAC ETHN CO; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Center for Medicare and Medicaid In- novation, 2011, PION ACO AL FIN REC; Center for Medicare and Medicaid Innovation, 2012, SEL PART POON ACO MO; Centers for Medicare and Medicaid Services, 2013, MED SHAR SAV PROGR A; Centers for Medicare and Medicaid Services, MED SCHAR SAV PROGR; Centers for Medicare and Medicaid Services, 2012, ACC CAR ORG 2013 PRO; Centers for Medicare and Medicaid Services, FEE FOR SERV FFS CAH; Centers for Medicare and Medicaid Services, 2014, PERF YEAR 1 INTERIM; Centers for Medicare and Medicaid Services, 2012, CMS NAM 88 NEW MED S; Centers for Medicare & Medicaid Services, 2011, PION ACC CAR ORG ACO; Goldstein E, 2001, HEALTH CARE FINANC R, V22, P101; Kranker K., 2022, EVALUATION MEDICARE; Landon BE, 2004, JAMA-J AM MED ASSOC, V291, P1744, DOI 10.1001/jama.291.14.1744; Lee TH, 2014, HARVARD BUSINESS REV; Lied TR, 2003, HEALTH CARE FINANC R, V25, P55; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x	19	125	125	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1715	1724		10.1056/NEJMsa1406552	http://dx.doi.org/10.1056/NEJMsa1406552			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354105	Green Accepted, Bronze			2022-12-28	WOS:000343768500009
J	Wakeford, R				Wakeford, Richard			Fire the Medical Schools Council if you want more GPs Specialists are massively over-represented in medical schools' representative body, and it shows, writes Richard Wakeford	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Wakeford, R (corresponding author), Univ Cambridge, Hughes Hall, Cambridge CB2 1TN, England.							Department of Health Higher Education Funding Council for England, 2012, HLTH ED NAT STRAT EX; Fysh Thomas H S, 2007, BMC Med Educ, V7, P2, DOI 10.1186/1472-6920-7-2; Limb M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4799; McManus IC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-5; McManus IC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2621; NHS GP Taskforce, 2014, SEC FUT GP WORKF DEL; Sinclair Hazel K, 2006, Eur J Gen Pract, V12, P120, DOI 10.1080/13814780600780833; Tiffin PA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2622; UK Foundation Programme, F2 CAR DEST REP 2013; vimeo.com, IMP TRAIN STUD GP PR; Wakeford R., 2013, ANN REP AUG 2012 JUL	11	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2014	349								g6245	10.1136/bmj.g6245	http://dx.doi.org/10.1136/bmj.g6245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DB	25352271				2022-12-28	WOS:000344155300004
J	Lingham-Soliar, T				Lingham-Soliar, Theagarten			Comment on "A Jurassic ornithischian dinosaur from Siberia with both feathers and scales"	SCIENCE			English	Editorial Material							COLLAGEN-FIBERS; MORPHOLOGY; SKIN	Godefroit et al. (Reports, 25 July 2014, p. 451) reported scales and feathers, including "basal plates," in an ornithischian dinosaur. Their arguments against the filaments being collagen fibers are not supported because of a fundamental misinterpretation of such structures and underestimation of their size. The parsimonious explanation is that the filaments are support fibers in association with badly degraded scales and that they do not represent early feather stages.	Nelson Mandela Metropolitan Univ, Port Elizabeth, South Africa	Nelson Mandela University	Lingham-Soliar, T (corresponding author), Nelson Mandela Metropolitan Univ, Port Elizabeth, South Africa.	theagarajen.soliar@nmmu.ac.za						Axer H, 2001, J SURG RES, V96, P127, DOI 10.1006/jsre.2000.6070; Godefroit P, 2014, SCIENCE, V345, P451, DOI 10.1126/science.1253351; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P563, DOI 10.1007/s00114-003-0483-7; Lingham-Soliar T, 2001, LETHAIA, V34, P287, DOI 10.1080/002411601753293042; Lingham-Soliar T, 2005, J MORPHOL, V263, P1, DOI 10.1002/jmor.10207; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2012, J ORNITHOL, V153, P699, DOI 10.1007/s10336-011-0787-x; Lingham-Soliar T, 2010, PALAEOGEOGR PALAEOCL, V291, P481, DOI 10.1016/j.palaeo.2010.03.019; Lingham-Soliar T, 2010, NATURWISSENSCHAFTEN, V97, P479, DOI 10.1007/s00114-010-0661-3; MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263; Pabst DA, 1996, J ZOOL, V238, P35, DOI 10.1111/j.1469-7998.1996.tb05378.x; Reichlin T, 2005, J STRUCT BIOL, V152, P52, DOI 10.1016/j.jsb.2005.07.009	12	3	3	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208								10.1126/science.1259983	http://dx.doi.org/10.1126/science.1259983			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342795				2022-12-28	WOS:000343822900030
J	Pullium, JK; Roble, GS; Raymond, MA				Pullium, Jennifer K.; Roble, Gordon S.; Raymond, Mark A.			Be prepared	NATURE			English	Editorial Material									[Pullium, Jennifer K.; Roble, Gordon S.; Raymond, Mark A.] NYU, Div Lab Anim Resources, Langone Med Ctr, New York, NY 10012 USA	New York University; NYU Langone Medical Center	Pullium, JK (corresponding author), NYU, Div Lab Anim Resources, Langone Med Ctr, New York, NY 10012 USA.	jennifer.pullium@nyumc.org						Crichton M, 2001, PSIHOL OBZ, V10, P7; Crichton MT, 2004, ANN NUCL ENERGY, V31, P1317, DOI 10.1016/j.anucene.2004.03.011; Fishell G, 2013, NATURE, V496, P421, DOI 10.1038/496421a	3	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					430	430		10.1038/514430a	http://dx.doi.org/10.1038/514430a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341773	Bronze			2022-12-28	WOS:000343775900017
J	Grigoryan, L; Trautner, BW; Gupta, K				Grigoryan, Larissa; Trautner, Barbara W.; Gupta, Kalpana			Diagnosis and Management of Urinary Tract Infections in the Outpatient Setting A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE UNCOMPLICATED CYSTITIS; SINGLE-DOSE FOSFOMYCIN; TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE; EXTENDED-RELEASE CIPROFLOXACIN; RANDOMIZED CONTROLLED TRIAL; TELEPHONE MANAGEMENT; WOMEN; NITROFURANTOIN; THERAPY; NORFLOXACIN	IMPORTANCE Urinary tract infection is among the most common reasons for an outpatient visit and antibiotic use in adult populations. The increasing prevalence of antibacterial resistance among community uropathogens affects the diagnosis and management of this clinical syndrome. OBJECTIVES To define the optimal approach for treating acute cystitis in young healthy women and in women with diabetes and men and to define the optimal approach for diagnosing acute cystitis in the outpatient setting. EVIDENCE REVIEW Evidence for optimal treatment regimens was obtained by searching PubMed and the Cochrane database for English-language studies published up to July 21, 2014. FINDINGS Twenty-seven randomized clinical trials (6463 patients), 6 systematic reviews, and 11 observational studies (252 934 patients) were included in our review. Acute uncomplicated cystitis in women can be diagnosed without an office visit or urine culture. Trimethoprim-sulfamethoxazole (160/800mg twice daily for 3 days), nitrofurantoin monohydrate/macrocrystals (100mg twice daily for 5-7 days), and fosfomycin trometamol (3 g in a single dose) are all appropriate first-line therapies for uncomplicated cystitis. Fluoroquinolones are effective for clinical outcomes but should be reserved for more invasive infections. beta-Lactam agents (amoxicillin-clavulanate and cefpodoxime-proxetil) are not as effective as empirical first-line therapies. Immediate antimicrobial therapy is recommended rather than delayed treatment or symptom management with ibuprofen alone. Limited observational studies support 7 to 14 days of therapy for acute urinary tract infection in men. Based on 1 observational study and our expert opinion, women with diabetes without voiding abnormalities presenting with acute cystitis should be treated similarly to women without diabetes. CONCLUSIONS AND RELEVANCE Immediate antimicrobial therapy with trimethoprim-sulfamethoxazole, nitrofurantoin, or fosfomycin is indicated for acute cystitis in adult women. Increasing resistance rates among uropathogens have complicated treatment of acute cystitis. Individualized assessment of risk factors for resistance and regimen tolerability is needed to choose the optimum empirical regimen. Copyright 2014 American Medical Association. All rights reserved.	[Grigoryan, Larissa] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA; [Trautner, Barbara W.] Michael E DeBakey VA Med Ctr, Houston VA Ctr Innovat Qual Effectiveness & Safet, Houston, TX USA; [Trautner, Barbara W.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Trautner, Barbara W.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Gupta, Kalpana] Boston Vet Affairs Healthcare Syst, Dept Med, Infect Dis Sect, Boston, MA USA; [Gupta, Kalpana] Boston Univ, Sch Med, Boston, MA 02118 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Boston University	Gupta, K (corresponding author), Boston Vet Affairs Healthcare Syst, 1400 VFW Pkwy,MED 111, West Roxbury, MA 02132 USA.	kalpana.gupta@va.gov			National Research Service Award [5 T32 HP10031]	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for this work includes resources and use of facilities at Boston Veterans Affairs Healthcare System, West Roxbury, Massachusetts (K. G.), and at the Houston VA Center for Innovations in Quality, Effectiveness and Safety (CIN13-413) at the Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas (B. W. T.). Dr Grigoryan also received support from a National Research Service Award (5 T32 HP10031).	Arredondo-Garcia JL, 2004, J ANTIMICROB CHEMOTH, V54, P840, DOI 10.1093/jac/dkh414; Asbach H W, 1991, Drugs, V42 Suppl 4, P10, DOI 10.2165/00003495-199100424-00005; Auquer F, 2002, CLIN MICROBIOL INFEC, V8, P50, DOI 10.1046/j.1198-743x.2001.00359.x; Barry HC, 2001, J FAM PRACTICE, V50, P589; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Bleidorn J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-30; BOEREMA JBJ, 1990, INFECTION, V18, pS80, DOI 10.1007/BF01643433; Brooks D, 1972, J R Coll Gen Pract, V22, P695; Burman WJ, 2003, AM J MED, V115, P358, DOI 10.1016/S0002-9343(03)00372-3; Ceran N, 2010, J INFECT CHEMOTHER, V16, P424, DOI 10.1007/s10156-010-0079-z; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Colgan R, 2008, ANTIMICROB AGENTS CH, V52, P846, DOI 10.1128/AAC.01200-07; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Donofrio JC, 2013, J EMERG MED, V45, P969, DOI 10.1016/j.jemermed.2013.07.019; Drekonja DM, 2013, JAMA INTERN MED, V173, P62, DOI 10.1001/2013.jamainternmed.829; DUBI J, 1982, SCHWEIZ MED WSCHR, V112, P90; ELHANAN G, 1994, ANTIMICROB AGENTS CH, V38, P2612, DOI 10.1128/AAC.38.11.2612; Falagas ME, 2010, J ANTIMICROB CHEMOTH, V65, P1862, DOI 10.1093/jac/dkq237; Falagas ME, 2009, J INFECTION, V58, P91, DOI 10.1016/j.jinf.2008.12.009; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Fourcroy JL, 2005, ANTIMICROB AGENTS CH, V49, P4137, DOI 10.1128/AAC.49.10.4137-4143.2005; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gagyor I, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-146; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Gupta K, 2007, ARCH INTERN MED, V167, P2207, DOI 10.1001/archinte.167.20.2207; Gupta K, 2014, INFECT DIS CLIN N AM, V28, P49, DOI 10.1016/j.idc.2013.10.002; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Henry DC, 2002, CLIN THER, V24, P2088, DOI 10.1016/S0149-2918(02)80099-6; Hooton TM, 2012, JAMA-J AM MED ASSOC, V307, P583, DOI 10.1001/jama.2012.80; Hooton TM, 2005, JAMA-J AM MED ASSOC, V293, P949, DOI 10.1001/jama.293.8.949; Iravani A, 1999, J ANTIMICROB CHEMOTH, V43, P67, DOI 10.1093/jac/43.suppl_1.67; Jepson R, 2013, JAMA-J AM MED ASSOC, V310, P1395, DOI 10.1001/jama.2013.277509; Kavatha D, 2003, ANTIMICROB AGENTS CH, V47, P897, DOI 10.1128/AAC.47.3.897-900.2003; Knottnerus BJ, 2012, FAM PRACT, V29, P659, DOI 10.1093/fampra/cms029; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Minassian MA, 1998, INT J ANTIMICROB AG, V10, P39, DOI 10.1016/S0924-8579(98)00021-1; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; Naber KG, 2004, INT J ANTIMICROB AG, V23, P596, DOI 10.1016/j.ijantimicag.2003.12.017; Nicolle LE, 2002, SCAND J INFECT DIS, V34, P487, DOI 10.1080/00365540110080728; Richard GA, 2002, UROLOGY, V59, P334, DOI 10.1016/S0090-4295(01)01562-X; Saint S, 1999, AM J MED, V106, P636, DOI 10.1016/S0002-9343(99)00122-9; Sanchez GV, 2012, ANTIMICROB AGENTS CH, V56, P2181, DOI 10.1128/AAC.06060-11; Sanchez GV, 2011, CLIN INFECT DIS, V53, P316, DOI 10.1093/cid/cir345; Schaeffer AJ, 1999, J UROLOGY, V161, P207, DOI 10.1016/S0022-5347(01)62099-8; Schauberger Charles W, 2007, WMJ, V106, P326; Schneeberger C, 2008, DIABETES CARE, V31, P1380, DOI 10.2337/dc07-2188; Shapiro T, 2005, ACAD EMERG MED, V12, P38, DOI 10.1197/j.aem.2004.08.051; SPENCER RC, 1994, J ANTIMICROB CHEMOTH, V33, P121, DOI 10.1093/jac/33.suppl_A.121; Stein GE, 1999, CLIN THER, V21, P1864, DOI 10.1016/S0149-2918(00)86734-X; Trestioreanu AZ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007182.pub2; Ulleryd P, 2003, SCAND J INFECT DIS, V35, P34, DOI 10.1080/0036554021000026988; VANPIENBROEK E, 1993, PHARM WORLD SCI, V15, P257; Vinson DR, 2004, ARCH INTERN MED, V164, P1026, DOI 10.1001/archinte.164.9.1026; Wilbanks MD, 2014, WEST J EMERG MED, V15, P227, DOI 10.5811/westjem.2013.12.18989; WONG ES, 1985, ANN INTERN MED, V102, P302, DOI 10.7326/0003-4819-102-3-302	57	91	97	2	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1677	1684		10.1001/jama.2014.12842	http://dx.doi.org/10.1001/jama.2014.12842			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335150				2022-12-28	WOS:000343301400025
J	Smith, JM				Smith, Jeanette M.			No Tomorrow Hath Nor Yesterday Ina Meares	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		ZEMANS J, 1964, CANADIAN ART, V21, P30	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1618	1618		10.1001/jama.2013.279797	http://dx.doi.org/10.1001/jama.2013.279797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335128				2022-12-28	WOS:000343301400001
J	Mars, B; Heron, J; Crane, C; Hawton, K; Lewis, G; Macleod, J; Tilling, K; Gunnell, D				Mars, Becky; Heron, Jon; Crane, Catherine; Hawton, Keith; Lewis, Glyn; Macleod, John; Tilling, Kate; Gunnell, David			Clinical and social outcomes of adolescent self harm: population based birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							YOUNG-PEOPLE; PSYCHIATRIC-DISORDER; SUICIDAL PHENOMENA; MENTAL-HEALTH; RISK-FACTORS; INJURY; DEPRESSION; COMMUNITY	Objectives To investigate the mental health, substance use, educational, and occupational outcomes of adolescents who self harm in a general population sample, and to examine whether these outcomes differ according to self reported suicidal intent. Design Population based birth cohort study. Setting Avon Longitudinal Study of Parents and Children (ALSPAC), a UK birth cohort of children born in 1991-92. Participants Data on lifetime history of self harm with and without suicidal intent were available for 4799 respondents who completed a detailed self harm questionnaire at age 16 years. Multiple imputation was used to account for missing data. Main outcome measures Mental health problems (depression and anxiety disorder), assessed using the clinical interview schedule-revised at age 18 years, self reported substance use (alcohol, cannabis, cigarette smoking, and illicit drugs) at age 18 years, educational attainment at age 16 and 19 years, occupational outcomes at age 19 years, and self harm at age 21 years. Results Participants who self harmed with and without suicidal intent at age 16 years were at increased risk of developing mental health problems, future self harm, and problem substance misuse, with stronger associations for suicidal self harm than for non-suicidal self harm. For example, in models adjusted for confounders the odds ratio for depression at age 18 years was 2.21 (95% confidence interval 1.55 to 3.15) in participants who had self harmed without suicidal intent at age 16 years and 3.94 (2.67 to 5.83) in those who had self harmed with suicidal intent. Suicidal self harm, but not self harm without suicidal intent, was also associated with poorer educational and employment outcomes. Conclusions Adolescents who self harm seem to be vulnerable to a range of adverse outcomes in early adulthood. Risks were generally stronger in those who had self harmed with suicidal intent, but outcomes were also poor among those who had self harmed without suicidal intent. These findings emphasise the need for early identification and treatment of adolescents who self harm.	[Mars, Becky; Heron, Jon; Macleod, John; Tilling, Kate; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Crane, Catherine] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Hawton, Keith] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Lewis, Glyn] UCL, Mental Hlth Sci Unit, London, England	University of Bristol; University of Oxford; University of Oxford; University of London; University College London	Mars, B (corresponding author), Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.	becky.mars@bristol.ac.uk	Tilling, Kate/AAY-1578-2021; Heron, Jon/D-5884-2011; Gunnell, David/ABE-6653-2020; Lewis, Glyn/E-9944-2012	Heron, Jon/0000-0001-6199-5644; Gunnell, David/0000-0002-0829-6470; Lewis, Glyn/0000-0001-5205-8245; Tilling, Kate/0000-0002-1010-8926; Mars, Becky/0000-0002-8132-6920	UK Medical Research Council; Wellcome Trust [092731]; University of Bristol; Medical Research Council [MR/J012661/1]; MRC [MR/J012661/1, MR/K023233/1, MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1, MR/K023233/1, MC_PC_15018, G9815508] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10053, NF-SI-0512-10068] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: ALSPAC receives core support from the UK Medical Research Council and the Wellcome Trust (grant reference 092731) and the University of Bristol. This research was specifically funded by the Medical Research Council to study the causes and consequences of self harm with and without suicidal intent in adolescence (grant reference MR/J012661/1). The study sponsor had no further role in the study design; the collection, analysis, and interpretation of data; or the writing of the article and the decision to submit it for publication.	[Anonymous], 2014, HOSP EPISODE STAT; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Bell T, 2005, SOC PSYCH PSYCH EPID, V40, P402, DOI 10.1007/s00127-005-0881-6; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brausch AM, 2010, J YOUTH ADOLESCENCE, V39, P233, DOI 10.1007/s10964-009-9482-0; Evans E, 2005, SUICIDE LIFE-THREAT, V35, P239, DOI 10.1521/suli.2005.35.3.239; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Fergusson DM, 2005, PSYCHOL MED, V35, P983, DOI 10.1017/S0033291704004167; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Groholt B, 2009, SUICIDE LIFE-THREAT, V39, P125, DOI 10.1521/suli.2009.39.2.125; Hargus E, 2009, SUICIDE LIFE-THREAT, V39, P518, DOI 10.1521/suli.2009.39.5.518; Harrington R, 2006, J AM ACAD CHILD PSY, V45, P337, DOI 10.1097/01.chi.0000194564.78536.f2; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; HAWTON K, 1993, BMJ-BRIT MED J, V306, P1641, DOI 10.1136/bmj.306.6893.1641; Hawton K, 2008, J CHILD PSYCHOL PSYC, V49, P441, DOI 10.1111/j.1469-7610.2007.01852.x; Hawton K, 2007, J CLIN PSYCHIAT, V68, P1574, DOI 10.4088/JCP.v68n1017; Hawton K, 2013, J AFFECT DISORDERS, V151, P821, DOI 10.1016/j.jad.2013.08.020; Heron J, 2013, ADDICTION, V108, P2129, DOI 10.1111/add.12268; Joiner T, 2009, WHY PEOPLE DIE SUICI; Kapur N, 2013, BRIT J PSYCHIAT, V202, P326, DOI 10.1192/bjp.bp.112.116111; Kidger J, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-69; Klonsky ED, 2007, J CLIN PSYCHOL, V63, P1045, DOI 10.1002/jclp.20412; Legleye S., 2007, Journal of Substance Use, V12, P233, DOI 10.1080/14659890701476532; LEWIS G, 1994, J EPIDEMIOL COMMUN H, V48, P207, DOI 10.1136/jech.48.2.207; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Mars B, 2014, J AFFECT DISORDERS, V168, P407, DOI 10.1016/j.jad.2014.07.009; Messer SC, 1995, INT J METH PSYCH RES, V5, P251; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Muehlenkamp J.J., 2010, PREV RES, V17, P8, DOI DOI 10.1037/E515372010-002; Muehlenkamp Jennifer J, 2007, Arch Suicide Res, V11, P69, DOI 10.1080/13811110600992902; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Office for National Statistics, 2013, YOUNG PEOPL NOT ED E; Patton GC, 1999, SOC PSYCH PSYCH EPID, V34, P166, DOI 10.1007/s001270050129; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; STANLEY B, 1992, International Review of Psychiatry, V4, P149, DOI 10.3109/09540269209066312; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wichstrom L, 2009, ARCH SUICIDE RES, V13, P105, DOI 10.1080/13811110902834992; Wilkinson P, 2013, EUR CHILD ADOLES PSY, V22, pS75, DOI 10.1007/s00787-012-0365-7; Zetterqvist M, 2013, J YOUTH ADOLESCENCE, V42, P1257, DOI 10.1007/s10964-012-9872-6	43	148	154	3	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2014	349								g5954	10.1136/bmj.g5954	http://dx.doi.org/10.1136/bmj.g5954			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OD	25335825	Green Published, hybrid			2022-12-28	WOS:000343768200001
J	Holgate, SA				Holgate, Sharon Ann			Life inspires applications	SCIENCE			English	Editorial Material																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					390	390		10.1126/science.346.6207.390	http://dx.doi.org/10.1126/science.346.6207.390			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ7ZY	25324393				2022-12-28	WOS:000343041100049
J	Ferrannini, E				Ferrannini, Ele			The Target of Metformin in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Pisa, Dept Clin & Expt Med, Pisa, Italy	University of Pisa	Ferrannini, E (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.							Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Brown JB, 2010, DIABETES CARE, V33, P501, DOI 10.2337/dc09-1749; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Natali A, 2004, DIABETES CARE, V27, P1349, DOI 10.2337/diacare.27.6.1349	5	76	83	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1547	1548		10.1056/NEJMcibr1409796	http://dx.doi.org/10.1056/NEJMcibr1409796			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317875				2022-12-28	WOS:000342994700014
J	Cole, TB				Cole, Thomas B.			Crimson Autumn Ural Tansykbaev	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1496	1497		10.1001/jama.2013.279783	http://dx.doi.org/10.1001/jama.2013.279783			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321897				2022-12-28	WOS:000342983200001
J	Ma, H; Groth, RD; Cohen, SM; Emery, JF; Li, BX; Hoedt, E; Zhang, GA; Neubert, TA; Tsien, RW				Ma, Huan; Groth, Rachel D.; Cohen, Samuel M.; Emery, John F.; Li, Boxing; Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.; Tsien, Richard W.			gamma CaMKII Shuttles Ca2+/CaM to the Nucleus to Trigger CREB Phosphorylation and Gene Expression	CELL			English	Article							PROTEIN-KINASE-II; CALMODULIN COMPLEX; TRANSCRIPTION; MEMORY; SIGNAL; DEPOLARIZATION; TRANSLOCATION; CALCINEURIN; ACTIVATION; SYNAPSE	Activity-dependent CREB phosphorylation and gene expression are critical for long-term neuronal plasticity. Local signaling at Ca(V)1 channels triggers these events, but how information is relayed onward to the nucleus remains unclear. Here, we report a mechanism that mediates long-distance communication within cells: a shuttle that transports Ca2+/calmodulin from the surface membrane to the nucleus. We show that the shuttle protein is gamma CaMKII, its phosphorylation at Thr287 by beta CaMKII protects the Ca2+/CaM signal, and CaN triggers its nuclear translocation. Both beta CaMKII and CaN act in close proximity to Ca(V)1 channels, supporting their dominance, whereas gamma CaMKII operates as a carrier, not as a kinase. Upon arrival within the nucleus, Ca2+/CaM activates CaMKK and its substrate CaMKIV, the CREB kinase. This mechanism resolves long-standing puzzles about CaM/CaMK-dependent signaling to the nucleus. The significance of the mechanism is emphasized by dysregulation of Ca(V)1, gamma CaMKII, beta CaMKII, and CaN in multiple neuropsychiatric disorders.	[Ma, Huan; Cohen, Samuel M.; Emery, John F.; Li, Boxing; Tsien, Richard W.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, Inst Neurosci, New York, NY 10016 USA; [Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.] NYU, Langone Med Ctr, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.] NYU, Langone Med Ctr, Skirball Inst, New York, NY 10016 USA; [Groth, Rachel D.] Pfizer, Ctr Therapeut Innovat, San Francisco, CA 94158 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Pfizer	Ma, H (corresponding author), NYU, Langone Med Ctr, Dept Neurosci & Physiol, Inst Neurosci, New York, NY 10016 USA.	mahuan@gmail.com; richard.tsien@nyumc.org	Ma, Huan/A-1379-2012	neubert, Thomas/0000-0001-7049-2088	National Institute of General Medical Sciences [GM058234]; National Institute of Neurological Disorders and Stroke [NS24067]; National Institute of Mental Health [MH071739]; Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Medical Scientist Training Program Fellowship; NIH [NP30 NS050276, S10 RR027990]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071739, R37MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, R01NS024067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA040484] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Medical Scientist Training Program Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Gord Fishell, Andy Hudmon, Paul De Koninck, Niels Ringstad, and Michael Tadross for insightful comments on an earlier manuscript and Steven Burden for valuable suggestions. We thank Kathleen Morgan and Cynthia Gallant for their support at initial stages. We also thank Tsien laboratory members for discussions throughout the execution of this project. This work was supported by research grants to R.W.T. from the National Institute of General Medical Sciences (GM058234), the National Institute of Neurological Disorders and Stroke (NS24067), the National Institute of Mental Health (MH071739), and the Simons, Mathers, and Burnett Family Foundations. S.C. is supported by a Medical Scientist Training Program Fellowship. The Neubert laboratory is supported by the NIH (NP30 NS050276 and S10 RR027990 to T.A.N.).	BACHS O, 1994, CELL CALCIUM, V16, P289, DOI 10.1016/0143-4160(94)90092-2; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Gangopadhyay SS, 2003, BIOCHEM J, V372, P347, DOI 10.1042/BJ20030015; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Hahm SH, 2003, MOL PHARMACOL, V64, P1503, DOI 10.1124/mol.64.6.1503; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma H, 2013, BIOSCIENCE REP, V33, P97, DOI 10.1042/BSR20120099; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mermelstein PG, 2001, P NATL ACAD SCI USA, V98, P15342, DOI 10.1073/pnas.211563998; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Saha RN, 2008, EXP BIOL MED, V233, P385, DOI 10.3181/0709-MR-241; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Stratton M, 2014, ELIFE, V3, DOI 10.7554/eLife.02490; Takeuchi M, 1998, GENE, V221, P107, DOI 10.1016/S0378-1119(98)00422-3; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Thorogate R, 2004, J CELL SCI, V117, P5923, DOI 10.1242/jcs.01510; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	62	151	152	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					281	294		10.1016/j.cell.2014.09.019	http://dx.doi.org/10.1016/j.cell.2014.09.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303525	Bronze, Green Accepted			2022-12-28	WOS:000343095600011
J	Dunn, AG; Arachi, D; Hudgins, J; Tsafnat, G; Coiera, E; Bourgeois, FT				Dunn, Adam G.; Arachi, Diana; Hudgins, Joel; Tsafnat, Guy; Coiera, Enrico; Bourgeois, Florence T.			Financial Conflicts of Interest and Conclusions About Neuraminidase Inhibitors for Influenza An Analysis of Systematic Reviews	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-STUDY REPORTS; DRUG TRIALS; INDUSTRY SPONSORSHIP; METAANALYSIS; OSELTAMIVIR; OUTCOMES; ADULTS; BIAS; ASSOCIATION; PUBLICATION	Background: Industry funding and financial conflicts of interest may contribute to bias in the synthesis and interpretation of scientific evidence. Objective: To examine the association between financial conflicts of interest and characteristics of systematic reviews of neuraminidase inhibitors. Design: Retrospective analysis. Setting: Reviews that examined the use of neuraminidase inhibitors in the prophylaxis or treatment of influenza, were published between January 2005 and May 2014, and used a systematic search protocol. Measurements: Two investigators blinded to all information regarding the review authors independently assessed the presentation of evidence on the use of neuraminidase inhibitors as favorable or not favorable. Financial conflicts of interest were identified using the index reviews, other publications, and Web-based searches. Associations between financial conflicts of interest, favorability assessments, and presence of critical appraisals of evidence quality were analyzed. Results: Twenty-six systematic reviews were identified, of which 13 examined prophylaxis and 24 examined treatment, accounting for 37 distinct assessments. Among assessments associated with a financial conflict of interest, 7 of 8 (88%) were classified as favorable, compared with 5 of 29 (17%) among those without a financial conflict of interest. Reviewers without financial conflicts of interest were more likely to include statements about the quality of the primary studies than those with financial conflicts of interest. Limitations: The heterogeneity in populations and outcomes examined in the reviews precluded analysis of the contribution of selective inclusion of evidence on the discordance of the assessments made in the reviews. Many of the systematic reviews had overlapping authorship. Conclusion: Reviewers with financial conflicts of interest may be more likely to present evidence about neuraminidase inhibitors in a favorable manner and recommend the use of these drugs than reviewers without financial conflicts of interest.	[Dunn, Adam G.] Univ New S Wales, Ctr Hlth Informat, Sydney, NSW 2052, Australia; Boston Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	University of New South Wales Sydney; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Dunn, AG (corresponding author), Univ New S Wales, Ctr Hlth Informat, Sydney, NSW 2052, Australia.	a.dunn@unsw.edu.au	Dunn, Adam/H-4425-2019; Arachi, Diana/AAY-8129-2020; Bourgeois, Florence/H-6710-2016	Dunn, Adam/0000-0002-1720-8209; Arachi, Diana/0000-0003-2446-7011; Bourgeois, Florence/0000-0001-7798-4560; Coiera, Enrico/0000-0002-6444-6584	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Primary Funding Source: Australian National Health and Medical Research Council.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Aoki FY, 2013, J INFECT DIS, V207, P547, DOI 10.1093/infdis/jis727; Beck CR, 2013, INFLUENZA OTHER RESP, V7, P14, DOI 10.1111/irv.12048; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Cohen D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2591; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Ebell MH, 2013, FAM PRACT, V30, P125, DOI 10.1093/fampra/cms059; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Groves T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4687; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2263; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Jones M, 2006, EXPERT OPIN DRUG SAF, V5, P603, DOI 10.1517/14740338.5.5.603; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Krumholz HM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2548; Krumholz HM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f547; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Payne D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7303; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Rattinger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005826; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Roundtree AK, 2009, J CLIN EPIDEMIOL, V62, P128, DOI 10.1016/j.jclinepi.2008.08.003; Schmidt AF, 2014, J CLIN EPIDEMIOL, V67, P635, DOI 10.1016/j.jclinepi.2013.12.005; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Smith JR, 2010, CRIT CARE MED, V38, pE43, DOI 10.1097/CCM.0b013e3181c85229; Smith R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g171; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	46	50	51	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					513	+		10.7326/M14-0933	http://dx.doi.org/10.7326/M14-0933			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25285542				2022-12-28	WOS:000343896700010
J	Kortepeter, MG; Smith, PW; Hewlett, A; Cieslak, TJ				Kortepeter, Mark G.; Smith, Philip W.; Hewlett, Angela; Cieslak, Theodore J.			Caring for Patients With Ebola: A Challenge in Any Care Facility	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS; UNIT		[Kortepeter, Mark G.] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Smith, Philip W.; Hewlett, Angela] Univ Nebraska Med Ctr, Div Infect Dis, Biocontainment Unit, Omaha, NE USA; [Cieslak, Theodore J.] San Antonio Mil Med Ctr, Dept Pediat, Ft Sam Houston, TX USA	Uniformed Services University of the Health Sciences - USA; University of Nebraska System; University of Nebraska Medical Center; San Antonio Military Medical Center	Kortepeter, MG (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.							Armstrong LR, 1999, INFECT CONT HOSP EP, V20, P176, DOI 10.1086/501607; Centers for Disease Control and Prevention, 2014, INFECT PREV CONTR RE; Centers for Disease Control and Prevention; Assistant Secretary of Preparedness and Response, HLTH CAR PROV PREP C; Fischer WA, 2014, ANN INTERN MED, V161, P753, DOI 10.7326/M14-1953; Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Smith PW, 2006, BIOSECUR BIOTERROR, V4, P351, DOI 10.1089/bsp.2006.4.351	6	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					68	U112		10.7326/M14-2289	http://dx.doi.org/10.7326/M14-2289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25320965				2022-12-28	WOS:000350103000010
J	Mizuguchi, T; Fudenberg, G; Mehta, S; Belton, JM; Taneja, N; Folco, HD; FitzGerald, P; Dekker, J; Mirny, L; Barrowman, J; Grewal, SIS				Mizuguchi, Takeshi; Fudenberg, Geoffrey; Mehta, Sameet; Belton, Jon-Matthew; Taneja, Nitika; Folco, Hernan Diego; FitzGerald, Peter; Dekker, Job; Mirny, Leonid; Barrowman, Jemima; Grewal, Shiv I. S.			Cohesin-dependent globules and heterochromatin shape 3D genome architecture in S. pombe	NATURE			English	Article							FISSION YEAST CHROMOSOMES; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; CHROMATIN INTERACTIONS; DROSOPHILA GENOME; HI-C; ORGANIZATION; CENTROMERES; PRINCIPLES; DOMAINS	Eukaryotic genomes are folded into three-dimensional structures, such as self-associating topological domains, the borders of which are enriched in cohesin and CCCTC-binding factor (CTCF) required for long-range interactions(1-7). How local chromatin interactions govern higher-order folding of chromatin fibres and the function of cohesin in this process remain poorly understood. Here we perform genome-wide chromatin conformation capture (Hi-C) analysis(8) to explore the high-resolution organization of the Schizosaccharomyces pombe genome, which despite its small size exhibits fundamental features found in other eukaryotes(9). Our analyses of wild-type and mutant strains reveal key elements of chromosome architecture and genome organization. On chromosome arms, small regions of chromatin locally interact to form 'globules'. This feature requires a function of cohesin distinct from its role in sister chromatid cohesion. Cohesin is enriched at globule boundaries and its loss causes disruption of local globule structures and global chromosome territories. By contrast, heterochromatin, which loads cohesin at specific sites including pericentromeric and subtelomeric domains(9-11), is dispensable for globule formation but nevertheless affects genome organization. We show that heterochromatin mediates chromatin fibre compaction at centromeres and promotes prominent inter-arm interactions within centromere-proximal regions, providing structural constraints crucial for proper genome organization. Loss of heterochromatin relaxes constraints on chromosomes, causing an increase in intra-and inter-chromosomal interactions. Together, our analyses uncover fundamental genome folding principles that drive higher-order chromosome organization crucial for coordinating nuclear functions.	[Mizuguchi, Takeshi; Mehta, Sameet; Taneja, Nitika; Folco, Hernan Diego; Barrowman, Jemima; Grewal, Shiv I. S.] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA; [Fudenberg, Geoffrey; Mirny, Leonid] Harvard Univ, Grad Program Biophys, Boston, MA 02115 USA; [Fudenberg, Geoffrey; Mirny, Leonid] MIT, Dept Phys, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Belton, Jon-Matthew; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [FitzGerald, Peter] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	TANEJA, NITIKA/T-5633-2017; Mehta, Sameet/A-1936-2011; TANEJA, NITIKA/AAY-8446-2021; Mirny, Leonid/ABE-8083-2020	TANEJA, NITIKA/0000-0002-5513-5282; Mehta, Sameet/0000-0002-3029-3217; TANEJA, NITIKA/0000-0002-5513-5282; Mirny, Leonid/0000-0002-0785-5410; Fudenberg, Geoffrey/0000-0001-5905-6517; Grewal, Shiv/0000-0002-4552-9261	National Institutes of Health, National Cancer Institute; NHGRI [HG003143]; NCI Physical Sciences-Oncology Center at MIT [U54CA143874]; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523, U54CA143874] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI Physical Sciences-Oncology Center at MIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Y. Watanabe and M. Yanagida for strains, M. Zofall for contributions, and A. Kelly for comments. This study used the Helix Systems and the Biowulf Linux cluster at the National Institutes of Health. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and by a grant from NHGRI (HG003143) to J.D. The work of G.F. and L.M is supported by NCI Physical Sciences-Oncology Center at MIT (U54CA143874).	Alfredsson-Timmins J, 2007, J CELL SCI, V120, P1935, DOI 10.1242/jcs.03457; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Gard S, 2009, J CELL BIOL, V187, P455, DOI 10.1083/jcb.200906075; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Molnar M, 2008, GENETICS, V178, P99, DOI 10.1534/genetics.107.082826; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Renauld H, 1997, TRENDS CELL BIOL, V7, P201, DOI 10.1016/S0962-8924(97)01034-9; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	35	168	171	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					432	+		10.1038/nature13833	http://dx.doi.org/10.1038/nature13833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25307058	Green Submitted, Green Accepted			2022-12-28	WOS:000346484800055
J	Stevenson, KB; Desert, JM; Line, MR; Bean, JL; Fortney, JJ; Showman, AP; Kataria, T; Kreidberg, L; McCullough, PR; Henry, GW; Charbonneau, D; Burrows, A; Seager, S; Madhusudhan, N; Williamson, MH; Homeier, D				Stevenson, Kevin B.; Desert, Jean-Michel; Line, Michael R.; Bean, Jacob L.; Fortney, Jonathan J.; Showman, Adam P.; Kataria, Tiffany; Kreidberg, Laura; McCullough, Peter R.; Henry, Gregory W.; Charbonneau, David; Burrows, Adam; Seager, Sara; Madhusudhan, Nikku; Williamson, Michael H.; Homeier, Derek			Thermal structure of an exoplanet atmosphere from phase-resolved emission spectroscopy	SCIENCE			English	Article							EXTRASOLAR GIANT PLANETS; HOT JUPITER WASP-43B; B-LIKE PLANETS; MU-M; LIGHT CURVES; HD 189733B; 209458B; SPECTRA; CIRCULATION; WASP-12B	Exoplanets that orbit close to their host stars are much more highly irradiated than their solar system counterparts. Understanding the thermal structures and appearances of these planets requires investigating how their atmospheres respond to such extreme stellar forcing. We present spectroscopic thermal emission measurements as a function of orbital phase ("phase-curve observations") for the highly irradiated exoplanet WASP-43b spanning three full planet rotations using the Hubble Space Telescope. With these data, we construct a map of the planet's atmospheric thermal structure, from which we find large day-night temperature variations at all measured altitudes and a monotonically decreasing temperature with pressure at all longitudes. We also derive a Bond albedo of 0.18(-0.12)(+0.07) and an altitude dependence in the hot-spot offset relative to the substellar point.	[Stevenson, Kevin B.; Bean, Jacob L.; Kreidberg, Laura] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Desert, Jean-Michel] Univ Colorado, Dept Astrophys & Planetary Sci, CASA, Boulder, CO 80309 USA; [Line, Michael R.; Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Showman, Adam P.; Kataria, Tiffany] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Showman, Adam P.; Kataria, Tiffany] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [McCullough, Peter R.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [McCullough, Peter R.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Henry, Gregory W.; Williamson, Michael H.] Tennessee State Univ, Ctr Excellence Informat Syst, Nashville, TN 37209 USA; [Charbonneau, David] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA; [Burrows, Adam] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Seager, Sara] MIT, Dept Earth Atmospher & Planetary Sci, Dept Phys, Cambridge, MA 02139 USA; [Madhusudhan, Nikku] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Homeier, Derek] Univ Lyon, Ctr Rech Astrophys Lyon, Ecole Normale Super Lyon, CNRS,UMR 5574, F-69364 Lyon 07, France	University of Chicago; University of Colorado System; University of Colorado Boulder; University of California System; University of California Santa Cruz; University of Arizona; University of Arizona; Space Telescope Science Institute; Johns Hopkins University; Tennessee State University; Harvard University; Princeton University; Massachusetts Institute of Technology (MIT); University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON)	Stevenson, KB (corresponding author), Univ Chicago, Dept Astron & Astrophys, 5640 South Ellis Ave, Chicago, IL 60637 USA.	kbs@uchicago.edu	Stevenson, Kevin/AAC-8222-2019	Stevenson, Kevin/0000-0002-7352-7941; Homeier, Derek/0000-0002-8546-9128; Bean, Jacob/0000-0003-4733-6532	NASA [NAS 5-26555]; STScI [GO-13467]; NASA through STScI; Sagan Fellowship Program; NASA; Alfred P. Sloan Foundation through a Sloan Research Fellowship; NSF through a Graduate Research Fellowship; NSF; Tennessee State University; State of Tennessee through its Centers of Excellence program; Massachusetts Institute of Technology; European Research Council under the European Community [247060]	NASA(National Aeronautics & Space Administration (NASA)); STScI(Space Telescope Science Institute); NASA through STScI; Sagan Fellowship Program; NASA(National Aeronautics & Space Administration (NASA)); Alfred P. Sloan Foundation through a Sloan Research Fellowship(Alfred P. Sloan Foundation); NSF through a Graduate Research Fellowship; NSF(National Science Foundation (NSF)); Tennessee State University; State of Tennessee through its Centers of Excellence program; Massachusetts Institute of Technology; European Research Council under the European Community(European Research Council (ERC))	This work is based on observations made with the NASA-European Space Agency Hubble Space Telescope that were obtained at the Space Telescope Science Institute (STScI), which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. Data are available through the Mikulski Archive for Space Telescopes (MAST). We thank A. Vick and M. Reinhart of STScI for scheduling these observations, which are associated with program GO-13467. Support for this work was provided by NASA through a grant from the STScI, the Sagan Fellowship Program (to K.B.S.) as supported by NASA and administered by the NASA Exoplanet Science Institute (NExScI), the Alfred P. Sloan Foundation through a Sloan Research Fellowship (to J.L.B.), and the NSF through a Graduate Research Fellowship (to L.K.). G.W.H. and M.H.W. acknowledge long-term support from NASA, NSF, Tennessee State University, and the State of Tennessee through its Centers of Excellence program. S.S. acknowledges funding from the Massachusetts Institute of Technology. D.H. acknowledges support from the European Research Council under the European Community's Seventh Framework Programme-FP7/2007-2013 grant agreement no. 247060.	Blecic J, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/116; Buenzli E, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L31; Burrows A, 2008, ASTROPHYS J, V682, P1277, DOI 10.1086/589824; Burrows A, 2000, ASTROPHYS J, V534, pL97, DOI 10.1086/312638; Burrows A, 2010, ASTROPHYS J, V719, P341, DOI 10.1088/0004-637X/719/1/341; Chen G, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322740; Cooper CS, 2005, ASTROPHYS J, V629, pL45, DOI 10.1086/444354; Cowan NB, 2008, ASTROPHYS J LETT, V678, pL129, DOI 10.1086/588553; Cowan NB, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/82; Crossfield IJM, 2010, ASTROPHYS J, V723, P1436, DOI 10.1088/0004-637X/723/2/1436; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Fortney JJ, 2006, ASTROPHYS J, V652, P746, DOI 10.1086/508442; Gillon M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218817; Guillot T, 2002, ASTRON ASTROPHYS, V385, P156, DOI 10.1051/0004-6361:20011624; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/22; Knutson HA, 2009, ASTROPHYS J, V703, P769, DOI 10.1088/0004-637X/703/1/769; Kreidberg L, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L27; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Lewis NK, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/95; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Marley MS, 1999, ASTROPHYS J, V513, P879, DOI 10.1086/306881; Maxted PFL, 2013, MON NOT R ASTRON SOC, V428, P2645, DOI 10.1093/mnras/sts231; Parmentier V., 2013, VIZIER ONLINE DATA C, V356, P29133; Perez-Becker D, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/134; Seager S, 1998, ASTROPHYS J, V502, pL157, DOI 10.1086/311498; Showman AP, 2009, ASTROPHYS J, V699, P564, DOI 10.1088/0004-637X/699/1/564; Showman AP, 2002, ASTRON ASTROPHYS, V385, P166, DOI 10.1051/0004-6361:20020101; Stevenson KB, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/161; Sudarsky D, 2003, ASTROPHYS J, V588, P1121, DOI 10.1086/374331; Wang W, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/70	33	201	203	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					838	841		10.1126/science.1256758	http://dx.doi.org/10.1126/science.1256758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25301972	Green Submitted			2022-12-28	WOS:000344659900041
J	Choi, SH; Kim, YH; Hebisch, M; Sliwinski, C; Lee, S; D'Avanzo, C; Chen, HC; Hooli, B; Asselin, C; Muffat, J; Klee, JB; Zhang, C; Wainger, BJ; Peitz, M; Kovacs, DM; Woolf, CJ; Wagner, SL; Tanzi, RE; Kim, DY				Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias; Sliwinski, Christopher; Lee, Seungkyu; D'Avanzo, Carla; Chen, Hechao; Hooli, Basavaraj; Asselin, Caroline; Muffat, Julien; Klee, Justin B.; Zhang, Can; Wainger, Brian J.; Peitz, Michael; Kovacs, Dora M.; Woolf, Clifford J.; Wagner, Steven L.; Tanzi, Rudolph E.; Kim, Doo Yeon			A three-dimensional human neural cell culture model of Alzheimer's disease	NATURE			English	Article							TRANSGENIC MOUSE MODELS; AMYLOID HYPOTHESIS; A-BETA; TAU; PATHOLOGY; IPSCS	Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-beta plaques and neurofibrillary tangles(1). The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-beta peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau(2,3). However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-beta-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology(4,5). Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-beta species and phosphorylated tau but did not demonstrate amyloid-beta plaquesor neurofibrillary tangles(6-11). Here we report that FAD mutations in beta-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-beta, including amyloid-beta plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloidb beta generation with beta- or gamma-secretase inhibitors not only decreased amyloid-beta pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-beta-mediated tau phosphorylation. We have successfully recapitulated amyloid-beta and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.	[Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias; Sliwinski, Christopher; D'Avanzo, Carla; Chen, Hechao; Hooli, Basavaraj; Asselin, Caroline; Klee, Justin B.; Zhang, Can; Kovacs, Dora M.; Tanzi, Rudolph E.; Kim, Doo Yeon] Harvard Univ, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Genet & Aging Res Unit,Med Sch, Charlestown, MA 02129 USA; [Kim, Young Hye] Korea Basic Sci Inst, Div Mass Spectrometry Res, Cheongju 363883, Chungbuk, South Korea; [Hebisch, Matthias; Peitz, Michael] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Hebisch, Matthias; Peitz, Michael] Hertie Fdn, D-53127 Bonn, Germany; [Lee, Seungkyu; Wainger, Brian J.; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Lee, Seungkyu; Wainger, Brian J.; Woolf, Clifford J.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Muffat, Julien] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; Korea Basic Science Institute (KBSI); University of Bonn; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Diego	Kim, DY (corresponding author), Harvard Univ, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Genet & Aging Res Unit,Med Sch, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; dkim@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; Wainger, Brian/L-7553-2017; Peitz, Michael/AHB-0741-2022; Woolf, Clifford/A-9784-2010	Tanzi, Rudolph/0000-0002-7032-1454; Lee, Seungkyu/0000-0002-1929-3320; Muffat, Julien/0000-0003-1889-7023	Cure Alzheimer's fund; national Institute of Health grants [5P01AG15379, 5R37MH060009]; NIH/NINDS [P30NS04776]; IBDG Grant [DK43351]; BADERC Award [DK57521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776, R01NS045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031483, P01AG004953, R01AG014713, P01AG015379, RF1AG048080, P50AG005134] Funding Source: NIH RePORTER	Cure Alzheimer's fund; national Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); IBDG Grant; BADERC Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the grants from the Cure Alzheimer's fund (D.Y.K., S.H.C. and R.E.T.) and national Institute of Health grants 5P01AG15379 (R.E.T.) and 5R37MH060009 (R.E.T.). We thank T. L. Spires, M. Polydoro and S. Wegmann for revising the manuscript, and M. L. McKee for the electron microscopy assistance. We also appreciate B. T. Hyman, O. Berezovska, J. Hardy and P. Davies for providing cDNAs and antibodies. We acknowledge Ragon Institute's Imaging Core facility (part of the Harvard CFAR Immunology Core), Massachusetts General Hospital (MGH) Viral Vector Core (supported by NIH/NINDS P30NS04776), MGH Microscopy Core of the Center for Systems Biology for immunoelectron microscopy (partially supported by an IBDG Grant DK43351 and a BADERC Award DK57521), MGH Confocal Microscope Core and MGH Pathology Core for technical and instrument support.	Chin J, 2011, METHODS MOL BIOL, V670, P169, DOI 10.1007/978-1-60761-744-0_13; Choi SH, 2012, CELL STEM CELL, V10, P235, DOI 10.1016/j.stem.2012.02.011; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; CRAS P, 1990, AM J PATHOL, V137, P241; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Duff K, 2001, BIOCHEM SOC SYMP, V67, P195; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jaworski T., 2003, NATURE, V423, P435; Julien C, 2012, METHODS MOL BIOL, V849, P473, DOI 10.1007/978-1-61779-551-0_32; Kirby LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039329; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee V. M.-Y., 2002, NEUROPSYCHOPHARMACOL, P1339; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Tang-Schomer M. D., 2014, P NATL ACAD SCI US; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Trojanowski JQ, 2002, MED CLIN N AM, V86, P615, DOI 10.1016/S0025-7125(02)00002-0; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	30	692	712	21	467	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					274	U293		10.1038/nature13800	http://dx.doi.org/10.1038/nature13800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25307057	Green Accepted, Green Submitted			2022-12-28	WOS:000344631400052
J	Smith, JG; Luk, K; Schulz, CA; Engert, JC; Do, R; Hindy, G; Rukh, G; Dufresne, L; Almgren, P; Owens, DS; Harris, TB; Peloso, GM; Kerr, KF; Wong, Q; Smith, AV; Budoff, MJ; Rotter, JI; Cupples, LA; Rich, S; Kathiresan, S; Orho-Melander, M; Gudnason, V; O'Donnell, CJ; Post, WS; Thanassoulis, G				Smith, J. Gustav; Luk, Kevin; Schulz, Christina-Alexandra; Engert, James C.; Do, Ron; Hindy, George; Rukh, Gull; Dufresne, Line; Almgren, Peter; Owens, David S.; Harris, Tamara B.; Peloso, Gina M.; Kerr, Kathleen F.; Wong, Quenna; Smith, Albert V.; Budoff, Matthew J.; Rotter, Jerome I.; Cupples, L. Adrienne; Rich, Stephen; Kathiresan, Sekar; Orho-Melander, Marju; Gudnason, Vilmundur; O'Donnell, Christopher J.; Post, Wendy S.; Thanassoulis, George		CHARGE Extracoronary	Association of Low-Density Lipoprotein Cholesterol-Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENDELIAN RANDOMIZATION; HEART-DISEASE; EARLY LESION; PROGRESSION; RISK; CALCIFICATION; DESIGN; LOCI	IMPORTANCE Plasma low-density lipoprotein cholesterol (LDL-C) has been associated with aortic stenosis in observational studies; however, randomized trials with cholesterol-lowering therapies in individuals with established valve disease have failed to demonstrate reduced disease progression. OBJECTIVE To evaluate whether genetic data are consistent with an association between LDL-C, high-density lipoprotein cholesterol (HDL-C), or triglycerides (TG) and aortic valve disease. DESIGN, SETTING, AND PARTICIPANTS Using a Mendelian randomization study design, we evaluated whether weighted genetic risk scores (GRSs), a measure of the genetic predisposition to elevations in plasma lipids, constructed using single-nucleotide polymorphisms identified in genome-wide association studies for plasma lipids, were associated with aortic valve disease. We included community-based cohorts participating in the CHARGE consortium (n = 6942), including the Framingham Heart Study (cohort inception to last follow-up: 1971-2013; n = 1295), Multi-Ethnic Study of Atherosclerosis (2000-2012; n = 2527), Age Gene/Environment Study-Reykjavik (2000-2012; n = 3120), and the Malmo Diet and Cancer Study (MDCS, 1991-2010; n = 28 461). MAIN OUTCOMES AND MEASURES Aortic valve calcium quantified by computed tomography in CHARGE and incident aortic stenosis in the MDCS. RESULTS The prevalence of aortic valve calcium across the 3 CHARGE cohorts was 32% (n = 2245). In the MDCS, over a median follow-up time of 16.1 years, aortic stenosis developed in 17 per 1000 participants (n = 473) and aortic valve replacement for aortic stenosis occurred in 7 per 1000 (n = 205). Plasma LDL-C, but not HDL-C or TG, was significantly associated with incident aortic stenosis (hazard ratio [HR] per mmol/L, 1.28; 95% CI, 1.04-1.57; P = .02; aortic stenosis incidence: 1.3% and 2.4% in lowest and highest LDL-C quartiles, respectively). The LDL-C GRS, but not HDL-C or TG GRS, was significantly associated with presence of aortic valve calcium in CHARGE (odds ratio [OR] per GRS increment, 1.38; 95% CI, 1.09-1.74; P = .007) and with incident aortic stenosis in MDCS (HR per GRS increment, 2.78; 95% CI, 1.22-6.37; P = .02; aortic stenosis incidence: 1.9% and 2.6% in lowest and highest GRS quartiles, respectively). In sensitivity analyses excluding variants weakly associated with HDL-C or TG, the LDL-C GRS remained associated with aortic valve calcium (P = .03) and aortic stenosis (P = .009). In instrumental variable analysis, LDL-C was associated with an increase in the risk of incident aortic stenosis (HR per mmol/L, 1.51; 95% CI, 1.07-2.14; P = .02). CONCLUSIONS AND RELEVANCE Genetic predisposition to elevated LDL-C was associated with presence of aortic valve calcium and incidence of aortic stenosis, providing evidence supportive of a causal association between LDL-C and aortic valve disease. Whether earlier intervention to reduce LDL-C could prevent aortic valve disease merits further investigation. Copyright 2014 American Medical Association. All rights reserved.	[Smith, J. Gustav] Lund Univ, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Dept Heart Failure & Valvular Dis, Lund, Sweden; [Smith, J. Gustav; Schulz, Christina-Alexandra; Hindy, George; Rukh, Gull; Almgren, Peter; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Smith, J. Gustav; Peloso, Gina M.; Kathiresan, Sekar] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Luk, Kevin; Engert, James C.; Dufresne, Line; Thanassoulis, George] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Engert, James C.; Thanassoulis, George] Res Inst, Dept Med, Montreal, PQ H3A 1A1, Canada; [Smith, J. Gustav; Do, Ron; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Smith, J. Gustav; Do, Ron; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA USA; [Owens, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Harris, Tamara B.] NIA, Bethesda, MD 20892 USA; [Kerr, Kathleen F.; Wong, Quenna] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Budoff, Matthew J.; Rotter, Jerome I.] Harbor UCLA, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Cupples, L. Adrienne; O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Rich, Stephen] Univ Virginia, Charlottesville, VA USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Donnell, Christopher J.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Bethesda, MD 20892 USA; [Post, Wendy S.] Johns Hopkins Univ, Dept Internal Med, Div Cardiol, Baltimore, MD USA	Lund University; Lund University; Skane University Hospital; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Boston University; Framingham Heart Study; University of Virginia; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Thanassoulis, G (corresponding author), McGill Univ, Ctr Hlth, 687 Pine Ave W H4-55, Montreal, PQ H3A 1A1, Canada.	george.thanassoulis@mcgill.ca	Rotter, Jerome/AAY-6598-2021; Gudnason, Vilmundur/K-6885-2015; Budoff, Matthew/ABD-5175-2021; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/AAE-7126-2019; Kerr, Kathleen F./A-2893-2013	Gudnason, Vilmundur/0000-0001-5696-0084; Budoff, Matthew/0000-0002-9616-1946; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Kerr, Kathleen F./0000-0002-6438-9583; Engert, James/0000-0001-8411-4790; Rich, Stephen/0000-0003-3872-7793; Owens, David/0000-0002-7293-9688; Hindy, George/0000-0002-7257-9299; Cupples, L. Adrienne/0000-0003-0273-7965	Swedish Cancer Society; Swedish Medical Research Council; Swedish Dairy Association; Albert Pahlsson Foundation; Gunnar Nilsson Foundation; Malmo city council; Swedish Heart-Lung Foundation; Swedish National Health Service; Crafoord Foundation; Skane University Hospital; Thorsten Westerstrom Foundation; National Institute on Aging [N01-AG-12100]; National Eye Institute; National Institute on Deafness and Other Communication Disorders; National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (Icelandic parliament); NHLBI [N02-HL-64278, UL1 RR024156, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259, N01-HC-25195]; American College of Cardiology Foundation/Merck Adult Cardiology Research Fellowship Award; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease Young Investigator Award; Clinician-Scientist Salary Award from the Fonds de la Recherche du Quebec-Sante; RI-MUHC/Merck Research Competition; Canadian Institutes of Health Research [MOP-119380, MOP-126033];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [N01-HC-65226];  [R01 HL071739]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095160, N01HC095169, N01HC095159, N01HC095165, N01HC095166, N01HC095161, N01HC095167, N01HC095163, N01HC095164, N01HC095168, N01HC095162, N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006175, R01HL071250, R01HL071259, R01HL071251, ZIAHL006002, R01HL071258, R01HL071739, R01HL071205, R01HL065226, R01HL071051, R01HL064278, ZIAHL006173, T32HL007208, R01HL071252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0011049] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Dairy Association; Albert Pahlsson Foundation; Gunnar Nilsson Foundation; Malmo city council; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish National Health Service; Crafoord Foundation; Skane University Hospital; Thorsten Westerstrom Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (Icelandic parliament); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American College of Cardiology Foundation/Merck Adult Cardiology Research Fellowship Award; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease Young Investigator Award; Clinician-Scientist Salary Award from the Fonds de la Recherche du Quebec-Sante; RI-MUHC/Merck Research Competition; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; ; ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The Malmo Diet and Cancer study was supported by the Swedish Cancer Society, the Swedish Medical Research Council, the Swedish Dairy Association, the Albert Pahlsson and Gunnar Nilsson Foundations, and the Malmo city council. Dr J. G. Smith was supported by the Swedish Heart-Lung Foundation, governmental funding of clinical research within the Swedish National Health Service, the Crafoord Foundation, Skane University Hospital, and the Thorsten Westerstrom Foundation. The Age, Gene/Environment Susceptibility-Reykjavik Study was supported by a grant from the National Institute on Aging (N01-AG-12100) and by the National Eye Institute, the National Institute on Deafness and Other Communication Disorders, the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (Icelandic parliament). The MESA, MESA CARe, and the MESA SHARe project were supported by contracts N01-HC-95159 through 95169, N01-HC-65226, and N02-HL-64278 and grants from the NHLBI (UL1 RR024156, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259). Computed tomographic measures in MESA were supported by a grant to Dr Budoff (R01 HL071739). The Framingham Heart Study was supported by contracts from the NHLBI (N01-HC-25195, N02-HL-64278) with Affymetrix for genotyping services. Dr Kathiresan was supported by the American College of Cardiology Foundation/Merck Adult Cardiology Research Fellowship Award and the GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease Young Investigator Award. Dr Thanassoulis was supported by a Clinician-Scientist Salary Award from the Fonds de la Recherche du Quebec-Sante and operating grants from the RI-MUHC/Merck Research Competition and the Canadian Institutes of Health Research (MOP-119380 and MOP-126033).	Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HIRSCH D, 1993, CALCIFIED TISSUE INT, V52, P94, DOI 10.1007/BF00308315; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Owens DS, 2008, ARCH INTERN MED, V168, P1200, DOI 10.1001/archinte.168.11.1200; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rajamannan NM, 2003, NEW ENGL J MED, V349, P717, DOI 10.1056/NEJMc031360; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Thanassoulis G, 2010, J AM COLL CARDIOL, V55, P2491, DOI 10.1016/j.jacc.2010.03.019; Tikkanen E, 2011, CIRC-CARDIOVASC GENE, V4, P673, DOI 10.1161/CIRCGENETICS.111.960369; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	30	145	154	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1764	1771		10.1001/jama.2014.13959	http://dx.doi.org/10.1001/jama.2014.13959			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25344734	Green Accepted			2022-12-28	WOS:000344194500014
J	Divins, NJ; Angurell, I; Escudero, C; Perez-Dieste, V; Llorca, J				Divins, Nuria J.; Angurell, Inma; Escudero, Carlos; Perez-Dieste, Virginia; Llorca, Jordi			Influence of the support on surface rearrangements of bimetallic nanoparticles in real catalysts	SCIENCE			English	Article							GAS-SHIFT REACTION; METAL-OXIDE INTERFACE; IN-SITU; OXYGEN REDUCTION; RH-PD; ETHANOL; WATER; HYDROGEN; CERIA; OXIDATION	Catalysts used for heterogeneous processes are usually composed of metal nanoparticles dispersed over a high-surface-area support. In recent years, near-ambient pressure techniques have allowed catalyst characterization under operating conditions, overcoming the pressure gap effect. However, the use of model systems may not truly represent the changes that occur in real catalysts (the so-called material gap effect). Supports can play an important role in the catalytic process by providing new active sites and may strongly affect both the physical and chemical properties of metal nanoparticles. We used near-ambient pressure x-ray photoelectron spectroscopy to show that the surface rearrangement of bimetallic (rhodium-palladium) nanoparticles under working conditions for ethanol steam reforming with real catalysts is strongly influenced by the presence of a reducible ceria support.	[Divins, Nuria J.; Llorca, Jordi] Tech Univ Catalonia, Inst Energy Technol, Barcelona 08028, Spain; [Divins, Nuria J.; Llorca, Jordi] Tech Univ Catalonia, Ctr Res NanoEngn, Barcelona 08028, Spain; [Angurell, Inma] Univ Barcelona, Dept Inorgan Chem, E-08028 Barcelona, Spain; [Escudero, Carlos; Perez-Dieste, Virginia] ALBA Synchrotron Light Source, Barcelona 08290, Spain	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya; University of Barcelona	Llorca, J (corresponding author), Tech Univ Catalonia, Inst Energy Technol, Diagonal 647, Barcelona 08028, Spain.	jordi.llorca@upc.edu	Angurell Purroy, Inmaculada/G-8774-2015; Escudero, Carlos/F-8044-2011; Llorca, Jordi/M-8134-2014; Divins, Nuria J./B-7332-2015	Angurell Purroy, Inmaculada/0000-0002-9537-5803; Escudero, Carlos/0000-0001-8716-9391; Llorca, Jordi/0000-0002-7447-9582; Divins, Nuria J./0000-0001-6010-5419	 [MINECO ENE2012-36368]		This work has been funded through grant MINECO ENE2012-36368. J.L. is grateful to the ICREA Academia program.	Aksoy F, 2011, NUCL INSTRUM METH A, V645, P260, DOI 10.1016/j.nima.2010.12.171; Bruix A, 2012, J AM CHEM SOC, V134, P8968, DOI 10.1021/ja302070k; Caballero A, 2010, CHEM COMMUN, V46, P1097, DOI 10.1039/b920803h; Casalongue HS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3817; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; Divins NJ, 2013, CHEM ENG PROCESS, V64, P31, DOI 10.1016/j.cep.2012.10.018; Escudero C, 2013, SURF SCI, V607, P2, DOI 10.1016/j.susc.2012.08.007; Force C, 2007, LANGMUIR, V23, P4569, DOI 10.1021/la0628118; Garcia-Martinez JC, 2004, J AM CHEM SOC, V126, P16170, DOI 10.1021/ja046567n; Idriss H, 2004, PLATIN MET REV, V48, P105, DOI 10.1595/147106704X1603; Idriss H, 2008, CHEMSUSCHEM, V1, P905, DOI 10.1002/cssc.200800196; Llorca J, 2013, RENEWABLE HYDROGEN TECHNOLOGIES: PRODUCTION, PURIFICATION, STORAGE, APPLICATIONS AND SAFETY, P135, DOI 10.1016/B978-0-444-56352-1.00007-6; Natilea MM, 2006, SURF SCI SPECTRA, V13, P17, DOI 10.1116/11.20060401; Mattevi C, 2008, J PHYS CHEM C, V112, P12207, DOI 10.1021/jp802474g; Mudiyanselage K, 2013, ANGEW CHEM INT EDIT, V52, P5101, DOI 10.1002/anie.201210077; Peng XH, 2009, CATAL COMMUN, V11, P62, DOI 10.1016/j.catcom.2009.08.011; Perez-Dieste V, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/7/072023; Powell C. J., 2010, NIST ELECT INELASTIC; Qi Y, 2014, NANOSCALE, V6, P7012, DOI 10.1039/c3nr06888a; Song H, 2007, CATAL TODAY, V129, P346, DOI 10.1016/j.cattod.2006.11.028; Starr DE, 2013, CHEM SOC REV, V42, P5833, DOI 10.1039/c3cs60057b; Starr DE, 2013, IN-SITU CHARACTERIZATION OF HETEROGENEOUS CATALYSTS, P315; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; Tao F, 2011, SCIENCE, V331, P171, DOI 10.1126/science.1197461; Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464; Wen C, 2012, ACS NANO, V6, P9305, DOI 10.1021/nn303901q; Wheeler C, 2004, J CATAL, V223, P191, DOI 10.1016/j.jcat.2004.01.002; Zafeiratos S, 2010, J CATAL, V269, P309, DOI 10.1016/j.jcat.2009.11.013; Zhu Y, 2013, ACS CATAL, V3, P2627, DOI 10.1021/cs400070y	29	158	159	9	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		620	623		10.1126/science.1258106	http://dx.doi.org/10.1126/science.1258106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359970				2022-12-28	WOS:000343799700045
J	Friedman, A				Friedman, Allyson			Jump-starting natural resilience reverses stress susceptibility	SCIENCE			English	Editorial Material							DOPAMINE NEURONS; REWARD CIRCUIT; SOCIAL DEFEAT; I-H; DEPRESSION; MIDBRAIN; TRAUMA; RISK		Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Friedman, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096464] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH096464] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2010, REPORT NATL ADVISORY; Arencibia-Albite F, 2007, NEUROSCIENCE, V149, P303, DOI 10.1016/j.neuroscience.2007.08.009; Atkinson PA, 2009, J PSYCHIATR MENT HLT, V16, P137, DOI 10.1111/j.1365-2850.2008.01341.x; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Culpepper L, 2010, J CLIN PSYCHIAT, V71, P4, DOI 10.4088/JCP.9104su1c.01; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lam RW, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810372979; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Vythilingam M, 2009, PSYCHIAT RES-NEUROIM, V172, P75, DOI 10.1016/j.pscychresns.2008.06.008; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; WHO, 2009, WHO IN DEPR PUBL HLT; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028	22	11	12	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209								10.1126/science.1260781	http://dx.doi.org/10.1126/science.1260781			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7VH	25359955				2022-12-28	WOS:000349836100001
J	Joo, W; Hippenmeyer, S; Luo, LQ				Joo, William; Hippenmeyer, Simon; Luo, Liqun			Dendrite morphogenesis depends on relative levels of NT-3/TrkC signaling	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; NERVOUS-SYSTEM; NEURONAL DEVELOPMENT; MOSAIC ANALYSIS; DOUBLE MARKERS; IN-VIVO; TRKC; RECEPTORS; NEUROTROPHIN-3; GROWTH	Neurotrophins regulate diverse aspects of neuronal development and plasticity, but their precise in vivo functions during neural circuit assembly in the central brain remain unclear. We show that the neurotrophin receptor tropomyosin-related kinase C (TrkC) is required for dendritic growth and branching of mouse cerebellar Purkinje cells. Sparse TrkC knockout reduced dendrite complexity, but global Purkinje cell knockout had no effect. Removal of the TrkC ligand neurotrophin-3 (NT-3) from cerebellar granule cells, which provide major afferent input to developing Purkinje cell dendrites, rescued the dendrite defects caused by sparse TrkC disruption in Purkinje cells. Our data demonstrate that NT-3 from presynaptic neurons (granule cells) is required for TrkC-dependent competitive dendrite morphogenesis in postsynaptic neurons (Purkinje cells)-a previously unknown mechanism of neural circuit development.	[Joo, William; Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Joo, William; Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Joo, William; Luo, Liqun] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu		Hippenmeyer, Simon/0000-0003-2279-1061; Luo, Liqun/0000-0001-5467-9264	Stanford Neurosciences Graduate Program; Lorraine Kendall Predoctoral Fellowship Fund; NIH National Research Service Award Predoctoral Fellowship [5 F31 NS071697]; NIH [R01-NS050835]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835, F31NS071697] Funding Source: NIH RePORTER	Stanford Neurosciences Graduate Program; Lorraine Kendall Predoctoral Fellowship Fund; NIH National Research Service Award Predoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty, L. Tessarollo, and D. Rowitch for mouse lines; the Stanford Gene Vector and Virus Core for AAV production; P. Mehlen and S. Tauszig-Delamasure for advice on cell culture experiments; B. Weissbourd for assistance with in situ hybridization; and T. Clandinin and members of the Luo Lab for helpful discussions and comments on the manuscript. W.J. was supported by the Stanford Neurosciences Graduate Program, the Lorraine Kendall Predoctoral Fellowship Fund, and an NIH National Research Service Award Predoctoral Fellowship (5 F31 NS071697). This research was also supported by an NIH grant (R01-NS050835). L. L. is an investigator of the Howard Hughes Medical Institute. The supplementary materials contain additional data. Stanford University holds a patent on the MADM technology (U. S. Patent 7,282,621) that is described in this paper. The MADM mice are available at the Jackson Laboratory. There is no restriction on sharing all materials with nonprofit organizations. Commercial use of the mice requires a license from Stanford. Please contact Kirsten Leute at kirsten.leute@stanford.edu for more information.	Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; English CN, 2012, P NATL ACAD SCI USA, V109, P19456, DOI 10.1073/pnas.1206492109; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Hippenmeyer S, 2013, CELL REP, V3, P960, DOI 10.1016/j.celrep.2013.02.002; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	31	64	64	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		626	629		10.1126/science.1258996	http://dx.doi.org/10.1126/science.1258996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359972	Green Accepted			2022-12-28	WOS:000343799700047
J	Lee, FS; Heimer, H; Giedd, JN; Lein, ES; Sestan, N; Weinberger, DR; Casey, BJ				Lee, Francis S.; Heimer, Hakon; Giedd, Jay N.; Lein, Edward S.; Sestan, Nenad; Weinberger, Daniel R.; Casey, B. J.			Adolescent mental health-Opportunity and obligation	SCIENCE			English	Editorial Material							DISORDERS; BRAIN; FEAR		[Lee, Francis S.; Casey, B. J.] Weill Cornell Med Coll, Dept Psychiat, Sackler Inst, New York, NY 10065 USA; [Heimer, Hakon] Brain & Behav Res Fdn, Schizophrenia Res Forum, Providence, RI 02906 USA; [Heimer, Hakon] Cold Spring Harbor Lab, Banbury Ctr, Cold Spring Harbor, NY 11724 USA; [Giedd, Jay N.] Univ Calif San Diego, Div Child & Adolescent Psychiat, San Diego, CA 92123 USA; [Lein, Edward S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol & Psychiat, New Haven, CT 06510 USA; [Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Casey, B. J.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 20215 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Inst Genom Med, Baltimore, MD 20215 USA	Cornell University; Cold Spring Harbor Laboratory; University of California System; University of California San Diego; Allen Institute for Brain Science; Yale University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Lee, FS (corresponding author), Weill Cornell Med Coll, Dept Psychiat, Sackler Inst, New York, NY 10065 USA.	bjc2002@med.cornell.edu	Giedd, Jay/J-9644-2015	Giedd, Jay/0000-0003-2002-8978; Heimer, Hakon/0000-0001-6827-7549	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794, P50MH079513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052819] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH079513] Funding Source: Medline; NINDS NIH HHS [R01 NS052819] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Beecham J, 2014, J CHILD PSYCHOL PSYC, V55, P714, DOI 10.1111/jcpp.12216; Bloom DE, 2011, GLOBAL EC BURDEN NON; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Drysdale AT, 2014, BIOL PSYCHIAT, V75, pE19, DOI 10.1016/j.biopsych.2013.08.015; Dunton GF, 2014, HEALTH PSYCHOL, V33, P255, DOI 10.1037/a0032640; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Spear L.P., 2010, BEHAV NEUROSCIENCE A; Tebbenkamp ATN, 2014, CURR OPIN NEUROL, V27, P149, DOI 10.1097/WCO.0000000000000069; WHO, 2007, EC ASP MENT HLTH CHI	17	247	254	12	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		547	549		10.1126/science.1260497	http://dx.doi.org/10.1126/science.1260497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359951	Green Accepted			2022-12-28	WOS:000343799700022
J	Fortunato, SAV; Adamski, M; Ramos, OM; Leininger, S; Liu, J; Ferrier, DEK; Adamska, M				Fortunato, Sofia A. V.; Adamski, Marcin; Ramos, Olivia Mendivil; Leininger, Sven; Liu, Jing; Ferrier, David E. K.; Adamska, Maja			Calcisponges have a ParaHox gene and dynamic expression of dispersed NK homeobox genes	NATURE			English	Article							RNA-SEQ DATA; EVOLUTION; HOX; GENOME; SPONGE; AMPHIOXUS; EXPANSION; SELECTION	Sponges are simple animals with few cell types, but their genomes paradoxically contain a wide variety of developmental transcription factors(1-4), including homeobox genes belonging to the Antennapedia (ANTP) class(5,6), which in bilaterians encompass Hox, ParaHox and NK genes. In the genome of the demosponge Amphimedon queens-landica, no Hox or ParaHox genes are present, but NK genes are linked in a tight cluster similar to the NK clusters of bilaterians(5). It has been proposed that Hox and ParaHox genes originated from NK cluster genes after divergence of sponges from the lineage leading to cnidarians and bilaterians(5,7). On the other hand, synteny analysis lends support to the notion that the absence of Hox and ParaHox genes in Amphimedon is a result of secondary loss (the ghost locus hypothesis)(8). Here we analysed complete suites of ANTP-class homeoboxes in two calcareous sponges, Sycon ciliatum and Leucosolenia complicata. Our phylogenetic analyses demonstrate that these calcisponges possess orthologues of bilaterian NK genes (Hex, Hmx and Msx), a varying number of additional NK genes and one ParaHox gene, Cdx. Despite the generation of scaffolds spanning multiple genes, we find no evidence of clustering of Sycon NK genes. All Sycon ANTP-class genes are developmentally expressed, with patterns suggesting their involvement in cell type specification in embryos and adults, metamorphosis and body plan patterning. These results demonstrate that ParaHox genes predate the origin of sponges, thus confirming the ghost locus hypothesis(8), and highlight the need to analyse the genomes of multiple sponge lineages to obtain a complete picture of the ancestral composition of the first animal genome.	[Fortunato, Sofia A. V.; Adamski, Marcin; Leininger, Sven; Liu, Jing; Adamska, Maja] Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; [Fortunato, Sofia A. V.] Univ Bergen, Dept Biol, N-5008 Bergen, Norway; [Ramos, Olivia Mendivil; Ferrier, David E. K.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland	University of Bergen; University of Bergen; University of St Andrews	Adamska, M (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	maja.adamska@sars.uib.no	Ferrier, David E.K./D-7595-2013; Adamska, Maja/L-3306-2015	Ferrier, David E.K./0000-0003-3247-6233; Adamska, Maja/0000-0002-4223-8450	Sars Centre core budget; Norwegian Research Council; BBSRC; School of Biology, University of St Andrews	Sars Centre core budget; Norwegian Research Council(Research Council of NorwayEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Biology, University of St Andrews	This study was funded by the Sars Centre core budget to M. Adamska. Sequencing was performed at the Norwegian High Throughput Sequencing Centre funded by the Norwegian Research Council. O.M.R. and D. E. K. F. acknowledge support from the BBSRC and the School of Biology, University of St Andrews. We thank B. Bergum for collecting samples in the 2011 season and R. Holdhus from the Genomics Core Facility at the University of Bergen for help with DNA shearing.	AMANO S, 1993, INVERTEBR REPROD DEV, V24, P13, DOI 10.1080/07924259.1993.9672327; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Fahey B, 2008, BIOL BULL-US, V214, P205, DOI 10.2307/25470664; Ferrier DEK, 2010, ADV EXP MED BIOL, V689, P91; Fortunato S, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-14; Fortunato SAV, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-23; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hui JHL, 2008, EVOL DEV, V10, P725, DOI 10.1111/j.1525-142X.2008.00286.x; Hui JHL, 2012, MOL BIOL EVOL, V29, P157, DOI 10.1093/molbev/msr175; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Leininger S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4905; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Peterson KJ, 2007, EVOL DEV, V9, P405, DOI 10.1111/j.1525-142X.2007.00179.x; Ramos OM, 2012, CURR BIOL, V22, P1951, DOI 10.1016/j.cub.2012.08.023; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Takatori N, 2008, DEV GENES EVOL, V218, P579, DOI 10.1007/s00427-008-0245-9; Voigt C., BMC EVOL BI IN PRESS; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	30	70	71	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					620	+		10.1038/nature13881	http://dx.doi.org/10.1038/nature13881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355364	Green Accepted			2022-12-28	WOS:000343801500047
J	Libby, E; Ratcliff, WC				Libby, Eric; Ratcliff, William C.			Ratcheting the evolution of multicellularity	SCIENCE			English	Editorial Material							INDIVIDUALITY; TRANSITION		[Libby, Eric] Santa Fe Inst, Santa Fe, NM 87501 USA; [Ratcliff, William C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	The Santa Fe Institute; University System of Georgia; Georgia Institute of Technology	Libby, E (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	elibby@santafe.edu						CRESPI BJ, 1995, BEHAV ECOL, V6, P109, DOI 10.1093/beheco/6.1.109; Folse HJ, 2010, Q REV BIOL, V85, P447, DOI 10.1086/656905; Godfrey-Smith Peter, 2009, DARWINIAN POPULATION; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; KARAKASHIAN STEPHEN J., 1963, PHYSIOL ZOOL, V36, P52; Libby E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003803; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Michod RE, 2007, P NATL ACAD SCI USA, V104, P8613, DOI 10.1073/pnas.0701489104; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Rainey PB, 2010, BIOESSAYS, V32, P872, DOI 10.1002/bies.201000039; Ratcliff WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3742; Ratcliff WC, 2012, P NATL ACAD SCI USA, V109, P1595, DOI 10.1073/pnas.1115323109; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Szathmary E, 1995, MAJOR TRANSITIONS EV; Williams G. C., 1966, P307	15	32	33	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					426	427		10.1126/science.1262053	http://dx.doi.org/10.1126/science.1262053			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8KB	25342789				2022-12-28	WOS:000343822900023
J	Birkhad, K				Birkhad, Kim			Stormy outlook for long-term ecology studies	NATURE			English	Editorial Material									Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Birkhad, K (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	t.r.birkhead@sheffield.ac.uk							0	31	32	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					405	405		10.1038/514405a	http://dx.doi.org/10.1038/514405a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341754	Bronze			2022-12-28	WOS:000343775900008
J	Carter, M				Carter, Meg			MEDICINE AND THE MEDIA Online sexual health advice? Access denied	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		BBC News, 2013, BBC NEWS; British Board of Film Classification, FRAMEWORK; Smith MD, 2013, BBC	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6271	10.1136/bmj.g6271	http://dx.doi.org/10.1136/bmj.g6271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25354271				2022-12-28	WOS:000343767700005
J	Kopfer, DA; Song, C; Gruene, T; Sheldrick, GM; Zachariae, U; de Groot, BL				Koepfer, David A.; Song, Chen; Gruene, Tim; Sheldrick, George M.; Zachariae, Ulrich; de Groot, Bert L.			Ion permeation in K+ channels occurs by direct Coulomb knock-on	SCIENCE			English	Article							MOLECULAR-DYNAMICS; POTASSIUM CHANNEL; STRUCTURAL BASIS; CONDUCTION; SELECTIVITY; MECHANISM; WATER; FILTER; KCSA; INACTIVATION	Potassium channels selectively conduct K+ ions across cellular membranes with extraordinary efficiency. Their selectivity filter exhibits four binding sites with approximately equal electron density in crystal structures with high K+ concentrations, previously thought to reflect a superposition of alternating ion-and water-occupied states. Consequently, cotranslocation of ions with water has become a widely accepted ion conduction mechanism for potassium channels. By analyzing more than 1300 permeation events from molecular dynamics simulations at physiological voltages, we observed instead that permeation occurs via ion-ion contacts between neighboring K+ ions. Coulomb repulsion between adjacent ions is found to be the key to high-efficiency K+ conduction. Crystallographic data are consistent with directly neighboring K+ ions in the selectivity filter, and our model offers an intuitive explanation for the high throughput rates of K+ channels.	[Koepfer, David A.; de Groot, Bert L.] Max Planck Inst Biophys Chem, Biomol Dynam Grp, D-37077 Gottingen, Germany; [Song, Chen] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Gruene, Tim; Sheldrick, George M.] Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany; [Zachariae, Ulrich] Univ Dundee, Sch Engn Phys & Math, Dundee DD1 4HN, Scotland; [Zachariae, Ulrich] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	Max Planck Society; University of Oxford; University of Gottingen; University of Dundee; University of Dundee	Song, C (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	sc3210@gmail.com; u.zachariae@dundee.ac.uk; bgroot@gwdg.de		Gruene, Tim/0000-0002-8873-4978; Zachariae, Ulrich/0000-0003-3287-8494	International Max Planck Research School for Biology and Complex Systems; Marie Curie Intra European Fellowship within European Community; Volkswagen Stiftung; Scottish Universities' Physics Alliance; German research foundation DFG [SFB803]	International Max Planck Research School for Biology and Complex Systems; Marie Curie Intra European Fellowship within European Community; Volkswagen Stiftung(Volkswagen); Scottish Universities' Physics Alliance; German research foundation DFG(German Research Foundation (DFG))	We thank H. Sun and S. Wacker tor simulations of K<INF>v</INF>1.2, R. Sknepnek for assistance with HOOMD-blue, and H. Grubmuller, M.S.P. Sansom, P. Pohl, T. Graen, and K. Zeth for helpful discussions. Supported by the International Max Planck Research School for Biology and Complex Systems (D.A.K.), a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (C.S.), the Volkswagen Stiftung (via the Niedersachsenprofessur awarded to G.M.S.) (T.G.), the Scottish Universities' Physics Alliance (U.Z.), and the German research foundation DFG through SFB803 (B.L.d.G.).	Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Ceccarini L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049017; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Domene C, 2003, BIOPHYS J, V85, P2787, DOI 10.1016/S0006-3495(03)74702-X; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fowler PW, 2013, J CHEM THEORY COMPUT, V9, P5176, DOI 10.1021/ct4005933; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Hubschle CB, 2011, J APPL CRYSTALLOGR, V44, P1281, DOI 10.1107/S0021889811043202; HUMMER G, 1994, MOL PHYS, V81, P1155, DOI 10.1080/00268979400100771; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Kasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056342; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Miller C, 2001, NATURE, V414, P23, DOI 10.1038/35102126; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Saparov SM, 2004, P NATL ACAD SCI USA, V101, P4805, DOI 10.1073/pnas.0308309101; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; Sumikama T, 2006, J PHYS CHEM B, V110, P20671, DOI 10.1021/jp062547r; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	36	198	199	6	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					352	355		10.1126/science.1254840	http://dx.doi.org/10.1126/science.1254840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324389	Green Published			2022-12-28	WOS:000343041100045
J	Chalmers, M				Chalmers, Matthew			Medical research masterclass	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					S1	S1		10.1038/514S1a	http://dx.doi.org/10.1038/514S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25317588	Bronze			2022-12-28	WOS:000342988600001
J	Elmegreen, B				Elmegreen, Bruce			ASTROPHYSICS How tiny galaxies form stars	NATURE			English	Editorial Material							METALLICITY		IBM Corp, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Elmegreen, B (corresponding author), IBM Corp, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	bge@us.ibm.com						BERGVALL N, 1995, MON NOT R ASTRON SOC, V273, P603, DOI 10.1093/mnras/273.3.603; Elmegreen BG, 2013, NATURE, V495, P487, DOI 10.1038/nature11933; Filho ME, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322098; Hand E, 2013, NATURE, V495, P156, DOI 10.1038/495156a; Karachentsev ID, 2004, ASTRON J, V127, P2031, DOI 10.1086/382905; Kniazev AY, 2005, ASTRON J, V130, P1558, DOI 10.1086/432931; Krumholz MR, 2013, MON NOT R ASTRON SOC, V436, P2747, DOI 10.1093/mnras/stt1780; Mannucci F, 2009, MON NOT R ASTRON SOC, V398, P1915, DOI 10.1111/j.1365-2966.2009.15185.x; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; Ostriker EC, 2010, ASTROPHYS J, V721, P975, DOI 10.1088/0004-637X/721/2/975; Ott J, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/123; Peters S. P. C., 2013, PREPRINT; Shi Y, 2014, NATURE, V514, P335, DOI 10.1038/nature13820; van der Kruit PC, 2011, ANNU REV ASTRON ASTR, V49, P301, DOI 10.1146/annurev-astro-083109-153241	14	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					310	311		10.1038/514310a	http://dx.doi.org/10.1038/514310a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318519				2022-12-28	WOS:000342988600037
J	Shi, Y; Armus, L; Helou, G; Stierwalt, S; Gao, Y; Wang, JZ; Zhang, ZY; Gu, QS				Shi, Yong; Armus, Lee; Helou, George; Stierwalt, Sabrina; Gao, Yu; Wang, Junzhi; Zhang, Zhi-Yu; Gu, Qiusheng			Inefficient star formation in extremely metal poor galaxies	NATURE			English	Article							CO-TO-H-2 CONVERSION FACTOR; LOW-METALLICITY; NEARBY GALAXIES; FORMATION LAW; DUST; GAS; EMISSION; ABUNDANCES; DISKS	The first galaxies contain stars born out of gas with few or no 'metals' (that is, elements heavier than helium). The lack of metals is expected to inhibit efficient gas cooling and star formation(1,2), but this effect has yet to be observed in galaxies with an oxygen abundance (relative to hydrogen) below a tenth of that of the Sun(2-4). Extremely metal poor nearby galaxies may be our best local laboratories for studying in detail the conditions that prevailed in low metallicity galaxies at early epochs. Carbon monoxide emission is unreliable as a tracer of gas at low metallicities(5-7), and while dust has been used to trace gas in low-metallicity galaxies(5,8-10), low spatial resolution in the far-infrared has typically led to large uncertainties(9,10). Here we report spatially resolved infrared observations of two galaxies with oxygen abundances below ten per cent of the solar value, and show that stars formed very inefficiently in seven star-forming clumps in these galaxies. The efficiencies are less than a tenth of those found in normal, metal rich galaxies today, suggesting that star formation may have been very inefficient in the early Universe.	[Shi, Yong; Gu, Qiusheng] Nanjing Univ, Sch Astron & Space Sci, Nanjing 210093, Jiangsu, Peoples R China; [Shi, Yong; Gu, Qiusheng] Nanjing Univ, Minist Educ, Key Lab Modern Astron & Astrophys, Nanjing 210093, Jiangsu, Peoples R China; [Armus, Lee; Helou, George] CALTECH, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Stierwalt, Sabrina] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Gao, Yu] Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China; [Gao, Yu] Chinese Acad Sci, Key Lab Radio Astron, Nanjing 210008, Peoples R China; [Wang, Junzhi] Chinese Acad Sci, Shanghai Astron Observ, Shanghai 200030, Peoples R China; [Zhang, Zhi-Yu] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland	Nanjing University; Nanjing University; California Institute of Technology; University of Virginia; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; University of Edinburgh	Shi, Y (corresponding author), Nanjing Univ, Sch Astron & Space Sci, Nanjing 210093, Jiangsu, Peoples R China.	yshipku@gmail.com	Gao, Yu/HGE-1937-2022	gao, yu/0000-0003-0007-2197; Wang, Junzhi/0000-0001-6106-1171; Helou, George/0000-0003-3367-3415; Zhang, Zhiyu/0000-0002-7299-2876; Armus, Lee/0000-0003-3498-2973	Natural Science Foundation of China (NSFC) [11373021]; Chinese Academy of Sciences (CAS) [XDB09000000]; Nanjing University [985]; NSFC [11173059, 11390373, 11173013, 11273015, 11133001]; CAS [XDB09000000]; National 973 programme [2012CB821805, 2013CB834905]; European Research Council (ERC); Spitzer Space Telescope; NASA; NASA issued by JPL/Caltech [OT2_yshi_3]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Nanjing University(Nanjing University); NSFC(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); National 973 programme(National Basic Research Program of China); European Research Council (ERC)(European Research Council (ERC)); Spitzer Space Telescope(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA issued by JPL/Caltech	Y.S. acknowledges support for this work from the Natural Science Foundation of China (NSFC), grant 11373021, the Strategic Priority Research Program 'The Emergence of Cosmological Structures' of the Chinese Academy of Sciences (CAS), grant XDB09000000, and Nanjing University grant 985. Y.G. acknowledges support from the NSFC (grants 11173059 and 11390373) and from the CAS Program (grant XDB09000000). J.W. was supported by the National 973 programme (grant 2012CB821805) and by the NSFC (grant 11173013). Z.-Y.Z. acknowledges support from the European Research Council (ERC) in the form of advanced grant COSMICISM. Q.G. was supported by the NSFC (11273015 and 11133001) and by the National 973 programme (grant 2013CB834905). We thank F. Bigiel for making his data points available to plot contours in Fig. 3, S. P. C. Peters for making available his HI gas map of ESO 146-G14 to us, and L. Piazzo for help in Herschel data reduction. Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. This work was supported in part by the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. It was also supported in part by a NASA Herschel grant (OT2_yshi_3) issued by JPL/Caltech.	Ali B., 2011, SURFACE BRIGHTNESS C; BERGVALL N, 1995, MON NOT R ASTRON SOC, V273, P603, DOI 10.1093/mnras/273.3.603; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bigiel F, 2008, ASTRON J, V136, P2846, DOI 10.1088/0004-6256/136/6/2846; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Bolatto AD, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/12; Cormier D, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322096; Daddi E, 2010, ASTROPHYS J LETT, V714, pL118, DOI 10.1088/2041-8205/714/1/L118; Dale DA, 2009, ASTROPHYS J, V703, P517, DOI 10.1088/0004-637X/703/1/517; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Draine BT, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/172; Egami E, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014696; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Elmegreen BG, 2013, NATURE, V495, P487, DOI 10.1038/nature11933; Engelbracht CW, 2008, ASTROPHYS J, V678, P804, DOI 10.1086/529513; Fisher DB, 2014, NATURE, V505, P186, DOI 10.1038/nature12765; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Hunt LK, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322739; Hunt LK, 2010, ASTROPHYS J, V712, P164, DOI 10.1088/0004-637X/712/1/164; Kniazev AY, 2005, ASTRON J, V130, P1558, DOI 10.1086/432931; Krumholz MR, 2013, MON NOT R ASTRON SOC, V436, P2747, DOI 10.1093/mnras/stt1780; Kuhlen M, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/36; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; Leroy AK, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/12; Morrissey P, 2007, ASTROPHYS J SUPPL S, V173, P682, DOI 10.1086/520512; Ostriker EC, 2010, ASTROPHYS J, V721, P975, DOI 10.1088/0004-637X/721/2/975; Ott J, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/123; Paladini R., 2013, PACKS MAP MAING TOOL; Paladini R., 2012, ASSESSMENT ANAL EXTE; Peters S. P. C., 2013, SHAPE DARKMATTER HAL; Pettini M, 2004, MON NOT R ASTRON SOC, V348, pL59, DOI 10.1111/j.1365-2966.2004.07591.x; Piazzo L, 2012, IEEE T IMAGE PROCESS, V21, P3687, DOI 10.1109/TIP.2012.2197009; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Remy-Ruyer A, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322803; Sandstrom KM, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/5; Sauvage M., 2011, EXPT PHOTOMETRIC MEA; Taylor CL, 1998, ASTRON J, V116, P2746, DOI 10.1086/300655; Traficante A, 2011, MON NOT R ASTRON SOC, V416, P2932, DOI 10.1111/j.1365-2966.2011.19244.x; Westmoquette MS, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220580; Wise JH, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/50	40	47	49	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					335	+		10.1038/nature13820	http://dx.doi.org/10.1038/nature13820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25318522	Green Submitted, Green Accepted			2022-12-28	WOS:000342988600044
J	Dzau, VJ; Pizzo, PA				Dzau, Victor J.; Pizzo, Philip A.			Relieving Pain in America Insights From an Institute of Medicine Committee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dzau, Victor J.] Inst Med, Washington, DC 20001 USA; [Pizzo, Philip A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Dzau, VJ (corresponding author), Inst Med, 500 Fifth St NW, Washington, DC 20001 USA.	vdzau@nas.edu						Fauber J., CHRONIC PAIN STAT CA; Institute of Medicine, REL PAIN AM BLUEPR T; National Academies, POL PROC COMM COMP B; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005	4	60	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1507	1508		10.1001/jama.2014.12986	http://dx.doi.org/10.1001/jama.2014.12986			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321905				2022-12-28	WOS:000342983200009
J	Eftekhari, S; Shahrokhi, A; Tsintsadze, V; Nardou, R; Brouchoud, C; Conesa, M; Burnashev, N; Ferrari, DC; Ben-Ari, Y				Eftekhari, Sanaz; Shahrokhi, Amene; Tsintsadze, Vera; Nardou, Romain; Brouchoud, Corinne; Conesa, Magali; Burnashev, Nail; Ferrari, Diana C.; Ben-Ari, Yehezkel			Response to Comment on "Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring"	SCIENCE			English	Editorial Material							ANIMAL-MODEL; MOUSE MODEL; BEHAVIORS	Bambini-Junior et al. questioned whether our treatment in two rodent models of autism has a long-lasting effect into adulthood. In response, we show that bumetanide treatment around delivery attenuates autistic behavioral features in adult offspring. Therefore, the polarity of gamma-aminobutyric acid (GABA) actions during delivery exerts long-lasting priming actions after birth.	[Eftekhari, Sanaz; Shahrokhi, Amene; Tsintsadze, Vera; Brouchoud, Corinne; Burnashev, Nail; Ben-Ari, Yehezkel] INSERM, U901, Mediterranean Inst Neurobiol INMED, F-13258 Marseille, France; [Eftekhari, Sanaz; Shahrokhi, Amene; Tsintsadze, Vera; Brouchoud, Corinne; Burnashev, Nail; Ben-Ari, Yehezkel] Aix Marseille Univ, UMR 901, Marseille, France; [Eftekhari, Sanaz; Shahrokhi, Amene; Nardou, Romain; Conesa, Magali; Ferrari, Diana C.; Ben-Ari, Yehezkel] Neurochlore, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Ben-Ari, Y (corresponding author), INSERM, U901, Mediterranean Inst Neurobiol INMED, F-13258 Marseille, France.	yehezkel.ben-ari@inserm.fr	Burnashev, Nail/G-4056-2013; Romain, Nardou/AAI-6027-2020	Ben-Ari, Yehezkel/0000-0001-6208-8480				Bambini-Junior V., 2014, SCIENCE, V343, P176; Bambini V, 2011, BRAIN RES, V1408, P8, DOI 10.1016/j.brainres.2011.06.015; Foley AG, 2012, NEUROPHARMACOLOGY, V63, P750, DOI 10.1016/j.neuropharm.2012.05.042; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190	9	27	28	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206								10.1126/science.1256009	http://dx.doi.org/10.1126/science.1256009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301611				2022-12-28	WOS:000342721500032
J	Dumont, DM; Allen, SA; Rich, JD				Dumont, Dora M.; Allen, Scott A.; Rich, Josiah D.			Sesame Street Goes to Jail: Physicians Should Follow	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH		[Dumont, Dora M.] Rhode Isl Dept Hlth, Providence, RI 02908 USA; Miriam Hosp, Providence, RI 02906 USA; Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA	Lifespan Health Rhode Island; Miriam Hospital; University of California System; University of California Riverside	Dumont, DM (corresponding author), Rhode Isl Dept Hlth, 3 Capitol Hill, Providence, RI 02908 USA.	dora.dumont@health.ri.gov	Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714	NIAID NIH HHS [P30AI042853, P30 AI042853] Funding Source: Medline; NIDA NIH HHS [K24 DA022112] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA022112] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Carson EA, 2012, PRISONERS 2011; Clear Todd R., 2007, IMPRISONING COMMUNIT; Dumont DM, 2013, J HEALTH CARE POOR U, V24, P78, DOI 10.1353/hpu.2013.0000; Mallik-Kane K, 2008, HLTH PRISONER REENTR; Marks JS, 2014, HEALTH AFFAIR, V33, P443, DOI 10.1377/hlthaff.2013.1350; National Research Council and Institute of Medicine, 2013, HLTH INC WORKSH SUMM; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; The Pew Charitable Trusts, 2010, COLL COSTS INC EFF E; Wakefield Sara., 2014, CHILDREN PRISON BOOM; Wang EA, 2011, J GEN INTERN MED, V26, P1012, DOI 10.1007/s11606-011-1723-8	10	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					522	+		10.7326/M14-0080	http://dx.doi.org/10.7326/M14-0080			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25285543	Green Accepted			2022-12-28	WOS:000343896700012
